data_2rs6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rs6 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -62.73 -46.95 85.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.612 1.165 . . . . 0.0 109.983 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -65.05 -33.85 77.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.331 1.052 . . . . 0.0 112.523 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -68.29 -45.27 73.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.988 0.813 . . . . 0.0 111.513 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.46 -43.23 97.93 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 111.234 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.36 -42.92 98.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.22 81.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.378 1.071 . . . . 0.0 112.436 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -60.75 -46.01 92.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.582 0.753 . . . . 0.0 111.462 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.99 -46.22 88.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.93 -27.32 73.35 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.4 1.0 . . . . 0.0 114.081 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.28 -8.53 57.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.402 1.101 . . . . 0.0 112.705 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -119.69 9.52 11.44 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.335 2.254 . . . . 0.0 112.503 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.08 31.1 11.29 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.597 1.959 . . . . 0.0 113.618 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 62.4 mtm -118.98 173.31 6.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.779 2.031 . . . . 0.0 111.57 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.19 132.07 12.43 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 126.248 1.819 . . . . 0.0 108.729 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.99 148.38 27.77 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.955 2.436 . . . . 0.0 110.936 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.73 115.71 23.84 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.878 1.271 . . . . 0.0 110.7 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.37 153.88 17.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.257 1.423 . . . . 0.0 111.839 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.2 129.38 15.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.761 1.624 . . . . 0.0 109.004 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.19 147.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.248 1.019 . . . . 0.0 112.291 -168.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 126.931 2.093 . . . . 0.0 110.453 176.295 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 121.057 0.456 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -135.4 142.63 45.69 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.641 1.177 . . . . 0.0 111.378 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.0 mtp -114.51 148.88 37.25 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.061 1.745 . . . . 0.0 109.19 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.0 t -139.2 145.02 38.78 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 110.922 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.3 149.4 50.05 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.445 1.898 . . . . 0.0 108.483 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.08 139.6 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.429 0.692 . . . . 0.0 111.665 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -136.35 160.1 39.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.961 2.104 . . . . 0.0 110.565 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -140.67 136.52 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.665 1.586 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.23 129.07 40.31 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.054 0.942 . . . . 0.0 111.668 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.99 1.79 67.06 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.498 1.047 . . . . 0.0 114.584 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.21 129.03 49.27 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.391 1.477 . . . . 0.0 110.145 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.32 -13.17 55.67 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -81.68 157.69 24.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.6 1.16 . . . . 0.0 113.021 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.51 120.53 23.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.839 1.256 . . . . 0.0 109.66 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.94 139.82 24.03 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.97 141.62 51.88 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.916 1.286 . . . . 0.0 112.482 -169.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.4 166.9 30.74 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.141 1.353 . . . . 0.0 113.644 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -157.36 159.91 37.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.686 1.194 . . . . 0.0 112.087 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -171.95 -171.04 0.82 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.909 1.683 . . . . 0.0 111.508 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.6 p -73.1 -8.77 57.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.098 1.759 . . . . 0.0 113.474 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.42 152.63 33.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.493 1.517 . . . . 0.0 111.751 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.61 -31.21 72.33 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -68.82 -47.66 65.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.198 0.999 . . . . 0.0 112.589 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -69.72 -30.87 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.605 0.762 . . . . 0.0 111.711 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.71 -44.73 77.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.989 -0.444 . . . . 0.0 111.421 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -61.1 -41.37 96.55 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.045 0.938 . . . . 0.0 112.105 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -64.76 -39.03 92.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.802 0.728 . . . . 0.0 111.813 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -67.77 -41.4 83.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.866 -0.521 . . . . 0.0 111.869 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.66 93.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.454 0.702 . . . . 0.0 112.11 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.31 78.17 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.604 1.162 . . . . 0.0 111.197 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -58.1 -39.53 78.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.28 -30.77 63.63 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.321 0.964 . . . . 0.0 113.514 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -75.51 -39.15 58.86 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.283 -0.886 . . . . 0.0 111.844 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.05 -38.33 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.291 -0.88 . . . . 0.0 110.605 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.15 -48.06 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.648 -0.691 . . . . 0.0 110.479 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -53.09 -40.66 64.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.216 1.371 . . . . 0.0 113.817 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.45 -22.49 66.91 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.6 t -81.92 -37.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.223 1.009 . . . . 0.0 110.948 168.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -61.41 -29.88 70.21 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.24 1.016 . . . . 0.0 112.313 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.6 pt -101.5 3.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 125.013 1.325 . . . . 0.0 114.07 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 t30 66.37 23.24 10.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.527 1.931 . . . . 0.0 114.692 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -84.86 -12.85 52.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.015 1.326 . . . . 0.0 113.014 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -139.68 142.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.396 1.878 . . . . 0.0 109.096 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.278 0.631 . . . . 0.0 111.07 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 p -55.46 -33.38 63.59 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -56.34 -22.28 29.81 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.147 1.379 . . . . 0.0 113.839 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.35 -16.32 27.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.476 1.11 . . . . 0.0 113.506 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.0 t -83.09 127.53 68.83 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.347 1.059 . . . . 0.0 111.093 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--N 1.351 0.707 0 C-N-CA 123.329 2.686 . . . . 0.0 112.436 179.62 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -44.51 82.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.189 0.996 . . . . 0.0 110.191 174.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -66.4 -30.92 71.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.428 1.091 . . . . 0.0 112.802 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.26 -43.42 77.87 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.043 0.838 . . . . 0.0 111.404 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.71 -43.94 97.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.527 0.603 . . . . 0.0 111.199 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.81 -41.69 98.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.63 77.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.599 1.16 . . . . 0.0 112.557 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -63.23 -41.54 99.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 111.916 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -63.03 -47.14 84.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.091 0.556 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.86 -28.46 73.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.305 0.955 . . . . 0.0 113.681 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -79.23 -17.53 54.61 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.312 1.056 . . . . 0.0 112.751 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -99.01 7.64 45.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.597 2.359 . . . . 0.0 112.957 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 66.25 28.72 9.9 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.728 2.011 . . . . 0.0 113.85 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.0 mtm -114.52 172.87 6.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.157 2.183 . . . . 0.0 111.519 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -140.52 131.76 13.99 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.972 1.709 . . . . 0.0 108.955 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.2 143.75 22.76 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.5 117.13 29.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.805 1.242 . . . . 0.0 110.779 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -100.05 157.99 16.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.672 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -146.93 144.69 29.41 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 109.445 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.7 147.24 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.094 1.358 . . . . 0.0 111.188 -169.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.472 0.668 0 C-N-CA 126.641 1.977 . . . . 0.0 110.117 175.539 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.34 0.591 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -132.34 132.33 42.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.778 1.231 . . . . 0.0 109.917 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtp -102.62 151.76 21.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.93 1.692 . . . . 0.0 109.092 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.2 t -144.1 147.28 33.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.956 0.902 . . . . 0.0 111.764 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -126.7 145.68 50.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.858 2.063 . . . . 0.0 108.542 175.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.15 140.41 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.88 0.872 . . . . 0.0 111.77 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -137.03 159.92 40.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.821 2.048 . . . . 0.0 110.883 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.23 134.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 108.411 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.61 129.49 41.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.028 0.931 . . . . 0.0 111.669 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 1.84 65.22 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.596 1.093 . . . . 0.0 114.669 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -122.08 134.11 54.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.29 1.436 . . . . 0.0 110.464 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -80.97 -12.13 59.44 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -91.19 159.23 16.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.045 1.338 . . . . 0.0 113.191 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.76 121.12 22.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.876 1.271 . . . . 0.0 109.684 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.7 141.28 23.44 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.1 mtm -138.9 142.35 38.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.777 0.831 . . . . 0.0 112.305 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 174.97 32.83 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 124.933 1.254 . . . . 0.0 113.624 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.03 161.5 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.244 1.018 . . . . 0.0 112.285 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -167.03 -171.0 1.66 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.082 1.353 . . . . 0.0 112.137 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -81.52 -6.81 59.34 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.56 1.944 . . . . 0.0 113.606 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -152.01 159.25 43.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.997 1.719 . . . . 0.0 111.655 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -67.03 -29.45 69.26 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.83 -45.64 50.01 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.153 -0.967 . . . . 0.0 112.3 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.47 -29.72 67.45 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.666 -0.646 . . . . 0.0 112.345 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.03 -45.48 77.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.699 -0.626 . . . . 0.0 111.771 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -62.04 -38.26 88.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.584 0.753 . . . . 0.0 112.001 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 m -63.26 -38.13 89.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.617 0.644 . . . . 0.0 112.106 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.5 -35.73 60.73 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.332 0.653 . . . . 0.0 111.716 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.76 -45.65 88.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 111.789 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.57 -47.58 85.55 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.212 1.005 . . . . 0.0 111.439 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -56.99 -38.05 72.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.132 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.2 -27.93 57.07 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -76.99 -37.93 54.17 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.241 -0.912 . . . . 0.0 111.695 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.04 -41.39 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.49 -0.756 . . . . 0.0 110.473 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.26 -49.78 73.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.726 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -52.57 -41.92 64.01 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.404 1.456 . . . . 0.0 113.696 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.05 -22.17 66.82 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 174.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.46 -36.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.407 1.083 . . . . 0.0 110.935 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -60.66 -29.91 69.57 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.57 1.148 . . . . 0.0 112.316 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.1 pt -103.8 4.62 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.074 1.349 . . . . 0.0 113.986 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.2 m120 66.86 19.1 10.69 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.521 1.928 . . . . 0.0 114.934 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -81.15 -12.28 59.26 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.46 . . . . 0.0 113.238 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.33 142.49 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 108.944 170.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -93.44 129.16 39.71 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.417 1.087 . . . . 0.0 109.843 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 p -60.0 -27.37 66.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.91 -1.119 . . . . 0.0 113.718 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.29 -19.74 62.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.313 1.045 . . . . 0.0 113.351 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -86.01 -17.45 35.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.359 1.064 . . . . 0.0 113.159 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.82 127.31 77.97 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.34 1.056 . . . . 0.0 110.406 -169.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 C--N 1.352 0.747 0 C-N-CA 123.122 2.548 . . . . 0.0 111.268 -178.413 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -67.81 -40.81 83.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.183 0.993 . . . . 0.0 110.601 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -67.89 -33.79 75.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.315 1.046 . . . . 0.0 112.703 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.72 -41.43 83.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.91 0.777 . . . . 0.0 111.97 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.24 -44.39 96.68 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.75 0.705 . . . . 0.0 111.285 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.3 -42.56 99.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.34 0.656 . . . . 0.0 112.76 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.46 -40.77 80.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.548 1.139 . . . . 0.0 112.45 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.31 -45.41 93.47 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.11 0.964 . . . . 0.0 111.448 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -58.15 -45.71 86.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.474 0.71 . . . . 0.0 111.652 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.07 -26.86 73.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.504 1.049 . . . . 0.0 114.102 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -78.1 -8.25 58.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.598 1.199 . . . . 0.0 112.853 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.115 2.166 . . . . 0.0 112.769 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 64.41 30.5 13.13 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.39 1.876 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.5 mtm -117.66 174.08 6.37 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.731 2.012 . . . . 0.0 111.415 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -143.53 133.31 11.83 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.825 1.65 . . . . 0.0 108.791 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.66 153.75 34.33 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.961 2.441 . . . . 0.0 110.97 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.22 116.17 20.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.71 157.31 16.78 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 112.225 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.62 148.49 34.39 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.07 1.748 . . . . 0.0 109.692 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.14 146.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.021 1.328 . . . . 0.0 111.89 -168.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 126.699 2.0 . . . . 0.0 110.196 175.151 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.174 0.511 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -135.2 141.82 45.92 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.85 1.26 . . . . 0.0 111.251 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 mtp -113.21 153.48 28.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.171 1.789 . . . . 0.0 109.249 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -146.58 146.49 30.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.011 0.924 . . . . 0.0 111.587 -177.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -128.04 149.23 50.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.947 1.699 . . . . 0.0 109.322 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.2 143.57 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.211 1.004 . . . . 0.0 111.966 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -137.03 165.63 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.512 1.925 . . . . 0.0 110.62 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.51 138.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.886 1.674 . . . . 0.0 108.158 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.51 128.42 37.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.938 0.895 . . . . 0.0 111.707 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 0.69 65.12 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.666 1.127 . . . . 0.0 114.765 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -122.96 129.76 51.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.202 1.401 . . . . 0.0 110.577 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.81 -20.88 45.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -70.82 157.95 37.21 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.643 1.177 . . . . 0.0 113.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.9 116.56 15.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.878 1.271 . . . . 0.0 109.591 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.29 143.52 22.91 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 mtt -137.89 144.29 41.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 112.953 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.68 169.45 27.85 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.851 1.691 . . . . 0.0 113.36 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -158.07 152.07 24.09 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.33 1.052 . . . . 0.0 112.186 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.6 t -169.08 -175.09 2.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.924 1.289 . . . . 0.0 112.264 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.7 p -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.717 1.607 . . . . 0.0 113.402 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -142.16 145.5 34.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.535 1.534 . . . . 0.0 111.44 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.33 -30.94 70.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 113.492 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.51 -46.18 70.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.651 1.18 . . . . 0.0 111.891 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -77.04 -27.89 54.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.553 0.741 . . . . 0.0 111.945 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.27 87.52 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.582 -0.699 . . . . 0.0 111.581 170.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.12 -38.75 90.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.688 0.795 . . . . 0.0 112.033 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.1 m -65.03 -36.31 83.95 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.656 -0.652 . . . . 0.0 112.255 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.33 -36.95 68.98 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.458 -0.776 . . . . 0.0 111.967 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.66 97.86 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.576 -0.703 . . . . 0.0 111.536 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.96 77.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.306 1.042 . . . . 0.0 111.618 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -52.09 -44.43 64.38 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.625 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.75 -35.16 70.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.95 0.9 . . . . 0.0 113.118 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.91 -37.6 62.02 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.686 -0.633 . . . . 0.0 112.291 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.88 -40.89 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.79 -31.68 71.91 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.64 -44.62 81.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.0 -1.687 . . . . 0.0 111.993 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.46 -33.2 73.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.647 0.658 . . . . 0.0 112.748 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.26 -44.46 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.026 0.93 . . . . 0.0 111.336 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -63.05 -22.5 66.9 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 pt -104.56 6.49 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.77 1.228 . . . . 0.0 113.983 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 67.51 21.29 9.59 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.446 1.899 . . . . 0.0 114.63 174.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -90.36 -5.72 55.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 113.195 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -136.11 136.88 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 127.034 2.133 . . . . 0.0 107.781 168.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.51 126.69 33.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.56 -32.49 63.04 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.336 -0.852 . . . . 0.0 113.246 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.92 -19.55 60.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.087 1.355 . . . . 0.0 113.561 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.76 -16.08 29.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.614 1.166 . . . . 0.0 113.322 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.19 124.11 85.88 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.238 1.015 . . . . 0.0 110.978 -169.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 C--N 1.35 0.649 0 C-N-CA 123.492 2.795 . . . . 0.0 111.844 178.869 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.18 -38.46 82.07 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.466 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -71.92 -30.38 65.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.017 0.927 . . . . 0.0 112.84 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -66.99 -43.78 82.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.842 0.857 . . . . 0.0 111.792 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 tp -62.79 -42.89 99.9 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.415 0.552 . . . . 0.0 111.25 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -63.33 -42.73 98.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.67 80.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.436 1.094 . . . . 0.0 112.453 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.98 -45.71 93.71 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 111.457 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.2 m -58.04 -46.27 85.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.588 0.755 . . . . 0.0 111.648 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.08 -26.9 73.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.47 1.033 . . . . 0.0 114.065 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.74 -8.36 57.86 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.413 1.107 . . . . 0.0 112.706 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.7 8.69 11.24 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.277 2.231 . . . . 0.0 112.687 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.4 30.93 12.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.556 1.943 . . . . 0.0 113.568 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtm -117.83 173.6 6.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.819 2.048 . . . . 0.0 111.425 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 m -143.05 132.46 11.78 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.054 1.742 . . . . 0.0 108.983 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 152.97 30.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.134 2.556 . . . . 0.0 110.986 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.12 117.47 21.67 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.88 156.31 17.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.462 1.505 . . . . 0.0 112.498 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.45 145.7 32.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.397 1.879 . . . . 0.0 109.262 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -133.17 148.41 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.187 1.395 . . . . 0.0 110.83 -169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 125.854 1.661 . . . . 0.0 110.653 -178.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.4 mttt . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.002 0.429 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.06 127.03 29.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.914 1.286 . . . . 0.0 111.075 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtp -91.25 154.87 18.98 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.427 1.491 . . . . 0.0 109.307 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.3 t -143.77 147.69 34.52 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.191 0.996 . . . . 0.0 111.212 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -132.84 141.37 48.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.588 1.955 . . . . 0.0 108.131 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.14 144.03 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.928 0.891 . . . . 0.0 112.1 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -137.82 166.51 23.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.123 1.769 . . . . 0.0 111.165 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.3 139.01 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.255 1.822 . . . . 0.0 107.764 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.54 127.67 33.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 111.834 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.89 -0.71 64.82 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.718 1.151 . . . . 0.0 114.96 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -117.46 126.95 53.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.846 1.323 . . . . 0.0 110.859 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -72.76 -23.37 60.81 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.183 0.993 . . . . 0.0 113.455 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -69.1 158.08 35.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.036 1.334 . . . . 0.0 113.697 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.57 119.58 17.52 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.252 1.421 . . . . 0.0 110.246 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.07 21.66 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtt -137.86 142.14 40.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.916 0.887 . . . . 0.0 112.823 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.42 170.1 26.84 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.737 1.637 . . . . 0.0 113.272 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -157.75 149.76 22.18 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.657 1.183 . . . . 0.0 111.216 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -166.42 -175.64 3.3 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.876 1.27 . . . . 0.0 112.54 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.6 p -75.61 -9.96 59.03 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.568 1.547 . . . . 0.0 113.317 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.44 150.57 30.58 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.452 1.501 . . . . 0.0 111.845 -170.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.05 -34.17 77.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.236 1.014 . . . . 0.0 113.649 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -64.55 -49.07 72.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.727 1.211 . . . . 0.0 111.983 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.24 -27.2 56.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.013 0.925 . . . . 0.0 112.153 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.35 84.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.527 -0.733 . . . . 0.0 111.719 171.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.2 -40.31 89.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.165 0.586 . . . . 0.0 111.72 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.7 m -64.88 -36.59 84.86 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.818 -0.551 . . . . 0.0 112.23 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -71.57 -38.91 70.88 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.306 -0.871 . . . . 0.0 111.824 173.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.4 98.91 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.727 0.694 . . . . 0.0 111.533 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.92 82.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.245 1.018 . . . . 0.0 111.554 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.4 tpt85 -56.15 -37.86 70.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.467 0.707 . . . . 0.0 112.441 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.4 -29.05 52.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 113.415 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.56 -37.99 55.68 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.412 -0.805 . . . . 0.0 111.664 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.42 -40.29 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.651 0.78 . . . . 0.0 110.582 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -53.32 -48.86 68.09 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 170.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -58.71 -44.76 90.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.915 -1.115 . . . . 0.0 112.816 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.79 -31.5 72.48 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -72.09 -41.29 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.866 0.867 . . . . 0.0 111.132 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -65.08 -26.53 68.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.226 1.011 . . . . 0.0 113.124 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 pt -98.66 4.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.611 1.165 . . . . 0.0 113.798 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 68.99 17.24 8.65 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.706 2.002 . . . . 0.0 114.63 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -85.17 -7.8 58.89 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.115 1.366 . . . . 0.0 113.209 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -132.58 137.45 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.998 2.119 . . . . 0.0 107.626 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -84.71 128.33 34.55 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.92 0.488 . . . . 0.0 109.919 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -55.13 -33.44 62.89 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.388 -0.82 . . . . 0.0 113.143 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.35 -19.07 61.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.946 1.298 . . . . 0.0 113.605 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -90.18 -16.84 28.7 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.508 1.123 . . . . 0.0 113.227 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.0 t -76.11 125.85 87.44 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.252 1.021 . . . . 0.0 110.496 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo . . . . . 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.571 . . . . 0.0 111.322 178.761 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -66.34 -43.37 86.29 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.801 1.24 . . . . 0.0 110.361 172.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.48 -32.0 73.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 112.854 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -69.08 -40.96 78.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.289 0.949 . . . . 0.0 111.993 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.77 -42.47 99.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -61.91 -41.93 98.49 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.36 82.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.509 1.124 . . . . 0.0 112.863 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.01 -43.79 94.58 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.83 0.852 . . . . 0.0 111.856 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.6 m -57.89 -43.88 86.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.096 0.558 . . . . 0.0 111.08 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.65 -28.64 73.81 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.561 1.076 . . . . 0.0 114.055 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -70.34 -12.91 61.9 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.637 1.218 . . . . 0.0 112.645 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -119.61 9.18 11.4 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.15 2.18 . . . . 0.0 113.257 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.39 24.03 13.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 114.044 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.97 174.04 6.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.013 2.125 . . . . 0.0 111.476 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.4 m -140.49 130.74 13.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.34 1.856 . . . . 0.0 108.528 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.36 147.63 29.25 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.003 2.469 . . . . 0.0 110.758 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.27 114.45 25.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.456 1.103 . . . . 0.0 110.641 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -95.74 153.8 17.55 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.004 1.321 . . . . 0.0 111.739 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -145.52 138.6 26.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.166 1.786 . . . . 0.0 108.556 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.08 147.45 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.423 1.089 . . . . 0.0 111.774 -168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 . . . . . 0 N--CA 1.469 0.508 0 C-N-CA 126.149 1.78 . . . . 0.0 110.44 172.919 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.93 128.87 35.41 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.346 1.058 . . . . 0.0 111.909 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtm -94.98 151.48 19.14 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.546 1.538 . . . . 0.0 108.948 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.2 t -144.68 149.56 35.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.971 0.908 . . . . 0.0 112.082 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -132.87 149.42 52.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.389 1.875 . . . . 0.0 109.044 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.36 140.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.868 0.867 . . . . 0.0 111.71 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -137.08 157.57 46.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.923 2.089 . . . . 0.0 110.546 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.9 t -140.63 136.31 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.729 1.612 . . . . 0.0 108.459 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.28 128.12 35.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.034 0.933 . . . . 0.0 111.73 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.45 2.89 65.24 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.543 1.068 . . . . 0.0 114.692 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.43 129.05 49.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.412 1.485 . . . . 0.0 110.261 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -81.5 -12.19 58.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -85.54 160.44 19.66 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.678 1.191 . . . . 0.0 113.1 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.7 117.68 16.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.84 1.256 . . . . 0.0 109.604 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.01 141.31 24.09 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.6 mtp -123.6 143.38 50.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.556 1.142 . . . . 0.0 112.747 -169.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.11 169.24 28.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.434 1.493 . . . . 0.0 113.633 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -159.88 148.98 17.68 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.934 1.294 . . . . 0.0 111.153 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.53 -176.18 3.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.769 1.228 . . . . 0.0 112.656 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 m -75.67 -19.99 58.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.15 1.38 . . . . 0.0 111.775 172.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -138.35 155.77 48.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 112.85 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -67.67 -40.82 84.45 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.365 -0.834 . . . . 0.0 112.133 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.29 -30.34 57.74 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 112.035 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -43.79 90.2 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.534 -0.729 . . . . 0.0 111.768 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -61.52 -39.48 91.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.538 0.735 . . . . 0.0 111.668 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -64.61 -35.13 80.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.996 0.817 . . . . 0.0 112.388 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.57 -38.18 67.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.28 -0.888 . . . . 0.0 112.017 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.02 97.27 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.59 -0.694 . . . . 0.0 111.563 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -47.59 83.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.576 1.15 . . . . 0.0 111.836 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -52.52 -43.21 64.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.874 0.87 . . . . 0.0 111.581 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.37 -34.26 63.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.22 -37.24 61.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.44 -0.788 . . . . 0.0 112.241 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.15 -42.47 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.342 -0.848 . . . . 0.0 110.092 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.36 -48.64 78.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.524 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -51.1 -42.65 60.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.726 1.603 . . . . 0.0 113.842 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.99 -22.27 66.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.25 -36.72 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.552 1.069 . . . . 0.0 110.903 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -60.4 -30.53 69.66 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.33 1.052 . . . . 0.0 112.112 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 pt -103.96 3.48 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.292 . . . . 0.0 114.211 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.86 23.16 11.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.509 1.924 . . . . 0.0 114.797 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -86.2 -9.75 55.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.51 1.524 . . . . 0.0 113.052 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -134.06 136.65 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 127.139 2.176 . . . . 0.0 107.433 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -86.65 137.44 32.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.319 0.509 . . . . 0.0 109.714 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 p -54.91 -32.09 60.79 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.977 -1.077 . . . . 0.0 113.094 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -53.5 -24.64 13.76 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.015 1.726 . . . . 0.0 114.177 173.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.27 -20.47 26.82 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.545 1.138 . . . . 0.0 113.104 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.1 t -80.45 129.43 69.03 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.583 1.153 . . . . 0.0 110.693 -168.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 123.06 2.507 . . . . 0.0 110.756 176.705 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 tp . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -48.26 76.99 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.302 1.041 . . . . 0.0 110.027 169.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -64.81 -29.57 70.54 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 112.685 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.81 -45.61 74.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.812 0.733 . . . . 0.0 111.476 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.63 -41.79 99.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.369 0.531 . . . . 0.0 111.153 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.01 -42.49 99.83 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -39.1 79.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.36 1.064 . . . . 0.0 112.419 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.8 t90 -61.0 -45.84 93.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.068 0.947 . . . . 0.0 111.427 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.3 m -58.22 -45.67 87.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.649 0.78 . . . . 0.0 111.711 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.67 -26.83 72.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.449 1.024 . . . . 0.0 114.051 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -78.12 -8.38 58.18 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.398 1.099 . . . . 0.0 112.744 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -119.68 9.3 11.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.377 2.271 . . . . 0.0 112.726 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.96 30.72 11.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.51 1.924 . . . . 0.0 113.623 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.8 mtm -118.33 172.36 7.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.756 2.022 . . . . 0.0 111.57 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -142.54 130.64 11.48 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.093 1.757 . . . . 0.0 108.685 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.6 149.96 27.44 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.011 2.474 . . . . 0.0 110.803 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.0 117.62 27.74 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.651 1.181 . . . . 0.0 110.68 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.26 158.03 16.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.336 1.455 . . . . 0.0 112.63 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.3 149.88 33.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.999 1.32 . . . . 0.0 110.33 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.1 mt -135.66 147.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.822 1.649 . . . . 0.0 111.149 -169.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 125.653 1.581 . . . . 0.0 111.06 176.664 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 121.289 0.566 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.28 133.88 46.81 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.239 1.416 . . . . 0.0 110.651 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 37.2 mtm -100.39 154.16 18.74 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.113 1.765 . . . . 0.0 109.211 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.6 t -147.54 148.69 31.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.376 1.07 . . . . 0.0 111.171 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.89 158.28 42.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.096 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.69 143.9 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.807 1.243 . . . . 0.0 111.611 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -139.44 158.19 44.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.436 1.895 . . . . 0.0 110.335 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.07 134.94 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.619 1.568 . . . . 0.0 108.619 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.67 130.14 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.04 0.936 . . . . 0.0 111.677 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.55 1.37 66.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.537 1.065 . . . . 0.0 114.567 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -125.14 128.84 49.03 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 110.363 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -77.25 -20.88 54.55 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -71.29 156.68 39.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.559 1.143 . . . . 0.0 113.377 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.66 116.99 15.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.035 1.334 . . . . 0.0 109.326 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.92 141.84 22.01 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 77.1 mtm -140.27 142.41 35.73 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.595 1.158 . . . . 0.0 112.232 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.26 173.92 31.3 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.264 1.411 . . . . 0.0 113.143 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -152.81 161.7 42.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.262 1.025 . . . . 0.0 111.953 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 t -167.34 -172.83 2.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.647 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.6 p -76.84 -9.57 58.77 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.544 1.538 . . . . 0.0 113.372 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.55 151.38 31.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.657 1.583 . . . . 0.0 111.779 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.34 -30.03 70.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -65.33 -54.61 26.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.708 1.203 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.84 -27.56 62.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.727 0.811 . . . . 0.0 112.171 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.41 95.08 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.814 -0.553 . . . . 0.0 111.749 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.01 -41.07 95.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.43 0.692 . . . . 0.0 112.034 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.4 m -59.03 -40.2 84.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.18 0.9 . . . . 0.0 112.34 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -72.46 -37.97 68.36 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.592 -0.692 . . . . 0.0 111.545 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.35 92.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.651 0.781 . . . . 0.0 112.282 172.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.59 -49.11 77.93 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.313 1.045 . . . . 0.0 111.593 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -58.65 -39.74 81.43 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.73 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.85 -30.78 70.25 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -77.94 -39.6 42.17 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.617 -0.677 . . . . 0.0 112.359 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.2 -38.7 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.41 -0.806 . . . . 0.0 110.798 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.82 -44.01 81.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.504 0.721 . . . . 0.0 111.578 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -60.41 -44.47 95.69 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.768 -1.207 . . . . 0.0 112.665 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.4 -34.27 75.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.065 0.848 . . . . 0.0 113.179 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.12 -42.64 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.908 0.883 . . . . 0.0 111.198 171.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -66.17 -21.36 66.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.508 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -103.38 6.75 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.939 1.296 . . . . 0.0 113.625 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m120 68.79 18.84 8.57 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.725 2.01 . . . . 0.0 114.675 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.67 -5.69 57.96 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.347 1.459 . . . . 0.0 113.322 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -136.83 139.33 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.906 2.082 . . . . 0.0 107.995 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -84.97 125.91 33.08 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.964 0.506 . . . . 0.0 110.067 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.08 -33.1 62.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.13 -19.47 61.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.909 1.284 . . . . 0.0 113.568 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -92.42 -15.64 26.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.648 1.179 . . . . 0.0 113.435 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 123.74 85.41 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.103 0.961 . . . . 0.0 111.64 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 CA--C 1.539 0.761 0 C-N-CA 123.785 2.99 . . . . 0.0 112.707 178.713 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -40.72 75.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.528 1.131 . . . . 0.0 110.542 174.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -69.38 -31.38 69.73 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.182 0.993 . . . . 0.0 112.828 170.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.18 -42.0 84.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.969 0.804 . . . . 0.0 111.947 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -62.65 -42.98 99.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.702 0.683 . . . . 0.0 111.258 173.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.87 -42.96 99.95 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.252 0.621 . . . . 0.0 112.556 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 -39.99 83.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.349 1.06 . . . . 0.0 112.667 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.37 -45.65 93.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 111.452 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.1 m -58.23 -45.45 87.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.545 0.738 . . . . 0.0 111.684 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.07 73.03 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.483 1.04 . . . . 0.0 114.034 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.46 -8.99 58.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.466 1.106 . . . . 0.0 112.838 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -119.64 9.35 11.43 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.251 2.22 . . . . 0.0 112.736 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 mttp 65.05 30.7 11.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.439 1.895 . . . . 0.0 113.568 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.7 mtm -118.6 172.38 7.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.688 1.995 . . . . 0.0 111.654 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.6 m -141.4 130.25 12.42 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 126.328 1.851 . . . . 0.0 108.581 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.62 142.13 20.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.928 2.419 . . . . 0.0 110.581 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.31 116.64 30.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.485 1.114 . . . . 0.0 110.558 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -98.23 154.9 17.46 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.098 1.359 . . . . 0.0 112.301 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.18 136.86 22.96 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.917 1.287 . . . . 0.0 110.287 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 70.0 mt -123.78 147.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.12 1.368 . . . . 0.0 110.97 -170.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 . . . . . 0 N--CA 1.47 0.528 0 C-N-CA 126.707 2.003 . . . . 0.0 110.106 -174.881 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 121.126 0.488 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -135.09 137.77 43.17 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.89 1.276 . . . . 0.0 111.6 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.6 mtp -102.67 152.19 21.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.588 1.555 . . . . 0.0 108.879 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.0 t -135.76 145.38 46.52 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.427 1.091 . . . . 0.0 110.194 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -122.46 152.23 40.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.202 1.801 . . . . 0.0 108.976 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.31 140.11 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.778 1.231 . . . . 0.0 110.894 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -140.79 153.39 45.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.945 1.698 . . . . 0.0 110.117 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.77 134.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.488 1.515 . . . . 0.0 108.88 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.79 130.01 44.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.131 0.972 . . . . 0.0 111.695 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.4 2.05 66.0 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.607 1.098 . . . . 0.0 114.627 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.83 130.85 53.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.397 1.479 . . . . 0.0 110.321 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -82.67 -14.72 54.15 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -80.93 155.75 26.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.407 1.083 . . . . 0.0 112.766 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.81 112.05 13.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.191 1.396 . . . . 0.0 108.911 170.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.16 147.19 25.76 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.5 ptm -147.19 150.29 34.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.6 173.78 30.1 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.248 1.88 . . . . 0.0 112.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -157.28 154.55 29.27 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.918 0.887 . . . . 0.0 112.753 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -168.28 -178.26 3.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.413 1.485 . . . . 0.0 111.471 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m -78.23 -2.69 39.02 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.578 1.551 . . . . 0.0 112.052 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -142.37 150.45 40.72 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.957 1.703 . . . . 0.0 111.786 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.72 -37.55 70.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.615 1.166 . . . . 0.0 113.631 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -71.54 -36.96 71.17 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.14 -0.975 . . . . 0.0 112.19 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.92 -30.92 70.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.159 0.984 . . . . 0.0 112.236 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.13 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.335 -0.853 . . . . 0.0 111.617 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -61.38 -42.2 98.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.898 0.879 . . . . 0.0 112.498 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -69.27 -32.05 70.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.542 1.065 . . . . 0.0 112.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -69.24 -40.52 77.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.476 -0.765 . . . . 0.0 111.804 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.32 99.79 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.831 0.742 . . . . 0.0 111.926 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.94 77.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.955 0.902 . . . . 0.0 111.452 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -57.84 -40.29 79.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.457 0.571 . . . . 0.0 111.968 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.15 -33.87 74.09 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.778 0.831 . . . . 0.0 113.104 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -76.11 -38.84 56.4 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.679 -0.638 . . . . 0.0 112.229 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.3 -41.45 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.451 -0.781 . . . . 0.0 110.591 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -56.75 -47.28 80.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.105 0.562 . . . . 0.0 111.588 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -56.48 -44.43 80.6 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 112.896 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.79 -31.89 72.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.375 -0.828 . . . . 0.0 113.209 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.62 -39.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.044 0.838 . . . . 0.0 111.388 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -61.38 -29.99 70.26 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.8 pt -98.32 5.1 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.9 t30 67.99 21.73 8.77 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.766 2.027 . . . . 0.0 114.576 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -89.61 -5.36 57.23 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.234 1.413 . . . . 0.0 113.118 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.1 t -138.2 144.36 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.797 2.439 . . . . 0.0 107.18 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -98.32 133.33 42.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.538 0.735 . . . . 0.0 110.336 169.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.8 p -58.2 -30.29 66.33 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.208 -0.933 . . . . 0.0 113.242 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.83 -21.91 57.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.534 1.134 . . . . 0.0 113.645 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -88.99 -17.26 29.8 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.39 1.076 . . . . 0.0 113.15 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.52 125.59 82.49 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 124.307 1.043 . . . . 0.0 110.733 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.351 0.702 0 C-N-CA 123.076 2.517 . . . . 0.0 110.288 177.736 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.52 -44.74 86.02 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.337 1.055 . . . . 0.0 110.241 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.54 -31.96 73.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.639 0.775 . . . . 0.0 112.673 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.25 -42.91 74.96 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.687 0.795 . . . . 0.0 111.71 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.52 -43.16 99.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.627 0.649 . . . . 0.0 111.231 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.45 -42.86 98.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.6 83.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.578 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -60.29 -45.57 92.89 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.296 1.038 . . . . 0.0 111.586 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.3 m -58.06 -44.01 87.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.474 0.71 . . . . 0.0 111.665 171.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.58 -26.63 72.9 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.424 1.011 . . . . 0.0 114.103 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -78.52 -6.63 55.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.629 1.215 . . . . 0.0 112.857 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -119.3 7.88 11.34 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.057 2.143 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 63.29 27.71 15.51 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.329 1.852 . . . . 0.0 113.519 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.0 mtm -110.79 174.15 6.0 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.878 2.071 . . . . 0.0 111.305 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.4 m -143.17 131.08 11.09 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.85 1.66 . . . . 0.0 108.509 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.04 146.25 25.5 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.986 2.457 . . . . 0.0 110.645 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.46 113.22 24.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.323 1.049 . . . . 0.0 110.786 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -98.55 155.19 17.4 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.538 1.535 . . . . 0.0 112.128 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.13 146.77 30.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.1 1.76 . . . . 0.0 109.866 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.82 147.73 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.306 1.442 . . . . 0.0 110.686 -169.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 . . . . . 0 N--CA 1.471 0.595 0 C-N-CA 126.73 2.012 . . . . 0.0 110.114 -176.102 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttp . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.893 0.378 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -135.11 135.3 41.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.388 1.075 . . . . 0.0 111.798 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.7 mtt -98.94 154.27 18.19 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.6 1.56 . . . . 0.0 108.881 168.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.6 t -142.48 147.39 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.162 0.985 . . . . 0.0 110.878 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -131.46 146.34 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.315 1.846 . . . . 0.0 108.828 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.26 139.79 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.324 1.05 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.16 158.98 43.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.878 1.671 . . . . 0.0 110.484 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.57 135.79 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.603 1.561 . . . . 0.0 108.678 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.05 129.44 41.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.126 0.97 . . . . 0.0 111.735 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.61 0.44 66.94 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.661 1.124 . . . . 0.0 114.694 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.58 132.44 56.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.335 1.454 . . . . 0.0 110.366 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -82.32 -12.93 57.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -171.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -90.05 155.76 18.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.913 1.285 . . . . 0.0 112.706 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.24 112.37 14.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.287 1.435 . . . . 0.0 108.759 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 149.26 30.38 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -148.98 147.39 28.53 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -168.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.34 176.42 29.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.917 1.722 . . . . 0.0 112.594 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.29 161.49 42.31 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.115 0.966 . . . . 0.0 112.076 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -168.63 -174.11 2.08 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.27 1.428 . . . . 0.0 111.836 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 p -75.31 -11.0 59.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.411 1.485 . . . . 0.0 113.347 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -150.08 151.52 33.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.409 1.483 . . . . 0.0 112.069 -169.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.57 -28.57 68.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -70.53 -50.41 37.92 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.844 0.857 . . . . 0.0 111.918 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.75 -29.65 63.5 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.572 -0.705 . . . . 0.0 112.182 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.14 89.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.671 -0.643 . . . . 0.0 111.941 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.25 -38.8 90.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.474 0.71 . . . . 0.0 112.037 172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -65.24 -36.94 85.7 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.899 -0.501 . . . . 0.0 111.82 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -73.79 -35.13 64.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.69 0.796 . . . . 0.0 111.713 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.48 93.37 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.466 -0.772 . . . . 0.0 112.125 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.38 -48.04 81.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.886 0.874 . . . . 0.0 111.543 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -53.58 -42.26 67.43 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.33 1.052 . . . . 0.0 111.932 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.05 -35.7 69.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.965 0.906 . . . . 0.0 113.223 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -75.11 -37.23 61.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.631 -0.668 . . . . 0.0 112.54 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.58 -38.36 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.352 -0.842 . . . . 0.0 110.494 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -55.83 -46.98 78.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 119.347 -0.358 . . . . 0.0 111.925 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -56.18 -46.72 79.26 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.031 -1.043 . . . . 0.0 112.969 170.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.13 -33.89 75.32 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.93 -41.99 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.983 0.913 . . . . 0.0 111.193 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -67.3 -19.97 65.55 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.356 1.062 . . . . 0.0 113.394 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -103.89 6.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.967 1.307 . . . . 0.0 113.576 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 68.0 20.38 9.13 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.843 2.057 . . . . 0.0 114.566 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.96 -6.09 57.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.039 1.336 . . . . 0.0 113.036 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.75 138.7 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.055 2.142 . . . . 0.0 107.525 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -89.4 131.34 35.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.538 0.685 . . . . 0.0 110.615 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -59.55 -33.62 71.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -62.32 -17.73 59.56 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.514 1.126 . . . . 0.0 113.471 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.94 -16.74 31.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.349 1.06 . . . . 0.0 113.227 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.12 125.97 78.23 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.367 1.067 . . . . 0.0 111.368 -168.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.351 0.695 0 C-N-CA 123.501 2.801 . . . . 0.0 111.379 175.189 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -66.61 -41.47 88.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.843 0.857 . . . . 0.0 110.468 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -63.4 -38.54 91.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.0 112.278 170.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -65.46 -44.37 87.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.601 0.76 . . . . 0.0 111.799 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.21 -43.25 98.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.449 0.568 . . . . 0.0 111.365 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.4 -42.92 98.79 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.36 -39.05 78.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 112.56 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -60.96 -45.82 93.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.219 1.008 . . . . 0.0 111.308 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.5 m -58.34 -46.07 86.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 111.722 172.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.8 -27.01 73.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.368 0.985 . . . . 0.0 114.104 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.01 -8.23 57.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.556 1.143 . . . . 0.0 112.775 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.68 8.9 11.29 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.666 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 64.91 30.43 12.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.482 1.913 . . . . 0.0 113.71 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.0 mtm -117.69 173.69 6.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.724 2.01 . . . . 0.0 111.521 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 m -143.47 132.38 11.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.828 1.651 . . . . 0.0 108.885 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.46 152.48 30.08 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.066 2.51 . . . . 0.0 110.954 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.51 116.87 22.48 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.716 1.207 . . . . 0.0 110.801 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.74 156.95 17.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.465 1.506 . . . . 0.0 112.174 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -147.2 138.46 23.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.09 1.356 . . . . 0.0 110.185 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.88 148.88 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.999 1.32 . . . . 0.0 111.746 -168.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 126.222 1.809 . . . . 0.0 110.682 175.753 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 120.906 0.384 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -134.02 124.15 25.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.866 1.267 . . . . 0.0 111.17 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 61.0 mtp -89.32 153.08 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 109.41 168.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 32.9 t -142.45 146.18 34.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.341 1.056 . . . . 0.0 111.042 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.548 1.939 . . . . 0.0 109.137 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -144.86 142.56 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.495 1.118 . . . . 0.0 111.726 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -137.49 160.27 39.59 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.056 2.142 . . . . 0.0 110.466 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.7 t -139.91 135.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.83 1.652 . . . . 0.0 108.297 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.38 129.54 42.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.002 0.921 . . . . 0.0 111.702 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.54 0.43 64.8 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.576 1.084 . . . . 0.0 114.73 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.32 129.28 52.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.205 1.402 . . . . 0.0 110.529 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.86 -22.29 50.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -71.64 156.31 39.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.665 1.186 . . . . 0.0 113.243 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.67 118.61 17.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.939 1.295 . . . . 0.0 109.573 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.1 150.4 23.83 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.4 ptm -148.75 151.65 35.21 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.52 177.98 29.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.916 1.722 . . . . 0.0 112.926 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -151.75 155.67 38.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.13 1.372 . . . . 0.0 110.691 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 t -166.99 -176.61 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.861 1.264 . . . . 0.0 112.428 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 p -76.92 -10.68 59.53 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.647 1.579 . . . . 0.0 113.292 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -150.25 151.77 33.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.273 1.429 . . . . 0.0 112.176 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.81 -27.65 68.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -71.75 -53.27 13.99 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.17 -31.65 71.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.161 0.584 . . . . 0.0 112.256 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.63 98.92 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.738 -0.601 . . . . 0.0 112.275 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -65.26 -41.32 94.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 m -60.27 -37.59 80.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.308 0.958 . . . . 0.0 112.555 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -73.71 -37.41 65.17 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.365 -0.835 . . . . 0.0 111.517 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.55 -42.93 98.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.762 0.825 . . . . 0.0 112.316 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.33 85.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.934 0.894 . . . . 0.0 111.454 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -56.87 -38.07 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.063 0.545 . . . . 0.0 112.445 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.47 -34.67 65.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.816 1.246 . . . . 0.0 112.86 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -73.38 -37.85 65.86 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.317 -0.864 . . . . 0.0 112.157 172.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.2 -35.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 121.52 -0.737 . . . . 0.0 110.973 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.24 87.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.229 0.612 . . . . 0.0 111.496 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.19 -45.15 89.6 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.897 -1.127 . . . . 0.0 112.391 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.71 -34.22 74.06 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.17 -43.55 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.758 0.823 . . . . 0.0 111.241 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -65.43 -24.99 67.33 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.1 pt -97.86 5.63 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.392 1.077 . . . . 0.0 113.671 170.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 68.06 21.64 8.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.529 1.932 . . . . 0.0 114.433 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -91.47 -5.05 54.88 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 113.195 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.2 t -137.24 137.95 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.176 2.19 . . . . 0.0 107.88 169.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.82 126.13 32.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.927 0.491 . . . . 0.0 109.898 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 p -55.3 -34.32 64.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.52 -15.35 57.65 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -91.26 -15.81 28.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.56 1.144 . . . . 0.0 113.126 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.42 123.25 86.87 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.055 0.942 . . . . 0.0 111.142 -169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 C--N 1.351 0.696 0 C-N-CA 123.504 2.803 . . . . 0.0 111.593 177.882 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.1 -42.45 84.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.011 0.925 . . . . 0.0 110.343 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -67.76 -31.11 70.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.903 0.881 . . . . 0.0 112.977 171.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -67.74 -41.84 82.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.241 0.928 . . . . 0.0 111.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.26 -43.86 96.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.661 0.664 . . . . 0.0 111.081 173.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.59 -42.56 99.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.8 79.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.547 1.139 . . . . 0.0 112.782 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.83 -46.94 87.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.901 0.881 . . . . 0.0 111.407 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 m -57.55 -44.67 85.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.916 0.887 . . . . 0.0 111.937 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.18 -26.52 72.52 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.336 0.969 . . . . 0.0 114.001 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -77.92 -7.86 57.33 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.49 1.116 . . . . 0.0 112.785 172.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -119.44 8.91 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.261 2.224 . . . . 0.0 112.797 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 63.62 28.44 15.09 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.426 1.89 . . . . 0.0 113.58 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.36 172.51 6.87 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.865 2.066 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 m -140.73 129.22 12.7 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.207 1.803 . . . . 0.0 108.609 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.57 145.88 26.69 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.056 2.504 . . . . 0.0 110.753 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.15 115.49 26.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.57 1.148 . . . . 0.0 110.681 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -99.1 156.85 16.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.448 1.499 . . . . 0.0 112.221 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.98 149.06 32.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.338 1.455 . . . . 0.0 110.097 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.4 mt -131.93 146.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.652 1.581 . . . . 0.0 110.756 -169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 . . . . . 0 N--CA 1.471 0.596 0 C-N-CA 125.56 1.544 . . . . 0.0 111.164 -171.79 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.307 0.575 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.94 130.69 39.91 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.338 1.055 . . . . 0.0 111.639 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.8 mtp -95.97 155.31 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.398 1.479 . . . . 0.0 108.822 167.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.5 t -142.27 149.77 40.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.251 1.021 . . . . 0.0 110.285 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.57 151.05 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.754 1.622 . . . . 0.0 109.861 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.78 142.23 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.687 1.195 . . . . 0.0 111.503 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -139.78 158.0 44.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.539 1.936 . . . . 0.0 110.066 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.77 135.5 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.443 1.497 . . . . 0.0 108.748 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.95 129.22 40.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 0.0 111.598 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.84 2.44 66.88 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.434 1.016 . . . . 0.0 114.482 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.95 127.28 44.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.451 1.5 . . . . 0.0 110.039 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -79.51 -11.52 59.89 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.3 155.8 29.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.506 1.122 . . . . 0.0 113.048 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.18 107.73 8.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 109.021 170.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.0 144.12 21.7 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ptm -149.11 152.84 36.85 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.01 -178.11 28.12 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.157 1.837 . . . . 0.0 112.663 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -154.9 162.58 41.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 112.877 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.5 t -168.59 -178.01 3.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.959 1.703 . . . . 0.0 111.154 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.4 m -74.63 -14.81 60.81 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.329 1.452 . . . . 0.0 112.139 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -138.97 146.83 41.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.628 1.571 . . . . 0.0 112.422 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.92 -28.22 67.31 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.24 -42.86 79.1 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.398 0.999 . . . . 0.0 112.014 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.81 -33.03 64.01 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.578 -0.701 . . . . 0.0 112.031 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.82 -46.01 89.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.825 -0.547 . . . . 0.0 111.674 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.29 -38.05 89.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.69 0.796 . . . . 0.0 112.271 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m -64.14 -38.39 90.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.729 0.695 . . . . 0.0 112.069 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -73.76 -37.19 65.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.377 0.671 . . . . 0.0 111.335 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.46 96.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.648 0.779 . . . . 0.0 112.381 170.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.36 77.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.005 0.922 . . . . 0.0 111.204 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -57.8 -40.26 79.51 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.916 0.486 . . . . 0.0 112.005 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.27 -32.37 70.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.35 -38.31 50.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.72 -0.613 . . . . 0.0 112.196 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -61.75 -41.29 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -59.87 -33.87 72.38 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 112.132 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -67.31 -44.43 79.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.054 -1.654 . . . . 0.0 112.03 169.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.94 -32.45 71.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.28 -44.7 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.002 0.921 . . . . 0.0 111.367 169.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -62.73 -22.66 66.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.29 8.12 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.799 1.239 . . . . 0.0 114.086 172.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 68.46 20.73 8.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.041 1.736 . . . . 0.0 114.321 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -93.19 -6.04 48.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.35 1.46 . . . . 0.0 113.298 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.53 139.27 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.887 2.075 . . . . 0.0 107.796 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -88.95 133.14 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.865 -0.522 . . . . 0.0 110.696 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -57.12 -35.39 69.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.09 -15.21 55.91 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -89.07 -17.5 29.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.359 1.063 . . . . 0.0 113.025 174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.23 123.78 85.88 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.055 0.942 . . . . 0.0 110.462 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 C--N 1.351 0.659 0 C-N-CA 123.354 2.702 . . . . 0.0 112.581 -177.339 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.97 78.2 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.549 -0.719 . . . . 0.0 111.509 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -76.91 -29.55 55.76 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.911 0.885 . . . . 0.0 112.553 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.49 -45.35 83.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.94 -43.07 99.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.155 0.434 . . . . 0.0 111.371 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -62.55 -42.71 99.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.248 0.619 . . . . 0.0 112.628 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.34 -41.11 81.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.345 1.058 . . . . 0.0 112.449 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.83 -45.28 95.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.943 . . . . 0.0 111.66 174.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.04 -44.1 91.72 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.882 0.873 . . . . 0.0 111.877 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.55 73.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.611 1.101 . . . . 0.0 114.163 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.5 -8.08 58.16 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.467 1.134 . . . . 0.0 112.846 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -119.72 8.17 11.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.071 2.149 . . . . 0.0 112.912 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm 66.75 28.54 8.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.742 2.017 . . . . 0.0 113.617 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.9 mtm -116.71 172.15 7.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 111.627 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.3 m -142.55 130.47 11.4 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 126.185 1.794 . . . . 0.0 108.771 174.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.9 136.59 18.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.906 2.404 . . . . 0.0 110.339 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.14 114.59 27.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.499 1.12 . . . . 0.0 111.437 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.04 152.27 19.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.746 1.218 . . . . 0.0 112.867 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.54 148.34 40.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.307 1.843 . . . . 0.0 108.971 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.23 147.04 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.017 1.327 . . . . 0.0 111.653 -168.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 125.707 1.603 . . . . 0.0 110.975 176.38 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 121.052 0.454 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.19 138.09 46.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.126 1.37 . . . . 0.0 111.203 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.6 mtm -103.38 153.85 20.03 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.094 1.757 . . . . 0.0 109.386 169.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 t -144.19 146.28 32.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.385 1.074 . . . . 0.0 111.886 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.38 136.8 50.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.546 1.938 . . . . 0.0 108.827 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.16 135.78 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.215 1.006 . . . . 0.0 111.657 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.94 153.37 42.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.11 135.61 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.645 1.578 . . . . 0.0 108.546 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.08 139.3 57.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.108 0.963 . . . . 0.0 112.06 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.69 -4.07 86.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.768 1.175 . . . . 0.0 114.916 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -117.72 133.01 56.39 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.895 1.347 . . . . 0.0 111.136 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -81.55 -16.03 52.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -83.42 157.55 22.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.69 1.196 . . . . 0.0 112.393 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.43 129.14 32.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.689 1.195 . . . . 0.0 109.856 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.23 144.5 28.44 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.4 mtm -134.7 135.46 42.02 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.802 1.241 . . . . 0.0 111.486 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.24 173.41 28.26 Favored Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.984 1.278 . . . . 0.0 113.259 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -154.6 160.32 41.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.433 1.093 . . . . 0.0 111.873 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -169.04 -173.6 1.83 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.418 1.487 . . . . 0.0 111.815 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -74.09 -12.49 60.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.525 1.53 . . . . 0.0 113.436 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.67 151.74 34.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.476 1.511 . . . . 0.0 111.822 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.56 -29.63 70.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.16 -46.63 41.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.082 0.953 . . . . 0.0 112.066 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.65 -28.45 60.86 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.492 -0.755 . . . . 0.0 112.05 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.89 89.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.657 -0.652 . . . . 0.0 111.756 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.1 -40.62 94.41 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.393 0.677 . . . . 0.0 111.872 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 m -64.22 -37.38 87.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.576 0.625 . . . . 0.0 112.057 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -72.83 -36.26 67.46 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.552 -0.717 . . . . 0.0 111.598 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.72 94.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.888 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.95 82.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 111.461 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -56.9 -41.29 77.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.302 0.501 . . . . 0.0 111.794 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -28.14 66.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -80.87 -37.71 29.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.703 0.683 . . . . 0.0 112.672 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.58 -40.54 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.961 0.8 . . . . 0.0 110.534 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -55.14 -47.51 74.97 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 170.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.18 -44.07 92.17 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.112 -0.993 . . . . 0.0 112.59 173.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.38 -35.9 80.61 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.51 -42.73 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.687 0.795 . . . . 0.0 111.071 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -66.36 -13.4 60.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.8 pt -114.04 9.92 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.21 1.404 . . . . 0.0 113.252 170.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 m120 67.23 17.52 10.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.507 1.923 . . . . 0.0 114.592 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.9 -11.09 57.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.242 1.417 . . . . 0.0 113.139 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -134.35 138.07 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.546 1.938 . . . . 0.0 107.923 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.72 126.13 32.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.826 0.451 . . . . 0.0 109.929 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.17 -33.04 62.63 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.38 61.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.943 1.297 . . . . 0.0 113.579 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -91.66 -16.51 26.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.627 1.171 . . . . 0.0 113.304 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -77.5 126.07 85.2 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.213 1.005 . . . . 0.0 110.871 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 C--N 1.352 0.713 0 C-N-CA 123.299 2.666 . . . . 0.0 111.962 178.813 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.74 -43.28 84.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.167 0.987 . . . . 0.0 110.313 174.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.94 -31.82 72.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 112.821 172.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.49 -42.91 77.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.994 0.815 . . . . 0.0 111.734 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.71 -42.88 99.87 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.626 0.648 . . . . 0.0 111.234 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -63.01 -42.28 99.79 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.05 -40.22 78.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.484 1.114 . . . . 0.0 112.434 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -60.42 -45.64 92.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.952 0.901 . . . . 0.0 111.456 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.7 m -58.05 -45.43 87.05 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.648 0.779 . . . . 0.0 111.758 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.81 -26.82 73.12 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.491 1.043 . . . . 0.0 114.145 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -78.92 -7.5 58.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.545 1.173 . . . . 0.0 112.876 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.55 9.21 11.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.166 2.187 . . . . 0.0 112.709 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.98 31.45 11.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.451 1.9 . . . . 0.0 113.549 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.3 mtm -119.79 172.83 7.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.804 2.041 . . . . 0.0 111.56 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.94 131.04 11.26 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.26 1.824 . . . . 0.0 108.755 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.82 147.37 24.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.954 2.436 . . . . 0.0 110.734 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.93 117.35 27.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.648 1.179 . . . . 0.0 110.761 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.3 156.52 17.19 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.328 1.451 . . . . 0.0 112.343 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.22 149.65 33.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.102 1.361 . . . . 0.0 110.318 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -134.26 147.89 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.566 1.547 . . . . 0.0 111.867 -168.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 . . . . . 0 N--CA 1.474 0.734 0 C-N-CA 125.773 1.629 . . . . 0.0 110.792 170.947 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -135.46 131.78 36.58 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.906 1.282 . . . . 0.0 111.343 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 mtm -99.17 152.14 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.612 1.565 . . . . 0.0 108.937 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -146.06 147.71 31.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 111.515 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.88 156.19 44.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.331 1.452 . . . . 0.0 110.757 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.48 143.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.892 1.277 . . . . 0.0 111.254 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -138.08 157.68 45.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.246 1.818 . . . . 0.0 110.688 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -140.62 135.92 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.851 1.661 . . . . 0.0 108.319 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.15 129.38 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.101 0.96 . . . . 0.0 111.731 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.95 0.62 65.97 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.653 1.12 . . . . 0.0 114.715 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -119.29 131.06 55.7 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.228 1.411 . . . . 0.0 110.631 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -77.85 -24.76 48.51 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -75.11 155.93 36.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.287 1.035 . . . . 0.0 113.144 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.44 114.22 15.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.261 1.424 . . . . 0.0 108.669 169.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.49 143.89 25.11 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mtp -137.98 146.64 43.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.28 177.67 31.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.789 1.662 . . . . 0.0 112.895 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -155.67 159.2 39.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.492 1.117 . . . . 0.0 111.981 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -169.2 -179.44 3.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.134 1.374 . . . . 0.0 112.083 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 m -78.64 -13.13 59.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.395 1.478 . . . . 0.0 112.101 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.21 142.89 47.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.238 1.415 . . . . 0.0 111.628 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.98 -30.81 71.86 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -69.85 -42.25 73.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.359 -0.838 . . . . 0.0 111.543 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.72 -29.46 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.456 0.702 . . . . 0.0 112.03 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.94 90.11 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.636 -0.665 . . . . 0.0 111.817 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -62.81 -39.13 93.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.509 0.724 . . . . 0.0 111.775 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.9 m -63.19 -36.42 83.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.558 0.617 . . . . 0.0 112.27 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -75.38 -34.11 61.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 111.749 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.08 91.48 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.523 -0.735 . . . . 0.0 111.924 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.81 83.18 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.29 1.036 . . . . 0.0 111.686 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -52.48 -44.4 65.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.337 1.055 . . . . 0.0 111.647 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.63 -35.98 70.61 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -73.41 -37.33 65.95 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.406 0.548 . . . . 0.0 112.428 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.05 -43.15 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.357 -0.84 . . . . 0.0 110.169 171.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -61.73 -33.68 74.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -63.9 -45.8 87.7 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.062 -1.649 . . . . 0.0 111.882 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.89 -33.84 74.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.531 0.732 . . . . 0.0 112.735 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.01 -43.89 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.842 0.857 . . . . 0.0 111.291 170.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -63.78 -21.1 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -106.03 6.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.794 1.238 . . . . 0.0 113.959 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 70.53 16.03 7.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.829 2.052 . . . . 0.0 114.82 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.25 -6.72 58.46 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.356 1.462 . . . . 0.0 113.364 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.5 t -135.05 137.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.058 2.143 . . . . 0.0 107.473 168.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -86.47 128.37 34.95 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.994 -0.441 . . . . 0.0 110.165 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.9 p -53.52 -33.13 53.39 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.12 -20.71 62.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.702 1.601 . . . . 0.0 113.339 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -88.37 -17.84 29.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 113.091 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.38 127.13 85.37 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.329 1.052 . . . . 0.0 110.258 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.351 0.689 0 C-N-CA 123.128 2.552 . . . . 0.0 111.46 -179.531 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -60.82 -46.18 91.55 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.463 0.705 . . . . 0.0 111.162 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -64.46 -36.49 84.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.335 0.654 . . . . 0.0 112.346 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.21 -45.31 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.741 0.7 . . . . 0.0 111.87 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.92 -43.22 96.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.66 0.664 . . . . 0.0 111.246 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -63.66 -43.02 97.95 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.0 88.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.901 0.88 . . . . 0.0 112.568 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -61.55 -45.52 93.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.769 0.827 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.36 -45.93 90.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.706 0.802 . . . . 0.0 111.751 172.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.56 -27.11 73.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.419 1.009 . . . . 0.0 113.963 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.14 -8.84 58.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.389 1.094 . . . . 0.0 112.715 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.63 8.83 11.31 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.248 2.219 . . . . 0.0 112.656 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 64.95 32.58 10.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.536 1.935 . . . . 0.0 113.547 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.1 mtm -120.46 171.73 8.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.741 2.016 . . . . 0.0 111.735 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -142.71 130.53 11.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 126.192 1.797 . . . . 0.0 109.011 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 145.22 23.27 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.151 2.567 . . . . 0.0 110.903 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.34 129.52 49.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.912 1.285 . . . . 0.0 111.046 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -114.72 160.1 19.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.997 1.319 . . . . 0.0 113.484 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.6 144.21 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.162 1.785 . . . . 0.0 109.075 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -130.03 144.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.596 1.558 . . . . 0.0 109.649 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.7 ttm105 . . . . . 0 N--CA 1.47 0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 111.458 -172.578 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.127 0.489 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.89 125.3 28.02 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.93 1.292 . . . . 0.0 111.126 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.1 mtp -89.47 155.35 19.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.055 1.342 . . . . 0.0 108.951 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.6 t -143.43 147.82 35.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.956 0.903 . . . . 0.0 111.536 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -129.12 145.12 51.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.302 1.841 . . . . 0.0 108.884 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.53 142.78 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.655 1.182 . . . . 0.0 111.439 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -137.88 157.15 47.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.656 1.982 . . . . 0.0 110.67 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.64 135.36 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.079 1.752 . . . . 0.0 108.282 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.82 129.6 42.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.146 0.978 . . . . 0.0 111.766 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 0.9 65.42 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.588 1.089 . . . . 0.0 114.762 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.23 132.09 54.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.65 -14.87 50.86 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.74 155.84 25.29 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.657 1.183 . . . . 0.0 112.675 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.26 120.14 25.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.847 1.259 . . . . 0.0 109.284 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 140.87 24.76 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.0 mtt -135.17 142.53 46.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.42 172.07 27.09 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 125.782 1.658 . . . . 0.0 113.35 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -158.32 149.69 21.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.776 1.23 . . . . 0.0 111.392 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.57 179.84 4.7 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.796 1.238 . . . . 0.0 112.703 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.5 p -78.51 -8.84 58.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.88 1.672 . . . . 0.0 112.999 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -137.87 142.75 40.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.661 1.584 . . . . 0.0 111.373 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.39 -42.34 95.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 113.231 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -66.96 -37.53 84.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.76 -29.71 58.9 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.475 -0.766 . . . . 0.0 111.834 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.1 -44.44 79.99 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.688 -0.632 . . . . 0.0 111.413 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.56 -39.07 86.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 112.031 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 m -67.25 -34.58 77.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.805 0.73 . . . . 0.0 112.413 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -71.72 -38.52 70.48 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.531 -0.731 . . . . 0.0 111.72 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.59 92.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.587 0.631 . . . . 0.0 111.644 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.23 82.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.346 1.058 . . . . 0.0 111.544 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -58.35 -39.48 79.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.202 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.35 -29.52 62.7 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.197 0.908 . . . . 0.0 113.2 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.38 -39.71 62.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.443 -0.786 . . . . 0.0 111.863 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.45 -40.93 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.49 -0.756 . . . . 0.0 110.761 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.44 -50.62 71.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.739 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.35 -41.41 63.02 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.086 1.312 . . . . 0.0 113.731 172.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.36 -22.52 66.98 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.7 -38.12 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.507 1.049 . . . . 0.0 110.726 168.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -59.74 -29.54 68.22 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.974 0.91 . . . . 0.0 112.35 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.63 4.93 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.047 1.339 . . . . 0.0 114.339 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 69.73 16.29 7.92 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.699 2.0 . . . . 0.0 115.162 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -83.91 -8.98 59.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.35 1.46 . . . . 0.0 113.392 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.96 141.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.792 2.037 . . . . 0.0 108.259 168.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.82 129.82 36.15 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.484 0.713 . . . . 0.0 110.218 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.6 p -55.26 -32.61 62.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.16 -19.38 53.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.837 1.255 . . . . 0.0 113.613 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -90.51 -16.77 28.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.645 1.178 . . . . 0.0 113.41 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.8 t -79.8 126.25 80.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.399 1.079 . . . . 0.0 110.851 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 CA--C 1.537 0.647 0 C-N-CA 123.448 2.765 . . . . 0.0 112.537 -178.906 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -40.65 88.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.931 0.892 . . . . 0.0 110.587 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.94 -36.4 84.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.439 1.496 . . . . 0.0 112.258 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -70.33 -41.41 73.26 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.926 0.891 . . . . 0.0 112.106 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.2 tp -62.64 -43.48 98.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.917 0.781 . . . . 0.0 111.143 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.59 -43.75 98.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.12 0.568 . . . . 0.0 112.52 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.85 88.29 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.167 0.987 . . . . 0.0 112.779 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.85 -45.8 92.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.139 0.976 . . . . 0.0 111.525 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.3 m -58.41 -45.33 88.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.542 0.737 . . . . 0.0 111.708 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.05 -26.12 73.32 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.355 0.979 . . . . 0.0 114.159 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.18 -8.68 58.6 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.498 1.149 . . . . 0.0 112.819 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -119.72 9.53 11.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.203 2.201 . . . . 0.0 112.669 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.02 29.66 12.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.408 1.883 . . . . 0.0 113.648 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.3 mtm -116.77 172.42 7.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.708 2.003 . . . . 0.0 111.547 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 m -141.96 130.72 12.07 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.116 1.766 . . . . 0.0 108.752 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.39 146.23 24.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.988 2.459 . . . . 0.0 110.578 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.56 114.8 23.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.597 1.159 . . . . 0.0 110.806 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.13 156.95 16.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.444 1.498 . . . . 0.0 112.287 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -146.47 151.74 37.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.598 1.559 . . . . 0.0 109.805 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.42 139.87 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 0.0 111.299 -169.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 128.264 2.626 . . . . 0.0 109.662 176.65 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 C--O 1.24 0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.75 149.72 49.26 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.836 1.255 . . . . 0.0 111.842 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.2 mtp -118.66 155.05 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.688 1.995 . . . . 0.0 109.081 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.31 154.78 40.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.574 0.75 . . . . 0.0 111.271 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.12 144.85 31.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.243 1.817 . . . . 0.0 109.475 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.24 142.21 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.2 1.0 . . . . 0.0 111.821 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -136.31 160.14 39.62 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.657 1.983 . . . . 0.0 110.482 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.59 136.11 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.746 1.618 . . . . 0.0 108.435 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.45 129.57 42.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 111.674 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.24 1.38 66.88 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.612 1.101 . . . . 0.0 114.601 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -124.08 131.47 53.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.334 1.454 . . . . 0.0 110.437 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -81.87 -12.14 58.6 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -83.77 157.06 22.23 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.461 1.104 . . . . 0.0 113.228 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.35 112.87 13.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.906 1.282 . . . . 0.0 109.348 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.44 142.38 23.81 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.43 148.91 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.5 170.09 26.26 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.116 1.817 . . . . 0.0 113.594 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -155.93 150.69 26.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.573 1.149 . . . . 0.0 112.001 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -168.87 -174.62 2.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.897 1.279 . . . . 0.0 112.381 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 p -77.04 -13.19 59.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.659 1.584 . . . . 0.0 113.407 173.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -148.26 152.33 36.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 112.286 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.08 -29.02 68.68 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.78 -51.45 33.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.339 -0.851 . . . . 0.0 111.369 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.61 -28.89 64.11 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.664 -0.648 . . . . 0.0 112.675 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.2 99.34 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.503 -0.748 . . . . 0.0 111.804 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -64.23 -40.33 95.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.31 0.644 . . . . 0.0 111.899 172.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -61.39 -35.92 78.84 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.277 0.944 . . . . 0.0 112.735 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.77 -37.34 67.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.232 -0.918 . . . . 0.0 111.905 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -44.78 90.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.741 0.701 . . . . 0.0 111.625 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.86 83.98 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.46 1.104 . . . . 0.0 111.537 173.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -54.58 -43.85 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 111.682 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.11 -29.29 62.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.119 0.872 . . . . 0.0 113.348 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.39 -38.09 50.64 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.462 -0.774 . . . . 0.0 112.154 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.98 -40.58 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.271 -0.893 . . . . 0.0 110.43 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -56.52 -49.12 75.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.411 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.87 -41.84 64.69 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.384 1.447 . . . . 0.0 113.767 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.1 -22.63 67.01 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.95 -38.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.511 1.05 . . . . 0.0 110.799 168.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -59.8 -29.69 68.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.302 1.041 . . . . 0.0 112.431 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -105.5 5.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.993 1.317 . . . . 0.0 114.344 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 68.69 17.11 8.94 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.481 1.912 . . . . 0.0 115.041 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.69 -13.57 58.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.374 1.469 . . . . 0.0 113.376 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -137.87 139.69 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 108.888 171.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -85.09 133.64 34.22 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -54.89 -33.95 62.53 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.333 -0.854 . . . . 0.0 113.084 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.96 -21.81 33.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.193 1.397 . . . . 0.0 113.923 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.61 -16.55 28.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.353 1.061 . . . . 0.0 113.514 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.4 124.06 84.22 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.281 1.033 . . . . 0.0 111.098 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 C--N 1.351 0.688 0 C-N-CA 123.281 2.654 . . . . 0.0 109.79 174.635 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.2 tp . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -43.75 76.79 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.336 1.054 . . . . 0.0 109.991 174.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -65.76 -32.42 73.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.536 0.734 . . . . 0.0 112.68 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -69.47 -43.01 74.09 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.532 -0.73 . . . . 0.0 112.006 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.8 -43.69 98.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.717 0.69 . . . . 0.0 110.992 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.13 -43.16 99.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.214 0.606 . . . . 0.0 112.63 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.91 83.88 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 112.678 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -61.87 -45.21 94.75 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.951 0.9 . . . . 0.0 111.596 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.2 m -58.62 -45.05 90.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.688 0.795 . . . . 0.0 111.591 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.05 73.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.503 1.049 . . . . 0.0 114.134 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.41 -9.22 58.74 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.425 1.113 . . . . 0.0 112.744 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.327 2.251 . . . . 0.0 112.688 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 64.95 29.58 12.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.456 1.902 . . . . 0.0 113.672 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.2 mtm -116.14 172.21 7.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.799 2.04 . . . . 0.0 111.443 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.5 m -143.04 130.54 10.96 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 126.062 1.745 . . . . 0.0 109.03 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.8 144.19 24.32 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.965 2.443 . . . . 0.0 110.68 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.85 119.72 34.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.861 1.264 . . . . 0.0 110.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.83 157.68 16.92 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.147 1.379 . . . . 0.0 112.783 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.23 146.07 30.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.865 1.666 . . . . 0.0 109.557 172.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.88 146.78 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.112 1.365 . . . . 0.0 110.983 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 126.772 2.029 . . . . 0.0 110.255 177.538 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.057 0.456 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.0 145.4 48.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.878 1.271 . . . . 0.0 111.497 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.1 mtp -116.97 154.84 30.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.229 1.812 . . . . 0.0 109.583 171.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.6 t -145.12 146.53 31.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.335 1.054 . . . . 0.0 111.722 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -125.7 146.96 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.402 1.881 . . . . 0.0 109.187 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.0 142.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.278 1.031 . . . . 0.0 111.669 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.97 159.29 42.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.409 1.883 . . . . 0.0 110.701 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.25 135.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.953 1.701 . . . . 0.0 108.209 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.66 130.02 44.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.082 0.953 . . . . 0.0 111.784 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.1 0.29 65.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.612 1.101 . . . . 0.0 114.822 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -120.72 135.35 55.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.235 1.414 . . . . 0.0 110.845 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -83.2 -11.69 57.61 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -82.98 159.66 22.18 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.762 1.225 . . . . 0.0 113.02 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.02 119.28 17.73 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.861 1.264 . . . . 0.0 109.504 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 139.29 22.21 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 84.3 mtp -129.36 140.43 51.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.954 0.902 . . . . 0.0 112.577 -170.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.14 165.89 28.97 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.132 1.348 . . . . 0.0 113.686 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.69 153.68 25.14 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.61 1.164 . . . . 0.0 112.581 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.6 t -169.59 -169.97 0.99 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.536 1.534 . . . . 0.0 111.541 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -73.47 -12.03 60.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.71 1.604 . . . . 0.0 113.613 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.64 157.36 42.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.291 1.436 . . . . 0.0 112.443 -170.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.62 -30.8 71.57 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.9 -49.25 47.95 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.39 -0.818 . . . . 0.0 111.888 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -68.37 -30.71 69.71 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.101 0.56 . . . . 0.0 112.311 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.66 86.17 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.19 -0.943 . . . . 0.0 111.612 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.71 -40.09 91.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.792 0.837 . . . . 0.0 112.727 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 99.3 p -69.65 -31.64 69.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.705 1.139 . . . . 0.0 112.371 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -69.04 -41.16 78.03 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.792 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.3 93.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.549 0.613 . . . . 0.0 111.714 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.91 79.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.237 1.015 . . . . 0.0 111.768 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -56.65 -40.4 75.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.669 -0.681 . . . . 0.0 112.008 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.92 -30.48 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.408 1.004 . . . . 0.0 113.216 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -75.53 -39.07 58.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.373 -0.829 . . . . 0.0 112.005 171.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.83 -42.37 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.496 -0.752 . . . . 0.0 110.407 172.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -57.51 -48.31 79.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.865 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -52.95 -42.67 65.68 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.517 1.508 . . . . 0.0 113.39 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.83 -21.23 66.46 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.171 -0.956 . . . . 0.0 113.537 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -81.5 -38.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.604 1.162 . . . . 0.0 110.873 168.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -59.1 -30.67 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.326 1.05 . . . . 0.0 112.143 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.4 pt -106.84 5.55 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.967 1.307 . . . . 0.0 114.387 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 67.17 16.98 10.32 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.504 1.922 . . . . 0.0 115.045 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -79.41 -12.78 59.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 113.264 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.6 t -132.56 134.59 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.53 1.932 . . . . 0.0 107.691 168.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -79.54 131.93 36.16 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.185 -0.322 . . . . 0.0 110.148 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.16 -34.54 63.89 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.439 -0.788 . . . . 0.0 112.883 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.25 -22.4 29.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.313 1.445 . . . . 0.0 113.909 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.05 -16.73 27.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.418 1.087 . . . . 0.0 113.312 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.91 127.65 83.34 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.236 1.014 . . . . 0.0 110.63 -169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--N 1.353 0.781 0 C-N-CA 122.739 2.293 . . . . 0.0 109.769 174.812 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -33.37 73.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.593 -0.692 . . . . 0.0 111.743 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -79.54 -28.67 41.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.981 0.912 . . . . 0.0 112.484 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -65.68 -44.56 85.84 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.987 0.915 . . . . 0.0 111.709 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.6 -42.81 98.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.317 0.508 . . . . 0.0 111.276 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.38 -42.76 99.67 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.14 77.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 112.707 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 81.6 t90 -60.84 -47.59 85.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.035 0.934 . . . . 0.0 111.316 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.73 -45.46 85.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.013 0.925 . . . . 0.0 112.021 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.1 72.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.28 0.943 . . . . 0.0 113.986 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.9 -7.25 58.64 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.506 1.122 . . . . 0.0 112.79 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -119.58 9.14 11.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.304 2.242 . . . . 0.0 112.64 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.74 31.45 11.86 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.452 1.901 . . . . 0.0 113.515 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.6 mtm -119.35 172.32 7.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.71 2.004 . . . . 0.0 111.643 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.2 m -141.97 129.36 11.49 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 126.227 1.811 . . . . 0.0 108.668 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.91 141.65 21.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.905 2.404 . . . . 0.0 110.588 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.13 117.23 30.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.602 1.161 . . . . 0.0 110.697 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.66 157.43 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.996 1.318 . . . . 0.0 112.672 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.6 149.67 33.98 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.506 1.523 . . . . 0.0 109.907 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.4 mt -132.64 145.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.632 1.573 . . . . 0.0 110.799 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 125.21 1.404 . . . . 0.0 111.45 -171.587 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -127.48 124.17 37.7 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.244 1.018 . . . . 0.0 111.883 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.4 mtp -89.49 155.16 19.48 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.756 1.222 . . . . 0.0 109.085 167.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.23 149.97 40.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.268 1.027 . . . . 0.0 110.149 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.74 153.02 51.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.528 1.531 . . . . 0.0 110.123 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.66 141.81 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.022 1.329 . . . . 0.0 111.228 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.97 153.74 49.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.072 1.749 . . . . 0.0 110.486 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -141.66 134.85 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.798 1.639 . . . . 0.0 108.557 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.59 129.68 42.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.015 0.926 . . . . 0.0 111.649 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.89 65.11 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.566 1.079 . . . . 0.0 114.742 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.22 130.88 54.73 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.182 1.393 . . . . 0.0 110.529 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -76.6 -25.75 54.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -79.21 155.45 28.6 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.338 1.055 . . . . 0.0 113.083 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.78 109.85 11.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.396 1.478 . . . . 0.0 108.603 170.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.82 149.24 26.66 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.1 ptm -151.19 151.94 32.6 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.0 179.67 25.63 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.52 2.009 . . . . 0.0 112.818 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -151.86 155.22 37.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.964 1.306 . . . . 0.0 111.455 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -168.04 -176.09 2.88 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.403 1.481 . . . . 0.0 112.149 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.1 m -79.93 -22.97 42.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.377 1.471 . . . . 0.0 111.471 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -119.6 142.96 47.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.069 1.348 . . . . 0.0 111.391 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -61.59 -30.66 70.82 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -74.32 -42.57 59.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.037 . . . . 0.0 112.541 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.49 -34.05 75.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.795 0.838 . . . . 0.0 111.693 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.74 80.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.417 0.687 . . . . 0.0 111.625 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.13 -41.14 92.02 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.623 0.769 . . . . 0.0 111.995 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.9 m -63.98 -37.69 88.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.661 0.664 . . . . 0.0 111.927 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.55 -37.07 68.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.429 -0.794 . . . . 0.0 111.955 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.41 98.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.781 0.833 . . . . 0.0 112.376 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.24 -49.04 78.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.878 0.871 . . . . 0.0 111.123 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -57.32 -38.05 73.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.2 -38.48 69.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.623 1.169 . . . . 0.0 112.885 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -72.16 -37.72 69.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.831 0.741 . . . . 0.0 112.169 174.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.49 -36.91 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.531 -0.73 . . . . 0.0 110.84 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -49.86 75.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.402 171.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -54.76 -42.94 72.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.224 -0.923 . . . . 0.0 113.086 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.02 -27.65 69.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.68 -40.41 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.294 0.952 . . . . 0.0 111.049 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -61.96 -30.94 71.26 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -96.91 4.91 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.457 1.103 . . . . 0.0 113.836 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 70.73 18.1 6.36 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.888 2.075 . . . . 0.0 114.625 173.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.74 -6.47 55.99 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.481 1.512 . . . . 0.0 113.363 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.7 t -136.68 139.26 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 127.011 2.125 . . . . 0.0 107.893 168.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.21 127.61 34.77 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.073 0.549 . . . . 0.0 110.068 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 p -54.72 -33.9 61.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.83 -19.13 59.27 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.044 1.337 . . . . 0.0 113.689 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.33 -16.43 27.5 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.543 1.137 . . . . 0.0 113.341 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.79 123.76 87.55 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.197 0.999 . . . . 0.0 111.119 -169.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 C--N 1.352 0.735 0 C-N-CA 123.492 2.795 . . . . 0.0 111.614 178.476 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -57.92 -51.51 69.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.377 1.071 . . . . 0.0 110.559 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.62 -26.94 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 112.744 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.47 -46.9 78.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.915 0.78 . . . . 0.0 111.518 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.8 tp -63.11 -41.86 99.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.138 0.426 . . . . 0.0 111.219 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -62.91 -42.35 99.76 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.56 73.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.328 1.051 . . . . 0.0 112.625 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -61.07 -46.52 90.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.893 0.877 . . . . 0.0 111.224 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.3 m -58.31 -45.91 87.12 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.657 0.783 . . . . 0.0 111.718 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.38 73.2 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.345 0.974 . . . . 0.0 114.092 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -79.56 -6.38 56.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.358 1.079 . . . . 0.0 112.915 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -119.53 9.29 11.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.301 2.24 . . . . 0.0 112.577 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.82 30.97 12.0 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.501 1.92 . . . . 0.0 113.59 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -118.93 172.53 7.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.718 2.007 . . . . 0.0 111.562 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 m -141.69 130.81 12.37 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.158 1.783 . . . . 0.0 108.557 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.16 146.68 25.55 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.967 2.445 . . . . 0.0 110.806 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.79 116.89 28.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.738 1.215 . . . . 0.0 110.576 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -99.89 157.62 16.39 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 112.372 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.39 150.36 34.52 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.318 1.447 . . . . 0.0 110.053 172.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.1 mt -138.53 145.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.228 1.411 . . . . 0.0 111.288 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 125.742 1.617 . . . . 0.0 111.046 178.199 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 120.841 0.353 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -134.8 124.08 24.57 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.2 1.4 . . . . 0.0 111.233 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.8 mtp -89.11 154.74 19.93 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.166 1.387 . . . . 0.0 109.395 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.9 t -143.84 145.05 32.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.224 1.01 . . . . 0.0 111.766 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -121.86 151.8 40.26 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.321 1.848 . . . . 0.0 109.563 170.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.74 141.2 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.994 . . . . 0.0 111.242 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -140.45 158.05 44.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.28 1.832 . . . . 0.0 110.404 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.86 135.44 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.551 1.54 . . . . 0.0 108.66 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.08 129.97 44.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 111.606 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.27 65.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.622 1.105 . . . . 0.0 114.604 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -123.86 128.36 49.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.278 1.431 . . . . 0.0 110.351 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -76.63 -22.76 53.67 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.04 155.98 39.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.583 1.153 . . . . 0.0 113.269 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.34 117.74 18.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.342 1.457 . . . . 0.0 109.232 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.39 141.66 21.48 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtt -136.06 144.04 44.99 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.79 173.0 28.86 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.83 1.681 . . . . 0.0 113.501 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -158.78 148.94 19.57 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.84 1.256 . . . . 0.0 111.337 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.4 t -168.15 178.86 4.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.725 1.21 . . . . 0.0 112.868 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 m -78.79 -8.66 58.98 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.756 1.623 . . . . 0.0 112.442 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -142.14 153.69 44.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.051 1.34 . . . . 0.0 112.229 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -67.1 -30.25 70.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -73.15 -41.99 63.32 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.169 0.895 . . . . 0.0 112.495 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.09 -29.48 61.88 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.602 -0.687 . . . . 0.0 111.858 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.66 85.88 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.548 -0.72 . . . . 0.0 111.692 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -63.38 -38.04 89.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.833 0.853 . . . . 0.0 112.252 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 m -63.2 -38.74 92.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.731 0.696 . . . . 0.0 111.565 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -69.26 -41.32 77.08 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.39 -0.819 . . . . 0.0 111.791 174.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.65 98.26 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.715 0.689 . . . . 0.0 112.055 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.95 76.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.28 1.032 . . . . 0.0 111.492 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -58.33 -37.07 74.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.971 -0.538 . . . . 0.0 112.431 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.88 -36.67 67.39 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.955 1.302 . . . . 0.0 112.835 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -70.21 -39.78 74.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.929 0.786 . . . . 0.0 111.821 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.83 -36.26 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.637 -0.664 . . . . 0.0 110.961 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -40.52 89.2 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.204 0.601 . . . . 0.0 111.347 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.62 -44.39 90.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.097 -1.002 . . . . 0.0 112.14 171.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.78 -34.91 75.2 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.49 -43.56 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.65 0.78 . . . . 0.0 111.221 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -65.16 -24.66 67.45 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.34 5.54 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.411 1.084 . . . . 0.0 113.623 171.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 71.35 17.31 5.88 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.898 2.079 . . . . 0.0 114.586 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -90.1 -5.09 56.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.203 1.401 . . . . 0.0 113.396 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.3 t -137.54 139.33 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.148 2.179 . . . . 0.0 107.826 169.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -87.13 129.18 35.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.82 0.448 . . . . 0.0 110.779 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 p -59.14 -30.15 67.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.25 -0.906 . . . . 0.0 113.357 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.54 -23.29 57.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.369 1.068 . . . . 0.0 113.417 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -90.13 -16.31 29.84 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.55 1.14 . . . . 0.0 113.482 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.06 124.42 86.01 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 124.102 0.961 . . . . 0.0 111.545 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 C--N 1.352 0.733 0 C-N-CA 123.447 2.765 . . . . 0.0 111.379 177.315 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -68.01 -40.61 82.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.827 0.851 . . . . 0.0 111.199 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.988 0.915 . . . . 0.0 112.606 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.91 -43.88 91.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.885 0.874 . . . . 0.0 111.286 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.4 tp -63.14 -42.09 99.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.485 0.584 . . . . 0.0 111.714 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -62.86 -42.5 99.78 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -38.31 77.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.486 1.114 . . . . 0.0 112.54 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -61.64 -43.32 99.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.552 1.141 . . . . 0.0 111.801 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 99.2 m -61.95 -43.23 99.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.353 1.061 . . . . 0.0 111.868 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.56 -25.23 72.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.487 1.042 . . . . 0.0 114.032 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -78.22 -7.08 56.69 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.358 1.079 . . . . 0.0 112.744 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -119.65 7.47 11.08 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.471 2.308 . . . . 0.0 112.619 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.87 28.47 14.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.416 1.886 . . . . 0.0 113.371 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.9 mtm -112.17 171.94 7.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.758 2.023 . . . . 0.0 111.583 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.5 m -140.86 129.87 12.82 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 126.324 1.85 . . . . 0.0 108.664 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.6 140.58 21.37 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.971 2.447 . . . . 0.0 110.588 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.91 118.05 32.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.582 1.153 . . . . 0.0 110.853 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -101.13 159.37 15.29 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.991 1.316 . . . . 0.0 112.954 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.09 149.23 32.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.405 1.482 . . . . 0.0 110.152 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.74 147.07 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.549 1.539 . . . . 0.0 111.54 -169.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.472 0.675 0 C-N-CA 126.56 1.944 . . . . 0.0 110.285 176.038 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.2 mttt . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.794 0.33 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -135.69 134.06 38.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.377 1.071 . . . . 0.0 112.071 -173.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.2 mtp -102.45 153.47 20.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.581 1.553 . . . . 0.0 108.938 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -148.19 149.25 31.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 111.322 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.8 159.64 40.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.092 1.357 . . . . 0.0 111.073 170.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.95 143.03 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.419 1.487 . . . . 0.0 111.0 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -137.42 155.54 49.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.05 1.74 . . . . 0.0 110.878 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.47 134.32 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.965 1.706 . . . . 0.0 108.461 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.75 128.7 37.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.115 0.966 . . . . 0.0 111.977 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.17 1.21 67.17 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.765 1.174 . . . . 0.0 115.0 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.15 140.74 45.44 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.001 1.32 . . . . 0.0 111.273 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -85.3 0.83 50.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -120.1 155.79 32.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.696 1.599 . . . . 0.0 112.898 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.96 110.3 13.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.358 1.463 . . . . 0.0 108.894 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.06 146.94 29.88 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.6 ptp -150.48 148.44 28.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.35 -179.25 27.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.36 1.934 . . . . 0.0 112.772 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -154.24 160.9 42.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 112.102 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 t -168.32 -179.65 4.07 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.37 1.468 . . . . 0.0 111.844 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.6 m -80.38 -6.56 58.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.23 1.412 . . . . 0.0 112.277 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -142.4 152.05 42.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.203 1.401 . . . . 0.0 112.224 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.48 -27.1 68.25 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.62 -52.51 17.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.773 0.829 . . . . 0.0 111.538 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.66 -27.28 64.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.762 0.825 . . . . 0.0 112.252 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.17 95.82 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.833 -0.542 . . . . 0.0 111.754 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.48 -40.01 92.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.386 0.675 . . . . 0.0 111.93 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.0 m -60.81 -37.12 80.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.407 1.003 . . . . 0.0 112.442 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -74.33 -37.28 63.6 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.278 -0.889 . . . . 0.0 111.657 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.2 99.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.632 0.773 . . . . 0.0 112.361 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.06 81.82 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.199 0.999 . . . . 0.0 111.546 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -56.59 -42.08 78.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.109 0.564 . . . . 0.0 111.819 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.05 -30.92 69.36 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -77.17 -37.41 53.78 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.628 -0.67 . . . . 0.0 112.422 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.72 -39.88 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.268 -0.895 . . . . 0.0 110.836 173.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -56.18 -46.15 79.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.122 0.569 . . . . 0.0 111.47 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.5 -43.56 89.09 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.951 -1.093 . . . . 0.0 113.062 170.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.54 -35.01 79.09 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.955 0.798 . . . . 0.0 113.059 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.62 -41.99 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.575 0.75 . . . . 0.0 111.091 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -66.89 -16.02 64.04 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.31 7.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 125.152 1.381 . . . . 0.0 113.398 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.4 t30 68.12 21.09 8.79 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.676 1.99 . . . . 0.0 114.381 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -86.0 -8.66 57.8 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.806 1.242 . . . . 0.0 113.348 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.09 139.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.167 1.787 . . . . 0.0 108.282 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -87.74 130.12 34.94 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.9 p -54.27 -33.78 59.36 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.26 -0.9 . . . . 0.0 113.131 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.38 -21.28 49.62 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.45 1.5 . . . . 0.0 113.955 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -90.19 -16.84 28.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.498 1.119 . . . . 0.0 113.308 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.79 122.75 87.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.979 0.912 . . . . 0.0 110.913 -169.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 C--N 1.352 0.732 0 C-N-CA 123.316 2.677 . . . . 0.0 111.099 178.664 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.36 -44.14 84.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.989 0.915 . . . . 0.0 110.081 170.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -65.74 -31.33 72.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.962 0.905 . . . . 0.0 112.784 172.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -66.75 -44.62 80.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.973 0.806 . . . . 0.0 111.678 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.86 -42.69 99.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.453 0.57 . . . . 0.0 111.245 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.04 -43.05 99.73 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.78 82.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.261 1.024 . . . . 0.0 112.419 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -59.89 -45.96 90.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.263 1.025 . . . . 0.0 111.514 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.8 m -58.01 -44.81 87.48 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.599 0.76 . . . . 0.0 111.778 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.88 73.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.443 1.02 . . . . 0.0 114.145 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -79.03 -7.25 57.94 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.481 1.141 . . . . 0.0 112.9 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.63 8.73 11.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.041 2.136 . . . . 0.0 112.755 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.42 31.15 12.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.406 1.883 . . . . 0.0 113.499 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -117.98 171.77 7.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.716 2.007 . . . . 0.0 111.536 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -140.44 130.71 13.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.24 1.816 . . . . 0.0 108.682 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.18 150.46 29.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.196 2.597 . . . . 0.0 110.953 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.34 115.66 24.0 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.588 1.155 . . . . 0.0 111.05 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.5 158.24 16.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.44 1.496 . . . . 0.0 112.703 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -147.22 145.15 29.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.955 1.702 . . . . 0.0 109.581 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.72 147.13 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.266 1.426 . . . . 0.0 110.849 -169.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 N--CA 1.473 0.7 0 C-N-CA 126.194 1.798 . . . . 0.0 110.777 176.026 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mttp . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 120.92 0.391 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.09 137.68 43.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.791 1.236 . . . . 0.0 111.535 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.9 mtp -106.86 155.05 20.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.173 1.789 . . . . 0.0 109.379 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.5 t -147.19 148.87 31.96 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.918 0.887 . . . . 0.0 112.047 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -129.33 151.58 49.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.396 1.879 . . . . 0.0 109.719 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.91 142.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.68 1.192 . . . . 0.0 111.62 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.73 162.25 34.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.242 1.817 . . . . 0.0 110.431 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -139.33 136.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.637 1.575 . . . . 0.0 108.521 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.68 129.29 40.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.208 1.003 . . . . 0.0 111.776 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.24 -0.17 66.01 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.63 1.109 . . . . 0.0 114.806 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.05 140.55 48.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 110.963 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.65 -0.49 50.86 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -112.83 160.37 18.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.703 1.601 . . . . 0.0 113.214 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.92 116.58 14.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.202 1.401 . . . . 0.0 109.412 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.99 149.78 25.69 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -146.64 150.49 35.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.19 175.0 33.31 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.571 1.558 . . . . 0.0 113.491 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.96 154.11 25.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 112.403 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -168.13 -173.72 2.12 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.362 . . . . 0.0 112.025 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.8 p -75.79 -10.34 59.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.5 1.52 . . . . 0.0 113.482 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -150.93 151.62 32.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.271 1.428 . . . . 0.0 111.925 -170.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.26 -30.27 70.67 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -68.25 -48.14 65.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.796 0.839 . . . . 0.0 112.045 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.47 -29.33 59.57 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.778 -0.576 . . . . 0.0 112.327 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.75 88.75 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.42 -0.8 . . . . 0.0 111.837 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -64.36 -38.17 90.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.407 0.683 . . . . 0.0 112.044 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.7 m -64.69 -35.75 82.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.787 0.721 . . . . 0.0 112.278 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -71.48 -39.99 70.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.226 -0.921 . . . . 0.0 111.709 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.93 99.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.652 0.66 . . . . 0.0 111.856 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.11 -49.44 75.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 111.559 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -56.35 -37.89 70.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.105 0.562 . . . . 0.0 112.354 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.9 -35.63 64.68 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.965 1.306 . . . . 0.0 112.737 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -72.55 -37.31 68.29 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.357 -0.839 . . . . 0.0 112.009 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.52 -37.1 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.465 -0.772 . . . . 0.0 110.87 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -40.88 89.32 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.232 0.613 . . . . 0.0 111.423 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -62.95 -45.7 91.2 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.052 -1.03 . . . . 0.0 112.488 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.7 -34.51 74.47 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.91 -42.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.69 0.796 . . . . 0.0 111.237 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -64.68 -26.03 68.2 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 pt -97.55 5.33 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.304 1.042 . . . . 0.0 113.67 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 71.02 17.37 6.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.957 2.103 . . . . 0.0 114.574 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -89.66 -5.33 57.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.248 1.419 . . . . 0.0 113.431 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.41 140.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 127.277 2.231 . . . . 0.0 107.844 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -86.86 130.61 34.4 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.88 -0.513 . . . . 0.0 110.293 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 p -53.57 -34.68 59.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.746 0.818 . . . . 0.0 112.905 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.04 -27.56 8.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.367 1.867 . . . . 0.0 114.022 175.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -93.4 -15.47 25.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.611 1.164 . . . . 0.0 113.549 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.57 123.61 87.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.139 0.976 . . . . 0.0 111.12 -169.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 C--N 1.35 0.642 0 C-N-CA 123.452 2.768 . . . . 0.0 111.305 177.951 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -37.13 82.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.531 -0.731 . . . . 0.0 111.627 177.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -78.75 -27.5 44.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.221 1.009 . . . . 0.0 112.49 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.6 -43.93 92.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 111.515 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.28 -43.53 98.61 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.464 0.575 . . . . 0.0 111.345 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -63.36 -42.56 98.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.374 0.67 . . . . 0.0 112.806 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.24 -39.31 78.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 112.451 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -61.05 -45.68 93.8 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.94 0.896 . . . . 0.0 111.342 173.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -58.06 -46.37 85.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.483 0.713 . . . . 0.0 111.669 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.93 73.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.396 0.998 . . . . 0.0 114.157 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -77.69 -8.27 57.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.476 1.11 . . . . 0.0 112.747 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -119.55 8.19 11.25 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.332 2.253 . . . . 0.0 112.769 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm 66.41 28.33 9.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.674 1.989 . . . . 0.0 113.705 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 mtm -116.05 173.45 6.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.666 1.986 . . . . 0.0 111.618 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.0 m -142.79 132.0 11.82 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 126.109 1.764 . . . . 0.0 108.696 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.35 154.58 32.05 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.04 2.494 . . . . 0.0 110.908 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.75 115.8 20.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.656 1.183 . . . . 0.0 110.564 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.23 158.37 16.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.63 1.572 . . . . 0.0 112.292 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.65 148.5 32.12 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.716 1.607 . . . . 0.0 109.927 171.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.7 mt -136.19 145.31 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.23 1.412 . . . . 0.0 111.449 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 126.485 1.914 . . . . 0.0 110.278 176.072 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.885 0.374 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.94 137.66 49.38 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.954 1.301 . . . . 0.0 111.127 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtp -108.55 153.88 22.74 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.881 1.672 . . . . 0.0 109.389 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.18 147.44 32.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.096 0.958 . . . . 0.0 111.84 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -129.29 147.02 51.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.78 2.032 . . . . 0.0 108.774 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.52 143.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.792 0.837 . . . . 0.0 112.294 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.5 mtm105 -138.69 165.26 27.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.676 1.99 . . . . 0.0 110.707 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.57 137.14 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.806 1.642 . . . . 0.0 108.209 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -58.28 129.03 40.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.021 0.928 . . . . 0.0 111.579 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 0.74 65.42 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.662 1.125 . . . . 0.0 114.618 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -124.0 129.59 51.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.295 1.438 . . . . 0.0 110.381 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -83.66 -11.99 56.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -74.25 157.32 36.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.5 1.12 . . . . 0.0 112.69 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.99 119.39 17.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 170.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.87 143.74 22.46 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.7 mtm -138.81 141.65 38.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.281 1.033 . . . . 0.0 112.12 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.72 173.25 31.75 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.035 1.302 . . . . 0.0 113.399 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -155.29 159.49 40.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.621 1.168 . . . . 0.0 112.01 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 t -170.06 -175.86 2.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.414 1.485 . . . . 0.0 112.069 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p -80.93 -7.66 59.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.675 1.59 . . . . 0.0 113.36 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -142.61 150.56 40.46 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.356 1.463 . . . . 0.0 111.8 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.82 -32.57 74.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.029 1.332 . . . . 0.0 113.795 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -71.35 -45.2 63.5 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.311 -0.868 . . . . 0.0 112.285 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.02 -26.48 61.33 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.732 0.413 . . . . 0.0 111.407 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.75 -46.3 72.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.894 0.478 . . . . 0.0 111.432 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.65 -40.4 94.8 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.436 0.694 . . . . 0.0 111.954 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.0 m -63.99 -37.23 86.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.886 0.767 . . . . 0.0 111.789 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.23 -38.12 71.97 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.562 -0.711 . . . . 0.0 111.64 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.49 93.47 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.614 -0.679 . . . . 0.0 112.191 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.75 82.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.609 1.164 . . . . 0.0 111.431 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.83 -40.99 81.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.375 0.534 . . . . 0.0 111.638 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.86 -31.08 70.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.757 0.823 . . . . 0.0 113.087 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -77.7 -40.08 42.57 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.567 -0.708 . . . . 0.0 112.414 172.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.11 -37.89 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.34 -0.85 . . . . 0.0 110.818 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -56.59 -42.86 79.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.284 0.634 . . . . 0.0 111.688 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.36 -43.32 99.1 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.859 -1.15 . . . . 0.0 112.722 170.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.49 -34.02 74.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.16 0.891 . . . . 0.0 113.038 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.49 -43.25 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.026 0.93 . . . . 0.0 111.137 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -62.49 -25.97 68.29 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.175 0.99 . . . . 0.0 113.326 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -101.1 6.01 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.619 1.168 . . . . 0.0 113.865 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 70.89 16.96 6.47 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.834 2.054 . . . . 0.0 114.669 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -88.57 -5.48 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 113.448 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.6 t -136.84 138.7 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.906 2.082 . . . . 0.0 108.155 169.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.82 125.69 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.901 0.48 . . . . 0.0 109.931 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 p -55.31 -32.79 62.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.95 -19.74 61.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.097 1.359 . . . . 0.0 113.475 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -92.0 -15.8 27.41 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.633 1.173 . . . . 0.0 113.342 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.8 124.06 83.56 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.132 0.973 . . . . 0.0 111.52 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.538 0.719 0 C-N-CA 123.803 3.002 . . . . 0.0 112.706 178.729 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.791 -0.524 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 16.2 m -67.64 -13.93 62.5 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 35.2 p -83.02 -5.07 58.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.416 1.486 . . . . 0.0 113.955 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 79.23 -132.03 11.13 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.663 1.125 . . . . 0.0 111.881 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.6 p -156.23 163.35 39.68 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.158 1.383 . . . . 0.0 111.772 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m -142.8 19.42 1.99 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.321 1.048 . . . . 0.0 112.686 -169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.47 -39.54 97.81 Favored Glycine 0 N--CA 1.47 0.902 0 O-C-N 121.178 -0.951 . . . . 0.0 114.65 -167.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp -78.01 -34.56 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.444 1.122 . . . . 0.0 112.868 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -62.73 -46.95 85.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.612 1.165 . . . . 0.0 109.983 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -65.05 -33.85 77.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.331 1.052 . . . . 0.0 112.523 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -68.29 -45.27 73.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.988 0.813 . . . . 0.0 111.513 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.46 -43.23 97.93 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 111.234 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.36 -42.92 98.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.22 81.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.378 1.071 . . . . 0.0 112.436 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -60.75 -46.01 92.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.582 0.753 . . . . 0.0 111.462 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.99 -46.22 88.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.93 -27.32 73.35 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.4 1.0 . . . . 0.0 114.081 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.28 -8.53 57.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.402 1.101 . . . . 0.0 112.705 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -119.69 9.52 11.44 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.335 2.254 . . . . 0.0 112.503 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.08 31.1 11.29 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.597 1.959 . . . . 0.0 113.618 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 62.4 mtm -118.98 173.31 6.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.779 2.031 . . . . 0.0 111.57 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.19 132.07 12.43 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 126.248 1.819 . . . . 0.0 108.729 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.99 148.38 27.77 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.955 2.436 . . . . 0.0 110.936 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.73 115.71 23.84 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.878 1.271 . . . . 0.0 110.7 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.37 153.88 17.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.257 1.423 . . . . 0.0 111.839 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.2 129.38 15.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.761 1.624 . . . . 0.0 109.004 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.19 147.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.248 1.019 . . . . 0.0 112.291 -168.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -134.07 139.85 46.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.931 2.093 . . . . 0.0 110.453 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.23 138.14 31.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.566 1.146 . . . . 0.0 110.75 172.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -145.51 165.01 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.567 1.547 . . . . 0.0 111.265 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.49 -165.84 43.05 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.025 0.822 . . . . 0.0 114.53 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.28 142.34 58.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.458 1.503 . . . . 0.0 113.066 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -60.76 -41.45 95.48 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -81.36 -32.58 32.85 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.364 1.066 . . . . 0.0 112.705 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -117.21 67.75 0.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.322 1.849 . . . . 0.0 109.889 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -74.37 152.25 39.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.7 1.2 . . . . 0.0 111.879 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -133.22 161.17 35.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.303 1.841 . . . . 0.0 110.672 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -135.4 142.63 45.69 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.641 1.177 . . . . 0.0 111.378 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.0 mtp -114.51 148.88 37.25 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.061 1.745 . . . . 0.0 109.19 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.0 t -139.2 145.02 38.78 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 110.922 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.3 149.4 50.05 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.445 1.898 . . . . 0.0 108.483 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.08 139.6 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.429 0.692 . . . . 0.0 111.665 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -136.35 160.1 39.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.961 2.104 . . . . 0.0 110.565 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -140.67 136.52 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.665 1.586 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.23 129.07 40.31 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.054 0.942 . . . . 0.0 111.668 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.99 1.79 67.06 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.498 1.047 . . . . 0.0 114.584 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.21 129.03 49.27 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.391 1.477 . . . . 0.0 110.145 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.32 -13.17 55.67 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -81.68 157.69 24.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.6 1.16 . . . . 0.0 113.021 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.51 120.53 23.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.839 1.256 . . . . 0.0 109.66 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.94 139.82 24.03 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.97 141.62 51.88 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.916 1.286 . . . . 0.0 112.482 -169.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.4 166.9 30.74 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.141 1.353 . . . . 0.0 113.644 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -157.36 159.91 37.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.686 1.194 . . . . 0.0 112.087 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -171.95 -171.04 0.82 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.909 1.683 . . . . 0.0 111.508 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.6 p -73.1 -8.77 57.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.098 1.759 . . . . 0.0 113.474 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.42 152.63 33.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.493 1.517 . . . . 0.0 111.751 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.61 -31.21 72.33 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -68.82 -47.66 65.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.198 0.999 . . . . 0.0 112.589 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -69.72 -30.87 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.605 0.762 . . . . 0.0 111.711 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.71 -44.73 77.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.989 -0.444 . . . . 0.0 111.421 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -61.1 -41.37 96.55 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.045 0.938 . . . . 0.0 112.105 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -64.76 -39.03 92.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.802 0.728 . . . . 0.0 111.813 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -67.77 -41.4 83.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.866 -0.521 . . . . 0.0 111.869 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.66 93.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.454 0.702 . . . . 0.0 112.11 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.31 78.17 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.604 1.162 . . . . 0.0 111.197 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -58.1 -39.53 78.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.28 -30.77 63.63 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.321 0.964 . . . . 0.0 113.514 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -75.51 -39.15 58.86 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.283 -0.886 . . . . 0.0 111.844 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.05 -38.33 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.291 -0.88 . . . . 0.0 110.605 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.15 -48.06 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.648 -0.691 . . . . 0.0 110.479 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -53.09 -40.66 64.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.216 1.371 . . . . 0.0 113.817 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.45 -22.49 66.91 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.6 t -81.92 -37.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.223 1.009 . . . . 0.0 110.948 168.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -61.41 -29.88 70.21 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.24 1.016 . . . . 0.0 112.313 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.6 pt -101.5 3.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 125.013 1.325 . . . . 0.0 114.07 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 t30 66.37 23.24 10.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.527 1.931 . . . . 0.0 114.692 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -84.86 -12.85 52.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.015 1.326 . . . . 0.0 113.014 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -139.68 142.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.396 1.878 . . . . 0.0 109.096 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.278 0.631 . . . . 0.0 111.07 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 p -55.46 -33.38 63.59 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -56.34 -22.28 29.81 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.147 1.379 . . . . 0.0 113.839 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.35 -16.32 27.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.476 1.11 . . . . 0.0 113.506 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.0 t -83.09 127.53 68.83 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.347 1.059 . . . . 0.0 111.093 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.36 159.61 36.26 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.329 2.686 . . . . 0.0 112.436 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.06 138.75 52.33 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.088 0.955 . . . . 0.0 111.731 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.7 p -66.71 -19.83 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 125.417 1.487 . . . . 0.0 114.852 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.03 9.43 86.68 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.617 1.103 . . . . 0.0 115.106 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.9 140.52 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.787 2.035 . . . . 0.0 109.146 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.3 m -136.46 146.56 56.3 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 125.787 1.635 . . . . 0.0 110.731 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.27 157.71 37.38 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.479 2.786 . . . . 0.0 111.959 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.86 158.39 53.0 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.613 2.875 . . . . 0.0 111.423 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.6 148.23 65.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.568 2.845 . . . . 0.0 111.538 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.9 m -75.84 -5.85 47.92 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.03 177.69 50.88 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 124.974 1.273 . . . . 0.0 113.968 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.56 149.84 73.09 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.304 3.336 . . . . 0.0 112.984 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 t -143.61 16.06 1.81 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.116 0.966 . . . . 0.0 112.716 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -84.03 -5.61 59.26 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.406 -1.434 . . . . 0.0 114.344 -173.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.47 1.509 . . . . 0.0 112.775 -179.212 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 18.9 m -84.02 -6.05 59.34 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.7 t -162.9 170.23 18.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.021 1.729 . . . . 0.0 110.948 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -159.11 171.93 35.73 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.119 1.342 . . . . 0.0 113.842 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.9 t -162.87 -167.55 1.55 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.683 1.593 . . . . 0.0 110.904 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.2 t -162.22 152.33 16.68 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.818 1.647 . . . . 0.0 110.842 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.43 -38.04 90.68 Favored Glycine 0 N--CA 1.469 0.898 0 O-C-N 121.646 -0.659 . . . . 0.0 113.884 -170.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.33 -32.91 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.478 1.139 . . . . 0.0 112.407 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -44.51 82.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.189 0.996 . . . . 0.0 110.191 174.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -66.4 -30.92 71.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.428 1.091 . . . . 0.0 112.802 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.26 -43.42 77.87 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.043 0.838 . . . . 0.0 111.404 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.71 -43.94 97.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.527 0.603 . . . . 0.0 111.199 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.81 -41.69 98.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.63 77.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.599 1.16 . . . . 0.0 112.557 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -63.23 -41.54 99.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 111.916 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -63.03 -47.14 84.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.091 0.556 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.86 -28.46 73.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.305 0.955 . . . . 0.0 113.681 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -79.23 -17.53 54.61 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.312 1.056 . . . . 0.0 112.751 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -99.01 7.64 45.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.597 2.359 . . . . 0.0 112.957 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 66.25 28.72 9.9 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.728 2.011 . . . . 0.0 113.85 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.0 mtm -114.52 172.87 6.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.157 2.183 . . . . 0.0 111.519 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -140.52 131.76 13.99 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.972 1.709 . . . . 0.0 108.955 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.2 143.75 22.76 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.5 117.13 29.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.805 1.242 . . . . 0.0 110.779 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -100.05 157.99 16.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.672 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -146.93 144.69 29.41 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 109.445 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.7 147.24 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.094 1.358 . . . . 0.0 111.188 -169.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -137.38 140.01 41.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.641 1.977 . . . . 0.0 110.117 175.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.23 141.36 28.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.778 0.831 . . . . 0.0 111.227 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.87 161.19 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.001 1.72 . . . . 0.0 111.101 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 -160.31 41.16 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.069 0.843 . . . . 0.0 114.375 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -60.18 138.99 57.8 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.502 1.521 . . . . 0.0 113.15 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -63.67 -42.11 98.09 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -78.32 -34.07 48.86 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.277 1.031 . . . . 0.0 113.022 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -117.61 75.64 1.0 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.136 1.774 . . . . 0.0 109.128 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -78.31 136.36 37.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.432 1.093 . . . . 0.0 111.403 -170.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -104.25 157.86 16.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.028 0.931 . . . . 0.0 110.757 169.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -132.34 132.33 42.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.778 1.231 . . . . 0.0 109.917 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtp -102.62 151.76 21.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.93 1.692 . . . . 0.0 109.092 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.2 t -144.1 147.28 33.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.956 0.902 . . . . 0.0 111.764 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -126.7 145.68 50.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.858 2.063 . . . . 0.0 108.542 175.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.15 140.41 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.88 0.872 . . . . 0.0 111.77 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -137.03 159.92 40.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.821 2.048 . . . . 0.0 110.883 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.23 134.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 108.411 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.61 129.49 41.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.028 0.931 . . . . 0.0 111.669 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 1.84 65.22 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.596 1.093 . . . . 0.0 114.669 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -122.08 134.11 54.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.29 1.436 . . . . 0.0 110.464 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -80.97 -12.13 59.44 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -91.19 159.23 16.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.045 1.338 . . . . 0.0 113.191 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.76 121.12 22.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.876 1.271 . . . . 0.0 109.684 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.7 141.28 23.44 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.1 mtm -138.9 142.35 38.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.777 0.831 . . . . 0.0 112.305 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 174.97 32.83 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 124.933 1.254 . . . . 0.0 113.624 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.03 161.5 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.244 1.018 . . . . 0.0 112.285 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -167.03 -171.0 1.66 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.082 1.353 . . . . 0.0 112.137 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -81.52 -6.81 59.34 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.56 1.944 . . . . 0.0 113.606 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -152.01 159.25 43.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.997 1.719 . . . . 0.0 111.655 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -67.03 -29.45 69.26 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.83 -45.64 50.01 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.153 -0.967 . . . . 0.0 112.3 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.47 -29.72 67.45 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.666 -0.646 . . . . 0.0 112.345 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.03 -45.48 77.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.699 -0.626 . . . . 0.0 111.771 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -62.04 -38.26 88.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.584 0.753 . . . . 0.0 112.001 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 m -63.26 -38.13 89.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.617 0.644 . . . . 0.0 112.106 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.5 -35.73 60.73 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.332 0.653 . . . . 0.0 111.716 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.76 -45.65 88.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 111.789 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.57 -47.58 85.55 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.212 1.005 . . . . 0.0 111.439 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -56.99 -38.05 72.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.132 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.2 -27.93 57.07 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -76.99 -37.93 54.17 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.241 -0.912 . . . . 0.0 111.695 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.04 -41.39 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.49 -0.756 . . . . 0.0 110.473 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.26 -49.78 73.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.726 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -52.57 -41.92 64.01 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.404 1.456 . . . . 0.0 113.696 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.05 -22.17 66.82 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 174.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.46 -36.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.407 1.083 . . . . 0.0 110.935 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -60.66 -29.91 69.57 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.57 1.148 . . . . 0.0 112.316 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.1 pt -103.8 4.62 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.074 1.349 . . . . 0.0 113.986 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.2 m120 66.86 19.1 10.69 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.521 1.928 . . . . 0.0 114.934 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -81.15 -12.28 59.26 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.46 . . . . 0.0 113.238 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.33 142.49 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 108.944 170.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -93.44 129.16 39.71 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.417 1.087 . . . . 0.0 109.843 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 p -60.0 -27.37 66.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.91 -1.119 . . . . 0.0 113.718 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.29 -19.74 62.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.313 1.045 . . . . 0.0 113.351 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -86.01 -17.45 35.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.359 1.064 . . . . 0.0 113.159 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.82 127.31 77.97 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.34 1.056 . . . . 0.0 110.406 -169.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.42 134.25 24.16 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.122 2.548 . . . . 0.0 111.268 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.36 168.02 24.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.174 1.79 . . . . 0.0 110.954 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -20.38 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.566 1.146 . . . . 0.0 113.273 176.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.2 149.83 21.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.111 1.815 . . . . 0.0 111.486 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.7 mt -124.6 138.38 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.11 1.364 . . . . 0.0 109.185 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.22 142.05 31.49 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.424 1.89 . . . . 0.0 108.579 -170.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -50.71 146.75 19.64 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.105 3.204 . . . . 0.0 113.712 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.41 154.58 45.61 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.534 2.823 . . . . 0.0 112.745 -169.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.05 170.46 20.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.161 3.241 . . . . 0.0 111.632 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 52.7 p -71.18 -11.93 61.2 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.72 142.56 8.11 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 126.044 1.783 . . . . 0.0 111.867 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.81 136.46 20.85 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.246 2.63 . . . . 0.0 111.297 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 t -151.65 14.95 0.67 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m 67.29 -7.49 0.52 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.464 2.306 . . . . 0.0 115.985 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 C-N-CA 125.954 1.74 . . . . 0.0 112.931 178.625 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 49.5 p -161.77 -78.08 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.576 1.15 . . . . 0.0 111.315 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 46.5 t -167.22 146.07 5.05 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.716 2.006 . . . . 0.0 110.822 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -103.03 2.83 47.88 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.897 1.237 . . . . 0.0 113.686 171.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 m -89.67 145.87 24.92 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.561 1.18 . . . . 0.0 113.665 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -159.5 131.99 6.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.0 1.72 . . . . 0.0 109.093 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.26 -39.92 87.77 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-O 119.417 -0.657 . . . . 0.0 113.915 -168.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.23 -34.23 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.559 1.179 . . . . 0.0 112.528 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -67.81 -40.81 83.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.183 0.993 . . . . 0.0 110.601 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -67.89 -33.79 75.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.315 1.046 . . . . 0.0 112.703 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.72 -41.43 83.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.91 0.777 . . . . 0.0 111.97 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.24 -44.39 96.68 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.75 0.705 . . . . 0.0 111.285 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.3 -42.56 99.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.34 0.656 . . . . 0.0 112.76 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.46 -40.77 80.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.548 1.139 . . . . 0.0 112.45 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.31 -45.41 93.47 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.11 0.964 . . . . 0.0 111.448 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -58.15 -45.71 86.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.474 0.71 . . . . 0.0 111.652 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.07 -26.86 73.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.504 1.049 . . . . 0.0 114.102 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -78.1 -8.25 58.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.598 1.199 . . . . 0.0 112.853 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.115 2.166 . . . . 0.0 112.769 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 64.41 30.5 13.13 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.39 1.876 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.5 mtm -117.66 174.08 6.37 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.731 2.012 . . . . 0.0 111.415 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -143.53 133.31 11.83 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.825 1.65 . . . . 0.0 108.791 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.66 153.75 34.33 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.961 2.441 . . . . 0.0 110.97 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.22 116.17 20.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.71 157.31 16.78 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 112.225 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.62 148.49 34.39 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.07 1.748 . . . . 0.0 109.692 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.14 146.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.021 1.328 . . . . 0.0 111.89 -168.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -134.34 141.31 46.86 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.699 2.0 . . . . 0.0 110.196 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.7 138.74 32.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.415 1.086 . . . . 0.0 111.011 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.0 m -147.08 176.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.07 1.748 . . . . 0.0 110.951 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.33 -158.23 28.69 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.979 0.799 . . . . 0.0 113.869 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -84.75 150.29 25.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.915 1.286 . . . . 0.0 112.47 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -61.72 -35.89 79.34 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -87.95 -22.95 24.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.068 1.347 . . . . 0.0 113.357 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -134.0 83.13 2.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.677 1.591 . . . . 0.0 110.335 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -82.44 152.28 26.19 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.65 1.18 . . . . 0.0 111.416 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -136.01 164.98 26.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.612 1.965 . . . . 0.0 110.974 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -135.2 141.82 45.92 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.85 1.26 . . . . 0.0 111.251 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 mtp -113.21 153.48 28.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.171 1.789 . . . . 0.0 109.249 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -146.58 146.49 30.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.011 0.924 . . . . 0.0 111.587 -177.056 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -128.04 149.23 50.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.947 1.699 . . . . 0.0 109.322 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.2 143.57 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.211 1.004 . . . . 0.0 111.966 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -137.03 165.63 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.512 1.925 . . . . 0.0 110.62 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.51 138.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.886 1.674 . . . . 0.0 108.158 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.51 128.42 37.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.938 0.895 . . . . 0.0 111.707 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 0.69 65.12 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.666 1.127 . . . . 0.0 114.765 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -122.96 129.76 51.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.202 1.401 . . . . 0.0 110.577 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.81 -20.88 45.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -70.82 157.95 37.21 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.643 1.177 . . . . 0.0 113.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.9 116.56 15.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.878 1.271 . . . . 0.0 109.591 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.29 143.52 22.91 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 mtt -137.89 144.29 41.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 112.953 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.68 169.45 27.85 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.851 1.691 . . . . 0.0 113.36 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -158.07 152.07 24.09 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.33 1.052 . . . . 0.0 112.186 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.6 t -169.08 -175.09 2.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.924 1.289 . . . . 0.0 112.264 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.7 p -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.717 1.607 . . . . 0.0 113.402 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -142.16 145.5 34.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.535 1.534 . . . . 0.0 111.44 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.33 -30.94 70.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 113.492 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.51 -46.18 70.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.651 1.18 . . . . 0.0 111.891 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -77.04 -27.89 54.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.553 0.741 . . . . 0.0 111.945 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.27 87.52 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.582 -0.699 . . . . 0.0 111.581 170.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.12 -38.75 90.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.688 0.795 . . . . 0.0 112.033 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.1 m -65.03 -36.31 83.95 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.656 -0.652 . . . . 0.0 112.255 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.33 -36.95 68.98 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.458 -0.776 . . . . 0.0 111.967 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.66 97.86 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.576 -0.703 . . . . 0.0 111.536 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.96 77.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.306 1.042 . . . . 0.0 111.618 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -52.09 -44.43 64.38 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.625 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.75 -35.16 70.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.95 0.9 . . . . 0.0 113.118 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.91 -37.6 62.02 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.686 -0.633 . . . . 0.0 112.291 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.88 -40.89 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.79 -31.68 71.91 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.64 -44.62 81.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.0 -1.687 . . . . 0.0 111.993 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.3 mt -61.46 -33.2 73.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.647 0.658 . . . . 0.0 112.748 176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.26 -44.46 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.026 0.93 . . . . 0.0 111.336 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -63.05 -22.5 66.9 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 pt -104.56 6.49 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.77 1.228 . . . . 0.0 113.983 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 67.51 21.29 9.59 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.446 1.899 . . . . 0.0 114.63 174.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -90.36 -5.72 55.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 113.195 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 70.0 t -136.11 136.88 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 127.034 2.133 . . . . 0.0 107.781 168.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.51 126.69 33.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.56 -32.49 63.04 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.336 -0.852 . . . . 0.0 113.246 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.92 -19.55 60.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.087 1.355 . . . . 0.0 113.561 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.76 -16.08 29.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.614 1.166 . . . . 0.0 113.322 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.19 124.11 85.88 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.238 1.015 . . . . 0.0 110.978 -169.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.83 153.74 19.78 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.492 2.795 . . . . 0.0 111.844 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.43 167.99 12.64 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.677 1.591 . . . . 0.0 111.891 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -14.19 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.713 1.605 . . . . 0.0 115.113 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.78 176.91 37.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.979 1.752 . . . . 0.0 112.187 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pp -84.6 157.62 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.219 1.807 . . . . 0.0 111.722 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 t 66.56 81.29 0.21 Allowed Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 126.379 1.872 . . . . 0.0 111.745 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.36 150.64 84.0 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.705 2.937 . . . . 0.0 112.901 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.4 136.11 35.86 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.145 2.563 . . . . 0.0 110.486 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.08 -14.1 26.07 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.472 2.781 . . . . 0.0 114.27 -170.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.1 m -115.0 4.87 14.84 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.731 1.213 . . . . 0.0 113.157 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.9 178.01 43.3 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.594 1.093 . . . . 0.0 113.677 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.1 159.83 37.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.017 3.145 . . . . 0.0 111.262 173.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.0 p -160.62 158.48 29.03 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.559 1.144 . . . . 0.0 112.467 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -87.54 -4.68 58.97 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.246 0 C-N-CA 125.253 1.406 . . . . 0.0 113.197 -177.285 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 71.9 p -165.16 165.7 19.58 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.446 1.499 . . . . 0.0 111.693 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 55.9 p -162.58 155.83 20.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.826 1.25 . . . . 0.0 112.276 -175.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -86.27 -174.95 49.71 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.706 1.146 . . . . 0.0 113.225 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 t -168.45 -176.19 2.76 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.084 1.754 . . . . 0.0 111.131 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -155.55 145.45 21.44 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.132 1.373 . . . . 0.0 111.45 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.6 -17.83 78.22 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.988 -0.895 . . . . 0.0 114.406 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tp -70.76 -33.94 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.284 1.542 . . . . 0.0 113.057 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.18 -38.46 82.07 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.466 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -71.92 -30.38 65.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.017 0.927 . . . . 0.0 112.84 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -66.99 -43.78 82.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.842 0.857 . . . . 0.0 111.792 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 tp -62.79 -42.89 99.9 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.415 0.552 . . . . 0.0 111.25 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -63.33 -42.73 98.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.67 80.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.436 1.094 . . . . 0.0 112.453 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.98 -45.71 93.71 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 111.457 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.2 m -58.04 -46.27 85.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.588 0.755 . . . . 0.0 111.648 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.08 -26.9 73.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.47 1.033 . . . . 0.0 114.065 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.74 -8.36 57.86 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.413 1.107 . . . . 0.0 112.706 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.7 8.69 11.24 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.277 2.231 . . . . 0.0 112.687 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.4 30.93 12.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.556 1.943 . . . . 0.0 113.568 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtm -117.83 173.6 6.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.819 2.048 . . . . 0.0 111.425 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 m -143.05 132.46 11.78 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.054 1.742 . . . . 0.0 108.983 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 152.97 30.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.134 2.556 . . . . 0.0 110.986 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.12 117.47 21.67 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.88 156.31 17.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.462 1.505 . . . . 0.0 112.498 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.45 145.7 32.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.397 1.879 . . . . 0.0 109.262 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -133.17 148.41 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.187 1.395 . . . . 0.0 110.83 -169.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 -143.4 134.43 25.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.854 1.661 . . . . 0.0 110.653 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.52 138.62 31.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.241 1.016 . . . . 0.0 111.122 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -146.86 168.59 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.643 1.577 . . . . 0.0 111.459 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.47 -163.48 39.0 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.34 0.971 . . . . 0.0 113.965 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -66.43 146.52 54.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.858 1.263 . . . . 0.0 112.448 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -57.59 -40.81 79.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.518 1.127 . . . . 0.0 113.947 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -86.43 -50.51 6.84 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.402 1.081 . . . . 0.0 111.703 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -89.47 63.16 6.25 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.346 1.458 . . . . 0.0 110.16 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -79.85 151.32 30.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.011 1.325 . . . . 0.0 112.032 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -134.34 161.94 33.59 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.605 1.962 . . . . 0.0 110.828 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.06 127.03 29.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.914 1.286 . . . . 0.0 111.075 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtp -91.25 154.87 18.98 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.427 1.491 . . . . 0.0 109.307 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.3 t -143.77 147.69 34.52 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.191 0.996 . . . . 0.0 111.212 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -132.84 141.37 48.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.588 1.955 . . . . 0.0 108.131 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.14 144.03 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.928 0.891 . . . . 0.0 112.1 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -137.82 166.51 23.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.123 1.769 . . . . 0.0 111.165 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.3 139.01 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.255 1.822 . . . . 0.0 107.764 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.54 127.67 33.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 111.834 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.89 -0.71 64.82 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.718 1.151 . . . . 0.0 114.96 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -117.46 126.95 53.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.846 1.323 . . . . 0.0 110.859 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -72.76 -23.37 60.81 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.183 0.993 . . . . 0.0 113.455 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -69.1 158.08 35.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.036 1.334 . . . . 0.0 113.697 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.57 119.58 17.52 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.252 1.421 . . . . 0.0 110.246 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.07 21.66 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtt -137.86 142.14 40.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.916 0.887 . . . . 0.0 112.823 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.42 170.1 26.84 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.737 1.637 . . . . 0.0 113.272 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -157.75 149.76 22.18 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.657 1.183 . . . . 0.0 111.216 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -166.42 -175.64 3.3 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.876 1.27 . . . . 0.0 112.54 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.6 p -75.61 -9.96 59.03 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.568 1.547 . . . . 0.0 113.317 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.44 150.57 30.58 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.452 1.501 . . . . 0.0 111.845 -170.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.05 -34.17 77.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.236 1.014 . . . . 0.0 113.649 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -64.55 -49.07 72.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.727 1.211 . . . . 0.0 111.983 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.24 -27.2 56.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.013 0.925 . . . . 0.0 112.153 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.35 84.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.527 -0.733 . . . . 0.0 111.719 171.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.2 -40.31 89.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.165 0.586 . . . . 0.0 111.72 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.7 m -64.88 -36.59 84.86 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.818 -0.551 . . . . 0.0 112.23 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -71.57 -38.91 70.88 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.306 -0.871 . . . . 0.0 111.824 173.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.4 98.91 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.727 0.694 . . . . 0.0 111.533 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.92 82.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.245 1.018 . . . . 0.0 111.554 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.4 tpt85 -56.15 -37.86 70.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.467 0.707 . . . . 0.0 112.441 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.4 -29.05 52.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 113.415 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.56 -37.99 55.68 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.412 -0.805 . . . . 0.0 111.664 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.42 -40.29 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.651 0.78 . . . . 0.0 110.582 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -53.32 -48.86 68.09 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 170.087 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -58.71 -44.76 90.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.915 -1.115 . . . . 0.0 112.816 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -62.79 -31.5 72.48 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -72.09 -41.29 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.866 0.867 . . . . 0.0 111.132 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -65.08 -26.53 68.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.226 1.011 . . . . 0.0 113.124 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 pt -98.66 4.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.611 1.165 . . . . 0.0 113.798 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 68.99 17.24 8.65 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.706 2.002 . . . . 0.0 114.63 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -85.17 -7.8 58.89 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.115 1.366 . . . . 0.0 113.209 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.4 t -132.58 137.45 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.998 2.119 . . . . 0.0 107.626 168.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -84.71 128.33 34.55 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.92 0.488 . . . . 0.0 109.919 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -55.13 -33.44 62.89 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.388 -0.82 . . . . 0.0 113.143 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.35 -19.07 61.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.946 1.298 . . . . 0.0 113.605 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -90.18 -16.84 28.7 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.508 1.123 . . . . 0.0 113.227 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.0 t -76.11 125.85 87.44 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.252 1.021 . . . . 0.0 110.496 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -73.48 144.82 36.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.571 . . . . 0.0 111.322 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.14 161.91 39.15 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.057 1.343 . . . . 0.0 112.121 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -12.53 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.83 162.69 33.23 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.721 1.153 . . . . 0.0 113.654 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.17 143.57 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.875 2.07 . . . . 0.0 108.806 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.74 156.28 71.32 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 125.659 1.584 . . . . 0.0 111.798 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -60.13 164.31 12.68 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 124.009 3.139 . . . . 0.0 113.866 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.31 152.81 30.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.247 3.298 . . . . 0.0 113.032 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.3 -16.11 43.36 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.593 2.862 . . . . 0.0 113.728 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 m -72.37 -13.6 61.51 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.17 0.988 . . . . 0.0 113.516 171.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.89 -176.52 51.03 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.652 1.596 . . . . 0.0 114.243 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -61.1 154.79 54.79 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 124.411 3.407 . . . . 0.0 112.786 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.2 p -161.94 160.69 28.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.852 1.261 . . . . 0.0 112.135 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.6 m -165.85 156.03 12.76 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.66 1.984 . . . . 0.0 110.87 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 118.447 -1.196 . . . . 0.0 112.959 178.896 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 43.6 m -76.87 120.53 22.14 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.853 0.861 . . . . 0.0 112.514 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 29.5 m 72.03 -42.62 0.54 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 128.044 2.538 . . . . 0.0 115.687 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 74.35 15.28 80.3 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.784 1.183 . . . . 0.0 114.994 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 m -72.09 -9.04 57.86 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -170.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -80.09 59.08 3.17 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.953 2.101 . . . . 0.0 111.839 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.28 -28.99 73.8 Favored Glycine 0 N--CA 1.472 1.067 0 O-C-N 120.783 -1.198 . . . . 0.0 114.686 -169.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.25 -33.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 118.263 1.032 . . . . 0.0 112.201 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -66.34 -43.37 86.29 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.801 1.24 . . . . 0.0 110.361 172.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.48 -32.0 73.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 112.854 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -69.08 -40.96 78.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.289 0.949 . . . . 0.0 111.993 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.77 -42.47 99.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -61.91 -41.93 98.49 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.36 82.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.509 1.124 . . . . 0.0 112.863 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.01 -43.79 94.58 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.83 0.852 . . . . 0.0 111.856 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.6 m -57.89 -43.88 86.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.096 0.558 . . . . 0.0 111.08 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.65 -28.64 73.81 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.561 1.076 . . . . 0.0 114.055 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -70.34 -12.91 61.9 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.637 1.218 . . . . 0.0 112.645 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -119.61 9.18 11.4 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.15 2.18 . . . . 0.0 113.257 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.39 24.03 13.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 114.044 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.97 174.04 6.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.013 2.125 . . . . 0.0 111.476 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.4 m -140.49 130.74 13.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.34 1.856 . . . . 0.0 108.528 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.36 147.63 29.25 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.003 2.469 . . . . 0.0 110.758 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.27 114.45 25.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.456 1.103 . . . . 0.0 110.641 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -95.74 153.8 17.55 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.004 1.321 . . . . 0.0 111.739 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -145.52 138.6 26.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.166 1.786 . . . . 0.0 108.556 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.08 147.45 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.423 1.089 . . . . 0.0 111.774 -168.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.04 135.45 41.32 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.149 1.78 . . . . 0.0 110.44 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.96 137.64 32.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.808 1.243 . . . . 0.0 111.016 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -146.86 176.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.236 1.814 . . . . 0.0 110.994 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.08 -151.09 17.92 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.657 1.122 . . . . 0.0 113.553 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -116.91 158.49 23.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.348 1.859 . . . . 0.0 111.773 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -58.25 -22.99 54.51 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -97.42 -9.3 27.57 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.509 1.524 . . . . 0.0 113.752 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -157.31 98.08 1.68 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.065 1.746 . . . . 0.0 110.384 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -87.11 151.35 23.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.463 1.105 . . . . 0.0 111.228 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -145.85 160.36 41.9 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.406 2.283 . . . . 0.0 110.163 -172.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.93 128.87 35.41 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.346 1.058 . . . . 0.0 111.909 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtm -94.98 151.48 19.14 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.546 1.538 . . . . 0.0 108.948 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.2 t -144.68 149.56 35.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.971 0.908 . . . . 0.0 112.082 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -132.87 149.42 52.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.389 1.875 . . . . 0.0 109.044 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.36 140.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.868 0.867 . . . . 0.0 111.71 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -137.08 157.57 46.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.923 2.089 . . . . 0.0 110.546 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.9 t -140.63 136.31 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.729 1.612 . . . . 0.0 108.459 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.28 128.12 35.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.034 0.933 . . . . 0.0 111.73 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.45 2.89 65.24 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.543 1.068 . . . . 0.0 114.692 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.43 129.05 49.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.412 1.485 . . . . 0.0 110.261 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -81.5 -12.19 58.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -85.54 160.44 19.66 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.678 1.191 . . . . 0.0 113.1 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.7 117.68 16.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.84 1.256 . . . . 0.0 109.604 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.01 141.31 24.09 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.6 mtp -123.6 143.38 50.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.556 1.142 . . . . 0.0 112.747 -169.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.11 169.24 28.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.434 1.493 . . . . 0.0 113.633 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -159.88 148.98 17.68 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.934 1.294 . . . . 0.0 111.153 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.53 -176.18 3.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.769 1.228 . . . . 0.0 112.656 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 m -75.67 -19.99 58.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.15 1.38 . . . . 0.0 111.775 172.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -138.35 155.77 48.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 112.85 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -67.67 -40.82 84.45 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.365 -0.834 . . . . 0.0 112.133 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.29 -30.34 57.74 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 112.035 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -43.79 90.2 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.534 -0.729 . . . . 0.0 111.768 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -61.52 -39.48 91.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.538 0.735 . . . . 0.0 111.668 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -64.61 -35.13 80.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.996 0.817 . . . . 0.0 112.388 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.57 -38.18 67.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.28 -0.888 . . . . 0.0 112.017 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.02 97.27 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.59 -0.694 . . . . 0.0 111.563 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -47.59 83.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.576 1.15 . . . . 0.0 111.836 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -52.52 -43.21 64.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.874 0.87 . . . . 0.0 111.581 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.37 -34.26 63.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.22 -37.24 61.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.44 -0.788 . . . . 0.0 112.241 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.15 -42.47 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.342 -0.848 . . . . 0.0 110.092 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.36 -48.64 78.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.524 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -51.1 -42.65 60.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.726 1.603 . . . . 0.0 113.842 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.99 -22.27 66.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.25 -36.72 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.552 1.069 . . . . 0.0 110.903 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -60.4 -30.53 69.66 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.33 1.052 . . . . 0.0 112.112 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 pt -103.96 3.48 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.292 . . . . 0.0 114.211 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.86 23.16 11.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.509 1.924 . . . . 0.0 114.797 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -86.2 -9.75 55.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.51 1.524 . . . . 0.0 113.052 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -134.06 136.65 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 127.139 2.176 . . . . 0.0 107.433 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -86.65 137.44 32.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.319 0.509 . . . . 0.0 109.714 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 p -54.91 -32.09 60.79 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.977 -1.077 . . . . 0.0 113.094 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -53.5 -24.64 13.76 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.015 1.726 . . . . 0.0 114.177 173.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.27 -20.47 26.82 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.545 1.138 . . . . 0.0 113.104 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.1 t -80.45 129.43 69.03 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.583 1.153 . . . . 0.0 110.693 -168.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.27 138.51 36.35 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.06 2.507 . . . . 0.0 110.756 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.28 125.38 27.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.447 0.699 . . . . 0.0 112.091 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.17 -11.5 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.863 1.665 . . . . 0.0 114.369 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.59 -160.24 26.01 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.326 1.917 . . . . 0.0 111.734 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.1 mt -84.44 130.55 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.477 1.111 . . . . 0.0 108.827 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.15 129.59 14.67 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 125.436 1.494 . . . . 0.0 108.914 -174.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.46 158.06 44.51 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.416 2.744 . . . . 0.0 112.235 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.68 161.3 44.3 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.698 2.932 . . . . 0.0 111.58 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.01 -14.01 37.64 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.446 2.764 . . . . 0.0 113.338 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.6 p -83.78 -1.24 53.83 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.462 1.505 . . . . 0.0 113.569 170.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.05 -178.57 51.8 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.684 1.612 . . . . 0.0 114.176 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.35 162.59 41.11 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.248 3.299 . . . . 0.0 112.124 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.7 t -162.74 -40.63 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.405 1.082 . . . . 0.0 112.697 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.7 p -160.16 163.87 33.33 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.981 1.312 . . . . 0.0 112.076 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.849 -179.623 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 99.2 p -163.86 170.17 17.18 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.149 1.38 . . . . 0.0 111.946 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 18.5 m -83.38 11.92 6.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.688 1.195 . . . . 0.0 114.044 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -75.79 142.67 29.07 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.949 1.261 . . . . 0.0 112.932 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 80.8 p -160.93 5.64 0.07 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -82.5 112.32 19.31 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.248 -1.532 . . . . 0.0 111.526 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.45 -41.06 31.24 Favored Glycine 0 N--CA 1.472 1.052 0 O-C-N 121.325 -0.859 . . . . 0.0 114.788 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 tp -73.63 -28.43 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 118.339 1.07 . . . . 0.0 112.104 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -48.26 76.99 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.302 1.041 . . . . 0.0 110.027 169.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -64.81 -29.57 70.54 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 112.685 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.81 -45.61 74.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.812 0.733 . . . . 0.0 111.476 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.63 -41.79 99.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.369 0.531 . . . . 0.0 111.153 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.01 -42.49 99.83 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -39.1 79.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.36 1.064 . . . . 0.0 112.419 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.8 t90 -61.0 -45.84 93.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.068 0.947 . . . . 0.0 111.427 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.3 m -58.22 -45.67 87.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.649 0.78 . . . . 0.0 111.711 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.67 -26.83 72.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.449 1.024 . . . . 0.0 114.051 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -78.12 -8.38 58.18 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.398 1.099 . . . . 0.0 112.744 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -119.68 9.3 11.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.377 2.271 . . . . 0.0 112.726 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.96 30.72 11.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.51 1.924 . . . . 0.0 113.623 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.8 mtm -118.33 172.36 7.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.756 2.022 . . . . 0.0 111.57 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -142.54 130.64 11.48 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.093 1.757 . . . . 0.0 108.685 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.6 149.96 27.44 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.011 2.474 . . . . 0.0 110.803 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.0 117.62 27.74 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.651 1.181 . . . . 0.0 110.68 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.26 158.03 16.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.336 1.455 . . . . 0.0 112.63 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.3 149.88 33.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.999 1.32 . . . . 0.0 110.33 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.1 mt -135.66 147.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.822 1.649 . . . . 0.0 111.149 -169.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -141.98 137.42 31.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.653 1.581 . . . . 0.0 111.06 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.46 141.92 28.26 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.204 1.002 . . . . 0.0 111.222 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 m -146.14 161.5 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.697 1.599 . . . . 0.0 111.213 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.79 158.29 12.2 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.794 1.188 . . . . 0.0 113.427 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.58 155.05 40.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.383 0.673 . . . . 0.0 111.727 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -54.85 -27.68 44.16 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -169.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -78.76 -24.34 44.78 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -125.83 29.64 5.88 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.973 2.509 . . . . 0.0 112.659 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -66.62 145.8 55.19 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 112.523 -169.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -140.43 165.63 26.9 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.536 2.334 . . . . 0.0 110.86 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.28 133.88 46.81 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.239 1.416 . . . . 0.0 110.651 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 37.2 mtm -100.39 154.16 18.74 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.113 1.765 . . . . 0.0 109.211 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.6 t -147.54 148.69 31.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.376 1.07 . . . . 0.0 111.171 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.89 158.28 42.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.096 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.69 143.9 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.807 1.243 . . . . 0.0 111.611 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -139.44 158.19 44.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.436 1.895 . . . . 0.0 110.335 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.07 134.94 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.619 1.568 . . . . 0.0 108.619 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.67 130.14 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.04 0.936 . . . . 0.0 111.677 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.55 1.37 66.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.537 1.065 . . . . 0.0 114.567 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -125.14 128.84 49.03 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 110.363 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -77.25 -20.88 54.55 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -71.29 156.68 39.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.559 1.143 . . . . 0.0 113.377 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.66 116.99 15.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.035 1.334 . . . . 0.0 109.326 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.92 141.84 22.01 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 77.1 mtm -140.27 142.41 35.73 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.595 1.158 . . . . 0.0 112.232 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.26 173.92 31.3 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.264 1.411 . . . . 0.0 113.143 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -152.81 161.7 42.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.262 1.025 . . . . 0.0 111.953 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 t -167.34 -172.83 2.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.647 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.6 p -76.84 -9.57 58.77 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.544 1.538 . . . . 0.0 113.372 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.55 151.38 31.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.657 1.583 . . . . 0.0 111.779 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.34 -30.03 70.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -65.33 -54.61 26.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.708 1.203 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.84 -27.56 62.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.727 0.811 . . . . 0.0 112.171 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.41 95.08 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.814 -0.553 . . . . 0.0 111.749 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.01 -41.07 95.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.43 0.692 . . . . 0.0 112.034 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.4 m -59.03 -40.2 84.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.18 0.9 . . . . 0.0 112.34 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -72.46 -37.97 68.36 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.592 -0.692 . . . . 0.0 111.545 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.35 92.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.651 0.781 . . . . 0.0 112.282 172.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.59 -49.11 77.93 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.313 1.045 . . . . 0.0 111.593 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -58.65 -39.74 81.43 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.73 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.85 -30.78 70.25 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -77.94 -39.6 42.17 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.617 -0.677 . . . . 0.0 112.359 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.2 -38.7 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.41 -0.806 . . . . 0.0 110.798 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.82 -44.01 81.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.504 0.721 . . . . 0.0 111.578 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -60.41 -44.47 95.69 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.768 -1.207 . . . . 0.0 112.665 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.4 -34.27 75.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.065 0.848 . . . . 0.0 113.179 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.12 -42.64 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.908 0.883 . . . . 0.0 111.198 171.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -66.17 -21.36 66.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.508 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -103.38 6.75 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.939 1.296 . . . . 0.0 113.625 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m120 68.79 18.84 8.57 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.725 2.01 . . . . 0.0 114.675 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.67 -5.69 57.96 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.347 1.459 . . . . 0.0 113.322 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -136.83 139.33 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.906 2.082 . . . . 0.0 107.995 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -84.97 125.91 33.08 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.964 0.506 . . . . 0.0 110.067 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.08 -33.1 62.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.13 -19.47 61.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.909 1.284 . . . . 0.0 113.568 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -92.42 -15.64 26.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.648 1.179 . . . . 0.0 113.435 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 123.74 85.41 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.103 0.961 . . . . 0.0 111.64 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -82.87 169.53 13.19 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.785 2.99 . . . . 0.0 112.707 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.79 154.31 43.29 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.591 1.556 . . . . 0.0 111.053 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -16.08 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.112 1.365 . . . . 0.0 114.576 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.02 158.56 30.9 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.753 1.644 . . . . 0.0 112.23 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.4 mm -117.84 127.0 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.455 1.502 . . . . 0.0 109.396 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 p -165.0 135.75 3.12 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 125.476 1.51 . . . . 0.0 109.73 -174.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.2 163.07 37.39 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.123 2.549 . . . . 0.0 112.003 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.73 148.21 75.82 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.908 3.072 . . . . 0.0 113.277 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.37 162.98 38.97 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.949 3.099 . . . . 0.0 112.018 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.4 m -146.24 151.21 37.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.462 1.505 . . . . 0.0 111.475 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.48 -173.7 49.85 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.669 1.128 . . . . 0.0 113.47 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.9 136.7 71.59 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.239 3.293 . . . . 0.0 112.505 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.2 p -79.91 -10.73 59.81 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.1 m -91.71 -4.33 55.22 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.128 1.371 . . . . 0.0 113.877 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.214 0 CA-C-O 118.206 -1.33 . . . . 0.0 113.449 -178.567 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 18.7 m -84.92 -6.87 59.34 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -172.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.4 t -163.61 172.86 13.72 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.938 1.695 . . . . 0.0 111.193 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 86.89 -172.53 44.13 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.356 1.455 . . . . 0.0 113.47 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.9 t -163.34 173.23 13.52 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.262 1.425 . . . . 0.0 111.558 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -159.3 29.88 0.2 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.197 2.199 . . . . 0.0 111.125 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.53 83.89 Favored Glycine 0 N--CA 1.471 0.999 0 O-C-N 120.801 -1.187 . . . . 0.0 114.24 -169.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -73.89 -30.31 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 118.304 1.052 . . . . 0.0 112.582 173.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -40.72 75.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.528 1.131 . . . . 0.0 110.542 174.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -69.38 -31.38 69.73 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.182 0.993 . . . . 0.0 112.828 170.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.18 -42.0 84.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.969 0.804 . . . . 0.0 111.947 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -62.65 -42.98 99.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.702 0.683 . . . . 0.0 111.258 173.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.87 -42.96 99.95 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.252 0.621 . . . . 0.0 112.556 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 -39.99 83.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.349 1.06 . . . . 0.0 112.667 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.37 -45.65 93.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 111.452 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.1 m -58.23 -45.45 87.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.545 0.738 . . . . 0.0 111.684 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.07 73.03 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.483 1.04 . . . . 0.0 114.034 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.46 -8.99 58.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.466 1.106 . . . . 0.0 112.838 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -119.64 9.35 11.43 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.251 2.22 . . . . 0.0 112.736 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 mttp 65.05 30.7 11.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.439 1.895 . . . . 0.0 113.568 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.7 mtm -118.6 172.38 7.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.688 1.995 . . . . 0.0 111.654 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.6 m -141.4 130.25 12.42 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 126.328 1.851 . . . . 0.0 108.581 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.62 142.13 20.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.928 2.419 . . . . 0.0 110.581 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.31 116.64 30.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.485 1.114 . . . . 0.0 110.558 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -98.23 154.9 17.46 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.098 1.359 . . . . 0.0 112.301 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.18 136.86 22.96 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.917 1.287 . . . . 0.0 110.287 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 70.0 mt -123.78 147.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.12 1.368 . . . . 0.0 110.97 -170.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 -142.21 140.41 32.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.707 2.003 . . . . 0.0 110.106 -174.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.0 140.62 29.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.329 1.052 . . . . 0.0 111.255 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.93 162.23 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.84 1.656 . . . . 0.0 111.017 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.22 -165.23 41.04 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.997 0.808 . . . . 0.0 114.336 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.93 147.21 51.99 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.481 1.512 . . . . 0.0 113.115 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -63.62 -39.2 93.77 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -81.82 -31.81 31.55 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.018 1.327 . . . . 0.0 112.853 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -122.02 77.79 1.41 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.704 1.601 . . . . 0.0 109.466 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -80.9 148.89 29.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.38 1.072 . . . . 0.0 111.419 -172.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -130.24 164.74 23.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.231 1.812 . . . . 0.0 111.042 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -135.09 137.77 43.17 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.89 1.276 . . . . 0.0 111.6 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.6 mtp -102.67 152.19 21.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.588 1.555 . . . . 0.0 108.879 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.0 t -135.76 145.38 46.52 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.427 1.091 . . . . 0.0 110.194 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -122.46 152.23 40.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.202 1.801 . . . . 0.0 108.976 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.31 140.11 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.778 1.231 . . . . 0.0 110.894 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -140.79 153.39 45.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.945 1.698 . . . . 0.0 110.117 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.77 134.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.488 1.515 . . . . 0.0 108.88 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.79 130.01 44.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.131 0.972 . . . . 0.0 111.695 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.4 2.05 66.0 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.607 1.098 . . . . 0.0 114.627 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.83 130.85 53.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.397 1.479 . . . . 0.0 110.321 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -82.67 -14.72 54.15 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -80.93 155.75 26.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.407 1.083 . . . . 0.0 112.766 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.81 112.05 13.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.191 1.396 . . . . 0.0 108.911 170.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.16 147.19 25.76 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.5 ptm -147.19 150.29 34.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -169.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.6 173.78 30.1 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.248 1.88 . . . . 0.0 112.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -157.28 154.55 29.27 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.918 0.887 . . . . 0.0 112.753 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -168.28 -178.26 3.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.413 1.485 . . . . 0.0 111.471 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m -78.23 -2.69 39.02 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.578 1.551 . . . . 0.0 112.052 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -142.37 150.45 40.72 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.957 1.703 . . . . 0.0 111.786 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.72 -37.55 70.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.615 1.166 . . . . 0.0 113.631 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -71.54 -36.96 71.17 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.14 -0.975 . . . . 0.0 112.19 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.92 -30.92 70.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.159 0.984 . . . . 0.0 112.236 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.13 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.335 -0.853 . . . . 0.0 111.617 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -61.38 -42.2 98.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.898 0.879 . . . . 0.0 112.498 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -69.27 -32.05 70.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.542 1.065 . . . . 0.0 112.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -69.24 -40.52 77.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.476 -0.765 . . . . 0.0 111.804 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.32 99.79 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.831 0.742 . . . . 0.0 111.926 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.94 77.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.955 0.902 . . . . 0.0 111.452 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -57.84 -40.29 79.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.457 0.571 . . . . 0.0 111.968 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.15 -33.87 74.09 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.778 0.831 . . . . 0.0 113.104 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -76.11 -38.84 56.4 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.679 -0.638 . . . . 0.0 112.229 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.3 -41.45 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.451 -0.781 . . . . 0.0 110.591 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -56.75 -47.28 80.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.105 0.562 . . . . 0.0 111.588 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -56.48 -44.43 80.6 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 112.896 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.79 -31.89 72.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.375 -0.828 . . . . 0.0 113.209 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.62 -39.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.044 0.838 . . . . 0.0 111.388 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -61.38 -29.99 70.26 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.8 pt -98.32 5.1 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.9 t30 67.99 21.73 8.77 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.766 2.027 . . . . 0.0 114.576 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -89.61 -5.36 57.23 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.234 1.413 . . . . 0.0 113.118 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.1 t -138.2 144.36 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.797 2.439 . . . . 0.0 107.18 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -98.32 133.33 42.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.538 0.735 . . . . 0.0 110.336 169.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.8 p -58.2 -30.29 66.33 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.208 -0.933 . . . . 0.0 113.242 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.83 -21.91 57.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.534 1.134 . . . . 0.0 113.645 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -88.99 -17.26 29.8 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.39 1.076 . . . . 0.0 113.15 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.52 125.59 82.49 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 124.307 1.043 . . . . 0.0 110.733 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.84 120.08 5.96 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.076 2.517 . . . . 0.0 110.288 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.06 171.0 18.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.233 1.813 . . . . 0.0 110.892 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -19.64 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.258 1.423 . . . . 0.0 114.25 175.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -168.92 158.75 31.54 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.3 1.905 . . . . 0.0 111.662 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.5 mm -78.55 102.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 121.831 -0.805 . . . . 0.0 109.084 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -142.55 128.96 10.76 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.169 1.788 . . . . 0.0 108.355 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.94 162.0 40.09 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.238 2.625 . . . . 0.0 112.005 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.8 146.31 93.24 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.687 2.925 . . . . 0.0 112.842 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.47 157.04 53.65 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.428 2.752 . . . . 0.0 111.637 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.9 p -161.61 163.86 29.71 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.585 1.554 . . . . 0.0 111.733 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.31 -164.2 31.39 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.652 1.12 . . . . 0.0 113.497 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.85 164.1 36.76 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.861 3.04 . . . . 0.0 111.686 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.9 m -60.73 134.49 57.14 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.735 1.214 . . . . 0.0 113.249 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 m -76.16 -6.22 50.26 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.762 1.648 . . . . 0.0 113.043 -178.636 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 34.0 p -68.98 -22.85 64.07 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.294 -1.121 . . . . 0.0 113.908 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 67.5 m -89.6 7.57 35.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.986 1.314 . . . . 0.0 113.087 171.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 85.86 -129.04 9.12 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.796 1.188 . . . . 0.0 111.086 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 p -136.67 12.48 3.18 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.176 1.39 . . . . 0.0 113.197 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -65.57 122.56 17.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.712 1.205 . . . . 0.0 113.538 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.35 -32.39 68.42 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.878 -173.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -74.63 -34.53 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.069 1.435 . . . . 0.0 113.173 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.52 -44.74 86.02 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.337 1.055 . . . . 0.0 110.241 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.54 -31.96 73.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.639 0.775 . . . . 0.0 112.673 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.25 -42.91 74.96 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.687 0.795 . . . . 0.0 111.71 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.52 -43.16 99.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.627 0.649 . . . . 0.0 111.231 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.45 -42.86 98.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.6 83.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.578 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -60.29 -45.57 92.89 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.296 1.038 . . . . 0.0 111.586 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.3 m -58.06 -44.01 87.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.474 0.71 . . . . 0.0 111.665 171.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.58 -26.63 72.9 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.424 1.011 . . . . 0.0 114.103 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -78.52 -6.63 55.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.629 1.215 . . . . 0.0 112.857 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -119.3 7.88 11.34 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.057 2.143 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 63.29 27.71 15.51 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.329 1.852 . . . . 0.0 113.519 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.0 mtm -110.79 174.15 6.0 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.878 2.071 . . . . 0.0 111.305 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.4 m -143.17 131.08 11.09 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.85 1.66 . . . . 0.0 108.509 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.04 146.25 25.5 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.986 2.457 . . . . 0.0 110.645 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.46 113.22 24.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.323 1.049 . . . . 0.0 110.786 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -98.55 155.19 17.4 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.538 1.535 . . . . 0.0 112.128 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.13 146.77 30.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.1 1.76 . . . . 0.0 109.866 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.82 147.73 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.306 1.442 . . . . 0.0 110.686 -169.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 -143.14 141.02 31.07 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.73 2.012 . . . . 0.0 110.114 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.1 138.33 32.95 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.438 1.095 . . . . 0.0 111.179 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -146.52 168.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.584 1.554 . . . . 0.0 111.571 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.28 174.53 50.4 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.359 0.98 . . . . 0.0 114.223 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -68.34 140.97 55.91 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.447 1.099 . . . . 0.0 112.066 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -58.89 -22.59 59.75 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -73.24 -21.46 60.63 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.258 1.023 . . . . 0.0 113.414 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -153.52 71.08 0.87 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.754 1.621 . . . . 0.0 109.989 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -67.01 150.81 48.73 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.977 1.311 . . . . 0.0 111.415 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -135.57 165.66 25.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.602 1.961 . . . . 0.0 111.011 -172.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -135.11 135.3 41.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.388 1.075 . . . . 0.0 111.798 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.7 mtt -98.94 154.27 18.19 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.6 1.56 . . . . 0.0 108.881 168.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.6 t -142.48 147.39 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.162 0.985 . . . . 0.0 110.878 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -131.46 146.34 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.315 1.846 . . . . 0.0 108.828 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.26 139.79 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.324 1.05 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.16 158.98 43.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.878 1.671 . . . . 0.0 110.484 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.57 135.79 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.603 1.561 . . . . 0.0 108.678 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.05 129.44 41.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.126 0.97 . . . . 0.0 111.735 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.61 0.44 66.94 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.661 1.124 . . . . 0.0 114.694 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.58 132.44 56.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.335 1.454 . . . . 0.0 110.366 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -82.32 -12.93 57.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -171.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -90.05 155.76 18.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.913 1.285 . . . . 0.0 112.706 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.24 112.37 14.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.287 1.435 . . . . 0.0 108.759 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 149.26 30.38 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -148.98 147.39 28.53 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -168.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.34 176.42 29.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.917 1.722 . . . . 0.0 112.594 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.29 161.49 42.31 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.115 0.966 . . . . 0.0 112.076 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -168.63 -174.11 2.08 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.27 1.428 . . . . 0.0 111.836 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 p -75.31 -11.0 59.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.411 1.485 . . . . 0.0 113.347 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -150.08 151.52 33.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.409 1.483 . . . . 0.0 112.069 -169.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.57 -28.57 68.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -70.53 -50.41 37.92 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.844 0.857 . . . . 0.0 111.918 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.75 -29.65 63.5 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.572 -0.705 . . . . 0.0 112.182 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.14 89.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.671 -0.643 . . . . 0.0 111.941 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.25 -38.8 90.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.474 0.71 . . . . 0.0 112.037 172.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -65.24 -36.94 85.7 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.899 -0.501 . . . . 0.0 111.82 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -73.79 -35.13 64.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.69 0.796 . . . . 0.0 111.713 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.48 93.37 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.466 -0.772 . . . . 0.0 112.125 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.38 -48.04 81.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.886 0.874 . . . . 0.0 111.543 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -53.58 -42.26 67.43 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.33 1.052 . . . . 0.0 111.932 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.05 -35.7 69.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.965 0.906 . . . . 0.0 113.223 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -75.11 -37.23 61.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.631 -0.668 . . . . 0.0 112.54 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.58 -38.36 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.352 -0.842 . . . . 0.0 110.494 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -55.83 -46.98 78.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 119.347 -0.358 . . . . 0.0 111.925 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -56.18 -46.72 79.26 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.031 -1.043 . . . . 0.0 112.969 170.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.13 -33.89 75.32 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.93 -41.99 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.983 0.913 . . . . 0.0 111.193 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -67.3 -19.97 65.55 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.356 1.062 . . . . 0.0 113.394 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -103.89 6.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.967 1.307 . . . . 0.0 113.576 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 68.0 20.38 9.13 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.843 2.057 . . . . 0.0 114.566 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.96 -6.09 57.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.039 1.336 . . . . 0.0 113.036 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.75 138.7 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.055 2.142 . . . . 0.0 107.525 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -89.4 131.34 35.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.538 0.685 . . . . 0.0 110.615 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -59.55 -33.62 71.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -62.32 -17.73 59.56 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.514 1.126 . . . . 0.0 113.471 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.94 -16.74 31.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.349 1.06 . . . . 0.0 113.227 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.12 125.97 78.23 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.367 1.067 . . . . 0.0 111.368 -168.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.03 145.48 19.55 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.501 2.801 . . . . 0.0 111.379 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 128.1 34.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.902 0.881 . . . . 0.0 112.011 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.52 -15.4 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.823 1.649 . . . . 0.0 114.248 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.77 169.72 34.92 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.52 1.533 . . . . 0.0 113.017 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.98 136.66 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.963 1.705 . . . . 0.0 109.594 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -141.76 134.72 14.13 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.521 1.529 . . . . 0.0 109.213 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -58.44 159.38 19.88 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.916 3.078 . . . . 0.0 114.013 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.93 149.3 62.31 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.941 3.094 . . . . 0.0 113.022 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -70.54 -13.21 32.5 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.593 2.862 . . . . 0.0 113.201 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.7 p -82.4 -4.98 58.34 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.375 1.47 . . . . 0.0 113.565 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.73 173.94 53.9 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 125.232 1.396 . . . . 0.0 113.766 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.68 147.9 57.94 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.928 3.085 . . . . 0.0 111.449 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t -166.84 -53.38 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.48 1.112 . . . . 0.0 112.221 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.8 m -114.99 6.58 15.33 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.657 1.183 . . . . 0.0 113.479 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 126.781 2.134 . . . . 0.0 112.947 -178.424 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 17.6 m -77.16 -11.64 59.84 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 22.8 t -163.33 160.2 23.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.392 1.877 . . . . 0.0 110.284 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -81.74 -18.98 66.74 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.136 0.874 . . . . 0.0 113.888 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 t -169.97 179.54 3.56 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.366 1.466 . . . . 0.0 112.328 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.8 p -159.88 177.6 10.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.082 2.153 . . . . 0.0 110.097 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.69 -81.99 1.63 Allowed Glycine 0 C--N 1.343 0.922 0 C-N-CA 124.088 0.852 . . . . 0.0 112.617 -173.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp -81.24 -32.25 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -170.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -66.61 -41.47 88.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.843 0.857 . . . . 0.0 110.468 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -63.4 -38.54 91.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.0 112.278 170.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -65.46 -44.37 87.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.601 0.76 . . . . 0.0 111.799 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.21 -43.25 98.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.449 0.568 . . . . 0.0 111.365 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.4 -42.92 98.79 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.36 -39.05 78.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 112.56 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -60.96 -45.82 93.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.219 1.008 . . . . 0.0 111.308 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.5 m -58.34 -46.07 86.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 111.722 172.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.8 -27.01 73.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.368 0.985 . . . . 0.0 114.104 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.01 -8.23 57.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.556 1.143 . . . . 0.0 112.775 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.68 8.9 11.29 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.666 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 64.91 30.43 12.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.482 1.913 . . . . 0.0 113.71 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.0 mtm -117.69 173.69 6.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.724 2.01 . . . . 0.0 111.521 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 m -143.47 132.38 11.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.828 1.651 . . . . 0.0 108.885 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.46 152.48 30.08 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.066 2.51 . . . . 0.0 110.954 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.51 116.87 22.48 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.716 1.207 . . . . 0.0 110.801 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.74 156.95 17.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.465 1.506 . . . . 0.0 112.174 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -147.2 138.46 23.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.09 1.356 . . . . 0.0 110.185 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.88 148.88 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.999 1.32 . . . . 0.0 111.746 -168.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -138.5 136.43 36.12 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.222 1.809 . . . . 0.0 110.682 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.11 138.01 31.86 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.342 1.057 . . . . 0.0 111.063 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.91 162.49 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.295 1.438 . . . . 0.0 111.857 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.37 -172.61 47.22 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.83 1.205 . . . . 0.0 114.473 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -57.61 141.04 49.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.229 1.412 . . . . 0.0 112.066 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -62.5 -45.49 92.75 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -174.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -71.89 -27.51 62.89 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -118.43 48.58 1.4 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.823 2.049 . . . . 0.0 111.174 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -74.31 151.03 39.88 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.861 0.839 . . . . 0.0 113.057 -168.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.48 164.1 25.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.17 2.188 . . . . 0.0 110.734 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -134.02 124.15 25.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.866 1.267 . . . . 0.0 111.17 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 61.0 mtp -89.32 153.08 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 109.41 168.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 32.9 t -142.45 146.18 34.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.341 1.056 . . . . 0.0 111.042 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.548 1.939 . . . . 0.0 109.137 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -144.86 142.56 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.495 1.118 . . . . 0.0 111.726 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -137.49 160.27 39.59 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.056 2.142 . . . . 0.0 110.466 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.7 t -139.91 135.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.83 1.652 . . . . 0.0 108.297 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.38 129.54 42.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.002 0.921 . . . . 0.0 111.702 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.54 0.43 64.8 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.576 1.084 . . . . 0.0 114.73 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.32 129.28 52.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.205 1.402 . . . . 0.0 110.529 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.86 -22.29 50.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -71.64 156.31 39.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.665 1.186 . . . . 0.0 113.243 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.67 118.61 17.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.939 1.295 . . . . 0.0 109.573 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.1 150.4 23.83 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.4 ptm -148.75 151.65 35.21 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.52 177.98 29.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.916 1.722 . . . . 0.0 112.926 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -151.75 155.67 38.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.13 1.372 . . . . 0.0 110.691 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 t -166.99 -176.61 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.861 1.264 . . . . 0.0 112.428 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 p -76.92 -10.68 59.53 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.647 1.579 . . . . 0.0 113.292 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -150.25 151.77 33.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.273 1.429 . . . . 0.0 112.176 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.81 -27.65 68.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -71.75 -53.27 13.99 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.17 -31.65 71.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.161 0.584 . . . . 0.0 112.256 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.63 98.92 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.738 -0.601 . . . . 0.0 112.275 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -65.26 -41.32 94.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 m -60.27 -37.59 80.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.308 0.958 . . . . 0.0 112.555 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -73.71 -37.41 65.17 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.365 -0.835 . . . . 0.0 111.517 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.55 -42.93 98.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.762 0.825 . . . . 0.0 112.316 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.33 85.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.934 0.894 . . . . 0.0 111.454 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -56.87 -38.07 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.063 0.545 . . . . 0.0 112.445 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.47 -34.67 65.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.816 1.246 . . . . 0.0 112.86 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -73.38 -37.85 65.86 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.317 -0.864 . . . . 0.0 112.157 172.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.2 -35.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 121.52 -0.737 . . . . 0.0 110.973 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.24 87.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.229 0.612 . . . . 0.0 111.496 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.19 -45.15 89.6 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.897 -1.127 . . . . 0.0 112.391 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.5 mt -60.71 -34.22 74.06 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.17 -43.55 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.758 0.823 . . . . 0.0 111.241 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -65.43 -24.99 67.33 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.1 pt -97.86 5.63 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.392 1.077 . . . . 0.0 113.671 170.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 68.06 21.64 8.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.529 1.932 . . . . 0.0 114.433 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -91.47 -5.05 54.88 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 113.195 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.2 t -137.24 137.95 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.176 2.19 . . . . 0.0 107.88 169.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.82 126.13 32.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.927 0.491 . . . . 0.0 109.898 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 p -55.3 -34.32 64.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.52 -15.35 57.65 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -91.26 -15.81 28.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.56 1.144 . . . . 0.0 113.126 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.42 123.25 86.87 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.055 0.942 . . . . 0.0 111.142 -169.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.59 150.11 14.69 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.504 2.803 . . . . 0.0 111.593 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.52 134.28 35.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.216 1.006 . . . . 0.0 111.181 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.03 -19.4 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.227 1.411 . . . . 0.0 114.123 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.77 151.88 18.1 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.218 1.866 . . . . 0.0 111.609 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.8 mt -129.65 124.72 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.069 1.348 . . . . 0.0 109.201 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -146.26 130.64 8.72 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 126.001 1.721 . . . . 0.0 108.432 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.6 156.76 53.43 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.174 2.583 . . . . 0.0 111.772 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -56.24 124.08 15.4 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.654 2.903 . . . . 0.0 112.521 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -82.75 161.62 16.38 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.671 2.914 . . . . 0.0 111.83 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 m -74.49 -3.49 31.08 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.16 -124.73 34.44 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.284 -1.287 . . . . 0.0 111.137 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.55 -11.68 17.05 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.295 2.663 . . . . 0.0 113.274 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.3 m -82.71 6.43 18.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.3 p -77.29 -10.7 59.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.884 1.274 . . . . 0.0 114.266 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 C-N-CA 125.341 1.448 . . . . 0.0 113.101 178.621 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 45.9 p -89.08 -9.97 49.15 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.1 t -163.61 151.24 12.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.685 1.594 . . . . 0.0 111.043 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -78.63 172.32 55.23 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.671 1.129 . . . . 0.0 113.898 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.5 p -159.63 174.51 14.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.492 1.517 . . . . 0.0 111.611 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 t -159.88 145.05 15.24 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.876 -1.14 . . . . 0.0 112.258 -172.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.3 64.46 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 124.119 0.866 . . . . 0.0 114.051 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp -77.11 -33.08 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.19 1.495 . . . . 0.0 112.3 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.1 -42.45 84.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.011 0.925 . . . . 0.0 110.343 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -67.76 -31.11 70.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.903 0.881 . . . . 0.0 112.977 171.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -67.74 -41.84 82.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.241 0.928 . . . . 0.0 111.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.26 -43.86 96.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.661 0.664 . . . . 0.0 111.081 173.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.59 -42.56 99.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.8 79.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.547 1.139 . . . . 0.0 112.782 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.83 -46.94 87.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.901 0.881 . . . . 0.0 111.407 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 m -57.55 -44.67 85.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.916 0.887 . . . . 0.0 111.937 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.18 -26.52 72.52 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.336 0.969 . . . . 0.0 114.001 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -77.92 -7.86 57.33 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.49 1.116 . . . . 0.0 112.785 172.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -119.44 8.91 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.261 2.224 . . . . 0.0 112.797 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 63.62 28.44 15.09 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.426 1.89 . . . . 0.0 113.58 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.36 172.51 6.87 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.865 2.066 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 m -140.73 129.22 12.7 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.207 1.803 . . . . 0.0 108.609 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.57 145.88 26.69 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.056 2.504 . . . . 0.0 110.753 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.15 115.49 26.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.57 1.148 . . . . 0.0 110.681 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -99.1 156.85 16.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.448 1.499 . . . . 0.0 112.221 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.98 149.06 32.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.338 1.455 . . . . 0.0 110.097 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.4 mt -131.93 146.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.652 1.581 . . . . 0.0 110.756 -169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 -145.11 134.2 22.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.56 1.544 . . . . 0.0 111.164 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.43 138.64 31.31 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.599 1.16 . . . . 0.0 111.618 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -148.61 155.33 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.346 1.458 . . . . 0.0 112.2 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.93 -157.46 28.44 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.525 1.059 . . . . 0.0 113.599 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -67.42 141.77 56.9 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.827 1.251 . . . . 0.0 112.674 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -63.92 -25.37 68.12 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -95.69 -50.18 5.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.768 1.227 . . . . 0.0 111.22 174.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -85.66 62.77 7.67 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.218 1.407 . . . . 0.0 110.113 173.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -69.12 143.35 54.18 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.816 1.646 . . . . 0.0 111.541 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -133.27 159.71 39.44 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.649 1.579 . . . . 0.0 110.943 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.94 130.69 39.91 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.338 1.055 . . . . 0.0 111.639 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.8 mtp -95.97 155.31 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.398 1.479 . . . . 0.0 108.822 167.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.5 t -142.27 149.77 40.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.251 1.021 . . . . 0.0 110.285 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.57 151.05 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.754 1.622 . . . . 0.0 109.861 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.78 142.23 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.687 1.195 . . . . 0.0 111.503 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -139.78 158.0 44.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.539 1.936 . . . . 0.0 110.066 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.77 135.5 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.443 1.497 . . . . 0.0 108.748 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.95 129.22 40.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 0.0 111.598 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.84 2.44 66.88 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.434 1.016 . . . . 0.0 114.482 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.95 127.28 44.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.451 1.5 . . . . 0.0 110.039 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -79.51 -11.52 59.89 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.3 155.8 29.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.506 1.122 . . . . 0.0 113.048 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.18 107.73 8.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 109.021 170.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.0 144.12 21.7 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ptm -149.11 152.84 36.85 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.01 -178.11 28.12 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.157 1.837 . . . . 0.0 112.663 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -154.9 162.58 41.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 112.877 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.5 t -168.59 -178.01 3.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.959 1.703 . . . . 0.0 111.154 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.4 m -74.63 -14.81 60.81 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.329 1.452 . . . . 0.0 112.139 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -138.97 146.83 41.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.628 1.571 . . . . 0.0 112.422 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.92 -28.22 67.31 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.24 -42.86 79.1 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.398 0.999 . . . . 0.0 112.014 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.81 -33.03 64.01 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.578 -0.701 . . . . 0.0 112.031 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.82 -46.01 89.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.825 -0.547 . . . . 0.0 111.674 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.29 -38.05 89.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.69 0.796 . . . . 0.0 112.271 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m -64.14 -38.39 90.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.729 0.695 . . . . 0.0 112.069 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -73.76 -37.19 65.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.377 0.671 . . . . 0.0 111.335 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.46 96.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.648 0.779 . . . . 0.0 112.381 170.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.36 77.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.005 0.922 . . . . 0.0 111.204 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -57.8 -40.26 79.51 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.916 0.486 . . . . 0.0 112.005 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.27 -32.37 70.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.35 -38.31 50.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.72 -0.613 . . . . 0.0 112.196 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -61.75 -41.29 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -59.87 -33.87 72.38 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 112.132 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -67.31 -44.43 79.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.054 -1.654 . . . . 0.0 112.03 169.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.94 -32.45 71.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.28 -44.7 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.002 0.921 . . . . 0.0 111.367 169.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -62.73 -22.66 66.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.29 8.12 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.799 1.239 . . . . 0.0 114.086 172.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 68.46 20.73 8.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.041 1.736 . . . . 0.0 114.321 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -93.19 -6.04 48.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.35 1.46 . . . . 0.0 113.298 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.53 139.27 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.887 2.075 . . . . 0.0 107.796 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -88.95 133.14 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.865 -0.522 . . . . 0.0 110.696 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -57.12 -35.39 69.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.09 -15.21 55.91 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -89.07 -17.5 29.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.359 1.063 . . . . 0.0 113.025 174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.23 123.78 85.88 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.055 0.942 . . . . 0.0 110.462 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -78.62 159.87 28.39 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.354 2.702 . . . . 0.0 112.581 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.69 170.54 20.63 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.503 1.921 . . . . 0.0 110.469 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.45 -21.02 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.228 1.411 . . . . 0.0 114.723 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.62 133.98 2.84 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.522 1.534 . . . . 0.0 111.653 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.5 mt -130.9 109.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.923 1.289 . . . . 0.0 108.976 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 m -151.98 149.07 22.63 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.84 2.056 . . . . 0.0 110.176 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.46 131.21 17.19 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.032 2.488 . . . . 0.0 110.287 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.96 140.1 22.56 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.978 2.452 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.58 -20.98 11.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.198 2.599 . . . . 0.0 113.054 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.4 t -170.47 162.32 8.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.613 1.965 . . . . 0.0 110.509 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.64 157.92 20.83 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.788 1.185 . . . . 0.0 113.635 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.82 143.01 26.08 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.798 2.999 . . . . 0.0 111.355 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.8 p -148.01 3.63 0.71 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.0 m -170.2 159.11 7.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.374 2.27 . . . . 0.0 110.631 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.848 179.314 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 29.0 m -124.39 7.21 8.36 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -170.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 19.5 m 68.48 -10.61 0.45 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 127.284 2.234 . . . . 0.0 116.029 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -85.42 150.45 24.59 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.279 1.419 . . . . 0.0 112.585 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.3 p -134.07 5.32 3.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.621 1.168 . . . . 0.0 113.935 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.7 m -75.82 104.68 6.47 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.77 -1.206 . . . . 0.0 111.49 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.1 -14.55 81.73 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 123.869 0.747 . . . . 0.0 114.928 -170.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -65.27 -31.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.803 1.302 . . . . 0.0 113.293 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.97 78.2 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.549 -0.719 . . . . 0.0 111.509 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -76.91 -29.55 55.76 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.911 0.885 . . . . 0.0 112.553 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.49 -45.35 83.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.94 -43.07 99.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.155 0.434 . . . . 0.0 111.371 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -62.55 -42.71 99.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.248 0.619 . . . . 0.0 112.628 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.34 -41.11 81.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.345 1.058 . . . . 0.0 112.449 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.83 -45.28 95.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.943 . . . . 0.0 111.66 174.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.04 -44.1 91.72 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.882 0.873 . . . . 0.0 111.877 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.55 73.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.611 1.101 . . . . 0.0 114.163 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.5 -8.08 58.16 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.467 1.134 . . . . 0.0 112.846 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -119.72 8.17 11.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.071 2.149 . . . . 0.0 112.912 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm 66.75 28.54 8.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.742 2.017 . . . . 0.0 113.617 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.9 mtm -116.71 172.15 7.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 111.627 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.3 m -142.55 130.47 11.4 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 126.185 1.794 . . . . 0.0 108.771 174.386 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.9 136.59 18.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.906 2.404 . . . . 0.0 110.339 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.14 114.59 27.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.499 1.12 . . . . 0.0 111.437 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.04 152.27 19.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.746 1.218 . . . . 0.0 112.867 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.54 148.34 40.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.307 1.843 . . . . 0.0 108.971 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.23 147.04 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.017 1.327 . . . . 0.0 111.653 -168.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -139.5 137.38 35.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.707 1.603 . . . . 0.0 110.975 176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.88 139.69 31.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.328 1.051 . . . . 0.0 111.338 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 m -146.84 176.78 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.33 1.852 . . . . 0.0 110.774 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.91 -149.74 19.27 Favored Glycine 0 N--CA 1.472 1.034 0 C-N-CA 124.339 0.971 . . . . 0.0 113.058 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -116.84 161.18 19.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.24 1.416 . . . . 0.0 112.364 -174.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -62.73 -21.31 65.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -96.86 -11.57 24.64 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.217 1.407 . . . . 0.0 113.648 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -159.3 98.57 1.43 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.943 1.697 . . . . 0.0 110.261 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -93.08 150.55 20.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.712 1.205 . . . . 0.0 111.062 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -138.08 167.03 22.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.216 2.207 . . . . 0.0 110.719 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.19 138.09 46.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.126 1.37 . . . . 0.0 111.203 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.6 mtm -103.38 153.85 20.03 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.094 1.757 . . . . 0.0 109.386 169.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 t -144.19 146.28 32.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.385 1.074 . . . . 0.0 111.886 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.38 136.8 50.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.546 1.938 . . . . 0.0 108.827 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.16 135.78 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.215 1.006 . . . . 0.0 111.657 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.94 153.37 42.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.11 135.61 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.645 1.578 . . . . 0.0 108.546 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.08 139.3 57.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.108 0.963 . . . . 0.0 112.06 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.69 -4.07 86.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.768 1.175 . . . . 0.0 114.916 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -117.72 133.01 56.39 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.895 1.347 . . . . 0.0 111.136 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -81.55 -16.03 52.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -83.42 157.55 22.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.69 1.196 . . . . 0.0 112.393 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.43 129.14 32.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.689 1.195 . . . . 0.0 109.856 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.23 144.5 28.44 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.4 mtm -134.7 135.46 42.02 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.802 1.241 . . . . 0.0 111.486 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.24 173.41 28.26 Favored Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.984 1.278 . . . . 0.0 113.259 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -154.6 160.32 41.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.433 1.093 . . . . 0.0 111.873 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -169.04 -173.6 1.83 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.418 1.487 . . . . 0.0 111.815 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -74.09 -12.49 60.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.525 1.53 . . . . 0.0 113.436 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.67 151.74 34.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.476 1.511 . . . . 0.0 111.822 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.56 -29.63 70.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.16 -46.63 41.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.082 0.953 . . . . 0.0 112.066 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.65 -28.45 60.86 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.492 -0.755 . . . . 0.0 112.05 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.89 89.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.657 -0.652 . . . . 0.0 111.756 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.1 -40.62 94.41 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.393 0.677 . . . . 0.0 111.872 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 m -64.22 -37.38 87.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.576 0.625 . . . . 0.0 112.057 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -72.83 -36.26 67.46 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.552 -0.717 . . . . 0.0 111.598 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.72 94.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.888 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.95 82.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 111.461 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -56.9 -41.29 77.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.302 0.501 . . . . 0.0 111.794 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -28.14 66.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -80.87 -37.71 29.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.703 0.683 . . . . 0.0 112.672 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.58 -40.54 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.961 0.8 . . . . 0.0 110.534 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -55.14 -47.51 74.97 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 170.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.18 -44.07 92.17 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.112 -0.993 . . . . 0.0 112.59 173.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.38 -35.9 80.61 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.51 -42.73 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.687 0.795 . . . . 0.0 111.071 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -66.36 -13.4 60.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.8 pt -114.04 9.92 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.21 1.404 . . . . 0.0 113.252 170.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 m120 67.23 17.52 10.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.507 1.923 . . . . 0.0 114.592 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.9 -11.09 57.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.242 1.417 . . . . 0.0 113.139 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -134.35 138.07 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.546 1.938 . . . . 0.0 107.923 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.72 126.13 32.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.826 0.451 . . . . 0.0 109.929 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.17 -33.04 62.63 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.38 61.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.943 1.297 . . . . 0.0 113.579 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -91.66 -16.51 26.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.627 1.171 . . . . 0.0 113.304 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -77.5 126.07 85.2 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.213 1.005 . . . . 0.0 110.871 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.26 150.98 37.85 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.299 2.666 . . . . 0.0 111.962 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.79 156.88 43.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.509 1.524 . . . . 0.0 111.688 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -14.98 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -174.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.85 177.0 47.73 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.084 1.326 . . . . 0.0 113.477 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.23 141.14 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.191 1.797 . . . . 0.0 109.846 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 m -140.4 150.58 61.49 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.093 1.757 . . . . 0.0 110.948 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.99 164.16 36.34 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.433 2.755 . . . . 0.0 111.81 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.28 145.88 85.08 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.797 2.998 . . . . 0.0 112.481 175.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -57.7 -23.62 58.71 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.679 2.919 . . . . 0.0 114.905 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 m -78.02 -7.23 56.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.423 1.089 . . . . 0.0 113.84 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.59 45.65 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 125.15 1.357 . . . . 0.0 113.825 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -66.26 -33.7 38.39 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.7 2.933 . . . . 0.0 114.006 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m 66.85 -9.78 0.34 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 127.307 2.243 . . . . 0.0 115.507 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.9 p -165.01 166.07 19.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.464 1.905 . . . . 0.0 111.695 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.251 -1.305 . . . . 0.0 112.887 179.627 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 8.7 t -163.69 175.43 10.58 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.636 1.574 . . . . 0.0 110.949 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.4 t -161.84 154.61 20.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.492 1.517 . . . . 0.0 111.572 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -89.45 165.75 32.71 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.938 1.256 . . . . 0.0 113.625 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.1 t -162.38 156.49 21.37 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.287 1.435 . . . . 0.0 111.234 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -169.2 140.57 2.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.972 1.709 . . . . 0.0 110.367 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.32 -38.5 81.27 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.183 -0.787 . . . . 0.0 113.817 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 tp -77.13 -34.5 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.843 1.321 . . . . 0.0 112.247 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.74 -43.28 84.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.167 0.987 . . . . 0.0 110.313 174.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.94 -31.82 72.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 112.821 172.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.49 -42.91 77.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.994 0.815 . . . . 0.0 111.734 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.71 -42.88 99.87 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.626 0.648 . . . . 0.0 111.234 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -63.01 -42.28 99.79 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.05 -40.22 78.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.484 1.114 . . . . 0.0 112.434 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -60.42 -45.64 92.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.952 0.901 . . . . 0.0 111.456 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.7 m -58.05 -45.43 87.05 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.648 0.779 . . . . 0.0 111.758 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.81 -26.82 73.12 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.491 1.043 . . . . 0.0 114.145 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -78.92 -7.5 58.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.545 1.173 . . . . 0.0 112.876 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.55 9.21 11.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.166 2.187 . . . . 0.0 112.709 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.98 31.45 11.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.451 1.9 . . . . 0.0 113.549 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.3 mtm -119.79 172.83 7.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.804 2.041 . . . . 0.0 111.56 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.94 131.04 11.26 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.26 1.824 . . . . 0.0 108.755 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.82 147.37 24.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.954 2.436 . . . . 0.0 110.734 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.93 117.35 27.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.648 1.179 . . . . 0.0 110.761 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.3 156.52 17.19 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.328 1.451 . . . . 0.0 112.343 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.22 149.65 33.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.102 1.361 . . . . 0.0 110.318 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -134.26 147.89 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.566 1.547 . . . . 0.0 111.867 -168.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -135.44 138.3 43.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.773 1.629 . . . . 0.0 110.792 170.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.93 145.67 35.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.754 0.822 . . . . 0.0 111.622 171.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 m -148.28 172.27 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.875 2.07 . . . . 0.0 110.456 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.46 176.64 50.48 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.092 0.853 . . . . 0.0 113.894 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.37 163.07 20.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.356 1.062 . . . . 0.0 112.988 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -58.17 -36.43 73.02 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.322 1.449 . . . . 0.0 114.148 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -70.68 -28.09 64.5 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -150.37 90.39 1.65 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.978 1.711 . . . . 0.0 110.238 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -78.94 148.12 32.77 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.191 0.996 . . . . 0.0 110.703 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -132.57 166.17 22.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.754 2.021 . . . . 0.0 110.905 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -135.46 131.78 36.58 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.906 1.282 . . . . 0.0 111.343 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 mtm -99.17 152.14 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.612 1.565 . . . . 0.0 108.937 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -146.06 147.71 31.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 111.515 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.88 156.19 44.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.331 1.452 . . . . 0.0 110.757 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.48 143.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.892 1.277 . . . . 0.0 111.254 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -138.08 157.68 45.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.246 1.818 . . . . 0.0 110.688 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -140.62 135.92 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.851 1.661 . . . . 0.0 108.319 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.15 129.38 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.101 0.96 . . . . 0.0 111.731 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.95 0.62 65.97 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.653 1.12 . . . . 0.0 114.715 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -119.29 131.06 55.7 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.228 1.411 . . . . 0.0 110.631 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -77.85 -24.76 48.51 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -75.11 155.93 36.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.287 1.035 . . . . 0.0 113.144 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.44 114.22 15.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.261 1.424 . . . . 0.0 108.669 169.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.49 143.89 25.11 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mtp -137.98 146.64 43.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.28 177.67 31.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.789 1.662 . . . . 0.0 112.895 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -155.67 159.2 39.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.492 1.117 . . . . 0.0 111.981 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -169.2 -179.44 3.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.134 1.374 . . . . 0.0 112.083 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 m -78.64 -13.13 59.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.395 1.478 . . . . 0.0 112.101 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.21 142.89 47.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.238 1.415 . . . . 0.0 111.628 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.98 -30.81 71.86 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -69.85 -42.25 73.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.359 -0.838 . . . . 0.0 111.543 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.72 -29.46 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.456 0.702 . . . . 0.0 112.03 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.94 90.11 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.636 -0.665 . . . . 0.0 111.817 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -62.81 -39.13 93.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.509 0.724 . . . . 0.0 111.775 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.9 m -63.19 -36.42 83.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.558 0.617 . . . . 0.0 112.27 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -75.38 -34.11 61.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 111.749 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.08 91.48 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.523 -0.735 . . . . 0.0 111.924 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.81 83.18 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.29 1.036 . . . . 0.0 111.686 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -52.48 -44.4 65.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.337 1.055 . . . . 0.0 111.647 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.63 -35.98 70.61 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -73.41 -37.33 65.95 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.406 0.548 . . . . 0.0 112.428 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.05 -43.15 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.357 -0.84 . . . . 0.0 110.169 171.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -61.73 -33.68 74.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -63.9 -45.8 87.7 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.062 -1.649 . . . . 0.0 111.882 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.89 -33.84 74.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.531 0.732 . . . . 0.0 112.735 176.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.01 -43.89 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.842 0.857 . . . . 0.0 111.291 170.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -63.78 -21.1 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -106.03 6.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.794 1.238 . . . . 0.0 113.959 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 70.53 16.03 7.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.829 2.052 . . . . 0.0 114.82 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.25 -6.72 58.46 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.356 1.462 . . . . 0.0 113.364 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 74.5 t -135.05 137.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.058 2.143 . . . . 0.0 107.473 168.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -86.47 128.37 34.95 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.994 -0.441 . . . . 0.0 110.165 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.9 p -53.52 -33.13 53.39 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.12 -20.71 62.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.702 1.601 . . . . 0.0 113.339 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -88.37 -17.84 29.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 113.091 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.38 127.13 85.37 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.329 1.052 . . . . 0.0 110.258 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.79 144.08 38.4 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.128 2.552 . . . . 0.0 111.46 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.89 163.89 39.29 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.513 1.525 . . . . 0.0 111.406 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.63 -15.88 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.469 1.507 . . . . 0.0 114.711 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -178.82 175.37 47.3 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.988 1.756 . . . . 0.0 112.323 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.8 mt -85.84 111.8 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 m -146.45 151.97 44.74 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 126.106 1.763 . . . . 0.0 111.098 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.95 158.53 56.39 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.31 2.673 . . . . 0.0 111.318 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.3 148.11 67.34 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.37 2.713 . . . . 0.0 111.641 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.92 163.52 33.17 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.899 3.066 . . . . 0.0 112.404 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 t -159.4 151.85 21.3 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.449 1.5 . . . . 0.0 110.659 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.38 -152.15 37.39 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 118.976 -0.902 . . . . 0.0 112.314 -172.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -56.78 148.06 68.39 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.331 3.354 . . . . 0.0 113.214 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 m -73.83 -5.24 39.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.9 m -146.23 145.83 30.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.03 1.732 . . . . 0.0 111.238 -175.199 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.88 178.893 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 76.7 p -164.56 165.15 21.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.297 1.439 . . . . 0.0 111.748 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 17.3 m -164.72 157.49 16.68 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.563 1.945 . . . . 0.0 110.665 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -176.29 162.08 30.69 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.994 0.807 . . . . 0.0 114.041 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.2 t -168.16 -161.52 0.37 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.807 2.043 . . . . 0.0 109.757 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.2 p -152.59 169.28 23.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.029 1.332 . . . . 0.0 112.484 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.68 -33.37 84.17 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 121.614 -0.679 . . . . 0.0 112.898 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.3 tp -79.03 -34.45 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.56 1.18 . . . . 0.0 112.268 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -60.82 -46.18 91.55 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.463 0.705 . . . . 0.0 111.162 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -64.46 -36.49 84.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.335 0.654 . . . . 0.0 112.346 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.21 -45.31 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.741 0.7 . . . . 0.0 111.87 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.92 -43.22 96.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.66 0.664 . . . . 0.0 111.246 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -63.66 -43.02 97.95 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.0 88.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.901 0.88 . . . . 0.0 112.568 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -61.55 -45.52 93.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.769 0.827 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.36 -45.93 90.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.706 0.802 . . . . 0.0 111.751 172.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.56 -27.11 73.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.419 1.009 . . . . 0.0 113.963 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.14 -8.84 58.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.389 1.094 . . . . 0.0 112.715 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.63 8.83 11.31 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.248 2.219 . . . . 0.0 112.656 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 64.95 32.58 10.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.536 1.935 . . . . 0.0 113.547 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.1 mtm -120.46 171.73 8.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.741 2.016 . . . . 0.0 111.735 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -142.71 130.53 11.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 126.192 1.797 . . . . 0.0 109.011 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 145.22 23.27 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.151 2.567 . . . . 0.0 110.903 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.34 129.52 49.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.912 1.285 . . . . 0.0 111.046 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -114.72 160.1 19.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.997 1.319 . . . . 0.0 113.484 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.6 144.21 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.162 1.785 . . . . 0.0 109.075 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -130.03 144.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.596 1.558 . . . . 0.0 109.649 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.7 ttm105 -143.9 129.9 19.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 111.458 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.72 137.19 34.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.024 0.93 . . . . 0.0 111.721 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -146.35 176.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 126.537 1.935 . . . . 0.0 110.616 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.4 -146.28 18.89 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.011 0.815 . . . . 0.0 112.666 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -116.1 164.39 14.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.018 1.327 . . . . 0.0 112.32 -174.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -61.84 -38.95 90.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.107 0.963 . . . . 0.0 113.104 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -80.17 -25.02 39.96 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.946 1.298 . . . . 0.0 114.349 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -142.93 87.06 1.96 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.504 1.921 . . . . 0.0 109.955 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -91.0 149.64 21.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.733 1.213 . . . . 0.0 110.853 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -136.77 164.3 28.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.729 2.012 . . . . 0.0 110.754 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.89 125.3 28.02 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.93 1.292 . . . . 0.0 111.126 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.1 mtp -89.47 155.35 19.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.055 1.342 . . . . 0.0 108.951 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.6 t -143.43 147.82 35.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.956 0.903 . . . . 0.0 111.536 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -129.12 145.12 51.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.302 1.841 . . . . 0.0 108.884 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.53 142.78 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.655 1.182 . . . . 0.0 111.439 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -137.88 157.15 47.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.656 1.982 . . . . 0.0 110.67 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.64 135.36 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.079 1.752 . . . . 0.0 108.282 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.82 129.6 42.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.146 0.978 . . . . 0.0 111.766 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 0.9 65.42 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.588 1.089 . . . . 0.0 114.762 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.23 132.09 54.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.65 -14.87 50.86 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.74 155.84 25.29 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.657 1.183 . . . . 0.0 112.675 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.26 120.14 25.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.847 1.259 . . . . 0.0 109.284 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 140.87 24.76 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.0 mtt -135.17 142.53 46.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.42 172.07 27.09 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 125.782 1.658 . . . . 0.0 113.35 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -158.32 149.69 21.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.776 1.23 . . . . 0.0 111.392 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.57 179.84 4.7 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.796 1.238 . . . . 0.0 112.703 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.5 p -78.51 -8.84 58.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.88 1.672 . . . . 0.0 112.999 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -137.87 142.75 40.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.661 1.584 . . . . 0.0 111.373 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.39 -42.34 95.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 113.231 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -66.96 -37.53 84.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.76 -29.71 58.9 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.475 -0.766 . . . . 0.0 111.834 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.1 -44.44 79.99 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.688 -0.632 . . . . 0.0 111.413 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.56 -39.07 86.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 112.031 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 m -67.25 -34.58 77.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.805 0.73 . . . . 0.0 112.413 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -71.72 -38.52 70.48 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.531 -0.731 . . . . 0.0 111.72 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.59 92.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.587 0.631 . . . . 0.0 111.644 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.23 82.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.346 1.058 . . . . 0.0 111.544 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -58.35 -39.48 79.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.202 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.35 -29.52 62.7 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.197 0.908 . . . . 0.0 113.2 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.38 -39.71 62.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.443 -0.786 . . . . 0.0 111.863 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.45 -40.93 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.49 -0.756 . . . . 0.0 110.761 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.44 -50.62 71.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.739 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.35 -41.41 63.02 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.086 1.312 . . . . 0.0 113.731 172.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.36 -22.52 66.98 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.7 -38.12 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.507 1.049 . . . . 0.0 110.726 168.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -59.74 -29.54 68.22 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.974 0.91 . . . . 0.0 112.35 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.63 4.93 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.047 1.339 . . . . 0.0 114.339 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 69.73 16.29 7.92 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.699 2.0 . . . . 0.0 115.162 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -83.91 -8.98 59.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.35 1.46 . . . . 0.0 113.392 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.96 141.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.792 2.037 . . . . 0.0 108.259 168.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.82 129.82 36.15 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.484 0.713 . . . . 0.0 110.218 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.6 p -55.26 -32.61 62.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.16 -19.38 53.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.837 1.255 . . . . 0.0 113.613 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -90.51 -16.77 28.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.645 1.178 . . . . 0.0 113.41 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.8 t -79.8 126.25 80.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.399 1.079 . . . . 0.0 110.851 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.24 155.57 32.98 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.448 2.765 . . . . 0.0 112.537 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.65 165.67 34.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.121 1.768 . . . . 0.0 111.218 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -18.58 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 125.314 1.446 . . . . 0.0 114.51 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.38 156.47 28.27 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.965 1.745 . . . . 0.0 111.879 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.1 mp -83.26 96.55 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 p -165.93 139.75 3.61 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 126.402 1.881 . . . . 0.0 110.018 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.84 150.87 75.03 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.296 2.664 . . . . 0.0 112.873 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.21 151.37 60.69 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.351 2.701 . . . . 0.0 111.39 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.24 144.86 37.86 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.664 2.909 . . . . 0.0 111.672 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.9 m -80.48 -3.86 51.59 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.34 157.43 44.48 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 124.663 1.125 . . . . 0.0 113.589 -177.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.36 161.64 37.41 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.077 3.185 . . . . 0.0 111.543 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.0 m -64.79 -12.31 46.39 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.1 m -80.6 -7.98 59.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.386 1.474 . . . . 0.0 113.946 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 CA-C-O 118.247 -1.307 . . . . 0.0 113.465 -179.562 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 10.2 m -77.01 -12.69 59.97 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 70.4 m -144.79 153.67 41.89 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.81 1.644 . . . . 0.0 111.066 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -78.59 -7.51 88.05 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.204 0.907 . . . . 0.0 115.013 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.0 t -165.91 176.42 7.86 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.597 1.959 . . . . 0.0 110.656 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 t -158.79 127.81 5.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.699 1.599 . . . . 0.0 110.133 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.86 -80.72 1.33 Allowed Glycine 0 C--N 1.341 0.847 0 C-N-CA 124.803 1.192 . . . . 0.0 112.784 -170.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp -75.49 -36.55 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -169.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -40.65 88.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.931 0.892 . . . . 0.0 110.587 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.94 -36.4 84.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.439 1.496 . . . . 0.0 112.258 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -70.33 -41.41 73.26 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.926 0.891 . . . . 0.0 112.106 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.2 tp -62.64 -43.48 98.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.917 0.781 . . . . 0.0 111.143 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.59 -43.75 98.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.12 0.568 . . . . 0.0 112.52 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.85 88.29 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.167 0.987 . . . . 0.0 112.779 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.85 -45.8 92.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.139 0.976 . . . . 0.0 111.525 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.3 m -58.41 -45.33 88.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.542 0.737 . . . . 0.0 111.708 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.05 -26.12 73.32 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.355 0.979 . . . . 0.0 114.159 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.18 -8.68 58.6 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.498 1.149 . . . . 0.0 112.819 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -119.72 9.53 11.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.203 2.201 . . . . 0.0 112.669 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.02 29.66 12.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.408 1.883 . . . . 0.0 113.648 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.3 mtm -116.77 172.42 7.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.708 2.003 . . . . 0.0 111.547 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 m -141.96 130.72 12.07 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.116 1.766 . . . . 0.0 108.752 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.39 146.23 24.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.988 2.459 . . . . 0.0 110.578 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.56 114.8 23.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.597 1.159 . . . . 0.0 110.806 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.13 156.95 16.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.444 1.498 . . . . 0.0 112.287 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -146.47 151.74 37.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.598 1.559 . . . . 0.0 109.805 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.42 139.87 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 0.0 111.299 -169.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -122.52 154.01 38.43 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.264 2.626 . . . . 0.0 109.662 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.52 141.38 48.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.466 1.107 . . . . 0.0 111.55 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.1 m -149.56 176.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.132 1.773 . . . . 0.0 111.102 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.78 -142.33 15.99 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 124.355 0.978 . . . . 0.0 112.427 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -128.47 165.45 20.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.516 1.526 . . . . 0.0 111.863 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -59.23 -34.57 72.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.135 0.974 . . . . 0.0 113.467 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -97.47 2.64 50.52 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.15 1.78 . . . . 0.0 113.726 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -153.62 72.84 0.93 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.288 1.835 . . . . 0.0 109.695 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -75.97 138.55 41.02 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.068 0.947 . . . . 0.0 110.848 -174.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -142.8 162.36 35.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 125.482 1.513 . . . . 0.0 111.061 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.75 149.72 49.26 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.836 1.255 . . . . 0.0 111.842 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.2 mtp -118.66 155.05 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.688 1.995 . . . . 0.0 109.081 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.31 154.78 40.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.574 0.75 . . . . 0.0 111.271 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.12 144.85 31.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.243 1.817 . . . . 0.0 109.475 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.24 142.21 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.2 1.0 . . . . 0.0 111.821 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -136.31 160.14 39.62 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.657 1.983 . . . . 0.0 110.482 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.59 136.11 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.746 1.618 . . . . 0.0 108.435 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.45 129.57 42.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 111.674 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.24 1.38 66.88 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.612 1.101 . . . . 0.0 114.601 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -124.08 131.47 53.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.334 1.454 . . . . 0.0 110.437 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -81.87 -12.14 58.6 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -83.77 157.06 22.23 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.461 1.104 . . . . 0.0 113.228 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.35 112.87 13.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.906 1.282 . . . . 0.0 109.348 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.44 142.38 23.81 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.43 148.91 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.5 170.09 26.26 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.116 1.817 . . . . 0.0 113.594 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -155.93 150.69 26.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.573 1.149 . . . . 0.0 112.001 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -168.87 -174.62 2.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.897 1.279 . . . . 0.0 112.381 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 p -77.04 -13.19 59.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.659 1.584 . . . . 0.0 113.407 173.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -148.26 152.33 36.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 112.286 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.08 -29.02 68.68 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.78 -51.45 33.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.339 -0.851 . . . . 0.0 111.369 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.61 -28.89 64.11 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.664 -0.648 . . . . 0.0 112.675 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.2 99.34 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.503 -0.748 . . . . 0.0 111.804 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -64.23 -40.33 95.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.31 0.644 . . . . 0.0 111.899 172.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -61.39 -35.92 78.84 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.277 0.944 . . . . 0.0 112.735 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.77 -37.34 67.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.232 -0.918 . . . . 0.0 111.905 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -44.78 90.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.741 0.701 . . . . 0.0 111.625 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.86 83.98 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.46 1.104 . . . . 0.0 111.537 173.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -54.58 -43.85 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 111.682 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.11 -29.29 62.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.119 0.872 . . . . 0.0 113.348 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.39 -38.09 50.64 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.462 -0.774 . . . . 0.0 112.154 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.98 -40.58 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.271 -0.893 . . . . 0.0 110.43 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -56.52 -49.12 75.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.411 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.87 -41.84 64.69 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.384 1.447 . . . . 0.0 113.767 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.1 -22.63 67.01 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.95 -38.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.511 1.05 . . . . 0.0 110.799 168.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -59.8 -29.69 68.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.302 1.041 . . . . 0.0 112.431 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -105.5 5.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.993 1.317 . . . . 0.0 114.344 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 68.69 17.11 8.94 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.481 1.912 . . . . 0.0 115.041 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.69 -13.57 58.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.374 1.469 . . . . 0.0 113.376 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -137.87 139.69 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 108.888 171.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -85.09 133.64 34.22 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -54.89 -33.95 62.53 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.333 -0.854 . . . . 0.0 113.084 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.96 -21.81 33.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.193 1.397 . . . . 0.0 113.923 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.61 -16.55 28.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.353 1.061 . . . . 0.0 113.514 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.4 124.06 84.22 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.281 1.033 . . . . 0.0 111.098 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.05 126.58 7.16 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.281 2.654 . . . . 0.0 109.79 174.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.95 130.06 11.9 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.996 0.919 . . . . 0.0 112.023 -175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -9.78 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.172 1.389 . . . . 0.0 113.2 173.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.15 -158.47 30.83 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.899 1.714 . . . . 0.0 112.491 -176.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.1 mm -104.8 132.43 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.261 1.424 . . . . 0.0 109.532 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.02 133.16 13.07 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.735 1.614 . . . . 0.0 110.256 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -88.35 153.03 6.64 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.126 2.551 . . . . 0.0 112.486 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.48 169.51 20.95 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.833 3.022 . . . . 0.0 110.819 169.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.48 128.53 28.23 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.112 3.208 . . . . 0.0 112.043 171.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.2 t -168.54 179.87 4.15 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.323 1.449 . . . . 0.0 111.21 -171.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.74 -159.8 26.03 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.303 1.43 . . . . 0.0 113.464 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.64 154.24 37.94 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.553 3.502 . . . . 0.0 113.787 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.5 m -75.71 19.66 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.883 1.673 . . . . 0.0 114.739 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.6 m 70.28 6.2 5.68 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.206 2.202 . . . . 0.0 114.829 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.613 1.577 . . . . 0.0 112.876 178.078 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 17.9 m -162.1 150.15 14.67 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.51 1.924 . . . . 0.0 110.495 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 65.1 p -124.8 7.38 8.11 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.849 1.26 . . . . 0.0 114.233 -170.33 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -86.05 -150.31 15.02 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.293 1.425 . . . . 0.0 113.44 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m -72.52 3.22 5.13 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -173.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -58.53 -10.97 2.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.726 2.01 . . . . 0.0 115.515 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.98 -22.74 67.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.411 1.005 . . . . 0.0 113.889 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.2 tp -72.2 -31.59 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.341 1.57 . . . . 0.0 112.664 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -43.75 76.79 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.336 1.054 . . . . 0.0 109.991 174.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -65.76 -32.42 73.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.536 0.734 . . . . 0.0 112.68 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -69.47 -43.01 74.09 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.532 -0.73 . . . . 0.0 112.006 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.8 -43.69 98.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.717 0.69 . . . . 0.0 110.992 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.13 -43.16 99.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.214 0.606 . . . . 0.0 112.63 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.91 83.88 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 112.678 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -61.87 -45.21 94.75 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.951 0.9 . . . . 0.0 111.596 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.2 m -58.62 -45.05 90.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.688 0.795 . . . . 0.0 111.591 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.05 73.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.503 1.049 . . . . 0.0 114.134 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.41 -9.22 58.74 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.425 1.113 . . . . 0.0 112.744 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.327 2.251 . . . . 0.0 112.688 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 64.95 29.58 12.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.456 1.902 . . . . 0.0 113.672 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.2 mtm -116.14 172.21 7.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.799 2.04 . . . . 0.0 111.443 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.5 m -143.04 130.54 10.96 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 126.062 1.745 . . . . 0.0 109.03 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.8 144.19 24.32 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.965 2.443 . . . . 0.0 110.68 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.85 119.72 34.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.861 1.264 . . . . 0.0 110.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.83 157.68 16.92 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.147 1.379 . . . . 0.0 112.783 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.23 146.07 30.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.865 1.666 . . . . 0.0 109.557 172.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.88 146.78 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.112 1.365 . . . . 0.0 110.983 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -134.98 140.53 45.76 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.772 2.029 . . . . 0.0 110.255 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.4 138.08 31.86 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.404 1.081 . . . . 0.0 110.996 172.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.49 -179.88 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.412 1.885 . . . . 0.0 110.63 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.74 -146.95 18.4 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.084 0.85 . . . . 0.0 112.899 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -116.43 163.21 16.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.066 1.346 . . . . 0.0 112.702 -172.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -62.22 -37.67 86.26 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.177 0.991 . . . . 0.0 113.336 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -80.94 -24.64 38.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.089 1.356 . . . . 0.0 114.294 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -145.75 89.74 1.93 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.38 1.872 . . . . 0.0 110.201 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -83.83 152.08 24.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.662 1.185 . . . . 0.0 110.812 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -139.09 167.18 22.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.889 2.076 . . . . 0.0 110.784 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.0 145.4 48.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.878 1.271 . . . . 0.0 111.497 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.1 mtp -116.97 154.84 30.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.229 1.812 . . . . 0.0 109.583 171.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.6 t -145.12 146.53 31.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.335 1.054 . . . . 0.0 111.722 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -125.7 146.96 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.402 1.881 . . . . 0.0 109.187 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.0 142.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.278 1.031 . . . . 0.0 111.669 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.97 159.29 42.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.409 1.883 . . . . 0.0 110.701 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.25 135.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.953 1.701 . . . . 0.0 108.209 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.66 130.02 44.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.082 0.953 . . . . 0.0 111.784 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.1 0.29 65.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.612 1.101 . . . . 0.0 114.822 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -120.72 135.35 55.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.235 1.414 . . . . 0.0 110.845 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -83.2 -11.69 57.61 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -82.98 159.66 22.18 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.762 1.225 . . . . 0.0 113.02 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.02 119.28 17.73 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.861 1.264 . . . . 0.0 109.504 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 139.29 22.21 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 84.3 mtp -129.36 140.43 51.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.954 0.902 . . . . 0.0 112.577 -170.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.14 165.89 28.97 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.132 1.348 . . . . 0.0 113.686 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.69 153.68 25.14 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.61 1.164 . . . . 0.0 112.581 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.6 t -169.59 -169.97 0.99 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.536 1.534 . . . . 0.0 111.541 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -73.47 -12.03 60.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.71 1.604 . . . . 0.0 113.613 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.64 157.36 42.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.291 1.436 . . . . 0.0 112.443 -170.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.62 -30.8 71.57 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.9 -49.25 47.95 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.39 -0.818 . . . . 0.0 111.888 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -68.37 -30.71 69.71 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.101 0.56 . . . . 0.0 112.311 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.66 86.17 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.19 -0.943 . . . . 0.0 111.612 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.71 -40.09 91.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.792 0.837 . . . . 0.0 112.727 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 99.3 p -69.65 -31.64 69.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.705 1.139 . . . . 0.0 112.371 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -69.04 -41.16 78.03 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.792 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.3 93.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.549 0.613 . . . . 0.0 111.714 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.91 79.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.237 1.015 . . . . 0.0 111.768 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -56.65 -40.4 75.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.669 -0.681 . . . . 0.0 112.008 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.92 -30.48 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.408 1.004 . . . . 0.0 113.216 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -75.53 -39.07 58.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.373 -0.829 . . . . 0.0 112.005 171.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.83 -42.37 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.496 -0.752 . . . . 0.0 110.407 172.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -57.51 -48.31 79.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.865 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -52.95 -42.67 65.68 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.517 1.508 . . . . 0.0 113.39 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.83 -21.23 66.46 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.171 -0.956 . . . . 0.0 113.537 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -81.5 -38.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.604 1.162 . . . . 0.0 110.873 168.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -59.1 -30.67 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.326 1.05 . . . . 0.0 112.143 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.4 pt -106.84 5.55 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.967 1.307 . . . . 0.0 114.387 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 67.17 16.98 10.32 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.504 1.922 . . . . 0.0 115.045 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -79.41 -12.78 59.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 113.264 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.6 t -132.56 134.59 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.53 1.932 . . . . 0.0 107.691 168.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -79.54 131.93 36.16 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.185 -0.322 . . . . 0.0 110.148 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.16 -34.54 63.89 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.439 -0.788 . . . . 0.0 112.883 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.25 -22.4 29.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.313 1.445 . . . . 0.0 113.909 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.05 -16.73 27.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.418 1.087 . . . . 0.0 113.312 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.91 127.65 83.34 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.236 1.014 . . . . 0.0 110.63 -169.454 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.09 113.61 3.82 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.739 2.293 . . . . 0.0 109.769 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.44 166.44 27.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.789 1.635 . . . . 0.0 111.235 -174.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -14.45 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.777 1.231 . . . . 0.0 113.671 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.63 162.98 36.34 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.585 1.564 . . . . 0.0 112.622 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.1 mm -110.51 136.28 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.38 1.472 . . . . 0.0 109.648 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -140.96 136.22 15.97 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.826 1.65 . . . . 0.0 108.846 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.4 155.51 16.23 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.197 3.265 . . . . 0.0 113.886 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -63.43 141.44 80.98 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.246 2.631 . . . . 0.0 111.194 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.71 144.32 35.11 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.446 2.764 . . . . 0.0 112.402 -170.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.4 t -166.7 165.61 16.38 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.181 1.793 . . . . 0.0 110.599 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.32 -163.76 43.24 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 124.418 1.009 . . . . 0.0 113.674 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.04 158.38 45.83 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.941 3.094 . . . . 0.0 112.031 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.7 m -66.48 138.85 57.83 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.57 1.148 . . . . 0.0 113.184 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.5 m -69.55 146.03 52.14 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.265 1.026 . . . . 0.0 112.946 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.2 0 CA-C-O 118.415 -1.214 . . . . 0.0 112.826 178.503 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 19.8 m -83.23 -6.03 59.33 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 85.1 p -162.92 170.64 17.84 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.938 1.695 . . . . 0.0 111.555 -175.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 94.32 -152.54 20.68 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.689 1.137 . . . . 0.0 112.724 -176.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 m 71.92 -4.73 1.87 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.934 2.093 . . . . 0.0 115.026 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 m -164.98 117.96 1.23 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.088 2.155 . . . . 0.0 109.74 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.88 -7.96 80.19 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 123.919 0.771 . . . . 0.0 114.774 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -64.88 -32.35 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.681 1.24 . . . . 0.0 113.891 -173.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -33.37 73.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.593 -0.692 . . . . 0.0 111.743 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -79.54 -28.67 41.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.981 0.912 . . . . 0.0 112.484 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -65.68 -44.56 85.84 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.987 0.915 . . . . 0.0 111.709 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.6 -42.81 98.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.317 0.508 . . . . 0.0 111.276 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.38 -42.76 99.67 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.14 77.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 112.707 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 81.6 t90 -60.84 -47.59 85.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.035 0.934 . . . . 0.0 111.316 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.73 -45.46 85.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.013 0.925 . . . . 0.0 112.021 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.1 72.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.28 0.943 . . . . 0.0 113.986 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.9 -7.25 58.64 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.506 1.122 . . . . 0.0 112.79 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -119.58 9.14 11.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.304 2.242 . . . . 0.0 112.64 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.74 31.45 11.86 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.452 1.901 . . . . 0.0 113.515 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.6 mtm -119.35 172.32 7.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.71 2.004 . . . . 0.0 111.643 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.2 m -141.97 129.36 11.49 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 126.227 1.811 . . . . 0.0 108.668 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.91 141.65 21.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.905 2.404 . . . . 0.0 110.588 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.13 117.23 30.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.602 1.161 . . . . 0.0 110.697 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.66 157.43 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.996 1.318 . . . . 0.0 112.672 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.6 149.67 33.98 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.506 1.523 . . . . 0.0 109.907 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.4 mt -132.64 145.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.632 1.573 . . . . 0.0 110.799 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 -145.25 133.5 21.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.21 1.404 . . . . 0.0 111.45 -171.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.53 137.38 32.39 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.784 1.234 . . . . 0.0 111.323 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -149.32 165.48 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.657 1.583 . . . . 0.0 111.397 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.49 -132.99 11.32 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.978 0.799 . . . . 0.0 112.208 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -116.61 156.32 27.23 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.314 1.445 . . . . 0.0 112.3 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -56.51 -44.2 80.52 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.549 1.14 . . . . 0.0 113.181 177.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.14 -28.24 27.57 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.038 1.335 . . . . 0.0 113.252 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.39 81.48 1.76 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.491 1.516 . . . . 0.0 110.264 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -71.49 148.99 46.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.253 1.421 . . . . 0.0 111.409 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -144.15 153.89 42.59 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.2 2.2 . . . . 0.0 109.957 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -127.48 124.17 37.7 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.244 1.018 . . . . 0.0 111.883 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.4 mtp -89.49 155.16 19.48 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.756 1.222 . . . . 0.0 109.085 167.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.23 149.97 40.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.268 1.027 . . . . 0.0 110.149 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.74 153.02 51.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.528 1.531 . . . . 0.0 110.123 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.66 141.81 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.022 1.329 . . . . 0.0 111.228 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.97 153.74 49.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.072 1.749 . . . . 0.0 110.486 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -141.66 134.85 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.798 1.639 . . . . 0.0 108.557 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.59 129.68 42.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.015 0.926 . . . . 0.0 111.649 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.89 65.11 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.566 1.079 . . . . 0.0 114.742 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.22 130.88 54.73 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.182 1.393 . . . . 0.0 110.529 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -76.6 -25.75 54.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -79.21 155.45 28.6 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.338 1.055 . . . . 0.0 113.083 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.78 109.85 11.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.396 1.478 . . . . 0.0 108.603 170.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.82 149.24 26.66 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.1 ptm -151.19 151.94 32.6 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.0 179.67 25.63 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.52 2.009 . . . . 0.0 112.818 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -151.86 155.22 37.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.964 1.306 . . . . 0.0 111.455 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -168.04 -176.09 2.88 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.403 1.481 . . . . 0.0 112.149 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.1 m -79.93 -22.97 42.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.377 1.471 . . . . 0.0 111.471 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -119.6 142.96 47.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.069 1.348 . . . . 0.0 111.391 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -61.59 -30.66 70.82 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -74.32 -42.57 59.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.037 . . . . 0.0 112.541 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.49 -34.05 75.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.795 0.838 . . . . 0.0 111.693 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.74 80.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.417 0.687 . . . . 0.0 111.625 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.13 -41.14 92.02 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.623 0.769 . . . . 0.0 111.995 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.9 m -63.98 -37.69 88.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.661 0.664 . . . . 0.0 111.927 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.55 -37.07 68.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.429 -0.794 . . . . 0.0 111.955 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.41 98.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.781 0.833 . . . . 0.0 112.376 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.24 -49.04 78.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.878 0.871 . . . . 0.0 111.123 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -57.32 -38.05 73.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.2 -38.48 69.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.623 1.169 . . . . 0.0 112.885 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -72.16 -37.72 69.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.831 0.741 . . . . 0.0 112.169 174.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.49 -36.91 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.531 -0.73 . . . . 0.0 110.84 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -49.86 75.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.402 171.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -54.76 -42.94 72.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.224 -0.923 . . . . 0.0 113.086 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.02 -27.65 69.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 175.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.68 -40.41 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.294 0.952 . . . . 0.0 111.049 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -61.96 -30.94 71.26 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -96.91 4.91 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.457 1.103 . . . . 0.0 113.836 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 70.73 18.1 6.36 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.888 2.075 . . . . 0.0 114.625 173.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.74 -6.47 55.99 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.481 1.512 . . . . 0.0 113.363 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 94.7 t -136.68 139.26 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 127.011 2.125 . . . . 0.0 107.893 168.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.21 127.61 34.77 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.073 0.549 . . . . 0.0 110.068 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 p -54.72 -33.9 61.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.83 -19.13 59.27 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.044 1.337 . . . . 0.0 113.689 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.33 -16.43 27.5 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.543 1.137 . . . . 0.0 113.341 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.79 123.76 87.55 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.197 0.999 . . . . 0.0 111.119 -169.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.37 150.66 19.8 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.492 2.795 . . . . 0.0 111.614 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.59 167.22 30.28 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.406 1.482 . . . . 0.0 111.555 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.65 -13.94 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 126.054 1.741 . . . . 0.0 115.444 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.9 136.28 9.18 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.378 1.466 . . . . 0.0 112.346 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.9 mt -133.62 135.98 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.736 1.615 . . . . 0.0 109.361 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.1 t -134.56 110.73 11.39 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.302 1.441 . . . . 0.0 108.307 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -61.21 144.56 98.94 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.445 2.763 . . . . 0.0 112.88 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.65 131.53 20.16 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.22 2.613 . . . . 0.0 110.612 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.74 -19.44 24.03 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.171 2.581 . . . . 0.0 113.016 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.5 p -89.6 -1.41 58.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.696 1.598 . . . . 0.0 113.37 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.52 164.99 39.78 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 125.642 1.592 . . . . 0.0 113.483 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.93 133.3 24.93 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.601 2.868 . . . . 0.0 110.79 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.4 p -168.31 165.3 12.94 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.388 1.475 . . . . 0.0 111.844 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.2 p -162.08 163.45 28.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.176 1.39 . . . . 0.0 111.945 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 C-N-CA 124.928 1.251 . . . . 0.0 112.928 -178.962 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 42.6 p -92.71 -15.31 26.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 61.5 p -110.28 -3.19 16.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.884 1.673 . . . . 0.0 113.71 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 166.6 -176.97 41.62 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.221 1.867 . . . . 0.0 112.248 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.5 p -72.89 -73.91 0.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.895 -0.768 . . . . 0.0 112.374 -175.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.3 p -90.7 -4.38 56.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.801 1.64 . . . . 0.0 113.705 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.45 8.32 71.07 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.71 1.148 . . . . 0.0 113.523 -169.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.7 -29.11 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.108 1.363 . . . . 0.0 113.951 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -57.92 -51.51 69.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.377 1.071 . . . . 0.0 110.559 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.62 -26.94 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 112.744 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.47 -46.9 78.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.915 0.78 . . . . 0.0 111.518 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.8 tp -63.11 -41.86 99.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.138 0.426 . . . . 0.0 111.219 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -62.91 -42.35 99.76 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.56 73.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.328 1.051 . . . . 0.0 112.625 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -61.07 -46.52 90.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.893 0.877 . . . . 0.0 111.224 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.3 m -58.31 -45.91 87.12 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.657 0.783 . . . . 0.0 111.718 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.38 73.2 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.345 0.974 . . . . 0.0 114.092 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -79.56 -6.38 56.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.358 1.079 . . . . 0.0 112.915 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -119.53 9.29 11.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.301 2.24 . . . . 0.0 112.577 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.82 30.97 12.0 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.501 1.92 . . . . 0.0 113.59 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -118.93 172.53 7.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.718 2.007 . . . . 0.0 111.562 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 m -141.69 130.81 12.37 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.158 1.783 . . . . 0.0 108.557 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.16 146.68 25.55 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.967 2.445 . . . . 0.0 110.806 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.79 116.89 28.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.738 1.215 . . . . 0.0 110.576 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -99.89 157.62 16.39 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 112.372 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.39 150.36 34.52 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.318 1.447 . . . . 0.0 110.053 172.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.1 mt -138.53 145.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.228 1.411 . . . . 0.0 111.288 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -139.16 135.1 33.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.742 1.617 . . . . 0.0 111.046 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.52 137.77 33.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.259 1.023 . . . . 0.0 111.378 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -144.28 176.15 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 126.086 1.754 . . . . 0.0 110.843 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.32 -150.04 20.6 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.297 0.951 . . . . 0.0 112.537 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -116.89 168.16 10.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.092 1.357 . . . . 0.0 112.231 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -54.46 -45.07 73.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.859 1.264 . . . . 0.0 113.589 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -79.59 -29.03 41.06 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -130.33 78.53 1.85 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.966 2.107 . . . . 0.0 109.897 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -94.24 145.35 24.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.505 1.122 . . . . 0.0 110.721 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -137.59 168.66 19.22 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.868 2.067 . . . . 0.0 111.2 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -134.8 124.08 24.57 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.2 1.4 . . . . 0.0 111.233 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.8 mtp -89.11 154.74 19.93 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.166 1.387 . . . . 0.0 109.395 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.9 t -143.84 145.05 32.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.224 1.01 . . . . 0.0 111.766 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -121.86 151.8 40.26 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.321 1.848 . . . . 0.0 109.563 170.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.74 141.2 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.994 . . . . 0.0 111.242 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -140.45 158.05 44.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.28 1.832 . . . . 0.0 110.404 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.86 135.44 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.551 1.54 . . . . 0.0 108.66 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.08 129.97 44.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 111.606 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.27 65.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.622 1.105 . . . . 0.0 114.604 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -123.86 128.36 49.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.278 1.431 . . . . 0.0 110.351 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -76.63 -22.76 53.67 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.04 155.98 39.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.583 1.153 . . . . 0.0 113.269 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.34 117.74 18.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.342 1.457 . . . . 0.0 109.232 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.39 141.66 21.48 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtt -136.06 144.04 44.99 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.79 173.0 28.86 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.83 1.681 . . . . 0.0 113.501 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -158.78 148.94 19.57 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.84 1.256 . . . . 0.0 111.337 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.4 t -168.15 178.86 4.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.725 1.21 . . . . 0.0 112.868 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 m -78.79 -8.66 58.98 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.756 1.623 . . . . 0.0 112.442 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -142.14 153.69 44.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.051 1.34 . . . . 0.0 112.229 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -67.1 -30.25 70.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -73.15 -41.99 63.32 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.169 0.895 . . . . 0.0 112.495 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.09 -29.48 61.88 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.602 -0.687 . . . . 0.0 111.858 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.66 85.88 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.548 -0.72 . . . . 0.0 111.692 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -63.38 -38.04 89.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.833 0.853 . . . . 0.0 112.252 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 m -63.2 -38.74 92.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.731 0.696 . . . . 0.0 111.565 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -69.26 -41.32 77.08 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.39 -0.819 . . . . 0.0 111.791 174.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.65 98.26 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.715 0.689 . . . . 0.0 112.055 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.95 76.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.28 1.032 . . . . 0.0 111.492 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -58.33 -37.07 74.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.971 -0.538 . . . . 0.0 112.431 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.88 -36.67 67.39 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.955 1.302 . . . . 0.0 112.835 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -70.21 -39.78 74.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.929 0.786 . . . . 0.0 111.821 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.83 -36.26 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.637 -0.664 . . . . 0.0 110.961 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -40.52 89.2 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.204 0.601 . . . . 0.0 111.347 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.62 -44.39 90.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.097 -1.002 . . . . 0.0 112.14 171.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.4 mt -60.78 -34.91 75.2 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.49 -43.56 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.65 0.78 . . . . 0.0 111.221 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -65.16 -24.66 67.45 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.34 5.54 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.411 1.084 . . . . 0.0 113.623 171.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 71.35 17.31 5.88 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.898 2.079 . . . . 0.0 114.586 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -90.1 -5.09 56.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.203 1.401 . . . . 0.0 113.396 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.3 t -137.54 139.33 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.148 2.179 . . . . 0.0 107.826 169.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -87.13 129.18 35.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.82 0.448 . . . . 0.0 110.779 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 p -59.14 -30.15 67.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.25 -0.906 . . . . 0.0 113.357 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.54 -23.29 57.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.369 1.068 . . . . 0.0 113.417 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -90.13 -16.31 29.84 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.55 1.14 . . . . 0.0 113.482 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.06 124.42 86.01 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 124.102 0.961 . . . . 0.0 111.545 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.62 143.07 16.63 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.447 2.765 . . . . 0.0 111.379 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.09 153.45 33.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.237 1.415 . . . . 0.0 111.225 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -16.68 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 125.005 1.322 . . . . 0.0 114.171 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.54 158.92 31.51 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.219 1.866 . . . . 0.0 111.945 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.6 mt -129.13 130.43 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.151 1.381 . . . . 0.0 109.272 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.93 134.0 11.91 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 125.883 1.673 . . . . 0.0 108.727 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.51 151.61 52.87 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.607 2.871 . . . . 0.0 113.655 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.31 145.33 88.05 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.764 2.976 . . . . 0.0 113.077 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -57.1 149.7 61.33 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.024 3.149 . . . . 0.0 113.521 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.2 m -84.92 2.29 43.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.73 -179.29 52.83 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.138 1.351 . . . . 0.0 113.79 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.86 -6.23 15.84 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.245 3.297 . . . . 0.0 113.964 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.5 p -163.11 -39.33 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.012 1.325 . . . . 0.0 112.5 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 t -160.79 -176.21 5.4 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.322 1.849 . . . . 0.0 110.741 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 C-N-CA 125.399 1.476 . . . . 0.0 112.843 -179.515 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 8.6 t -163.17 172.79 14.31 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.554 1.542 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 54.6 p -165.03 156.89 15.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.574 1.55 . . . . 0.0 112.373 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -84.29 172.23 48.87 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.408 1.004 . . . . 0.0 112.912 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.2 m -73.1 -11.89 60.7 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.6 p -163.22 166.67 23.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.208 1.803 . . . . 0.0 110.987 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.86 1.52 88.66 Favored Glycine 0 N--CA 1.472 1.083 0 C-N-CA 124.217 0.913 . . . . 0.0 115.217 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp -64.29 -31.05 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.221 1.51 . . . . 0.0 113.99 -172.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -68.01 -40.61 82.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.827 0.851 . . . . 0.0 111.199 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.988 0.915 . . . . 0.0 112.606 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.91 -43.88 91.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.885 0.874 . . . . 0.0 111.286 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.4 tp -63.14 -42.09 99.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.485 0.584 . . . . 0.0 111.714 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -62.86 -42.5 99.78 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -38.31 77.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.486 1.114 . . . . 0.0 112.54 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -61.64 -43.32 99.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.552 1.141 . . . . 0.0 111.801 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 99.2 m -61.95 -43.23 99.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.353 1.061 . . . . 0.0 111.868 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.56 -25.23 72.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.487 1.042 . . . . 0.0 114.032 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -78.22 -7.08 56.69 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.358 1.079 . . . . 0.0 112.744 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -119.65 7.47 11.08 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.471 2.308 . . . . 0.0 112.619 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.87 28.47 14.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.416 1.886 . . . . 0.0 113.371 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.9 mtm -112.17 171.94 7.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.758 2.023 . . . . 0.0 111.583 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.5 m -140.86 129.87 12.82 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 126.324 1.85 . . . . 0.0 108.664 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.6 140.58 21.37 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.971 2.447 . . . . 0.0 110.588 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.91 118.05 32.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.582 1.153 . . . . 0.0 110.853 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -101.13 159.37 15.29 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.991 1.316 . . . . 0.0 112.954 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.09 149.23 32.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.405 1.482 . . . . 0.0 110.152 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.74 147.07 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.549 1.539 . . . . 0.0 111.54 -169.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -134.96 138.96 44.53 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.56 1.944 . . . . 0.0 110.285 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.66 137.32 32.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.433 1.093 . . . . 0.0 111.423 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.21 -174.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 126.911 2.085 . . . . 0.0 110.138 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 -147.1 18.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.097 0.856 . . . . 0.0 112.983 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -116.82 162.13 18.21 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.084 1.353 . . . . 0.0 112.436 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -62.1 -35.92 80.16 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.236 -0.915 . . . . 0.0 112.944 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -75.92 -24.16 55.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.038 1.335 . . . . 0.0 113.722 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -154.42 97.27 2.0 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.702 1.601 . . . . 0.0 110.277 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -78.2 148.51 33.99 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.235 1.014 . . . . 0.0 110.499 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -135.56 165.35 25.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.476 1.911 . . . . 0.0 111.003 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -135.69 134.06 38.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.377 1.071 . . . . 0.0 112.071 -173.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.2 mtp -102.45 153.47 20.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.581 1.553 . . . . 0.0 108.938 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -148.19 149.25 31.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 111.322 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.8 159.64 40.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.092 1.357 . . . . 0.0 111.073 170.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.95 143.03 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.419 1.487 . . . . 0.0 111.0 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -137.42 155.54 49.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.05 1.74 . . . . 0.0 110.878 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.47 134.32 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.965 1.706 . . . . 0.0 108.461 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.75 128.7 37.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.115 0.966 . . . . 0.0 111.977 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.17 1.21 67.17 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.765 1.174 . . . . 0.0 115.0 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.15 140.74 45.44 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.001 1.32 . . . . 0.0 111.273 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -85.3 0.83 50.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -120.1 155.79 32.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.696 1.599 . . . . 0.0 112.898 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.96 110.3 13.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.358 1.463 . . . . 0.0 108.894 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.06 146.94 29.88 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.6 ptp -150.48 148.44 28.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.35 -179.25 27.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.36 1.934 . . . . 0.0 112.772 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -154.24 160.9 42.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 112.102 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 t -168.32 -179.65 4.07 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.37 1.468 . . . . 0.0 111.844 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.6 m -80.38 -6.56 58.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.23 1.412 . . . . 0.0 112.277 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -142.4 152.05 42.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.203 1.401 . . . . 0.0 112.224 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.48 -27.1 68.25 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.62 -52.51 17.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.773 0.829 . . . . 0.0 111.538 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.66 -27.28 64.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.762 0.825 . . . . 0.0 112.252 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.17 95.82 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.833 -0.542 . . . . 0.0 111.754 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.48 -40.01 92.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.386 0.675 . . . . 0.0 111.93 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.0 m -60.81 -37.12 80.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.407 1.003 . . . . 0.0 112.442 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -74.33 -37.28 63.6 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.278 -0.889 . . . . 0.0 111.657 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.2 99.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.632 0.773 . . . . 0.0 112.361 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.06 81.82 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.199 0.999 . . . . 0.0 111.546 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -56.59 -42.08 78.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.109 0.564 . . . . 0.0 111.819 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.05 -30.92 69.36 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -77.17 -37.41 53.78 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.628 -0.67 . . . . 0.0 112.422 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.72 -39.88 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.268 -0.895 . . . . 0.0 110.836 173.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -56.18 -46.15 79.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.122 0.569 . . . . 0.0 111.47 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.5 -43.56 89.09 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.951 -1.093 . . . . 0.0 113.062 170.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.54 -35.01 79.09 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.955 0.798 . . . . 0.0 113.059 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.62 -41.99 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.575 0.75 . . . . 0.0 111.091 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -66.89 -16.02 64.04 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.31 7.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 125.152 1.381 . . . . 0.0 113.398 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.4 t30 68.12 21.09 8.79 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.676 1.99 . . . . 0.0 114.381 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -86.0 -8.66 57.8 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.806 1.242 . . . . 0.0 113.348 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.09 139.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.167 1.787 . . . . 0.0 108.282 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -87.74 130.12 34.94 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.9 p -54.27 -33.78 59.36 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.26 -0.9 . . . . 0.0 113.131 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.38 -21.28 49.62 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.45 1.5 . . . . 0.0 113.955 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -90.19 -16.84 28.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.498 1.119 . . . . 0.0 113.308 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.79 122.75 87.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.979 0.912 . . . . 0.0 110.913 -169.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.64 141.44 15.52 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.316 2.677 . . . . 0.0 111.099 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.78 161.27 41.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.498 1.519 . . . . 0.0 111.141 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -67.4 -17.05 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -177.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.3 -162.19 34.14 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.285 1.421 . . . . 0.0 113.863 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.6 mt -125.04 145.35 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.194 1.797 . . . . 0.0 108.226 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t 81.4 132.3 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 129.026 2.931 . . . . 0.0 110.578 -175.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -56.7 156.91 21.01 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.977 3.118 . . . . 0.0 114.279 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.57 131.06 41.83 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.001 3.134 . . . . 0.0 113.099 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.64 160.86 25.0 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.888 3.059 . . . . 0.0 112.205 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.7 m -91.73 0.32 57.5 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.38 -176.43 49.69 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.185 1.374 . . . . 0.0 114.084 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.37 150.75 57.13 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.588 3.526 . . . . 0.0 113.304 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 p -81.24 -4.08 54.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.719 1.208 . . . . 0.0 114.195 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.7 m -166.21 152.43 9.03 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 127.38 2.272 . . . . 0.0 110.769 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.823 -179.882 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 8.9 m -164.15 156.64 17.18 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.551 1.94 . . . . 0.0 110.653 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.0 t -162.9 179.06 7.87 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.263 1.425 . . . . 0.0 111.343 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 93.92 -178.14 37.43 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.677 1.608 . . . . 0.0 113.272 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 86.0 p -163.08 167.24 22.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.825 1.25 . . . . 0.0 112.509 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m -150.96 47.54 0.85 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.385 1.474 . . . . 0.0 110.259 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.2 -29.38 75.18 Favored Glycine 0 N--CA 1.473 1.108 0 O-C-N 121.026 -1.047 . . . . 0.0 114.68 -168.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.4 tp -79.23 -30.03 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 118.214 1.007 . . . . 0.0 112.584 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.36 -44.14 84.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.989 0.915 . . . . 0.0 110.081 170.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -65.74 -31.33 72.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.962 0.905 . . . . 0.0 112.784 172.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -66.75 -44.62 80.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.973 0.806 . . . . 0.0 111.678 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.86 -42.69 99.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.453 0.57 . . . . 0.0 111.245 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.04 -43.05 99.73 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.78 82.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.261 1.024 . . . . 0.0 112.419 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -59.89 -45.96 90.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.263 1.025 . . . . 0.0 111.514 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.8 m -58.01 -44.81 87.48 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.599 0.76 . . . . 0.0 111.778 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.88 73.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.443 1.02 . . . . 0.0 114.145 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -79.03 -7.25 57.94 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.481 1.141 . . . . 0.0 112.9 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.63 8.73 11.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.041 2.136 . . . . 0.0 112.755 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.42 31.15 12.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.406 1.883 . . . . 0.0 113.499 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -117.98 171.77 7.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.716 2.007 . . . . 0.0 111.536 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -140.44 130.71 13.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.24 1.816 . . . . 0.0 108.682 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.18 150.46 29.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.196 2.597 . . . . 0.0 110.953 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.34 115.66 24.0 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.588 1.155 . . . . 0.0 111.05 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.5 158.24 16.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.44 1.496 . . . . 0.0 112.703 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -147.22 145.15 29.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.955 1.702 . . . . 0.0 109.581 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.72 147.13 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.266 1.426 . . . . 0.0 110.849 -169.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -137.53 137.19 38.35 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.194 1.798 . . . . 0.0 110.777 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.67 137.22 32.52 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.444 1.098 . . . . 0.0 110.916 175.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -147.02 171.74 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.501 1.52 . . . . 0.0 111.533 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.71 179.91 51.31 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.438 1.018 . . . . 0.0 114.34 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.59 139.65 58.46 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.427 1.091 . . . . 0.0 112.144 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -53.27 -38.03 62.69 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.271 1.428 . . . . 0.0 114.356 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -74.39 -16.63 60.88 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.659 1.183 . . . . 0.0 114.105 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -149.46 67.38 1.01 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.536 1.534 . . . . 0.0 110.13 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -68.96 151.68 46.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.248 1.419 . . . . 0.0 111.727 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -136.23 166.14 24.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.598 1.959 . . . . 0.0 111.141 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.09 137.68 43.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.791 1.236 . . . . 0.0 111.535 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.9 mtp -106.86 155.05 20.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.173 1.789 . . . . 0.0 109.379 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.5 t -147.19 148.87 31.96 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.918 0.887 . . . . 0.0 112.047 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -129.33 151.58 49.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.396 1.879 . . . . 0.0 109.719 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.91 142.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.68 1.192 . . . . 0.0 111.62 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.73 162.25 34.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.242 1.817 . . . . 0.0 110.431 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -139.33 136.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.637 1.575 . . . . 0.0 108.521 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.68 129.29 40.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.208 1.003 . . . . 0.0 111.776 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.24 -0.17 66.01 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.63 1.109 . . . . 0.0 114.806 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.05 140.55 48.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 110.963 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.65 -0.49 50.86 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -112.83 160.37 18.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.703 1.601 . . . . 0.0 113.214 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.92 116.58 14.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.202 1.401 . . . . 0.0 109.412 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.99 149.78 25.69 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -146.64 150.49 35.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.19 175.0 33.31 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.571 1.558 . . . . 0.0 113.491 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.96 154.11 25.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 112.403 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -168.13 -173.72 2.12 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.362 . . . . 0.0 112.025 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.8 p -75.79 -10.34 59.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.5 1.52 . . . . 0.0 113.482 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -150.93 151.62 32.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.271 1.428 . . . . 0.0 111.925 -170.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.26 -30.27 70.67 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -68.25 -48.14 65.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.796 0.839 . . . . 0.0 112.045 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.47 -29.33 59.57 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.778 -0.576 . . . . 0.0 112.327 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.75 88.75 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.42 -0.8 . . . . 0.0 111.837 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -64.36 -38.17 90.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.407 0.683 . . . . 0.0 112.044 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.7 m -64.69 -35.75 82.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.787 0.721 . . . . 0.0 112.278 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -71.48 -39.99 70.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.226 -0.921 . . . . 0.0 111.709 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.93 99.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.652 0.66 . . . . 0.0 111.856 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.11 -49.44 75.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 111.559 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -56.35 -37.89 70.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.105 0.562 . . . . 0.0 112.354 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.9 -35.63 64.68 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.965 1.306 . . . . 0.0 112.737 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -72.55 -37.31 68.29 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.357 -0.839 . . . . 0.0 112.009 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.52 -37.1 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.465 -0.772 . . . . 0.0 110.87 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -40.88 89.32 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.232 0.613 . . . . 0.0 111.423 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -62.95 -45.7 91.2 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.052 -1.03 . . . . 0.0 112.488 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.7 -34.51 74.47 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.91 -42.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.69 0.796 . . . . 0.0 111.237 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -64.68 -26.03 68.2 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 pt -97.55 5.33 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.304 1.042 . . . . 0.0 113.67 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 71.02 17.37 6.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.957 2.103 . . . . 0.0 114.574 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -89.66 -5.33 57.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.248 1.419 . . . . 0.0 113.431 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.41 140.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 127.277 2.231 . . . . 0.0 107.844 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -86.86 130.61 34.4 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.88 -0.513 . . . . 0.0 110.293 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 p -53.57 -34.68 59.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.746 0.818 . . . . 0.0 112.905 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.04 -27.56 8.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.367 1.867 . . . . 0.0 114.022 175.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -93.4 -15.47 25.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.611 1.164 . . . . 0.0 113.549 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.57 123.61 87.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.139 0.976 . . . . 0.0 111.12 -169.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.27 143.48 17.58 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.452 2.768 . . . . 0.0 111.305 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.51 162.33 41.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.327 1.451 . . . . 0.0 111.513 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -13.22 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.872 1.269 . . . . 0.0 113.816 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -167.77 177.65 42.0 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.824 1.678 . . . . 0.0 112.562 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.1 mt -124.56 124.48 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.301 1.44 . . . . 0.0 108.76 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.6 t -146.34 136.43 11.99 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.854 1.662 . . . . 0.0 108.772 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.17 159.42 15.39 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.8 3.0 . . . . 0.0 113.904 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.12 140.92 80.75 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.921 3.081 . . . . 0.0 112.98 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.45 148.55 43.05 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.548 2.832 . . . . 0.0 112.031 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 t -164.62 158.0 17.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.759 1.624 . . . . 0.0 110.779 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.91 -148.86 32.22 Favored Glycine 0 CA--C 1.542 1.726 0 CA-C-O 118.8 -1.0 . . . . 0.0 112.657 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -55.89 149.76 49.72 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.514 3.476 . . . . 0.0 113.413 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.2 t -162.21 -179.76 7.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.16 1.384 . . . . 0.0 111.529 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.5 m -66.41 139.17 57.98 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.168 1.387 . . . . 0.0 113.156 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.982 1.277 . . . . 0.0 112.802 178.697 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 90.0 p -164.65 173.21 12.18 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.32 1.448 . . . . 0.0 111.686 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.0 m -78.47 9.93 3.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.665 1.186 . . . . 0.0 114.048 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -77.11 38.34 1.56 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.237 1.875 . . . . 0.0 114.157 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.4 m -71.3 -18.06 62.43 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.955 1.302 . . . . 0.0 114.202 -172.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 t -156.71 146.65 20.98 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.804 1.642 . . . . 0.0 110.642 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.2 2.34 65.6 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.916 1.246 . . . . 0.0 114.358 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.16 -32.39 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.384 1.592 . . . . 0.0 114.388 -171.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -37.13 82.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.531 -0.731 . . . . 0.0 111.627 177.131 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -78.75 -27.5 44.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.221 1.009 . . . . 0.0 112.49 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.6 -43.93 92.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 111.515 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.28 -43.53 98.61 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.464 0.575 . . . . 0.0 111.345 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -63.36 -42.56 98.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.374 0.67 . . . . 0.0 112.806 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.24 -39.31 78.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 112.451 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -61.05 -45.68 93.8 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.94 0.896 . . . . 0.0 111.342 173.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -58.06 -46.37 85.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.483 0.713 . . . . 0.0 111.669 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.93 73.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.396 0.998 . . . . 0.0 114.157 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -77.69 -8.27 57.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.476 1.11 . . . . 0.0 112.747 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -119.55 8.19 11.25 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.332 2.253 . . . . 0.0 112.769 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm 66.41 28.33 9.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.674 1.989 . . . . 0.0 113.705 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 mtm -116.05 173.45 6.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.666 1.986 . . . . 0.0 111.618 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.0 m -142.79 132.0 11.82 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 126.109 1.764 . . . . 0.0 108.696 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.35 154.58 32.05 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.04 2.494 . . . . 0.0 110.908 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.75 115.8 20.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.656 1.183 . . . . 0.0 110.564 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.23 158.37 16.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.63 1.572 . . . . 0.0 112.292 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.65 148.5 32.12 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.716 1.607 . . . . 0.0 109.927 171.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.7 mt -136.19 145.31 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.23 1.412 . . . . 0.0 111.449 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -133.67 139.04 46.21 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.485 1.914 . . . . 0.0 110.278 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.86 136.49 33.11 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.486 1.114 . . . . 0.0 110.767 172.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -145.39 176.31 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 125.691 1.597 . . . . 0.0 111.138 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.93 -170.04 37.44 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.213 0.911 . . . . 0.0 114.126 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -74.05 148.17 42.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.546 1.138 . . . . 0.0 112.565 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -65.44 -21.13 66.62 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -87.62 -19.11 28.22 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.716 1.206 . . . . 0.0 113.572 175.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -157.96 93.12 1.23 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.796 1.638 . . . . 0.0 110.166 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -83.85 166.02 18.28 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.539 1.136 . . . . 0.0 112.895 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -139.58 167.96 20.91 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.601 2.36 . . . . 0.0 110.715 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.94 137.66 49.38 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.954 1.301 . . . . 0.0 111.127 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtp -108.55 153.88 22.74 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.881 1.672 . . . . 0.0 109.389 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.18 147.44 32.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.096 0.958 . . . . 0.0 111.84 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -129.29 147.02 51.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.78 2.032 . . . . 0.0 108.774 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.52 143.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.792 0.837 . . . . 0.0 112.294 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.5 mtm105 -138.69 165.26 27.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.676 1.99 . . . . 0.0 110.707 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.57 137.14 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.806 1.642 . . . . 0.0 108.209 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -58.28 129.03 40.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.021 0.928 . . . . 0.0 111.579 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 0.74 65.42 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.662 1.125 . . . . 0.0 114.618 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -124.0 129.59 51.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.295 1.438 . . . . 0.0 110.381 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -83.66 -11.99 56.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -74.25 157.32 36.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.5 1.12 . . . . 0.0 112.69 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.99 119.39 17.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 170.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.87 143.74 22.46 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.7 mtm -138.81 141.65 38.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.281 1.033 . . . . 0.0 112.12 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.72 173.25 31.75 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.035 1.302 . . . . 0.0 113.399 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -155.29 159.49 40.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.621 1.168 . . . . 0.0 112.01 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 t -170.06 -175.86 2.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.414 1.485 . . . . 0.0 112.069 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p -80.93 -7.66 59.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.675 1.59 . . . . 0.0 113.36 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -142.61 150.56 40.46 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.356 1.463 . . . . 0.0 111.8 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.82 -32.57 74.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.029 1.332 . . . . 0.0 113.795 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -71.35 -45.2 63.5 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.311 -0.868 . . . . 0.0 112.285 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.02 -26.48 61.33 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.732 0.413 . . . . 0.0 111.407 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.75 -46.3 72.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.894 0.478 . . . . 0.0 111.432 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.65 -40.4 94.8 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.436 0.694 . . . . 0.0 111.954 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.0 m -63.99 -37.23 86.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.886 0.767 . . . . 0.0 111.789 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.23 -38.12 71.97 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.562 -0.711 . . . . 0.0 111.64 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.49 93.47 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.614 -0.679 . . . . 0.0 112.191 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.75 82.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.609 1.164 . . . . 0.0 111.431 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.83 -40.99 81.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.375 0.534 . . . . 0.0 111.638 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.86 -31.08 70.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.757 0.823 . . . . 0.0 113.087 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -77.7 -40.08 42.57 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.567 -0.708 . . . . 0.0 112.414 172.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.11 -37.89 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.34 -0.85 . . . . 0.0 110.818 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -56.59 -42.86 79.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.284 0.634 . . . . 0.0 111.688 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.36 -43.32 99.1 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.859 -1.15 . . . . 0.0 112.722 170.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -61.49 -34.02 74.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.16 0.891 . . . . 0.0 113.038 176.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.49 -43.25 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.026 0.93 . . . . 0.0 111.137 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -62.49 -25.97 68.29 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.175 0.99 . . . . 0.0 113.326 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -101.1 6.01 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.619 1.168 . . . . 0.0 113.865 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 70.89 16.96 6.47 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.834 2.054 . . . . 0.0 114.669 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -88.57 -5.48 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 113.448 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.6 t -136.84 138.7 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.906 2.082 . . . . 0.0 108.155 169.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.82 125.69 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.901 0.48 . . . . 0.0 109.931 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 p -55.31 -32.79 62.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.95 -19.74 61.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.097 1.359 . . . . 0.0 113.475 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -92.0 -15.8 27.41 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.633 1.173 . . . . 0.0 113.342 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.8 124.06 83.56 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.132 0.973 . . . . 0.0 111.52 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.99 167.63 17.96 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.803 3.002 . . . . 0.0 112.706 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.69 166.52 31.02 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.654 1.582 . . . . 0.0 111.487 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -14.69 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.561 1.545 . . . . 0.0 114.782 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.87 170.26 19.69 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.977 1.751 . . . . 0.0 112.782 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.5 mt -124.82 115.91 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.097 1.359 . . . . 0.0 108.716 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 m -151.01 150.87 28.58 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.56 1.944 . . . . 0.0 110.317 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.47 151.83 59.64 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.164 2.576 . . . . 0.0 111.057 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.98 149.14 46.42 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.314 2.676 . . . . 0.0 111.436 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.16 141.12 32.03 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.482 2.788 . . . . 0.0 111.215 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.5 p -87.97 -5.31 58.6 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.16 -173.95 54.98 Favored Glycine 0 CA--C 1.542 1.726 0 C-N-CA 125.072 1.32 . . . . 0.0 113.839 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.41 146.19 39.35 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.75 2.967 . . . . 0.0 111.299 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.9 p -144.84 9.14 1.3 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.5 p -162.89 165.72 24.85 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.641 1.576 . . . . 0.0 112.011 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.998 1.285 . . . . 0.0 112.955 -179.088 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -62.73 -46.95 85.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.612 1.165 . . . . 0.0 109.983 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -65.05 -33.85 77.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.331 1.052 . . . . 0.0 112.523 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -68.29 -45.27 73.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.988 0.813 . . . . 0.0 111.513 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.46 -43.23 97.93 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 111.234 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.36 -42.92 98.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.22 81.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.378 1.071 . . . . 0.0 112.436 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -60.75 -46.01 92.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.582 0.753 . . . . 0.0 111.462 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.99 -46.22 88.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.93 -27.32 73.35 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.4 1.0 . . . . 0.0 114.081 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.28 -8.53 57.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.402 1.101 . . . . 0.0 112.705 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -119.69 9.52 11.44 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.335 2.254 . . . . 0.0 112.503 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.08 31.1 11.29 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.597 1.959 . . . . 0.0 113.618 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 62.4 mtm -118.98 173.31 6.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.779 2.031 . . . . 0.0 111.57 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.19 132.07 12.43 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 126.248 1.819 . . . . 0.0 108.729 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.99 148.38 27.77 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.955 2.436 . . . . 0.0 110.936 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.73 115.71 23.84 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.878 1.271 . . . . 0.0 110.7 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.37 153.88 17.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.257 1.423 . . . . 0.0 111.839 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.2 129.38 15.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.761 1.624 . . . . 0.0 109.004 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.19 147.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.248 1.019 . . . . 0.0 112.291 -168.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 126.931 2.093 . . . . 0.0 110.453 176.295 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 121.057 0.456 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -135.4 142.63 45.69 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.641 1.177 . . . . 0.0 111.378 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.0 mtp -114.51 148.88 37.25 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.061 1.745 . . . . 0.0 109.19 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.0 t -139.2 145.02 38.78 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 110.922 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.3 149.4 50.05 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.445 1.898 . . . . 0.0 108.483 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.08 139.6 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.429 0.692 . . . . 0.0 111.665 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -136.35 160.1 39.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.961 2.104 . . . . 0.0 110.565 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -140.67 136.52 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.665 1.586 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.23 129.07 40.31 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.054 0.942 . . . . 0.0 111.668 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.99 1.79 67.06 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.498 1.047 . . . . 0.0 114.584 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.21 129.03 49.27 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.391 1.477 . . . . 0.0 110.145 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.32 -13.17 55.67 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -81.68 157.69 24.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.6 1.16 . . . . 0.0 113.021 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.51 120.53 23.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.839 1.256 . . . . 0.0 109.66 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.94 139.82 24.03 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.97 141.62 51.88 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.916 1.286 . . . . 0.0 112.482 -169.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.4 166.9 30.74 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.141 1.353 . . . . 0.0 113.644 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -157.36 159.91 37.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.686 1.194 . . . . 0.0 112.087 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -171.95 -171.04 0.82 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.909 1.683 . . . . 0.0 111.508 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.6 p -73.1 -8.77 57.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.098 1.759 . . . . 0.0 113.474 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.42 152.63 33.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.493 1.517 . . . . 0.0 111.751 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.61 -31.21 72.33 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -68.82 -47.66 65.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.198 0.999 . . . . 0.0 112.589 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -69.72 -30.87 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.605 0.762 . . . . 0.0 111.711 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.71 -44.73 77.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.989 -0.444 . . . . 0.0 111.421 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -61.1 -41.37 96.55 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.045 0.938 . . . . 0.0 112.105 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -64.76 -39.03 92.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.802 0.728 . . . . 0.0 111.813 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -67.77 -41.4 83.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.866 -0.521 . . . . 0.0 111.869 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.66 93.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.454 0.702 . . . . 0.0 112.11 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.31 78.17 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.604 1.162 . . . . 0.0 111.197 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -58.1 -39.53 78.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.28 -30.77 63.63 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.321 0.964 . . . . 0.0 113.514 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -75.51 -39.15 58.86 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.283 -0.886 . . . . 0.0 111.844 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.05 -38.33 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.291 -0.88 . . . . 0.0 110.605 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.15 -48.06 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.648 -0.691 . . . . 0.0 110.479 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -53.09 -40.66 64.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.216 1.371 . . . . 0.0 113.817 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.45 -22.49 66.91 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.6 t -81.92 -37.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.223 1.009 . . . . 0.0 110.948 168.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -61.41 -29.88 70.21 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.24 1.016 . . . . 0.0 112.313 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.6 pt -101.5 3.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 125.013 1.325 . . . . 0.0 114.07 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 t30 66.37 23.24 10.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.527 1.931 . . . . 0.0 114.692 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -84.86 -12.85 52.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.015 1.326 . . . . 0.0 113.014 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -139.68 142.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.396 1.878 . . . . 0.0 109.096 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.278 0.631 . . . . 0.0 111.07 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 p -55.46 -33.38 63.59 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -56.34 -22.28 29.81 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.147 1.379 . . . . 0.0 113.839 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.35 -16.32 27.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.476 1.11 . . . . 0.0 113.506 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.0 t -83.09 127.53 68.83 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.347 1.059 . . . . 0.0 111.093 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--N 1.351 0.707 0 C-N-CA 123.329 2.686 . . . . 0.0 112.436 179.62 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -44.51 82.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.189 0.996 . . . . 0.0 110.191 174.033 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -66.4 -30.92 71.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.428 1.091 . . . . 0.0 112.802 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.26 -43.42 77.87 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.043 0.838 . . . . 0.0 111.404 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.71 -43.94 97.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.527 0.603 . . . . 0.0 111.199 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.81 -41.69 98.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.63 77.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.599 1.16 . . . . 0.0 112.557 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -63.23 -41.54 99.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 111.916 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -63.03 -47.14 84.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.091 0.556 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.86 -28.46 73.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.305 0.955 . . . . 0.0 113.681 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -79.23 -17.53 54.61 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.312 1.056 . . . . 0.0 112.751 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -99.01 7.64 45.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.597 2.359 . . . . 0.0 112.957 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 66.25 28.72 9.9 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.728 2.011 . . . . 0.0 113.85 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.0 mtm -114.52 172.87 6.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.157 2.183 . . . . 0.0 111.519 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -140.52 131.76 13.99 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.972 1.709 . . . . 0.0 108.955 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.2 143.75 22.76 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.5 117.13 29.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.805 1.242 . . . . 0.0 110.779 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -100.05 157.99 16.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.672 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -146.93 144.69 29.41 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 109.445 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.7 147.24 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.094 1.358 . . . . 0.0 111.188 -169.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.472 0.668 0 C-N-CA 126.641 1.977 . . . . 0.0 110.117 175.539 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.34 0.591 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -132.34 132.33 42.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.778 1.231 . . . . 0.0 109.917 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtp -102.62 151.76 21.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.93 1.692 . . . . 0.0 109.092 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.2 t -144.1 147.28 33.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.956 0.902 . . . . 0.0 111.764 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -126.7 145.68 50.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.858 2.063 . . . . 0.0 108.542 175.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.15 140.41 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.88 0.872 . . . . 0.0 111.77 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -137.03 159.92 40.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.821 2.048 . . . . 0.0 110.883 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.23 134.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 108.411 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.61 129.49 41.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.028 0.931 . . . . 0.0 111.669 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 1.84 65.22 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.596 1.093 . . . . 0.0 114.669 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -122.08 134.11 54.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.29 1.436 . . . . 0.0 110.464 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -80.97 -12.13 59.44 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -91.19 159.23 16.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.045 1.338 . . . . 0.0 113.191 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.76 121.12 22.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.876 1.271 . . . . 0.0 109.684 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.7 141.28 23.44 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.1 mtm -138.9 142.35 38.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.777 0.831 . . . . 0.0 112.305 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 174.97 32.83 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 124.933 1.254 . . . . 0.0 113.624 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.03 161.5 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.244 1.018 . . . . 0.0 112.285 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -167.03 -171.0 1.66 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.082 1.353 . . . . 0.0 112.137 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -81.52 -6.81 59.34 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.56 1.944 . . . . 0.0 113.606 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -152.01 159.25 43.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.997 1.719 . . . . 0.0 111.655 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -67.03 -29.45 69.26 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.83 -45.64 50.01 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.153 -0.967 . . . . 0.0 112.3 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.47 -29.72 67.45 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.666 -0.646 . . . . 0.0 112.345 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.03 -45.48 77.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.699 -0.626 . . . . 0.0 111.771 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -62.04 -38.26 88.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.584 0.753 . . . . 0.0 112.001 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 m -63.26 -38.13 89.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.617 0.644 . . . . 0.0 112.106 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.5 -35.73 60.73 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.332 0.653 . . . . 0.0 111.716 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.76 -45.65 88.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 111.789 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.57 -47.58 85.55 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.212 1.005 . . . . 0.0 111.439 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -56.99 -38.05 72.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.132 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.2 -27.93 57.07 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -76.99 -37.93 54.17 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.241 -0.912 . . . . 0.0 111.695 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.04 -41.39 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.49 -0.756 . . . . 0.0 110.473 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.26 -49.78 73.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.726 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -52.57 -41.92 64.01 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.404 1.456 . . . . 0.0 113.696 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.05 -22.17 66.82 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 174.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.46 -36.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.407 1.083 . . . . 0.0 110.935 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -60.66 -29.91 69.57 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.57 1.148 . . . . 0.0 112.316 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.1 pt -103.8 4.62 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.074 1.349 . . . . 0.0 113.986 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.2 m120 66.86 19.1 10.69 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.521 1.928 . . . . 0.0 114.934 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -81.15 -12.28 59.26 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.46 . . . . 0.0 113.238 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.33 142.49 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 108.944 170.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -93.44 129.16 39.71 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.417 1.087 . . . . 0.0 109.843 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 p -60.0 -27.37 66.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.91 -1.119 . . . . 0.0 113.718 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.29 -19.74 62.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.313 1.045 . . . . 0.0 113.351 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -86.01 -17.45 35.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.359 1.064 . . . . 0.0 113.159 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.82 127.31 77.97 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.34 1.056 . . . . 0.0 110.406 -169.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 C--N 1.352 0.747 0 C-N-CA 123.122 2.548 . . . . 0.0 111.268 -178.413 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -67.81 -40.81 83.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.183 0.993 . . . . 0.0 110.601 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -67.89 -33.79 75.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.315 1.046 . . . . 0.0 112.703 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.72 -41.43 83.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.91 0.777 . . . . 0.0 111.97 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.24 -44.39 96.68 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.75 0.705 . . . . 0.0 111.285 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.3 -42.56 99.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.34 0.656 . . . . 0.0 112.76 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.46 -40.77 80.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.548 1.139 . . . . 0.0 112.45 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.31 -45.41 93.47 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.11 0.964 . . . . 0.0 111.448 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -58.15 -45.71 86.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.474 0.71 . . . . 0.0 111.652 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.07 -26.86 73.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.504 1.049 . . . . 0.0 114.102 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -78.1 -8.25 58.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.598 1.199 . . . . 0.0 112.853 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.115 2.166 . . . . 0.0 112.769 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 64.41 30.5 13.13 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.39 1.876 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.5 mtm -117.66 174.08 6.37 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.731 2.012 . . . . 0.0 111.415 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -143.53 133.31 11.83 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.825 1.65 . . . . 0.0 108.791 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.66 153.75 34.33 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.961 2.441 . . . . 0.0 110.97 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.22 116.17 20.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.71 157.31 16.78 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 112.225 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.62 148.49 34.39 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.07 1.748 . . . . 0.0 109.692 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.14 146.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.021 1.328 . . . . 0.0 111.89 -168.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 126.699 2.0 . . . . 0.0 110.196 175.151 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.174 0.511 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -135.2 141.82 45.92 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.85 1.26 . . . . 0.0 111.251 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 mtp -113.21 153.48 28.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.171 1.789 . . . . 0.0 109.249 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -146.58 146.49 30.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.011 0.924 . . . . 0.0 111.587 -177.056 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -128.04 149.23 50.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.947 1.699 . . . . 0.0 109.322 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.2 143.57 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.211 1.004 . . . . 0.0 111.966 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -137.03 165.63 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.512 1.925 . . . . 0.0 110.62 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.51 138.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.886 1.674 . . . . 0.0 108.158 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.51 128.42 37.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.938 0.895 . . . . 0.0 111.707 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 0.69 65.12 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.666 1.127 . . . . 0.0 114.765 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -122.96 129.76 51.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.202 1.401 . . . . 0.0 110.577 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.81 -20.88 45.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -70.82 157.95 37.21 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.643 1.177 . . . . 0.0 113.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.9 116.56 15.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.878 1.271 . . . . 0.0 109.591 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.29 143.52 22.91 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 mtt -137.89 144.29 41.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 112.953 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.68 169.45 27.85 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.851 1.691 . . . . 0.0 113.36 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -158.07 152.07 24.09 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.33 1.052 . . . . 0.0 112.186 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.6 t -169.08 -175.09 2.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.924 1.289 . . . . 0.0 112.264 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.7 p -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.717 1.607 . . . . 0.0 113.402 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -142.16 145.5 34.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.535 1.534 . . . . 0.0 111.44 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.33 -30.94 70.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 113.492 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.51 -46.18 70.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.651 1.18 . . . . 0.0 111.891 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -77.04 -27.89 54.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.553 0.741 . . . . 0.0 111.945 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.27 87.52 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.582 -0.699 . . . . 0.0 111.581 170.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.12 -38.75 90.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.688 0.795 . . . . 0.0 112.033 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.1 m -65.03 -36.31 83.95 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.656 -0.652 . . . . 0.0 112.255 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.33 -36.95 68.98 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.458 -0.776 . . . . 0.0 111.967 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.66 97.86 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.576 -0.703 . . . . 0.0 111.536 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.96 77.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.306 1.042 . . . . 0.0 111.618 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -52.09 -44.43 64.38 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.625 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.75 -35.16 70.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.95 0.9 . . . . 0.0 113.118 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.91 -37.6 62.02 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.686 -0.633 . . . . 0.0 112.291 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.88 -40.89 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.79 -31.68 71.91 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.64 -44.62 81.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.0 -1.687 . . . . 0.0 111.993 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' HG23 ' A' ' 75' ' ' VAL . 94.3 mt -61.46 -33.2 73.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.647 0.658 . . . . 0.0 112.748 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.26 -44.46 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.026 0.93 . . . . 0.0 111.336 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -63.05 -22.5 66.9 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 pt -104.56 6.49 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.77 1.228 . . . . 0.0 113.983 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 67.51 21.29 9.59 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.446 1.899 . . . . 0.0 114.63 174.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -90.36 -5.72 55.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 113.195 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 69' ' ' LEU . 70.0 t -136.11 136.88 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 127.034 2.133 . . . . 0.0 107.781 168.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.51 126.69 33.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.56 -32.49 63.04 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.336 -0.852 . . . . 0.0 113.246 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.92 -19.55 60.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.087 1.355 . . . . 0.0 113.561 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.76 -16.08 29.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.614 1.166 . . . . 0.0 113.322 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.19 124.11 85.88 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.238 1.015 . . . . 0.0 110.978 -169.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 C--N 1.35 0.649 0 C-N-CA 123.492 2.795 . . . . 0.0 111.844 178.869 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.18 -38.46 82.07 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.466 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -71.92 -30.38 65.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.017 0.927 . . . . 0.0 112.84 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -66.99 -43.78 82.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.842 0.857 . . . . 0.0 111.792 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 tp -62.79 -42.89 99.9 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.415 0.552 . . . . 0.0 111.25 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -63.33 -42.73 98.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.67 80.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.436 1.094 . . . . 0.0 112.453 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.98 -45.71 93.71 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 111.457 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.2 m -58.04 -46.27 85.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.588 0.755 . . . . 0.0 111.648 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.08 -26.9 73.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.47 1.033 . . . . 0.0 114.065 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.74 -8.36 57.86 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.413 1.107 . . . . 0.0 112.706 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.7 8.69 11.24 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.277 2.231 . . . . 0.0 112.687 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.4 30.93 12.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.556 1.943 . . . . 0.0 113.568 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtm -117.83 173.6 6.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.819 2.048 . . . . 0.0 111.425 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 m -143.05 132.46 11.78 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.054 1.742 . . . . 0.0 108.983 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 152.97 30.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.134 2.556 . . . . 0.0 110.986 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.12 117.47 21.67 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.88 156.31 17.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.462 1.505 . . . . 0.0 112.498 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.45 145.7 32.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.397 1.879 . . . . 0.0 109.262 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -133.17 148.41 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.187 1.395 . . . . 0.0 110.83 -169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 125.854 1.661 . . . . 0.0 110.653 -178.95 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.4 mttt . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.002 0.429 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.06 127.03 29.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.914 1.286 . . . . 0.0 111.075 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtp -91.25 154.87 18.98 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.427 1.491 . . . . 0.0 109.307 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.3 t -143.77 147.69 34.52 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.191 0.996 . . . . 0.0 111.212 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -132.84 141.37 48.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.588 1.955 . . . . 0.0 108.131 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.14 144.03 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.928 0.891 . . . . 0.0 112.1 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -137.82 166.51 23.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.123 1.769 . . . . 0.0 111.165 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.3 139.01 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.255 1.822 . . . . 0.0 107.764 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.54 127.67 33.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 111.834 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.89 -0.71 64.82 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.718 1.151 . . . . 0.0 114.96 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -117.46 126.95 53.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.846 1.323 . . . . 0.0 110.859 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -72.76 -23.37 60.81 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.183 0.993 . . . . 0.0 113.455 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -69.1 158.08 35.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.036 1.334 . . . . 0.0 113.697 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.57 119.58 17.52 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.252 1.421 . . . . 0.0 110.246 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.07 21.66 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtt -137.86 142.14 40.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.916 0.887 . . . . 0.0 112.823 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.42 170.1 26.84 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.737 1.637 . . . . 0.0 113.272 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -157.75 149.76 22.18 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.657 1.183 . . . . 0.0 111.216 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -166.42 -175.64 3.3 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.876 1.27 . . . . 0.0 112.54 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.6 p -75.61 -9.96 59.03 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.568 1.547 . . . . 0.0 113.317 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.44 150.57 30.58 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.452 1.501 . . . . 0.0 111.845 -170.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.05 -34.17 77.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.236 1.014 . . . . 0.0 113.649 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -64.55 -49.07 72.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.727 1.211 . . . . 0.0 111.983 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.24 -27.2 56.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.013 0.925 . . . . 0.0 112.153 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.35 84.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.527 -0.733 . . . . 0.0 111.719 171.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.2 -40.31 89.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.165 0.586 . . . . 0.0 111.72 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.7 m -64.88 -36.59 84.86 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.818 -0.551 . . . . 0.0 112.23 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -71.57 -38.91 70.88 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.306 -0.871 . . . . 0.0 111.824 173.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.4 98.91 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.727 0.694 . . . . 0.0 111.533 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.92 82.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.245 1.018 . . . . 0.0 111.554 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.4 tpt85 -56.15 -37.86 70.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.467 0.707 . . . . 0.0 112.441 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.4 -29.05 52.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 113.415 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.56 -37.99 55.68 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.412 -0.805 . . . . 0.0 111.664 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.42 -40.29 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.651 0.78 . . . . 0.0 110.582 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -53.32 -48.86 68.09 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 170.087 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -58.71 -44.76 90.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.915 -1.115 . . . . 0.0 112.816 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.439 ' HB3' HG23 ' A' ' 75' ' ' VAL . 96.1 mt -62.79 -31.5 72.48 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -72.09 -41.29 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.866 0.867 . . . . 0.0 111.132 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -65.08 -26.53 68.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.226 1.011 . . . . 0.0 113.124 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 pt -98.66 4.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.611 1.165 . . . . 0.0 113.798 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 68.99 17.24 8.65 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.706 2.002 . . . . 0.0 114.63 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -85.17 -7.8 58.89 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.115 1.366 . . . . 0.0 113.209 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 69' ' ' LEU . 72.4 t -132.58 137.45 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.998 2.119 . . . . 0.0 107.626 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -84.71 128.33 34.55 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.92 0.488 . . . . 0.0 109.919 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -55.13 -33.44 62.89 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.388 -0.82 . . . . 0.0 113.143 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.35 -19.07 61.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.946 1.298 . . . . 0.0 113.605 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -90.18 -16.84 28.7 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.508 1.123 . . . . 0.0 113.227 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.0 t -76.11 125.85 87.44 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.252 1.021 . . . . 0.0 110.496 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo . . . . . 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.571 . . . . 0.0 111.322 178.761 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -66.34 -43.37 86.29 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.801 1.24 . . . . 0.0 110.361 172.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.48 -32.0 73.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 112.854 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -69.08 -40.96 78.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.289 0.949 . . . . 0.0 111.993 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.77 -42.47 99.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -61.91 -41.93 98.49 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.36 82.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.509 1.124 . . . . 0.0 112.863 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.01 -43.79 94.58 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.83 0.852 . . . . 0.0 111.856 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.6 m -57.89 -43.88 86.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.096 0.558 . . . . 0.0 111.08 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.65 -28.64 73.81 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.561 1.076 . . . . 0.0 114.055 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -70.34 -12.91 61.9 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.637 1.218 . . . . 0.0 112.645 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -119.61 9.18 11.4 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.15 2.18 . . . . 0.0 113.257 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.39 24.03 13.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 114.044 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.97 174.04 6.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.013 2.125 . . . . 0.0 111.476 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.4 m -140.49 130.74 13.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.34 1.856 . . . . 0.0 108.528 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.36 147.63 29.25 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.003 2.469 . . . . 0.0 110.758 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.27 114.45 25.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.456 1.103 . . . . 0.0 110.641 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -95.74 153.8 17.55 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.004 1.321 . . . . 0.0 111.739 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -145.52 138.6 26.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.166 1.786 . . . . 0.0 108.556 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.08 147.45 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.423 1.089 . . . . 0.0 111.774 -168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 . . . . . 0 N--CA 1.469 0.508 0 C-N-CA 126.149 1.78 . . . . 0.0 110.44 172.919 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.93 128.87 35.41 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.346 1.058 . . . . 0.0 111.909 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtm -94.98 151.48 19.14 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.546 1.538 . . . . 0.0 108.948 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.2 t -144.68 149.56 35.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.971 0.908 . . . . 0.0 112.082 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -132.87 149.42 52.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.389 1.875 . . . . 0.0 109.044 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.36 140.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.868 0.867 . . . . 0.0 111.71 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -137.08 157.57 46.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.923 2.089 . . . . 0.0 110.546 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.9 t -140.63 136.31 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.729 1.612 . . . . 0.0 108.459 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.28 128.12 35.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.034 0.933 . . . . 0.0 111.73 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.45 2.89 65.24 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.543 1.068 . . . . 0.0 114.692 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.43 129.05 49.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.412 1.485 . . . . 0.0 110.261 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -81.5 -12.19 58.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -85.54 160.44 19.66 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.678 1.191 . . . . 0.0 113.1 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.7 117.68 16.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.84 1.256 . . . . 0.0 109.604 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.01 141.31 24.09 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.6 mtp -123.6 143.38 50.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.556 1.142 . . . . 0.0 112.747 -169.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.11 169.24 28.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.434 1.493 . . . . 0.0 113.633 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -159.88 148.98 17.68 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.934 1.294 . . . . 0.0 111.153 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.53 -176.18 3.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.769 1.228 . . . . 0.0 112.656 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 m -75.67 -19.99 58.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.15 1.38 . . . . 0.0 111.775 172.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -138.35 155.77 48.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 112.85 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -67.67 -40.82 84.45 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.365 -0.834 . . . . 0.0 112.133 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.29 -30.34 57.74 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 112.035 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -43.79 90.2 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.534 -0.729 . . . . 0.0 111.768 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -61.52 -39.48 91.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.538 0.735 . . . . 0.0 111.668 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -64.61 -35.13 80.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.996 0.817 . . . . 0.0 112.388 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.57 -38.18 67.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.28 -0.888 . . . . 0.0 112.017 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.02 97.27 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.59 -0.694 . . . . 0.0 111.563 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -47.59 83.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.576 1.15 . . . . 0.0 111.836 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -52.52 -43.21 64.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.874 0.87 . . . . 0.0 111.581 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.37 -34.26 63.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.22 -37.24 61.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.44 -0.788 . . . . 0.0 112.241 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.15 -42.47 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.342 -0.848 . . . . 0.0 110.092 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.36 -48.64 78.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.524 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -51.1 -42.65 60.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.726 1.603 . . . . 0.0 113.842 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.99 -22.27 66.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.25 -36.72 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.552 1.069 . . . . 0.0 110.903 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -60.4 -30.53 69.66 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.33 1.052 . . . . 0.0 112.112 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 pt -103.96 3.48 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.292 . . . . 0.0 114.211 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.86 23.16 11.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.509 1.924 . . . . 0.0 114.797 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -86.2 -9.75 55.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.51 1.524 . . . . 0.0 113.052 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -134.06 136.65 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 127.139 2.176 . . . . 0.0 107.433 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -86.65 137.44 32.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.319 0.509 . . . . 0.0 109.714 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 p -54.91 -32.09 60.79 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.977 -1.077 . . . . 0.0 113.094 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -53.5 -24.64 13.76 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.015 1.726 . . . . 0.0 114.177 173.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.27 -20.47 26.82 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.545 1.138 . . . . 0.0 113.104 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.1 t -80.45 129.43 69.03 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.583 1.153 . . . . 0.0 110.693 -168.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 123.06 2.507 . . . . 0.0 110.756 176.705 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 tp . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -48.26 76.99 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.302 1.041 . . . . 0.0 110.027 169.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -64.81 -29.57 70.54 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 112.685 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.81 -45.61 74.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.812 0.733 . . . . 0.0 111.476 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.63 -41.79 99.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.369 0.531 . . . . 0.0 111.153 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.01 -42.49 99.83 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -39.1 79.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.36 1.064 . . . . 0.0 112.419 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.8 t90 -61.0 -45.84 93.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.068 0.947 . . . . 0.0 111.427 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.3 m -58.22 -45.67 87.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.649 0.78 . . . . 0.0 111.711 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.67 -26.83 72.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.449 1.024 . . . . 0.0 114.051 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -78.12 -8.38 58.18 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.398 1.099 . . . . 0.0 112.744 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -119.68 9.3 11.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.377 2.271 . . . . 0.0 112.726 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.96 30.72 11.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.51 1.924 . . . . 0.0 113.623 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.8 mtm -118.33 172.36 7.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.756 2.022 . . . . 0.0 111.57 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -142.54 130.64 11.48 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.093 1.757 . . . . 0.0 108.685 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.6 149.96 27.44 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.011 2.474 . . . . 0.0 110.803 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.0 117.62 27.74 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.651 1.181 . . . . 0.0 110.68 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.26 158.03 16.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.336 1.455 . . . . 0.0 112.63 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.3 149.88 33.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.999 1.32 . . . . 0.0 110.33 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.1 mt -135.66 147.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.822 1.649 . . . . 0.0 111.149 -169.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 125.653 1.581 . . . . 0.0 111.06 176.664 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 121.289 0.566 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.28 133.88 46.81 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.239 1.416 . . . . 0.0 110.651 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 37.2 mtm -100.39 154.16 18.74 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.113 1.765 . . . . 0.0 109.211 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.6 t -147.54 148.69 31.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.376 1.07 . . . . 0.0 111.171 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.89 158.28 42.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.096 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.69 143.9 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.807 1.243 . . . . 0.0 111.611 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -139.44 158.19 44.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.436 1.895 . . . . 0.0 110.335 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.07 134.94 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.619 1.568 . . . . 0.0 108.619 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.67 130.14 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.04 0.936 . . . . 0.0 111.677 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.55 1.37 66.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.537 1.065 . . . . 0.0 114.567 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -125.14 128.84 49.03 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 110.363 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -77.25 -20.88 54.55 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -71.29 156.68 39.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.559 1.143 . . . . 0.0 113.377 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.66 116.99 15.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.035 1.334 . . . . 0.0 109.326 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.92 141.84 22.01 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 77.1 mtm -140.27 142.41 35.73 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.595 1.158 . . . . 0.0 112.232 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.26 173.92 31.3 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.264 1.411 . . . . 0.0 113.143 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -152.81 161.7 42.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.262 1.025 . . . . 0.0 111.953 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 t -167.34 -172.83 2.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.647 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.6 p -76.84 -9.57 58.77 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.544 1.538 . . . . 0.0 113.372 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.55 151.38 31.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.657 1.583 . . . . 0.0 111.779 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.34 -30.03 70.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -65.33 -54.61 26.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.708 1.203 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.84 -27.56 62.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.727 0.811 . . . . 0.0 112.171 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.41 95.08 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.814 -0.553 . . . . 0.0 111.749 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.01 -41.07 95.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.43 0.692 . . . . 0.0 112.034 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.4 m -59.03 -40.2 84.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.18 0.9 . . . . 0.0 112.34 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -72.46 -37.97 68.36 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.592 -0.692 . . . . 0.0 111.545 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.35 92.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.651 0.781 . . . . 0.0 112.282 172.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.59 -49.11 77.93 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.313 1.045 . . . . 0.0 111.593 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -58.65 -39.74 81.43 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.73 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.85 -30.78 70.25 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -77.94 -39.6 42.17 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.617 -0.677 . . . . 0.0 112.359 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.2 -38.7 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.41 -0.806 . . . . 0.0 110.798 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.82 -44.01 81.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.504 0.721 . . . . 0.0 111.578 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -60.41 -44.47 95.69 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.768 -1.207 . . . . 0.0 112.665 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.4 -34.27 75.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.065 0.848 . . . . 0.0 113.179 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.12 -42.64 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.908 0.883 . . . . 0.0 111.198 171.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -66.17 -21.36 66.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.508 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -103.38 6.75 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.939 1.296 . . . . 0.0 113.625 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m120 68.79 18.84 8.57 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.725 2.01 . . . . 0.0 114.675 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.67 -5.69 57.96 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.347 1.459 . . . . 0.0 113.322 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -136.83 139.33 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.906 2.082 . . . . 0.0 107.995 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -84.97 125.91 33.08 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.964 0.506 . . . . 0.0 110.067 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.08 -33.1 62.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.13 -19.47 61.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.909 1.284 . . . . 0.0 113.568 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -92.42 -15.64 26.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.648 1.179 . . . . 0.0 113.435 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 123.74 85.41 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.103 0.961 . . . . 0.0 111.64 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 CA--C 1.539 0.761 0 C-N-CA 123.785 2.99 . . . . 0.0 112.707 178.713 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -40.72 75.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.528 1.131 . . . . 0.0 110.542 174.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -69.38 -31.38 69.73 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.182 0.993 . . . . 0.0 112.828 170.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.18 -42.0 84.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.969 0.804 . . . . 0.0 111.947 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -62.65 -42.98 99.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.702 0.683 . . . . 0.0 111.258 173.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.87 -42.96 99.95 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.252 0.621 . . . . 0.0 112.556 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 -39.99 83.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.349 1.06 . . . . 0.0 112.667 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.37 -45.65 93.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 111.452 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.1 m -58.23 -45.45 87.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.545 0.738 . . . . 0.0 111.684 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.07 73.03 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.483 1.04 . . . . 0.0 114.034 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.46 -8.99 58.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.466 1.106 . . . . 0.0 112.838 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -119.64 9.35 11.43 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.251 2.22 . . . . 0.0 112.736 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 mttp 65.05 30.7 11.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.439 1.895 . . . . 0.0 113.568 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.7 mtm -118.6 172.38 7.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.688 1.995 . . . . 0.0 111.654 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.6 m -141.4 130.25 12.42 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 126.328 1.851 . . . . 0.0 108.581 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.62 142.13 20.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.928 2.419 . . . . 0.0 110.581 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.31 116.64 30.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.485 1.114 . . . . 0.0 110.558 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -98.23 154.9 17.46 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.098 1.359 . . . . 0.0 112.301 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.18 136.86 22.96 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.917 1.287 . . . . 0.0 110.287 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 70.0 mt -123.78 147.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.12 1.368 . . . . 0.0 110.97 -170.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 . . . . . 0 N--CA 1.47 0.528 0 C-N-CA 126.707 2.003 . . . . 0.0 110.106 -174.881 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 121.126 0.488 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -135.09 137.77 43.17 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.89 1.276 . . . . 0.0 111.6 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.6 mtp -102.67 152.19 21.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.588 1.555 . . . . 0.0 108.879 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.0 t -135.76 145.38 46.52 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.427 1.091 . . . . 0.0 110.194 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -122.46 152.23 40.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.202 1.801 . . . . 0.0 108.976 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.31 140.11 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.778 1.231 . . . . 0.0 110.894 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -140.79 153.39 45.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.945 1.698 . . . . 0.0 110.117 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.77 134.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.488 1.515 . . . . 0.0 108.88 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.79 130.01 44.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.131 0.972 . . . . 0.0 111.695 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.4 2.05 66.0 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.607 1.098 . . . . 0.0 114.627 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.83 130.85 53.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.397 1.479 . . . . 0.0 110.321 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -82.67 -14.72 54.15 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -80.93 155.75 26.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.407 1.083 . . . . 0.0 112.766 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.81 112.05 13.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.191 1.396 . . . . 0.0 108.911 170.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.16 147.19 25.76 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.5 ptm -147.19 150.29 34.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.6 173.78 30.1 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.248 1.88 . . . . 0.0 112.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -157.28 154.55 29.27 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.918 0.887 . . . . 0.0 112.753 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -168.28 -178.26 3.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.413 1.485 . . . . 0.0 111.471 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m -78.23 -2.69 39.02 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.578 1.551 . . . . 0.0 112.052 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -142.37 150.45 40.72 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.957 1.703 . . . . 0.0 111.786 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.72 -37.55 70.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.615 1.166 . . . . 0.0 113.631 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -71.54 -36.96 71.17 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.14 -0.975 . . . . 0.0 112.19 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.92 -30.92 70.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.159 0.984 . . . . 0.0 112.236 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.13 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.335 -0.853 . . . . 0.0 111.617 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -61.38 -42.2 98.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.898 0.879 . . . . 0.0 112.498 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -69.27 -32.05 70.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.542 1.065 . . . . 0.0 112.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -69.24 -40.52 77.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.476 -0.765 . . . . 0.0 111.804 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.32 99.79 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.831 0.742 . . . . 0.0 111.926 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.94 77.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.955 0.902 . . . . 0.0 111.452 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -57.84 -40.29 79.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.457 0.571 . . . . 0.0 111.968 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.15 -33.87 74.09 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.778 0.831 . . . . 0.0 113.104 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -76.11 -38.84 56.4 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.679 -0.638 . . . . 0.0 112.229 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.3 -41.45 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.451 -0.781 . . . . 0.0 110.591 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -56.75 -47.28 80.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.105 0.562 . . . . 0.0 111.588 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -56.48 -44.43 80.6 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 112.896 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.79 -31.89 72.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.375 -0.828 . . . . 0.0 113.209 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.62 -39.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.044 0.838 . . . . 0.0 111.388 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -61.38 -29.99 70.26 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.8 pt -98.32 5.1 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.9 t30 67.99 21.73 8.77 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.766 2.027 . . . . 0.0 114.576 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -89.61 -5.36 57.23 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.234 1.413 . . . . 0.0 113.118 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.1 t -138.2 144.36 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.797 2.439 . . . . 0.0 107.18 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -98.32 133.33 42.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.538 0.735 . . . . 0.0 110.336 169.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.8 p -58.2 -30.29 66.33 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.208 -0.933 . . . . 0.0 113.242 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.83 -21.91 57.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.534 1.134 . . . . 0.0 113.645 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -88.99 -17.26 29.8 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.39 1.076 . . . . 0.0 113.15 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.52 125.59 82.49 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 124.307 1.043 . . . . 0.0 110.733 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.351 0.702 0 C-N-CA 123.076 2.517 . . . . 0.0 110.288 177.736 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.52 -44.74 86.02 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.337 1.055 . . . . 0.0 110.241 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.54 -31.96 73.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.639 0.775 . . . . 0.0 112.673 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.25 -42.91 74.96 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.687 0.795 . . . . 0.0 111.71 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.52 -43.16 99.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.627 0.649 . . . . 0.0 111.231 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.45 -42.86 98.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.6 83.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.578 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -60.29 -45.57 92.89 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.296 1.038 . . . . 0.0 111.586 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.3 m -58.06 -44.01 87.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.474 0.71 . . . . 0.0 111.665 171.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.58 -26.63 72.9 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.424 1.011 . . . . 0.0 114.103 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -78.52 -6.63 55.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.629 1.215 . . . . 0.0 112.857 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -119.3 7.88 11.34 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.057 2.143 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 63.29 27.71 15.51 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.329 1.852 . . . . 0.0 113.519 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.0 mtm -110.79 174.15 6.0 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.878 2.071 . . . . 0.0 111.305 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.4 m -143.17 131.08 11.09 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.85 1.66 . . . . 0.0 108.509 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.04 146.25 25.5 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.986 2.457 . . . . 0.0 110.645 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.46 113.22 24.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.323 1.049 . . . . 0.0 110.786 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -98.55 155.19 17.4 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.538 1.535 . . . . 0.0 112.128 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.13 146.77 30.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.1 1.76 . . . . 0.0 109.866 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.82 147.73 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.306 1.442 . . . . 0.0 110.686 -169.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 . . . . . 0 N--CA 1.471 0.595 0 C-N-CA 126.73 2.012 . . . . 0.0 110.114 -176.102 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttp . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.893 0.378 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -135.11 135.3 41.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.388 1.075 . . . . 0.0 111.798 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.7 mtt -98.94 154.27 18.19 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.6 1.56 . . . . 0.0 108.881 168.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.6 t -142.48 147.39 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.162 0.985 . . . . 0.0 110.878 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -131.46 146.34 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.315 1.846 . . . . 0.0 108.828 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.26 139.79 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.324 1.05 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.16 158.98 43.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.878 1.671 . . . . 0.0 110.484 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.57 135.79 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.603 1.561 . . . . 0.0 108.678 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.05 129.44 41.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.126 0.97 . . . . 0.0 111.735 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.61 0.44 66.94 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.661 1.124 . . . . 0.0 114.694 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.58 132.44 56.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.335 1.454 . . . . 0.0 110.366 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -82.32 -12.93 57.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -171.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -90.05 155.76 18.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.913 1.285 . . . . 0.0 112.706 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.24 112.37 14.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.287 1.435 . . . . 0.0 108.759 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 149.26 30.38 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -148.98 147.39 28.53 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -168.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.34 176.42 29.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.917 1.722 . . . . 0.0 112.594 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.29 161.49 42.31 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.115 0.966 . . . . 0.0 112.076 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -168.63 -174.11 2.08 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.27 1.428 . . . . 0.0 111.836 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 p -75.31 -11.0 59.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.411 1.485 . . . . 0.0 113.347 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -150.08 151.52 33.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.409 1.483 . . . . 0.0 112.069 -169.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.57 -28.57 68.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -70.53 -50.41 37.92 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.844 0.857 . . . . 0.0 111.918 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.75 -29.65 63.5 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.572 -0.705 . . . . 0.0 112.182 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.14 89.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.671 -0.643 . . . . 0.0 111.941 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.25 -38.8 90.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.474 0.71 . . . . 0.0 112.037 172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -65.24 -36.94 85.7 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.899 -0.501 . . . . 0.0 111.82 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -73.79 -35.13 64.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.69 0.796 . . . . 0.0 111.713 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.48 93.37 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.466 -0.772 . . . . 0.0 112.125 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.38 -48.04 81.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.886 0.874 . . . . 0.0 111.543 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -53.58 -42.26 67.43 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.33 1.052 . . . . 0.0 111.932 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.05 -35.7 69.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.965 0.906 . . . . 0.0 113.223 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -75.11 -37.23 61.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.631 -0.668 . . . . 0.0 112.54 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.58 -38.36 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.352 -0.842 . . . . 0.0 110.494 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -55.83 -46.98 78.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 119.347 -0.358 . . . . 0.0 111.925 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -56.18 -46.72 79.26 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.031 -1.043 . . . . 0.0 112.969 170.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.13 -33.89 75.32 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.93 -41.99 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.983 0.913 . . . . 0.0 111.193 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -67.3 -19.97 65.55 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.356 1.062 . . . . 0.0 113.394 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -103.89 6.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.967 1.307 . . . . 0.0 113.576 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 68.0 20.38 9.13 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.843 2.057 . . . . 0.0 114.566 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.96 -6.09 57.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.039 1.336 . . . . 0.0 113.036 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.75 138.7 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.055 2.142 . . . . 0.0 107.525 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -89.4 131.34 35.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.538 0.685 . . . . 0.0 110.615 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -59.55 -33.62 71.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -62.32 -17.73 59.56 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.514 1.126 . . . . 0.0 113.471 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.94 -16.74 31.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.349 1.06 . . . . 0.0 113.227 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.12 125.97 78.23 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.367 1.067 . . . . 0.0 111.368 -168.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.351 0.695 0 C-N-CA 123.501 2.801 . . . . 0.0 111.379 175.189 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -66.61 -41.47 88.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.843 0.857 . . . . 0.0 110.468 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -63.4 -38.54 91.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.0 112.278 170.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -65.46 -44.37 87.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.601 0.76 . . . . 0.0 111.799 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.21 -43.25 98.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.449 0.568 . . . . 0.0 111.365 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.4 -42.92 98.79 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.36 -39.05 78.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 112.56 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -60.96 -45.82 93.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.219 1.008 . . . . 0.0 111.308 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.5 m -58.34 -46.07 86.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 111.722 172.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.8 -27.01 73.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.368 0.985 . . . . 0.0 114.104 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.01 -8.23 57.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.556 1.143 . . . . 0.0 112.775 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.68 8.9 11.29 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.666 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 64.91 30.43 12.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.482 1.913 . . . . 0.0 113.71 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.0 mtm -117.69 173.69 6.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.724 2.01 . . . . 0.0 111.521 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 m -143.47 132.38 11.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.828 1.651 . . . . 0.0 108.885 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.46 152.48 30.08 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.066 2.51 . . . . 0.0 110.954 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.51 116.87 22.48 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.716 1.207 . . . . 0.0 110.801 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.74 156.95 17.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.465 1.506 . . . . 0.0 112.174 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -147.2 138.46 23.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.09 1.356 . . . . 0.0 110.185 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.88 148.88 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.999 1.32 . . . . 0.0 111.746 -168.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 126.222 1.809 . . . . 0.0 110.682 175.753 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 120.906 0.384 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -134.02 124.15 25.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.866 1.267 . . . . 0.0 111.17 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 61.0 mtp -89.32 153.08 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 109.41 168.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 32.9 t -142.45 146.18 34.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.341 1.056 . . . . 0.0 111.042 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.548 1.939 . . . . 0.0 109.137 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -144.86 142.56 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.495 1.118 . . . . 0.0 111.726 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -137.49 160.27 39.59 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.056 2.142 . . . . 0.0 110.466 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.7 t -139.91 135.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.83 1.652 . . . . 0.0 108.297 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.38 129.54 42.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.002 0.921 . . . . 0.0 111.702 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.54 0.43 64.8 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.576 1.084 . . . . 0.0 114.73 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.32 129.28 52.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.205 1.402 . . . . 0.0 110.529 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.86 -22.29 50.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -71.64 156.31 39.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.665 1.186 . . . . 0.0 113.243 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.67 118.61 17.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.939 1.295 . . . . 0.0 109.573 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.1 150.4 23.83 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.4 ptm -148.75 151.65 35.21 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.52 177.98 29.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.916 1.722 . . . . 0.0 112.926 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -151.75 155.67 38.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.13 1.372 . . . . 0.0 110.691 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 t -166.99 -176.61 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.861 1.264 . . . . 0.0 112.428 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 p -76.92 -10.68 59.53 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.647 1.579 . . . . 0.0 113.292 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -150.25 151.77 33.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.273 1.429 . . . . 0.0 112.176 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.81 -27.65 68.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -71.75 -53.27 13.99 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.17 -31.65 71.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.161 0.584 . . . . 0.0 112.256 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.63 98.92 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.738 -0.601 . . . . 0.0 112.275 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -65.26 -41.32 94.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 m -60.27 -37.59 80.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.308 0.958 . . . . 0.0 112.555 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -73.71 -37.41 65.17 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.365 -0.835 . . . . 0.0 111.517 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.55 -42.93 98.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.762 0.825 . . . . 0.0 112.316 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.33 85.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.934 0.894 . . . . 0.0 111.454 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -56.87 -38.07 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.063 0.545 . . . . 0.0 112.445 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.47 -34.67 65.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.816 1.246 . . . . 0.0 112.86 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -73.38 -37.85 65.86 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.317 -0.864 . . . . 0.0 112.157 172.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.2 -35.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 121.52 -0.737 . . . . 0.0 110.973 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.24 87.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.229 0.612 . . . . 0.0 111.496 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.19 -45.15 89.6 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.897 -1.127 . . . . 0.0 112.391 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.5 mt -60.71 -34.22 74.06 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.17 -43.55 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.758 0.823 . . . . 0.0 111.241 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -65.43 -24.99 67.33 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.1 pt -97.86 5.63 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.392 1.077 . . . . 0.0 113.671 170.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 68.06 21.64 8.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.529 1.932 . . . . 0.0 114.433 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -91.47 -5.05 54.88 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 113.195 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 69' ' ' LEU . 90.2 t -137.24 137.95 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.176 2.19 . . . . 0.0 107.88 169.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.82 126.13 32.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.927 0.491 . . . . 0.0 109.898 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 p -55.3 -34.32 64.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.52 -15.35 57.65 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -91.26 -15.81 28.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.56 1.144 . . . . 0.0 113.126 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.42 123.25 86.87 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.055 0.942 . . . . 0.0 111.142 -169.279 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 C--N 1.351 0.696 0 C-N-CA 123.504 2.803 . . . . 0.0 111.593 177.882 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.1 -42.45 84.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.011 0.925 . . . . 0.0 110.343 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -67.76 -31.11 70.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.903 0.881 . . . . 0.0 112.977 171.556 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -67.74 -41.84 82.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.241 0.928 . . . . 0.0 111.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.26 -43.86 96.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.661 0.664 . . . . 0.0 111.081 173.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.59 -42.56 99.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.8 79.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.547 1.139 . . . . 0.0 112.782 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.83 -46.94 87.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.901 0.881 . . . . 0.0 111.407 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 m -57.55 -44.67 85.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.916 0.887 . . . . 0.0 111.937 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.18 -26.52 72.52 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.336 0.969 . . . . 0.0 114.001 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -77.92 -7.86 57.33 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.49 1.116 . . . . 0.0 112.785 172.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -119.44 8.91 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.261 2.224 . . . . 0.0 112.797 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 63.62 28.44 15.09 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.426 1.89 . . . . 0.0 113.58 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.36 172.51 6.87 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.865 2.066 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 m -140.73 129.22 12.7 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.207 1.803 . . . . 0.0 108.609 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.57 145.88 26.69 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.056 2.504 . . . . 0.0 110.753 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.15 115.49 26.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.57 1.148 . . . . 0.0 110.681 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -99.1 156.85 16.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.448 1.499 . . . . 0.0 112.221 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.98 149.06 32.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.338 1.455 . . . . 0.0 110.097 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.4 mt -131.93 146.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.652 1.581 . . . . 0.0 110.756 -169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 . . . . . 0 N--CA 1.471 0.596 0 C-N-CA 125.56 1.544 . . . . 0.0 111.164 -171.79 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.307 0.575 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.94 130.69 39.91 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.338 1.055 . . . . 0.0 111.639 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.8 mtp -95.97 155.31 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.398 1.479 . . . . 0.0 108.822 167.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.5 t -142.27 149.77 40.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.251 1.021 . . . . 0.0 110.285 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.57 151.05 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.754 1.622 . . . . 0.0 109.861 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.78 142.23 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.687 1.195 . . . . 0.0 111.503 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -139.78 158.0 44.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.539 1.936 . . . . 0.0 110.066 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.77 135.5 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.443 1.497 . . . . 0.0 108.748 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.95 129.22 40.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 0.0 111.598 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.84 2.44 66.88 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.434 1.016 . . . . 0.0 114.482 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.95 127.28 44.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.451 1.5 . . . . 0.0 110.039 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -79.51 -11.52 59.89 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.3 155.8 29.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.506 1.122 . . . . 0.0 113.048 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.18 107.73 8.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 109.021 170.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.0 144.12 21.7 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ptm -149.11 152.84 36.85 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.01 -178.11 28.12 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.157 1.837 . . . . 0.0 112.663 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -154.9 162.58 41.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 112.877 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.5 t -168.59 -178.01 3.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.959 1.703 . . . . 0.0 111.154 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.4 m -74.63 -14.81 60.81 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.329 1.452 . . . . 0.0 112.139 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -138.97 146.83 41.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.628 1.571 . . . . 0.0 112.422 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.92 -28.22 67.31 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.24 -42.86 79.1 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.398 0.999 . . . . 0.0 112.014 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.81 -33.03 64.01 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.578 -0.701 . . . . 0.0 112.031 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.82 -46.01 89.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.825 -0.547 . . . . 0.0 111.674 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.29 -38.05 89.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.69 0.796 . . . . 0.0 112.271 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m -64.14 -38.39 90.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.729 0.695 . . . . 0.0 112.069 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -73.76 -37.19 65.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.377 0.671 . . . . 0.0 111.335 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.46 96.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.648 0.779 . . . . 0.0 112.381 170.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.36 77.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.005 0.922 . . . . 0.0 111.204 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -57.8 -40.26 79.51 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.916 0.486 . . . . 0.0 112.005 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.27 -32.37 70.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.35 -38.31 50.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.72 -0.613 . . . . 0.0 112.196 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -61.75 -41.29 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -59.87 -33.87 72.38 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 112.132 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -67.31 -44.43 79.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.054 -1.654 . . . . 0.0 112.03 169.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.94 -32.45 71.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.28 -44.7 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.002 0.921 . . . . 0.0 111.367 169.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -62.73 -22.66 66.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.29 8.12 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.799 1.239 . . . . 0.0 114.086 172.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 68.46 20.73 8.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.041 1.736 . . . . 0.0 114.321 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -93.19 -6.04 48.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.35 1.46 . . . . 0.0 113.298 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.53 139.27 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.887 2.075 . . . . 0.0 107.796 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -88.95 133.14 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.865 -0.522 . . . . 0.0 110.696 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -57.12 -35.39 69.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.09 -15.21 55.91 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -89.07 -17.5 29.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.359 1.063 . . . . 0.0 113.025 174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.23 123.78 85.88 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.055 0.942 . . . . 0.0 110.462 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 C--N 1.351 0.659 0 C-N-CA 123.354 2.702 . . . . 0.0 112.581 -177.339 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.97 78.2 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.549 -0.719 . . . . 0.0 111.509 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -76.91 -29.55 55.76 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.911 0.885 . . . . 0.0 112.553 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.49 -45.35 83.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.94 -43.07 99.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.155 0.434 . . . . 0.0 111.371 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -62.55 -42.71 99.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.248 0.619 . . . . 0.0 112.628 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.34 -41.11 81.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.345 1.058 . . . . 0.0 112.449 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.83 -45.28 95.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.943 . . . . 0.0 111.66 174.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.04 -44.1 91.72 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.882 0.873 . . . . 0.0 111.877 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.55 73.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.611 1.101 . . . . 0.0 114.163 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.5 -8.08 58.16 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.467 1.134 . . . . 0.0 112.846 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -119.72 8.17 11.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.071 2.149 . . . . 0.0 112.912 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm 66.75 28.54 8.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.742 2.017 . . . . 0.0 113.617 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.9 mtm -116.71 172.15 7.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 111.627 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.3 m -142.55 130.47 11.4 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 126.185 1.794 . . . . 0.0 108.771 174.386 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.9 136.59 18.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.906 2.404 . . . . 0.0 110.339 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.14 114.59 27.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.499 1.12 . . . . 0.0 111.437 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.04 152.27 19.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.746 1.218 . . . . 0.0 112.867 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.54 148.34 40.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.307 1.843 . . . . 0.0 108.971 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.23 147.04 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.017 1.327 . . . . 0.0 111.653 -168.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 125.707 1.603 . . . . 0.0 110.975 176.38 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 121.052 0.454 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.19 138.09 46.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.126 1.37 . . . . 0.0 111.203 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.6 mtm -103.38 153.85 20.03 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.094 1.757 . . . . 0.0 109.386 169.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 t -144.19 146.28 32.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.385 1.074 . . . . 0.0 111.886 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.38 136.8 50.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.546 1.938 . . . . 0.0 108.827 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.16 135.78 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.215 1.006 . . . . 0.0 111.657 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.94 153.37 42.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.11 135.61 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.645 1.578 . . . . 0.0 108.546 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.08 139.3 57.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.108 0.963 . . . . 0.0 112.06 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.69 -4.07 86.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.768 1.175 . . . . 0.0 114.916 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -117.72 133.01 56.39 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.895 1.347 . . . . 0.0 111.136 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -81.55 -16.03 52.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -83.42 157.55 22.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.69 1.196 . . . . 0.0 112.393 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.43 129.14 32.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.689 1.195 . . . . 0.0 109.856 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.23 144.5 28.44 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.4 mtm -134.7 135.46 42.02 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.802 1.241 . . . . 0.0 111.486 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.24 173.41 28.26 Favored Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.984 1.278 . . . . 0.0 113.259 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -154.6 160.32 41.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.433 1.093 . . . . 0.0 111.873 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -169.04 -173.6 1.83 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.418 1.487 . . . . 0.0 111.815 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -74.09 -12.49 60.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.525 1.53 . . . . 0.0 113.436 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.67 151.74 34.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.476 1.511 . . . . 0.0 111.822 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.56 -29.63 70.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.16 -46.63 41.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.082 0.953 . . . . 0.0 112.066 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.65 -28.45 60.86 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.492 -0.755 . . . . 0.0 112.05 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.89 89.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.657 -0.652 . . . . 0.0 111.756 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.1 -40.62 94.41 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.393 0.677 . . . . 0.0 111.872 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 m -64.22 -37.38 87.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.576 0.625 . . . . 0.0 112.057 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -72.83 -36.26 67.46 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.552 -0.717 . . . . 0.0 111.598 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.72 94.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.888 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.95 82.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 111.461 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -56.9 -41.29 77.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.302 0.501 . . . . 0.0 111.794 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -28.14 66.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -80.87 -37.71 29.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.703 0.683 . . . . 0.0 112.672 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.58 -40.54 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.961 0.8 . . . . 0.0 110.534 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -55.14 -47.51 74.97 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 170.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.18 -44.07 92.17 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.112 -0.993 . . . . 0.0 112.59 173.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.38 -35.9 80.61 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.51 -42.73 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.687 0.795 . . . . 0.0 111.071 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -66.36 -13.4 60.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.8 pt -114.04 9.92 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.21 1.404 . . . . 0.0 113.252 170.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 m120 67.23 17.52 10.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.507 1.923 . . . . 0.0 114.592 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.9 -11.09 57.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.242 1.417 . . . . 0.0 113.139 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -134.35 138.07 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.546 1.938 . . . . 0.0 107.923 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.72 126.13 32.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.826 0.451 . . . . 0.0 109.929 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.17 -33.04 62.63 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.38 61.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.943 1.297 . . . . 0.0 113.579 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -91.66 -16.51 26.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.627 1.171 . . . . 0.0 113.304 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -77.5 126.07 85.2 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.213 1.005 . . . . 0.0 110.871 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 C--N 1.352 0.713 0 C-N-CA 123.299 2.666 . . . . 0.0 111.962 178.813 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.74 -43.28 84.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.167 0.987 . . . . 0.0 110.313 174.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.94 -31.82 72.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 112.821 172.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.49 -42.91 77.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.994 0.815 . . . . 0.0 111.734 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.71 -42.88 99.87 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.626 0.648 . . . . 0.0 111.234 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -63.01 -42.28 99.79 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.05 -40.22 78.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.484 1.114 . . . . 0.0 112.434 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -60.42 -45.64 92.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.952 0.901 . . . . 0.0 111.456 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.7 m -58.05 -45.43 87.05 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.648 0.779 . . . . 0.0 111.758 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.81 -26.82 73.12 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.491 1.043 . . . . 0.0 114.145 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -78.92 -7.5 58.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.545 1.173 . . . . 0.0 112.876 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.55 9.21 11.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.166 2.187 . . . . 0.0 112.709 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.98 31.45 11.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.451 1.9 . . . . 0.0 113.549 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.3 mtm -119.79 172.83 7.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.804 2.041 . . . . 0.0 111.56 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.94 131.04 11.26 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.26 1.824 . . . . 0.0 108.755 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.82 147.37 24.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.954 2.436 . . . . 0.0 110.734 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.93 117.35 27.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.648 1.179 . . . . 0.0 110.761 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.3 156.52 17.19 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.328 1.451 . . . . 0.0 112.343 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.22 149.65 33.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.102 1.361 . . . . 0.0 110.318 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -134.26 147.89 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.566 1.547 . . . . 0.0 111.867 -168.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 . . . . . 0 N--CA 1.474 0.734 0 C-N-CA 125.773 1.629 . . . . 0.0 110.792 170.947 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -135.46 131.78 36.58 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.906 1.282 . . . . 0.0 111.343 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 mtm -99.17 152.14 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.612 1.565 . . . . 0.0 108.937 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -146.06 147.71 31.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 111.515 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.88 156.19 44.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.331 1.452 . . . . 0.0 110.757 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.48 143.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.892 1.277 . . . . 0.0 111.254 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -138.08 157.68 45.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.246 1.818 . . . . 0.0 110.688 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -140.62 135.92 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.851 1.661 . . . . 0.0 108.319 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.15 129.38 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.101 0.96 . . . . 0.0 111.731 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.95 0.62 65.97 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.653 1.12 . . . . 0.0 114.715 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -119.29 131.06 55.7 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.228 1.411 . . . . 0.0 110.631 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -77.85 -24.76 48.51 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -75.11 155.93 36.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.287 1.035 . . . . 0.0 113.144 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.44 114.22 15.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.261 1.424 . . . . 0.0 108.669 169.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.49 143.89 25.11 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mtp -137.98 146.64 43.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.28 177.67 31.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.789 1.662 . . . . 0.0 112.895 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -155.67 159.2 39.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.492 1.117 . . . . 0.0 111.981 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -169.2 -179.44 3.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.134 1.374 . . . . 0.0 112.083 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 m -78.64 -13.13 59.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.395 1.478 . . . . 0.0 112.101 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.21 142.89 47.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.238 1.415 . . . . 0.0 111.628 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.98 -30.81 71.86 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -69.85 -42.25 73.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.359 -0.838 . . . . 0.0 111.543 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.72 -29.46 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.456 0.702 . . . . 0.0 112.03 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.94 90.11 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.636 -0.665 . . . . 0.0 111.817 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -62.81 -39.13 93.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.509 0.724 . . . . 0.0 111.775 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.9 m -63.19 -36.42 83.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.558 0.617 . . . . 0.0 112.27 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -75.38 -34.11 61.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 111.749 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.08 91.48 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.523 -0.735 . . . . 0.0 111.924 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.81 83.18 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.29 1.036 . . . . 0.0 111.686 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -52.48 -44.4 65.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.337 1.055 . . . . 0.0 111.647 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.63 -35.98 70.61 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -73.41 -37.33 65.95 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.406 0.548 . . . . 0.0 112.428 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.05 -43.15 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.357 -0.84 . . . . 0.0 110.169 171.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -61.73 -33.68 74.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -63.9 -45.8 87.7 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.062 -1.649 . . . . 0.0 111.882 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.414 ' HB3' HG23 ' A' ' 75' ' ' VAL . 91.7 mt -61.89 -33.84 74.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.531 0.732 . . . . 0.0 112.735 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.01 -43.89 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.842 0.857 . . . . 0.0 111.291 170.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -63.78 -21.1 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -106.03 6.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.794 1.238 . . . . 0.0 113.959 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 70.53 16.03 7.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.829 2.052 . . . . 0.0 114.82 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.25 -6.72 58.46 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.356 1.462 . . . . 0.0 113.364 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 69' ' ' LEU . 74.5 t -135.05 137.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.058 2.143 . . . . 0.0 107.473 168.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -86.47 128.37 34.95 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.994 -0.441 . . . . 0.0 110.165 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.9 p -53.52 -33.13 53.39 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.12 -20.71 62.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.702 1.601 . . . . 0.0 113.339 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -88.37 -17.84 29.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 113.091 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.38 127.13 85.37 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.329 1.052 . . . . 0.0 110.258 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.351 0.689 0 C-N-CA 123.128 2.552 . . . . 0.0 111.46 -179.531 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -60.82 -46.18 91.55 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.463 0.705 . . . . 0.0 111.162 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -64.46 -36.49 84.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.335 0.654 . . . . 0.0 112.346 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.21 -45.31 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.741 0.7 . . . . 0.0 111.87 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.92 -43.22 96.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.66 0.664 . . . . 0.0 111.246 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -63.66 -43.02 97.95 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.0 88.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.901 0.88 . . . . 0.0 112.568 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -61.55 -45.52 93.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.769 0.827 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.36 -45.93 90.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.706 0.802 . . . . 0.0 111.751 172.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.56 -27.11 73.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.419 1.009 . . . . 0.0 113.963 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.14 -8.84 58.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.389 1.094 . . . . 0.0 112.715 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.63 8.83 11.31 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.248 2.219 . . . . 0.0 112.656 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 64.95 32.58 10.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.536 1.935 . . . . 0.0 113.547 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.1 mtm -120.46 171.73 8.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.741 2.016 . . . . 0.0 111.735 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -142.71 130.53 11.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 126.192 1.797 . . . . 0.0 109.011 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 145.22 23.27 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.151 2.567 . . . . 0.0 110.903 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.34 129.52 49.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.912 1.285 . . . . 0.0 111.046 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -114.72 160.1 19.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.997 1.319 . . . . 0.0 113.484 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.6 144.21 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.162 1.785 . . . . 0.0 109.075 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -130.03 144.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.596 1.558 . . . . 0.0 109.649 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.7 ttm105 . . . . . 0 N--CA 1.47 0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 111.458 -172.578 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.127 0.489 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.89 125.3 28.02 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.93 1.292 . . . . 0.0 111.126 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.1 mtp -89.47 155.35 19.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.055 1.342 . . . . 0.0 108.951 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.6 t -143.43 147.82 35.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.956 0.903 . . . . 0.0 111.536 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -129.12 145.12 51.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.302 1.841 . . . . 0.0 108.884 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.53 142.78 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.655 1.182 . . . . 0.0 111.439 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -137.88 157.15 47.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.656 1.982 . . . . 0.0 110.67 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.64 135.36 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.079 1.752 . . . . 0.0 108.282 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.82 129.6 42.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.146 0.978 . . . . 0.0 111.766 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 0.9 65.42 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.588 1.089 . . . . 0.0 114.762 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.23 132.09 54.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.65 -14.87 50.86 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.74 155.84 25.29 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.657 1.183 . . . . 0.0 112.675 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.26 120.14 25.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.847 1.259 . . . . 0.0 109.284 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 140.87 24.76 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.0 mtt -135.17 142.53 46.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.42 172.07 27.09 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 125.782 1.658 . . . . 0.0 113.35 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -158.32 149.69 21.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.776 1.23 . . . . 0.0 111.392 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.57 179.84 4.7 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.796 1.238 . . . . 0.0 112.703 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.5 p -78.51 -8.84 58.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.88 1.672 . . . . 0.0 112.999 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -137.87 142.75 40.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.661 1.584 . . . . 0.0 111.373 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.39 -42.34 95.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 113.231 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -66.96 -37.53 84.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.76 -29.71 58.9 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.475 -0.766 . . . . 0.0 111.834 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.1 -44.44 79.99 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.688 -0.632 . . . . 0.0 111.413 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.56 -39.07 86.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 112.031 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 m -67.25 -34.58 77.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.805 0.73 . . . . 0.0 112.413 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -71.72 -38.52 70.48 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.531 -0.731 . . . . 0.0 111.72 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.59 92.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.587 0.631 . . . . 0.0 111.644 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.23 82.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.346 1.058 . . . . 0.0 111.544 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -58.35 -39.48 79.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.202 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.35 -29.52 62.7 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.197 0.908 . . . . 0.0 113.2 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.38 -39.71 62.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.443 -0.786 . . . . 0.0 111.863 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.45 -40.93 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.49 -0.756 . . . . 0.0 110.761 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.44 -50.62 71.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.739 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.35 -41.41 63.02 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.086 1.312 . . . . 0.0 113.731 172.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.36 -22.52 66.98 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.7 -38.12 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.507 1.049 . . . . 0.0 110.726 168.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -59.74 -29.54 68.22 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.974 0.91 . . . . 0.0 112.35 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.63 4.93 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.047 1.339 . . . . 0.0 114.339 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 69.73 16.29 7.92 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.699 2.0 . . . . 0.0 115.162 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -83.91 -8.98 59.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.35 1.46 . . . . 0.0 113.392 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.96 141.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.792 2.037 . . . . 0.0 108.259 168.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.82 129.82 36.15 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.484 0.713 . . . . 0.0 110.218 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.6 p -55.26 -32.61 62.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.16 -19.38 53.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.837 1.255 . . . . 0.0 113.613 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -90.51 -16.77 28.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.645 1.178 . . . . 0.0 113.41 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.8 t -79.8 126.25 80.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.399 1.079 . . . . 0.0 110.851 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 CA--C 1.537 0.647 0 C-N-CA 123.448 2.765 . . . . 0.0 112.537 -178.906 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -40.65 88.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.931 0.892 . . . . 0.0 110.587 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.94 -36.4 84.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.439 1.496 . . . . 0.0 112.258 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -70.33 -41.41 73.26 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.926 0.891 . . . . 0.0 112.106 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.2 tp -62.64 -43.48 98.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.917 0.781 . . . . 0.0 111.143 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.59 -43.75 98.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.12 0.568 . . . . 0.0 112.52 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.85 88.29 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.167 0.987 . . . . 0.0 112.779 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.85 -45.8 92.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.139 0.976 . . . . 0.0 111.525 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.3 m -58.41 -45.33 88.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.542 0.737 . . . . 0.0 111.708 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.05 -26.12 73.32 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.355 0.979 . . . . 0.0 114.159 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.18 -8.68 58.6 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.498 1.149 . . . . 0.0 112.819 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -119.72 9.53 11.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.203 2.201 . . . . 0.0 112.669 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.02 29.66 12.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.408 1.883 . . . . 0.0 113.648 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.3 mtm -116.77 172.42 7.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.708 2.003 . . . . 0.0 111.547 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 m -141.96 130.72 12.07 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.116 1.766 . . . . 0.0 108.752 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.39 146.23 24.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.988 2.459 . . . . 0.0 110.578 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.56 114.8 23.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.597 1.159 . . . . 0.0 110.806 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.13 156.95 16.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.444 1.498 . . . . 0.0 112.287 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -146.47 151.74 37.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.598 1.559 . . . . 0.0 109.805 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.42 139.87 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 0.0 111.299 -169.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 128.264 2.626 . . . . 0.0 109.662 176.65 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 C--O 1.24 0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.75 149.72 49.26 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.836 1.255 . . . . 0.0 111.842 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.2 mtp -118.66 155.05 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.688 1.995 . . . . 0.0 109.081 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.31 154.78 40.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.574 0.75 . . . . 0.0 111.271 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.12 144.85 31.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.243 1.817 . . . . 0.0 109.475 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.24 142.21 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.2 1.0 . . . . 0.0 111.821 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -136.31 160.14 39.62 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.657 1.983 . . . . 0.0 110.482 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.59 136.11 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.746 1.618 . . . . 0.0 108.435 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.45 129.57 42.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 111.674 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.24 1.38 66.88 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.612 1.101 . . . . 0.0 114.601 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -124.08 131.47 53.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.334 1.454 . . . . 0.0 110.437 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -81.87 -12.14 58.6 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -83.77 157.06 22.23 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.461 1.104 . . . . 0.0 113.228 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.35 112.87 13.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.906 1.282 . . . . 0.0 109.348 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.44 142.38 23.81 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.43 148.91 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.5 170.09 26.26 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.116 1.817 . . . . 0.0 113.594 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -155.93 150.69 26.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.573 1.149 . . . . 0.0 112.001 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -168.87 -174.62 2.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.897 1.279 . . . . 0.0 112.381 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 p -77.04 -13.19 59.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.659 1.584 . . . . 0.0 113.407 173.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -148.26 152.33 36.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 112.286 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.08 -29.02 68.68 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.78 -51.45 33.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.339 -0.851 . . . . 0.0 111.369 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.61 -28.89 64.11 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.664 -0.648 . . . . 0.0 112.675 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.2 99.34 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.503 -0.748 . . . . 0.0 111.804 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -64.23 -40.33 95.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.31 0.644 . . . . 0.0 111.899 172.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -61.39 -35.92 78.84 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.277 0.944 . . . . 0.0 112.735 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.77 -37.34 67.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.232 -0.918 . . . . 0.0 111.905 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -44.78 90.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.741 0.701 . . . . 0.0 111.625 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.86 83.98 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.46 1.104 . . . . 0.0 111.537 173.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -54.58 -43.85 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 111.682 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.11 -29.29 62.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.119 0.872 . . . . 0.0 113.348 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.39 -38.09 50.64 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.462 -0.774 . . . . 0.0 112.154 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.98 -40.58 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.271 -0.893 . . . . 0.0 110.43 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -56.52 -49.12 75.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.411 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.87 -41.84 64.69 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.384 1.447 . . . . 0.0 113.767 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.1 -22.63 67.01 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.95 -38.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.511 1.05 . . . . 0.0 110.799 168.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -59.8 -29.69 68.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.302 1.041 . . . . 0.0 112.431 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -105.5 5.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.993 1.317 . . . . 0.0 114.344 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 68.69 17.11 8.94 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.481 1.912 . . . . 0.0 115.041 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.69 -13.57 58.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.374 1.469 . . . . 0.0 113.376 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -137.87 139.69 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 108.888 171.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -85.09 133.64 34.22 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -54.89 -33.95 62.53 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.333 -0.854 . . . . 0.0 113.084 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.96 -21.81 33.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.193 1.397 . . . . 0.0 113.923 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.61 -16.55 28.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.353 1.061 . . . . 0.0 113.514 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.4 124.06 84.22 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.281 1.033 . . . . 0.0 111.098 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 C--N 1.351 0.688 0 C-N-CA 123.281 2.654 . . . . 0.0 109.79 174.635 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.2 tp . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -43.75 76.79 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.336 1.054 . . . . 0.0 109.991 174.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -65.76 -32.42 73.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.536 0.734 . . . . 0.0 112.68 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -69.47 -43.01 74.09 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.532 -0.73 . . . . 0.0 112.006 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.8 -43.69 98.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.717 0.69 . . . . 0.0 110.992 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.13 -43.16 99.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.214 0.606 . . . . 0.0 112.63 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.91 83.88 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 112.678 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -61.87 -45.21 94.75 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.951 0.9 . . . . 0.0 111.596 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.2 m -58.62 -45.05 90.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.688 0.795 . . . . 0.0 111.591 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.05 73.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.503 1.049 . . . . 0.0 114.134 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.41 -9.22 58.74 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.425 1.113 . . . . 0.0 112.744 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.327 2.251 . . . . 0.0 112.688 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 64.95 29.58 12.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.456 1.902 . . . . 0.0 113.672 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.2 mtm -116.14 172.21 7.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.799 2.04 . . . . 0.0 111.443 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.5 m -143.04 130.54 10.96 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 126.062 1.745 . . . . 0.0 109.03 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.8 144.19 24.32 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.965 2.443 . . . . 0.0 110.68 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.85 119.72 34.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.861 1.264 . . . . 0.0 110.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.83 157.68 16.92 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.147 1.379 . . . . 0.0 112.783 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.23 146.07 30.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.865 1.666 . . . . 0.0 109.557 172.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.88 146.78 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.112 1.365 . . . . 0.0 110.983 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 126.772 2.029 . . . . 0.0 110.255 177.538 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.057 0.456 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.0 145.4 48.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.878 1.271 . . . . 0.0 111.497 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.1 mtp -116.97 154.84 30.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.229 1.812 . . . . 0.0 109.583 171.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.6 t -145.12 146.53 31.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.335 1.054 . . . . 0.0 111.722 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -125.7 146.96 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.402 1.881 . . . . 0.0 109.187 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.0 142.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.278 1.031 . . . . 0.0 111.669 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.97 159.29 42.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.409 1.883 . . . . 0.0 110.701 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.25 135.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.953 1.701 . . . . 0.0 108.209 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.66 130.02 44.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.082 0.953 . . . . 0.0 111.784 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.1 0.29 65.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.612 1.101 . . . . 0.0 114.822 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -120.72 135.35 55.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.235 1.414 . . . . 0.0 110.845 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -83.2 -11.69 57.61 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -82.98 159.66 22.18 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.762 1.225 . . . . 0.0 113.02 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.02 119.28 17.73 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.861 1.264 . . . . 0.0 109.504 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 139.29 22.21 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 84.3 mtp -129.36 140.43 51.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.954 0.902 . . . . 0.0 112.577 -170.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.14 165.89 28.97 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.132 1.348 . . . . 0.0 113.686 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.69 153.68 25.14 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.61 1.164 . . . . 0.0 112.581 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.6 t -169.59 -169.97 0.99 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.536 1.534 . . . . 0.0 111.541 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -73.47 -12.03 60.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.71 1.604 . . . . 0.0 113.613 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.64 157.36 42.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.291 1.436 . . . . 0.0 112.443 -170.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.62 -30.8 71.57 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.9 -49.25 47.95 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.39 -0.818 . . . . 0.0 111.888 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -68.37 -30.71 69.71 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.101 0.56 . . . . 0.0 112.311 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.66 86.17 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.19 -0.943 . . . . 0.0 111.612 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.71 -40.09 91.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.792 0.837 . . . . 0.0 112.727 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 99.3 p -69.65 -31.64 69.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.705 1.139 . . . . 0.0 112.371 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -69.04 -41.16 78.03 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.792 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.3 93.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.549 0.613 . . . . 0.0 111.714 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.91 79.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.237 1.015 . . . . 0.0 111.768 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -56.65 -40.4 75.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.669 -0.681 . . . . 0.0 112.008 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.92 -30.48 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.408 1.004 . . . . 0.0 113.216 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -75.53 -39.07 58.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.373 -0.829 . . . . 0.0 112.005 171.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.83 -42.37 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.496 -0.752 . . . . 0.0 110.407 172.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -57.51 -48.31 79.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.865 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -52.95 -42.67 65.68 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.517 1.508 . . . . 0.0 113.39 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.83 -21.23 66.46 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.171 -0.956 . . . . 0.0 113.537 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -81.5 -38.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.604 1.162 . . . . 0.0 110.873 168.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -59.1 -30.67 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.326 1.05 . . . . 0.0 112.143 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.4 pt -106.84 5.55 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.967 1.307 . . . . 0.0 114.387 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 67.17 16.98 10.32 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.504 1.922 . . . . 0.0 115.045 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -79.41 -12.78 59.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 113.264 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.6 t -132.56 134.59 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.53 1.932 . . . . 0.0 107.691 168.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -79.54 131.93 36.16 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.185 -0.322 . . . . 0.0 110.148 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.16 -34.54 63.89 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.439 -0.788 . . . . 0.0 112.883 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.25 -22.4 29.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.313 1.445 . . . . 0.0 113.909 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.05 -16.73 27.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.418 1.087 . . . . 0.0 113.312 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.91 127.65 83.34 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.236 1.014 . . . . 0.0 110.63 -169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--N 1.353 0.781 0 C-N-CA 122.739 2.293 . . . . 0.0 109.769 174.812 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -33.37 73.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.593 -0.692 . . . . 0.0 111.743 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -79.54 -28.67 41.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.981 0.912 . . . . 0.0 112.484 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -65.68 -44.56 85.84 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.987 0.915 . . . . 0.0 111.709 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.6 -42.81 98.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.317 0.508 . . . . 0.0 111.276 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.38 -42.76 99.67 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.14 77.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 112.707 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 81.6 t90 -60.84 -47.59 85.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.035 0.934 . . . . 0.0 111.316 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.73 -45.46 85.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.013 0.925 . . . . 0.0 112.021 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.1 72.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.28 0.943 . . . . 0.0 113.986 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.9 -7.25 58.64 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.506 1.122 . . . . 0.0 112.79 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -119.58 9.14 11.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.304 2.242 . . . . 0.0 112.64 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.74 31.45 11.86 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.452 1.901 . . . . 0.0 113.515 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.6 mtm -119.35 172.32 7.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.71 2.004 . . . . 0.0 111.643 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.2 m -141.97 129.36 11.49 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 126.227 1.811 . . . . 0.0 108.668 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.91 141.65 21.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.905 2.404 . . . . 0.0 110.588 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.13 117.23 30.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.602 1.161 . . . . 0.0 110.697 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.66 157.43 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.996 1.318 . . . . 0.0 112.672 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.6 149.67 33.98 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.506 1.523 . . . . 0.0 109.907 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.4 mt -132.64 145.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.632 1.573 . . . . 0.0 110.799 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 125.21 1.404 . . . . 0.0 111.45 -171.587 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -127.48 124.17 37.7 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.244 1.018 . . . . 0.0 111.883 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.4 mtp -89.49 155.16 19.48 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.756 1.222 . . . . 0.0 109.085 167.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.23 149.97 40.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.268 1.027 . . . . 0.0 110.149 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.74 153.02 51.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.528 1.531 . . . . 0.0 110.123 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.66 141.81 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.022 1.329 . . . . 0.0 111.228 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.97 153.74 49.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.072 1.749 . . . . 0.0 110.486 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -141.66 134.85 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.798 1.639 . . . . 0.0 108.557 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.59 129.68 42.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.015 0.926 . . . . 0.0 111.649 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.89 65.11 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.566 1.079 . . . . 0.0 114.742 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.22 130.88 54.73 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.182 1.393 . . . . 0.0 110.529 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -76.6 -25.75 54.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -79.21 155.45 28.6 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.338 1.055 . . . . 0.0 113.083 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.78 109.85 11.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.396 1.478 . . . . 0.0 108.603 170.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.82 149.24 26.66 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.1 ptm -151.19 151.94 32.6 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.0 179.67 25.63 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.52 2.009 . . . . 0.0 112.818 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -151.86 155.22 37.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.964 1.306 . . . . 0.0 111.455 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -168.04 -176.09 2.88 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.403 1.481 . . . . 0.0 112.149 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.1 m -79.93 -22.97 42.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.377 1.471 . . . . 0.0 111.471 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -119.6 142.96 47.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.069 1.348 . . . . 0.0 111.391 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -61.59 -30.66 70.82 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -74.32 -42.57 59.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.037 . . . . 0.0 112.541 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.49 -34.05 75.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.795 0.838 . . . . 0.0 111.693 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.74 80.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.417 0.687 . . . . 0.0 111.625 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.13 -41.14 92.02 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.623 0.769 . . . . 0.0 111.995 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.9 m -63.98 -37.69 88.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.661 0.664 . . . . 0.0 111.927 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.55 -37.07 68.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.429 -0.794 . . . . 0.0 111.955 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.41 98.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.781 0.833 . . . . 0.0 112.376 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.24 -49.04 78.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.878 0.871 . . . . 0.0 111.123 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -57.32 -38.05 73.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.2 -38.48 69.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.623 1.169 . . . . 0.0 112.885 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -72.16 -37.72 69.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.831 0.741 . . . . 0.0 112.169 174.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.49 -36.91 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.531 -0.73 . . . . 0.0 110.84 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -49.86 75.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.402 171.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -54.76 -42.94 72.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.224 -0.923 . . . . 0.0 113.086 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.9 mt -63.02 -27.65 69.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.68 -40.41 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.294 0.952 . . . . 0.0 111.049 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -61.96 -30.94 71.26 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -96.91 4.91 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.457 1.103 . . . . 0.0 113.836 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 70.73 18.1 6.36 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.888 2.075 . . . . 0.0 114.625 173.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.74 -6.47 55.99 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.481 1.512 . . . . 0.0 113.363 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 69' ' ' LEU . 94.7 t -136.68 139.26 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 127.011 2.125 . . . . 0.0 107.893 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.21 127.61 34.77 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.073 0.549 . . . . 0.0 110.068 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 p -54.72 -33.9 61.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.83 -19.13 59.27 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.044 1.337 . . . . 0.0 113.689 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.33 -16.43 27.5 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.543 1.137 . . . . 0.0 113.341 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.79 123.76 87.55 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.197 0.999 . . . . 0.0 111.119 -169.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 C--N 1.352 0.735 0 C-N-CA 123.492 2.795 . . . . 0.0 111.614 178.476 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -57.92 -51.51 69.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.377 1.071 . . . . 0.0 110.559 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.62 -26.94 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 112.744 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.47 -46.9 78.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.915 0.78 . . . . 0.0 111.518 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.8 tp -63.11 -41.86 99.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.138 0.426 . . . . 0.0 111.219 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -62.91 -42.35 99.76 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.56 73.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.328 1.051 . . . . 0.0 112.625 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -61.07 -46.52 90.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.893 0.877 . . . . 0.0 111.224 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.3 m -58.31 -45.91 87.12 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.657 0.783 . . . . 0.0 111.718 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.38 73.2 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.345 0.974 . . . . 0.0 114.092 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -79.56 -6.38 56.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.358 1.079 . . . . 0.0 112.915 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -119.53 9.29 11.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.301 2.24 . . . . 0.0 112.577 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.82 30.97 12.0 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.501 1.92 . . . . 0.0 113.59 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -118.93 172.53 7.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.718 2.007 . . . . 0.0 111.562 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 m -141.69 130.81 12.37 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.158 1.783 . . . . 0.0 108.557 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.16 146.68 25.55 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.967 2.445 . . . . 0.0 110.806 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.79 116.89 28.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.738 1.215 . . . . 0.0 110.576 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -99.89 157.62 16.39 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 112.372 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.39 150.36 34.52 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.318 1.447 . . . . 0.0 110.053 172.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.1 mt -138.53 145.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.228 1.411 . . . . 0.0 111.288 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 125.742 1.617 . . . . 0.0 111.046 178.199 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 120.841 0.353 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -134.8 124.08 24.57 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.2 1.4 . . . . 0.0 111.233 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.8 mtp -89.11 154.74 19.93 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.166 1.387 . . . . 0.0 109.395 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.9 t -143.84 145.05 32.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.224 1.01 . . . . 0.0 111.766 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -121.86 151.8 40.26 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.321 1.848 . . . . 0.0 109.563 170.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.74 141.2 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.994 . . . . 0.0 111.242 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -140.45 158.05 44.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.28 1.832 . . . . 0.0 110.404 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.86 135.44 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.551 1.54 . . . . 0.0 108.66 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.08 129.97 44.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 111.606 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.27 65.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.622 1.105 . . . . 0.0 114.604 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -123.86 128.36 49.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.278 1.431 . . . . 0.0 110.351 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -76.63 -22.76 53.67 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.04 155.98 39.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.583 1.153 . . . . 0.0 113.269 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.34 117.74 18.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.342 1.457 . . . . 0.0 109.232 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.39 141.66 21.48 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtt -136.06 144.04 44.99 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.79 173.0 28.86 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.83 1.681 . . . . 0.0 113.501 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -158.78 148.94 19.57 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.84 1.256 . . . . 0.0 111.337 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.4 t -168.15 178.86 4.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.725 1.21 . . . . 0.0 112.868 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 m -78.79 -8.66 58.98 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.756 1.623 . . . . 0.0 112.442 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -142.14 153.69 44.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.051 1.34 . . . . 0.0 112.229 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -67.1 -30.25 70.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -73.15 -41.99 63.32 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.169 0.895 . . . . 0.0 112.495 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.09 -29.48 61.88 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.602 -0.687 . . . . 0.0 111.858 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.66 85.88 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.548 -0.72 . . . . 0.0 111.692 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -63.38 -38.04 89.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.833 0.853 . . . . 0.0 112.252 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 m -63.2 -38.74 92.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.731 0.696 . . . . 0.0 111.565 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -69.26 -41.32 77.08 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.39 -0.819 . . . . 0.0 111.791 174.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.65 98.26 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.715 0.689 . . . . 0.0 112.055 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.95 76.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.28 1.032 . . . . 0.0 111.492 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -58.33 -37.07 74.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.971 -0.538 . . . . 0.0 112.431 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.88 -36.67 67.39 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.955 1.302 . . . . 0.0 112.835 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -70.21 -39.78 74.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.929 0.786 . . . . 0.0 111.821 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.83 -36.26 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.637 -0.664 . . . . 0.0 110.961 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -40.52 89.2 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.204 0.601 . . . . 0.0 111.347 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.62 -44.39 90.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.097 -1.002 . . . . 0.0 112.14 171.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.4 mt -60.78 -34.91 75.2 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.49 -43.56 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.65 0.78 . . . . 0.0 111.221 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -65.16 -24.66 67.45 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.34 5.54 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.411 1.084 . . . . 0.0 113.623 171.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 71.35 17.31 5.88 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.898 2.079 . . . . 0.0 114.586 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -90.1 -5.09 56.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.203 1.401 . . . . 0.0 113.396 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 69' ' ' LEU . 96.3 t -137.54 139.33 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.148 2.179 . . . . 0.0 107.826 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -87.13 129.18 35.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.82 0.448 . . . . 0.0 110.779 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 p -59.14 -30.15 67.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.25 -0.906 . . . . 0.0 113.357 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.54 -23.29 57.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.369 1.068 . . . . 0.0 113.417 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -90.13 -16.31 29.84 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.55 1.14 . . . . 0.0 113.482 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.06 124.42 86.01 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 124.102 0.961 . . . . 0.0 111.545 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 C--N 1.352 0.733 0 C-N-CA 123.447 2.765 . . . . 0.0 111.379 177.315 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -68.01 -40.61 82.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.827 0.851 . . . . 0.0 111.199 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.988 0.915 . . . . 0.0 112.606 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.91 -43.88 91.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.885 0.874 . . . . 0.0 111.286 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.4 tp -63.14 -42.09 99.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.485 0.584 . . . . 0.0 111.714 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -62.86 -42.5 99.78 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -38.31 77.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.486 1.114 . . . . 0.0 112.54 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -61.64 -43.32 99.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.552 1.141 . . . . 0.0 111.801 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 99.2 m -61.95 -43.23 99.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.353 1.061 . . . . 0.0 111.868 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.56 -25.23 72.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.487 1.042 . . . . 0.0 114.032 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -78.22 -7.08 56.69 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.358 1.079 . . . . 0.0 112.744 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -119.65 7.47 11.08 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.471 2.308 . . . . 0.0 112.619 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.87 28.47 14.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.416 1.886 . . . . 0.0 113.371 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.9 mtm -112.17 171.94 7.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.758 2.023 . . . . 0.0 111.583 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.5 m -140.86 129.87 12.82 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 126.324 1.85 . . . . 0.0 108.664 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.6 140.58 21.37 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.971 2.447 . . . . 0.0 110.588 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.91 118.05 32.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.582 1.153 . . . . 0.0 110.853 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -101.13 159.37 15.29 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.991 1.316 . . . . 0.0 112.954 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.09 149.23 32.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.405 1.482 . . . . 0.0 110.152 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.74 147.07 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.549 1.539 . . . . 0.0 111.54 -169.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.472 0.675 0 C-N-CA 126.56 1.944 . . . . 0.0 110.285 176.038 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.2 mttt . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.794 0.33 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -135.69 134.06 38.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.377 1.071 . . . . 0.0 112.071 -173.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.2 mtp -102.45 153.47 20.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.581 1.553 . . . . 0.0 108.938 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -148.19 149.25 31.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 111.322 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.8 159.64 40.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.092 1.357 . . . . 0.0 111.073 170.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.95 143.03 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.419 1.487 . . . . 0.0 111.0 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -137.42 155.54 49.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.05 1.74 . . . . 0.0 110.878 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.47 134.32 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.965 1.706 . . . . 0.0 108.461 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.75 128.7 37.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.115 0.966 . . . . 0.0 111.977 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.17 1.21 67.17 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.765 1.174 . . . . 0.0 115.0 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.15 140.74 45.44 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.001 1.32 . . . . 0.0 111.273 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -85.3 0.83 50.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -120.1 155.79 32.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.696 1.599 . . . . 0.0 112.898 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.96 110.3 13.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.358 1.463 . . . . 0.0 108.894 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.06 146.94 29.88 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.6 ptp -150.48 148.44 28.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.35 -179.25 27.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.36 1.934 . . . . 0.0 112.772 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -154.24 160.9 42.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 112.102 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 t -168.32 -179.65 4.07 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.37 1.468 . . . . 0.0 111.844 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.6 m -80.38 -6.56 58.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.23 1.412 . . . . 0.0 112.277 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -142.4 152.05 42.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.203 1.401 . . . . 0.0 112.224 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.48 -27.1 68.25 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.62 -52.51 17.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.773 0.829 . . . . 0.0 111.538 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.66 -27.28 64.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.762 0.825 . . . . 0.0 112.252 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.17 95.82 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.833 -0.542 . . . . 0.0 111.754 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.48 -40.01 92.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.386 0.675 . . . . 0.0 111.93 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.0 m -60.81 -37.12 80.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.407 1.003 . . . . 0.0 112.442 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -74.33 -37.28 63.6 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.278 -0.889 . . . . 0.0 111.657 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.2 99.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.632 0.773 . . . . 0.0 112.361 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.06 81.82 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.199 0.999 . . . . 0.0 111.546 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -56.59 -42.08 78.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.109 0.564 . . . . 0.0 111.819 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.05 -30.92 69.36 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -77.17 -37.41 53.78 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.628 -0.67 . . . . 0.0 112.422 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.72 -39.88 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.268 -0.895 . . . . 0.0 110.836 173.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -56.18 -46.15 79.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.122 0.569 . . . . 0.0 111.47 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.5 -43.56 89.09 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.951 -1.093 . . . . 0.0 113.062 170.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.54 -35.01 79.09 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.955 0.798 . . . . 0.0 113.059 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.62 -41.99 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.575 0.75 . . . . 0.0 111.091 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -66.89 -16.02 64.04 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.31 7.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 125.152 1.381 . . . . 0.0 113.398 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.4 t30 68.12 21.09 8.79 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.676 1.99 . . . . 0.0 114.381 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -86.0 -8.66 57.8 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.806 1.242 . . . . 0.0 113.348 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.09 139.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.167 1.787 . . . . 0.0 108.282 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -87.74 130.12 34.94 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.9 p -54.27 -33.78 59.36 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.26 -0.9 . . . . 0.0 113.131 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.38 -21.28 49.62 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.45 1.5 . . . . 0.0 113.955 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -90.19 -16.84 28.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.498 1.119 . . . . 0.0 113.308 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.79 122.75 87.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.979 0.912 . . . . 0.0 110.913 -169.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 C--N 1.352 0.732 0 C-N-CA 123.316 2.677 . . . . 0.0 111.099 178.664 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.36 -44.14 84.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.989 0.915 . . . . 0.0 110.081 170.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -65.74 -31.33 72.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.962 0.905 . . . . 0.0 112.784 172.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -66.75 -44.62 80.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.973 0.806 . . . . 0.0 111.678 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.86 -42.69 99.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.453 0.57 . . . . 0.0 111.245 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.04 -43.05 99.73 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.78 82.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.261 1.024 . . . . 0.0 112.419 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -59.89 -45.96 90.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.263 1.025 . . . . 0.0 111.514 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.8 m -58.01 -44.81 87.48 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.599 0.76 . . . . 0.0 111.778 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.88 73.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.443 1.02 . . . . 0.0 114.145 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -79.03 -7.25 57.94 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.481 1.141 . . . . 0.0 112.9 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.63 8.73 11.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.041 2.136 . . . . 0.0 112.755 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.42 31.15 12.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.406 1.883 . . . . 0.0 113.499 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -117.98 171.77 7.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.716 2.007 . . . . 0.0 111.536 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -140.44 130.71 13.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.24 1.816 . . . . 0.0 108.682 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.18 150.46 29.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.196 2.597 . . . . 0.0 110.953 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.34 115.66 24.0 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.588 1.155 . . . . 0.0 111.05 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.5 158.24 16.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.44 1.496 . . . . 0.0 112.703 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -147.22 145.15 29.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.955 1.702 . . . . 0.0 109.581 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.72 147.13 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.266 1.426 . . . . 0.0 110.849 -169.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 N--CA 1.473 0.7 0 C-N-CA 126.194 1.798 . . . . 0.0 110.777 176.026 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mttp . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 120.92 0.391 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.09 137.68 43.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.791 1.236 . . . . 0.0 111.535 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.9 mtp -106.86 155.05 20.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.173 1.789 . . . . 0.0 109.379 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.5 t -147.19 148.87 31.96 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.918 0.887 . . . . 0.0 112.047 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -129.33 151.58 49.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.396 1.879 . . . . 0.0 109.719 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.91 142.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.68 1.192 . . . . 0.0 111.62 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.73 162.25 34.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.242 1.817 . . . . 0.0 110.431 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -139.33 136.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.637 1.575 . . . . 0.0 108.521 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.68 129.29 40.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.208 1.003 . . . . 0.0 111.776 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.24 -0.17 66.01 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.63 1.109 . . . . 0.0 114.806 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.05 140.55 48.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 110.963 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.65 -0.49 50.86 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -112.83 160.37 18.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.703 1.601 . . . . 0.0 113.214 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.92 116.58 14.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.202 1.401 . . . . 0.0 109.412 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.99 149.78 25.69 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -146.64 150.49 35.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.19 175.0 33.31 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.571 1.558 . . . . 0.0 113.491 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.96 154.11 25.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 112.403 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -168.13 -173.72 2.12 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.362 . . . . 0.0 112.025 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.8 p -75.79 -10.34 59.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.5 1.52 . . . . 0.0 113.482 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -150.93 151.62 32.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.271 1.428 . . . . 0.0 111.925 -170.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.26 -30.27 70.67 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -68.25 -48.14 65.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.796 0.839 . . . . 0.0 112.045 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.47 -29.33 59.57 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.778 -0.576 . . . . 0.0 112.327 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.75 88.75 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.42 -0.8 . . . . 0.0 111.837 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -64.36 -38.17 90.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.407 0.683 . . . . 0.0 112.044 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.7 m -64.69 -35.75 82.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.787 0.721 . . . . 0.0 112.278 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -71.48 -39.99 70.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.226 -0.921 . . . . 0.0 111.709 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.93 99.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.652 0.66 . . . . 0.0 111.856 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.11 -49.44 75.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 111.559 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -56.35 -37.89 70.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.105 0.562 . . . . 0.0 112.354 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.9 -35.63 64.68 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.965 1.306 . . . . 0.0 112.737 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -72.55 -37.31 68.29 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.357 -0.839 . . . . 0.0 112.009 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.52 -37.1 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.465 -0.772 . . . . 0.0 110.87 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -40.88 89.32 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.232 0.613 . . . . 0.0 111.423 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -62.95 -45.7 91.2 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.052 -1.03 . . . . 0.0 112.488 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.7 -34.51 74.47 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.91 -42.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.69 0.796 . . . . 0.0 111.237 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -64.68 -26.03 68.2 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 pt -97.55 5.33 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.304 1.042 . . . . 0.0 113.67 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 71.02 17.37 6.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.957 2.103 . . . . 0.0 114.574 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -89.66 -5.33 57.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.248 1.419 . . . . 0.0 113.431 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.41 140.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 127.277 2.231 . . . . 0.0 107.844 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -86.86 130.61 34.4 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.88 -0.513 . . . . 0.0 110.293 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 p -53.57 -34.68 59.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.746 0.818 . . . . 0.0 112.905 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.04 -27.56 8.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.367 1.867 . . . . 0.0 114.022 175.589 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -93.4 -15.47 25.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.611 1.164 . . . . 0.0 113.549 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.57 123.61 87.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.139 0.976 . . . . 0.0 111.12 -169.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 C--N 1.35 0.642 0 C-N-CA 123.452 2.768 . . . . 0.0 111.305 177.951 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -37.13 82.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.531 -0.731 . . . . 0.0 111.627 177.131 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -78.75 -27.5 44.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.221 1.009 . . . . 0.0 112.49 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.6 -43.93 92.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 111.515 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.28 -43.53 98.61 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.464 0.575 . . . . 0.0 111.345 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -63.36 -42.56 98.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.374 0.67 . . . . 0.0 112.806 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.24 -39.31 78.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 112.451 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -61.05 -45.68 93.8 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.94 0.896 . . . . 0.0 111.342 173.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -58.06 -46.37 85.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.483 0.713 . . . . 0.0 111.669 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.93 73.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.396 0.998 . . . . 0.0 114.157 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -77.69 -8.27 57.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.476 1.11 . . . . 0.0 112.747 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -119.55 8.19 11.25 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.332 2.253 . . . . 0.0 112.769 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm 66.41 28.33 9.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.674 1.989 . . . . 0.0 113.705 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 mtm -116.05 173.45 6.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.666 1.986 . . . . 0.0 111.618 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.0 m -142.79 132.0 11.82 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 126.109 1.764 . . . . 0.0 108.696 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.35 154.58 32.05 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.04 2.494 . . . . 0.0 110.908 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.75 115.8 20.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.656 1.183 . . . . 0.0 110.564 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.23 158.37 16.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.63 1.572 . . . . 0.0 112.292 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.65 148.5 32.12 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.716 1.607 . . . . 0.0 109.927 171.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.7 mt -136.19 145.31 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.23 1.412 . . . . 0.0 111.449 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 126.485 1.914 . . . . 0.0 110.278 176.072 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.885 0.374 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.94 137.66 49.38 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.954 1.301 . . . . 0.0 111.127 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtp -108.55 153.88 22.74 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.881 1.672 . . . . 0.0 109.389 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.18 147.44 32.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.096 0.958 . . . . 0.0 111.84 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -129.29 147.02 51.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.78 2.032 . . . . 0.0 108.774 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.52 143.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.792 0.837 . . . . 0.0 112.294 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.5 mtm105 -138.69 165.26 27.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.676 1.99 . . . . 0.0 110.707 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.57 137.14 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.806 1.642 . . . . 0.0 108.209 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -58.28 129.03 40.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.021 0.928 . . . . 0.0 111.579 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 0.74 65.42 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.662 1.125 . . . . 0.0 114.618 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -124.0 129.59 51.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.295 1.438 . . . . 0.0 110.381 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -83.66 -11.99 56.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -74.25 157.32 36.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.5 1.12 . . . . 0.0 112.69 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.99 119.39 17.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 170.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.87 143.74 22.46 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.7 mtm -138.81 141.65 38.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.281 1.033 . . . . 0.0 112.12 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.72 173.25 31.75 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.035 1.302 . . . . 0.0 113.399 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -155.29 159.49 40.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.621 1.168 . . . . 0.0 112.01 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 t -170.06 -175.86 2.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.414 1.485 . . . . 0.0 112.069 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p -80.93 -7.66 59.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.675 1.59 . . . . 0.0 113.36 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -142.61 150.56 40.46 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.356 1.463 . . . . 0.0 111.8 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.82 -32.57 74.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.029 1.332 . . . . 0.0 113.795 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -71.35 -45.2 63.5 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.311 -0.868 . . . . 0.0 112.285 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.02 -26.48 61.33 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.732 0.413 . . . . 0.0 111.407 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.75 -46.3 72.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.894 0.478 . . . . 0.0 111.432 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.65 -40.4 94.8 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.436 0.694 . . . . 0.0 111.954 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.0 m -63.99 -37.23 86.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.886 0.767 . . . . 0.0 111.789 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.23 -38.12 71.97 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.562 -0.711 . . . . 0.0 111.64 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.49 93.47 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.614 -0.679 . . . . 0.0 112.191 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.75 82.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.609 1.164 . . . . 0.0 111.431 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.83 -40.99 81.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.375 0.534 . . . . 0.0 111.638 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.86 -31.08 70.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.757 0.823 . . . . 0.0 113.087 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -77.7 -40.08 42.57 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.567 -0.708 . . . . 0.0 112.414 172.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.11 -37.89 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.34 -0.85 . . . . 0.0 110.818 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -56.59 -42.86 79.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.284 0.634 . . . . 0.0 111.688 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.36 -43.32 99.1 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.859 -1.15 . . . . 0.0 112.722 170.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' A' ' 75' ' ' VAL . 96.0 mt -61.49 -34.02 74.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.16 0.891 . . . . 0.0 113.038 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.49 -43.25 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.026 0.93 . . . . 0.0 111.137 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -62.49 -25.97 68.29 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.175 0.99 . . . . 0.0 113.326 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -101.1 6.01 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.619 1.168 . . . . 0.0 113.865 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 70.89 16.96 6.47 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.834 2.054 . . . . 0.0 114.669 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -88.57 -5.48 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 113.448 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 69' ' ' LEU . 90.6 t -136.84 138.7 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.906 2.082 . . . . 0.0 108.155 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.82 125.69 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.901 0.48 . . . . 0.0 109.931 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 p -55.31 -32.79 62.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.95 -19.74 61.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.097 1.359 . . . . 0.0 113.475 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -92.0 -15.8 27.41 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.633 1.173 . . . . 0.0 113.342 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.8 124.06 83.56 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.132 0.973 . . . . 0.0 111.52 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.538 0.719 0 C-N-CA 123.803 3.002 . . . . 0.0 112.706 178.729 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.791 -0.524 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 16.2 m -67.64 -13.93 62.5 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 35.2 p -83.02 -5.07 58.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.416 1.486 . . . . 0.0 113.955 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 79.23 -132.03 11.13 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.663 1.125 . . . . 0.0 111.881 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.6 p -156.23 163.35 39.68 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.158 1.383 . . . . 0.0 111.772 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m -142.8 19.42 1.99 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.321 1.048 . . . . 0.0 112.686 -169.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.47 -39.54 97.81 Favored Glycine 0 N--CA 1.47 0.902 0 O-C-N 121.178 -0.951 . . . . 0.0 114.65 -167.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp -78.01 -34.56 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.444 1.122 . . . . 0.0 112.868 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -62.73 -46.95 85.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.612 1.165 . . . . 0.0 109.983 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -65.05 -33.85 77.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.331 1.052 . . . . 0.0 112.523 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -68.29 -45.27 73.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.988 0.813 . . . . 0.0 111.513 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.46 -43.23 97.93 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 111.234 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.36 -42.92 98.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.22 81.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.378 1.071 . . . . 0.0 112.436 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -60.75 -46.01 92.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.582 0.753 . . . . 0.0 111.462 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.99 -46.22 88.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.93 -27.32 73.35 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.4 1.0 . . . . 0.0 114.081 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.28 -8.53 57.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.402 1.101 . . . . 0.0 112.705 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -119.69 9.52 11.44 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.335 2.254 . . . . 0.0 112.503 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.08 31.1 11.29 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.597 1.959 . . . . 0.0 113.618 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 62.4 mtm -118.98 173.31 6.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.779 2.031 . . . . 0.0 111.57 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.19 132.07 12.43 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 126.248 1.819 . . . . 0.0 108.729 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.99 148.38 27.77 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.955 2.436 . . . . 0.0 110.936 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.73 115.71 23.84 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.878 1.271 . . . . 0.0 110.7 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.37 153.88 17.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.257 1.423 . . . . 0.0 111.839 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.2 129.38 15.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.761 1.624 . . . . 0.0 109.004 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.19 147.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.248 1.019 . . . . 0.0 112.291 -168.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -134.07 139.85 46.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.931 2.093 . . . . 0.0 110.453 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.23 138.14 31.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.566 1.146 . . . . 0.0 110.75 172.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -145.51 165.01 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.567 1.547 . . . . 0.0 111.265 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.49 -165.84 43.05 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.025 0.822 . . . . 0.0 114.53 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.28 142.34 58.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.458 1.503 . . . . 0.0 113.066 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -60.76 -41.45 95.48 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -81.36 -32.58 32.85 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.364 1.066 . . . . 0.0 112.705 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -117.21 67.75 0.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.322 1.849 . . . . 0.0 109.889 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -74.37 152.25 39.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.7 1.2 . . . . 0.0 111.879 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -133.22 161.17 35.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.303 1.841 . . . . 0.0 110.672 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -135.4 142.63 45.69 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.641 1.177 . . . . 0.0 111.378 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.0 mtp -114.51 148.88 37.25 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.061 1.745 . . . . 0.0 109.19 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.0 t -139.2 145.02 38.78 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 110.922 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.3 149.4 50.05 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.445 1.898 . . . . 0.0 108.483 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.08 139.6 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.429 0.692 . . . . 0.0 111.665 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -136.35 160.1 39.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.961 2.104 . . . . 0.0 110.565 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -140.67 136.52 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.665 1.586 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.23 129.07 40.31 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.054 0.942 . . . . 0.0 111.668 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.99 1.79 67.06 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.498 1.047 . . . . 0.0 114.584 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.21 129.03 49.27 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.391 1.477 . . . . 0.0 110.145 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.32 -13.17 55.67 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -81.68 157.69 24.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.6 1.16 . . . . 0.0 113.021 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.51 120.53 23.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.839 1.256 . . . . 0.0 109.66 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.94 139.82 24.03 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.97 141.62 51.88 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.916 1.286 . . . . 0.0 112.482 -169.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.4 166.9 30.74 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.141 1.353 . . . . 0.0 113.644 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -157.36 159.91 37.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.686 1.194 . . . . 0.0 112.087 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -171.95 -171.04 0.82 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.909 1.683 . . . . 0.0 111.508 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.6 p -73.1 -8.77 57.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.098 1.759 . . . . 0.0 113.474 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.42 152.63 33.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.493 1.517 . . . . 0.0 111.751 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.61 -31.21 72.33 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -68.82 -47.66 65.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.198 0.999 . . . . 0.0 112.589 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -69.72 -30.87 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.605 0.762 . . . . 0.0 111.711 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.71 -44.73 77.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.989 -0.444 . . . . 0.0 111.421 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -61.1 -41.37 96.55 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.045 0.938 . . . . 0.0 112.105 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -64.76 -39.03 92.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.802 0.728 . . . . 0.0 111.813 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -67.77 -41.4 83.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.866 -0.521 . . . . 0.0 111.869 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.66 93.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.454 0.702 . . . . 0.0 112.11 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.31 78.17 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.604 1.162 . . . . 0.0 111.197 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -58.1 -39.53 78.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.28 -30.77 63.63 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.321 0.964 . . . . 0.0 113.514 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -75.51 -39.15 58.86 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.283 -0.886 . . . . 0.0 111.844 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.05 -38.33 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.291 -0.88 . . . . 0.0 110.605 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.15 -48.06 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.648 -0.691 . . . . 0.0 110.479 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -53.09 -40.66 64.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.216 1.371 . . . . 0.0 113.817 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.45 -22.49 66.91 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.6 t -81.92 -37.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.223 1.009 . . . . 0.0 110.948 168.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -61.41 -29.88 70.21 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.24 1.016 . . . . 0.0 112.313 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.6 pt -101.5 3.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 125.013 1.325 . . . . 0.0 114.07 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 t30 66.37 23.24 10.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.527 1.931 . . . . 0.0 114.692 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -84.86 -12.85 52.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.015 1.326 . . . . 0.0 113.014 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -139.68 142.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.396 1.878 . . . . 0.0 109.096 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.278 0.631 . . . . 0.0 111.07 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 p -55.46 -33.38 63.59 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -56.34 -22.28 29.81 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.147 1.379 . . . . 0.0 113.839 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.35 -16.32 27.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.476 1.11 . . . . 0.0 113.506 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.0 t -83.09 127.53 68.83 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.347 1.059 . . . . 0.0 111.093 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.36 159.61 36.26 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.329 2.686 . . . . 0.0 112.436 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.06 138.75 52.33 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.088 0.955 . . . . 0.0 111.731 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.7 p -66.71 -19.83 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 125.417 1.487 . . . . 0.0 114.852 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.03 9.43 86.68 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.617 1.103 . . . . 0.0 115.106 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.9 140.52 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.787 2.035 . . . . 0.0 109.146 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.3 m -136.46 146.56 56.3 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 125.787 1.635 . . . . 0.0 110.731 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.27 157.71 37.38 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.479 2.786 . . . . 0.0 111.959 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.86 158.39 53.0 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.613 2.875 . . . . 0.0 111.423 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.6 148.23 65.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.568 2.845 . . . . 0.0 111.538 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.9 m -75.84 -5.85 47.92 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.03 177.69 50.88 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 124.974 1.273 . . . . 0.0 113.968 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.56 149.84 73.09 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.304 3.336 . . . . 0.0 112.984 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 t -143.61 16.06 1.81 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.116 0.966 . . . . 0.0 112.716 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -84.03 -5.61 59.26 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.406 -1.434 . . . . 0.0 114.344 -173.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.47 1.509 . . . . 0.0 112.775 -179.212 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 18.9 m -84.02 -6.05 59.34 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.7 t -162.9 170.23 18.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.021 1.729 . . . . 0.0 110.948 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -159.11 171.93 35.73 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.119 1.342 . . . . 0.0 113.842 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.9 t -162.87 -167.55 1.55 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.683 1.593 . . . . 0.0 110.904 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.2 t -162.22 152.33 16.68 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.818 1.647 . . . . 0.0 110.842 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.43 -38.04 90.68 Favored Glycine 0 N--CA 1.469 0.898 0 O-C-N 121.646 -0.659 . . . . 0.0 113.884 -170.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.33 -32.91 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.478 1.139 . . . . 0.0 112.407 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -44.51 82.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.189 0.996 . . . . 0.0 110.191 174.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -66.4 -30.92 71.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.428 1.091 . . . . 0.0 112.802 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.26 -43.42 77.87 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.043 0.838 . . . . 0.0 111.404 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.71 -43.94 97.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.527 0.603 . . . . 0.0 111.199 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.81 -41.69 98.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.63 77.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.599 1.16 . . . . 0.0 112.557 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -63.23 -41.54 99.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 111.916 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -63.03 -47.14 84.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.091 0.556 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.86 -28.46 73.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.305 0.955 . . . . 0.0 113.681 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -79.23 -17.53 54.61 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.312 1.056 . . . . 0.0 112.751 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -99.01 7.64 45.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.597 2.359 . . . . 0.0 112.957 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 66.25 28.72 9.9 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.728 2.011 . . . . 0.0 113.85 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.0 mtm -114.52 172.87 6.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.157 2.183 . . . . 0.0 111.519 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -140.52 131.76 13.99 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.972 1.709 . . . . 0.0 108.955 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.2 143.75 22.76 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.5 117.13 29.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.805 1.242 . . . . 0.0 110.779 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -100.05 157.99 16.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.672 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -146.93 144.69 29.41 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 109.445 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.7 147.24 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.094 1.358 . . . . 0.0 111.188 -169.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -137.38 140.01 41.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.641 1.977 . . . . 0.0 110.117 175.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.23 141.36 28.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.778 0.831 . . . . 0.0 111.227 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.87 161.19 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.001 1.72 . . . . 0.0 111.101 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 -160.31 41.16 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.069 0.843 . . . . 0.0 114.375 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -60.18 138.99 57.8 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.502 1.521 . . . . 0.0 113.15 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -63.67 -42.11 98.09 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -78.32 -34.07 48.86 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.277 1.031 . . . . 0.0 113.022 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -117.61 75.64 1.0 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.136 1.774 . . . . 0.0 109.128 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -78.31 136.36 37.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.432 1.093 . . . . 0.0 111.403 -170.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -104.25 157.86 16.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.028 0.931 . . . . 0.0 110.757 169.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -132.34 132.33 42.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.778 1.231 . . . . 0.0 109.917 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtp -102.62 151.76 21.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.93 1.692 . . . . 0.0 109.092 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.2 t -144.1 147.28 33.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.956 0.902 . . . . 0.0 111.764 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -126.7 145.68 50.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.858 2.063 . . . . 0.0 108.542 175.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.15 140.41 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.88 0.872 . . . . 0.0 111.77 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -137.03 159.92 40.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.821 2.048 . . . . 0.0 110.883 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.23 134.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 108.411 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.61 129.49 41.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.028 0.931 . . . . 0.0 111.669 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 1.84 65.22 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.596 1.093 . . . . 0.0 114.669 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -122.08 134.11 54.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.29 1.436 . . . . 0.0 110.464 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -80.97 -12.13 59.44 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -91.19 159.23 16.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.045 1.338 . . . . 0.0 113.191 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.76 121.12 22.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.876 1.271 . . . . 0.0 109.684 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.7 141.28 23.44 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.1 mtm -138.9 142.35 38.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.777 0.831 . . . . 0.0 112.305 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 174.97 32.83 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 124.933 1.254 . . . . 0.0 113.624 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.03 161.5 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.244 1.018 . . . . 0.0 112.285 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -167.03 -171.0 1.66 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.082 1.353 . . . . 0.0 112.137 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -81.52 -6.81 59.34 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.56 1.944 . . . . 0.0 113.606 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -152.01 159.25 43.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.997 1.719 . . . . 0.0 111.655 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -67.03 -29.45 69.26 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.83 -45.64 50.01 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.153 -0.967 . . . . 0.0 112.3 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.47 -29.72 67.45 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.666 -0.646 . . . . 0.0 112.345 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.03 -45.48 77.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.699 -0.626 . . . . 0.0 111.771 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -62.04 -38.26 88.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.584 0.753 . . . . 0.0 112.001 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 m -63.26 -38.13 89.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.617 0.644 . . . . 0.0 112.106 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.5 -35.73 60.73 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.332 0.653 . . . . 0.0 111.716 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.76 -45.65 88.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 111.789 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.57 -47.58 85.55 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.212 1.005 . . . . 0.0 111.439 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -56.99 -38.05 72.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.132 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.2 -27.93 57.07 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -76.99 -37.93 54.17 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.241 -0.912 . . . . 0.0 111.695 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.04 -41.39 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.49 -0.756 . . . . 0.0 110.473 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.26 -49.78 73.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.726 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -52.57 -41.92 64.01 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.404 1.456 . . . . 0.0 113.696 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.05 -22.17 66.82 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 174.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.46 -36.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.407 1.083 . . . . 0.0 110.935 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -60.66 -29.91 69.57 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.57 1.148 . . . . 0.0 112.316 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.1 pt -103.8 4.62 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.074 1.349 . . . . 0.0 113.986 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.2 m120 66.86 19.1 10.69 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.521 1.928 . . . . 0.0 114.934 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -81.15 -12.28 59.26 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.46 . . . . 0.0 113.238 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.33 142.49 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 108.944 170.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -93.44 129.16 39.71 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.417 1.087 . . . . 0.0 109.843 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 p -60.0 -27.37 66.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.91 -1.119 . . . . 0.0 113.718 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.29 -19.74 62.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.313 1.045 . . . . 0.0 113.351 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -86.01 -17.45 35.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.359 1.064 . . . . 0.0 113.159 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.82 127.31 77.97 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.34 1.056 . . . . 0.0 110.406 -169.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.42 134.25 24.16 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.122 2.548 . . . . 0.0 111.268 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.36 168.02 24.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.174 1.79 . . . . 0.0 110.954 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -20.38 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.566 1.146 . . . . 0.0 113.273 176.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.2 149.83 21.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.111 1.815 . . . . 0.0 111.486 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.7 mt -124.6 138.38 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.11 1.364 . . . . 0.0 109.185 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.22 142.05 31.49 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.424 1.89 . . . . 0.0 108.579 -170.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -50.71 146.75 19.64 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.105 3.204 . . . . 0.0 113.712 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.41 154.58 45.61 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.534 2.823 . . . . 0.0 112.745 -169.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.05 170.46 20.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.161 3.241 . . . . 0.0 111.632 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 52.7 p -71.18 -11.93 61.2 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.72 142.56 8.11 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 126.044 1.783 . . . . 0.0 111.867 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.81 136.46 20.85 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.246 2.63 . . . . 0.0 111.297 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 t -151.65 14.95 0.67 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m 67.29 -7.49 0.52 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.464 2.306 . . . . 0.0 115.985 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 C-N-CA 125.954 1.74 . . . . 0.0 112.931 178.625 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 49.5 p -161.77 -78.08 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.576 1.15 . . . . 0.0 111.315 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 46.5 t -167.22 146.07 5.05 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.716 2.006 . . . . 0.0 110.822 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -103.03 2.83 47.88 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.897 1.237 . . . . 0.0 113.686 171.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 m -89.67 145.87 24.92 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.561 1.18 . . . . 0.0 113.665 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -159.5 131.99 6.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.0 1.72 . . . . 0.0 109.093 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.26 -39.92 87.77 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-O 119.417 -0.657 . . . . 0.0 113.915 -168.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.23 -34.23 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.559 1.179 . . . . 0.0 112.528 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -67.81 -40.81 83.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.183 0.993 . . . . 0.0 110.601 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -67.89 -33.79 75.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.315 1.046 . . . . 0.0 112.703 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.72 -41.43 83.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.91 0.777 . . . . 0.0 111.97 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.24 -44.39 96.68 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.75 0.705 . . . . 0.0 111.285 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.3 -42.56 99.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.34 0.656 . . . . 0.0 112.76 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.46 -40.77 80.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.548 1.139 . . . . 0.0 112.45 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.31 -45.41 93.47 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.11 0.964 . . . . 0.0 111.448 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -58.15 -45.71 86.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.474 0.71 . . . . 0.0 111.652 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.07 -26.86 73.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.504 1.049 . . . . 0.0 114.102 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -78.1 -8.25 58.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.598 1.199 . . . . 0.0 112.853 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.115 2.166 . . . . 0.0 112.769 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 64.41 30.5 13.13 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.39 1.876 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.5 mtm -117.66 174.08 6.37 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.731 2.012 . . . . 0.0 111.415 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -143.53 133.31 11.83 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.825 1.65 . . . . 0.0 108.791 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.66 153.75 34.33 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.961 2.441 . . . . 0.0 110.97 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.22 116.17 20.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.71 157.31 16.78 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 112.225 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.62 148.49 34.39 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.07 1.748 . . . . 0.0 109.692 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.14 146.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.021 1.328 . . . . 0.0 111.89 -168.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -134.34 141.31 46.86 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.699 2.0 . . . . 0.0 110.196 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.7 138.74 32.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.415 1.086 . . . . 0.0 111.011 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.0 m -147.08 176.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.07 1.748 . . . . 0.0 110.951 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.33 -158.23 28.69 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.979 0.799 . . . . 0.0 113.869 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -84.75 150.29 25.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.915 1.286 . . . . 0.0 112.47 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -61.72 -35.89 79.34 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -87.95 -22.95 24.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.068 1.347 . . . . 0.0 113.357 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -134.0 83.13 2.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.677 1.591 . . . . 0.0 110.335 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -82.44 152.28 26.19 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.65 1.18 . . . . 0.0 111.416 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -136.01 164.98 26.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.612 1.965 . . . . 0.0 110.974 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -135.2 141.82 45.92 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.85 1.26 . . . . 0.0 111.251 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 mtp -113.21 153.48 28.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.171 1.789 . . . . 0.0 109.249 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -146.58 146.49 30.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.011 0.924 . . . . 0.0 111.587 -177.056 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -128.04 149.23 50.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.947 1.699 . . . . 0.0 109.322 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.2 143.57 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.211 1.004 . . . . 0.0 111.966 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -137.03 165.63 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.512 1.925 . . . . 0.0 110.62 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.51 138.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.886 1.674 . . . . 0.0 108.158 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.51 128.42 37.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.938 0.895 . . . . 0.0 111.707 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 0.69 65.12 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.666 1.127 . . . . 0.0 114.765 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -122.96 129.76 51.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.202 1.401 . . . . 0.0 110.577 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.81 -20.88 45.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -70.82 157.95 37.21 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.643 1.177 . . . . 0.0 113.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.9 116.56 15.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.878 1.271 . . . . 0.0 109.591 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.29 143.52 22.91 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 mtt -137.89 144.29 41.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 112.953 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.68 169.45 27.85 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.851 1.691 . . . . 0.0 113.36 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -158.07 152.07 24.09 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.33 1.052 . . . . 0.0 112.186 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.6 t -169.08 -175.09 2.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.924 1.289 . . . . 0.0 112.264 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.7 p -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.717 1.607 . . . . 0.0 113.402 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -142.16 145.5 34.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.535 1.534 . . . . 0.0 111.44 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.33 -30.94 70.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 113.492 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.51 -46.18 70.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.651 1.18 . . . . 0.0 111.891 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -77.04 -27.89 54.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.553 0.741 . . . . 0.0 111.945 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.27 87.52 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.582 -0.699 . . . . 0.0 111.581 170.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.12 -38.75 90.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.688 0.795 . . . . 0.0 112.033 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.1 m -65.03 -36.31 83.95 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.656 -0.652 . . . . 0.0 112.255 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.33 -36.95 68.98 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.458 -0.776 . . . . 0.0 111.967 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.66 97.86 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.576 -0.703 . . . . 0.0 111.536 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.96 77.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.306 1.042 . . . . 0.0 111.618 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -52.09 -44.43 64.38 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.625 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.75 -35.16 70.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.95 0.9 . . . . 0.0 113.118 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.91 -37.6 62.02 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.686 -0.633 . . . . 0.0 112.291 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.88 -40.89 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.79 -31.68 71.91 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.64 -44.62 81.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.0 -1.687 . . . . 0.0 111.993 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' HG23 ' A' ' 75' ' ' VAL . 94.3 mt -61.46 -33.2 73.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.647 0.658 . . . . 0.0 112.748 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.26 -44.46 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.026 0.93 . . . . 0.0 111.336 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -63.05 -22.5 66.9 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 pt -104.56 6.49 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.77 1.228 . . . . 0.0 113.983 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 67.51 21.29 9.59 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.446 1.899 . . . . 0.0 114.63 174.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -90.36 -5.72 55.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 113.195 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 69' ' ' LEU . 70.0 t -136.11 136.88 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 127.034 2.133 . . . . 0.0 107.781 168.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.51 126.69 33.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.56 -32.49 63.04 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.336 -0.852 . . . . 0.0 113.246 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.92 -19.55 60.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.087 1.355 . . . . 0.0 113.561 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.76 -16.08 29.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.614 1.166 . . . . 0.0 113.322 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.19 124.11 85.88 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.238 1.015 . . . . 0.0 110.978 -169.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.83 153.74 19.78 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.492 2.795 . . . . 0.0 111.844 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.43 167.99 12.64 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.677 1.591 . . . . 0.0 111.891 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -14.19 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.713 1.605 . . . . 0.0 115.113 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.78 176.91 37.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.979 1.752 . . . . 0.0 112.187 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pp -84.6 157.62 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.219 1.807 . . . . 0.0 111.722 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 t 66.56 81.29 0.21 Allowed Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 126.379 1.872 . . . . 0.0 111.745 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.36 150.64 84.0 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.705 2.937 . . . . 0.0 112.901 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.4 136.11 35.86 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.145 2.563 . . . . 0.0 110.486 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.08 -14.1 26.07 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.472 2.781 . . . . 0.0 114.27 -170.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.1 m -115.0 4.87 14.84 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.731 1.213 . . . . 0.0 113.157 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.9 178.01 43.3 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.594 1.093 . . . . 0.0 113.677 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.1 159.83 37.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.017 3.145 . . . . 0.0 111.262 173.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.0 p -160.62 158.48 29.03 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.559 1.144 . . . . 0.0 112.467 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -87.54 -4.68 58.97 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.246 0 C-N-CA 125.253 1.406 . . . . 0.0 113.197 -177.285 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 71.9 p -165.16 165.7 19.58 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.446 1.499 . . . . 0.0 111.693 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 55.9 p -162.58 155.83 20.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.826 1.25 . . . . 0.0 112.276 -175.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -86.27 -174.95 49.71 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.706 1.146 . . . . 0.0 113.225 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 t -168.45 -176.19 2.76 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.084 1.754 . . . . 0.0 111.131 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -155.55 145.45 21.44 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.132 1.373 . . . . 0.0 111.45 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.6 -17.83 78.22 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.988 -0.895 . . . . 0.0 114.406 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tp -70.76 -33.94 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.284 1.542 . . . . 0.0 113.057 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.18 -38.46 82.07 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.466 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -71.92 -30.38 65.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.017 0.927 . . . . 0.0 112.84 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -66.99 -43.78 82.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.842 0.857 . . . . 0.0 111.792 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 tp -62.79 -42.89 99.9 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.415 0.552 . . . . 0.0 111.25 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -63.33 -42.73 98.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.67 80.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.436 1.094 . . . . 0.0 112.453 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.98 -45.71 93.71 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 111.457 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.2 m -58.04 -46.27 85.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.588 0.755 . . . . 0.0 111.648 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.08 -26.9 73.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.47 1.033 . . . . 0.0 114.065 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.74 -8.36 57.86 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.413 1.107 . . . . 0.0 112.706 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.7 8.69 11.24 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.277 2.231 . . . . 0.0 112.687 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.4 30.93 12.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.556 1.943 . . . . 0.0 113.568 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtm -117.83 173.6 6.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.819 2.048 . . . . 0.0 111.425 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 m -143.05 132.46 11.78 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.054 1.742 . . . . 0.0 108.983 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 152.97 30.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.134 2.556 . . . . 0.0 110.986 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.12 117.47 21.67 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.88 156.31 17.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.462 1.505 . . . . 0.0 112.498 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.45 145.7 32.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.397 1.879 . . . . 0.0 109.262 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -133.17 148.41 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.187 1.395 . . . . 0.0 110.83 -169.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 -143.4 134.43 25.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.854 1.661 . . . . 0.0 110.653 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.52 138.62 31.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.241 1.016 . . . . 0.0 111.122 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -146.86 168.59 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.643 1.577 . . . . 0.0 111.459 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.47 -163.48 39.0 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.34 0.971 . . . . 0.0 113.965 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -66.43 146.52 54.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.858 1.263 . . . . 0.0 112.448 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -57.59 -40.81 79.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.518 1.127 . . . . 0.0 113.947 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -86.43 -50.51 6.84 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.402 1.081 . . . . 0.0 111.703 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -89.47 63.16 6.25 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.346 1.458 . . . . 0.0 110.16 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -79.85 151.32 30.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.011 1.325 . . . . 0.0 112.032 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -134.34 161.94 33.59 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.605 1.962 . . . . 0.0 110.828 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.06 127.03 29.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.914 1.286 . . . . 0.0 111.075 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtp -91.25 154.87 18.98 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.427 1.491 . . . . 0.0 109.307 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.3 t -143.77 147.69 34.52 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.191 0.996 . . . . 0.0 111.212 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -132.84 141.37 48.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.588 1.955 . . . . 0.0 108.131 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.14 144.03 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.928 0.891 . . . . 0.0 112.1 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -137.82 166.51 23.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.123 1.769 . . . . 0.0 111.165 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.3 139.01 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.255 1.822 . . . . 0.0 107.764 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.54 127.67 33.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 111.834 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.89 -0.71 64.82 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.718 1.151 . . . . 0.0 114.96 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -117.46 126.95 53.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.846 1.323 . . . . 0.0 110.859 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -72.76 -23.37 60.81 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.183 0.993 . . . . 0.0 113.455 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -69.1 158.08 35.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.036 1.334 . . . . 0.0 113.697 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.57 119.58 17.52 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.252 1.421 . . . . 0.0 110.246 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.07 21.66 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtt -137.86 142.14 40.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.916 0.887 . . . . 0.0 112.823 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.42 170.1 26.84 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.737 1.637 . . . . 0.0 113.272 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -157.75 149.76 22.18 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.657 1.183 . . . . 0.0 111.216 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -166.42 -175.64 3.3 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.876 1.27 . . . . 0.0 112.54 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.6 p -75.61 -9.96 59.03 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.568 1.547 . . . . 0.0 113.317 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.44 150.57 30.58 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.452 1.501 . . . . 0.0 111.845 -170.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.05 -34.17 77.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.236 1.014 . . . . 0.0 113.649 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -64.55 -49.07 72.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.727 1.211 . . . . 0.0 111.983 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.24 -27.2 56.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.013 0.925 . . . . 0.0 112.153 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.35 84.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.527 -0.733 . . . . 0.0 111.719 171.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.2 -40.31 89.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.165 0.586 . . . . 0.0 111.72 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.7 m -64.88 -36.59 84.86 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.818 -0.551 . . . . 0.0 112.23 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -71.57 -38.91 70.88 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.306 -0.871 . . . . 0.0 111.824 173.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.4 98.91 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.727 0.694 . . . . 0.0 111.533 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.92 82.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.245 1.018 . . . . 0.0 111.554 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.4 tpt85 -56.15 -37.86 70.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.467 0.707 . . . . 0.0 112.441 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.4 -29.05 52.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 113.415 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.56 -37.99 55.68 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.412 -0.805 . . . . 0.0 111.664 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.42 -40.29 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.651 0.78 . . . . 0.0 110.582 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -53.32 -48.86 68.09 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 170.087 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -58.71 -44.76 90.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.915 -1.115 . . . . 0.0 112.816 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.439 ' HB3' HG23 ' A' ' 75' ' ' VAL . 96.1 mt -62.79 -31.5 72.48 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -72.09 -41.29 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.866 0.867 . . . . 0.0 111.132 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -65.08 -26.53 68.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.226 1.011 . . . . 0.0 113.124 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 pt -98.66 4.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.611 1.165 . . . . 0.0 113.798 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 68.99 17.24 8.65 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.706 2.002 . . . . 0.0 114.63 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -85.17 -7.8 58.89 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.115 1.366 . . . . 0.0 113.209 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 69' ' ' LEU . 72.4 t -132.58 137.45 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.998 2.119 . . . . 0.0 107.626 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -84.71 128.33 34.55 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.92 0.488 . . . . 0.0 109.919 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -55.13 -33.44 62.89 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.388 -0.82 . . . . 0.0 113.143 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.35 -19.07 61.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.946 1.298 . . . . 0.0 113.605 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -90.18 -16.84 28.7 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.508 1.123 . . . . 0.0 113.227 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.0 t -76.11 125.85 87.44 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.252 1.021 . . . . 0.0 110.496 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -73.48 144.82 36.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.571 . . . . 0.0 111.322 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.14 161.91 39.15 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.057 1.343 . . . . 0.0 112.121 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -12.53 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.83 162.69 33.23 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.721 1.153 . . . . 0.0 113.654 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.17 143.57 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.875 2.07 . . . . 0.0 108.806 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.74 156.28 71.32 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 125.659 1.584 . . . . 0.0 111.798 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -60.13 164.31 12.68 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 124.009 3.139 . . . . 0.0 113.866 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.31 152.81 30.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.247 3.298 . . . . 0.0 113.032 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.3 -16.11 43.36 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.593 2.862 . . . . 0.0 113.728 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 m -72.37 -13.6 61.51 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.17 0.988 . . . . 0.0 113.516 171.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.89 -176.52 51.03 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.652 1.596 . . . . 0.0 114.243 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -61.1 154.79 54.79 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 124.411 3.407 . . . . 0.0 112.786 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.2 p -161.94 160.69 28.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.852 1.261 . . . . 0.0 112.135 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.6 m -165.85 156.03 12.76 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.66 1.984 . . . . 0.0 110.87 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 118.447 -1.196 . . . . 0.0 112.959 178.896 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 43.6 m -76.87 120.53 22.14 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.853 0.861 . . . . 0.0 112.514 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 29.5 m 72.03 -42.62 0.54 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 128.044 2.538 . . . . 0.0 115.687 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 74.35 15.28 80.3 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.784 1.183 . . . . 0.0 114.994 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 m -72.09 -9.04 57.86 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -170.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -80.09 59.08 3.17 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.953 2.101 . . . . 0.0 111.839 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.28 -28.99 73.8 Favored Glycine 0 N--CA 1.472 1.067 0 O-C-N 120.783 -1.198 . . . . 0.0 114.686 -169.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.25 -33.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 118.263 1.032 . . . . 0.0 112.201 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -66.34 -43.37 86.29 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.801 1.24 . . . . 0.0 110.361 172.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.48 -32.0 73.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 112.854 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -69.08 -40.96 78.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.289 0.949 . . . . 0.0 111.993 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.77 -42.47 99.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -61.91 -41.93 98.49 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.36 82.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.509 1.124 . . . . 0.0 112.863 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.01 -43.79 94.58 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.83 0.852 . . . . 0.0 111.856 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.6 m -57.89 -43.88 86.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.096 0.558 . . . . 0.0 111.08 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.65 -28.64 73.81 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.561 1.076 . . . . 0.0 114.055 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -70.34 -12.91 61.9 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.637 1.218 . . . . 0.0 112.645 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -119.61 9.18 11.4 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.15 2.18 . . . . 0.0 113.257 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.39 24.03 13.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 114.044 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.97 174.04 6.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.013 2.125 . . . . 0.0 111.476 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.4 m -140.49 130.74 13.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.34 1.856 . . . . 0.0 108.528 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.36 147.63 29.25 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.003 2.469 . . . . 0.0 110.758 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.27 114.45 25.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.456 1.103 . . . . 0.0 110.641 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -95.74 153.8 17.55 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.004 1.321 . . . . 0.0 111.739 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -145.52 138.6 26.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.166 1.786 . . . . 0.0 108.556 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.08 147.45 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.423 1.089 . . . . 0.0 111.774 -168.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.04 135.45 41.32 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.149 1.78 . . . . 0.0 110.44 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.96 137.64 32.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.808 1.243 . . . . 0.0 111.016 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -146.86 176.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.236 1.814 . . . . 0.0 110.994 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.08 -151.09 17.92 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.657 1.122 . . . . 0.0 113.553 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -116.91 158.49 23.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.348 1.859 . . . . 0.0 111.773 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -58.25 -22.99 54.51 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -97.42 -9.3 27.57 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.509 1.524 . . . . 0.0 113.752 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -157.31 98.08 1.68 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.065 1.746 . . . . 0.0 110.384 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -87.11 151.35 23.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.463 1.105 . . . . 0.0 111.228 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -145.85 160.36 41.9 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.406 2.283 . . . . 0.0 110.163 -172.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.93 128.87 35.41 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.346 1.058 . . . . 0.0 111.909 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtm -94.98 151.48 19.14 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.546 1.538 . . . . 0.0 108.948 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.2 t -144.68 149.56 35.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.971 0.908 . . . . 0.0 112.082 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -132.87 149.42 52.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.389 1.875 . . . . 0.0 109.044 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.36 140.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.868 0.867 . . . . 0.0 111.71 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -137.08 157.57 46.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.923 2.089 . . . . 0.0 110.546 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.9 t -140.63 136.31 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.729 1.612 . . . . 0.0 108.459 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.28 128.12 35.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.034 0.933 . . . . 0.0 111.73 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.45 2.89 65.24 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.543 1.068 . . . . 0.0 114.692 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.43 129.05 49.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.412 1.485 . . . . 0.0 110.261 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -81.5 -12.19 58.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -85.54 160.44 19.66 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.678 1.191 . . . . 0.0 113.1 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.7 117.68 16.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.84 1.256 . . . . 0.0 109.604 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.01 141.31 24.09 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.6 mtp -123.6 143.38 50.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.556 1.142 . . . . 0.0 112.747 -169.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.11 169.24 28.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.434 1.493 . . . . 0.0 113.633 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -159.88 148.98 17.68 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.934 1.294 . . . . 0.0 111.153 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.53 -176.18 3.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.769 1.228 . . . . 0.0 112.656 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 m -75.67 -19.99 58.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.15 1.38 . . . . 0.0 111.775 172.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -138.35 155.77 48.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 112.85 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -67.67 -40.82 84.45 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.365 -0.834 . . . . 0.0 112.133 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.29 -30.34 57.74 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 112.035 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -43.79 90.2 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.534 -0.729 . . . . 0.0 111.768 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -61.52 -39.48 91.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.538 0.735 . . . . 0.0 111.668 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -64.61 -35.13 80.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.996 0.817 . . . . 0.0 112.388 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.57 -38.18 67.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.28 -0.888 . . . . 0.0 112.017 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.02 97.27 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.59 -0.694 . . . . 0.0 111.563 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -47.59 83.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.576 1.15 . . . . 0.0 111.836 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -52.52 -43.21 64.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.874 0.87 . . . . 0.0 111.581 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.37 -34.26 63.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.22 -37.24 61.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.44 -0.788 . . . . 0.0 112.241 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.15 -42.47 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.342 -0.848 . . . . 0.0 110.092 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.36 -48.64 78.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.524 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -51.1 -42.65 60.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.726 1.603 . . . . 0.0 113.842 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.99 -22.27 66.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.25 -36.72 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.552 1.069 . . . . 0.0 110.903 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -60.4 -30.53 69.66 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.33 1.052 . . . . 0.0 112.112 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 pt -103.96 3.48 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.292 . . . . 0.0 114.211 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.86 23.16 11.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.509 1.924 . . . . 0.0 114.797 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -86.2 -9.75 55.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.51 1.524 . . . . 0.0 113.052 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -134.06 136.65 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 127.139 2.176 . . . . 0.0 107.433 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -86.65 137.44 32.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.319 0.509 . . . . 0.0 109.714 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 p -54.91 -32.09 60.79 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.977 -1.077 . . . . 0.0 113.094 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -53.5 -24.64 13.76 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.015 1.726 . . . . 0.0 114.177 173.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.27 -20.47 26.82 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.545 1.138 . . . . 0.0 113.104 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.1 t -80.45 129.43 69.03 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.583 1.153 . . . . 0.0 110.693 -168.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.27 138.51 36.35 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.06 2.507 . . . . 0.0 110.756 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.28 125.38 27.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.447 0.699 . . . . 0.0 112.091 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.17 -11.5 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.863 1.665 . . . . 0.0 114.369 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.59 -160.24 26.01 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.326 1.917 . . . . 0.0 111.734 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.1 mt -84.44 130.55 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.477 1.111 . . . . 0.0 108.827 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.15 129.59 14.67 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 125.436 1.494 . . . . 0.0 108.914 -174.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.46 158.06 44.51 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.416 2.744 . . . . 0.0 112.235 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.68 161.3 44.3 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.698 2.932 . . . . 0.0 111.58 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.01 -14.01 37.64 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.446 2.764 . . . . 0.0 113.338 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.6 p -83.78 -1.24 53.83 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.462 1.505 . . . . 0.0 113.569 170.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.05 -178.57 51.8 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.684 1.612 . . . . 0.0 114.176 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.35 162.59 41.11 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.248 3.299 . . . . 0.0 112.124 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.7 t -162.74 -40.63 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.405 1.082 . . . . 0.0 112.697 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.7 p -160.16 163.87 33.33 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.981 1.312 . . . . 0.0 112.076 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.849 -179.623 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 99.2 p -163.86 170.17 17.18 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.149 1.38 . . . . 0.0 111.946 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 18.5 m -83.38 11.92 6.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.688 1.195 . . . . 0.0 114.044 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -75.79 142.67 29.07 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.949 1.261 . . . . 0.0 112.932 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 80.8 p -160.93 5.64 0.07 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -82.5 112.32 19.31 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.248 -1.532 . . . . 0.0 111.526 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.45 -41.06 31.24 Favored Glycine 0 N--CA 1.472 1.052 0 O-C-N 121.325 -0.859 . . . . 0.0 114.788 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 tp -73.63 -28.43 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 118.339 1.07 . . . . 0.0 112.104 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -48.26 76.99 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.302 1.041 . . . . 0.0 110.027 169.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -64.81 -29.57 70.54 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 112.685 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.81 -45.61 74.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.812 0.733 . . . . 0.0 111.476 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.63 -41.79 99.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.369 0.531 . . . . 0.0 111.153 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.01 -42.49 99.83 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -39.1 79.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.36 1.064 . . . . 0.0 112.419 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.8 t90 -61.0 -45.84 93.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.068 0.947 . . . . 0.0 111.427 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.3 m -58.22 -45.67 87.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.649 0.78 . . . . 0.0 111.711 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.67 -26.83 72.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.449 1.024 . . . . 0.0 114.051 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -78.12 -8.38 58.18 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.398 1.099 . . . . 0.0 112.744 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -119.68 9.3 11.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.377 2.271 . . . . 0.0 112.726 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.96 30.72 11.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.51 1.924 . . . . 0.0 113.623 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.8 mtm -118.33 172.36 7.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.756 2.022 . . . . 0.0 111.57 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -142.54 130.64 11.48 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.093 1.757 . . . . 0.0 108.685 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.6 149.96 27.44 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.011 2.474 . . . . 0.0 110.803 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.0 117.62 27.74 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.651 1.181 . . . . 0.0 110.68 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.26 158.03 16.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.336 1.455 . . . . 0.0 112.63 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.3 149.88 33.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.999 1.32 . . . . 0.0 110.33 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.1 mt -135.66 147.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.822 1.649 . . . . 0.0 111.149 -169.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -141.98 137.42 31.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.653 1.581 . . . . 0.0 111.06 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.46 141.92 28.26 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.204 1.002 . . . . 0.0 111.222 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 m -146.14 161.5 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.697 1.599 . . . . 0.0 111.213 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.79 158.29 12.2 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.794 1.188 . . . . 0.0 113.427 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.58 155.05 40.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.383 0.673 . . . . 0.0 111.727 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -54.85 -27.68 44.16 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -169.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -78.76 -24.34 44.78 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -125.83 29.64 5.88 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.973 2.509 . . . . 0.0 112.659 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -66.62 145.8 55.19 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 112.523 -169.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -140.43 165.63 26.9 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.536 2.334 . . . . 0.0 110.86 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.28 133.88 46.81 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.239 1.416 . . . . 0.0 110.651 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 37.2 mtm -100.39 154.16 18.74 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.113 1.765 . . . . 0.0 109.211 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.6 t -147.54 148.69 31.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.376 1.07 . . . . 0.0 111.171 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.89 158.28 42.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.096 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.69 143.9 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.807 1.243 . . . . 0.0 111.611 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -139.44 158.19 44.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.436 1.895 . . . . 0.0 110.335 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.07 134.94 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.619 1.568 . . . . 0.0 108.619 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.67 130.14 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.04 0.936 . . . . 0.0 111.677 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.55 1.37 66.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.537 1.065 . . . . 0.0 114.567 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -125.14 128.84 49.03 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 110.363 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -77.25 -20.88 54.55 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -71.29 156.68 39.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.559 1.143 . . . . 0.0 113.377 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.66 116.99 15.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.035 1.334 . . . . 0.0 109.326 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.92 141.84 22.01 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 77.1 mtm -140.27 142.41 35.73 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.595 1.158 . . . . 0.0 112.232 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.26 173.92 31.3 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.264 1.411 . . . . 0.0 113.143 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -152.81 161.7 42.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.262 1.025 . . . . 0.0 111.953 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 t -167.34 -172.83 2.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.647 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.6 p -76.84 -9.57 58.77 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.544 1.538 . . . . 0.0 113.372 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.55 151.38 31.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.657 1.583 . . . . 0.0 111.779 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.34 -30.03 70.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -65.33 -54.61 26.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.708 1.203 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.84 -27.56 62.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.727 0.811 . . . . 0.0 112.171 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.41 95.08 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.814 -0.553 . . . . 0.0 111.749 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.01 -41.07 95.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.43 0.692 . . . . 0.0 112.034 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.4 m -59.03 -40.2 84.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.18 0.9 . . . . 0.0 112.34 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -72.46 -37.97 68.36 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.592 -0.692 . . . . 0.0 111.545 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.35 92.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.651 0.781 . . . . 0.0 112.282 172.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.59 -49.11 77.93 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.313 1.045 . . . . 0.0 111.593 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -58.65 -39.74 81.43 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.73 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.85 -30.78 70.25 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -77.94 -39.6 42.17 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.617 -0.677 . . . . 0.0 112.359 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.2 -38.7 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.41 -0.806 . . . . 0.0 110.798 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.82 -44.01 81.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.504 0.721 . . . . 0.0 111.578 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -60.41 -44.47 95.69 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.768 -1.207 . . . . 0.0 112.665 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.4 -34.27 75.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.065 0.848 . . . . 0.0 113.179 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.12 -42.64 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.908 0.883 . . . . 0.0 111.198 171.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -66.17 -21.36 66.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.508 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -103.38 6.75 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.939 1.296 . . . . 0.0 113.625 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m120 68.79 18.84 8.57 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.725 2.01 . . . . 0.0 114.675 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.67 -5.69 57.96 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.347 1.459 . . . . 0.0 113.322 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -136.83 139.33 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.906 2.082 . . . . 0.0 107.995 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -84.97 125.91 33.08 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.964 0.506 . . . . 0.0 110.067 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.08 -33.1 62.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.13 -19.47 61.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.909 1.284 . . . . 0.0 113.568 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -92.42 -15.64 26.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.648 1.179 . . . . 0.0 113.435 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 123.74 85.41 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.103 0.961 . . . . 0.0 111.64 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -82.87 169.53 13.19 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.785 2.99 . . . . 0.0 112.707 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.79 154.31 43.29 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.591 1.556 . . . . 0.0 111.053 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -16.08 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.112 1.365 . . . . 0.0 114.576 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.02 158.56 30.9 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.753 1.644 . . . . 0.0 112.23 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.4 mm -117.84 127.0 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.455 1.502 . . . . 0.0 109.396 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 p -165.0 135.75 3.12 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 125.476 1.51 . . . . 0.0 109.73 -174.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.2 163.07 37.39 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.123 2.549 . . . . 0.0 112.003 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.73 148.21 75.82 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.908 3.072 . . . . 0.0 113.277 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.37 162.98 38.97 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.949 3.099 . . . . 0.0 112.018 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.4 m -146.24 151.21 37.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.462 1.505 . . . . 0.0 111.475 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.48 -173.7 49.85 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.669 1.128 . . . . 0.0 113.47 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.9 136.7 71.59 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.239 3.293 . . . . 0.0 112.505 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.2 p -79.91 -10.73 59.81 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.1 m -91.71 -4.33 55.22 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.128 1.371 . . . . 0.0 113.877 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.214 0 CA-C-O 118.206 -1.33 . . . . 0.0 113.449 -178.567 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 18.7 m -84.92 -6.87 59.34 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -172.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.4 t -163.61 172.86 13.72 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.938 1.695 . . . . 0.0 111.193 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 86.89 -172.53 44.13 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.356 1.455 . . . . 0.0 113.47 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.9 t -163.34 173.23 13.52 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.262 1.425 . . . . 0.0 111.558 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -159.3 29.88 0.2 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.197 2.199 . . . . 0.0 111.125 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.53 83.89 Favored Glycine 0 N--CA 1.471 0.999 0 O-C-N 120.801 -1.187 . . . . 0.0 114.24 -169.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -73.89 -30.31 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 118.304 1.052 . . . . 0.0 112.582 173.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -40.72 75.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.528 1.131 . . . . 0.0 110.542 174.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -69.38 -31.38 69.73 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.182 0.993 . . . . 0.0 112.828 170.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.18 -42.0 84.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.969 0.804 . . . . 0.0 111.947 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -62.65 -42.98 99.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.702 0.683 . . . . 0.0 111.258 173.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.87 -42.96 99.95 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.252 0.621 . . . . 0.0 112.556 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 -39.99 83.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.349 1.06 . . . . 0.0 112.667 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.37 -45.65 93.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 111.452 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.1 m -58.23 -45.45 87.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.545 0.738 . . . . 0.0 111.684 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.07 73.03 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.483 1.04 . . . . 0.0 114.034 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.46 -8.99 58.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.466 1.106 . . . . 0.0 112.838 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -119.64 9.35 11.43 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.251 2.22 . . . . 0.0 112.736 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 mttp 65.05 30.7 11.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.439 1.895 . . . . 0.0 113.568 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.7 mtm -118.6 172.38 7.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.688 1.995 . . . . 0.0 111.654 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.6 m -141.4 130.25 12.42 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 126.328 1.851 . . . . 0.0 108.581 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.62 142.13 20.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.928 2.419 . . . . 0.0 110.581 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.31 116.64 30.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.485 1.114 . . . . 0.0 110.558 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -98.23 154.9 17.46 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.098 1.359 . . . . 0.0 112.301 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.18 136.86 22.96 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.917 1.287 . . . . 0.0 110.287 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 70.0 mt -123.78 147.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.12 1.368 . . . . 0.0 110.97 -170.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 -142.21 140.41 32.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.707 2.003 . . . . 0.0 110.106 -174.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.0 140.62 29.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.329 1.052 . . . . 0.0 111.255 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.93 162.23 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.84 1.656 . . . . 0.0 111.017 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.22 -165.23 41.04 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.997 0.808 . . . . 0.0 114.336 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.93 147.21 51.99 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.481 1.512 . . . . 0.0 113.115 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -63.62 -39.2 93.77 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -81.82 -31.81 31.55 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.018 1.327 . . . . 0.0 112.853 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -122.02 77.79 1.41 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.704 1.601 . . . . 0.0 109.466 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -80.9 148.89 29.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.38 1.072 . . . . 0.0 111.419 -172.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -130.24 164.74 23.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.231 1.812 . . . . 0.0 111.042 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -135.09 137.77 43.17 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.89 1.276 . . . . 0.0 111.6 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.6 mtp -102.67 152.19 21.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.588 1.555 . . . . 0.0 108.879 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.0 t -135.76 145.38 46.52 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.427 1.091 . . . . 0.0 110.194 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -122.46 152.23 40.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.202 1.801 . . . . 0.0 108.976 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.31 140.11 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.778 1.231 . . . . 0.0 110.894 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -140.79 153.39 45.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.945 1.698 . . . . 0.0 110.117 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.77 134.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.488 1.515 . . . . 0.0 108.88 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.79 130.01 44.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.131 0.972 . . . . 0.0 111.695 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.4 2.05 66.0 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.607 1.098 . . . . 0.0 114.627 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.83 130.85 53.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.397 1.479 . . . . 0.0 110.321 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -82.67 -14.72 54.15 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -80.93 155.75 26.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.407 1.083 . . . . 0.0 112.766 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.81 112.05 13.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.191 1.396 . . . . 0.0 108.911 170.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.16 147.19 25.76 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.5 ptm -147.19 150.29 34.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -169.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.6 173.78 30.1 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.248 1.88 . . . . 0.0 112.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -157.28 154.55 29.27 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.918 0.887 . . . . 0.0 112.753 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -168.28 -178.26 3.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.413 1.485 . . . . 0.0 111.471 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m -78.23 -2.69 39.02 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.578 1.551 . . . . 0.0 112.052 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -142.37 150.45 40.72 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.957 1.703 . . . . 0.0 111.786 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.72 -37.55 70.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.615 1.166 . . . . 0.0 113.631 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -71.54 -36.96 71.17 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.14 -0.975 . . . . 0.0 112.19 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.92 -30.92 70.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.159 0.984 . . . . 0.0 112.236 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.13 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.335 -0.853 . . . . 0.0 111.617 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -61.38 -42.2 98.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.898 0.879 . . . . 0.0 112.498 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -69.27 -32.05 70.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.542 1.065 . . . . 0.0 112.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -69.24 -40.52 77.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.476 -0.765 . . . . 0.0 111.804 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.32 99.79 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.831 0.742 . . . . 0.0 111.926 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.94 77.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.955 0.902 . . . . 0.0 111.452 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -57.84 -40.29 79.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.457 0.571 . . . . 0.0 111.968 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.15 -33.87 74.09 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.778 0.831 . . . . 0.0 113.104 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -76.11 -38.84 56.4 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.679 -0.638 . . . . 0.0 112.229 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.3 -41.45 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.451 -0.781 . . . . 0.0 110.591 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -56.75 -47.28 80.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.105 0.562 . . . . 0.0 111.588 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -56.48 -44.43 80.6 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 112.896 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.79 -31.89 72.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.375 -0.828 . . . . 0.0 113.209 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.62 -39.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.044 0.838 . . . . 0.0 111.388 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -61.38 -29.99 70.26 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.8 pt -98.32 5.1 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.9 t30 67.99 21.73 8.77 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.766 2.027 . . . . 0.0 114.576 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -89.61 -5.36 57.23 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.234 1.413 . . . . 0.0 113.118 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.1 t -138.2 144.36 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.797 2.439 . . . . 0.0 107.18 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -98.32 133.33 42.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.538 0.735 . . . . 0.0 110.336 169.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.8 p -58.2 -30.29 66.33 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.208 -0.933 . . . . 0.0 113.242 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.83 -21.91 57.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.534 1.134 . . . . 0.0 113.645 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -88.99 -17.26 29.8 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.39 1.076 . . . . 0.0 113.15 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.52 125.59 82.49 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 124.307 1.043 . . . . 0.0 110.733 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.84 120.08 5.96 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.076 2.517 . . . . 0.0 110.288 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.06 171.0 18.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.233 1.813 . . . . 0.0 110.892 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -19.64 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.258 1.423 . . . . 0.0 114.25 175.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -168.92 158.75 31.54 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.3 1.905 . . . . 0.0 111.662 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.5 mm -78.55 102.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 121.831 -0.805 . . . . 0.0 109.084 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -142.55 128.96 10.76 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.169 1.788 . . . . 0.0 108.355 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.94 162.0 40.09 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.238 2.625 . . . . 0.0 112.005 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.8 146.31 93.24 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.687 2.925 . . . . 0.0 112.842 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.47 157.04 53.65 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.428 2.752 . . . . 0.0 111.637 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.9 p -161.61 163.86 29.71 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.585 1.554 . . . . 0.0 111.733 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.31 -164.2 31.39 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.652 1.12 . . . . 0.0 113.497 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.85 164.1 36.76 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.861 3.04 . . . . 0.0 111.686 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.9 m -60.73 134.49 57.14 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.735 1.214 . . . . 0.0 113.249 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 m -76.16 -6.22 50.26 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.762 1.648 . . . . 0.0 113.043 -178.636 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 34.0 p -68.98 -22.85 64.07 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.294 -1.121 . . . . 0.0 113.908 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 67.5 m -89.6 7.57 35.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.986 1.314 . . . . 0.0 113.087 171.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 85.86 -129.04 9.12 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.796 1.188 . . . . 0.0 111.086 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 p -136.67 12.48 3.18 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.176 1.39 . . . . 0.0 113.197 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -65.57 122.56 17.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.712 1.205 . . . . 0.0 113.538 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.35 -32.39 68.42 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.878 -173.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -74.63 -34.53 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.069 1.435 . . . . 0.0 113.173 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.52 -44.74 86.02 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.337 1.055 . . . . 0.0 110.241 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.54 -31.96 73.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.639 0.775 . . . . 0.0 112.673 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.25 -42.91 74.96 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.687 0.795 . . . . 0.0 111.71 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.52 -43.16 99.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.627 0.649 . . . . 0.0 111.231 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.45 -42.86 98.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.6 83.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.578 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -60.29 -45.57 92.89 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.296 1.038 . . . . 0.0 111.586 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.3 m -58.06 -44.01 87.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.474 0.71 . . . . 0.0 111.665 171.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.58 -26.63 72.9 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.424 1.011 . . . . 0.0 114.103 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -78.52 -6.63 55.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.629 1.215 . . . . 0.0 112.857 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -119.3 7.88 11.34 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.057 2.143 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 63.29 27.71 15.51 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.329 1.852 . . . . 0.0 113.519 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.0 mtm -110.79 174.15 6.0 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.878 2.071 . . . . 0.0 111.305 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.4 m -143.17 131.08 11.09 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.85 1.66 . . . . 0.0 108.509 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.04 146.25 25.5 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.986 2.457 . . . . 0.0 110.645 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.46 113.22 24.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.323 1.049 . . . . 0.0 110.786 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -98.55 155.19 17.4 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.538 1.535 . . . . 0.0 112.128 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.13 146.77 30.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.1 1.76 . . . . 0.0 109.866 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.82 147.73 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.306 1.442 . . . . 0.0 110.686 -169.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 -143.14 141.02 31.07 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.73 2.012 . . . . 0.0 110.114 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.1 138.33 32.95 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.438 1.095 . . . . 0.0 111.179 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -146.52 168.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.584 1.554 . . . . 0.0 111.571 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.28 174.53 50.4 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.359 0.98 . . . . 0.0 114.223 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -68.34 140.97 55.91 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.447 1.099 . . . . 0.0 112.066 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -58.89 -22.59 59.75 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -73.24 -21.46 60.63 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.258 1.023 . . . . 0.0 113.414 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -153.52 71.08 0.87 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.754 1.621 . . . . 0.0 109.989 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -67.01 150.81 48.73 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.977 1.311 . . . . 0.0 111.415 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -135.57 165.66 25.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.602 1.961 . . . . 0.0 111.011 -172.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -135.11 135.3 41.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.388 1.075 . . . . 0.0 111.798 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.7 mtt -98.94 154.27 18.19 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.6 1.56 . . . . 0.0 108.881 168.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.6 t -142.48 147.39 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.162 0.985 . . . . 0.0 110.878 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -131.46 146.34 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.315 1.846 . . . . 0.0 108.828 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.26 139.79 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.324 1.05 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.16 158.98 43.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.878 1.671 . . . . 0.0 110.484 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.57 135.79 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.603 1.561 . . . . 0.0 108.678 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.05 129.44 41.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.126 0.97 . . . . 0.0 111.735 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.61 0.44 66.94 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.661 1.124 . . . . 0.0 114.694 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.58 132.44 56.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.335 1.454 . . . . 0.0 110.366 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -82.32 -12.93 57.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -171.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -90.05 155.76 18.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.913 1.285 . . . . 0.0 112.706 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.24 112.37 14.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.287 1.435 . . . . 0.0 108.759 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 149.26 30.38 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -148.98 147.39 28.53 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -168.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.34 176.42 29.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.917 1.722 . . . . 0.0 112.594 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.29 161.49 42.31 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.115 0.966 . . . . 0.0 112.076 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -168.63 -174.11 2.08 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.27 1.428 . . . . 0.0 111.836 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 p -75.31 -11.0 59.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.411 1.485 . . . . 0.0 113.347 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -150.08 151.52 33.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.409 1.483 . . . . 0.0 112.069 -169.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.57 -28.57 68.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -70.53 -50.41 37.92 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.844 0.857 . . . . 0.0 111.918 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.75 -29.65 63.5 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.572 -0.705 . . . . 0.0 112.182 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.14 89.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.671 -0.643 . . . . 0.0 111.941 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.25 -38.8 90.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.474 0.71 . . . . 0.0 112.037 172.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -65.24 -36.94 85.7 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.899 -0.501 . . . . 0.0 111.82 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -73.79 -35.13 64.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.69 0.796 . . . . 0.0 111.713 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.48 93.37 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.466 -0.772 . . . . 0.0 112.125 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.38 -48.04 81.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.886 0.874 . . . . 0.0 111.543 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -53.58 -42.26 67.43 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.33 1.052 . . . . 0.0 111.932 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.05 -35.7 69.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.965 0.906 . . . . 0.0 113.223 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -75.11 -37.23 61.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.631 -0.668 . . . . 0.0 112.54 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.58 -38.36 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.352 -0.842 . . . . 0.0 110.494 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -55.83 -46.98 78.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 119.347 -0.358 . . . . 0.0 111.925 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -56.18 -46.72 79.26 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.031 -1.043 . . . . 0.0 112.969 170.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.13 -33.89 75.32 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.93 -41.99 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.983 0.913 . . . . 0.0 111.193 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -67.3 -19.97 65.55 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.356 1.062 . . . . 0.0 113.394 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -103.89 6.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.967 1.307 . . . . 0.0 113.576 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 68.0 20.38 9.13 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.843 2.057 . . . . 0.0 114.566 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.96 -6.09 57.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.039 1.336 . . . . 0.0 113.036 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.75 138.7 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.055 2.142 . . . . 0.0 107.525 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -89.4 131.34 35.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.538 0.685 . . . . 0.0 110.615 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -59.55 -33.62 71.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -62.32 -17.73 59.56 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.514 1.126 . . . . 0.0 113.471 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.94 -16.74 31.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.349 1.06 . . . . 0.0 113.227 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.12 125.97 78.23 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.367 1.067 . . . . 0.0 111.368 -168.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.03 145.48 19.55 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.501 2.801 . . . . 0.0 111.379 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 128.1 34.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.902 0.881 . . . . 0.0 112.011 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.52 -15.4 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.823 1.649 . . . . 0.0 114.248 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.77 169.72 34.92 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.52 1.533 . . . . 0.0 113.017 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.98 136.66 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.963 1.705 . . . . 0.0 109.594 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -141.76 134.72 14.13 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.521 1.529 . . . . 0.0 109.213 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -58.44 159.38 19.88 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.916 3.078 . . . . 0.0 114.013 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.93 149.3 62.31 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.941 3.094 . . . . 0.0 113.022 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -70.54 -13.21 32.5 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.593 2.862 . . . . 0.0 113.201 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.7 p -82.4 -4.98 58.34 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.375 1.47 . . . . 0.0 113.565 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.73 173.94 53.9 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 125.232 1.396 . . . . 0.0 113.766 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.68 147.9 57.94 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.928 3.085 . . . . 0.0 111.449 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t -166.84 -53.38 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.48 1.112 . . . . 0.0 112.221 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.8 m -114.99 6.58 15.33 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.657 1.183 . . . . 0.0 113.479 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 126.781 2.134 . . . . 0.0 112.947 -178.424 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 17.6 m -77.16 -11.64 59.84 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 22.8 t -163.33 160.2 23.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.392 1.877 . . . . 0.0 110.284 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -81.74 -18.98 66.74 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.136 0.874 . . . . 0.0 113.888 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 t -169.97 179.54 3.56 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.366 1.466 . . . . 0.0 112.328 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.8 p -159.88 177.6 10.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.082 2.153 . . . . 0.0 110.097 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.69 -81.99 1.63 Allowed Glycine 0 C--N 1.343 0.922 0 C-N-CA 124.088 0.852 . . . . 0.0 112.617 -173.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp -81.24 -32.25 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -170.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -66.61 -41.47 88.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.843 0.857 . . . . 0.0 110.468 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -63.4 -38.54 91.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.0 112.278 170.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -65.46 -44.37 87.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.601 0.76 . . . . 0.0 111.799 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.21 -43.25 98.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.449 0.568 . . . . 0.0 111.365 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.4 -42.92 98.79 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.36 -39.05 78.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 112.56 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -60.96 -45.82 93.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.219 1.008 . . . . 0.0 111.308 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.5 m -58.34 -46.07 86.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 111.722 172.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.8 -27.01 73.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.368 0.985 . . . . 0.0 114.104 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.01 -8.23 57.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.556 1.143 . . . . 0.0 112.775 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.68 8.9 11.29 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.666 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 64.91 30.43 12.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.482 1.913 . . . . 0.0 113.71 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.0 mtm -117.69 173.69 6.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.724 2.01 . . . . 0.0 111.521 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 m -143.47 132.38 11.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.828 1.651 . . . . 0.0 108.885 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.46 152.48 30.08 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.066 2.51 . . . . 0.0 110.954 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.51 116.87 22.48 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.716 1.207 . . . . 0.0 110.801 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.74 156.95 17.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.465 1.506 . . . . 0.0 112.174 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -147.2 138.46 23.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.09 1.356 . . . . 0.0 110.185 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.88 148.88 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.999 1.32 . . . . 0.0 111.746 -168.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -138.5 136.43 36.12 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.222 1.809 . . . . 0.0 110.682 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.11 138.01 31.86 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.342 1.057 . . . . 0.0 111.063 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.91 162.49 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.295 1.438 . . . . 0.0 111.857 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.37 -172.61 47.22 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.83 1.205 . . . . 0.0 114.473 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -57.61 141.04 49.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.229 1.412 . . . . 0.0 112.066 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -62.5 -45.49 92.75 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -174.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -71.89 -27.51 62.89 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -118.43 48.58 1.4 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.823 2.049 . . . . 0.0 111.174 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -74.31 151.03 39.88 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.861 0.839 . . . . 0.0 113.057 -168.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.48 164.1 25.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.17 2.188 . . . . 0.0 110.734 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -134.02 124.15 25.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.866 1.267 . . . . 0.0 111.17 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 61.0 mtp -89.32 153.08 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 109.41 168.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 32.9 t -142.45 146.18 34.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.341 1.056 . . . . 0.0 111.042 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.548 1.939 . . . . 0.0 109.137 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -144.86 142.56 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.495 1.118 . . . . 0.0 111.726 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -137.49 160.27 39.59 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.056 2.142 . . . . 0.0 110.466 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.7 t -139.91 135.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.83 1.652 . . . . 0.0 108.297 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.38 129.54 42.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.002 0.921 . . . . 0.0 111.702 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.54 0.43 64.8 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.576 1.084 . . . . 0.0 114.73 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.32 129.28 52.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.205 1.402 . . . . 0.0 110.529 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.86 -22.29 50.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -71.64 156.31 39.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.665 1.186 . . . . 0.0 113.243 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.67 118.61 17.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.939 1.295 . . . . 0.0 109.573 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.1 150.4 23.83 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.4 ptm -148.75 151.65 35.21 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.52 177.98 29.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.916 1.722 . . . . 0.0 112.926 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -151.75 155.67 38.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.13 1.372 . . . . 0.0 110.691 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 t -166.99 -176.61 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.861 1.264 . . . . 0.0 112.428 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 p -76.92 -10.68 59.53 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.647 1.579 . . . . 0.0 113.292 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -150.25 151.77 33.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.273 1.429 . . . . 0.0 112.176 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.81 -27.65 68.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -71.75 -53.27 13.99 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.17 -31.65 71.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.161 0.584 . . . . 0.0 112.256 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.63 98.92 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.738 -0.601 . . . . 0.0 112.275 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -65.26 -41.32 94.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 m -60.27 -37.59 80.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.308 0.958 . . . . 0.0 112.555 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -73.71 -37.41 65.17 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.365 -0.835 . . . . 0.0 111.517 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.55 -42.93 98.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.762 0.825 . . . . 0.0 112.316 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.33 85.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.934 0.894 . . . . 0.0 111.454 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -56.87 -38.07 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.063 0.545 . . . . 0.0 112.445 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.47 -34.67 65.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.816 1.246 . . . . 0.0 112.86 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -73.38 -37.85 65.86 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.317 -0.864 . . . . 0.0 112.157 172.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.2 -35.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 121.52 -0.737 . . . . 0.0 110.973 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.24 87.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.229 0.612 . . . . 0.0 111.496 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.19 -45.15 89.6 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.897 -1.127 . . . . 0.0 112.391 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.5 mt -60.71 -34.22 74.06 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.17 -43.55 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.758 0.823 . . . . 0.0 111.241 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -65.43 -24.99 67.33 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.1 pt -97.86 5.63 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.392 1.077 . . . . 0.0 113.671 170.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 68.06 21.64 8.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.529 1.932 . . . . 0.0 114.433 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -91.47 -5.05 54.88 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 113.195 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 69' ' ' LEU . 90.2 t -137.24 137.95 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.176 2.19 . . . . 0.0 107.88 169.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.82 126.13 32.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.927 0.491 . . . . 0.0 109.898 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 p -55.3 -34.32 64.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.52 -15.35 57.65 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -91.26 -15.81 28.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.56 1.144 . . . . 0.0 113.126 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.42 123.25 86.87 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.055 0.942 . . . . 0.0 111.142 -169.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.59 150.11 14.69 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.504 2.803 . . . . 0.0 111.593 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.52 134.28 35.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.216 1.006 . . . . 0.0 111.181 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.03 -19.4 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.227 1.411 . . . . 0.0 114.123 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.77 151.88 18.1 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.218 1.866 . . . . 0.0 111.609 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.8 mt -129.65 124.72 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.069 1.348 . . . . 0.0 109.201 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -146.26 130.64 8.72 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 126.001 1.721 . . . . 0.0 108.432 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.6 156.76 53.43 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.174 2.583 . . . . 0.0 111.772 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -56.24 124.08 15.4 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.654 2.903 . . . . 0.0 112.521 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -82.75 161.62 16.38 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.671 2.914 . . . . 0.0 111.83 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 m -74.49 -3.49 31.08 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.16 -124.73 34.44 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.284 -1.287 . . . . 0.0 111.137 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.55 -11.68 17.05 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.295 2.663 . . . . 0.0 113.274 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.3 m -82.71 6.43 18.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.3 p -77.29 -10.7 59.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.884 1.274 . . . . 0.0 114.266 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 C-N-CA 125.341 1.448 . . . . 0.0 113.101 178.621 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 45.9 p -89.08 -9.97 49.15 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.1 t -163.61 151.24 12.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.685 1.594 . . . . 0.0 111.043 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -78.63 172.32 55.23 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.671 1.129 . . . . 0.0 113.898 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.5 p -159.63 174.51 14.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.492 1.517 . . . . 0.0 111.611 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 t -159.88 145.05 15.24 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.876 -1.14 . . . . 0.0 112.258 -172.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.3 64.46 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 124.119 0.866 . . . . 0.0 114.051 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp -77.11 -33.08 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.19 1.495 . . . . 0.0 112.3 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.1 -42.45 84.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.011 0.925 . . . . 0.0 110.343 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -67.76 -31.11 70.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.903 0.881 . . . . 0.0 112.977 171.556 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -67.74 -41.84 82.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.241 0.928 . . . . 0.0 111.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.26 -43.86 96.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.661 0.664 . . . . 0.0 111.081 173.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.59 -42.56 99.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.8 79.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.547 1.139 . . . . 0.0 112.782 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.83 -46.94 87.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.901 0.881 . . . . 0.0 111.407 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 m -57.55 -44.67 85.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.916 0.887 . . . . 0.0 111.937 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.18 -26.52 72.52 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.336 0.969 . . . . 0.0 114.001 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -77.92 -7.86 57.33 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.49 1.116 . . . . 0.0 112.785 172.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -119.44 8.91 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.261 2.224 . . . . 0.0 112.797 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 63.62 28.44 15.09 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.426 1.89 . . . . 0.0 113.58 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.36 172.51 6.87 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.865 2.066 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 m -140.73 129.22 12.7 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.207 1.803 . . . . 0.0 108.609 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.57 145.88 26.69 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.056 2.504 . . . . 0.0 110.753 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.15 115.49 26.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.57 1.148 . . . . 0.0 110.681 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -99.1 156.85 16.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.448 1.499 . . . . 0.0 112.221 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.98 149.06 32.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.338 1.455 . . . . 0.0 110.097 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.4 mt -131.93 146.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.652 1.581 . . . . 0.0 110.756 -169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 -145.11 134.2 22.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.56 1.544 . . . . 0.0 111.164 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.43 138.64 31.31 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.599 1.16 . . . . 0.0 111.618 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -148.61 155.33 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.346 1.458 . . . . 0.0 112.2 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.93 -157.46 28.44 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.525 1.059 . . . . 0.0 113.599 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -67.42 141.77 56.9 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.827 1.251 . . . . 0.0 112.674 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -63.92 -25.37 68.12 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -95.69 -50.18 5.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.768 1.227 . . . . 0.0 111.22 174.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -85.66 62.77 7.67 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.218 1.407 . . . . 0.0 110.113 173.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -69.12 143.35 54.18 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.816 1.646 . . . . 0.0 111.541 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -133.27 159.71 39.44 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.649 1.579 . . . . 0.0 110.943 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.94 130.69 39.91 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.338 1.055 . . . . 0.0 111.639 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.8 mtp -95.97 155.31 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.398 1.479 . . . . 0.0 108.822 167.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.5 t -142.27 149.77 40.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.251 1.021 . . . . 0.0 110.285 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.57 151.05 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.754 1.622 . . . . 0.0 109.861 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.78 142.23 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.687 1.195 . . . . 0.0 111.503 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -139.78 158.0 44.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.539 1.936 . . . . 0.0 110.066 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.77 135.5 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.443 1.497 . . . . 0.0 108.748 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.95 129.22 40.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 0.0 111.598 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.84 2.44 66.88 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.434 1.016 . . . . 0.0 114.482 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.95 127.28 44.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.451 1.5 . . . . 0.0 110.039 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -79.51 -11.52 59.89 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.3 155.8 29.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.506 1.122 . . . . 0.0 113.048 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.18 107.73 8.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 109.021 170.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.0 144.12 21.7 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ptm -149.11 152.84 36.85 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.01 -178.11 28.12 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.157 1.837 . . . . 0.0 112.663 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -154.9 162.58 41.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 112.877 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.5 t -168.59 -178.01 3.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.959 1.703 . . . . 0.0 111.154 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.4 m -74.63 -14.81 60.81 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.329 1.452 . . . . 0.0 112.139 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -138.97 146.83 41.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.628 1.571 . . . . 0.0 112.422 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.92 -28.22 67.31 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.24 -42.86 79.1 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.398 0.999 . . . . 0.0 112.014 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.81 -33.03 64.01 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.578 -0.701 . . . . 0.0 112.031 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.82 -46.01 89.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.825 -0.547 . . . . 0.0 111.674 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.29 -38.05 89.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.69 0.796 . . . . 0.0 112.271 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m -64.14 -38.39 90.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.729 0.695 . . . . 0.0 112.069 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -73.76 -37.19 65.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.377 0.671 . . . . 0.0 111.335 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.46 96.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.648 0.779 . . . . 0.0 112.381 170.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.36 77.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.005 0.922 . . . . 0.0 111.204 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -57.8 -40.26 79.51 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.916 0.486 . . . . 0.0 112.005 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.27 -32.37 70.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.35 -38.31 50.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.72 -0.613 . . . . 0.0 112.196 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -61.75 -41.29 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -59.87 -33.87 72.38 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 112.132 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -67.31 -44.43 79.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.054 -1.654 . . . . 0.0 112.03 169.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.94 -32.45 71.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.28 -44.7 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.002 0.921 . . . . 0.0 111.367 169.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -62.73 -22.66 66.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.29 8.12 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.799 1.239 . . . . 0.0 114.086 172.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 68.46 20.73 8.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.041 1.736 . . . . 0.0 114.321 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -93.19 -6.04 48.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.35 1.46 . . . . 0.0 113.298 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.53 139.27 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.887 2.075 . . . . 0.0 107.796 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -88.95 133.14 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.865 -0.522 . . . . 0.0 110.696 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -57.12 -35.39 69.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.09 -15.21 55.91 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -89.07 -17.5 29.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.359 1.063 . . . . 0.0 113.025 174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.23 123.78 85.88 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.055 0.942 . . . . 0.0 110.462 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -78.62 159.87 28.39 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.354 2.702 . . . . 0.0 112.581 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.69 170.54 20.63 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.503 1.921 . . . . 0.0 110.469 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.45 -21.02 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.228 1.411 . . . . 0.0 114.723 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.62 133.98 2.84 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.522 1.534 . . . . 0.0 111.653 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.5 mt -130.9 109.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.923 1.289 . . . . 0.0 108.976 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 m -151.98 149.07 22.63 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.84 2.056 . . . . 0.0 110.176 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.46 131.21 17.19 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.032 2.488 . . . . 0.0 110.287 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.96 140.1 22.56 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.978 2.452 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.58 -20.98 11.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.198 2.599 . . . . 0.0 113.054 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.4 t -170.47 162.32 8.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.613 1.965 . . . . 0.0 110.509 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.64 157.92 20.83 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.788 1.185 . . . . 0.0 113.635 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.82 143.01 26.08 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.798 2.999 . . . . 0.0 111.355 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.8 p -148.01 3.63 0.71 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.0 m -170.2 159.11 7.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.374 2.27 . . . . 0.0 110.631 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.848 179.314 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 29.0 m -124.39 7.21 8.36 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -170.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 19.5 m 68.48 -10.61 0.45 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 127.284 2.234 . . . . 0.0 116.029 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -85.42 150.45 24.59 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.279 1.419 . . . . 0.0 112.585 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.3 p -134.07 5.32 3.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.621 1.168 . . . . 0.0 113.935 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.7 m -75.82 104.68 6.47 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.77 -1.206 . . . . 0.0 111.49 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.1 -14.55 81.73 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 123.869 0.747 . . . . 0.0 114.928 -170.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -65.27 -31.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.803 1.302 . . . . 0.0 113.293 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.97 78.2 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.549 -0.719 . . . . 0.0 111.509 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -76.91 -29.55 55.76 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.911 0.885 . . . . 0.0 112.553 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.49 -45.35 83.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.94 -43.07 99.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.155 0.434 . . . . 0.0 111.371 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -62.55 -42.71 99.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.248 0.619 . . . . 0.0 112.628 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.34 -41.11 81.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.345 1.058 . . . . 0.0 112.449 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.83 -45.28 95.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.943 . . . . 0.0 111.66 174.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.04 -44.1 91.72 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.882 0.873 . . . . 0.0 111.877 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.55 73.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.611 1.101 . . . . 0.0 114.163 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.5 -8.08 58.16 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.467 1.134 . . . . 0.0 112.846 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -119.72 8.17 11.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.071 2.149 . . . . 0.0 112.912 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm 66.75 28.54 8.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.742 2.017 . . . . 0.0 113.617 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.9 mtm -116.71 172.15 7.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 111.627 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.3 m -142.55 130.47 11.4 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 126.185 1.794 . . . . 0.0 108.771 174.386 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.9 136.59 18.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.906 2.404 . . . . 0.0 110.339 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.14 114.59 27.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.499 1.12 . . . . 0.0 111.437 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.04 152.27 19.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.746 1.218 . . . . 0.0 112.867 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.54 148.34 40.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.307 1.843 . . . . 0.0 108.971 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.23 147.04 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.017 1.327 . . . . 0.0 111.653 -168.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -139.5 137.38 35.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.707 1.603 . . . . 0.0 110.975 176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.88 139.69 31.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.328 1.051 . . . . 0.0 111.338 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 m -146.84 176.78 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.33 1.852 . . . . 0.0 110.774 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.91 -149.74 19.27 Favored Glycine 0 N--CA 1.472 1.034 0 C-N-CA 124.339 0.971 . . . . 0.0 113.058 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -116.84 161.18 19.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.24 1.416 . . . . 0.0 112.364 -174.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -62.73 -21.31 65.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -96.86 -11.57 24.64 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.217 1.407 . . . . 0.0 113.648 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -159.3 98.57 1.43 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.943 1.697 . . . . 0.0 110.261 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -93.08 150.55 20.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.712 1.205 . . . . 0.0 111.062 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -138.08 167.03 22.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.216 2.207 . . . . 0.0 110.719 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.19 138.09 46.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.126 1.37 . . . . 0.0 111.203 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.6 mtm -103.38 153.85 20.03 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.094 1.757 . . . . 0.0 109.386 169.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 t -144.19 146.28 32.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.385 1.074 . . . . 0.0 111.886 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.38 136.8 50.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.546 1.938 . . . . 0.0 108.827 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.16 135.78 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.215 1.006 . . . . 0.0 111.657 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.94 153.37 42.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.11 135.61 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.645 1.578 . . . . 0.0 108.546 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.08 139.3 57.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.108 0.963 . . . . 0.0 112.06 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.69 -4.07 86.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.768 1.175 . . . . 0.0 114.916 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -117.72 133.01 56.39 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.895 1.347 . . . . 0.0 111.136 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -81.55 -16.03 52.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -83.42 157.55 22.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.69 1.196 . . . . 0.0 112.393 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.43 129.14 32.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.689 1.195 . . . . 0.0 109.856 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.23 144.5 28.44 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.4 mtm -134.7 135.46 42.02 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.802 1.241 . . . . 0.0 111.486 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.24 173.41 28.26 Favored Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.984 1.278 . . . . 0.0 113.259 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -154.6 160.32 41.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.433 1.093 . . . . 0.0 111.873 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -169.04 -173.6 1.83 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.418 1.487 . . . . 0.0 111.815 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -74.09 -12.49 60.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.525 1.53 . . . . 0.0 113.436 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.67 151.74 34.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.476 1.511 . . . . 0.0 111.822 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.56 -29.63 70.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.16 -46.63 41.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.082 0.953 . . . . 0.0 112.066 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.65 -28.45 60.86 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.492 -0.755 . . . . 0.0 112.05 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.89 89.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.657 -0.652 . . . . 0.0 111.756 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.1 -40.62 94.41 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.393 0.677 . . . . 0.0 111.872 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 m -64.22 -37.38 87.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.576 0.625 . . . . 0.0 112.057 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -72.83 -36.26 67.46 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.552 -0.717 . . . . 0.0 111.598 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.72 94.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.888 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.95 82.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 111.461 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -56.9 -41.29 77.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.302 0.501 . . . . 0.0 111.794 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -28.14 66.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -80.87 -37.71 29.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.703 0.683 . . . . 0.0 112.672 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.58 -40.54 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.961 0.8 . . . . 0.0 110.534 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -55.14 -47.51 74.97 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 170.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.18 -44.07 92.17 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.112 -0.993 . . . . 0.0 112.59 173.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.38 -35.9 80.61 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.51 -42.73 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.687 0.795 . . . . 0.0 111.071 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -66.36 -13.4 60.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.8 pt -114.04 9.92 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.21 1.404 . . . . 0.0 113.252 170.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 m120 67.23 17.52 10.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.507 1.923 . . . . 0.0 114.592 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.9 -11.09 57.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.242 1.417 . . . . 0.0 113.139 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -134.35 138.07 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.546 1.938 . . . . 0.0 107.923 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.72 126.13 32.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.826 0.451 . . . . 0.0 109.929 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.17 -33.04 62.63 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.38 61.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.943 1.297 . . . . 0.0 113.579 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -91.66 -16.51 26.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.627 1.171 . . . . 0.0 113.304 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -77.5 126.07 85.2 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.213 1.005 . . . . 0.0 110.871 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.26 150.98 37.85 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.299 2.666 . . . . 0.0 111.962 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.79 156.88 43.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.509 1.524 . . . . 0.0 111.688 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -14.98 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -174.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.85 177.0 47.73 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.084 1.326 . . . . 0.0 113.477 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.23 141.14 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.191 1.797 . . . . 0.0 109.846 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 m -140.4 150.58 61.49 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.093 1.757 . . . . 0.0 110.948 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.99 164.16 36.34 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.433 2.755 . . . . 0.0 111.81 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.28 145.88 85.08 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.797 2.998 . . . . 0.0 112.481 175.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -57.7 -23.62 58.71 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.679 2.919 . . . . 0.0 114.905 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 m -78.02 -7.23 56.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.423 1.089 . . . . 0.0 113.84 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.59 45.65 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 125.15 1.357 . . . . 0.0 113.825 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -66.26 -33.7 38.39 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.7 2.933 . . . . 0.0 114.006 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m 66.85 -9.78 0.34 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 127.307 2.243 . . . . 0.0 115.507 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.9 p -165.01 166.07 19.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.464 1.905 . . . . 0.0 111.695 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.251 -1.305 . . . . 0.0 112.887 179.627 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 8.7 t -163.69 175.43 10.58 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.636 1.574 . . . . 0.0 110.949 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.4 t -161.84 154.61 20.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.492 1.517 . . . . 0.0 111.572 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -89.45 165.75 32.71 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.938 1.256 . . . . 0.0 113.625 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.1 t -162.38 156.49 21.37 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.287 1.435 . . . . 0.0 111.234 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -169.2 140.57 2.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.972 1.709 . . . . 0.0 110.367 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.32 -38.5 81.27 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.183 -0.787 . . . . 0.0 113.817 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 tp -77.13 -34.5 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.843 1.321 . . . . 0.0 112.247 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.74 -43.28 84.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.167 0.987 . . . . 0.0 110.313 174.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.94 -31.82 72.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 112.821 172.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.49 -42.91 77.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.994 0.815 . . . . 0.0 111.734 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.71 -42.88 99.87 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.626 0.648 . . . . 0.0 111.234 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -63.01 -42.28 99.79 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.05 -40.22 78.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.484 1.114 . . . . 0.0 112.434 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -60.42 -45.64 92.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.952 0.901 . . . . 0.0 111.456 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.7 m -58.05 -45.43 87.05 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.648 0.779 . . . . 0.0 111.758 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.81 -26.82 73.12 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.491 1.043 . . . . 0.0 114.145 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -78.92 -7.5 58.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.545 1.173 . . . . 0.0 112.876 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.55 9.21 11.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.166 2.187 . . . . 0.0 112.709 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.98 31.45 11.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.451 1.9 . . . . 0.0 113.549 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.3 mtm -119.79 172.83 7.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.804 2.041 . . . . 0.0 111.56 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.94 131.04 11.26 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.26 1.824 . . . . 0.0 108.755 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.82 147.37 24.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.954 2.436 . . . . 0.0 110.734 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.93 117.35 27.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.648 1.179 . . . . 0.0 110.761 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.3 156.52 17.19 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.328 1.451 . . . . 0.0 112.343 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.22 149.65 33.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.102 1.361 . . . . 0.0 110.318 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -134.26 147.89 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.566 1.547 . . . . 0.0 111.867 -168.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -135.44 138.3 43.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.773 1.629 . . . . 0.0 110.792 170.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.93 145.67 35.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.754 0.822 . . . . 0.0 111.622 171.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 m -148.28 172.27 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.875 2.07 . . . . 0.0 110.456 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.46 176.64 50.48 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.092 0.853 . . . . 0.0 113.894 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.37 163.07 20.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.356 1.062 . . . . 0.0 112.988 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -58.17 -36.43 73.02 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.322 1.449 . . . . 0.0 114.148 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -70.68 -28.09 64.5 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -150.37 90.39 1.65 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.978 1.711 . . . . 0.0 110.238 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -78.94 148.12 32.77 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.191 0.996 . . . . 0.0 110.703 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -132.57 166.17 22.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.754 2.021 . . . . 0.0 110.905 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -135.46 131.78 36.58 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.906 1.282 . . . . 0.0 111.343 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 mtm -99.17 152.14 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.612 1.565 . . . . 0.0 108.937 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -146.06 147.71 31.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 111.515 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.88 156.19 44.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.331 1.452 . . . . 0.0 110.757 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.48 143.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.892 1.277 . . . . 0.0 111.254 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -138.08 157.68 45.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.246 1.818 . . . . 0.0 110.688 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -140.62 135.92 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.851 1.661 . . . . 0.0 108.319 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.15 129.38 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.101 0.96 . . . . 0.0 111.731 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.95 0.62 65.97 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.653 1.12 . . . . 0.0 114.715 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -119.29 131.06 55.7 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.228 1.411 . . . . 0.0 110.631 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -77.85 -24.76 48.51 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -75.11 155.93 36.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.287 1.035 . . . . 0.0 113.144 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.44 114.22 15.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.261 1.424 . . . . 0.0 108.669 169.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.49 143.89 25.11 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mtp -137.98 146.64 43.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.28 177.67 31.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.789 1.662 . . . . 0.0 112.895 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -155.67 159.2 39.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.492 1.117 . . . . 0.0 111.981 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -169.2 -179.44 3.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.134 1.374 . . . . 0.0 112.083 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 m -78.64 -13.13 59.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.395 1.478 . . . . 0.0 112.101 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.21 142.89 47.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.238 1.415 . . . . 0.0 111.628 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.98 -30.81 71.86 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -69.85 -42.25 73.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.359 -0.838 . . . . 0.0 111.543 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.72 -29.46 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.456 0.702 . . . . 0.0 112.03 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.94 90.11 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.636 -0.665 . . . . 0.0 111.817 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -62.81 -39.13 93.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.509 0.724 . . . . 0.0 111.775 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.9 m -63.19 -36.42 83.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.558 0.617 . . . . 0.0 112.27 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -75.38 -34.11 61.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 111.749 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.08 91.48 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.523 -0.735 . . . . 0.0 111.924 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.81 83.18 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.29 1.036 . . . . 0.0 111.686 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -52.48 -44.4 65.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.337 1.055 . . . . 0.0 111.647 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.63 -35.98 70.61 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -73.41 -37.33 65.95 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.406 0.548 . . . . 0.0 112.428 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.05 -43.15 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.357 -0.84 . . . . 0.0 110.169 171.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -61.73 -33.68 74.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -63.9 -45.8 87.7 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.062 -1.649 . . . . 0.0 111.882 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.414 ' HB3' HG23 ' A' ' 75' ' ' VAL . 91.7 mt -61.89 -33.84 74.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.531 0.732 . . . . 0.0 112.735 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.01 -43.89 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.842 0.857 . . . . 0.0 111.291 170.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -63.78 -21.1 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -106.03 6.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.794 1.238 . . . . 0.0 113.959 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 70.53 16.03 7.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.829 2.052 . . . . 0.0 114.82 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.25 -6.72 58.46 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.356 1.462 . . . . 0.0 113.364 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 69' ' ' LEU . 74.5 t -135.05 137.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.058 2.143 . . . . 0.0 107.473 168.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -86.47 128.37 34.95 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.994 -0.441 . . . . 0.0 110.165 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.9 p -53.52 -33.13 53.39 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.12 -20.71 62.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.702 1.601 . . . . 0.0 113.339 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -88.37 -17.84 29.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 113.091 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.38 127.13 85.37 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.329 1.052 . . . . 0.0 110.258 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.79 144.08 38.4 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.128 2.552 . . . . 0.0 111.46 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.89 163.89 39.29 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.513 1.525 . . . . 0.0 111.406 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.63 -15.88 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.469 1.507 . . . . 0.0 114.711 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -178.82 175.37 47.3 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.988 1.756 . . . . 0.0 112.323 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.8 mt -85.84 111.8 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 m -146.45 151.97 44.74 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 126.106 1.763 . . . . 0.0 111.098 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.95 158.53 56.39 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.31 2.673 . . . . 0.0 111.318 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.3 148.11 67.34 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.37 2.713 . . . . 0.0 111.641 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.92 163.52 33.17 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.899 3.066 . . . . 0.0 112.404 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 t -159.4 151.85 21.3 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.449 1.5 . . . . 0.0 110.659 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.38 -152.15 37.39 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 118.976 -0.902 . . . . 0.0 112.314 -172.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -56.78 148.06 68.39 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.331 3.354 . . . . 0.0 113.214 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 m -73.83 -5.24 39.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.9 m -146.23 145.83 30.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.03 1.732 . . . . 0.0 111.238 -175.199 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.88 178.893 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 76.7 p -164.56 165.15 21.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.297 1.439 . . . . 0.0 111.748 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 17.3 m -164.72 157.49 16.68 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.563 1.945 . . . . 0.0 110.665 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -176.29 162.08 30.69 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.994 0.807 . . . . 0.0 114.041 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.2 t -168.16 -161.52 0.37 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.807 2.043 . . . . 0.0 109.757 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.2 p -152.59 169.28 23.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.029 1.332 . . . . 0.0 112.484 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.68 -33.37 84.17 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 121.614 -0.679 . . . . 0.0 112.898 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.3 tp -79.03 -34.45 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.56 1.18 . . . . 0.0 112.268 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -60.82 -46.18 91.55 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.463 0.705 . . . . 0.0 111.162 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -64.46 -36.49 84.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.335 0.654 . . . . 0.0 112.346 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.21 -45.31 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.741 0.7 . . . . 0.0 111.87 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.92 -43.22 96.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.66 0.664 . . . . 0.0 111.246 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -63.66 -43.02 97.95 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.0 88.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.901 0.88 . . . . 0.0 112.568 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -61.55 -45.52 93.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.769 0.827 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.36 -45.93 90.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.706 0.802 . . . . 0.0 111.751 172.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.56 -27.11 73.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.419 1.009 . . . . 0.0 113.963 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.14 -8.84 58.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.389 1.094 . . . . 0.0 112.715 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.63 8.83 11.31 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.248 2.219 . . . . 0.0 112.656 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 64.95 32.58 10.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.536 1.935 . . . . 0.0 113.547 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.1 mtm -120.46 171.73 8.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.741 2.016 . . . . 0.0 111.735 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -142.71 130.53 11.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 126.192 1.797 . . . . 0.0 109.011 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 145.22 23.27 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.151 2.567 . . . . 0.0 110.903 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.34 129.52 49.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.912 1.285 . . . . 0.0 111.046 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -114.72 160.1 19.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.997 1.319 . . . . 0.0 113.484 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.6 144.21 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.162 1.785 . . . . 0.0 109.075 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -130.03 144.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.596 1.558 . . . . 0.0 109.649 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.7 ttm105 -143.9 129.9 19.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 111.458 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.72 137.19 34.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.024 0.93 . . . . 0.0 111.721 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -146.35 176.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 126.537 1.935 . . . . 0.0 110.616 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.4 -146.28 18.89 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.011 0.815 . . . . 0.0 112.666 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -116.1 164.39 14.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.018 1.327 . . . . 0.0 112.32 -174.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -61.84 -38.95 90.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.107 0.963 . . . . 0.0 113.104 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -80.17 -25.02 39.96 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.946 1.298 . . . . 0.0 114.349 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -142.93 87.06 1.96 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.504 1.921 . . . . 0.0 109.955 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -91.0 149.64 21.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.733 1.213 . . . . 0.0 110.853 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -136.77 164.3 28.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.729 2.012 . . . . 0.0 110.754 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.89 125.3 28.02 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.93 1.292 . . . . 0.0 111.126 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.1 mtp -89.47 155.35 19.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.055 1.342 . . . . 0.0 108.951 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.6 t -143.43 147.82 35.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.956 0.903 . . . . 0.0 111.536 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -129.12 145.12 51.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.302 1.841 . . . . 0.0 108.884 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.53 142.78 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.655 1.182 . . . . 0.0 111.439 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -137.88 157.15 47.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.656 1.982 . . . . 0.0 110.67 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.64 135.36 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.079 1.752 . . . . 0.0 108.282 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.82 129.6 42.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.146 0.978 . . . . 0.0 111.766 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 0.9 65.42 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.588 1.089 . . . . 0.0 114.762 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.23 132.09 54.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.65 -14.87 50.86 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.74 155.84 25.29 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.657 1.183 . . . . 0.0 112.675 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.26 120.14 25.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.847 1.259 . . . . 0.0 109.284 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 140.87 24.76 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.0 mtt -135.17 142.53 46.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.42 172.07 27.09 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 125.782 1.658 . . . . 0.0 113.35 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -158.32 149.69 21.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.776 1.23 . . . . 0.0 111.392 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.57 179.84 4.7 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.796 1.238 . . . . 0.0 112.703 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.5 p -78.51 -8.84 58.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.88 1.672 . . . . 0.0 112.999 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -137.87 142.75 40.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.661 1.584 . . . . 0.0 111.373 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.39 -42.34 95.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 113.231 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -66.96 -37.53 84.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.76 -29.71 58.9 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.475 -0.766 . . . . 0.0 111.834 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.1 -44.44 79.99 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.688 -0.632 . . . . 0.0 111.413 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.56 -39.07 86.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 112.031 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 m -67.25 -34.58 77.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.805 0.73 . . . . 0.0 112.413 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -71.72 -38.52 70.48 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.531 -0.731 . . . . 0.0 111.72 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.59 92.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.587 0.631 . . . . 0.0 111.644 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.23 82.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.346 1.058 . . . . 0.0 111.544 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -58.35 -39.48 79.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.202 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.35 -29.52 62.7 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.197 0.908 . . . . 0.0 113.2 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.38 -39.71 62.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.443 -0.786 . . . . 0.0 111.863 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.45 -40.93 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.49 -0.756 . . . . 0.0 110.761 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.44 -50.62 71.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.739 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.35 -41.41 63.02 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.086 1.312 . . . . 0.0 113.731 172.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.36 -22.52 66.98 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.7 -38.12 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.507 1.049 . . . . 0.0 110.726 168.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -59.74 -29.54 68.22 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.974 0.91 . . . . 0.0 112.35 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.63 4.93 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.047 1.339 . . . . 0.0 114.339 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 69.73 16.29 7.92 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.699 2.0 . . . . 0.0 115.162 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -83.91 -8.98 59.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.35 1.46 . . . . 0.0 113.392 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.96 141.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.792 2.037 . . . . 0.0 108.259 168.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.82 129.82 36.15 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.484 0.713 . . . . 0.0 110.218 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.6 p -55.26 -32.61 62.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.16 -19.38 53.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.837 1.255 . . . . 0.0 113.613 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -90.51 -16.77 28.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.645 1.178 . . . . 0.0 113.41 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.8 t -79.8 126.25 80.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.399 1.079 . . . . 0.0 110.851 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.24 155.57 32.98 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.448 2.765 . . . . 0.0 112.537 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.65 165.67 34.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.121 1.768 . . . . 0.0 111.218 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -18.58 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 125.314 1.446 . . . . 0.0 114.51 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.38 156.47 28.27 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.965 1.745 . . . . 0.0 111.879 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.1 mp -83.26 96.55 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 p -165.93 139.75 3.61 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 126.402 1.881 . . . . 0.0 110.018 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.84 150.87 75.03 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.296 2.664 . . . . 0.0 112.873 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.21 151.37 60.69 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.351 2.701 . . . . 0.0 111.39 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.24 144.86 37.86 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.664 2.909 . . . . 0.0 111.672 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.9 m -80.48 -3.86 51.59 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.34 157.43 44.48 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 124.663 1.125 . . . . 0.0 113.589 -177.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.36 161.64 37.41 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.077 3.185 . . . . 0.0 111.543 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.0 m -64.79 -12.31 46.39 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.1 m -80.6 -7.98 59.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.386 1.474 . . . . 0.0 113.946 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 CA-C-O 118.247 -1.307 . . . . 0.0 113.465 -179.562 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 10.2 m -77.01 -12.69 59.97 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 70.4 m -144.79 153.67 41.89 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.81 1.644 . . . . 0.0 111.066 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -78.59 -7.51 88.05 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.204 0.907 . . . . 0.0 115.013 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.0 t -165.91 176.42 7.86 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.597 1.959 . . . . 0.0 110.656 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 t -158.79 127.81 5.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.699 1.599 . . . . 0.0 110.133 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.86 -80.72 1.33 Allowed Glycine 0 C--N 1.341 0.847 0 C-N-CA 124.803 1.192 . . . . 0.0 112.784 -170.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp -75.49 -36.55 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -169.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -40.65 88.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.931 0.892 . . . . 0.0 110.587 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.94 -36.4 84.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.439 1.496 . . . . 0.0 112.258 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -70.33 -41.41 73.26 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.926 0.891 . . . . 0.0 112.106 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.2 tp -62.64 -43.48 98.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.917 0.781 . . . . 0.0 111.143 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.59 -43.75 98.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.12 0.568 . . . . 0.0 112.52 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.85 88.29 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.167 0.987 . . . . 0.0 112.779 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.85 -45.8 92.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.139 0.976 . . . . 0.0 111.525 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.3 m -58.41 -45.33 88.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.542 0.737 . . . . 0.0 111.708 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.05 -26.12 73.32 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.355 0.979 . . . . 0.0 114.159 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.18 -8.68 58.6 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.498 1.149 . . . . 0.0 112.819 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -119.72 9.53 11.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.203 2.201 . . . . 0.0 112.669 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.02 29.66 12.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.408 1.883 . . . . 0.0 113.648 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.3 mtm -116.77 172.42 7.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.708 2.003 . . . . 0.0 111.547 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 m -141.96 130.72 12.07 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.116 1.766 . . . . 0.0 108.752 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.39 146.23 24.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.988 2.459 . . . . 0.0 110.578 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.56 114.8 23.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.597 1.159 . . . . 0.0 110.806 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.13 156.95 16.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.444 1.498 . . . . 0.0 112.287 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -146.47 151.74 37.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.598 1.559 . . . . 0.0 109.805 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.42 139.87 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 0.0 111.299 -169.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -122.52 154.01 38.43 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.264 2.626 . . . . 0.0 109.662 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.52 141.38 48.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.466 1.107 . . . . 0.0 111.55 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.1 m -149.56 176.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.132 1.773 . . . . 0.0 111.102 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.78 -142.33 15.99 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 124.355 0.978 . . . . 0.0 112.427 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -128.47 165.45 20.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.516 1.526 . . . . 0.0 111.863 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -59.23 -34.57 72.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.135 0.974 . . . . 0.0 113.467 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -97.47 2.64 50.52 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.15 1.78 . . . . 0.0 113.726 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -153.62 72.84 0.93 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.288 1.835 . . . . 0.0 109.695 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -75.97 138.55 41.02 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.068 0.947 . . . . 0.0 110.848 -174.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -142.8 162.36 35.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 125.482 1.513 . . . . 0.0 111.061 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.75 149.72 49.26 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.836 1.255 . . . . 0.0 111.842 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.2 mtp -118.66 155.05 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.688 1.995 . . . . 0.0 109.081 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.31 154.78 40.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.574 0.75 . . . . 0.0 111.271 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.12 144.85 31.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.243 1.817 . . . . 0.0 109.475 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.24 142.21 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.2 1.0 . . . . 0.0 111.821 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -136.31 160.14 39.62 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.657 1.983 . . . . 0.0 110.482 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.59 136.11 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.746 1.618 . . . . 0.0 108.435 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.45 129.57 42.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 111.674 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.24 1.38 66.88 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.612 1.101 . . . . 0.0 114.601 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -124.08 131.47 53.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.334 1.454 . . . . 0.0 110.437 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -81.87 -12.14 58.6 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -83.77 157.06 22.23 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.461 1.104 . . . . 0.0 113.228 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.35 112.87 13.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.906 1.282 . . . . 0.0 109.348 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.44 142.38 23.81 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.43 148.91 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.5 170.09 26.26 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.116 1.817 . . . . 0.0 113.594 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -155.93 150.69 26.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.573 1.149 . . . . 0.0 112.001 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -168.87 -174.62 2.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.897 1.279 . . . . 0.0 112.381 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 p -77.04 -13.19 59.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.659 1.584 . . . . 0.0 113.407 173.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -148.26 152.33 36.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 112.286 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.08 -29.02 68.68 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.78 -51.45 33.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.339 -0.851 . . . . 0.0 111.369 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.61 -28.89 64.11 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.664 -0.648 . . . . 0.0 112.675 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.2 99.34 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.503 -0.748 . . . . 0.0 111.804 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -64.23 -40.33 95.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.31 0.644 . . . . 0.0 111.899 172.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -61.39 -35.92 78.84 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.277 0.944 . . . . 0.0 112.735 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.77 -37.34 67.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.232 -0.918 . . . . 0.0 111.905 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -44.78 90.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.741 0.701 . . . . 0.0 111.625 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.86 83.98 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.46 1.104 . . . . 0.0 111.537 173.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -54.58 -43.85 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 111.682 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.11 -29.29 62.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.119 0.872 . . . . 0.0 113.348 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.39 -38.09 50.64 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.462 -0.774 . . . . 0.0 112.154 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.98 -40.58 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.271 -0.893 . . . . 0.0 110.43 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -56.52 -49.12 75.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.411 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.87 -41.84 64.69 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.384 1.447 . . . . 0.0 113.767 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.1 -22.63 67.01 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.95 -38.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.511 1.05 . . . . 0.0 110.799 168.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -59.8 -29.69 68.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.302 1.041 . . . . 0.0 112.431 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -105.5 5.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.993 1.317 . . . . 0.0 114.344 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 68.69 17.11 8.94 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.481 1.912 . . . . 0.0 115.041 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.69 -13.57 58.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.374 1.469 . . . . 0.0 113.376 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -137.87 139.69 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 108.888 171.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -85.09 133.64 34.22 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -54.89 -33.95 62.53 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.333 -0.854 . . . . 0.0 113.084 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.96 -21.81 33.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.193 1.397 . . . . 0.0 113.923 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.61 -16.55 28.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.353 1.061 . . . . 0.0 113.514 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.4 124.06 84.22 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.281 1.033 . . . . 0.0 111.098 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.05 126.58 7.16 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.281 2.654 . . . . 0.0 109.79 174.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.95 130.06 11.9 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.996 0.919 . . . . 0.0 112.023 -175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -9.78 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.172 1.389 . . . . 0.0 113.2 173.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.15 -158.47 30.83 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.899 1.714 . . . . 0.0 112.491 -176.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.1 mm -104.8 132.43 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.261 1.424 . . . . 0.0 109.532 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.02 133.16 13.07 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.735 1.614 . . . . 0.0 110.256 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -88.35 153.03 6.64 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.126 2.551 . . . . 0.0 112.486 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.48 169.51 20.95 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.833 3.022 . . . . 0.0 110.819 169.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.48 128.53 28.23 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.112 3.208 . . . . 0.0 112.043 171.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.2 t -168.54 179.87 4.15 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.323 1.449 . . . . 0.0 111.21 -171.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.74 -159.8 26.03 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.303 1.43 . . . . 0.0 113.464 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.64 154.24 37.94 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.553 3.502 . . . . 0.0 113.787 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.5 m -75.71 19.66 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.883 1.673 . . . . 0.0 114.739 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.6 m 70.28 6.2 5.68 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.206 2.202 . . . . 0.0 114.829 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.613 1.577 . . . . 0.0 112.876 178.078 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 17.9 m -162.1 150.15 14.67 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.51 1.924 . . . . 0.0 110.495 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 65.1 p -124.8 7.38 8.11 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.849 1.26 . . . . 0.0 114.233 -170.33 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -86.05 -150.31 15.02 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.293 1.425 . . . . 0.0 113.44 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m -72.52 3.22 5.13 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -173.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -58.53 -10.97 2.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.726 2.01 . . . . 0.0 115.515 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.98 -22.74 67.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.411 1.005 . . . . 0.0 113.889 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.2 tp -72.2 -31.59 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.341 1.57 . . . . 0.0 112.664 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -43.75 76.79 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.336 1.054 . . . . 0.0 109.991 174.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -65.76 -32.42 73.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.536 0.734 . . . . 0.0 112.68 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -69.47 -43.01 74.09 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.532 -0.73 . . . . 0.0 112.006 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.8 -43.69 98.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.717 0.69 . . . . 0.0 110.992 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.13 -43.16 99.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.214 0.606 . . . . 0.0 112.63 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.91 83.88 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 112.678 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -61.87 -45.21 94.75 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.951 0.9 . . . . 0.0 111.596 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.2 m -58.62 -45.05 90.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.688 0.795 . . . . 0.0 111.591 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.05 73.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.503 1.049 . . . . 0.0 114.134 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.41 -9.22 58.74 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.425 1.113 . . . . 0.0 112.744 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.327 2.251 . . . . 0.0 112.688 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 64.95 29.58 12.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.456 1.902 . . . . 0.0 113.672 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.2 mtm -116.14 172.21 7.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.799 2.04 . . . . 0.0 111.443 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.5 m -143.04 130.54 10.96 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 126.062 1.745 . . . . 0.0 109.03 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.8 144.19 24.32 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.965 2.443 . . . . 0.0 110.68 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.85 119.72 34.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.861 1.264 . . . . 0.0 110.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.83 157.68 16.92 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.147 1.379 . . . . 0.0 112.783 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.23 146.07 30.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.865 1.666 . . . . 0.0 109.557 172.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.88 146.78 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.112 1.365 . . . . 0.0 110.983 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -134.98 140.53 45.76 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.772 2.029 . . . . 0.0 110.255 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.4 138.08 31.86 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.404 1.081 . . . . 0.0 110.996 172.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.49 -179.88 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.412 1.885 . . . . 0.0 110.63 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.74 -146.95 18.4 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.084 0.85 . . . . 0.0 112.899 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -116.43 163.21 16.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.066 1.346 . . . . 0.0 112.702 -172.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -62.22 -37.67 86.26 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.177 0.991 . . . . 0.0 113.336 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -80.94 -24.64 38.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.089 1.356 . . . . 0.0 114.294 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -145.75 89.74 1.93 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.38 1.872 . . . . 0.0 110.201 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -83.83 152.08 24.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.662 1.185 . . . . 0.0 110.812 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -139.09 167.18 22.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.889 2.076 . . . . 0.0 110.784 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.0 145.4 48.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.878 1.271 . . . . 0.0 111.497 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.1 mtp -116.97 154.84 30.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.229 1.812 . . . . 0.0 109.583 171.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.6 t -145.12 146.53 31.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.335 1.054 . . . . 0.0 111.722 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -125.7 146.96 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.402 1.881 . . . . 0.0 109.187 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.0 142.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.278 1.031 . . . . 0.0 111.669 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.97 159.29 42.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.409 1.883 . . . . 0.0 110.701 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.25 135.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.953 1.701 . . . . 0.0 108.209 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.66 130.02 44.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.082 0.953 . . . . 0.0 111.784 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.1 0.29 65.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.612 1.101 . . . . 0.0 114.822 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -120.72 135.35 55.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.235 1.414 . . . . 0.0 110.845 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -83.2 -11.69 57.61 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -82.98 159.66 22.18 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.762 1.225 . . . . 0.0 113.02 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.02 119.28 17.73 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.861 1.264 . . . . 0.0 109.504 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 139.29 22.21 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 84.3 mtp -129.36 140.43 51.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.954 0.902 . . . . 0.0 112.577 -170.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.14 165.89 28.97 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.132 1.348 . . . . 0.0 113.686 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.69 153.68 25.14 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.61 1.164 . . . . 0.0 112.581 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.6 t -169.59 -169.97 0.99 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.536 1.534 . . . . 0.0 111.541 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -73.47 -12.03 60.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.71 1.604 . . . . 0.0 113.613 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.64 157.36 42.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.291 1.436 . . . . 0.0 112.443 -170.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.62 -30.8 71.57 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.9 -49.25 47.95 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.39 -0.818 . . . . 0.0 111.888 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -68.37 -30.71 69.71 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.101 0.56 . . . . 0.0 112.311 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.66 86.17 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.19 -0.943 . . . . 0.0 111.612 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.71 -40.09 91.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.792 0.837 . . . . 0.0 112.727 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 99.3 p -69.65 -31.64 69.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.705 1.139 . . . . 0.0 112.371 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -69.04 -41.16 78.03 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.792 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.3 93.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.549 0.613 . . . . 0.0 111.714 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.91 79.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.237 1.015 . . . . 0.0 111.768 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -56.65 -40.4 75.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.669 -0.681 . . . . 0.0 112.008 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.92 -30.48 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.408 1.004 . . . . 0.0 113.216 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -75.53 -39.07 58.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.373 -0.829 . . . . 0.0 112.005 171.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.83 -42.37 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.496 -0.752 . . . . 0.0 110.407 172.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -57.51 -48.31 79.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.865 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -52.95 -42.67 65.68 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.517 1.508 . . . . 0.0 113.39 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.83 -21.23 66.46 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.171 -0.956 . . . . 0.0 113.537 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -81.5 -38.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.604 1.162 . . . . 0.0 110.873 168.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -59.1 -30.67 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.326 1.05 . . . . 0.0 112.143 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.4 pt -106.84 5.55 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.967 1.307 . . . . 0.0 114.387 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 67.17 16.98 10.32 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.504 1.922 . . . . 0.0 115.045 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -79.41 -12.78 59.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 113.264 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.6 t -132.56 134.59 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.53 1.932 . . . . 0.0 107.691 168.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -79.54 131.93 36.16 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.185 -0.322 . . . . 0.0 110.148 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.16 -34.54 63.89 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.439 -0.788 . . . . 0.0 112.883 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.25 -22.4 29.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.313 1.445 . . . . 0.0 113.909 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.05 -16.73 27.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.418 1.087 . . . . 0.0 113.312 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.91 127.65 83.34 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.236 1.014 . . . . 0.0 110.63 -169.454 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.09 113.61 3.82 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.739 2.293 . . . . 0.0 109.769 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.44 166.44 27.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.789 1.635 . . . . 0.0 111.235 -174.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -14.45 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.777 1.231 . . . . 0.0 113.671 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.63 162.98 36.34 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.585 1.564 . . . . 0.0 112.622 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.1 mm -110.51 136.28 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.38 1.472 . . . . 0.0 109.648 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -140.96 136.22 15.97 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.826 1.65 . . . . 0.0 108.846 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.4 155.51 16.23 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.197 3.265 . . . . 0.0 113.886 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -63.43 141.44 80.98 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.246 2.631 . . . . 0.0 111.194 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.71 144.32 35.11 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.446 2.764 . . . . 0.0 112.402 -170.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.4 t -166.7 165.61 16.38 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.181 1.793 . . . . 0.0 110.599 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.32 -163.76 43.24 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 124.418 1.009 . . . . 0.0 113.674 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.04 158.38 45.83 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.941 3.094 . . . . 0.0 112.031 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.7 m -66.48 138.85 57.83 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.57 1.148 . . . . 0.0 113.184 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.5 m -69.55 146.03 52.14 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.265 1.026 . . . . 0.0 112.946 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.2 0 CA-C-O 118.415 -1.214 . . . . 0.0 112.826 178.503 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 19.8 m -83.23 -6.03 59.33 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 85.1 p -162.92 170.64 17.84 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.938 1.695 . . . . 0.0 111.555 -175.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 94.32 -152.54 20.68 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.689 1.137 . . . . 0.0 112.724 -176.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 m 71.92 -4.73 1.87 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.934 2.093 . . . . 0.0 115.026 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 m -164.98 117.96 1.23 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.088 2.155 . . . . 0.0 109.74 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.88 -7.96 80.19 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 123.919 0.771 . . . . 0.0 114.774 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -64.88 -32.35 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.681 1.24 . . . . 0.0 113.891 -173.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -33.37 73.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.593 -0.692 . . . . 0.0 111.743 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -79.54 -28.67 41.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.981 0.912 . . . . 0.0 112.484 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -65.68 -44.56 85.84 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.987 0.915 . . . . 0.0 111.709 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.6 -42.81 98.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.317 0.508 . . . . 0.0 111.276 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.38 -42.76 99.67 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.14 77.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 112.707 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 81.6 t90 -60.84 -47.59 85.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.035 0.934 . . . . 0.0 111.316 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.73 -45.46 85.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.013 0.925 . . . . 0.0 112.021 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.1 72.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.28 0.943 . . . . 0.0 113.986 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.9 -7.25 58.64 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.506 1.122 . . . . 0.0 112.79 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -119.58 9.14 11.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.304 2.242 . . . . 0.0 112.64 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.74 31.45 11.86 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.452 1.901 . . . . 0.0 113.515 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.6 mtm -119.35 172.32 7.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.71 2.004 . . . . 0.0 111.643 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.2 m -141.97 129.36 11.49 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 126.227 1.811 . . . . 0.0 108.668 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.91 141.65 21.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.905 2.404 . . . . 0.0 110.588 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.13 117.23 30.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.602 1.161 . . . . 0.0 110.697 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.66 157.43 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.996 1.318 . . . . 0.0 112.672 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.6 149.67 33.98 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.506 1.523 . . . . 0.0 109.907 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.4 mt -132.64 145.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.632 1.573 . . . . 0.0 110.799 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 -145.25 133.5 21.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.21 1.404 . . . . 0.0 111.45 -171.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.53 137.38 32.39 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.784 1.234 . . . . 0.0 111.323 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -149.32 165.48 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.657 1.583 . . . . 0.0 111.397 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.49 -132.99 11.32 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.978 0.799 . . . . 0.0 112.208 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -116.61 156.32 27.23 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.314 1.445 . . . . 0.0 112.3 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -56.51 -44.2 80.52 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.549 1.14 . . . . 0.0 113.181 177.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.14 -28.24 27.57 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.038 1.335 . . . . 0.0 113.252 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.39 81.48 1.76 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.491 1.516 . . . . 0.0 110.264 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -71.49 148.99 46.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.253 1.421 . . . . 0.0 111.409 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -144.15 153.89 42.59 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.2 2.2 . . . . 0.0 109.957 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -127.48 124.17 37.7 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.244 1.018 . . . . 0.0 111.883 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.4 mtp -89.49 155.16 19.48 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.756 1.222 . . . . 0.0 109.085 167.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.23 149.97 40.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.268 1.027 . . . . 0.0 110.149 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.74 153.02 51.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.528 1.531 . . . . 0.0 110.123 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.66 141.81 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.022 1.329 . . . . 0.0 111.228 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.97 153.74 49.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.072 1.749 . . . . 0.0 110.486 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -141.66 134.85 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.798 1.639 . . . . 0.0 108.557 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.59 129.68 42.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.015 0.926 . . . . 0.0 111.649 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.89 65.11 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.566 1.079 . . . . 0.0 114.742 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.22 130.88 54.73 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.182 1.393 . . . . 0.0 110.529 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -76.6 -25.75 54.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -79.21 155.45 28.6 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.338 1.055 . . . . 0.0 113.083 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.78 109.85 11.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.396 1.478 . . . . 0.0 108.603 170.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.82 149.24 26.66 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.1 ptm -151.19 151.94 32.6 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.0 179.67 25.63 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.52 2.009 . . . . 0.0 112.818 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -151.86 155.22 37.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.964 1.306 . . . . 0.0 111.455 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -168.04 -176.09 2.88 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.403 1.481 . . . . 0.0 112.149 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.1 m -79.93 -22.97 42.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.377 1.471 . . . . 0.0 111.471 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -119.6 142.96 47.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.069 1.348 . . . . 0.0 111.391 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -61.59 -30.66 70.82 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -74.32 -42.57 59.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.037 . . . . 0.0 112.541 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.49 -34.05 75.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.795 0.838 . . . . 0.0 111.693 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.74 80.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.417 0.687 . . . . 0.0 111.625 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.13 -41.14 92.02 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.623 0.769 . . . . 0.0 111.995 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.9 m -63.98 -37.69 88.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.661 0.664 . . . . 0.0 111.927 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.55 -37.07 68.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.429 -0.794 . . . . 0.0 111.955 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.41 98.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.781 0.833 . . . . 0.0 112.376 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.24 -49.04 78.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.878 0.871 . . . . 0.0 111.123 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -57.32 -38.05 73.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.2 -38.48 69.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.623 1.169 . . . . 0.0 112.885 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -72.16 -37.72 69.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.831 0.741 . . . . 0.0 112.169 174.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.49 -36.91 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.531 -0.73 . . . . 0.0 110.84 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -49.86 75.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.402 171.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -54.76 -42.94 72.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.224 -0.923 . . . . 0.0 113.086 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.9 mt -63.02 -27.65 69.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.68 -40.41 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.294 0.952 . . . . 0.0 111.049 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -61.96 -30.94 71.26 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -96.91 4.91 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.457 1.103 . . . . 0.0 113.836 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 70.73 18.1 6.36 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.888 2.075 . . . . 0.0 114.625 173.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.74 -6.47 55.99 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.481 1.512 . . . . 0.0 113.363 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 69' ' ' LEU . 94.7 t -136.68 139.26 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 127.011 2.125 . . . . 0.0 107.893 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.21 127.61 34.77 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.073 0.549 . . . . 0.0 110.068 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 p -54.72 -33.9 61.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.83 -19.13 59.27 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.044 1.337 . . . . 0.0 113.689 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.33 -16.43 27.5 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.543 1.137 . . . . 0.0 113.341 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.79 123.76 87.55 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.197 0.999 . . . . 0.0 111.119 -169.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.37 150.66 19.8 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.492 2.795 . . . . 0.0 111.614 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.59 167.22 30.28 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.406 1.482 . . . . 0.0 111.555 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.65 -13.94 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 126.054 1.741 . . . . 0.0 115.444 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.9 136.28 9.18 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.378 1.466 . . . . 0.0 112.346 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.9 mt -133.62 135.98 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.736 1.615 . . . . 0.0 109.361 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.1 t -134.56 110.73 11.39 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.302 1.441 . . . . 0.0 108.307 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -61.21 144.56 98.94 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.445 2.763 . . . . 0.0 112.88 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.65 131.53 20.16 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.22 2.613 . . . . 0.0 110.612 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.74 -19.44 24.03 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.171 2.581 . . . . 0.0 113.016 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.5 p -89.6 -1.41 58.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.696 1.598 . . . . 0.0 113.37 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.52 164.99 39.78 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 125.642 1.592 . . . . 0.0 113.483 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.93 133.3 24.93 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.601 2.868 . . . . 0.0 110.79 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.4 p -168.31 165.3 12.94 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.388 1.475 . . . . 0.0 111.844 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.2 p -162.08 163.45 28.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.176 1.39 . . . . 0.0 111.945 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 C-N-CA 124.928 1.251 . . . . 0.0 112.928 -178.962 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 42.6 p -92.71 -15.31 26.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 61.5 p -110.28 -3.19 16.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.884 1.673 . . . . 0.0 113.71 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 166.6 -176.97 41.62 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.221 1.867 . . . . 0.0 112.248 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.5 p -72.89 -73.91 0.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.895 -0.768 . . . . 0.0 112.374 -175.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.3 p -90.7 -4.38 56.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.801 1.64 . . . . 0.0 113.705 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.45 8.32 71.07 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.71 1.148 . . . . 0.0 113.523 -169.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.7 -29.11 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.108 1.363 . . . . 0.0 113.951 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -57.92 -51.51 69.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.377 1.071 . . . . 0.0 110.559 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.62 -26.94 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 112.744 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.47 -46.9 78.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.915 0.78 . . . . 0.0 111.518 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.8 tp -63.11 -41.86 99.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.138 0.426 . . . . 0.0 111.219 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -62.91 -42.35 99.76 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.56 73.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.328 1.051 . . . . 0.0 112.625 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -61.07 -46.52 90.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.893 0.877 . . . . 0.0 111.224 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.3 m -58.31 -45.91 87.12 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.657 0.783 . . . . 0.0 111.718 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.38 73.2 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.345 0.974 . . . . 0.0 114.092 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -79.56 -6.38 56.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.358 1.079 . . . . 0.0 112.915 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -119.53 9.29 11.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.301 2.24 . . . . 0.0 112.577 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.82 30.97 12.0 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.501 1.92 . . . . 0.0 113.59 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -118.93 172.53 7.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.718 2.007 . . . . 0.0 111.562 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 m -141.69 130.81 12.37 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.158 1.783 . . . . 0.0 108.557 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.16 146.68 25.55 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.967 2.445 . . . . 0.0 110.806 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.79 116.89 28.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.738 1.215 . . . . 0.0 110.576 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -99.89 157.62 16.39 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 112.372 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.39 150.36 34.52 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.318 1.447 . . . . 0.0 110.053 172.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.1 mt -138.53 145.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.228 1.411 . . . . 0.0 111.288 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -139.16 135.1 33.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.742 1.617 . . . . 0.0 111.046 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.52 137.77 33.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.259 1.023 . . . . 0.0 111.378 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -144.28 176.15 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 126.086 1.754 . . . . 0.0 110.843 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.32 -150.04 20.6 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.297 0.951 . . . . 0.0 112.537 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -116.89 168.16 10.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.092 1.357 . . . . 0.0 112.231 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -54.46 -45.07 73.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.859 1.264 . . . . 0.0 113.589 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -79.59 -29.03 41.06 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -130.33 78.53 1.85 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.966 2.107 . . . . 0.0 109.897 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -94.24 145.35 24.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.505 1.122 . . . . 0.0 110.721 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -137.59 168.66 19.22 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.868 2.067 . . . . 0.0 111.2 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -134.8 124.08 24.57 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.2 1.4 . . . . 0.0 111.233 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.8 mtp -89.11 154.74 19.93 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.166 1.387 . . . . 0.0 109.395 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.9 t -143.84 145.05 32.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.224 1.01 . . . . 0.0 111.766 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -121.86 151.8 40.26 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.321 1.848 . . . . 0.0 109.563 170.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.74 141.2 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.994 . . . . 0.0 111.242 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -140.45 158.05 44.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.28 1.832 . . . . 0.0 110.404 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.86 135.44 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.551 1.54 . . . . 0.0 108.66 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.08 129.97 44.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 111.606 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.27 65.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.622 1.105 . . . . 0.0 114.604 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -123.86 128.36 49.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.278 1.431 . . . . 0.0 110.351 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -76.63 -22.76 53.67 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.04 155.98 39.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.583 1.153 . . . . 0.0 113.269 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.34 117.74 18.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.342 1.457 . . . . 0.0 109.232 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.39 141.66 21.48 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtt -136.06 144.04 44.99 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.79 173.0 28.86 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.83 1.681 . . . . 0.0 113.501 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -158.78 148.94 19.57 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.84 1.256 . . . . 0.0 111.337 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.4 t -168.15 178.86 4.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.725 1.21 . . . . 0.0 112.868 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 m -78.79 -8.66 58.98 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.756 1.623 . . . . 0.0 112.442 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -142.14 153.69 44.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.051 1.34 . . . . 0.0 112.229 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -67.1 -30.25 70.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -73.15 -41.99 63.32 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.169 0.895 . . . . 0.0 112.495 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.09 -29.48 61.88 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.602 -0.687 . . . . 0.0 111.858 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.66 85.88 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.548 -0.72 . . . . 0.0 111.692 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -63.38 -38.04 89.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.833 0.853 . . . . 0.0 112.252 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 m -63.2 -38.74 92.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.731 0.696 . . . . 0.0 111.565 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -69.26 -41.32 77.08 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.39 -0.819 . . . . 0.0 111.791 174.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.65 98.26 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.715 0.689 . . . . 0.0 112.055 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.95 76.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.28 1.032 . . . . 0.0 111.492 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -58.33 -37.07 74.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.971 -0.538 . . . . 0.0 112.431 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.88 -36.67 67.39 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.955 1.302 . . . . 0.0 112.835 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -70.21 -39.78 74.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.929 0.786 . . . . 0.0 111.821 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.83 -36.26 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.637 -0.664 . . . . 0.0 110.961 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -40.52 89.2 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.204 0.601 . . . . 0.0 111.347 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.62 -44.39 90.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.097 -1.002 . . . . 0.0 112.14 171.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.4 mt -60.78 -34.91 75.2 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.49 -43.56 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.65 0.78 . . . . 0.0 111.221 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -65.16 -24.66 67.45 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.34 5.54 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.411 1.084 . . . . 0.0 113.623 171.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 71.35 17.31 5.88 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.898 2.079 . . . . 0.0 114.586 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -90.1 -5.09 56.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.203 1.401 . . . . 0.0 113.396 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 69' ' ' LEU . 96.3 t -137.54 139.33 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.148 2.179 . . . . 0.0 107.826 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -87.13 129.18 35.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.82 0.448 . . . . 0.0 110.779 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 p -59.14 -30.15 67.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.25 -0.906 . . . . 0.0 113.357 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.54 -23.29 57.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.369 1.068 . . . . 0.0 113.417 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -90.13 -16.31 29.84 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.55 1.14 . . . . 0.0 113.482 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.06 124.42 86.01 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 124.102 0.961 . . . . 0.0 111.545 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.62 143.07 16.63 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.447 2.765 . . . . 0.0 111.379 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.09 153.45 33.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.237 1.415 . . . . 0.0 111.225 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -16.68 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 125.005 1.322 . . . . 0.0 114.171 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.54 158.92 31.51 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.219 1.866 . . . . 0.0 111.945 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.6 mt -129.13 130.43 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.151 1.381 . . . . 0.0 109.272 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.93 134.0 11.91 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 125.883 1.673 . . . . 0.0 108.727 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.51 151.61 52.87 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.607 2.871 . . . . 0.0 113.655 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.31 145.33 88.05 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.764 2.976 . . . . 0.0 113.077 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -57.1 149.7 61.33 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.024 3.149 . . . . 0.0 113.521 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.2 m -84.92 2.29 43.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.73 -179.29 52.83 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.138 1.351 . . . . 0.0 113.79 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.86 -6.23 15.84 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.245 3.297 . . . . 0.0 113.964 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.5 p -163.11 -39.33 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.012 1.325 . . . . 0.0 112.5 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 t -160.79 -176.21 5.4 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.322 1.849 . . . . 0.0 110.741 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 C-N-CA 125.399 1.476 . . . . 0.0 112.843 -179.515 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 8.6 t -163.17 172.79 14.31 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.554 1.542 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 54.6 p -165.03 156.89 15.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.574 1.55 . . . . 0.0 112.373 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -84.29 172.23 48.87 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.408 1.004 . . . . 0.0 112.912 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.2 m -73.1 -11.89 60.7 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.6 p -163.22 166.67 23.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.208 1.803 . . . . 0.0 110.987 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.86 1.52 88.66 Favored Glycine 0 N--CA 1.472 1.083 0 C-N-CA 124.217 0.913 . . . . 0.0 115.217 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp -64.29 -31.05 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.221 1.51 . . . . 0.0 113.99 -172.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -68.01 -40.61 82.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.827 0.851 . . . . 0.0 111.199 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.988 0.915 . . . . 0.0 112.606 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.91 -43.88 91.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.885 0.874 . . . . 0.0 111.286 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.4 tp -63.14 -42.09 99.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.485 0.584 . . . . 0.0 111.714 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -62.86 -42.5 99.78 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -38.31 77.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.486 1.114 . . . . 0.0 112.54 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -61.64 -43.32 99.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.552 1.141 . . . . 0.0 111.801 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 99.2 m -61.95 -43.23 99.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.353 1.061 . . . . 0.0 111.868 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.56 -25.23 72.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.487 1.042 . . . . 0.0 114.032 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -78.22 -7.08 56.69 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.358 1.079 . . . . 0.0 112.744 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -119.65 7.47 11.08 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.471 2.308 . . . . 0.0 112.619 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.87 28.47 14.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.416 1.886 . . . . 0.0 113.371 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.9 mtm -112.17 171.94 7.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.758 2.023 . . . . 0.0 111.583 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.5 m -140.86 129.87 12.82 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 126.324 1.85 . . . . 0.0 108.664 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.6 140.58 21.37 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.971 2.447 . . . . 0.0 110.588 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.91 118.05 32.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.582 1.153 . . . . 0.0 110.853 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -101.13 159.37 15.29 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.991 1.316 . . . . 0.0 112.954 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.09 149.23 32.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.405 1.482 . . . . 0.0 110.152 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.74 147.07 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.549 1.539 . . . . 0.0 111.54 -169.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -134.96 138.96 44.53 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.56 1.944 . . . . 0.0 110.285 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.66 137.32 32.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.433 1.093 . . . . 0.0 111.423 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.21 -174.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 126.911 2.085 . . . . 0.0 110.138 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 -147.1 18.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.097 0.856 . . . . 0.0 112.983 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -116.82 162.13 18.21 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.084 1.353 . . . . 0.0 112.436 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -62.1 -35.92 80.16 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.236 -0.915 . . . . 0.0 112.944 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -75.92 -24.16 55.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.038 1.335 . . . . 0.0 113.722 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -154.42 97.27 2.0 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.702 1.601 . . . . 0.0 110.277 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -78.2 148.51 33.99 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.235 1.014 . . . . 0.0 110.499 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -135.56 165.35 25.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.476 1.911 . . . . 0.0 111.003 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -135.69 134.06 38.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.377 1.071 . . . . 0.0 112.071 -173.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.2 mtp -102.45 153.47 20.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.581 1.553 . . . . 0.0 108.938 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -148.19 149.25 31.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 111.322 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.8 159.64 40.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.092 1.357 . . . . 0.0 111.073 170.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.95 143.03 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.419 1.487 . . . . 0.0 111.0 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -137.42 155.54 49.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.05 1.74 . . . . 0.0 110.878 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.47 134.32 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.965 1.706 . . . . 0.0 108.461 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.75 128.7 37.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.115 0.966 . . . . 0.0 111.977 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.17 1.21 67.17 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.765 1.174 . . . . 0.0 115.0 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.15 140.74 45.44 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.001 1.32 . . . . 0.0 111.273 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -85.3 0.83 50.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -120.1 155.79 32.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.696 1.599 . . . . 0.0 112.898 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.96 110.3 13.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.358 1.463 . . . . 0.0 108.894 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.06 146.94 29.88 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.6 ptp -150.48 148.44 28.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.35 -179.25 27.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.36 1.934 . . . . 0.0 112.772 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -154.24 160.9 42.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 112.102 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 t -168.32 -179.65 4.07 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.37 1.468 . . . . 0.0 111.844 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.6 m -80.38 -6.56 58.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.23 1.412 . . . . 0.0 112.277 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -142.4 152.05 42.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.203 1.401 . . . . 0.0 112.224 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.48 -27.1 68.25 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.62 -52.51 17.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.773 0.829 . . . . 0.0 111.538 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.66 -27.28 64.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.762 0.825 . . . . 0.0 112.252 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.17 95.82 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.833 -0.542 . . . . 0.0 111.754 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.48 -40.01 92.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.386 0.675 . . . . 0.0 111.93 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.0 m -60.81 -37.12 80.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.407 1.003 . . . . 0.0 112.442 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -74.33 -37.28 63.6 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.278 -0.889 . . . . 0.0 111.657 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.2 99.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.632 0.773 . . . . 0.0 112.361 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.06 81.82 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.199 0.999 . . . . 0.0 111.546 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -56.59 -42.08 78.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.109 0.564 . . . . 0.0 111.819 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.05 -30.92 69.36 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -77.17 -37.41 53.78 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.628 -0.67 . . . . 0.0 112.422 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.72 -39.88 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.268 -0.895 . . . . 0.0 110.836 173.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -56.18 -46.15 79.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.122 0.569 . . . . 0.0 111.47 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.5 -43.56 89.09 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.951 -1.093 . . . . 0.0 113.062 170.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.54 -35.01 79.09 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.955 0.798 . . . . 0.0 113.059 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.62 -41.99 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.575 0.75 . . . . 0.0 111.091 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -66.89 -16.02 64.04 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.31 7.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 125.152 1.381 . . . . 0.0 113.398 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.4 t30 68.12 21.09 8.79 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.676 1.99 . . . . 0.0 114.381 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -86.0 -8.66 57.8 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.806 1.242 . . . . 0.0 113.348 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.09 139.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.167 1.787 . . . . 0.0 108.282 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -87.74 130.12 34.94 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.9 p -54.27 -33.78 59.36 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.26 -0.9 . . . . 0.0 113.131 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.38 -21.28 49.62 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.45 1.5 . . . . 0.0 113.955 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -90.19 -16.84 28.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.498 1.119 . . . . 0.0 113.308 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.79 122.75 87.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.979 0.912 . . . . 0.0 110.913 -169.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.64 141.44 15.52 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.316 2.677 . . . . 0.0 111.099 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.78 161.27 41.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.498 1.519 . . . . 0.0 111.141 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -67.4 -17.05 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -177.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.3 -162.19 34.14 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.285 1.421 . . . . 0.0 113.863 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.6 mt -125.04 145.35 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.194 1.797 . . . . 0.0 108.226 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t 81.4 132.3 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 129.026 2.931 . . . . 0.0 110.578 -175.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -56.7 156.91 21.01 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.977 3.118 . . . . 0.0 114.279 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.57 131.06 41.83 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.001 3.134 . . . . 0.0 113.099 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.64 160.86 25.0 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.888 3.059 . . . . 0.0 112.205 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.7 m -91.73 0.32 57.5 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.38 -176.43 49.69 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.185 1.374 . . . . 0.0 114.084 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.37 150.75 57.13 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.588 3.526 . . . . 0.0 113.304 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 p -81.24 -4.08 54.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.719 1.208 . . . . 0.0 114.195 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.7 m -166.21 152.43 9.03 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 127.38 2.272 . . . . 0.0 110.769 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.823 -179.882 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 8.9 m -164.15 156.64 17.18 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.551 1.94 . . . . 0.0 110.653 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.0 t -162.9 179.06 7.87 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.263 1.425 . . . . 0.0 111.343 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 93.92 -178.14 37.43 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.677 1.608 . . . . 0.0 113.272 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 86.0 p -163.08 167.24 22.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.825 1.25 . . . . 0.0 112.509 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m -150.96 47.54 0.85 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.385 1.474 . . . . 0.0 110.259 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.2 -29.38 75.18 Favored Glycine 0 N--CA 1.473 1.108 0 O-C-N 121.026 -1.047 . . . . 0.0 114.68 -168.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.4 tp -79.23 -30.03 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 118.214 1.007 . . . . 0.0 112.584 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.36 -44.14 84.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.989 0.915 . . . . 0.0 110.081 170.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -65.74 -31.33 72.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.962 0.905 . . . . 0.0 112.784 172.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -66.75 -44.62 80.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.973 0.806 . . . . 0.0 111.678 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.86 -42.69 99.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.453 0.57 . . . . 0.0 111.245 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.04 -43.05 99.73 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.78 82.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.261 1.024 . . . . 0.0 112.419 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -59.89 -45.96 90.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.263 1.025 . . . . 0.0 111.514 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.8 m -58.01 -44.81 87.48 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.599 0.76 . . . . 0.0 111.778 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.88 73.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.443 1.02 . . . . 0.0 114.145 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -79.03 -7.25 57.94 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.481 1.141 . . . . 0.0 112.9 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.63 8.73 11.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.041 2.136 . . . . 0.0 112.755 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.42 31.15 12.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.406 1.883 . . . . 0.0 113.499 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -117.98 171.77 7.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.716 2.007 . . . . 0.0 111.536 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -140.44 130.71 13.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.24 1.816 . . . . 0.0 108.682 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.18 150.46 29.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.196 2.597 . . . . 0.0 110.953 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.34 115.66 24.0 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.588 1.155 . . . . 0.0 111.05 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.5 158.24 16.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.44 1.496 . . . . 0.0 112.703 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -147.22 145.15 29.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.955 1.702 . . . . 0.0 109.581 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.72 147.13 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.266 1.426 . . . . 0.0 110.849 -169.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -137.53 137.19 38.35 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.194 1.798 . . . . 0.0 110.777 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.67 137.22 32.52 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.444 1.098 . . . . 0.0 110.916 175.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -147.02 171.74 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.501 1.52 . . . . 0.0 111.533 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.71 179.91 51.31 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.438 1.018 . . . . 0.0 114.34 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.59 139.65 58.46 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.427 1.091 . . . . 0.0 112.144 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -53.27 -38.03 62.69 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.271 1.428 . . . . 0.0 114.356 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -74.39 -16.63 60.88 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.659 1.183 . . . . 0.0 114.105 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -149.46 67.38 1.01 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.536 1.534 . . . . 0.0 110.13 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -68.96 151.68 46.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.248 1.419 . . . . 0.0 111.727 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -136.23 166.14 24.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.598 1.959 . . . . 0.0 111.141 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.09 137.68 43.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.791 1.236 . . . . 0.0 111.535 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.9 mtp -106.86 155.05 20.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.173 1.789 . . . . 0.0 109.379 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.5 t -147.19 148.87 31.96 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.918 0.887 . . . . 0.0 112.047 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -129.33 151.58 49.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.396 1.879 . . . . 0.0 109.719 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.91 142.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.68 1.192 . . . . 0.0 111.62 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.73 162.25 34.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.242 1.817 . . . . 0.0 110.431 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -139.33 136.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.637 1.575 . . . . 0.0 108.521 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.68 129.29 40.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.208 1.003 . . . . 0.0 111.776 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.24 -0.17 66.01 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.63 1.109 . . . . 0.0 114.806 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.05 140.55 48.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 110.963 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.65 -0.49 50.86 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -112.83 160.37 18.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.703 1.601 . . . . 0.0 113.214 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.92 116.58 14.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.202 1.401 . . . . 0.0 109.412 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.99 149.78 25.69 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -146.64 150.49 35.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.19 175.0 33.31 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.571 1.558 . . . . 0.0 113.491 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.96 154.11 25.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 112.403 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -168.13 -173.72 2.12 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.362 . . . . 0.0 112.025 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.8 p -75.79 -10.34 59.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.5 1.52 . . . . 0.0 113.482 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -150.93 151.62 32.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.271 1.428 . . . . 0.0 111.925 -170.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.26 -30.27 70.67 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -68.25 -48.14 65.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.796 0.839 . . . . 0.0 112.045 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.47 -29.33 59.57 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.778 -0.576 . . . . 0.0 112.327 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.75 88.75 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.42 -0.8 . . . . 0.0 111.837 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -64.36 -38.17 90.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.407 0.683 . . . . 0.0 112.044 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.7 m -64.69 -35.75 82.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.787 0.721 . . . . 0.0 112.278 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -71.48 -39.99 70.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.226 -0.921 . . . . 0.0 111.709 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.93 99.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.652 0.66 . . . . 0.0 111.856 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.11 -49.44 75.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 111.559 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -56.35 -37.89 70.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.105 0.562 . . . . 0.0 112.354 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.9 -35.63 64.68 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.965 1.306 . . . . 0.0 112.737 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -72.55 -37.31 68.29 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.357 -0.839 . . . . 0.0 112.009 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.52 -37.1 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.465 -0.772 . . . . 0.0 110.87 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -40.88 89.32 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.232 0.613 . . . . 0.0 111.423 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -62.95 -45.7 91.2 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.052 -1.03 . . . . 0.0 112.488 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.7 -34.51 74.47 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.91 -42.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.69 0.796 . . . . 0.0 111.237 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -64.68 -26.03 68.2 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 pt -97.55 5.33 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.304 1.042 . . . . 0.0 113.67 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 71.02 17.37 6.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.957 2.103 . . . . 0.0 114.574 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -89.66 -5.33 57.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.248 1.419 . . . . 0.0 113.431 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.41 140.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 127.277 2.231 . . . . 0.0 107.844 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -86.86 130.61 34.4 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.88 -0.513 . . . . 0.0 110.293 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 p -53.57 -34.68 59.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.746 0.818 . . . . 0.0 112.905 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.04 -27.56 8.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.367 1.867 . . . . 0.0 114.022 175.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -93.4 -15.47 25.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.611 1.164 . . . . 0.0 113.549 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.57 123.61 87.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.139 0.976 . . . . 0.0 111.12 -169.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.27 143.48 17.58 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.452 2.768 . . . . 0.0 111.305 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.51 162.33 41.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.327 1.451 . . . . 0.0 111.513 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -13.22 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.872 1.269 . . . . 0.0 113.816 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -167.77 177.65 42.0 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.824 1.678 . . . . 0.0 112.562 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.1 mt -124.56 124.48 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.301 1.44 . . . . 0.0 108.76 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.6 t -146.34 136.43 11.99 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.854 1.662 . . . . 0.0 108.772 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.17 159.42 15.39 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.8 3.0 . . . . 0.0 113.904 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.12 140.92 80.75 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.921 3.081 . . . . 0.0 112.98 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.45 148.55 43.05 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.548 2.832 . . . . 0.0 112.031 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 t -164.62 158.0 17.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.759 1.624 . . . . 0.0 110.779 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.91 -148.86 32.22 Favored Glycine 0 CA--C 1.542 1.726 0 CA-C-O 118.8 -1.0 . . . . 0.0 112.657 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -55.89 149.76 49.72 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.514 3.476 . . . . 0.0 113.413 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.2 t -162.21 -179.76 7.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.16 1.384 . . . . 0.0 111.529 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.5 m -66.41 139.17 57.98 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.168 1.387 . . . . 0.0 113.156 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.982 1.277 . . . . 0.0 112.802 178.697 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 90.0 p -164.65 173.21 12.18 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.32 1.448 . . . . 0.0 111.686 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.0 m -78.47 9.93 3.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.665 1.186 . . . . 0.0 114.048 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -77.11 38.34 1.56 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.237 1.875 . . . . 0.0 114.157 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.4 m -71.3 -18.06 62.43 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.955 1.302 . . . . 0.0 114.202 -172.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 t -156.71 146.65 20.98 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.804 1.642 . . . . 0.0 110.642 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.2 2.34 65.6 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.916 1.246 . . . . 0.0 114.358 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.16 -32.39 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.384 1.592 . . . . 0.0 114.388 -171.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -37.13 82.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.531 -0.731 . . . . 0.0 111.627 177.131 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -78.75 -27.5 44.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.221 1.009 . . . . 0.0 112.49 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.6 -43.93 92.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 111.515 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.28 -43.53 98.61 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.464 0.575 . . . . 0.0 111.345 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -63.36 -42.56 98.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.374 0.67 . . . . 0.0 112.806 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.24 -39.31 78.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 112.451 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -61.05 -45.68 93.8 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.94 0.896 . . . . 0.0 111.342 173.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -58.06 -46.37 85.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.483 0.713 . . . . 0.0 111.669 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.93 73.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.396 0.998 . . . . 0.0 114.157 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -77.69 -8.27 57.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.476 1.11 . . . . 0.0 112.747 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -119.55 8.19 11.25 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.332 2.253 . . . . 0.0 112.769 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm 66.41 28.33 9.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.674 1.989 . . . . 0.0 113.705 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 mtm -116.05 173.45 6.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.666 1.986 . . . . 0.0 111.618 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.0 m -142.79 132.0 11.82 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 126.109 1.764 . . . . 0.0 108.696 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.35 154.58 32.05 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.04 2.494 . . . . 0.0 110.908 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.75 115.8 20.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.656 1.183 . . . . 0.0 110.564 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.23 158.37 16.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.63 1.572 . . . . 0.0 112.292 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.65 148.5 32.12 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.716 1.607 . . . . 0.0 109.927 171.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.7 mt -136.19 145.31 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.23 1.412 . . . . 0.0 111.449 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -133.67 139.04 46.21 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.485 1.914 . . . . 0.0 110.278 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.86 136.49 33.11 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.486 1.114 . . . . 0.0 110.767 172.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -145.39 176.31 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 125.691 1.597 . . . . 0.0 111.138 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.93 -170.04 37.44 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.213 0.911 . . . . 0.0 114.126 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -74.05 148.17 42.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.546 1.138 . . . . 0.0 112.565 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -65.44 -21.13 66.62 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -87.62 -19.11 28.22 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.716 1.206 . . . . 0.0 113.572 175.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -157.96 93.12 1.23 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.796 1.638 . . . . 0.0 110.166 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -83.85 166.02 18.28 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.539 1.136 . . . . 0.0 112.895 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -139.58 167.96 20.91 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.601 2.36 . . . . 0.0 110.715 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.94 137.66 49.38 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.954 1.301 . . . . 0.0 111.127 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtp -108.55 153.88 22.74 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.881 1.672 . . . . 0.0 109.389 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.18 147.44 32.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.096 0.958 . . . . 0.0 111.84 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -129.29 147.02 51.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.78 2.032 . . . . 0.0 108.774 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.52 143.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.792 0.837 . . . . 0.0 112.294 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.5 mtm105 -138.69 165.26 27.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.676 1.99 . . . . 0.0 110.707 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.57 137.14 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.806 1.642 . . . . 0.0 108.209 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -58.28 129.03 40.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.021 0.928 . . . . 0.0 111.579 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 0.74 65.42 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.662 1.125 . . . . 0.0 114.618 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -124.0 129.59 51.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.295 1.438 . . . . 0.0 110.381 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -83.66 -11.99 56.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -74.25 157.32 36.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.5 1.12 . . . . 0.0 112.69 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.99 119.39 17.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 170.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.87 143.74 22.46 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.7 mtm -138.81 141.65 38.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.281 1.033 . . . . 0.0 112.12 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.72 173.25 31.75 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.035 1.302 . . . . 0.0 113.399 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -155.29 159.49 40.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.621 1.168 . . . . 0.0 112.01 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 t -170.06 -175.86 2.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.414 1.485 . . . . 0.0 112.069 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p -80.93 -7.66 59.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.675 1.59 . . . . 0.0 113.36 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -142.61 150.56 40.46 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.356 1.463 . . . . 0.0 111.8 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.82 -32.57 74.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.029 1.332 . . . . 0.0 113.795 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -71.35 -45.2 63.5 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.311 -0.868 . . . . 0.0 112.285 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.02 -26.48 61.33 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.732 0.413 . . . . 0.0 111.407 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.75 -46.3 72.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.894 0.478 . . . . 0.0 111.432 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.65 -40.4 94.8 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.436 0.694 . . . . 0.0 111.954 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.0 m -63.99 -37.23 86.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.886 0.767 . . . . 0.0 111.789 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.23 -38.12 71.97 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.562 -0.711 . . . . 0.0 111.64 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.49 93.47 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.614 -0.679 . . . . 0.0 112.191 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.75 82.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.609 1.164 . . . . 0.0 111.431 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.83 -40.99 81.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.375 0.534 . . . . 0.0 111.638 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.86 -31.08 70.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.757 0.823 . . . . 0.0 113.087 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -77.7 -40.08 42.57 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.567 -0.708 . . . . 0.0 112.414 172.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.11 -37.89 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.34 -0.85 . . . . 0.0 110.818 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -56.59 -42.86 79.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.284 0.634 . . . . 0.0 111.688 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.36 -43.32 99.1 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.859 -1.15 . . . . 0.0 112.722 170.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' A' ' 75' ' ' VAL . 96.0 mt -61.49 -34.02 74.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.16 0.891 . . . . 0.0 113.038 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.49 -43.25 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.026 0.93 . . . . 0.0 111.137 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -62.49 -25.97 68.29 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.175 0.99 . . . . 0.0 113.326 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -101.1 6.01 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.619 1.168 . . . . 0.0 113.865 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 70.89 16.96 6.47 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.834 2.054 . . . . 0.0 114.669 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -88.57 -5.48 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 113.448 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 69' ' ' LEU . 90.6 t -136.84 138.7 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.906 2.082 . . . . 0.0 108.155 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.82 125.69 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.901 0.48 . . . . 0.0 109.931 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 p -55.31 -32.79 62.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.95 -19.74 61.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.097 1.359 . . . . 0.0 113.475 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -92.0 -15.8 27.41 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.633 1.173 . . . . 0.0 113.342 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.8 124.06 83.56 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.132 0.973 . . . . 0.0 111.52 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.99 167.63 17.96 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.803 3.002 . . . . 0.0 112.706 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.69 166.52 31.02 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.654 1.582 . . . . 0.0 111.487 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -14.69 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.561 1.545 . . . . 0.0 114.782 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.87 170.26 19.69 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.977 1.751 . . . . 0.0 112.782 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.5 mt -124.82 115.91 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.097 1.359 . . . . 0.0 108.716 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 m -151.01 150.87 28.58 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.56 1.944 . . . . 0.0 110.317 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.47 151.83 59.64 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.164 2.576 . . . . 0.0 111.057 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.98 149.14 46.42 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.314 2.676 . . . . 0.0 111.436 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.16 141.12 32.03 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.482 2.788 . . . . 0.0 111.215 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.5 p -87.97 -5.31 58.6 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.16 -173.95 54.98 Favored Glycine 0 CA--C 1.542 1.726 0 C-N-CA 125.072 1.32 . . . . 0.0 113.839 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.41 146.19 39.35 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.75 2.967 . . . . 0.0 111.299 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.9 p -144.84 9.14 1.3 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.5 p -162.89 165.72 24.85 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.641 1.576 . . . . 0.0 112.011 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.998 1.285 . . . . 0.0 112.955 -179.088 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -62.73 -46.95 85.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.612 1.165 . . . . 0.0 109.983 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -65.05 -33.85 77.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.331 1.052 . . . . 0.0 112.523 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -68.29 -45.27 73.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.988 0.813 . . . . 0.0 111.513 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.46 -43.23 97.93 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 111.234 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.36 -42.92 98.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.22 81.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.378 1.071 . . . . 0.0 112.436 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -60.75 -46.01 92.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.582 0.753 . . . . 0.0 111.462 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.99 -46.22 88.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.93 -27.32 73.35 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.4 1.0 . . . . 0.0 114.081 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.28 -8.53 57.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.402 1.101 . . . . 0.0 112.705 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -119.69 9.52 11.44 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.335 2.254 . . . . 0.0 112.503 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.08 31.1 11.29 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.597 1.959 . . . . 0.0 113.618 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 62.4 mtm -118.98 173.31 6.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.779 2.031 . . . . 0.0 111.57 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.19 132.07 12.43 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 126.248 1.819 . . . . 0.0 108.729 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.99 148.38 27.77 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.955 2.436 . . . . 0.0 110.936 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.73 115.71 23.84 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.878 1.271 . . . . 0.0 110.7 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.37 153.88 17.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.257 1.423 . . . . 0.0 111.839 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.2 129.38 15.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.761 1.624 . . . . 0.0 109.004 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.19 147.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.248 1.019 . . . . 0.0 112.291 -168.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 . . . . . 0 N--CA 1.471 0.578 0 C-N-CA 126.931 2.093 . . . . 0.0 110.453 176.295 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.9 mttt . . . . . 0 CA--C 1.539 0.555 0 CA-C-O 121.057 0.456 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -135.4 142.63 45.69 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.641 1.177 . . . . 0.0 111.378 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.0 mtp -114.51 148.88 37.25 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.061 1.745 . . . . 0.0 109.19 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.0 t -139.2 145.02 38.78 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 110.922 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.3 149.4 50.05 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.445 1.898 . . . . 0.0 108.483 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.08 139.6 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.429 0.692 . . . . 0.0 111.665 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -136.35 160.1 39.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.961 2.104 . . . . 0.0 110.565 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -140.67 136.52 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.665 1.586 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.23 129.07 40.31 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.054 0.942 . . . . 0.0 111.668 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.99 1.79 67.06 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.498 1.047 . . . . 0.0 114.584 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.21 129.03 49.27 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.391 1.477 . . . . 0.0 110.145 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.32 -13.17 55.67 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -81.68 157.69 24.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.6 1.16 . . . . 0.0 113.021 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.51 120.53 23.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.839 1.256 . . . . 0.0 109.66 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.94 139.82 24.03 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.97 141.62 51.88 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.916 1.286 . . . . 0.0 112.482 -169.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.4 166.9 30.74 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.141 1.353 . . . . 0.0 113.644 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -157.36 159.91 37.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.686 1.194 . . . . 0.0 112.087 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -171.95 -171.04 0.82 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.909 1.683 . . . . 0.0 111.508 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.6 p -73.1 -8.77 57.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.098 1.759 . . . . 0.0 113.474 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.42 152.63 33.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.493 1.517 . . . . 0.0 111.751 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.61 -31.21 72.33 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -68.82 -47.66 65.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.198 0.999 . . . . 0.0 112.589 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -69.72 -30.87 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.605 0.762 . . . . 0.0 111.711 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.71 -44.73 77.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.989 -0.444 . . . . 0.0 111.421 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -61.1 -41.37 96.55 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.045 0.938 . . . . 0.0 112.105 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -64.76 -39.03 92.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.802 0.728 . . . . 0.0 111.813 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -67.77 -41.4 83.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.866 -0.521 . . . . 0.0 111.869 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.66 93.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.454 0.702 . . . . 0.0 112.11 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.31 78.17 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.604 1.162 . . . . 0.0 111.197 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -58.1 -39.53 78.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.28 -30.77 63.63 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.321 0.964 . . . . 0.0 113.514 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -75.51 -39.15 58.86 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.283 -0.886 . . . . 0.0 111.844 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.05 -38.33 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.291 -0.88 . . . . 0.0 110.605 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.15 -48.06 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.648 -0.691 . . . . 0.0 110.479 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -53.09 -40.66 64.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.216 1.371 . . . . 0.0 113.817 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.45 -22.49 66.91 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.6 t -81.92 -37.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.223 1.009 . . . . 0.0 110.948 168.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -61.41 -29.88 70.21 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.24 1.016 . . . . 0.0 112.313 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.6 pt -101.5 3.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 125.013 1.325 . . . . 0.0 114.07 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 t30 66.37 23.24 10.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.527 1.931 . . . . 0.0 114.692 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -84.86 -12.85 52.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.015 1.326 . . . . 0.0 113.014 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -139.68 142.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.396 1.878 . . . . 0.0 109.096 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.278 0.631 . . . . 0.0 111.07 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 p -55.46 -33.38 63.59 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -56.34 -22.28 29.81 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.147 1.379 . . . . 0.0 113.839 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.35 -16.32 27.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.476 1.11 . . . . 0.0 113.506 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.0 t -83.09 127.53 68.83 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.347 1.059 . . . . 0.0 111.093 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo . . . . . 0 C--N 1.351 0.707 0 C-N-CA 123.329 2.686 . . . . 0.0 112.436 179.62 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -44.51 82.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.189 0.996 . . . . 0.0 110.191 174.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -66.4 -30.92 71.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.428 1.091 . . . . 0.0 112.802 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.26 -43.42 77.87 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.043 0.838 . . . . 0.0 111.404 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.71 -43.94 97.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.527 0.603 . . . . 0.0 111.199 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.81 -41.69 98.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.63 77.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.599 1.16 . . . . 0.0 112.557 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -63.23 -41.54 99.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 111.916 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -63.03 -47.14 84.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.091 0.556 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.86 -28.46 73.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.305 0.955 . . . . 0.0 113.681 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -79.23 -17.53 54.61 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.312 1.056 . . . . 0.0 112.751 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -99.01 7.64 45.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.597 2.359 . . . . 0.0 112.957 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 66.25 28.72 9.9 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.728 2.011 . . . . 0.0 113.85 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.0 mtm -114.52 172.87 6.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.157 2.183 . . . . 0.0 111.519 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -140.52 131.76 13.99 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.972 1.709 . . . . 0.0 108.955 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.2 143.75 22.76 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.5 117.13 29.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.805 1.242 . . . . 0.0 110.779 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -100.05 157.99 16.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.672 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -146.93 144.69 29.41 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 109.445 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.7 147.24 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.094 1.358 . . . . 0.0 111.188 -169.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.472 0.668 0 C-N-CA 126.641 1.977 . . . . 0.0 110.117 175.539 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt . . . . . 0 C--O 1.236 0.373 0 CA-C-O 121.34 0.591 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -132.34 132.33 42.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.778 1.231 . . . . 0.0 109.917 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtp -102.62 151.76 21.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.93 1.692 . . . . 0.0 109.092 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.2 t -144.1 147.28 33.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.956 0.902 . . . . 0.0 111.764 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -126.7 145.68 50.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.858 2.063 . . . . 0.0 108.542 175.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.15 140.41 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.88 0.872 . . . . 0.0 111.77 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -137.03 159.92 40.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.821 2.048 . . . . 0.0 110.883 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.23 134.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 108.411 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.61 129.49 41.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.028 0.931 . . . . 0.0 111.669 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 1.84 65.22 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.596 1.093 . . . . 0.0 114.669 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -122.08 134.11 54.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.29 1.436 . . . . 0.0 110.464 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -80.97 -12.13 59.44 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -91.19 159.23 16.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.045 1.338 . . . . 0.0 113.191 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.76 121.12 22.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.876 1.271 . . . . 0.0 109.684 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.7 141.28 23.44 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.1 mtm -138.9 142.35 38.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.777 0.831 . . . . 0.0 112.305 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 174.97 32.83 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 124.933 1.254 . . . . 0.0 113.624 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.03 161.5 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.244 1.018 . . . . 0.0 112.285 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -167.03 -171.0 1.66 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.082 1.353 . . . . 0.0 112.137 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -81.52 -6.81 59.34 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.56 1.944 . . . . 0.0 113.606 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -152.01 159.25 43.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.997 1.719 . . . . 0.0 111.655 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -67.03 -29.45 69.26 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.83 -45.64 50.01 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.153 -0.967 . . . . 0.0 112.3 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.47 -29.72 67.45 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.666 -0.646 . . . . 0.0 112.345 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.03 -45.48 77.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.699 -0.626 . . . . 0.0 111.771 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -62.04 -38.26 88.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.584 0.753 . . . . 0.0 112.001 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 m -63.26 -38.13 89.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.617 0.644 . . . . 0.0 112.106 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.5 -35.73 60.73 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.332 0.653 . . . . 0.0 111.716 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.76 -45.65 88.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 111.789 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.57 -47.58 85.55 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.212 1.005 . . . . 0.0 111.439 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -56.99 -38.05 72.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.132 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.2 -27.93 57.07 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -76.99 -37.93 54.17 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.241 -0.912 . . . . 0.0 111.695 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.04 -41.39 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.49 -0.756 . . . . 0.0 110.473 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.26 -49.78 73.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.726 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -52.57 -41.92 64.01 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.404 1.456 . . . . 0.0 113.696 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.05 -22.17 66.82 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 174.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.46 -36.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.407 1.083 . . . . 0.0 110.935 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -60.66 -29.91 69.57 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.57 1.148 . . . . 0.0 112.316 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.1 pt -103.8 4.62 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.074 1.349 . . . . 0.0 113.986 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.2 m120 66.86 19.1 10.69 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.521 1.928 . . . . 0.0 114.934 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -81.15 -12.28 59.26 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.46 . . . . 0.0 113.238 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.33 142.49 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 108.944 170.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -93.44 129.16 39.71 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.417 1.087 . . . . 0.0 109.843 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 p -60.0 -27.37 66.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.91 -1.119 . . . . 0.0 113.718 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.29 -19.74 62.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.313 1.045 . . . . 0.0 113.351 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -86.01 -17.45 35.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.359 1.064 . . . . 0.0 113.159 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.82 127.31 77.97 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.34 1.056 . . . . 0.0 110.406 -169.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo . . . . . 0 C--N 1.352 0.747 0 C-N-CA 123.122 2.548 . . . . 0.0 111.268 -178.413 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -67.81 -40.81 83.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.183 0.993 . . . . 0.0 110.601 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -67.89 -33.79 75.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.315 1.046 . . . . 0.0 112.703 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.72 -41.43 83.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.91 0.777 . . . . 0.0 111.97 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.24 -44.39 96.68 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.75 0.705 . . . . 0.0 111.285 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.3 -42.56 99.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.34 0.656 . . . . 0.0 112.76 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.46 -40.77 80.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.548 1.139 . . . . 0.0 112.45 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.31 -45.41 93.47 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.11 0.964 . . . . 0.0 111.448 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -58.15 -45.71 86.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.474 0.71 . . . . 0.0 111.652 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.07 -26.86 73.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.504 1.049 . . . . 0.0 114.102 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -78.1 -8.25 58.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.598 1.199 . . . . 0.0 112.853 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.115 2.166 . . . . 0.0 112.769 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 64.41 30.5 13.13 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.39 1.876 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.5 mtm -117.66 174.08 6.37 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.731 2.012 . . . . 0.0 111.415 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -143.53 133.31 11.83 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.825 1.65 . . . . 0.0 108.791 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.66 153.75 34.33 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.961 2.441 . . . . 0.0 110.97 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.22 116.17 20.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.71 157.31 16.78 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 112.225 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.62 148.49 34.39 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.07 1.748 . . . . 0.0 109.692 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.14 146.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.021 1.328 . . . . 0.0 111.89 -168.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.472 0.667 0 C-N-CA 126.699 2.0 . . . . 0.0 110.196 175.151 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.539 0.545 0 CA-C-O 121.174 0.511 . . . . 0.0 110.974 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -135.2 141.82 45.92 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.85 1.26 . . . . 0.0 111.251 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 mtp -113.21 153.48 28.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.171 1.789 . . . . 0.0 109.249 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -146.58 146.49 30.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.011 0.924 . . . . 0.0 111.587 -177.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -128.04 149.23 50.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.947 1.699 . . . . 0.0 109.322 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.2 143.57 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.211 1.004 . . . . 0.0 111.966 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -137.03 165.63 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.512 1.925 . . . . 0.0 110.62 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.51 138.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.886 1.674 . . . . 0.0 108.158 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.51 128.42 37.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.938 0.895 . . . . 0.0 111.707 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 0.69 65.12 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.666 1.127 . . . . 0.0 114.765 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -122.96 129.76 51.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.202 1.401 . . . . 0.0 110.577 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.81 -20.88 45.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -70.82 157.95 37.21 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.643 1.177 . . . . 0.0 113.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.9 116.56 15.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.878 1.271 . . . . 0.0 109.591 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.29 143.52 22.91 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 mtt -137.89 144.29 41.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 112.953 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.68 169.45 27.85 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.851 1.691 . . . . 0.0 113.36 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -158.07 152.07 24.09 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.33 1.052 . . . . 0.0 112.186 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.6 t -169.08 -175.09 2.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.924 1.289 . . . . 0.0 112.264 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.7 p -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.717 1.607 . . . . 0.0 113.402 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -142.16 145.5 34.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.535 1.534 . . . . 0.0 111.44 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.33 -30.94 70.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 113.492 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.51 -46.18 70.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.651 1.18 . . . . 0.0 111.891 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -77.04 -27.89 54.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.553 0.741 . . . . 0.0 111.945 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.27 87.52 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.582 -0.699 . . . . 0.0 111.581 170.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.12 -38.75 90.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.688 0.795 . . . . 0.0 112.033 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.1 m -65.03 -36.31 83.95 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.656 -0.652 . . . . 0.0 112.255 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.33 -36.95 68.98 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.458 -0.776 . . . . 0.0 111.967 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.66 97.86 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.576 -0.703 . . . . 0.0 111.536 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.96 77.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.306 1.042 . . . . 0.0 111.618 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -52.09 -44.43 64.38 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.625 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.75 -35.16 70.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.95 0.9 . . . . 0.0 113.118 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.91 -37.6 62.02 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.686 -0.633 . . . . 0.0 112.291 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.88 -40.89 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.79 -31.68 71.91 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.64 -44.62 81.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.0 -1.687 . . . . 0.0 111.993 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' HG23 ' A' ' 75' ' ' VAL . 94.3 mt -61.46 -33.2 73.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.647 0.658 . . . . 0.0 112.748 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.26 -44.46 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.026 0.93 . . . . 0.0 111.336 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -63.05 -22.5 66.9 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 pt -104.56 6.49 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.77 1.228 . . . . 0.0 113.983 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 67.51 21.29 9.59 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.446 1.899 . . . . 0.0 114.63 174.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -90.36 -5.72 55.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 113.195 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 69' ' ' LEU . 70.0 t -136.11 136.88 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 127.034 2.133 . . . . 0.0 107.781 168.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.51 126.69 33.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.56 -32.49 63.04 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.336 -0.852 . . . . 0.0 113.246 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.92 -19.55 60.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.087 1.355 . . . . 0.0 113.561 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.76 -16.08 29.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.614 1.166 . . . . 0.0 113.322 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.19 124.11 85.88 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.238 1.015 . . . . 0.0 110.978 -169.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo . . . . . 0 C--N 1.35 0.649 0 C-N-CA 123.492 2.795 . . . . 0.0 111.844 178.869 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tp . . . . . 0 N--CA 1.478 0.937 0 N-CA-C 113.057 0.762 . . . . 0.0 113.057 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.18 -38.46 82.07 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.466 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -71.92 -30.38 65.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.017 0.927 . . . . 0.0 112.84 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -66.99 -43.78 82.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.842 0.857 . . . . 0.0 111.792 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 tp -62.79 -42.89 99.9 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.415 0.552 . . . . 0.0 111.25 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -63.33 -42.73 98.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.67 80.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.436 1.094 . . . . 0.0 112.453 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.98 -45.71 93.71 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 111.457 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.2 m -58.04 -46.27 85.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.588 0.755 . . . . 0.0 111.648 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.08 -26.9 73.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.47 1.033 . . . . 0.0 114.065 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.74 -8.36 57.86 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.413 1.107 . . . . 0.0 112.706 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.7 8.69 11.24 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.277 2.231 . . . . 0.0 112.687 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.4 30.93 12.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.556 1.943 . . . . 0.0 113.568 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtm -117.83 173.6 6.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.819 2.048 . . . . 0.0 111.425 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 m -143.05 132.46 11.78 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.054 1.742 . . . . 0.0 108.983 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 152.97 30.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.134 2.556 . . . . 0.0 110.986 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.12 117.47 21.67 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.88 156.31 17.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.462 1.505 . . . . 0.0 112.498 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.45 145.7 32.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.397 1.879 . . . . 0.0 109.262 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -133.17 148.41 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.187 1.395 . . . . 0.0 110.83 -169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 . . . . . 0 N--CA 1.471 0.607 0 C-N-CA 125.854 1.661 . . . . 0.0 110.653 -178.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.4 mttt . . . . . 0 CA--C 1.54 0.595 0 CA-C-O 121.002 0.429 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.06 127.03 29.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.914 1.286 . . . . 0.0 111.075 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtp -91.25 154.87 18.98 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.427 1.491 . . . . 0.0 109.307 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.3 t -143.77 147.69 34.52 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.191 0.996 . . . . 0.0 111.212 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -132.84 141.37 48.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.588 1.955 . . . . 0.0 108.131 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.14 144.03 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.928 0.891 . . . . 0.0 112.1 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -137.82 166.51 23.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.123 1.769 . . . . 0.0 111.165 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.3 139.01 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.255 1.822 . . . . 0.0 107.764 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.54 127.67 33.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 111.834 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.89 -0.71 64.82 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.718 1.151 . . . . 0.0 114.96 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -117.46 126.95 53.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.846 1.323 . . . . 0.0 110.859 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -72.76 -23.37 60.81 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.183 0.993 . . . . 0.0 113.455 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -69.1 158.08 35.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.036 1.334 . . . . 0.0 113.697 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.57 119.58 17.52 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.252 1.421 . . . . 0.0 110.246 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.07 21.66 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtt -137.86 142.14 40.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.916 0.887 . . . . 0.0 112.823 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.42 170.1 26.84 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.737 1.637 . . . . 0.0 113.272 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -157.75 149.76 22.18 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.657 1.183 . . . . 0.0 111.216 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -166.42 -175.64 3.3 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.876 1.27 . . . . 0.0 112.54 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.6 p -75.61 -9.96 59.03 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.568 1.547 . . . . 0.0 113.317 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.44 150.57 30.58 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.452 1.501 . . . . 0.0 111.845 -170.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.05 -34.17 77.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.236 1.014 . . . . 0.0 113.649 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -64.55 -49.07 72.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.727 1.211 . . . . 0.0 111.983 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.24 -27.2 56.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.013 0.925 . . . . 0.0 112.153 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.35 84.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.527 -0.733 . . . . 0.0 111.719 171.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.2 -40.31 89.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.165 0.586 . . . . 0.0 111.72 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.7 m -64.88 -36.59 84.86 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.818 -0.551 . . . . 0.0 112.23 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -71.57 -38.91 70.88 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.306 -0.871 . . . . 0.0 111.824 173.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.4 98.91 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.727 0.694 . . . . 0.0 111.533 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.92 82.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.245 1.018 . . . . 0.0 111.554 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.4 tpt85 -56.15 -37.86 70.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.467 0.707 . . . . 0.0 112.441 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.4 -29.05 52.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 113.415 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.56 -37.99 55.68 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.412 -0.805 . . . . 0.0 111.664 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.42 -40.29 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.651 0.78 . . . . 0.0 110.582 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -53.32 -48.86 68.09 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 170.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -58.71 -44.76 90.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.915 -1.115 . . . . 0.0 112.816 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.439 ' HB3' HG23 ' A' ' 75' ' ' VAL . 96.1 mt -62.79 -31.5 72.48 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -72.09 -41.29 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.866 0.867 . . . . 0.0 111.132 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -65.08 -26.53 68.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.226 1.011 . . . . 0.0 113.124 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 pt -98.66 4.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.611 1.165 . . . . 0.0 113.798 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 68.99 17.24 8.65 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.706 2.002 . . . . 0.0 114.63 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -85.17 -7.8 58.89 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.115 1.366 . . . . 0.0 113.209 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 69' ' ' LEU . 72.4 t -132.58 137.45 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.998 2.119 . . . . 0.0 107.626 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -84.71 128.33 34.55 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.92 0.488 . . . . 0.0 109.919 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -55.13 -33.44 62.89 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.388 -0.82 . . . . 0.0 113.143 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.35 -19.07 61.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.946 1.298 . . . . 0.0 113.605 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -90.18 -16.84 28.7 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.508 1.123 . . . . 0.0 113.227 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.0 t -76.11 125.85 87.44 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.252 1.021 . . . . 0.0 110.496 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo . . . . . 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.571 . . . . 0.0 111.322 178.761 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.7 tp . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -66.34 -43.37 86.29 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.801 1.24 . . . . 0.0 110.361 172.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.48 -32.0 73.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 112.854 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -69.08 -40.96 78.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.289 0.949 . . . . 0.0 111.993 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.77 -42.47 99.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -61.91 -41.93 98.49 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.36 82.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.509 1.124 . . . . 0.0 112.863 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.01 -43.79 94.58 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.83 0.852 . . . . 0.0 111.856 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.6 m -57.89 -43.88 86.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.096 0.558 . . . . 0.0 111.08 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.65 -28.64 73.81 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.561 1.076 . . . . 0.0 114.055 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -70.34 -12.91 61.9 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.637 1.218 . . . . 0.0 112.645 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -119.61 9.18 11.4 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.15 2.18 . . . . 0.0 113.257 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.39 24.03 13.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 114.044 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.97 174.04 6.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.013 2.125 . . . . 0.0 111.476 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.4 m -140.49 130.74 13.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.34 1.856 . . . . 0.0 108.528 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.36 147.63 29.25 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.003 2.469 . . . . 0.0 110.758 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.27 114.45 25.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.456 1.103 . . . . 0.0 110.641 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -95.74 153.8 17.55 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.004 1.321 . . . . 0.0 111.739 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -145.52 138.6 26.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.166 1.786 . . . . 0.0 108.556 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.08 147.45 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.423 1.089 . . . . 0.0 111.774 -168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 . . . . . 0 N--CA 1.469 0.508 0 C-N-CA 126.149 1.78 . . . . 0.0 110.44 172.919 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt . . . . . 0 CA--C 1.543 0.692 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.93 128.87 35.41 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.346 1.058 . . . . 0.0 111.909 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtm -94.98 151.48 19.14 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.546 1.538 . . . . 0.0 108.948 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.2 t -144.68 149.56 35.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.971 0.908 . . . . 0.0 112.082 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -132.87 149.42 52.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.389 1.875 . . . . 0.0 109.044 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.36 140.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.868 0.867 . . . . 0.0 111.71 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -137.08 157.57 46.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.923 2.089 . . . . 0.0 110.546 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.9 t -140.63 136.31 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.729 1.612 . . . . 0.0 108.459 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.28 128.12 35.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.034 0.933 . . . . 0.0 111.73 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.45 2.89 65.24 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.543 1.068 . . . . 0.0 114.692 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.43 129.05 49.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.412 1.485 . . . . 0.0 110.261 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -81.5 -12.19 58.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -85.54 160.44 19.66 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.678 1.191 . . . . 0.0 113.1 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.7 117.68 16.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.84 1.256 . . . . 0.0 109.604 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.01 141.31 24.09 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.6 mtp -123.6 143.38 50.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.556 1.142 . . . . 0.0 112.747 -169.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.11 169.24 28.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.434 1.493 . . . . 0.0 113.633 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -159.88 148.98 17.68 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.934 1.294 . . . . 0.0 111.153 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.53 -176.18 3.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.769 1.228 . . . . 0.0 112.656 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 m -75.67 -19.99 58.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.15 1.38 . . . . 0.0 111.775 172.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -138.35 155.77 48.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 112.85 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -67.67 -40.82 84.45 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.365 -0.834 . . . . 0.0 112.133 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.29 -30.34 57.74 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 112.035 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -43.79 90.2 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.534 -0.729 . . . . 0.0 111.768 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -61.52 -39.48 91.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.538 0.735 . . . . 0.0 111.668 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -64.61 -35.13 80.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.996 0.817 . . . . 0.0 112.388 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.57 -38.18 67.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.28 -0.888 . . . . 0.0 112.017 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.02 97.27 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.59 -0.694 . . . . 0.0 111.563 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -47.59 83.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.576 1.15 . . . . 0.0 111.836 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -52.52 -43.21 64.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.874 0.87 . . . . 0.0 111.581 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.37 -34.26 63.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.22 -37.24 61.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.44 -0.788 . . . . 0.0 112.241 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.15 -42.47 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.342 -0.848 . . . . 0.0 110.092 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.36 -48.64 78.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.524 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -51.1 -42.65 60.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.726 1.603 . . . . 0.0 113.842 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.99 -22.27 66.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.25 -36.72 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.552 1.069 . . . . 0.0 110.903 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -60.4 -30.53 69.66 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.33 1.052 . . . . 0.0 112.112 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 pt -103.96 3.48 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.292 . . . . 0.0 114.211 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.86 23.16 11.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.509 1.924 . . . . 0.0 114.797 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -86.2 -9.75 55.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.51 1.524 . . . . 0.0 113.052 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -134.06 136.65 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 127.139 2.176 . . . . 0.0 107.433 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -86.65 137.44 32.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.319 0.509 . . . . 0.0 109.714 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 p -54.91 -32.09 60.79 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.977 -1.077 . . . . 0.0 113.094 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -53.5 -24.64 13.76 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.015 1.726 . . . . 0.0 114.177 173.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.27 -20.47 26.82 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.545 1.138 . . . . 0.0 113.104 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.1 t -80.45 129.43 69.03 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.583 1.153 . . . . 0.0 110.693 -168.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo . . . . . 0 C--N 1.353 0.774 0 C-N-CA 123.06 2.507 . . . . 0.0 110.756 176.705 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 tp . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -48.26 76.99 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.302 1.041 . . . . 0.0 110.027 169.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -64.81 -29.57 70.54 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 112.685 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.81 -45.61 74.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.812 0.733 . . . . 0.0 111.476 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.63 -41.79 99.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.369 0.531 . . . . 0.0 111.153 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.01 -42.49 99.83 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -39.1 79.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.36 1.064 . . . . 0.0 112.419 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.8 t90 -61.0 -45.84 93.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.068 0.947 . . . . 0.0 111.427 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.3 m -58.22 -45.67 87.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.649 0.78 . . . . 0.0 111.711 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.67 -26.83 72.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.449 1.024 . . . . 0.0 114.051 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -78.12 -8.38 58.18 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.398 1.099 . . . . 0.0 112.744 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -119.68 9.3 11.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.377 2.271 . . . . 0.0 112.726 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.96 30.72 11.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.51 1.924 . . . . 0.0 113.623 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.8 mtm -118.33 172.36 7.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.756 2.022 . . . . 0.0 111.57 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -142.54 130.64 11.48 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.093 1.757 . . . . 0.0 108.685 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.6 149.96 27.44 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.011 2.474 . . . . 0.0 110.803 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.0 117.62 27.74 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.651 1.181 . . . . 0.0 110.68 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.26 158.03 16.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.336 1.455 . . . . 0.0 112.63 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.3 149.88 33.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.999 1.32 . . . . 0.0 110.33 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.1 mt -135.66 147.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.822 1.649 . . . . 0.0 111.149 -169.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 . . . . . 0 N--CA 1.474 0.731 0 C-N-CA 125.653 1.581 . . . . 0.0 111.06 176.664 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 121.289 0.566 . . . . 0.0 110.86 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.28 133.88 46.81 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.239 1.416 . . . . 0.0 110.651 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 37.2 mtm -100.39 154.16 18.74 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.113 1.765 . . . . 0.0 109.211 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.6 t -147.54 148.69 31.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.376 1.07 . . . . 0.0 111.171 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.89 158.28 42.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.096 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.69 143.9 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.807 1.243 . . . . 0.0 111.611 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -139.44 158.19 44.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.436 1.895 . . . . 0.0 110.335 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.07 134.94 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.619 1.568 . . . . 0.0 108.619 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.67 130.14 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.04 0.936 . . . . 0.0 111.677 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.55 1.37 66.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.537 1.065 . . . . 0.0 114.567 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -125.14 128.84 49.03 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 110.363 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -77.25 -20.88 54.55 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -71.29 156.68 39.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.559 1.143 . . . . 0.0 113.377 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.66 116.99 15.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.035 1.334 . . . . 0.0 109.326 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.92 141.84 22.01 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 77.1 mtm -140.27 142.41 35.73 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.595 1.158 . . . . 0.0 112.232 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.26 173.92 31.3 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.264 1.411 . . . . 0.0 113.143 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -152.81 161.7 42.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.262 1.025 . . . . 0.0 111.953 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 t -167.34 -172.83 2.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.647 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.6 p -76.84 -9.57 58.77 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.544 1.538 . . . . 0.0 113.372 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.55 151.38 31.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.657 1.583 . . . . 0.0 111.779 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.34 -30.03 70.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -65.33 -54.61 26.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.708 1.203 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.84 -27.56 62.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.727 0.811 . . . . 0.0 112.171 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.41 95.08 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.814 -0.553 . . . . 0.0 111.749 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.01 -41.07 95.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.43 0.692 . . . . 0.0 112.034 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.4 m -59.03 -40.2 84.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.18 0.9 . . . . 0.0 112.34 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -72.46 -37.97 68.36 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.592 -0.692 . . . . 0.0 111.545 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.35 92.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.651 0.781 . . . . 0.0 112.282 172.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.59 -49.11 77.93 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.313 1.045 . . . . 0.0 111.593 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -58.65 -39.74 81.43 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.73 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.85 -30.78 70.25 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -77.94 -39.6 42.17 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.617 -0.677 . . . . 0.0 112.359 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.2 -38.7 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.41 -0.806 . . . . 0.0 110.798 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.82 -44.01 81.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.504 0.721 . . . . 0.0 111.578 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -60.41 -44.47 95.69 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.768 -1.207 . . . . 0.0 112.665 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.4 -34.27 75.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.065 0.848 . . . . 0.0 113.179 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.12 -42.64 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.908 0.883 . . . . 0.0 111.198 171.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -66.17 -21.36 66.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.508 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -103.38 6.75 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.939 1.296 . . . . 0.0 113.625 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m120 68.79 18.84 8.57 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.725 2.01 . . . . 0.0 114.675 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.67 -5.69 57.96 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.347 1.459 . . . . 0.0 113.322 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -136.83 139.33 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.906 2.082 . . . . 0.0 107.995 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -84.97 125.91 33.08 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.964 0.506 . . . . 0.0 110.067 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.08 -33.1 62.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.13 -19.47 61.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.909 1.284 . . . . 0.0 113.568 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -92.42 -15.64 26.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.648 1.179 . . . . 0.0 113.435 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 123.74 85.41 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.103 0.961 . . . . 0.0 111.64 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo . . . . . 0 CA--C 1.539 0.761 0 C-N-CA 123.785 2.99 . . . . 0.0 112.707 178.713 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 112.582 0.586 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -40.72 75.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.528 1.131 . . . . 0.0 110.542 174.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -69.38 -31.38 69.73 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.182 0.993 . . . . 0.0 112.828 170.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.18 -42.0 84.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.969 0.804 . . . . 0.0 111.947 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -62.65 -42.98 99.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.702 0.683 . . . . 0.0 111.258 173.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.87 -42.96 99.95 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.252 0.621 . . . . 0.0 112.556 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 -39.99 83.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.349 1.06 . . . . 0.0 112.667 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.37 -45.65 93.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 111.452 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.1 m -58.23 -45.45 87.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.545 0.738 . . . . 0.0 111.684 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.07 73.03 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.483 1.04 . . . . 0.0 114.034 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.46 -8.99 58.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.466 1.106 . . . . 0.0 112.838 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -119.64 9.35 11.43 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.251 2.22 . . . . 0.0 112.736 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 mttp 65.05 30.7 11.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.439 1.895 . . . . 0.0 113.568 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.7 mtm -118.6 172.38 7.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.688 1.995 . . . . 0.0 111.654 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.6 m -141.4 130.25 12.42 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 126.328 1.851 . . . . 0.0 108.581 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.62 142.13 20.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.928 2.419 . . . . 0.0 110.581 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.31 116.64 30.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.485 1.114 . . . . 0.0 110.558 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -98.23 154.9 17.46 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.098 1.359 . . . . 0.0 112.301 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.18 136.86 22.96 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.917 1.287 . . . . 0.0 110.287 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 70.0 mt -123.78 147.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.12 1.368 . . . . 0.0 110.97 -170.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 . . . . . 0 N--CA 1.47 0.528 0 C-N-CA 126.707 2.003 . . . . 0.0 110.106 -174.881 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm . . . . . 0 CA--C 1.54 0.582 0 CA-C-O 121.126 0.488 . . . . 0.0 111.042 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -135.09 137.77 43.17 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.89 1.276 . . . . 0.0 111.6 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.6 mtp -102.67 152.19 21.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.588 1.555 . . . . 0.0 108.879 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.0 t -135.76 145.38 46.52 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.427 1.091 . . . . 0.0 110.194 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -122.46 152.23 40.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.202 1.801 . . . . 0.0 108.976 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.31 140.11 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.778 1.231 . . . . 0.0 110.894 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -140.79 153.39 45.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.945 1.698 . . . . 0.0 110.117 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.77 134.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.488 1.515 . . . . 0.0 108.88 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.79 130.01 44.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.131 0.972 . . . . 0.0 111.695 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.4 2.05 66.0 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.607 1.098 . . . . 0.0 114.627 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.83 130.85 53.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.397 1.479 . . . . 0.0 110.321 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -82.67 -14.72 54.15 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -80.93 155.75 26.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.407 1.083 . . . . 0.0 112.766 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.81 112.05 13.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.191 1.396 . . . . 0.0 108.911 170.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.16 147.19 25.76 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.5 ptm -147.19 150.29 34.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.6 173.78 30.1 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.248 1.88 . . . . 0.0 112.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -157.28 154.55 29.27 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.918 0.887 . . . . 0.0 112.753 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -168.28 -178.26 3.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.413 1.485 . . . . 0.0 111.471 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m -78.23 -2.69 39.02 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.578 1.551 . . . . 0.0 112.052 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -142.37 150.45 40.72 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.957 1.703 . . . . 0.0 111.786 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.72 -37.55 70.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.615 1.166 . . . . 0.0 113.631 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -71.54 -36.96 71.17 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.14 -0.975 . . . . 0.0 112.19 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.92 -30.92 70.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.159 0.984 . . . . 0.0 112.236 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.13 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.335 -0.853 . . . . 0.0 111.617 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -61.38 -42.2 98.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.898 0.879 . . . . 0.0 112.498 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -69.27 -32.05 70.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.542 1.065 . . . . 0.0 112.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -69.24 -40.52 77.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.476 -0.765 . . . . 0.0 111.804 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.32 99.79 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.831 0.742 . . . . 0.0 111.926 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.94 77.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.955 0.902 . . . . 0.0 111.452 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -57.84 -40.29 79.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.457 0.571 . . . . 0.0 111.968 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.15 -33.87 74.09 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.778 0.831 . . . . 0.0 113.104 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -76.11 -38.84 56.4 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.679 -0.638 . . . . 0.0 112.229 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.3 -41.45 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.451 -0.781 . . . . 0.0 110.591 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -56.75 -47.28 80.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.105 0.562 . . . . 0.0 111.588 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -56.48 -44.43 80.6 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 112.896 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.79 -31.89 72.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.375 -0.828 . . . . 0.0 113.209 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.62 -39.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.044 0.838 . . . . 0.0 111.388 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -61.38 -29.99 70.26 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.8 pt -98.32 5.1 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.9 t30 67.99 21.73 8.77 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.766 2.027 . . . . 0.0 114.576 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -89.61 -5.36 57.23 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.234 1.413 . . . . 0.0 113.118 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.1 t -138.2 144.36 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.797 2.439 . . . . 0.0 107.18 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -98.32 133.33 42.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.538 0.735 . . . . 0.0 110.336 169.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.8 p -58.2 -30.29 66.33 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.208 -0.933 . . . . 0.0 113.242 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.83 -21.91 57.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.534 1.134 . . . . 0.0 113.645 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -88.99 -17.26 29.8 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.39 1.076 . . . . 0.0 113.15 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.52 125.59 82.49 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 124.307 1.043 . . . . 0.0 110.733 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--N 1.351 0.702 0 C-N-CA 123.076 2.517 . . . . 0.0 110.288 177.736 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp . . . . . 0 N--CA 1.479 1.009 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.52 -44.74 86.02 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.337 1.055 . . . . 0.0 110.241 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.54 -31.96 73.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.639 0.775 . . . . 0.0 112.673 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.25 -42.91 74.96 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.687 0.795 . . . . 0.0 111.71 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.52 -43.16 99.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.627 0.649 . . . . 0.0 111.231 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.45 -42.86 98.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.6 83.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.578 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -60.29 -45.57 92.89 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.296 1.038 . . . . 0.0 111.586 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.3 m -58.06 -44.01 87.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.474 0.71 . . . . 0.0 111.665 171.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.58 -26.63 72.9 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.424 1.011 . . . . 0.0 114.103 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -78.52 -6.63 55.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.629 1.215 . . . . 0.0 112.857 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -119.3 7.88 11.34 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.057 2.143 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 63.29 27.71 15.51 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.329 1.852 . . . . 0.0 113.519 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.0 mtm -110.79 174.15 6.0 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.878 2.071 . . . . 0.0 111.305 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.4 m -143.17 131.08 11.09 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.85 1.66 . . . . 0.0 108.509 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.04 146.25 25.5 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.986 2.457 . . . . 0.0 110.645 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.46 113.22 24.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.323 1.049 . . . . 0.0 110.786 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -98.55 155.19 17.4 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.538 1.535 . . . . 0.0 112.128 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.13 146.77 30.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.1 1.76 . . . . 0.0 109.866 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.82 147.73 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.306 1.442 . . . . 0.0 110.686 -169.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 . . . . . 0 N--CA 1.471 0.595 0 C-N-CA 126.73 2.012 . . . . 0.0 110.114 -176.102 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttp . . . . . 0 CA--C 1.539 0.556 0 CA-C-O 120.893 0.378 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -135.11 135.3 41.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.388 1.075 . . . . 0.0 111.798 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.7 mtt -98.94 154.27 18.19 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.6 1.56 . . . . 0.0 108.881 168.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.6 t -142.48 147.39 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.162 0.985 . . . . 0.0 110.878 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -131.46 146.34 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.315 1.846 . . . . 0.0 108.828 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.26 139.79 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.324 1.05 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.16 158.98 43.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.878 1.671 . . . . 0.0 110.484 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.57 135.79 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.603 1.561 . . . . 0.0 108.678 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.05 129.44 41.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.126 0.97 . . . . 0.0 111.735 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.61 0.44 66.94 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.661 1.124 . . . . 0.0 114.694 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.58 132.44 56.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.335 1.454 . . . . 0.0 110.366 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -82.32 -12.93 57.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -171.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -90.05 155.76 18.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.913 1.285 . . . . 0.0 112.706 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.24 112.37 14.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.287 1.435 . . . . 0.0 108.759 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 149.26 30.38 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -148.98 147.39 28.53 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -168.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.34 176.42 29.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.917 1.722 . . . . 0.0 112.594 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.29 161.49 42.31 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.115 0.966 . . . . 0.0 112.076 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -168.63 -174.11 2.08 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.27 1.428 . . . . 0.0 111.836 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 p -75.31 -11.0 59.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.411 1.485 . . . . 0.0 113.347 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -150.08 151.52 33.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.409 1.483 . . . . 0.0 112.069 -169.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.57 -28.57 68.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -70.53 -50.41 37.92 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.844 0.857 . . . . 0.0 111.918 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.75 -29.65 63.5 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.572 -0.705 . . . . 0.0 112.182 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.14 89.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.671 -0.643 . . . . 0.0 111.941 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.25 -38.8 90.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.474 0.71 . . . . 0.0 112.037 172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -65.24 -36.94 85.7 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.899 -0.501 . . . . 0.0 111.82 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -73.79 -35.13 64.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.69 0.796 . . . . 0.0 111.713 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.48 93.37 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.466 -0.772 . . . . 0.0 112.125 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.38 -48.04 81.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.886 0.874 . . . . 0.0 111.543 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -53.58 -42.26 67.43 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.33 1.052 . . . . 0.0 111.932 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.05 -35.7 69.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.965 0.906 . . . . 0.0 113.223 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -75.11 -37.23 61.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.631 -0.668 . . . . 0.0 112.54 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.58 -38.36 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.352 -0.842 . . . . 0.0 110.494 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -55.83 -46.98 78.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 119.347 -0.358 . . . . 0.0 111.925 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -56.18 -46.72 79.26 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.031 -1.043 . . . . 0.0 112.969 170.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.13 -33.89 75.32 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.93 -41.99 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.983 0.913 . . . . 0.0 111.193 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -67.3 -19.97 65.55 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.356 1.062 . . . . 0.0 113.394 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -103.89 6.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.967 1.307 . . . . 0.0 113.576 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 68.0 20.38 9.13 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.843 2.057 . . . . 0.0 114.566 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.96 -6.09 57.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.039 1.336 . . . . 0.0 113.036 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.75 138.7 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.055 2.142 . . . . 0.0 107.525 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -89.4 131.34 35.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.538 0.685 . . . . 0.0 110.615 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -59.55 -33.62 71.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -62.32 -17.73 59.56 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.514 1.126 . . . . 0.0 113.471 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.94 -16.74 31.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.349 1.06 . . . . 0.0 113.227 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.12 125.97 78.23 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.367 1.067 . . . . 0.0 111.368 -168.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo . . . . . 0 C--N 1.351 0.695 0 C-N-CA 123.501 2.801 . . . . 0.0 111.379 175.189 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp . . . . . 0 N--CA 1.479 0.999 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -66.61 -41.47 88.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.843 0.857 . . . . 0.0 110.468 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -63.4 -38.54 91.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.0 112.278 170.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -65.46 -44.37 87.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.601 0.76 . . . . 0.0 111.799 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.21 -43.25 98.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.449 0.568 . . . . 0.0 111.365 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.4 -42.92 98.79 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.36 -39.05 78.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 112.56 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -60.96 -45.82 93.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.219 1.008 . . . . 0.0 111.308 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.5 m -58.34 -46.07 86.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 111.722 172.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.8 -27.01 73.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.368 0.985 . . . . 0.0 114.104 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.01 -8.23 57.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.556 1.143 . . . . 0.0 112.775 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.68 8.9 11.29 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.666 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 64.91 30.43 12.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.482 1.913 . . . . 0.0 113.71 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.0 mtm -117.69 173.69 6.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.724 2.01 . . . . 0.0 111.521 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 m -143.47 132.38 11.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.828 1.651 . . . . 0.0 108.885 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.46 152.48 30.08 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.066 2.51 . . . . 0.0 110.954 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.51 116.87 22.48 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.716 1.207 . . . . 0.0 110.801 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.74 156.95 17.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.465 1.506 . . . . 0.0 112.174 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -147.2 138.46 23.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.09 1.356 . . . . 0.0 110.185 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.88 148.88 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.999 1.32 . . . . 0.0 111.746 -168.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 . . . . . 0 N--CA 1.474 0.727 0 C-N-CA 126.222 1.809 . . . . 0.0 110.682 175.753 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.3 mttt . . . . . 0 CA--C 1.539 0.521 0 CA-C-O 120.906 0.384 . . . . 0.0 110.734 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -134.02 124.15 25.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.866 1.267 . . . . 0.0 111.17 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 61.0 mtp -89.32 153.08 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 109.41 168.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 32.9 t -142.45 146.18 34.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.341 1.056 . . . . 0.0 111.042 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.548 1.939 . . . . 0.0 109.137 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -144.86 142.56 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.495 1.118 . . . . 0.0 111.726 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -137.49 160.27 39.59 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.056 2.142 . . . . 0.0 110.466 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.7 t -139.91 135.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.83 1.652 . . . . 0.0 108.297 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.38 129.54 42.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.002 0.921 . . . . 0.0 111.702 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.54 0.43 64.8 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.576 1.084 . . . . 0.0 114.73 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.32 129.28 52.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.205 1.402 . . . . 0.0 110.529 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.86 -22.29 50.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -71.64 156.31 39.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.665 1.186 . . . . 0.0 113.243 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.67 118.61 17.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.939 1.295 . . . . 0.0 109.573 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.1 150.4 23.83 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.4 ptm -148.75 151.65 35.21 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.52 177.98 29.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.916 1.722 . . . . 0.0 112.926 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -151.75 155.67 38.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.13 1.372 . . . . 0.0 110.691 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 t -166.99 -176.61 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.861 1.264 . . . . 0.0 112.428 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 p -76.92 -10.68 59.53 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.647 1.579 . . . . 0.0 113.292 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -150.25 151.77 33.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.273 1.429 . . . . 0.0 112.176 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.81 -27.65 68.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -71.75 -53.27 13.99 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.17 -31.65 71.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.161 0.584 . . . . 0.0 112.256 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.63 98.92 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.738 -0.601 . . . . 0.0 112.275 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -65.26 -41.32 94.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 m -60.27 -37.59 80.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.308 0.958 . . . . 0.0 112.555 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -73.71 -37.41 65.17 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.365 -0.835 . . . . 0.0 111.517 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.55 -42.93 98.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.762 0.825 . . . . 0.0 112.316 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.33 85.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.934 0.894 . . . . 0.0 111.454 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -56.87 -38.07 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.063 0.545 . . . . 0.0 112.445 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.47 -34.67 65.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.816 1.246 . . . . 0.0 112.86 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -73.38 -37.85 65.86 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.317 -0.864 . . . . 0.0 112.157 172.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.2 -35.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 121.52 -0.737 . . . . 0.0 110.973 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.24 87.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.229 0.612 . . . . 0.0 111.496 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.19 -45.15 89.6 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.897 -1.127 . . . . 0.0 112.391 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.5 mt -60.71 -34.22 74.06 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.17 -43.55 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.758 0.823 . . . . 0.0 111.241 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -65.43 -24.99 67.33 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.1 pt -97.86 5.63 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.392 1.077 . . . . 0.0 113.671 170.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 68.06 21.64 8.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.529 1.932 . . . . 0.0 114.433 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -91.47 -5.05 54.88 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 113.195 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 69' ' ' LEU . 90.2 t -137.24 137.95 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.176 2.19 . . . . 0.0 107.88 169.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.82 126.13 32.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.927 0.491 . . . . 0.0 109.898 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 p -55.3 -34.32 64.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.52 -15.35 57.65 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -91.26 -15.81 28.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.56 1.144 . . . . 0.0 113.126 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.42 123.25 86.87 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.055 0.942 . . . . 0.0 111.142 -169.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo . . . . . 0 C--N 1.351 0.696 0 C-N-CA 123.504 2.803 . . . . 0.0 111.593 177.882 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp . . . . . 0 N--CA 1.481 1.111 0 N-CA-C 112.3 0.482 . . . . 0.0 112.3 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.1 -42.45 84.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.011 0.925 . . . . 0.0 110.343 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -67.76 -31.11 70.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.903 0.881 . . . . 0.0 112.977 171.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -67.74 -41.84 82.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.241 0.928 . . . . 0.0 111.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.26 -43.86 96.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.661 0.664 . . . . 0.0 111.081 173.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.59 -42.56 99.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.8 79.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.547 1.139 . . . . 0.0 112.782 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.83 -46.94 87.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.901 0.881 . . . . 0.0 111.407 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 m -57.55 -44.67 85.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.916 0.887 . . . . 0.0 111.937 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.18 -26.52 72.52 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.336 0.969 . . . . 0.0 114.001 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -77.92 -7.86 57.33 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.49 1.116 . . . . 0.0 112.785 172.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -119.44 8.91 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.261 2.224 . . . . 0.0 112.797 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 63.62 28.44 15.09 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.426 1.89 . . . . 0.0 113.58 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.36 172.51 6.87 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.865 2.066 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 m -140.73 129.22 12.7 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.207 1.803 . . . . 0.0 108.609 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.57 145.88 26.69 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.056 2.504 . . . . 0.0 110.753 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.15 115.49 26.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.57 1.148 . . . . 0.0 110.681 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -99.1 156.85 16.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.448 1.499 . . . . 0.0 112.221 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.98 149.06 32.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.338 1.455 . . . . 0.0 110.097 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.4 mt -131.93 146.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.652 1.581 . . . . 0.0 110.756 -169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 . . . . . 0 N--CA 1.471 0.596 0 C-N-CA 125.56 1.544 . . . . 0.0 111.164 -171.79 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm . . . . . 0 N--CA 1.469 0.517 0 CA-C-O 121.307 0.575 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.94 130.69 39.91 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.338 1.055 . . . . 0.0 111.639 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.8 mtp -95.97 155.31 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.398 1.479 . . . . 0.0 108.822 167.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.5 t -142.27 149.77 40.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.251 1.021 . . . . 0.0 110.285 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.57 151.05 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.754 1.622 . . . . 0.0 109.861 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.78 142.23 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.687 1.195 . . . . 0.0 111.503 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -139.78 158.0 44.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.539 1.936 . . . . 0.0 110.066 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.77 135.5 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.443 1.497 . . . . 0.0 108.748 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.95 129.22 40.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 0.0 111.598 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.84 2.44 66.88 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.434 1.016 . . . . 0.0 114.482 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.95 127.28 44.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.451 1.5 . . . . 0.0 110.039 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -79.51 -11.52 59.89 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.3 155.8 29.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.506 1.122 . . . . 0.0 113.048 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.18 107.73 8.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 109.021 170.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.0 144.12 21.7 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ptm -149.11 152.84 36.85 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.01 -178.11 28.12 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.157 1.837 . . . . 0.0 112.663 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -154.9 162.58 41.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 112.877 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.5 t -168.59 -178.01 3.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.959 1.703 . . . . 0.0 111.154 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.4 m -74.63 -14.81 60.81 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.329 1.452 . . . . 0.0 112.139 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -138.97 146.83 41.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.628 1.571 . . . . 0.0 112.422 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.92 -28.22 67.31 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.24 -42.86 79.1 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.398 0.999 . . . . 0.0 112.014 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.81 -33.03 64.01 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.578 -0.701 . . . . 0.0 112.031 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.82 -46.01 89.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.825 -0.547 . . . . 0.0 111.674 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.29 -38.05 89.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.69 0.796 . . . . 0.0 112.271 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m -64.14 -38.39 90.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.729 0.695 . . . . 0.0 112.069 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -73.76 -37.19 65.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.377 0.671 . . . . 0.0 111.335 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.46 96.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.648 0.779 . . . . 0.0 112.381 170.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.36 77.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.005 0.922 . . . . 0.0 111.204 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -57.8 -40.26 79.51 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.916 0.486 . . . . 0.0 112.005 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.27 -32.37 70.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.35 -38.31 50.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.72 -0.613 . . . . 0.0 112.196 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -61.75 -41.29 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -59.87 -33.87 72.38 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 112.132 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -67.31 -44.43 79.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.054 -1.654 . . . . 0.0 112.03 169.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.94 -32.45 71.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.28 -44.7 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.002 0.921 . . . . 0.0 111.367 169.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -62.73 -22.66 66.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.29 8.12 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.799 1.239 . . . . 0.0 114.086 172.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 68.46 20.73 8.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.041 1.736 . . . . 0.0 114.321 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -93.19 -6.04 48.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.35 1.46 . . . . 0.0 113.298 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.53 139.27 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.887 2.075 . . . . 0.0 107.796 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -88.95 133.14 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.865 -0.522 . . . . 0.0 110.696 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -57.12 -35.39 69.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.09 -15.21 55.91 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -89.07 -17.5 29.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.359 1.063 . . . . 0.0 113.025 174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.23 123.78 85.88 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.055 0.942 . . . . 0.0 110.462 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo . . . . . 0 C--N 1.351 0.659 0 C-N-CA 123.354 2.702 . . . . 0.0 112.581 -177.339 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 N--CA 1.475 0.823 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.97 78.2 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.549 -0.719 . . . . 0.0 111.509 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -76.91 -29.55 55.76 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.911 0.885 . . . . 0.0 112.553 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.49 -45.35 83.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.94 -43.07 99.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.155 0.434 . . . . 0.0 111.371 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -62.55 -42.71 99.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.248 0.619 . . . . 0.0 112.628 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.34 -41.11 81.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.345 1.058 . . . . 0.0 112.449 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.83 -45.28 95.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.943 . . . . 0.0 111.66 174.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.04 -44.1 91.72 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.882 0.873 . . . . 0.0 111.877 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.55 73.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.611 1.101 . . . . 0.0 114.163 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.5 -8.08 58.16 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.467 1.134 . . . . 0.0 112.846 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -119.72 8.17 11.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.071 2.149 . . . . 0.0 112.912 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm 66.75 28.54 8.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.742 2.017 . . . . 0.0 113.617 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.9 mtm -116.71 172.15 7.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 111.627 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.3 m -142.55 130.47 11.4 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 126.185 1.794 . . . . 0.0 108.771 174.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.9 136.59 18.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.906 2.404 . . . . 0.0 110.339 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.14 114.59 27.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.499 1.12 . . . . 0.0 111.437 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.04 152.27 19.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.746 1.218 . . . . 0.0 112.867 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.54 148.34 40.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.307 1.843 . . . . 0.0 108.971 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.23 147.04 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.017 1.327 . . . . 0.0 111.653 -168.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 125.707 1.603 . . . . 0.0 110.975 176.38 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.4 mttt . . . . . 0 CA--C 1.541 0.632 0 CA-C-O 121.052 0.454 . . . . 0.0 110.719 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.19 138.09 46.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.126 1.37 . . . . 0.0 111.203 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.6 mtm -103.38 153.85 20.03 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.094 1.757 . . . . 0.0 109.386 169.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 t -144.19 146.28 32.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.385 1.074 . . . . 0.0 111.886 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.38 136.8 50.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.546 1.938 . . . . 0.0 108.827 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.16 135.78 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.215 1.006 . . . . 0.0 111.657 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.94 153.37 42.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.11 135.61 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.645 1.578 . . . . 0.0 108.546 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.08 139.3 57.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.108 0.963 . . . . 0.0 112.06 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.69 -4.07 86.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.768 1.175 . . . . 0.0 114.916 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -117.72 133.01 56.39 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.895 1.347 . . . . 0.0 111.136 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -81.55 -16.03 52.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -83.42 157.55 22.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.69 1.196 . . . . 0.0 112.393 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.43 129.14 32.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.689 1.195 . . . . 0.0 109.856 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.23 144.5 28.44 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.4 mtm -134.7 135.46 42.02 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.802 1.241 . . . . 0.0 111.486 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.24 173.41 28.26 Favored Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.984 1.278 . . . . 0.0 113.259 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -154.6 160.32 41.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.433 1.093 . . . . 0.0 111.873 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -169.04 -173.6 1.83 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.418 1.487 . . . . 0.0 111.815 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -74.09 -12.49 60.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.525 1.53 . . . . 0.0 113.436 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.67 151.74 34.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.476 1.511 . . . . 0.0 111.822 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.56 -29.63 70.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.16 -46.63 41.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.082 0.953 . . . . 0.0 112.066 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.65 -28.45 60.86 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.492 -0.755 . . . . 0.0 112.05 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.89 89.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.657 -0.652 . . . . 0.0 111.756 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.1 -40.62 94.41 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.393 0.677 . . . . 0.0 111.872 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 m -64.22 -37.38 87.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.576 0.625 . . . . 0.0 112.057 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -72.83 -36.26 67.46 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.552 -0.717 . . . . 0.0 111.598 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.72 94.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.888 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.95 82.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 111.461 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -56.9 -41.29 77.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.302 0.501 . . . . 0.0 111.794 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -28.14 66.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -80.87 -37.71 29.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.703 0.683 . . . . 0.0 112.672 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.58 -40.54 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.961 0.8 . . . . 0.0 110.534 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -55.14 -47.51 74.97 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 170.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.18 -44.07 92.17 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.112 -0.993 . . . . 0.0 112.59 173.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.38 -35.9 80.61 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.51 -42.73 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.687 0.795 . . . . 0.0 111.071 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -66.36 -13.4 60.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.8 pt -114.04 9.92 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.21 1.404 . . . . 0.0 113.252 170.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 m120 67.23 17.52 10.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.507 1.923 . . . . 0.0 114.592 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.9 -11.09 57.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.242 1.417 . . . . 0.0 113.139 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -134.35 138.07 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.546 1.938 . . . . 0.0 107.923 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.72 126.13 32.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.826 0.451 . . . . 0.0 109.929 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.17 -33.04 62.63 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.38 61.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.943 1.297 . . . . 0.0 113.579 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -91.66 -16.51 26.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.627 1.171 . . . . 0.0 113.304 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -77.5 126.07 85.2 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.213 1.005 . . . . 0.0 110.871 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 C--N 1.352 0.713 0 C-N-CA 123.299 2.666 . . . . 0.0 111.962 178.813 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 tp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.74 -43.28 84.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.167 0.987 . . . . 0.0 110.313 174.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.94 -31.82 72.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 112.821 172.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.49 -42.91 77.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.994 0.815 . . . . 0.0 111.734 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.71 -42.88 99.87 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.626 0.648 . . . . 0.0 111.234 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -63.01 -42.28 99.79 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.05 -40.22 78.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.484 1.114 . . . . 0.0 112.434 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -60.42 -45.64 92.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.952 0.901 . . . . 0.0 111.456 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.7 m -58.05 -45.43 87.05 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.648 0.779 . . . . 0.0 111.758 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.81 -26.82 73.12 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.491 1.043 . . . . 0.0 114.145 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -78.92 -7.5 58.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.545 1.173 . . . . 0.0 112.876 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.55 9.21 11.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.166 2.187 . . . . 0.0 112.709 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.98 31.45 11.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.451 1.9 . . . . 0.0 113.549 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.3 mtm -119.79 172.83 7.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.804 2.041 . . . . 0.0 111.56 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.94 131.04 11.26 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.26 1.824 . . . . 0.0 108.755 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.82 147.37 24.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.954 2.436 . . . . 0.0 110.734 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.93 117.35 27.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.648 1.179 . . . . 0.0 110.761 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.3 156.52 17.19 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.328 1.451 . . . . 0.0 112.343 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.22 149.65 33.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.102 1.361 . . . . 0.0 110.318 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -134.26 147.89 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.566 1.547 . . . . 0.0 111.867 -168.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 . . . . . 0 N--CA 1.474 0.734 0 C-N-CA 125.773 1.629 . . . . 0.0 110.792 170.947 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm . . . . . 0 CA--C 1.54 0.58 0 CA-C-O 121.094 0.473 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -135.46 131.78 36.58 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.906 1.282 . . . . 0.0 111.343 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 mtm -99.17 152.14 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.612 1.565 . . . . 0.0 108.937 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -146.06 147.71 31.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 111.515 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.88 156.19 44.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.331 1.452 . . . . 0.0 110.757 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.48 143.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.892 1.277 . . . . 0.0 111.254 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -138.08 157.68 45.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.246 1.818 . . . . 0.0 110.688 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -140.62 135.92 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.851 1.661 . . . . 0.0 108.319 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.15 129.38 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.101 0.96 . . . . 0.0 111.731 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.95 0.62 65.97 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.653 1.12 . . . . 0.0 114.715 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -119.29 131.06 55.7 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.228 1.411 . . . . 0.0 110.631 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -77.85 -24.76 48.51 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -75.11 155.93 36.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.287 1.035 . . . . 0.0 113.144 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.44 114.22 15.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.261 1.424 . . . . 0.0 108.669 169.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.49 143.89 25.11 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mtp -137.98 146.64 43.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.28 177.67 31.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.789 1.662 . . . . 0.0 112.895 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -155.67 159.2 39.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.492 1.117 . . . . 0.0 111.981 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -169.2 -179.44 3.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.134 1.374 . . . . 0.0 112.083 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 m -78.64 -13.13 59.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.395 1.478 . . . . 0.0 112.101 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.21 142.89 47.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.238 1.415 . . . . 0.0 111.628 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.98 -30.81 71.86 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -69.85 -42.25 73.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.359 -0.838 . . . . 0.0 111.543 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.72 -29.46 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.456 0.702 . . . . 0.0 112.03 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.94 90.11 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.636 -0.665 . . . . 0.0 111.817 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -62.81 -39.13 93.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.509 0.724 . . . . 0.0 111.775 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.9 m -63.19 -36.42 83.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.558 0.617 . . . . 0.0 112.27 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -75.38 -34.11 61.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 111.749 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.08 91.48 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.523 -0.735 . . . . 0.0 111.924 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.81 83.18 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.29 1.036 . . . . 0.0 111.686 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -52.48 -44.4 65.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.337 1.055 . . . . 0.0 111.647 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.63 -35.98 70.61 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -73.41 -37.33 65.95 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.406 0.548 . . . . 0.0 112.428 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.05 -43.15 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.357 -0.84 . . . . 0.0 110.169 171.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -61.73 -33.68 74.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -63.9 -45.8 87.7 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.062 -1.649 . . . . 0.0 111.882 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.414 ' HB3' HG23 ' A' ' 75' ' ' VAL . 91.7 mt -61.89 -33.84 74.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.531 0.732 . . . . 0.0 112.735 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.01 -43.89 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.842 0.857 . . . . 0.0 111.291 170.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -63.78 -21.1 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -106.03 6.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.794 1.238 . . . . 0.0 113.959 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 70.53 16.03 7.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.829 2.052 . . . . 0.0 114.82 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.25 -6.72 58.46 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.356 1.462 . . . . 0.0 113.364 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 69' ' ' LEU . 74.5 t -135.05 137.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.058 2.143 . . . . 0.0 107.473 168.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -86.47 128.37 34.95 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.994 -0.441 . . . . 0.0 110.165 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.9 p -53.52 -33.13 53.39 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.12 -20.71 62.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.702 1.601 . . . . 0.0 113.339 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -88.37 -17.84 29.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 113.091 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.38 127.13 85.37 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.329 1.052 . . . . 0.0 110.258 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.351 0.689 0 C-N-CA 123.128 2.552 . . . . 0.0 111.46 -179.531 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.3 tp . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -60.82 -46.18 91.55 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.463 0.705 . . . . 0.0 111.162 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -64.46 -36.49 84.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.335 0.654 . . . . 0.0 112.346 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.21 -45.31 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.741 0.7 . . . . 0.0 111.87 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.92 -43.22 96.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.66 0.664 . . . . 0.0 111.246 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -63.66 -43.02 97.95 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.0 88.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.901 0.88 . . . . 0.0 112.568 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -61.55 -45.52 93.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.769 0.827 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.36 -45.93 90.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.706 0.802 . . . . 0.0 111.751 172.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.56 -27.11 73.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.419 1.009 . . . . 0.0 113.963 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.14 -8.84 58.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.389 1.094 . . . . 0.0 112.715 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.63 8.83 11.31 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.248 2.219 . . . . 0.0 112.656 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 64.95 32.58 10.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.536 1.935 . . . . 0.0 113.547 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.1 mtm -120.46 171.73 8.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.741 2.016 . . . . 0.0 111.735 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -142.71 130.53 11.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 126.192 1.797 . . . . 0.0 109.011 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 145.22 23.27 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.151 2.567 . . . . 0.0 110.903 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.34 129.52 49.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.912 1.285 . . . . 0.0 111.046 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -114.72 160.1 19.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.997 1.319 . . . . 0.0 113.484 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.6 144.21 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.162 1.785 . . . . 0.0 109.075 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -130.03 144.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.596 1.558 . . . . 0.0 109.649 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.7 ttm105 . . . . . 0 N--CA 1.47 0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 111.458 -172.578 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt . . . . . 0 CA--C 1.54 0.573 0 CA-C-O 121.127 0.489 . . . . 0.0 110.754 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.89 125.3 28.02 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.93 1.292 . . . . 0.0 111.126 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.1 mtp -89.47 155.35 19.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.055 1.342 . . . . 0.0 108.951 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.6 t -143.43 147.82 35.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.956 0.903 . . . . 0.0 111.536 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -129.12 145.12 51.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.302 1.841 . . . . 0.0 108.884 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.53 142.78 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.655 1.182 . . . . 0.0 111.439 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -137.88 157.15 47.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.656 1.982 . . . . 0.0 110.67 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.64 135.36 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.079 1.752 . . . . 0.0 108.282 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.82 129.6 42.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.146 0.978 . . . . 0.0 111.766 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 0.9 65.42 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.588 1.089 . . . . 0.0 114.762 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.23 132.09 54.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.65 -14.87 50.86 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.74 155.84 25.29 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.657 1.183 . . . . 0.0 112.675 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.26 120.14 25.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.847 1.259 . . . . 0.0 109.284 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 140.87 24.76 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.0 mtt -135.17 142.53 46.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.42 172.07 27.09 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 125.782 1.658 . . . . 0.0 113.35 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -158.32 149.69 21.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.776 1.23 . . . . 0.0 111.392 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.57 179.84 4.7 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.796 1.238 . . . . 0.0 112.703 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.5 p -78.51 -8.84 58.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.88 1.672 . . . . 0.0 112.999 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -137.87 142.75 40.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.661 1.584 . . . . 0.0 111.373 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.39 -42.34 95.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 113.231 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -66.96 -37.53 84.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.76 -29.71 58.9 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.475 -0.766 . . . . 0.0 111.834 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.1 -44.44 79.99 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.688 -0.632 . . . . 0.0 111.413 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.56 -39.07 86.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 112.031 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 m -67.25 -34.58 77.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.805 0.73 . . . . 0.0 112.413 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -71.72 -38.52 70.48 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.531 -0.731 . . . . 0.0 111.72 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.59 92.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.587 0.631 . . . . 0.0 111.644 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.23 82.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.346 1.058 . . . . 0.0 111.544 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -58.35 -39.48 79.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.202 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.35 -29.52 62.7 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.197 0.908 . . . . 0.0 113.2 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.38 -39.71 62.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.443 -0.786 . . . . 0.0 111.863 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.45 -40.93 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.49 -0.756 . . . . 0.0 110.761 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.44 -50.62 71.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.739 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.35 -41.41 63.02 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.086 1.312 . . . . 0.0 113.731 172.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.36 -22.52 66.98 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.7 -38.12 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.507 1.049 . . . . 0.0 110.726 168.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -59.74 -29.54 68.22 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.974 0.91 . . . . 0.0 112.35 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.63 4.93 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.047 1.339 . . . . 0.0 114.339 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 69.73 16.29 7.92 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.699 2.0 . . . . 0.0 115.162 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -83.91 -8.98 59.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.35 1.46 . . . . 0.0 113.392 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.96 141.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.792 2.037 . . . . 0.0 108.259 168.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.82 129.82 36.15 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.484 0.713 . . . . 0.0 110.218 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.6 p -55.26 -32.61 62.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.16 -19.38 53.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.837 1.255 . . . . 0.0 113.613 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -90.51 -16.77 28.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.645 1.178 . . . . 0.0 113.41 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.8 t -79.8 126.25 80.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.399 1.079 . . . . 0.0 110.851 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo . . . . . 0 CA--C 1.537 0.647 0 C-N-CA 123.448 2.765 . . . . 0.0 112.537 -178.906 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -40.65 88.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.931 0.892 . . . . 0.0 110.587 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.94 -36.4 84.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.439 1.496 . . . . 0.0 112.258 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -70.33 -41.41 73.26 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.926 0.891 . . . . 0.0 112.106 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.2 tp -62.64 -43.48 98.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.917 0.781 . . . . 0.0 111.143 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.59 -43.75 98.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.12 0.568 . . . . 0.0 112.52 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.85 88.29 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.167 0.987 . . . . 0.0 112.779 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.85 -45.8 92.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.139 0.976 . . . . 0.0 111.525 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.3 m -58.41 -45.33 88.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.542 0.737 . . . . 0.0 111.708 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.05 -26.12 73.32 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.355 0.979 . . . . 0.0 114.159 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.18 -8.68 58.6 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.498 1.149 . . . . 0.0 112.819 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -119.72 9.53 11.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.203 2.201 . . . . 0.0 112.669 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.02 29.66 12.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.408 1.883 . . . . 0.0 113.648 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.3 mtm -116.77 172.42 7.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.708 2.003 . . . . 0.0 111.547 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 m -141.96 130.72 12.07 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.116 1.766 . . . . 0.0 108.752 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.39 146.23 24.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.988 2.459 . . . . 0.0 110.578 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.56 114.8 23.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.597 1.159 . . . . 0.0 110.806 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.13 156.95 16.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.444 1.498 . . . . 0.0 112.287 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -146.47 151.74 37.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.598 1.559 . . . . 0.0 109.805 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.42 139.87 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 0.0 111.299 -169.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? . . . . . 0 CA--C 1.539 0.551 0 C-N-CA 128.264 2.626 . . . . 0.0 109.662 176.65 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 C--O 1.24 0.596 0 CA-C-O 121.167 0.508 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.75 149.72 49.26 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.836 1.255 . . . . 0.0 111.842 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.2 mtp -118.66 155.05 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.688 1.995 . . . . 0.0 109.081 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.31 154.78 40.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.574 0.75 . . . . 0.0 111.271 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.12 144.85 31.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.243 1.817 . . . . 0.0 109.475 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.24 142.21 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.2 1.0 . . . . 0.0 111.821 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -136.31 160.14 39.62 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.657 1.983 . . . . 0.0 110.482 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.59 136.11 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.746 1.618 . . . . 0.0 108.435 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.45 129.57 42.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 111.674 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.24 1.38 66.88 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.612 1.101 . . . . 0.0 114.601 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -124.08 131.47 53.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.334 1.454 . . . . 0.0 110.437 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -81.87 -12.14 58.6 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -83.77 157.06 22.23 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.461 1.104 . . . . 0.0 113.228 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.35 112.87 13.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.906 1.282 . . . . 0.0 109.348 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.44 142.38 23.81 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.43 148.91 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.5 170.09 26.26 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.116 1.817 . . . . 0.0 113.594 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -155.93 150.69 26.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.573 1.149 . . . . 0.0 112.001 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -168.87 -174.62 2.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.897 1.279 . . . . 0.0 112.381 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 p -77.04 -13.19 59.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.659 1.584 . . . . 0.0 113.407 173.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -148.26 152.33 36.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 112.286 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.08 -29.02 68.68 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.78 -51.45 33.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.339 -0.851 . . . . 0.0 111.369 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.61 -28.89 64.11 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.664 -0.648 . . . . 0.0 112.675 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.2 99.34 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.503 -0.748 . . . . 0.0 111.804 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -64.23 -40.33 95.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.31 0.644 . . . . 0.0 111.899 172.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -61.39 -35.92 78.84 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.277 0.944 . . . . 0.0 112.735 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.77 -37.34 67.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.232 -0.918 . . . . 0.0 111.905 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -44.78 90.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.741 0.701 . . . . 0.0 111.625 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.86 83.98 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.46 1.104 . . . . 0.0 111.537 173.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -54.58 -43.85 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 111.682 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.11 -29.29 62.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.119 0.872 . . . . 0.0 113.348 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.39 -38.09 50.64 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.462 -0.774 . . . . 0.0 112.154 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.98 -40.58 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.271 -0.893 . . . . 0.0 110.43 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -56.52 -49.12 75.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.411 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.87 -41.84 64.69 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.384 1.447 . . . . 0.0 113.767 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.1 -22.63 67.01 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.95 -38.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.511 1.05 . . . . 0.0 110.799 168.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -59.8 -29.69 68.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.302 1.041 . . . . 0.0 112.431 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -105.5 5.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.993 1.317 . . . . 0.0 114.344 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 68.69 17.11 8.94 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.481 1.912 . . . . 0.0 115.041 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.69 -13.57 58.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.374 1.469 . . . . 0.0 113.376 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -137.87 139.69 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 108.888 171.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -85.09 133.64 34.22 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -54.89 -33.95 62.53 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.333 -0.854 . . . . 0.0 113.084 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.96 -21.81 33.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.193 1.397 . . . . 0.0 113.923 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.61 -16.55 28.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.353 1.061 . . . . 0.0 113.514 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.4 124.06 84.22 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.281 1.033 . . . . 0.0 111.098 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo . . . . . 0 C--N 1.351 0.688 0 C-N-CA 123.281 2.654 . . . . 0.0 109.79 174.635 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.2 tp . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -43.75 76.79 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.336 1.054 . . . . 0.0 109.991 174.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -65.76 -32.42 73.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.536 0.734 . . . . 0.0 112.68 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -69.47 -43.01 74.09 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.532 -0.73 . . . . 0.0 112.006 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.8 -43.69 98.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.717 0.69 . . . . 0.0 110.992 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.13 -43.16 99.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.214 0.606 . . . . 0.0 112.63 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.91 83.88 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 112.678 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -61.87 -45.21 94.75 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.951 0.9 . . . . 0.0 111.596 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.2 m -58.62 -45.05 90.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.688 0.795 . . . . 0.0 111.591 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.05 73.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.503 1.049 . . . . 0.0 114.134 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.41 -9.22 58.74 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.425 1.113 . . . . 0.0 112.744 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.327 2.251 . . . . 0.0 112.688 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 64.95 29.58 12.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.456 1.902 . . . . 0.0 113.672 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.2 mtm -116.14 172.21 7.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.799 2.04 . . . . 0.0 111.443 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.5 m -143.04 130.54 10.96 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 126.062 1.745 . . . . 0.0 109.03 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.8 144.19 24.32 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.965 2.443 . . . . 0.0 110.68 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.85 119.72 34.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.861 1.264 . . . . 0.0 110.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.83 157.68 16.92 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.147 1.379 . . . . 0.0 112.783 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.23 146.07 30.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.865 1.666 . . . . 0.0 109.557 172.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.88 146.78 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.112 1.365 . . . . 0.0 110.983 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.471 0.616 0 C-N-CA 126.772 2.029 . . . . 0.0 110.255 177.538 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 CA--C 1.542 0.636 0 CA-C-O 121.057 0.456 . . . . 0.0 110.784 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.0 145.4 48.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.878 1.271 . . . . 0.0 111.497 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.1 mtp -116.97 154.84 30.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.229 1.812 . . . . 0.0 109.583 171.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.6 t -145.12 146.53 31.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.335 1.054 . . . . 0.0 111.722 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -125.7 146.96 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.402 1.881 . . . . 0.0 109.187 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.0 142.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.278 1.031 . . . . 0.0 111.669 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.97 159.29 42.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.409 1.883 . . . . 0.0 110.701 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.25 135.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.953 1.701 . . . . 0.0 108.209 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.66 130.02 44.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.082 0.953 . . . . 0.0 111.784 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.1 0.29 65.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.612 1.101 . . . . 0.0 114.822 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -120.72 135.35 55.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.235 1.414 . . . . 0.0 110.845 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -83.2 -11.69 57.61 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -82.98 159.66 22.18 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.762 1.225 . . . . 0.0 113.02 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.02 119.28 17.73 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.861 1.264 . . . . 0.0 109.504 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 139.29 22.21 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 84.3 mtp -129.36 140.43 51.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.954 0.902 . . . . 0.0 112.577 -170.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.14 165.89 28.97 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.132 1.348 . . . . 0.0 113.686 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.69 153.68 25.14 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.61 1.164 . . . . 0.0 112.581 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.6 t -169.59 -169.97 0.99 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.536 1.534 . . . . 0.0 111.541 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -73.47 -12.03 60.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.71 1.604 . . . . 0.0 113.613 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.64 157.36 42.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.291 1.436 . . . . 0.0 112.443 -170.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.62 -30.8 71.57 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.9 -49.25 47.95 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.39 -0.818 . . . . 0.0 111.888 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -68.37 -30.71 69.71 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.101 0.56 . . . . 0.0 112.311 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.66 86.17 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.19 -0.943 . . . . 0.0 111.612 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.71 -40.09 91.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.792 0.837 . . . . 0.0 112.727 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 99.3 p -69.65 -31.64 69.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.705 1.139 . . . . 0.0 112.371 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -69.04 -41.16 78.03 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.792 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.3 93.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.549 0.613 . . . . 0.0 111.714 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.91 79.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.237 1.015 . . . . 0.0 111.768 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -56.65 -40.4 75.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.669 -0.681 . . . . 0.0 112.008 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.92 -30.48 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.408 1.004 . . . . 0.0 113.216 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -75.53 -39.07 58.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.373 -0.829 . . . . 0.0 112.005 171.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.83 -42.37 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.496 -0.752 . . . . 0.0 110.407 172.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -57.51 -48.31 79.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.865 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -52.95 -42.67 65.68 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.517 1.508 . . . . 0.0 113.39 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.83 -21.23 66.46 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.171 -0.956 . . . . 0.0 113.537 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -81.5 -38.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.604 1.162 . . . . 0.0 110.873 168.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -59.1 -30.67 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.326 1.05 . . . . 0.0 112.143 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.4 pt -106.84 5.55 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.967 1.307 . . . . 0.0 114.387 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 67.17 16.98 10.32 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.504 1.922 . . . . 0.0 115.045 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -79.41 -12.78 59.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 113.264 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.6 t -132.56 134.59 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.53 1.932 . . . . 0.0 107.691 168.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -79.54 131.93 36.16 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.185 -0.322 . . . . 0.0 110.148 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.16 -34.54 63.89 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.439 -0.788 . . . . 0.0 112.883 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.25 -22.4 29.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.313 1.445 . . . . 0.0 113.909 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.05 -16.73 27.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.418 1.087 . . . . 0.0 113.312 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.91 127.65 83.34 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.236 1.014 . . . . 0.0 110.63 -169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 C--N 1.353 0.781 0 C-N-CA 122.739 2.293 . . . . 0.0 109.769 174.812 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 113.891 1.071 . . . . 0.0 113.891 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -33.37 73.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.593 -0.692 . . . . 0.0 111.743 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -79.54 -28.67 41.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.981 0.912 . . . . 0.0 112.484 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -65.68 -44.56 85.84 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.987 0.915 . . . . 0.0 111.709 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.6 -42.81 98.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.317 0.508 . . . . 0.0 111.276 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.38 -42.76 99.67 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.14 77.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 112.707 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 81.6 t90 -60.84 -47.59 85.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.035 0.934 . . . . 0.0 111.316 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.73 -45.46 85.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.013 0.925 . . . . 0.0 112.021 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.1 72.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.28 0.943 . . . . 0.0 113.986 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.9 -7.25 58.64 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.506 1.122 . . . . 0.0 112.79 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -119.58 9.14 11.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.304 2.242 . . . . 0.0 112.64 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.74 31.45 11.86 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.452 1.901 . . . . 0.0 113.515 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.6 mtm -119.35 172.32 7.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.71 2.004 . . . . 0.0 111.643 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.2 m -141.97 129.36 11.49 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 126.227 1.811 . . . . 0.0 108.668 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.91 141.65 21.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.905 2.404 . . . . 0.0 110.588 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.13 117.23 30.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.602 1.161 . . . . 0.0 110.697 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.66 157.43 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.996 1.318 . . . . 0.0 112.672 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.6 149.67 33.98 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.506 1.523 . . . . 0.0 109.907 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.4 mt -132.64 145.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.632 1.573 . . . . 0.0 110.799 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 . . . . . 0 N--CA 1.471 0.599 0 C-N-CA 125.21 1.404 . . . . 0.0 111.45 -171.587 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -127.48 124.17 37.7 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.244 1.018 . . . . 0.0 111.883 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.4 mtp -89.49 155.16 19.48 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.756 1.222 . . . . 0.0 109.085 167.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.23 149.97 40.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.268 1.027 . . . . 0.0 110.149 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.74 153.02 51.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.528 1.531 . . . . 0.0 110.123 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.66 141.81 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.022 1.329 . . . . 0.0 111.228 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.97 153.74 49.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.072 1.749 . . . . 0.0 110.486 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -141.66 134.85 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.798 1.639 . . . . 0.0 108.557 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.59 129.68 42.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.015 0.926 . . . . 0.0 111.649 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.89 65.11 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.566 1.079 . . . . 0.0 114.742 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.22 130.88 54.73 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.182 1.393 . . . . 0.0 110.529 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -76.6 -25.75 54.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -79.21 155.45 28.6 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.338 1.055 . . . . 0.0 113.083 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.78 109.85 11.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.396 1.478 . . . . 0.0 108.603 170.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.82 149.24 26.66 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.1 ptm -151.19 151.94 32.6 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.0 179.67 25.63 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.52 2.009 . . . . 0.0 112.818 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -151.86 155.22 37.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.964 1.306 . . . . 0.0 111.455 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -168.04 -176.09 2.88 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.403 1.481 . . . . 0.0 112.149 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.1 m -79.93 -22.97 42.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.377 1.471 . . . . 0.0 111.471 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -119.6 142.96 47.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.069 1.348 . . . . 0.0 111.391 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -61.59 -30.66 70.82 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -74.32 -42.57 59.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.037 . . . . 0.0 112.541 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.49 -34.05 75.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.795 0.838 . . . . 0.0 111.693 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.74 80.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.417 0.687 . . . . 0.0 111.625 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.13 -41.14 92.02 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.623 0.769 . . . . 0.0 111.995 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.9 m -63.98 -37.69 88.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.661 0.664 . . . . 0.0 111.927 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.55 -37.07 68.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.429 -0.794 . . . . 0.0 111.955 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.41 98.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.781 0.833 . . . . 0.0 112.376 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.24 -49.04 78.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.878 0.871 . . . . 0.0 111.123 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -57.32 -38.05 73.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.2 -38.48 69.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.623 1.169 . . . . 0.0 112.885 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -72.16 -37.72 69.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.831 0.741 . . . . 0.0 112.169 174.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.49 -36.91 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.531 -0.73 . . . . 0.0 110.84 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -49.86 75.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.402 171.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -54.76 -42.94 72.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.224 -0.923 . . . . 0.0 113.086 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.9 mt -63.02 -27.65 69.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.68 -40.41 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.294 0.952 . . . . 0.0 111.049 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -61.96 -30.94 71.26 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -96.91 4.91 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.457 1.103 . . . . 0.0 113.836 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 70.73 18.1 6.36 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.888 2.075 . . . . 0.0 114.625 173.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.74 -6.47 55.99 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.481 1.512 . . . . 0.0 113.363 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 69' ' ' LEU . 94.7 t -136.68 139.26 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 127.011 2.125 . . . . 0.0 107.893 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.21 127.61 34.77 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.073 0.549 . . . . 0.0 110.068 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 p -54.72 -33.9 61.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.83 -19.13 59.27 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.044 1.337 . . . . 0.0 113.689 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.33 -16.43 27.5 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.543 1.137 . . . . 0.0 113.341 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.79 123.76 87.55 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.197 0.999 . . . . 0.0 111.119 -169.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo . . . . . 0 C--N 1.352 0.735 0 C-N-CA 123.492 2.795 . . . . 0.0 111.614 178.476 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tp . . . . . 0 N--CA 1.477 0.92 0 N-CA-C 113.951 1.093 . . . . 0.0 113.951 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -57.92 -51.51 69.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.377 1.071 . . . . 0.0 110.559 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.62 -26.94 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 112.744 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.47 -46.9 78.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.915 0.78 . . . . 0.0 111.518 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.8 tp -63.11 -41.86 99.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.138 0.426 . . . . 0.0 111.219 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -62.91 -42.35 99.76 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.56 73.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.328 1.051 . . . . 0.0 112.625 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -61.07 -46.52 90.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.893 0.877 . . . . 0.0 111.224 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.3 m -58.31 -45.91 87.12 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.657 0.783 . . . . 0.0 111.718 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.38 73.2 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.345 0.974 . . . . 0.0 114.092 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -79.56 -6.38 56.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.358 1.079 . . . . 0.0 112.915 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -119.53 9.29 11.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.301 2.24 . . . . 0.0 112.577 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.82 30.97 12.0 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.501 1.92 . . . . 0.0 113.59 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -118.93 172.53 7.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.718 2.007 . . . . 0.0 111.562 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 m -141.69 130.81 12.37 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.158 1.783 . . . . 0.0 108.557 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.16 146.68 25.55 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.967 2.445 . . . . 0.0 110.806 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.79 116.89 28.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.738 1.215 . . . . 0.0 110.576 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -99.89 157.62 16.39 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 112.372 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.39 150.36 34.52 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.318 1.447 . . . . 0.0 110.053 172.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.1 mt -138.53 145.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.228 1.411 . . . . 0.0 111.288 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 . . . . . 0 N--CA 1.473 0.715 0 C-N-CA 125.742 1.617 . . . . 0.0 111.046 178.199 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 120.841 0.353 . . . . 0.0 111.2 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -134.8 124.08 24.57 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.2 1.4 . . . . 0.0 111.233 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.8 mtp -89.11 154.74 19.93 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.166 1.387 . . . . 0.0 109.395 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.9 t -143.84 145.05 32.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.224 1.01 . . . . 0.0 111.766 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -121.86 151.8 40.26 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.321 1.848 . . . . 0.0 109.563 170.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.74 141.2 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.994 . . . . 0.0 111.242 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -140.45 158.05 44.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.28 1.832 . . . . 0.0 110.404 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.86 135.44 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.551 1.54 . . . . 0.0 108.66 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.08 129.97 44.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 111.606 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.27 65.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.622 1.105 . . . . 0.0 114.604 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -123.86 128.36 49.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.278 1.431 . . . . 0.0 110.351 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -76.63 -22.76 53.67 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.04 155.98 39.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.583 1.153 . . . . 0.0 113.269 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.34 117.74 18.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.342 1.457 . . . . 0.0 109.232 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.39 141.66 21.48 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtt -136.06 144.04 44.99 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.79 173.0 28.86 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.83 1.681 . . . . 0.0 113.501 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -158.78 148.94 19.57 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.84 1.256 . . . . 0.0 111.337 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.4 t -168.15 178.86 4.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.725 1.21 . . . . 0.0 112.868 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 m -78.79 -8.66 58.98 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.756 1.623 . . . . 0.0 112.442 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -142.14 153.69 44.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.051 1.34 . . . . 0.0 112.229 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -67.1 -30.25 70.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -73.15 -41.99 63.32 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.169 0.895 . . . . 0.0 112.495 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.09 -29.48 61.88 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.602 -0.687 . . . . 0.0 111.858 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.66 85.88 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.548 -0.72 . . . . 0.0 111.692 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -63.38 -38.04 89.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.833 0.853 . . . . 0.0 112.252 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 m -63.2 -38.74 92.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.731 0.696 . . . . 0.0 111.565 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -69.26 -41.32 77.08 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.39 -0.819 . . . . 0.0 111.791 174.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.65 98.26 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.715 0.689 . . . . 0.0 112.055 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.95 76.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.28 1.032 . . . . 0.0 111.492 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -58.33 -37.07 74.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.971 -0.538 . . . . 0.0 112.431 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.88 -36.67 67.39 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.955 1.302 . . . . 0.0 112.835 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -70.21 -39.78 74.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.929 0.786 . . . . 0.0 111.821 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.83 -36.26 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.637 -0.664 . . . . 0.0 110.961 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -40.52 89.2 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.204 0.601 . . . . 0.0 111.347 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.62 -44.39 90.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.097 -1.002 . . . . 0.0 112.14 171.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.4 mt -60.78 -34.91 75.2 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.49 -43.56 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.65 0.78 . . . . 0.0 111.221 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -65.16 -24.66 67.45 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.34 5.54 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.411 1.084 . . . . 0.0 113.623 171.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 71.35 17.31 5.88 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.898 2.079 . . . . 0.0 114.586 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -90.1 -5.09 56.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.203 1.401 . . . . 0.0 113.396 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 69' ' ' LEU . 96.3 t -137.54 139.33 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.148 2.179 . . . . 0.0 107.826 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -87.13 129.18 35.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.82 0.448 . . . . 0.0 110.779 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 p -59.14 -30.15 67.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.25 -0.906 . . . . 0.0 113.357 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.54 -23.29 57.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.369 1.068 . . . . 0.0 113.417 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -90.13 -16.31 29.84 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.55 1.14 . . . . 0.0 113.482 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.06 124.42 86.01 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 124.102 0.961 . . . . 0.0 111.545 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo . . . . . 0 C--N 1.352 0.733 0 C-N-CA 123.447 2.765 . . . . 0.0 111.379 177.315 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 N--CA 1.48 1.026 0 N-CA-C 113.99 1.108 . . . . 0.0 113.99 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -68.01 -40.61 82.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.827 0.851 . . . . 0.0 111.199 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.988 0.915 . . . . 0.0 112.606 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.91 -43.88 91.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.885 0.874 . . . . 0.0 111.286 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.4 tp -63.14 -42.09 99.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.485 0.584 . . . . 0.0 111.714 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -62.86 -42.5 99.78 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -38.31 77.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.486 1.114 . . . . 0.0 112.54 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -61.64 -43.32 99.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.552 1.141 . . . . 0.0 111.801 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 99.2 m -61.95 -43.23 99.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.353 1.061 . . . . 0.0 111.868 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.56 -25.23 72.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.487 1.042 . . . . 0.0 114.032 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -78.22 -7.08 56.69 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.358 1.079 . . . . 0.0 112.744 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -119.65 7.47 11.08 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.471 2.308 . . . . 0.0 112.619 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.87 28.47 14.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.416 1.886 . . . . 0.0 113.371 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.9 mtm -112.17 171.94 7.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.758 2.023 . . . . 0.0 111.583 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.5 m -140.86 129.87 12.82 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 126.324 1.85 . . . . 0.0 108.664 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.6 140.58 21.37 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.971 2.447 . . . . 0.0 110.588 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.91 118.05 32.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.582 1.153 . . . . 0.0 110.853 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -101.13 159.37 15.29 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.991 1.316 . . . . 0.0 112.954 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.09 149.23 32.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.405 1.482 . . . . 0.0 110.152 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.74 147.07 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.549 1.539 . . . . 0.0 111.54 -169.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 . . . . . 0 N--CA 1.472 0.675 0 C-N-CA 126.56 1.944 . . . . 0.0 110.285 176.038 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.2 mttt . . . . . 0 CA--C 1.54 0.567 0 CA-C-O 120.794 0.33 . . . . 0.0 111.003 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -135.69 134.06 38.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.377 1.071 . . . . 0.0 112.071 -173.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.2 mtp -102.45 153.47 20.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.581 1.553 . . . . 0.0 108.938 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -148.19 149.25 31.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 111.322 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.8 159.64 40.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.092 1.357 . . . . 0.0 111.073 170.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.95 143.03 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.419 1.487 . . . . 0.0 111.0 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -137.42 155.54 49.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.05 1.74 . . . . 0.0 110.878 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.47 134.32 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.965 1.706 . . . . 0.0 108.461 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.75 128.7 37.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.115 0.966 . . . . 0.0 111.977 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.17 1.21 67.17 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.765 1.174 . . . . 0.0 115.0 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.15 140.74 45.44 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.001 1.32 . . . . 0.0 111.273 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -85.3 0.83 50.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -120.1 155.79 32.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.696 1.599 . . . . 0.0 112.898 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.96 110.3 13.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.358 1.463 . . . . 0.0 108.894 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.06 146.94 29.88 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.6 ptp -150.48 148.44 28.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.35 -179.25 27.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.36 1.934 . . . . 0.0 112.772 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -154.24 160.9 42.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 112.102 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 t -168.32 -179.65 4.07 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.37 1.468 . . . . 0.0 111.844 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.6 m -80.38 -6.56 58.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.23 1.412 . . . . 0.0 112.277 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -142.4 152.05 42.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.203 1.401 . . . . 0.0 112.224 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.48 -27.1 68.25 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.62 -52.51 17.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.773 0.829 . . . . 0.0 111.538 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.66 -27.28 64.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.762 0.825 . . . . 0.0 112.252 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.17 95.82 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.833 -0.542 . . . . 0.0 111.754 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.48 -40.01 92.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.386 0.675 . . . . 0.0 111.93 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.0 m -60.81 -37.12 80.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.407 1.003 . . . . 0.0 112.442 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -74.33 -37.28 63.6 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.278 -0.889 . . . . 0.0 111.657 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.2 99.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.632 0.773 . . . . 0.0 112.361 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.06 81.82 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.199 0.999 . . . . 0.0 111.546 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -56.59 -42.08 78.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.109 0.564 . . . . 0.0 111.819 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.05 -30.92 69.36 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -77.17 -37.41 53.78 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.628 -0.67 . . . . 0.0 112.422 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.72 -39.88 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.268 -0.895 . . . . 0.0 110.836 173.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -56.18 -46.15 79.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.122 0.569 . . . . 0.0 111.47 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.5 -43.56 89.09 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.951 -1.093 . . . . 0.0 113.062 170.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.54 -35.01 79.09 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.955 0.798 . . . . 0.0 113.059 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.62 -41.99 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.575 0.75 . . . . 0.0 111.091 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -66.89 -16.02 64.04 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.31 7.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 125.152 1.381 . . . . 0.0 113.398 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.4 t30 68.12 21.09 8.79 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.676 1.99 . . . . 0.0 114.381 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -86.0 -8.66 57.8 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.806 1.242 . . . . 0.0 113.348 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.09 139.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.167 1.787 . . . . 0.0 108.282 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -87.74 130.12 34.94 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.9 p -54.27 -33.78 59.36 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.26 -0.9 . . . . 0.0 113.131 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.38 -21.28 49.62 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.45 1.5 . . . . 0.0 113.955 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -90.19 -16.84 28.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.498 1.119 . . . . 0.0 113.308 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.79 122.75 87.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.979 0.912 . . . . 0.0 110.913 -169.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo . . . . . 0 C--N 1.352 0.732 0 C-N-CA 123.316 2.677 . . . . 0.0 111.099 178.664 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 N--CA 1.478 0.962 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.36 -44.14 84.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.989 0.915 . . . . 0.0 110.081 170.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -65.74 -31.33 72.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.962 0.905 . . . . 0.0 112.784 172.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -66.75 -44.62 80.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.973 0.806 . . . . 0.0 111.678 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.86 -42.69 99.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.453 0.57 . . . . 0.0 111.245 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.04 -43.05 99.73 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.78 82.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.261 1.024 . . . . 0.0 112.419 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -59.89 -45.96 90.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.263 1.025 . . . . 0.0 111.514 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.8 m -58.01 -44.81 87.48 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.599 0.76 . . . . 0.0 111.778 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.88 73.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.443 1.02 . . . . 0.0 114.145 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -79.03 -7.25 57.94 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.481 1.141 . . . . 0.0 112.9 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.63 8.73 11.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.041 2.136 . . . . 0.0 112.755 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.42 31.15 12.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.406 1.883 . . . . 0.0 113.499 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -117.98 171.77 7.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.716 2.007 . . . . 0.0 111.536 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -140.44 130.71 13.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.24 1.816 . . . . 0.0 108.682 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.18 150.46 29.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.196 2.597 . . . . 0.0 110.953 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.34 115.66 24.0 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.588 1.155 . . . . 0.0 111.05 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.5 158.24 16.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.44 1.496 . . . . 0.0 112.703 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -147.22 145.15 29.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.955 1.702 . . . . 0.0 109.581 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.72 147.13 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.266 1.426 . . . . 0.0 110.849 -169.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 . . . . . 0 N--CA 1.473 0.7 0 C-N-CA 126.194 1.798 . . . . 0.0 110.777 176.026 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mttp . . . . . 0 CA--C 1.539 0.544 0 CA-C-O 120.92 0.391 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.09 137.68 43.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.791 1.236 . . . . 0.0 111.535 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.9 mtp -106.86 155.05 20.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.173 1.789 . . . . 0.0 109.379 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.5 t -147.19 148.87 31.96 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.918 0.887 . . . . 0.0 112.047 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -129.33 151.58 49.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.396 1.879 . . . . 0.0 109.719 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.91 142.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.68 1.192 . . . . 0.0 111.62 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.73 162.25 34.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.242 1.817 . . . . 0.0 110.431 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -139.33 136.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.637 1.575 . . . . 0.0 108.521 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.68 129.29 40.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.208 1.003 . . . . 0.0 111.776 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.24 -0.17 66.01 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.63 1.109 . . . . 0.0 114.806 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.05 140.55 48.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 110.963 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.65 -0.49 50.86 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -112.83 160.37 18.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.703 1.601 . . . . 0.0 113.214 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.92 116.58 14.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.202 1.401 . . . . 0.0 109.412 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.99 149.78 25.69 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -146.64 150.49 35.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.19 175.0 33.31 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.571 1.558 . . . . 0.0 113.491 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.96 154.11 25.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 112.403 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -168.13 -173.72 2.12 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.362 . . . . 0.0 112.025 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.8 p -75.79 -10.34 59.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.5 1.52 . . . . 0.0 113.482 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -150.93 151.62 32.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.271 1.428 . . . . 0.0 111.925 -170.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.26 -30.27 70.67 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -68.25 -48.14 65.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.796 0.839 . . . . 0.0 112.045 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.47 -29.33 59.57 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.778 -0.576 . . . . 0.0 112.327 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.75 88.75 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.42 -0.8 . . . . 0.0 111.837 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -64.36 -38.17 90.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.407 0.683 . . . . 0.0 112.044 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.7 m -64.69 -35.75 82.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.787 0.721 . . . . 0.0 112.278 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -71.48 -39.99 70.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.226 -0.921 . . . . 0.0 111.709 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.93 99.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.652 0.66 . . . . 0.0 111.856 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.11 -49.44 75.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 111.559 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -56.35 -37.89 70.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.105 0.562 . . . . 0.0 112.354 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.9 -35.63 64.68 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.965 1.306 . . . . 0.0 112.737 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -72.55 -37.31 68.29 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.357 -0.839 . . . . 0.0 112.009 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.52 -37.1 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.465 -0.772 . . . . 0.0 110.87 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -40.88 89.32 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.232 0.613 . . . . 0.0 111.423 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -62.95 -45.7 91.2 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.052 -1.03 . . . . 0.0 112.488 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.7 -34.51 74.47 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.91 -42.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.69 0.796 . . . . 0.0 111.237 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -64.68 -26.03 68.2 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 pt -97.55 5.33 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.304 1.042 . . . . 0.0 113.67 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 71.02 17.37 6.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.957 2.103 . . . . 0.0 114.574 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -89.66 -5.33 57.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.248 1.419 . . . . 0.0 113.431 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.41 140.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 127.277 2.231 . . . . 0.0 107.844 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -86.86 130.61 34.4 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.88 -0.513 . . . . 0.0 110.293 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 p -53.57 -34.68 59.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.746 0.818 . . . . 0.0 112.905 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.04 -27.56 8.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.367 1.867 . . . . 0.0 114.022 175.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -93.4 -15.47 25.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.611 1.164 . . . . 0.0 113.549 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.57 123.61 87.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.139 0.976 . . . . 0.0 111.12 -169.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo . . . . . 0 C--N 1.35 0.642 0 C-N-CA 123.452 2.768 . . . . 0.0 111.305 177.951 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -37.13 82.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.531 -0.731 . . . . 0.0 111.627 177.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -78.75 -27.5 44.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.221 1.009 . . . . 0.0 112.49 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.6 -43.93 92.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 111.515 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.28 -43.53 98.61 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.464 0.575 . . . . 0.0 111.345 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -63.36 -42.56 98.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.374 0.67 . . . . 0.0 112.806 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.24 -39.31 78.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 112.451 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -61.05 -45.68 93.8 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.94 0.896 . . . . 0.0 111.342 173.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -58.06 -46.37 85.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.483 0.713 . . . . 0.0 111.669 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.93 73.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.396 0.998 . . . . 0.0 114.157 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -77.69 -8.27 57.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.476 1.11 . . . . 0.0 112.747 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -119.55 8.19 11.25 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.332 2.253 . . . . 0.0 112.769 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm 66.41 28.33 9.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.674 1.989 . . . . 0.0 113.705 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 mtm -116.05 173.45 6.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.666 1.986 . . . . 0.0 111.618 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.0 m -142.79 132.0 11.82 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 126.109 1.764 . . . . 0.0 108.696 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.35 154.58 32.05 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.04 2.494 . . . . 0.0 110.908 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.75 115.8 20.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.656 1.183 . . . . 0.0 110.564 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.23 158.37 16.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.63 1.572 . . . . 0.0 112.292 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.65 148.5 32.12 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.716 1.607 . . . . 0.0 109.927 171.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.7 mt -136.19 145.31 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.23 1.412 . . . . 0.0 111.449 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 . . . . . 0 N--CA 1.472 0.625 0 C-N-CA 126.485 1.914 . . . . 0.0 110.278 176.072 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt . . . . . 0 CA--C 1.54 0.575 0 CA-C-O 120.885 0.374 . . . . 0.0 110.715 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.94 137.66 49.38 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.954 1.301 . . . . 0.0 111.127 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtp -108.55 153.88 22.74 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.881 1.672 . . . . 0.0 109.389 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.18 147.44 32.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.096 0.958 . . . . 0.0 111.84 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -129.29 147.02 51.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.78 2.032 . . . . 0.0 108.774 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.52 143.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.792 0.837 . . . . 0.0 112.294 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.5 mtm105 -138.69 165.26 27.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.676 1.99 . . . . 0.0 110.707 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.57 137.14 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.806 1.642 . . . . 0.0 108.209 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -58.28 129.03 40.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.021 0.928 . . . . 0.0 111.579 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 0.74 65.42 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.662 1.125 . . . . 0.0 114.618 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -124.0 129.59 51.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.295 1.438 . . . . 0.0 110.381 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -83.66 -11.99 56.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -74.25 157.32 36.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.5 1.12 . . . . 0.0 112.69 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.99 119.39 17.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 170.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.87 143.74 22.46 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.7 mtm -138.81 141.65 38.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.281 1.033 . . . . 0.0 112.12 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.72 173.25 31.75 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.035 1.302 . . . . 0.0 113.399 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -155.29 159.49 40.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.621 1.168 . . . . 0.0 112.01 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 t -170.06 -175.86 2.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.414 1.485 . . . . 0.0 112.069 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p -80.93 -7.66 59.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.675 1.59 . . . . 0.0 113.36 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -142.61 150.56 40.46 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.356 1.463 . . . . 0.0 111.8 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.82 -32.57 74.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.029 1.332 . . . . 0.0 113.795 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -71.35 -45.2 63.5 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.311 -0.868 . . . . 0.0 112.285 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.02 -26.48 61.33 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.732 0.413 . . . . 0.0 111.407 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.75 -46.3 72.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.894 0.478 . . . . 0.0 111.432 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.65 -40.4 94.8 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.436 0.694 . . . . 0.0 111.954 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.0 m -63.99 -37.23 86.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.886 0.767 . . . . 0.0 111.789 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.23 -38.12 71.97 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.562 -0.711 . . . . 0.0 111.64 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.49 93.47 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.614 -0.679 . . . . 0.0 112.191 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.75 82.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.609 1.164 . . . . 0.0 111.431 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.83 -40.99 81.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.375 0.534 . . . . 0.0 111.638 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.86 -31.08 70.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.757 0.823 . . . . 0.0 113.087 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -77.7 -40.08 42.57 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.567 -0.708 . . . . 0.0 112.414 172.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.11 -37.89 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.34 -0.85 . . . . 0.0 110.818 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -56.59 -42.86 79.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.284 0.634 . . . . 0.0 111.688 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.36 -43.32 99.1 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.859 -1.15 . . . . 0.0 112.722 170.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' A' ' 75' ' ' VAL . 96.0 mt -61.49 -34.02 74.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.16 0.891 . . . . 0.0 113.038 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.49 -43.25 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.026 0.93 . . . . 0.0 111.137 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -62.49 -25.97 68.29 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.175 0.99 . . . . 0.0 113.326 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -101.1 6.01 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.619 1.168 . . . . 0.0 113.865 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 70.89 16.96 6.47 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.834 2.054 . . . . 0.0 114.669 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -88.57 -5.48 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 113.448 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 69' ' ' LEU . 90.6 t -136.84 138.7 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.906 2.082 . . . . 0.0 108.155 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.82 125.69 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.901 0.48 . . . . 0.0 109.931 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 p -55.31 -32.79 62.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.95 -19.74 61.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.097 1.359 . . . . 0.0 113.475 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -92.0 -15.8 27.41 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.633 1.173 . . . . 0.0 113.342 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.8 124.06 83.56 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.132 0.973 . . . . 0.0 111.52 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 CA--C 1.538 0.719 0 C-N-CA 123.803 3.002 . . . . 0.0 112.706 178.729 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 111.791 -0.524 . . . . 0.0 111.791 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 16.2 m -67.64 -13.93 62.5 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 -172.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 35.2 p -83.02 -5.07 58.96 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.416 1.486 . . . . 0.0 113.955 173.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 79.23 -132.03 11.13 Favored Glycine 0 CA--C 1.53 1.019 0 C-N-CA 124.663 1.125 . . . . 0.0 111.881 -178.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 82.6 p -156.23 163.35 39.68 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.158 1.383 . . . . 0.0 111.772 -179.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.8 m -142.8 19.42 1.99 Allowed 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.321 1.048 . . . . 0.0 112.686 -169.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.47 -39.54 97.81 Favored Glycine 0 N--CA 1.47 0.902 0 O-C-N 121.178 -0.951 . . . . 0.0 114.65 -167.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp -78.01 -34.56 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 118.444 1.122 . . . . 0.0 112.868 179.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -62.73 -46.95 85.71 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.612 1.165 . . . . 0.0 109.983 172.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -65.05 -33.85 77.03 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.331 1.052 . . . . 0.0 112.523 174.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 70.2 t80 -68.29 -45.27 73.52 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.988 0.813 . . . . 0.0 111.513 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.9 tp -63.46 -43.23 97.93 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 118.405 0.548 . . . . 0.0 111.234 174.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 47.1 t80 -63.36 -42.92 98.91 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 112.714 0.635 . . . . 0.0 112.714 178.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.42 -39.22 81.66 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.378 1.071 . . . . 0.0 112.436 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 88.5 t90 -60.75 -46.01 92.11 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.582 0.753 . . . . 0.0 111.462 174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.6 m -58.99 -46.22 88.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.504 0.722 . . . . 0.0 111.697 172.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.93 -27.32 73.35 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.4 1.0 . . . . 0.0 114.081 -177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.28 -8.53 57.77 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.402 1.101 . . . . 0.0 112.705 173.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.1 mtp180 -119.69 9.52 11.44 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 127.335 2.254 . . . . 0.0 112.503 -178.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 65.08 31.1 11.29 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 126.597 1.959 . . . . 0.0 113.618 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 62.4 mtm -118.98 173.31 6.97 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 126.779 2.031 . . . . 0.0 111.57 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.19 132.07 12.43 Favored Pre-proline 0 N--CA 1.477 0.88 0 C-N-CA 126.248 1.819 . . . . 0.0 108.729 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -76.99 148.38 27.77 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 122.955 2.436 . . . . 0.0 110.936 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.73 115.71 23.84 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.878 1.271 . . . . 0.0 110.7 -179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -97.37 153.88 17.81 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.257 1.423 . . . . 0.0 111.839 -179.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 87.6 tt0 -147.2 129.38 15.6 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.761 1.624 . . . . 0.0 109.004 -175.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.2 mt -130.19 147.47 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 C-N-CA 124.248 1.019 . . . . 0.0 112.291 -168.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 60.6 ttt85 -134.07 139.85 46.25 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 126.931 2.093 . . . . 0.0 110.453 176.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.23 138.14 31.89 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.566 1.146 . . . . 0.0 110.75 172.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -145.51 165.01 11.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 C-N-CA 125.567 1.547 . . . . 0.0 111.265 -173.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.49 -165.84 43.05 Favored Glycine 0 CA--C 1.534 1.242 0 C-N-CA 124.025 0.822 . . . . 0.0 114.53 175.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -64.28 142.34 58.45 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.458 1.503 . . . . 0.0 113.066 -175.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 41.0 ttmt -60.76 -41.45 95.48 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -176.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 -81.36 -32.58 32.85 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.364 1.066 . . . . 0.0 112.705 178.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.7 mtt85 -117.21 67.75 0.74 Allowed 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 126.322 1.849 . . . . 0.0 109.889 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 20.5 tp60 -74.37 152.25 39.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.7 1.2 . . . . 0.0 111.879 -169.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -133.22 161.17 35.18 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 126.303 1.841 . . . . 0.0 110.672 176.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -135.4 142.63 45.69 Favored 'General case' 0 N--CA 1.462 0.168 0 C-N-CA 124.641 1.177 . . . . 0.0 111.378 -175.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.0 mtp -114.51 148.88 37.25 Favored 'General case' 0 N--CA 1.464 0.263 0 C-N-CA 126.061 1.745 . . . . 0.0 109.19 172.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 35.0 t -139.2 145.02 38.78 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.778 1.231 . . . . 0.0 110.922 -176.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -127.3 149.4 50.05 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 126.445 1.898 . . . . 0.0 108.483 171.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -140.08 139.6 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.429 0.692 . . . . 0.0 111.665 175.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 41.9 mtm105 -136.35 160.1 39.74 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.961 2.104 . . . . 0.0 110.565 -173.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 49.1 t -140.67 136.52 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.665 1.586 . . . . 0.0 108.5 177.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.23 129.07 40.31 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.054 0.942 . . . . 0.0 111.668 -178.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.99 1.79 67.06 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.498 1.047 . . . . 0.0 114.584 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -125.21 129.03 49.27 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 125.391 1.477 . . . . 0.0 110.145 177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -83.32 -13.17 55.67 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.819 1.044 . . . . 0.0 113.819 -173.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -81.68 157.69 24.53 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.6 1.16 . . . . 0.0 113.021 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -131.51 120.53 23.08 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.839 1.256 . . . . 0.0 109.66 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -76.94 139.82 24.03 Favored Glycine 0 N--CA 1.468 0.784 0 N-CA-C 110.041 -1.224 . . . . 0.0 110.041 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 75.4 mtm -123.97 141.62 51.88 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.916 1.286 . . . . 0.0 112.482 -169.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.4 166.9 30.74 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 125.141 1.353 . . . . 0.0 113.644 177.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 12.0 p30 -157.36 159.91 37.94 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 124.686 1.194 . . . . 0.0 112.087 174.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.4 t -171.95 -171.04 0.82 Allowed 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.909 1.683 . . . . 0.0 111.508 174.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 66.6 p -73.1 -8.77 57.26 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 126.098 1.759 . . . . 0.0 113.474 170.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.9 p30 -151.42 152.63 33.32 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.493 1.517 . . . . 0.0 111.751 -171.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -64.61 -31.21 72.33 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 113.702 1.001 . . . . 0.0 113.702 -175.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.4 tttp -68.82 -47.66 65.49 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.198 0.999 . . . . 0.0 112.589 -177.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -69.72 -30.87 68.6 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.605 0.762 . . . . 0.0 111.711 175.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.71 -44.73 77.01 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.989 -0.444 . . . . 0.0 111.421 174.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 63.4 mt-30 -61.1 -41.37 96.55 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 124.045 0.938 . . . . 0.0 112.105 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 70.1 m -64.76 -39.03 92.95 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 118.802 0.728 . . . . 0.0 111.813 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 73.1 m-20 -67.77 -41.4 83.33 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 121.866 -0.521 . . . . 0.0 111.869 173.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.56 -44.66 93.47 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 123.454 0.702 . . . . 0.0 112.11 176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.95 -49.31 78.17 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.604 1.162 . . . . 0.0 111.197 174.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -58.1 -39.53 78.85 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 118.74 -0.648 . . . . 0.0 111.964 177.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -73.28 -30.77 63.63 Favored 'General case' 0 CA--C 1.543 0.699 0 CA-C-N 119.321 0.964 . . . . 0.0 113.514 179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -75.51 -39.15 58.86 Favored 'General case' 0 N--CA 1.468 0.459 0 O-C-N 121.283 -0.886 . . . . 0.0 111.844 171.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.4 t -65.05 -38.33 82.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 O-C-N 121.291 -0.88 . . . . 0.0 110.605 173.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -57.15 -48.06 79.64 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 118.648 -0.691 . . . . 0.0 110.479 169.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 19.9 t80 -53.09 -40.66 64.26 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 120.216 1.371 . . . . 0.0 113.817 170.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.1 mt -63.45 -22.49 66.91 Favored 'General case' 0 N--CA 1.473 0.706 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 173.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 38.6 t -81.92 -37.32 14.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 C-N-CA 124.223 1.009 . . . . 0.0 110.948 168.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -61.41 -29.88 70.21 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 124.24 1.016 . . . . 0.0 112.313 175.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.6 pt -101.5 3.47 10.63 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 C-N-CA 125.013 1.325 . . . . 0.0 114.07 173.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.4 t30 66.37 23.24 10.68 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 126.527 1.931 . . . . 0.0 114.692 173.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 61.5 mm-40 -84.86 -12.85 52.65 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 125.015 1.326 . . . . 0.0 113.014 172.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 80.3 t -139.68 142.78 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.91 0 C-N-CA 126.396 1.878 . . . . 0.0 109.096 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 51.7 mtpt -86.57 132.72 33.83 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.278 0.631 . . . . 0.0 111.07 169.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 21.0 p -55.46 -33.38 63.59 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -56.34 -22.28 29.81 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 125.147 1.379 . . . . 0.0 113.839 177.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.35 -16.32 27.63 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.476 1.11 . . . . 0.0 113.506 178.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 37.0 t -83.09 127.53 68.83 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.347 1.059 . . . . 0.0 111.093 -168.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.36 159.61 36.26 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 123.329 2.686 . . . . 0.0 112.436 179.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.06 138.75 52.33 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.088 0.955 . . . . 0.0 111.731 175.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.7 p -66.71 -19.83 26.23 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.715 0 C-N-CA 125.417 1.487 . . . . 0.0 114.852 -175.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 80.03 9.43 86.68 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.617 1.103 . . . . 0.0 115.106 176.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 61.6 mt -124.9 140.52 47.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 126.787 2.035 . . . . 0.0 109.146 -173.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 11.3 m -136.46 146.56 56.3 Favored Pre-proline 0 N--CA 1.473 0.707 0 C-N-CA 125.787 1.635 . . . . 0.0 110.731 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.27 157.71 37.38 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 123.479 2.786 . . . . 0.0 111.959 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -71.86 158.39 53.0 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.613 2.875 . . . . 0.0 111.423 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.6 148.23 65.62 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.568 2.845 . . . . 0.0 111.538 178.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 18.9 m -75.84 -5.85 47.92 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -174.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -85.03 177.69 50.88 Favored Glycine 0 CA--C 1.542 1.754 0 C-N-CA 124.974 1.273 . . . . 0.0 113.968 179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -58.56 149.84 73.09 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 124.304 3.336 . . . . 0.0 112.984 176.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 2.8 t -143.61 16.06 1.81 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 124.116 0.966 . . . . 0.0 112.716 -176.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.0 m -84.03 -5.61 59.26 Favored 'General case' 0 N--CA 1.477 0.913 0 O-C-N 120.406 -1.434 . . . . 0.0 114.344 -173.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 125.47 1.509 . . . . 0.0 112.775 -179.212 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.556 0 N-CA-C 111.557 -0.617 . . . . 0.0 111.557 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 18.9 m -84.02 -6.05 59.34 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -173.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.7 t -162.9 170.23 18.5 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 126.021 1.729 . . . . 0.0 110.948 -178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -159.11 171.93 35.73 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 125.119 1.342 . . . . 0.0 113.842 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 7.9 t -162.87 -167.55 1.55 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.683 1.593 . . . . 0.0 110.904 -177.638 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 47.2 t -162.22 152.33 16.68 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.818 1.647 . . . . 0.0 110.842 -175.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.43 -38.04 90.68 Favored Glycine 0 N--CA 1.469 0.898 0 O-C-N 121.646 -0.659 . . . . 0.0 113.884 -170.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.33 -32.91 19.24 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.478 1.139 . . . . 0.0 112.407 176.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.51 -44.51 82.35 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.189 0.996 . . . . 0.0 110.191 174.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -66.4 -30.92 71.4 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.428 1.091 . . . . 0.0 112.802 172.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.9 t80 -68.26 -43.42 77.87 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.043 0.838 . . . . 0.0 111.404 176.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.4 tp -62.71 -43.94 97.5 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.527 0.603 . . . . 0.0 111.199 172.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.5 t80 -61.81 -41.69 98.08 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 178.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.69 -38.63 77.07 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.599 1.16 . . . . 0.0 112.557 175.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.9 t90 -63.23 -41.54 99.12 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.916 0.887 . . . . 0.0 111.916 174.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -63.03 -47.14 84.31 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.091 0.556 . . . . 0.0 111.275 170.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.86 -28.46 73.05 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.305 0.955 . . . . 0.0 113.681 -171.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 58.7 pttt -79.23 -17.53 54.61 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 118.312 1.056 . . . . 0.0 112.751 176.238 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 50.5 mtt180 -99.01 7.64 45.79 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 127.597 2.359 . . . . 0.0 112.957 172.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 66.25 28.72 9.9 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 126.728 2.011 . . . . 0.0 113.85 179.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 69.0 mtm -114.52 172.87 6.76 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 127.157 2.183 . . . . 0.0 111.519 178.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 60.1 m -140.52 131.76 13.99 Favored Pre-proline 0 N--CA 1.478 0.968 0 C-N-CA 125.972 1.709 . . . . 0.0 108.955 174.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -77.2 143.75 22.76 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.025 2.483 . . . . 0.0 110.687 176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.5 117.13 29.05 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.805 1.242 . . . . 0.0 110.779 -178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -100.05 157.99 16.16 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 125.189 1.396 . . . . 0.0 112.672 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -146.93 144.69 29.41 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.802 1.641 . . . . 0.0 109.445 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 72.2 mt -134.7 147.24 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 125.094 1.358 . . . . 0.0 111.188 -169.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -137.38 140.01 41.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 126.641 1.977 . . . . 0.0 110.117 175.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -93.23 141.36 28.52 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.778 0.831 . . . . 0.0 111.227 172.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.9 m -146.87 161.19 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.997 0 C-N-CA 126.001 1.72 . . . . 0.0 111.101 -175.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.72 -160.31 41.16 Favored Glycine 0 CA--C 1.534 1.251 0 C-N-CA 124.069 0.843 . . . . 0.0 114.375 176.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -60.18 138.99 57.8 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 125.502 1.521 . . . . 0.0 113.15 -175.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.5 tptt -63.67 -42.11 98.09 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 113.958 1.096 . . . . 0.0 113.958 -175.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 53.4 t30 -78.32 -34.07 48.86 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.277 1.031 . . . . 0.0 113.022 -179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 2.2 tpm_? -117.61 75.64 1.0 Allowed 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 126.136 1.774 . . . . 0.0 109.128 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.9 tp60 -78.31 136.36 37.71 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 124.432 1.093 . . . . 0.0 111.403 -170.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 42.9 mtpt -104.25 157.86 16.85 Favored 'General case' 0 C--O 1.236 0.373 0 C-N-CA 124.028 0.931 . . . . 0.0 110.757 169.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -132.34 132.33 42.81 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 124.778 1.231 . . . . 0.0 109.917 -176.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.3 mtp -102.62 151.76 21.97 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 125.93 1.692 . . . . 0.0 109.092 170.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.2 t -144.1 147.28 33.54 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 123.956 0.902 . . . . 0.0 111.764 -178.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.8 mt-10 -126.7 145.68 50.49 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.858 2.063 . . . . 0.0 108.542 175.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -139.15 140.41 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 123.88 0.872 . . . . 0.0 111.77 174.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.3 mtm-85 -137.03 159.92 40.46 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.821 2.048 . . . . 0.0 110.883 -176.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 46.3 t -140.23 134.49 35.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 126.014 1.726 . . . . 0.0 108.411 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.61 129.49 41.84 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.028 0.931 . . . . 0.0 111.669 -177.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.86 1.84 65.22 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.596 1.093 . . . . 0.0 114.669 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -122.08 134.11 54.77 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 125.29 1.436 . . . . 0.0 110.464 177.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 10.6 p-10 -80.97 -12.13 59.44 Favored 'General case' 0 CA--C 1.546 0.79 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.6 t80 -91.19 159.23 16.18 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 125.045 1.338 . . . . 0.0 113.191 -176.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.76 121.12 22.56 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.876 1.271 . . . . 0.0 109.684 170.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.7 141.28 23.44 Favored Glycine 0 N--CA 1.467 0.764 0 N-CA-C 110.097 -1.201 . . . . 0.0 110.097 175.26 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 73.1 mtm -138.9 142.35 38.52 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.777 0.831 . . . . 0.0 112.305 -170.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.54 174.97 32.83 Favored Glycine 0 N--CA 1.468 0.824 0 C-N-CA 124.933 1.254 . . . . 0.0 113.624 -179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 p30 -152.03 161.5 42.54 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.244 1.018 . . . . 0.0 112.285 173.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -167.03 -171.0 1.66 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.082 1.353 . . . . 0.0 112.137 175.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -81.52 -6.81 59.34 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 126.56 1.944 . . . . 0.0 113.606 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -152.01 159.25 43.78 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.997 1.719 . . . . 0.0 111.655 -178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -67.03 -29.45 69.26 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 114.537 1.31 . . . . 0.0 114.537 -174.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -73.83 -45.64 50.01 Favored 'General case' 0 N--CA 1.476 0.839 0 O-C-N 121.153 -0.967 . . . . 0.0 112.3 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.47 -29.72 67.45 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 121.666 -0.646 . . . . 0.0 112.345 174.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.03 -45.48 77.35 Favored 'General case' 0 CA--C 1.54 0.581 0 O-C-N 121.699 -0.626 . . . . 0.0 111.771 173.322 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.6 mt-30 -62.04 -38.26 88.04 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 123.584 0.753 . . . . 0.0 112.001 171.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.1 m -63.26 -38.13 89.97 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 118.617 0.644 . . . . 0.0 112.106 176.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 99.1 m-20 -75.5 -35.73 60.73 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.332 0.653 . . . . 0.0 111.716 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.76 -45.65 88.83 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 123.418 0.687 . . . . 0.0 111.789 170.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.57 -47.58 85.55 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.212 1.005 . . . . 0.0 111.439 175.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -56.99 -38.05 72.49 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-O 118.838 -0.601 . . . . 0.0 112.132 177.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -76.2 -27.93 57.07 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -76.99 -37.93 54.17 Favored 'General case' 0 N--CA 1.469 0.514 0 O-C-N 121.241 -0.912 . . . . 0.0 111.695 169.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.0 t -62.04 -41.39 90.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 O-C-N 121.49 -0.756 . . . . 0.0 110.473 171.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.26 -49.78 73.23 Favored 'General case' 0 CA--C 1.535 0.366 0 CA-C-O 118.492 -0.766 . . . . 0.0 110.726 169.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -52.57 -41.92 64.01 Favored 'General case' 0 N--CA 1.475 0.795 0 CA-C-N 120.404 1.456 . . . . 0.0 113.696 172.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 87.2 mt -64.05 -22.17 66.82 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.677 0.991 . . . . 0.0 113.677 174.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.46 -36.61 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 124.407 1.083 . . . . 0.0 110.935 168.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 53.1 mtt180 -60.66 -29.91 69.57 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.57 1.148 . . . . 0.0 112.316 174.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 17.1 pt -103.8 4.62 10.56 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.074 1.349 . . . . 0.0 113.986 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 20.2 m120 66.86 19.1 10.69 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 126.521 1.928 . . . . 0.0 114.934 172.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -81.15 -12.28 59.26 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.349 1.46 . . . . 0.0 113.238 171.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 97.8 t -134.33 142.49 40.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 126.35 1.86 . . . . 0.0 108.944 170.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -93.44 129.16 39.71 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 124.417 1.087 . . . . 0.0 109.843 171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 36.3 p -60.0 -27.37 66.81 Favored 'General case' 0 N--CA 1.473 0.697 0 O-C-N 120.91 -1.119 . . . . 0.0 113.718 -172.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -61.29 -19.74 62.1 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.313 1.045 . . . . 0.0 113.351 177.696 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.1 mm-40 -86.01 -17.45 35.22 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.359 1.064 . . . . 0.0 113.159 176.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.8 t -79.82 127.31 77.97 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.34 1.056 . . . . 0.0 110.406 -169.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_endo -71.42 134.25 24.16 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.122 2.548 . . . . 0.0 111.268 -178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.36 168.02 24.69 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.174 1.79 . . . . 0.0 110.954 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -64.06 -20.38 26.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 C-N-CA 124.566 1.146 . . . . 0.0 113.273 176.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.2 149.83 21.15 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.111 1.815 . . . . 0.0 111.486 171.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.7 mt -124.6 138.38 54.23 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 C-N-CA 125.11 1.364 . . . . 0.0 109.185 -178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.9 t -139.22 142.05 31.49 Favored Pre-proline 0 N--CA 1.479 0.994 0 C-N-CA 126.424 1.89 . . . . 0.0 108.579 -170.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_exo -50.71 146.75 19.64 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 124.105 3.204 . . . . 0.0 113.712 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -74.41 154.58 45.61 Favored 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.534 2.823 . . . . 0.0 112.745 -169.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.05 170.46 20.36 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 124.161 3.241 . . . . 0.0 111.632 173.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 52.7 p -71.18 -11.93 61.2 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.077 1.14 . . . . 0.0 114.077 175.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -161.72 142.56 8.11 Favored Glycine 0 CA--C 1.539 1.54 0 C-N-CA 126.044 1.783 . . . . 0.0 111.867 171.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.81 136.46 20.85 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.246 2.63 . . . . 0.0 111.297 -175.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 7.1 t -151.65 14.95 0.67 Allowed 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 13.7 m 67.29 -7.49 0.52 Allowed 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 127.464 2.306 . . . . 0.0 115.985 177.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 C-N-CA 125.954 1.74 . . . . 0.0 112.931 178.625 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.507 0 N-CA-C 111.889 -0.484 . . . . 0.0 111.889 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 49.5 p -161.77 -78.08 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 124.576 1.15 . . . . 0.0 111.315 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 46.5 t -167.22 146.07 5.05 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 126.716 2.006 . . . . 0.0 110.822 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -103.03 2.83 47.88 Favored Glycine 0 CA--C 1.534 1.237 0 C-N-CA 124.897 1.237 . . . . 0.0 113.686 171.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 58.8 m -89.67 145.87 24.92 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 118.561 1.18 . . . . 0.0 113.665 -169.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 37.3 t -159.5 131.99 6.65 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.0 1.72 . . . . 0.0 109.093 173.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -68.26 -39.92 87.77 Favored Glycine 0 N--CA 1.468 0.806 0 CA-C-O 119.417 -0.657 . . . . 0.0 113.915 -168.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.8 tp -77.23 -34.23 21.03 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 CA-C-N 118.559 1.179 . . . . 0.0 112.528 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.0 tmtt? -67.81 -40.81 83.8 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.183 0.993 . . . . 0.0 110.601 175.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.5 t30 -67.89 -33.79 75.4 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 124.315 1.046 . . . . 0.0 112.703 171.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -67.72 -41.43 83.54 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.91 0.777 . . . . 0.0 111.97 -178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.24 -44.39 96.68 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 118.75 0.705 . . . . 0.0 111.285 173.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.9 t80 -63.3 -42.56 99.07 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.34 0.656 . . . . 0.0 112.76 178.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.46 -40.77 80.91 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.548 1.139 . . . . 0.0 112.45 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.3 t90 -60.31 -45.41 93.47 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 124.11 0.964 . . . . 0.0 111.448 174.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 93.2 m -58.15 -45.71 86.93 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 123.474 0.71 . . . . 0.0 111.652 172.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.07 -26.86 73.31 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 124.504 1.049 . . . . 0.0 114.102 -178.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -78.1 -8.25 58.01 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.598 1.199 . . . . 0.0 112.853 172.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.115 2.166 . . . . 0.0 112.769 -178.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.3 mttm 64.41 30.5 13.13 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 126.39 1.876 . . . . 0.0 113.593 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.5 mtm -117.66 174.08 6.37 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 126.731 2.012 . . . . 0.0 111.415 179.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 19.6 m -143.53 133.31 11.83 Favored Pre-proline 0 N--CA 1.478 0.933 0 C-N-CA 125.825 1.65 . . . . 0.0 108.791 173.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -76.66 153.75 34.33 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 122.961 2.441 . . . . 0.0 110.97 177.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.22 116.17 20.89 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.687 1.195 . . . . 0.0 110.752 -179.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.71 157.31 16.78 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 125.456 1.502 . . . . 0.0 112.225 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -144.62 148.49 34.39 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.07 1.748 . . . . 0.0 109.692 173.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 56.9 mt -137.14 146.74 27.61 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 125.021 1.328 . . . . 0.0 111.89 -168.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -134.34 141.31 46.86 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 126.699 2.0 . . . . 0.0 110.196 175.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.7 138.74 32.16 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.415 1.086 . . . . 0.0 111.011 172.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.0 m -147.08 176.39 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 126.07 1.748 . . . . 0.0 110.951 -173.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.33 -158.23 28.69 Favored Glycine 0 CA--C 1.531 1.058 0 C-N-CA 123.979 0.799 . . . . 0.0 113.869 174.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -84.75 150.29 25.18 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 124.915 1.286 . . . . 0.0 112.47 -174.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 ttpp -61.72 -35.89 79.34 Favored 'General case' 0 CA--C 1.547 0.831 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -179.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -87.95 -22.95 24.03 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 125.068 1.347 . . . . 0.0 113.357 177.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -134.0 83.13 2.02 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.677 1.591 . . . . 0.0 110.335 176.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -82.44 152.28 26.19 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.65 1.18 . . . . 0.0 111.416 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -136.01 164.98 26.73 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.612 1.965 . . . . 0.0 110.974 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -135.2 141.82 45.92 Favored 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 124.85 1.26 . . . . 0.0 111.251 -175.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 56.6 mtp -113.21 153.48 28.27 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.171 1.789 . . . . 0.0 109.249 171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -146.58 146.49 30.47 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.011 0.924 . . . . 0.0 111.587 -177.056 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -128.04 149.23 50.47 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.947 1.699 . . . . 0.0 109.322 174.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -140.2 143.57 29.43 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 124.211 1.004 . . . . 0.0 111.966 177.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -137.03 165.63 25.56 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.512 1.925 . . . . 0.0 110.62 179.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.51 138.11 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 125.886 1.674 . . . . 0.0 108.158 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -58.51 128.42 37.09 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.938 0.895 . . . . 0.0 111.707 -178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.3 0.69 65.12 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 124.666 1.127 . . . . 0.0 114.765 -177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -122.96 129.76 51.96 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 125.202 1.401 . . . . 0.0 110.577 177.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -79.81 -20.88 45.06 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 113.636 0.976 . . . . 0.0 113.636 -174.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -70.82 157.95 37.21 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.643 1.177 . . . . 0.0 113.324 179.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.9 116.56 15.76 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 124.878 1.271 . . . . 0.0 109.591 169.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.29 143.52 22.91 Favored Glycine 0 C--N 1.338 0.669 0 N-CA-C 109.998 -1.241 . . . . 0.0 109.998 175.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 44.3 mtt -137.89 144.29 41.27 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.65 0.78 . . . . 0.0 112.953 -169.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.68 169.45 27.85 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 125.851 1.691 . . . . 0.0 113.36 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.8 p30 -158.07 152.07 24.09 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.33 1.052 . . . . 0.0 112.186 174.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.6 t -169.08 -175.09 2.2 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 124.924 1.289 . . . . 0.0 112.264 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.7 p -78.34 -9.54 59.3 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.717 1.607 . . . . 0.0 113.402 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 48.1 m-80 -142.16 145.5 34.26 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.535 1.534 . . . . 0.0 111.44 -176.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.33 -30.94 70.82 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.69 1.196 . . . . 0.0 113.492 -179.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -68.51 -46.18 70.31 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 124.651 1.18 . . . . 0.0 111.891 179.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -77.04 -27.89 54.63 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.553 0.741 . . . . 0.0 111.945 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.64 -45.27 87.52 Favored 'General case' 0 CA--C 1.542 0.67 0 O-C-N 121.582 -0.699 . . . . 0.0 111.581 170.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -62.12 -38.75 90.12 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.688 0.795 . . . . 0.0 112.033 171.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 53.1 m -65.03 -36.31 83.95 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 121.656 -0.652 . . . . 0.0 112.255 177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -72.33 -36.95 68.98 Favored 'General case' 0 CA--C 1.542 0.639 0 O-C-N 121.458 -0.776 . . . . 0.0 111.967 173.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.1 -43.66 97.86 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 121.576 -0.703 . . . . 0.0 111.536 173.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.3 -48.96 77.58 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.306 1.042 . . . . 0.0 111.618 175.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -52.09 -44.43 64.38 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.169 0.988 . . . . 0.0 111.625 174.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -71.75 -35.16 70.03 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.95 0.9 . . . . 0.0 113.118 -178.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -74.91 -37.6 62.02 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 121.686 -0.633 . . . . 0.0 112.291 174.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.5 t -62.88 -40.89 90.56 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 O-C-N 121.258 -0.901 . . . . 0.0 110.218 172.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 11.0 m-80 -61.79 -31.68 71.91 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.808 0.67 . . . . 0.0 112.808 171.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 13.3 t80 -66.64 -44.62 81.49 Favored 'General case' 0 N--CA 1.475 0.79 0 O-C-N 120.0 -1.687 . . . . 0.0 111.993 168.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' HG23 ' A' ' 75' ' ' VAL . 94.3 mt -61.46 -33.2 73.36 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-N 118.647 0.658 . . . . 0.0 112.748 176.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 73.1 t -68.26 -44.46 83.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 124.026 0.93 . . . . 0.0 111.336 169.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.6 mtm180 -63.05 -22.5 66.9 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 113.634 0.976 . . . . 0.0 113.634 177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.2 pt -104.56 6.49 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 124.77 1.228 . . . . 0.0 113.983 171.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.0 t30 67.51 21.29 9.59 Favored 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 126.446 1.899 . . . . 0.0 114.63 174.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -90.36 -5.72 55.85 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 125.367 1.467 . . . . 0.0 113.195 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 69' ' ' LEU . 70.0 t -136.11 136.88 49.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 C-N-CA 127.034 2.133 . . . . 0.0 107.781 168.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -83.51 126.69 33.05 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 169.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.56 -32.49 63.04 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.336 -0.852 . . . . 0.0 113.246 -177.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -60.92 -19.55 60.75 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.087 1.355 . . . . 0.0 113.561 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -90.76 -16.08 29.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.614 1.166 . . . . 0.0 113.322 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.6 t -78.19 124.11 85.88 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 124.238 1.015 . . . . 0.0 110.978 -169.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -80.83 153.74 19.78 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 123.492 2.795 . . . . 0.0 111.844 178.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -122.43 167.99 12.64 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.677 1.591 . . . . 0.0 111.891 176.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.89 -14.19 14.68 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.757 0 C-N-CA 125.713 1.605 . . . . 0.0 115.113 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.78 176.91 37.36 Favored Glycine 0 CA--C 1.53 1.028 0 C-N-CA 125.979 1.752 . . . . 0.0 112.187 176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 1.3 pp -84.6 157.62 3.55 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 C-N-CA 126.219 1.807 . . . . 0.0 111.722 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 6.1 t 66.56 81.29 0.21 Allowed Pre-proline 0 N--CA 1.479 1.005 0 C-N-CA 126.379 1.872 . . . . 0.0 111.745 175.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -61.36 150.64 84.0 Favored 'Trans proline' 0 CA--C 1.541 0.863 0 C-N-CA 123.705 2.937 . . . . 0.0 112.901 178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -68.4 136.11 35.86 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.145 2.563 . . . . 0.0 110.486 175.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -73.08 -14.1 26.07 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.472 2.781 . . . . 0.0 114.27 -170.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 53.1 m -115.0 4.87 14.84 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.731 1.213 . . . . 0.0 113.157 175.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.9 178.01 43.3 Favored Glycine 0 CA--C 1.543 1.798 0 C-N-CA 124.594 1.093 . . . . 0.0 113.677 -174.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -76.1 159.83 37.03 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 124.017 3.145 . . . . 0.0 111.262 173.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 94.0 p -160.62 158.48 29.03 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.559 1.144 . . . . 0.0 112.467 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 19.8 m -87.54 -4.68 58.97 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -174.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.246 0 C-N-CA 125.253 1.406 . . . . 0.0 113.197 -177.285 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 71.9 p -165.16 165.7 19.58 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.446 1.499 . . . . 0.0 111.693 -176.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 55.9 p -162.58 155.83 20.06 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.826 1.25 . . . . 0.0 112.276 -175.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -86.27 -174.95 49.71 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.706 1.146 . . . . 0.0 113.225 175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 5.5 t -168.45 -176.19 2.76 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 126.084 1.754 . . . . 0.0 111.131 178.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.8 t -155.55 145.45 21.44 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.132 1.373 . . . . 0.0 111.45 175.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -72.6 -17.83 78.22 Favored Glycine 0 CA--C 1.528 0.876 0 CA-C-O 118.988 -0.895 . . . . 0.0 114.406 -172.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.7 tp -70.76 -33.94 54.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-N 119.284 1.542 . . . . 0.0 113.057 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.18 -38.46 82.07 Favored 'General case' 0 CA--C 1.542 0.659 0 O-C-N 121.543 -0.723 . . . . 0.0 110.466 176.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -71.92 -30.38 65.29 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 124.017 0.927 . . . . 0.0 112.84 171.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 93.4 t80 -66.99 -43.78 82.11 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 123.842 0.857 . . . . 0.0 111.792 179.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.9 tp -62.79 -42.89 99.9 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 118.415 0.552 . . . . 0.0 111.25 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.9 t80 -63.33 -42.73 98.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 112.733 0.642 . . . . 0.0 112.733 177.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.61 -39.67 80.73 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.436 1.094 . . . . 0.0 112.453 176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.98 -45.71 93.71 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 123.993 0.917 . . . . 0.0 111.457 173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.2 m -58.04 -46.27 85.64 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.588 0.755 . . . . 0.0 111.648 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.08 -26.9 73.32 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.47 1.033 . . . . 0.0 114.065 -178.063 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.6 mtpt -77.74 -8.36 57.86 Favored 'General case' 0 N--CA 1.476 0.828 0 CA-C-N 118.413 1.107 . . . . 0.0 112.706 173.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.7 8.69 11.24 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.277 2.231 . . . . 0.0 112.687 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 54.8 mtpt 64.4 30.93 12.99 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.556 1.943 . . . . 0.0 113.568 -178.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 63.2 mtm -117.83 173.6 6.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 126.819 2.048 . . . . 0.0 111.425 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 26.5 m -143.05 132.46 11.78 Favored Pre-proline 0 N--CA 1.477 0.879 0 C-N-CA 126.054 1.742 . . . . 0.0 108.983 176.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -77.45 152.97 30.52 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.134 2.556 . . . . 0.0 110.986 176.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -128.12 117.47 21.67 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.752 1.221 . . . . 0.0 110.794 -178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -102.88 156.31 17.75 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.462 1.505 . . . . 0.0 112.498 -176.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -143.45 145.7 32.82 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.397 1.879 . . . . 0.0 109.262 173.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 65.0 mt -133.17 148.41 31.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 C-N-CA 125.187 1.395 . . . . 0.0 110.83 -169.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 36.5 ttm105 -143.4 134.43 25.59 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.854 1.661 . . . . 0.0 110.653 -178.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -88.52 138.62 31.26 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 124.241 1.016 . . . . 0.0 111.122 178.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.5 m -146.86 168.59 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 C-N-CA 125.643 1.577 . . . . 0.0 111.459 -174.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.47 -163.48 39.0 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 124.34 0.971 . . . . 0.0 113.965 176.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -66.43 146.52 54.46 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.858 1.263 . . . . 0.0 112.448 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.7 tptm -57.59 -40.81 79.9 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.518 1.127 . . . . 0.0 113.947 -176.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -86.43 -50.51 6.84 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.402 1.081 . . . . 0.0 111.703 176.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.2 mtp180 -89.47 63.16 6.25 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 125.346 1.458 . . . . 0.0 110.16 177.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 44.9 tt0 -79.85 151.32 30.29 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.011 1.325 . . . . 0.0 112.032 -170.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -134.34 161.94 33.59 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.605 1.962 . . . . 0.0 110.828 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.06 127.03 29.6 Favored 'General case' 0 C--N 1.332 -0.165 0 C-N-CA 124.914 1.286 . . . . 0.0 111.075 -174.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 70.4 mtp -91.25 154.87 18.98 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 125.427 1.491 . . . . 0.0 109.307 168.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.3 t -143.77 147.69 34.52 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.191 0.996 . . . . 0.0 111.212 175.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 51.9 mt-10 -132.84 141.37 48.41 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 126.588 1.955 . . . . 0.0 108.131 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.2 p -139.14 144.03 30.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.928 0.891 . . . . 0.0 112.1 -177.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.7 mtp180 -137.82 166.51 23.83 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.123 1.769 . . . . 0.0 111.165 176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.5 t -135.3 139.01 47.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 C-N-CA 126.255 1.822 . . . . 0.0 107.764 174.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -57.54 127.67 33.19 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.964 0.906 . . . . 0.0 111.834 -177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.89 -0.71 64.82 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.718 1.151 . . . . 0.0 114.96 -179.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -117.46 126.95 53.49 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 118.846 1.323 . . . . 0.0 110.859 177.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -72.76 -23.37 60.81 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.183 0.993 . . . . 0.0 113.455 -177.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -69.1 158.08 35.57 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.036 1.334 . . . . 0.0 113.697 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.57 119.58 17.52 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.252 1.421 . . . . 0.0 110.246 169.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.65 145.07 21.66 Favored Glycine 0 N--CA 1.468 0.794 0 N-CA-C 110.296 -1.122 . . . . 0.0 110.296 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 42.2 mtt -137.86 142.14 40.72 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.916 0.887 . . . . 0.0 112.823 -169.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -145.42 170.1 26.84 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 125.737 1.637 . . . . 0.0 113.272 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 8.3 t30 -157.75 149.76 22.18 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.657 1.183 . . . . 0.0 111.216 175.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -166.42 -175.64 3.3 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.876 1.27 . . . . 0.0 112.54 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 56.6 p -75.61 -9.96 59.03 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.568 1.547 . . . . 0.0 113.317 173.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.44 150.57 30.58 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 125.452 1.501 . . . . 0.0 111.845 -170.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -64.05 -34.17 77.42 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.236 1.014 . . . . 0.0 113.649 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 34.2 tptt -64.55 -49.07 72.66 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 124.727 1.211 . . . . 0.0 111.983 -177.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -76.24 -27.2 56.66 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.013 0.925 . . . . 0.0 112.153 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.19 -46.35 84.3 Favored 'General case' 0 CA--C 1.541 0.621 0 O-C-N 121.527 -0.733 . . . . 0.0 111.719 171.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 81.9 mt-30 -60.2 -40.31 89.59 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.165 0.586 . . . . 0.0 111.72 171.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 48.7 m -64.88 -36.59 84.86 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.818 -0.551 . . . . 0.0 112.23 179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.5 m-80 -71.57 -38.91 70.88 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 121.306 -0.871 . . . . 0.0 111.824 173.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.4 98.91 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 118.727 0.694 . . . . 0.0 111.533 174.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.92 -47.92 82.78 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.245 1.018 . . . . 0.0 111.554 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 42.4 tpt85 -56.15 -37.86 70.08 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 123.467 0.707 . . . . 0.0 112.441 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -77.4 -29.05 52.91 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 125.087 1.355 . . . . 0.0 113.415 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.56 -37.99 55.68 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 121.412 -0.805 . . . . 0.0 111.664 170.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 60.5 t -61.42 -40.29 85.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.651 0.78 . . . . 0.0 110.582 172.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 41.2 m-20 -53.32 -48.86 68.09 Favored 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 170.087 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -58.71 -44.76 90.45 Favored 'General case' 0 N--CA 1.471 0.598 0 O-C-N 120.915 -1.115 . . . . 0.0 112.816 172.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.439 ' HB3' HG23 ' A' ' 75' ' ' VAL . 96.1 mt -62.79 -31.5 72.48 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 177.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 70.6 t -72.09 -41.29 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.866 0.867 . . . . 0.0 111.132 171.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -65.08 -26.53 68.27 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.226 1.011 . . . . 0.0 113.124 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.0 pt -98.66 4.48 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 124.611 1.165 . . . . 0.0 113.798 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 68.99 17.24 8.65 Favored 'General case' 0 CA--C 1.553 1.068 0 C-N-CA 126.706 2.002 . . . . 0.0 114.63 174.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -85.17 -7.8 58.89 Favored 'General case' 0 CA--C 1.547 0.842 0 C-N-CA 125.115 1.366 . . . . 0.0 113.209 174.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.439 HG23 ' HB3' ' A' ' 69' ' ' LEU . 72.4 t -132.58 137.45 54.16 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 126.998 2.119 . . . . 0.0 107.626 168.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -84.71 128.33 34.55 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 122.92 0.488 . . . . 0.0 109.919 169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -55.13 -33.44 62.89 Favored 'General case' 0 N--CA 1.475 0.793 0 O-C-N 121.388 -0.82 . . . . 0.0 113.143 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -61.35 -19.07 61.43 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.946 1.298 . . . . 0.0 113.605 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.5 mm-40 -90.18 -16.84 28.7 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.508 1.123 . . . . 0.0 113.227 177.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.0 t -76.11 125.85 87.44 Favored Pre-proline 0 N--CA 1.476 0.845 0 C-N-CA 124.252 1.021 . . . . 0.0 110.496 -169.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -73.48 144.82 36.83 Favored 'Trans proline' 0 C--N 1.352 0.72 0 C-N-CA 123.157 2.571 . . . . 0.0 111.322 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -146.14 161.91 39.15 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.057 1.343 . . . . 0.0 112.121 -177.483 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.89 -12.53 15.17 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.751 0 N-CA-C 115.467 1.654 . . . . 0.0 115.467 -172.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -159.83 162.69 33.23 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 124.721 1.153 . . . . 0.0 113.654 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 55.0 mt -127.17 143.57 40.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 126.875 2.07 . . . . 0.0 108.806 178.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 19.8 m -125.74 156.28 71.32 Favored Pre-proline 0 N--CA 1.479 0.976 0 C-N-CA 125.659 1.584 . . . . 0.0 111.798 -175.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -60.13 164.31 12.68 Favored 'Trans proline' 0 CA--C 1.545 1.031 0 C-N-CA 124.009 3.139 . . . . 0.0 113.866 177.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.31 152.81 30.26 Favored 'Trans proline' 0 CA--C 1.542 0.884 0 C-N-CA 124.247 3.298 . . . . 0.0 113.032 172.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -68.3 -16.11 43.36 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.593 2.862 . . . . 0.0 113.728 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.4 m -72.37 -13.6 61.51 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.17 0.988 . . . . 0.0 113.516 171.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 75.89 -176.52 51.03 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.652 1.596 . . . . 0.0 114.243 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -61.1 154.79 54.79 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 124.411 3.407 . . . . 0.0 112.786 175.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 79.2 p -161.94 160.69 28.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.852 1.261 . . . . 0.0 112.135 179.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.6 m -165.85 156.03 12.76 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 126.66 1.984 . . . . 0.0 110.87 -179.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 118.447 -1.196 . . . . 0.0 112.959 178.896 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.592 0 N-CA-C 111.421 -0.672 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 43.6 m -76.87 120.53 22.14 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 123.853 0.861 . . . . 0.0 112.514 -175.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 29.5 m 72.03 -42.62 0.54 Allowed 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 128.044 2.538 . . . . 0.0 115.687 169.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 74.35 15.28 80.3 Favored Glycine 0 CA--C 1.535 1.315 0 C-N-CA 124.784 1.183 . . . . 0.0 114.994 176.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.9 m -72.09 -9.04 57.86 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -170.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.6 p -80.09 59.08 3.17 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 126.953 2.101 . . . . 0.0 111.839 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -67.28 -28.99 73.8 Favored Glycine 0 N--CA 1.472 1.067 0 O-C-N 120.783 -1.198 . . . . 0.0 114.686 -169.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.7 tp -76.25 -33.05 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 CA-C-N 118.263 1.032 . . . . 0.0 112.201 173.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.8 tmmm? -66.34 -43.37 86.29 Favored 'General case' 0 N--CA 1.471 0.594 0 C-N-CA 124.801 1.24 . . . . 0.0 110.361 172.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -66.48 -32.0 73.08 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.302 1.041 . . . . 0.0 112.854 172.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -69.08 -40.96 78.12 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.289 0.949 . . . . 0.0 111.993 177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 27.1 tp -62.77 -42.47 99.71 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 118.999 0.818 . . . . 0.0 111.247 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -61.91 -41.93 98.49 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 112.508 0.558 . . . . 0.0 112.508 176.325 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.96 -38.36 82.68 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.509 1.124 . . . . 0.0 112.863 175.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 89.2 t90 -64.01 -43.79 94.58 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.83 0.852 . . . . 0.0 111.856 174.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 90.6 m -57.89 -43.88 86.36 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.096 0.558 . . . . 0.0 111.08 171.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -65.65 -28.64 73.81 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.561 1.076 . . . . 0.0 114.055 177.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -70.34 -12.91 61.9 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 118.637 1.218 . . . . 0.0 112.645 171.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -119.61 9.18 11.4 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 127.15 2.18 . . . . 0.0 113.257 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.39 24.03 13.99 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.32 1.848 . . . . 0.0 114.044 -177.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 67.3 mtm -103.97 174.04 6.04 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 127.013 2.125 . . . . 0.0 111.476 177.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.4 m -140.49 130.74 13.6 Favored Pre-proline 0 N--CA 1.475 0.78 0 C-N-CA 126.34 1.856 . . . . 0.0 108.528 173.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -76.36 147.63 29.25 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.003 2.469 . . . . 0.0 110.758 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -115.27 114.45 25.21 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.456 1.103 . . . . 0.0 110.641 178.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -95.74 153.8 17.55 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.004 1.321 . . . . 0.0 111.739 178.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 75.4 tt0 -145.52 138.6 26.2 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.166 1.786 . . . . 0.0 108.556 -176.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 55.9 mt -136.08 147.45 28.13 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 124.423 1.089 . . . . 0.0 111.774 -168.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.6 tpt180 -135.04 135.45 41.32 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 126.149 1.78 . . . . 0.0 110.44 172.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.96 137.64 32.58 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.808 1.243 . . . . 0.0 111.016 176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.6 m -146.86 176.57 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 C-N-CA 126.236 1.814 . . . . 0.0 110.994 -175.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 103.08 -151.09 17.92 Favored Glycine 0 CA--C 1.531 1.079 0 C-N-CA 124.657 1.122 . . . . 0.0 113.553 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 t-20 -116.91 158.49 23.93 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.348 1.859 . . . . 0.0 111.773 -173.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 8.7 ptpp? -58.25 -22.99 54.51 Favored 'General case' 0 CA--C 1.551 0.981 0 N-CA-C 115.015 1.487 . . . . 0.0 115.015 176.169 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -97.42 -9.3 27.57 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 125.509 1.524 . . . . 0.0 113.752 176.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.7 ttt85 -157.31 98.08 1.68 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 126.065 1.746 . . . . 0.0 110.384 177.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -87.11 151.35 23.29 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.463 1.105 . . . . 0.0 111.228 175.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -145.85 160.36 41.9 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 127.406 2.283 . . . . 0.0 110.163 -172.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -133.93 128.87 35.41 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 124.346 1.058 . . . . 0.0 111.909 -175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 39.3 mtm -94.98 151.48 19.14 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 125.546 1.538 . . . . 0.0 108.948 168.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 41.2 t -144.68 149.56 35.85 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.971 0.908 . . . . 0.0 112.082 -177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -132.87 149.42 52.26 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.389 1.875 . . . . 0.0 109.044 173.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.6 p -135.36 140.97 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 123.868 0.867 . . . . 0.0 111.71 175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.2 mtm105 -137.08 157.57 46.4 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.923 2.089 . . . . 0.0 110.546 -175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.9 t -140.63 136.31 35.38 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 C-N-CA 125.729 1.612 . . . . 0.0 108.459 178.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.28 128.12 35.15 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.034 0.933 . . . . 0.0 111.73 -177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.45 2.89 65.24 Favored Glycine 0 CA--C 1.536 1.353 0 C-N-CA 124.543 1.068 . . . . 0.0 114.692 -177.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -124.43 129.05 49.97 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.412 1.485 . . . . 0.0 110.261 178.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -81.5 -12.19 58.94 Favored 'General case' 0 CA--C 1.546 0.796 0 N-CA-C 114.44 1.274 . . . . 0.0 114.44 -173.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -85.54 160.44 19.66 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.678 1.191 . . . . 0.0 113.1 -179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.7 117.68 16.3 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.84 1.256 . . . . 0.0 109.604 169.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.01 141.31 24.09 Favored Glycine 0 N--CA 1.469 0.846 0 N-CA-C 110.129 -1.188 . . . . 0.0 110.129 176.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.6 mtp -123.6 143.38 50.26 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 124.556 1.142 . . . . 0.0 112.747 -169.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.11 169.24 28.84 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.434 1.493 . . . . 0.0 113.633 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 6.3 t30 -159.88 148.98 17.68 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.934 1.294 . . . . 0.0 111.153 176.144 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.53 -176.18 3.1 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 124.769 1.228 . . . . 0.0 112.656 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 77.0 m -75.67 -19.99 58.76 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 125.15 1.38 . . . . 0.0 111.775 172.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.7 p30 -138.35 155.77 48.24 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.787 1.235 . . . . 0.0 112.85 -177.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -64.71 -38.76 92.08 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 113.829 1.048 . . . . 0.0 113.829 -173.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -67.67 -40.82 84.45 Favored 'General case' 0 N--CA 1.475 0.819 0 O-C-N 121.365 -0.834 . . . . 0.0 112.133 -177.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -76.29 -30.34 57.74 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.388 0.675 . . . . 0.0 112.035 176.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.25 -43.79 90.2 Favored 'General case' 0 CA--C 1.542 0.669 0 O-C-N 121.534 -0.729 . . . . 0.0 111.768 170.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -61.52 -39.48 91.18 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.538 0.735 . . . . 0.0 111.668 170.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.5 m -64.61 -35.13 80.02 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-N 118.996 0.817 . . . . 0.0 112.388 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -72.57 -38.18 67.98 Favored 'General case' 0 CA--C 1.542 0.661 0 O-C-N 121.28 -0.888 . . . . 0.0 112.017 173.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.77 -44.02 97.27 Favored 'General case' 0 CA--C 1.537 0.474 0 O-C-N 121.59 -0.694 . . . . 0.0 111.563 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -47.59 83.67 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 124.576 1.15 . . . . 0.0 111.836 174.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 30.4 tpt180 -52.52 -43.21 64.99 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 123.874 0.87 . . . . 0.0 111.581 175.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -74.37 -34.26 63.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -75.22 -37.24 61.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 121.44 -0.788 . . . . 0.0 112.241 174.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -62.15 -42.47 95.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 O-C-N 121.342 -0.848 . . . . 0.0 110.092 171.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -57.36 -48.64 78.48 Favored 'General case' 0 CA--C 1.536 0.431 0 CA-C-O 118.173 -0.918 . . . . 0.0 111.524 170.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -51.1 -42.65 60.79 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 120.726 1.603 . . . . 0.0 113.842 170.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.3 mt -64.99 -22.27 66.97 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 175.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.5 t -82.25 -36.72 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 CA-C-N 119.552 1.069 . . . . 0.0 110.903 168.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 48.4 mtt180 -60.4 -30.53 69.66 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.33 1.052 . . . . 0.0 112.112 174.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 16.5 pt -103.96 3.48 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 C-N-CA 124.929 1.292 . . . . 0.0 114.211 174.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.7 t30 65.86 23.16 11.38 Favored 'General case' 0 CA--C 1.554 1.126 0 C-N-CA 126.509 1.924 . . . . 0.0 114.797 174.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -86.2 -9.75 55.99 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.51 1.524 . . . . 0.0 113.052 171.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 75.2 t -134.06 136.65 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 127.139 2.176 . . . . 0.0 107.433 168.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.7 mtpt -86.65 137.44 32.47 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 118.319 0.509 . . . . 0.0 109.714 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 38.5 p -54.91 -32.09 60.79 Favored 'General case' 0 N--CA 1.475 0.788 0 O-C-N 120.977 -1.077 . . . . 0.0 113.094 179.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -53.5 -24.64 13.76 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.015 1.726 . . . . 0.0 114.177 173.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -87.27 -20.47 26.82 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.545 1.138 . . . . 0.0 113.104 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.1 t -80.45 129.43 69.03 Favored Pre-proline 0 N--CA 1.473 0.708 0 C-N-CA 124.583 1.153 . . . . 0.0 110.693 -168.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -70.27 138.51 36.35 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.06 2.507 . . . . 0.0 110.756 176.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -73.28 125.38 27.67 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.447 0.699 . . . . 0.0 112.091 -176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -71.17 -11.5 15.13 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 125.863 1.665 . . . . 0.0 114.369 -178.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 139.59 -160.24 26.01 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.326 1.917 . . . . 0.0 111.734 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 75.1 mt -84.44 130.55 35.79 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.477 1.111 . . . . 0.0 108.827 173.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 61.0 t -139.15 129.59 14.67 Favored Pre-proline 0 N--CA 1.479 0.979 0 C-N-CA 125.436 1.494 . . . . 0.0 108.914 -174.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.6 Cg_endo -74.46 158.06 44.51 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.416 2.744 . . . . 0.0 112.235 -176.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -72.68 161.3 44.3 Favored 'Trans proline' 0 CA--C 1.544 0.984 0 C-N-CA 123.698 2.932 . . . . 0.0 111.58 177.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -69.01 -14.01 37.64 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 123.446 2.764 . . . . 0.0 113.338 177.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.6 p -83.78 -1.24 53.83 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.462 1.505 . . . . 0.0 113.569 170.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.05 -178.57 51.8 Favored Glycine 0 CA--C 1.542 1.752 0 C-N-CA 125.684 1.612 . . . . 0.0 114.176 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -72.35 162.59 41.11 Favored 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 124.248 3.299 . . . . 0.0 112.124 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 21.7 t -162.74 -40.63 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.405 1.082 . . . . 0.0 112.697 -179.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 83.7 p -160.16 163.87 33.33 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 124.981 1.312 . . . . 0.0 112.076 -179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.216 0 CA-C-O 118.271 -1.294 . . . . 0.0 112.849 -179.623 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.607 0 N-CA-C 111.963 -0.455 . . . . 0.0 111.963 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 99.2 p -163.86 170.17 17.18 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 125.149 1.38 . . . . 0.0 111.946 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 18.5 m -83.38 11.92 6.17 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 124.688 1.195 . . . . 0.0 114.044 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -75.79 142.67 29.07 Favored Glycine 0 CA--C 1.534 1.235 0 C-N-CA 124.949 1.261 . . . . 0.0 112.932 -178.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 80.8 p -160.93 5.64 0.07 Allowed 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 p -82.5 112.32 19.31 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 120.248 -1.532 . . . . 0.0 111.526 -176.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.45 -41.06 31.24 Favored Glycine 0 N--CA 1.472 1.052 0 O-C-N 121.325 -0.859 . . . . 0.0 114.788 -168.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.8 tp -73.63 -28.43 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 118.339 1.07 . . . . 0.0 112.104 174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -64.03 -48.26 76.99 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.302 1.041 . . . . 0.0 110.027 169.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -64.81 -29.57 70.54 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.535 0.734 . . . . 0.0 112.685 174.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -67.81 -45.61 74.24 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 118.812 0.733 . . . . 0.0 111.476 176.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 35.4 tp -62.63 -41.79 99.22 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 118.369 0.531 . . . . 0.0 111.153 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 36.5 t80 -63.01 -42.49 99.83 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 177.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.15 -39.1 79.0 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.36 1.064 . . . . 0.0 112.419 176.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.8 t90 -61.0 -45.84 93.2 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.068 0.947 . . . . 0.0 111.427 173.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 86.3 m -58.22 -45.67 87.25 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 123.649 0.78 . . . . 0.0 111.711 172.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.67 -26.83 72.99 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.449 1.024 . . . . 0.0 114.051 -178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.9 mtpt -78.12 -8.38 58.18 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 118.398 1.099 . . . . 0.0 112.744 173.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.8 mtp180 -119.68 9.3 11.39 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.377 2.271 . . . . 0.0 112.726 -178.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 64.96 30.72 11.77 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.51 1.924 . . . . 0.0 113.623 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.8 mtm -118.33 172.36 7.5 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 126.756 2.022 . . . . 0.0 111.57 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 29.4 m -142.54 130.64 11.48 Favored Pre-proline 0 N--CA 1.477 0.901 0 C-N-CA 126.093 1.757 . . . . 0.0 108.685 174.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.6 149.96 27.44 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 123.011 2.474 . . . . 0.0 110.803 177.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -121.0 117.62 27.74 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.651 1.181 . . . . 0.0 110.68 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 -101.26 158.03 16.34 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 125.336 1.455 . . . . 0.0 112.63 -177.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.3 149.88 33.69 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.999 1.32 . . . . 0.0 110.33 169.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 67.1 mt -135.66 147.76 28.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.092 0 C-N-CA 125.822 1.649 . . . . 0.0 111.149 -169.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -141.98 137.42 31.17 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 125.653 1.581 . . . . 0.0 111.06 176.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.46 141.92 28.26 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.204 1.002 . . . . 0.0 111.222 174.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 22.7 m -146.14 161.5 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 125.697 1.599 . . . . 0.0 111.213 -176.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.79 158.29 12.2 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.794 1.188 . . . . 0.0 113.427 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.4 t30 -67.58 155.05 40.06 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.383 0.673 . . . . 0.0 111.727 176.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.4 pttt -54.85 -27.68 44.16 Favored 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 116.337 1.977 . . . . 0.0 116.337 -169.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -78.76 -24.34 44.78 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 177.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.2 ptt85 -125.83 29.64 5.88 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 127.973 2.509 . . . . 0.0 112.659 -176.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.8 tt0 -66.62 145.8 55.19 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.419 1.088 . . . . 0.0 112.523 -169.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -140.43 165.63 26.9 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 127.536 2.334 . . . . 0.0 110.86 -176.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -130.28 133.88 46.81 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.239 1.416 . . . . 0.0 110.651 178.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 37.2 mtm -100.39 154.16 18.74 Favored 'General case' 0 N--CA 1.465 0.307 0 C-N-CA 126.113 1.765 . . . . 0.0 109.211 169.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.6 t -147.54 148.69 31.44 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 124.376 1.07 . . . . 0.0 111.171 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -132.89 158.28 42.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.085 1.354 . . . . 0.0 111.096 170.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 p -142.69 143.9 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 C-N-CA 124.807 1.243 . . . . 0.0 111.611 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 47.3 mtt180 -139.44 158.19 44.56 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.436 1.895 . . . . 0.0 110.335 -178.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.4 t -140.07 134.94 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 C-N-CA 125.619 1.568 . . . . 0.0 108.619 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.67 130.14 45.36 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 124.04 0.936 . . . . 0.0 111.677 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.55 1.37 66.22 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 124.537 1.065 . . . . 0.0 114.567 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -125.14 128.84 49.03 Favored 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 110.363 177.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -77.25 -20.88 54.55 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -177.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 42.9 t80 -71.29 156.68 39.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.559 1.143 . . . . 0.0 113.377 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.66 116.99 15.59 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.035 1.334 . . . . 0.0 109.326 170.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -81.92 141.84 22.01 Favored Glycine 0 N--CA 1.466 0.677 0 N-CA-C 109.966 -1.253 . . . . 0.0 109.966 177.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 77.1 mtm -140.27 142.41 35.73 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.595 1.158 . . . . 0.0 112.232 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.26 173.92 31.3 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 125.264 1.411 . . . . 0.0 113.143 178.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -152.81 161.7 42.22 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.262 1.025 . . . . 0.0 111.953 173.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 t -167.34 -172.83 2.07 Favored 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 125.179 1.392 . . . . 0.0 111.647 176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 64.6 p -76.84 -9.57 58.77 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.544 1.538 . . . . 0.0 113.372 173.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -151.55 151.38 31.49 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.657 1.583 . . . . 0.0 111.779 -169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -65.34 -30.03 70.83 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 -175.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -65.33 -54.61 26.49 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.708 1.203 . . . . 0.0 112.048 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -72.84 -27.56 62.02 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.727 0.811 . . . . 0.0 112.171 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.3 -44.41 95.08 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.814 -0.553 . . . . 0.0 111.749 170.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 37.3 mt-30 -65.01 -41.07 95.68 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.43 0.692 . . . . 0.0 112.034 173.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 62.4 m -59.03 -40.2 84.3 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-N 119.18 0.9 . . . . 0.0 112.34 173.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -72.46 -37.97 68.36 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.592 -0.692 . . . . 0.0 111.545 179.694 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.18 -44.35 92.3 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.651 0.781 . . . . 0.0 112.282 172.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.59 -49.11 77.93 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.313 1.045 . . . . 0.0 111.593 175.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 5.2 tpt180 -58.65 -39.74 81.43 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-O 119.094 -0.479 . . . . 0.0 111.73 177.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -67.85 -30.78 70.25 Favored 'General case' 0 CA--C 1.545 0.773 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -77.94 -39.6 42.17 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.617 -0.677 . . . . 0.0 112.359 171.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 82.2 t -63.2 -38.7 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 O-C-N 121.41 -0.806 . . . . 0.0 110.798 174.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -56.82 -44.01 81.62 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.504 0.721 . . . . 0.0 111.578 171.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 42.1 t80 -60.41 -44.47 95.69 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.768 -1.207 . . . . 0.0 112.665 170.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.4 -34.27 75.08 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 119.065 0.848 . . . . 0.0 113.179 176.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 74.7 t -68.12 -42.64 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.028 0 C-N-CA 123.908 0.883 . . . . 0.0 111.198 171.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -66.17 -21.36 66.32 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.16 0.984 . . . . 0.0 113.508 179.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -103.38 6.75 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.234 0 C-N-CA 124.939 1.296 . . . . 0.0 113.625 170.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 19.0 m120 68.79 18.84 8.57 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 126.725 2.01 . . . . 0.0 114.675 173.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 72.7 mm-40 -88.67 -5.69 57.96 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.347 1.459 . . . . 0.0 113.322 176.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -136.83 139.33 44.92 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 C-N-CA 126.906 2.082 . . . . 0.0 107.995 169.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -84.97 125.91 33.08 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 122.964 0.506 . . . . 0.0 110.067 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.6 p -55.08 -33.1 62.48 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.502 0.927 . . . . 0.0 113.502 -177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -61.13 -19.47 61.55 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.909 1.284 . . . . 0.0 113.568 -179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.5 mm-40 -92.42 -15.64 26.93 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.648 1.179 . . . . 0.0 113.435 177.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.3 t -78.62 123.74 85.41 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.103 0.961 . . . . 0.0 111.64 -168.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -82.87 169.53 13.19 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 123.785 2.99 . . . . 0.0 112.707 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -143.79 154.31 43.29 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.591 1.556 . . . . 0.0 111.053 174.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -65.14 -16.08 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 125.112 1.365 . . . . 0.0 114.576 -177.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.02 158.56 30.9 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 125.753 1.644 . . . . 0.0 112.23 175.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.4 mm -117.84 127.0 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.746 0 C-N-CA 125.455 1.502 . . . . 0.0 109.396 -176.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 p -165.0 135.75 3.12 Favored Pre-proline 0 N--CA 1.478 0.938 0 C-N-CA 125.476 1.51 . . . . 0.0 109.73 -174.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.2 163.07 37.39 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.123 2.549 . . . . 0.0 112.003 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.73 148.21 75.82 Favored 'Trans proline' 0 CA--C 1.544 0.98 0 C-N-CA 123.908 3.072 . . . . 0.0 113.277 177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -73.37 162.98 38.97 Favored 'Trans proline' 0 CA--C 1.538 0.718 0 C-N-CA 123.949 3.099 . . . . 0.0 112.018 178.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 68.4 m -146.24 151.21 37.21 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.462 1.505 . . . . 0.0 111.475 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 84.48 -173.7 49.85 Favored Glycine 0 CA--C 1.542 1.743 0 C-N-CA 124.669 1.128 . . . . 0.0 113.47 -176.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -59.9 136.7 71.59 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.239 3.293 . . . . 0.0 112.505 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 37.2 p -79.91 -10.73 59.81 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 41.1 m -91.71 -4.33 55.22 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.128 1.371 . . . . 0.0 113.877 -179.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.214 0 CA-C-O 118.206 -1.33 . . . . 0.0 113.449 -178.567 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.529 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 18.7 m -84.92 -6.87 59.34 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 -172.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.4 t -163.61 172.86 13.72 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.938 1.695 . . . . 0.0 111.193 -178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 86.89 -172.53 44.13 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 125.356 1.455 . . . . 0.0 113.47 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 12.9 t -163.34 173.23 13.52 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 125.262 1.425 . . . . 0.0 111.558 -178.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 44.2 m -159.3 29.88 0.2 Allowed 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.197 2.199 . . . . 0.0 111.125 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.38 -32.53 83.89 Favored Glycine 0 N--CA 1.471 0.999 0 O-C-N 120.801 -1.187 . . . . 0.0 114.24 -169.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -73.89 -30.31 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 118.304 1.052 . . . . 0.0 112.582 173.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -40.72 75.81 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.528 1.131 . . . . 0.0 110.542 174.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -69.38 -31.38 69.73 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.182 0.993 . . . . 0.0 112.828 170.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.3 t80 -67.18 -42.0 84.97 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 118.969 0.804 . . . . 0.0 111.947 178.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.1 tp -62.65 -42.98 99.91 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 118.702 0.683 . . . . 0.0 111.258 173.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 58.6 t80 -62.87 -42.96 99.95 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.252 0.621 . . . . 0.0 112.556 177.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.94 -39.99 83.38 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.349 1.06 . . . . 0.0 112.667 176.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.37 -45.65 93.49 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.245 1.018 . . . . 0.0 111.452 174.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 89.1 m -58.23 -45.45 87.7 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.545 0.738 . . . . 0.0 111.684 172.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.07 73.03 Favored Glycine 0 CA--C 1.532 1.098 0 C-N-CA 124.483 1.04 . . . . 0.0 114.034 -178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -77.46 -8.99 58.62 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 124.466 1.106 . . . . 0.0 112.838 173.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 28.8 mtp180 -119.64 9.35 11.43 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 127.251 2.22 . . . . 0.0 112.736 -177.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.3 mttp 65.05 30.7 11.57 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 126.439 1.895 . . . . 0.0 113.568 -179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.7 mtm -118.6 172.38 7.53 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.688 1.995 . . . . 0.0 111.654 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 46.6 m -141.4 130.25 12.42 Favored Pre-proline 0 N--CA 1.475 0.819 0 C-N-CA 126.328 1.851 . . . . 0.0 108.581 174.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.62 142.13 20.29 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 122.928 2.419 . . . . 0.0 110.581 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -112.31 116.64 30.7 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.485 1.114 . . . . 0.0 110.558 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -98.23 154.9 17.46 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.098 1.359 . . . . 0.0 112.301 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -147.18 136.86 22.96 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.917 1.287 . . . . 0.0 110.287 174.149 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 70.0 mt -123.78 147.13 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.12 1.368 . . . . 0.0 110.97 -170.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 34.5 ttp-105 -142.21 140.41 32.32 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.707 2.003 . . . . 0.0 110.106 -174.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -94.0 140.62 29.5 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.329 1.052 . . . . 0.0 111.255 179.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.5 m -145.93 162.23 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 125.84 1.656 . . . . 0.0 111.017 -176.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.22 -165.23 41.04 Favored Glycine 0 CA--C 1.534 1.239 0 C-N-CA 123.997 0.808 . . . . 0.0 114.336 176.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.5 t-20 -68.93 147.21 51.99 Favored 'General case' 0 CA--C 1.547 0.856 0 C-N-CA 125.481 1.512 . . . . 0.0 113.115 -174.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -63.62 -39.2 93.77 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -177.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -81.82 -31.81 31.55 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.018 1.327 . . . . 0.0 112.853 179.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 5.4 tmm_? -122.02 77.79 1.41 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.704 1.601 . . . . 0.0 109.466 174.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 22.3 tp60 -80.9 148.89 29.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.38 1.072 . . . . 0.0 111.419 -172.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 63.4 mttm -130.24 164.74 23.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.231 1.812 . . . . 0.0 111.042 174.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 -135.09 137.77 43.17 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 124.89 1.276 . . . . 0.0 111.6 -173.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.6 mtp -102.67 152.19 21.49 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.588 1.555 . . . . 0.0 108.879 168.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.0 t -135.76 145.38 46.52 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 124.427 1.091 . . . . 0.0 110.194 173.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -122.46 152.23 40.49 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 126.202 1.801 . . . . 0.0 108.976 170.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.0 p -140.31 140.11 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.778 1.231 . . . . 0.0 110.894 174.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -140.79 153.39 45.82 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.945 1.698 . . . . 0.0 110.117 -172.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 44.6 t -140.77 134.47 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 125.488 1.515 . . . . 0.0 108.88 -177.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -60.79 130.01 44.36 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.131 0.972 . . . . 0.0 111.695 -178.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.4 2.05 66.0 Favored Glycine 0 CA--C 1.534 1.234 0 C-N-CA 124.607 1.098 . . . . 0.0 114.627 -177.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.0 m-85 -123.83 130.85 53.27 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 125.397 1.479 . . . . 0.0 110.321 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -82.67 -14.72 54.15 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 -173.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -80.93 155.75 26.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.407 1.083 . . . . 0.0 112.766 177.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.81 112.05 13.2 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.191 1.396 . . . . 0.0 108.911 170.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.16 147.19 25.76 Favored Glycine 0 N--CA 1.466 0.673 0 N-CA-C 110.834 -0.906 . . . . 0.0 110.834 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.5 ptm -147.19 150.29 34.61 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 -169.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -150.6 173.78 30.1 Favored Glycine 0 CA--C 1.528 0.844 0 C-N-CA 126.248 1.88 . . . . 0.0 112.668 -179.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -157.28 154.55 29.27 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.918 0.887 . . . . 0.0 112.753 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.9 t -168.28 -178.26 3.55 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.413 1.485 . . . . 0.0 111.471 178.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 3.2 m -78.23 -2.69 39.02 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.578 1.551 . . . . 0.0 112.052 172.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.9 t30 -142.37 150.45 40.72 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.957 1.703 . . . . 0.0 111.786 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -71.72 -37.55 70.61 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.615 1.166 . . . . 0.0 113.631 -172.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 35.8 mtmm -71.54 -36.96 71.17 Favored 'General case' 0 N--CA 1.477 0.881 0 O-C-N 121.14 -0.975 . . . . 0.0 112.19 176.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -67.92 -30.92 70.36 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.159 0.984 . . . . 0.0 112.236 173.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.15 -41.42 67.13 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.335 -0.853 . . . . 0.0 111.617 172.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 60.2 mt-30 -61.38 -42.2 98.32 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.898 0.879 . . . . 0.0 112.498 174.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 89.7 p -69.27 -32.05 70.97 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 119.542 1.065 . . . . 0.0 112.566 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.4 m-80 -69.24 -40.52 77.84 Favored 'General case' 0 CA--C 1.541 0.605 0 O-C-N 121.476 -0.765 . . . . 0.0 111.804 169.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.96 -42.32 99.79 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 118.831 0.742 . . . . 0.0 111.926 175.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.25 -48.94 77.72 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.955 0.902 . . . . 0.0 111.452 174.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.5 tpt180 -57.84 -40.29 79.75 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 118.457 0.571 . . . . 0.0 111.968 176.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.15 -33.87 74.09 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.778 0.831 . . . . 0.0 113.104 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.3 t80 -76.11 -38.84 56.4 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.679 -0.638 . . . . 0.0 112.229 172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.9 t -61.3 -41.45 89.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 O-C-N 121.451 -0.781 . . . . 0.0 110.591 172.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -56.75 -47.28 80.44 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 123.105 0.562 . . . . 0.0 111.588 171.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.1 t80 -56.48 -44.43 80.6 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 120.947 -1.096 . . . . 0.0 112.896 170.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 97.3 mt -62.79 -31.89 72.95 Favored 'General case' 0 N--CA 1.472 0.637 0 O-C-N 121.375 -0.828 . . . . 0.0 113.209 176.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 97.8 t -72.62 -39.9 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 CA-C-N 119.044 0.838 . . . . 0.0 111.388 171.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 64.8 mtt85 -61.38 -29.99 70.26 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 175.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.8 pt -98.32 5.1 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 N-CA-C 113.932 1.086 . . . . 0.0 113.932 174.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.9 t30 67.99 21.73 8.77 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 126.766 2.027 . . . . 0.0 114.576 174.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.4 mm-40 -89.61 -5.36 57.23 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.234 1.413 . . . . 0.0 113.118 174.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 96.1 t -138.2 144.36 30.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 127.797 2.439 . . . . 0.0 107.18 168.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 7.3 mtpm? -98.32 133.33 42.87 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 123.538 0.735 . . . . 0.0 110.336 169.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 55.8 p -58.2 -30.29 66.33 Favored 'General case' 0 N--CA 1.473 0.71 0 O-C-N 121.208 -0.933 . . . . 0.0 113.242 -174.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.83 -21.91 57.65 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.534 1.134 . . . . 0.0 113.645 177.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.0 mm-40 -88.99 -17.26 29.8 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.39 1.076 . . . . 0.0 113.15 178.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.8 t -79.52 125.59 82.49 Favored Pre-proline 0 N--CA 1.474 0.726 0 C-N-CA 124.307 1.043 . . . . 0.0 110.733 -169.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.84 120.08 5.96 Favored 'Trans proline' 0 C--N 1.351 0.702 0 C-N-CA 123.076 2.517 . . . . 0.0 110.288 177.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -162.06 171.0 18.23 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.233 1.813 . . . . 0.0 110.892 -177.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -59.28 -19.64 16.5 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 125.258 1.423 . . . . 0.0 114.25 175.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -168.92 158.75 31.54 Favored Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.3 1.905 . . . . 0.0 111.662 172.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.5 mm -78.55 102.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 O-C-N 121.831 -0.805 . . . . 0.0 109.084 177.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 50.3 t -142.55 128.96 10.76 Favored Pre-proline 0 N--CA 1.475 0.803 0 C-N-CA 126.169 1.788 . . . . 0.0 108.355 -176.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -73.94 162.0 40.09 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.238 2.625 . . . . 0.0 112.005 -177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -58.8 146.31 93.24 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 123.687 2.925 . . . . 0.0 112.842 177.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.47 157.04 53.65 Favored 'Trans proline' 0 CA--C 1.536 0.597 0 C-N-CA 123.428 2.752 . . . . 0.0 111.637 176.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 95.9 p -161.61 163.86 29.71 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.585 1.554 . . . . 0.0 111.733 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.31 -164.2 31.39 Favored Glycine 0 CA--C 1.539 1.555 0 C-N-CA 124.652 1.12 . . . . 0.0 113.497 -175.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -71.85 164.1 36.76 Favored 'Trans proline' 0 CA--C 1.537 0.66 0 C-N-CA 123.861 3.04 . . . . 0.0 111.686 178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.9 m -60.73 134.49 57.14 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.735 1.214 . . . . 0.0 113.249 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 15.7 m -76.16 -6.22 50.26 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 -173.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.219 0 C-N-CA 125.762 1.648 . . . . 0.0 113.043 -178.636 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.672 0 N-CA-C 111.903 -0.479 . . . . 0.0 111.903 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 34.0 p -68.98 -22.85 64.07 Favored 'General case' 0 N--CA 1.479 0.978 0 O-C-N 121.294 -1.121 . . . . 0.0 113.908 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 67.5 m -89.6 7.57 35.76 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.986 1.314 . . . . 0.0 113.087 171.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 85.86 -129.04 9.12 Favored Glycine 0 C--N 1.341 0.837 0 C-N-CA 124.796 1.188 . . . . 0.0 111.086 -173.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 68.8 p -136.67 12.48 3.18 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.176 1.39 . . . . 0.0 113.197 -175.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.0 m -65.57 122.56 17.51 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.712 1.205 . . . . 0.0 113.538 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -70.35 -32.39 68.42 Favored Glycine 0 C--N 1.341 0.841 0 CA-C-O 119.117 -0.824 . . . . 0.0 113.878 -173.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.9 tp -74.63 -34.53 35.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 CA-C-N 119.069 1.435 . . . . 0.0 113.173 -178.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 3.5 tmtm? -65.52 -44.74 86.02 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.337 1.055 . . . . 0.0 110.241 173.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.54 -31.96 73.0 Favored 'General case' 0 CA--C 1.543 0.711 0 C-N-CA 123.639 0.775 . . . . 0.0 112.673 173.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -69.25 -42.91 74.96 Favored 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 123.687 0.795 . . . . 0.0 111.71 -179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.9 tp -62.52 -43.16 99.49 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.627 0.649 . . . . 0.0 111.231 173.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.8 t80 -63.45 -42.86 98.65 Favored 'General case' 0 CA--C 1.543 0.697 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 177.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.78 -40.6 83.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.578 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.0 t90 -60.29 -45.57 92.89 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.296 1.038 . . . . 0.0 111.586 174.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 98.3 m -58.06 -44.01 87.26 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 123.474 0.71 . . . . 0.0 111.665 171.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.58 -26.63 72.9 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.424 1.011 . . . . 0.0 114.103 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 30.8 mmmt -78.52 -6.63 55.99 Favored 'General case' 0 N--CA 1.476 0.837 0 CA-C-N 118.629 1.215 . . . . 0.0 112.857 172.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 43.7 mtt180 -119.3 7.88 11.34 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.057 2.143 . . . . 0.0 112.851 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 63.29 27.71 15.51 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 126.329 1.852 . . . . 0.0 113.519 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 64.0 mtm -110.79 174.15 6.0 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.878 2.071 . . . . 0.0 111.305 178.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 24.4 m -143.17 131.08 11.09 Favored Pre-proline 0 N--CA 1.477 0.888 0 C-N-CA 125.85 1.66 . . . . 0.0 108.509 173.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -77.04 146.25 25.5 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.986 2.457 . . . . 0.0 110.645 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.46 113.22 24.19 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.323 1.049 . . . . 0.0 110.786 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -98.55 155.19 17.4 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 125.538 1.535 . . . . 0.0 112.128 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -147.13 146.77 30.03 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 126.1 1.76 . . . . 0.0 109.866 174.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.5 mt -132.82 147.73 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 125.306 1.442 . . . . 0.0 110.686 -169.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 30.8 ttp-105 -143.14 141.02 31.07 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 126.73 2.012 . . . . 0.0 110.114 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -95.1 138.33 32.95 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.438 1.095 . . . . 0.0 111.179 178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.8 m -146.52 168.09 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 125.584 1.554 . . . . 0.0 111.571 -175.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.28 174.53 50.4 Favored Glycine 0 CA--C 1.533 1.214 0 C-N-CA 124.359 0.98 . . . . 0.0 114.223 176.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -68.34 140.97 55.91 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.447 1.099 . . . . 0.0 112.066 -179.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -58.89 -22.59 59.75 Favored 'General case' 0 CA--C 1.547 0.85 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -177.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.0 t30 -73.24 -21.46 60.63 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 124.258 1.023 . . . . 0.0 113.414 176.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 18.3 tpp180 -153.52 71.08 0.87 Allowed 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.754 1.621 . . . . 0.0 109.989 174.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 41.2 tt0 -67.01 150.81 48.73 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.977 1.311 . . . . 0.0 111.415 -174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -135.57 165.66 25.02 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.602 1.961 . . . . 0.0 111.011 -172.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -135.11 135.3 41.07 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.388 1.075 . . . . 0.0 111.798 -175.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 25.7 mtt -98.94 154.27 18.19 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 125.6 1.56 . . . . 0.0 108.881 168.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 45.6 t -142.48 147.39 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 124.162 0.985 . . . . 0.0 110.878 175.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -131.46 146.34 52.2 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 126.315 1.846 . . . . 0.0 108.828 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.9 p -141.26 139.79 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.643 0 C-N-CA 124.324 1.05 . . . . 0.0 111.377 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.16 158.98 43.22 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.878 1.671 . . . . 0.0 110.484 -173.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 59.1 t -140.57 135.79 35.28 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 C-N-CA 125.603 1.561 . . . . 0.0 108.678 178.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.05 129.44 41.41 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.126 0.97 . . . . 0.0 111.735 -177.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.61 0.44 66.94 Favored Glycine 0 CA--C 1.535 1.337 0 C-N-CA 124.661 1.124 . . . . 0.0 114.694 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -117.58 132.44 56.52 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.335 1.454 . . . . 0.0 110.366 177.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -82.32 -12.93 57.68 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.031 1.122 . . . . 0.0 114.031 -171.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -90.05 155.76 18.86 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.913 1.285 . . . . 0.0 112.706 178.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -128.24 112.37 14.42 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 125.287 1.435 . . . . 0.0 108.759 169.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.37 149.26 30.38 Favored Glycine 0 N--CA 1.466 0.674 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -148.98 147.39 28.53 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 114.397 1.258 . . . . 0.0 114.397 -168.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -151.34 176.42 29.8 Favored Glycine 0 CA--C 1.526 0.752 0 C-N-CA 125.917 1.722 . . . . 0.0 112.594 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.8 p30 -153.29 161.49 42.31 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.115 0.966 . . . . 0.0 112.076 175.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.5 t -168.63 -174.11 2.08 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.27 1.428 . . . . 0.0 111.836 177.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.8 p -75.31 -11.0 59.96 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 125.411 1.485 . . . . 0.0 113.347 172.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -150.08 151.52 33.33 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.409 1.483 . . . . 0.0 112.069 -169.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -66.57 -28.57 68.63 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 -173.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -70.53 -50.41 37.92 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.844 0.857 . . . . 0.0 111.918 179.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -72.75 -29.65 63.5 Favored 'General case' 0 CA--C 1.538 0.516 0 O-C-N 121.572 -0.705 . . . . 0.0 112.182 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.71 -46.14 89.48 Favored 'General case' 0 CA--C 1.542 0.636 0 O-C-N 121.671 -0.643 . . . . 0.0 111.941 171.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -62.25 -38.8 90.66 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 123.474 0.71 . . . . 0.0 112.037 172.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 39.0 m -65.24 -36.94 85.7 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 121.899 -0.501 . . . . 0.0 111.82 177.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -73.79 -35.13 64.9 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.69 0.796 . . . . 0.0 111.713 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -43.48 93.37 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 121.466 -0.772 . . . . 0.0 112.125 171.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.38 -48.04 81.51 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.886 0.874 . . . . 0.0 111.543 174.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 29.0 tpt180 -53.58 -42.26 67.43 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 124.33 1.052 . . . . 0.0 111.932 174.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -72.05 -35.7 69.4 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.965 0.906 . . . . 0.0 113.223 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 47.2 t80 -75.11 -37.23 61.53 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.631 -0.668 . . . . 0.0 112.54 174.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.7 t -64.58 -38.36 82.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 O-C-N 121.352 -0.842 . . . . 0.0 110.494 173.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -55.83 -46.98 78.0 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 119.347 -0.358 . . . . 0.0 111.925 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.8 t80 -56.18 -46.72 79.26 Favored 'General case' 0 N--CA 1.474 0.742 0 O-C-N 121.031 -1.043 . . . . 0.0 112.969 170.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.6 mt -62.13 -33.89 75.32 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 178.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.3 t -68.93 -41.99 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 C-N-CA 123.983 0.913 . . . . 0.0 111.193 171.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt180 -67.3 -19.97 65.55 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 124.356 1.062 . . . . 0.0 113.394 179.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -103.89 6.31 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.267 0 C-N-CA 124.967 1.307 . . . . 0.0 113.576 169.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 61.8 t30 68.0 20.38 9.13 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.843 2.057 . . . . 0.0 114.566 174.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.3 mm-40 -88.96 -6.09 57.5 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.039 1.336 . . . . 0.0 113.036 174.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -136.75 138.7 45.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 C-N-CA 127.055 2.142 . . . . 0.0 107.525 169.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 28.8 mmmt -89.4 131.34 35.51 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.538 0.685 . . . . 0.0 110.615 169.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.8 p -59.55 -33.62 71.64 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -171.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 30.2 mm-40 -62.32 -17.73 59.56 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.514 1.126 . . . . 0.0 113.471 179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -88.94 -16.74 31.07 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.349 1.06 . . . . 0.0 113.227 176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -81.12 125.97 78.23 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.367 1.067 . . . . 0.0 111.368 -168.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -79.03 145.48 19.55 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.501 2.801 . . . . 0.0 111.379 175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.87 128.1 34.74 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.902 0.881 . . . . 0.0 112.011 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.4 p -68.52 -15.4 19.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 C-N-CA 125.823 1.649 . . . . 0.0 114.248 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.77 169.72 34.92 Favored Glycine 0 CA--C 1.531 1.032 0 C-N-CA 125.52 1.533 . . . . 0.0 113.017 179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 36.8 mm -116.98 136.66 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 C-N-CA 125.963 1.705 . . . . 0.0 109.594 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 39.9 t -141.76 134.72 14.13 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 125.521 1.529 . . . . 0.0 109.213 -176.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_exo -58.44 159.38 19.88 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.916 3.078 . . . . 0.0 114.013 177.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -56.93 149.3 62.31 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.941 3.094 . . . . 0.0 113.022 174.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -70.54 -13.21 32.5 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 C-N-CA 123.593 2.862 . . . . 0.0 113.201 178.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.7 p -82.4 -4.98 58.34 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 125.375 1.47 . . . . 0.0 113.565 171.218 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -81.73 173.94 53.9 Favored Glycine 0 CA--C 1.542 1.761 0 C-N-CA 125.232 1.396 . . . . 0.0 113.766 177.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.68 147.9 57.94 Favored 'Trans proline' 0 CA--C 1.537 0.633 0 C-N-CA 123.928 3.085 . . . . 0.0 111.449 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.4 t -166.84 -53.38 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.48 1.112 . . . . 0.0 112.221 -179.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 55.8 m -114.99 6.58 15.33 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.657 1.183 . . . . 0.0 113.479 -178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.189 0 C-N-CA 126.781 2.134 . . . . 0.0 112.947 -178.424 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.602 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 17.6 m -77.16 -11.64 59.84 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 22.8 t -163.33 160.2 23.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.392 1.877 . . . . 0.0 110.284 177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -81.74 -18.98 66.74 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 124.136 0.874 . . . . 0.0 113.888 176.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 6.6 t -169.97 179.54 3.56 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.366 1.466 . . . . 0.0 112.328 -177.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.8 p -159.88 177.6 10.62 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 127.082 2.153 . . . . 0.0 110.097 170.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -98.69 -81.99 1.63 Allowed Glycine 0 C--N 1.343 0.922 0 C-N-CA 124.088 0.852 . . . . 0.0 112.617 -173.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.4 tp -81.24 -32.25 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 -170.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -66.61 -41.47 88.35 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.843 0.857 . . . . 0.0 110.468 173.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -63.4 -38.54 91.55 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.391 1.476 . . . . 0.0 112.278 170.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 80.8 t80 -65.46 -44.37 87.42 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.601 0.76 . . . . 0.0 111.799 -178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.21 -43.25 98.65 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 118.449 0.568 . . . . 0.0 111.365 175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -63.4 -42.92 98.79 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 177.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.36 -39.05 78.33 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.479 1.112 . . . . 0.0 112.56 176.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.9 t90 -60.96 -45.82 93.23 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.219 1.008 . . . . 0.0 111.308 173.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.5 m -58.34 -46.07 86.93 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.431 0.692 . . . . 0.0 111.722 172.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.8 -27.01 73.12 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 124.368 0.985 . . . . 0.0 114.104 -178.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.01 -8.23 57.91 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.556 1.143 . . . . 0.0 112.775 173.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.68 8.9 11.29 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.248 2.219 . . . . 0.0 112.666 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.2 mtmt 64.91 30.43 12.01 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.482 1.913 . . . . 0.0 113.71 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.0 mtm -117.69 173.69 6.59 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.724 2.01 . . . . 0.0 111.521 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 21.0 m -143.47 132.38 11.42 Favored Pre-proline 0 N--CA 1.476 0.857 0 C-N-CA 125.828 1.651 . . . . 0.0 108.885 173.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -77.46 152.48 30.08 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.066 2.51 . . . . 0.0 110.954 177.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.51 116.87 22.48 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.716 1.207 . . . . 0.0 110.801 -179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 85.9 m-85 -100.74 156.95 17.05 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.465 1.506 . . . . 0.0 112.174 -177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -147.2 138.46 23.91 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 125.09 1.356 . . . . 0.0 110.185 174.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 77.8 mt -126.88 148.88 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.999 1.32 . . . . 0.0 111.746 -168.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.3 ttt180 -138.5 136.43 36.12 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 126.222 1.809 . . . . 0.0 110.682 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.11 138.01 31.86 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.342 1.057 . . . . 0.0 111.063 174.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.3 m -145.91 162.49 11.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.295 1.438 . . . . 0.0 111.857 -174.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.37 -172.61 47.22 Favored Glycine 0 CA--C 1.533 1.193 0 C-N-CA 124.83 1.205 . . . . 0.0 114.473 176.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.7 t-20 -57.61 141.04 49.47 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.229 1.412 . . . . 0.0 112.066 176.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -62.5 -45.49 92.75 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -174.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -71.89 -27.51 62.89 Favored 'General case' 0 CA--C 1.549 0.911 0 N-CA-C 113.287 0.847 . . . . 0.0 113.287 177.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -118.43 48.58 1.4 Allowed 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 126.823 2.049 . . . . 0.0 111.174 179.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 16.2 tt0 -74.31 151.03 39.88 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.861 0.839 . . . . 0.0 113.057 -168.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -130.48 164.1 25.55 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 127.17 2.188 . . . . 0.0 110.734 -177.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -134.02 124.15 25.76 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 124.866 1.267 . . . . 0.0 111.17 -174.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 61.0 mtp -89.32 153.08 21.16 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 125.155 1.382 . . . . 0.0 109.41 168.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 32.9 t -142.45 146.18 34.53 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.341 1.056 . . . . 0.0 111.042 178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 64.0 mt-10 -123.53 155.38 37.68 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.548 1.939 . . . . 0.0 109.137 170.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.7 p -144.86 142.56 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.696 0 C-N-CA 124.495 1.118 . . . . 0.0 111.726 174.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 79.3 mtt85 -137.49 160.27 39.59 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 127.056 2.142 . . . . 0.0 110.466 -177.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.7 t -139.91 135.91 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 125.83 1.652 . . . . 0.0 108.297 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.38 129.54 42.51 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.002 0.921 . . . . 0.0 111.702 -178.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.54 0.43 64.8 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.576 1.084 . . . . 0.0 114.73 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -122.32 129.28 52.0 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.205 1.402 . . . . 0.0 110.529 177.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 -77.86 -22.29 50.08 Favored 'General case' 0 CA--C 1.547 0.83 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 -176.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -71.64 156.31 39.52 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.665 1.186 . . . . 0.0 113.243 178.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.67 118.61 17.34 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.939 1.295 . . . . 0.0 109.573 169.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -86.1 150.4 23.83 Favored Glycine 0 N--CA 1.466 0.649 0 N-CA-C 110.511 -1.036 . . . . 0.0 110.511 177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.4 ptm -148.75 151.65 35.21 Favored 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.52 177.98 29.95 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 125.916 1.722 . . . . 0.0 112.926 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -151.75 155.67 38.74 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.13 1.372 . . . . 0.0 110.691 176.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 t -166.99 -176.61 3.45 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.861 1.264 . . . . 0.0 112.428 177.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 52.4 p -76.92 -10.68 59.53 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.647 1.579 . . . . 0.0 113.292 173.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -150.25 151.77 33.52 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 125.273 1.429 . . . . 0.0 112.176 -172.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.81 -27.65 68.42 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -174.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -71.75 -53.27 13.99 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 121.439 -0.788 . . . . 0.0 111.155 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -68.17 -31.65 71.35 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.161 0.584 . . . . 0.0 112.256 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.19 -42.63 98.92 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.738 -0.601 . . . . 0.0 112.275 171.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -65.26 -41.32 94.35 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 123.166 0.586 . . . . 0.0 111.706 173.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.4 m -60.27 -37.59 80.93 Favored 'General case' 0 N--CA 1.47 0.572 0 CA-C-N 119.308 0.958 . . . . 0.0 112.555 174.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -73.71 -37.41 65.17 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 121.365 -0.835 . . . . 0.0 111.517 178.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.55 -42.93 98.35 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.762 0.825 . . . . 0.0 112.316 170.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.79 -47.33 85.6 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.934 0.894 . . . . 0.0 111.454 175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.7 tpt85 -56.87 -38.07 72.22 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 123.063 0.545 . . . . 0.0 112.445 177.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -73.47 -34.67 65.46 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.816 1.246 . . . . 0.0 112.86 178.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -73.38 -37.85 65.86 Favored 'General case' 0 N--CA 1.469 0.487 0 O-C-N 121.317 -0.864 . . . . 0.0 112.157 172.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -63.2 -35.48 72.14 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.023 0 O-C-N 121.52 -0.737 . . . . 0.0 110.973 173.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.87 -40.24 87.96 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.229 0.612 . . . . 0.0 111.496 172.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 17.7 t80 -64.19 -45.15 89.6 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 120.897 -1.127 . . . . 0.0 112.391 169.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.5 mt -60.71 -34.22 74.06 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.191 0.812 . . . . 0.0 113.191 178.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 71.1 t -68.17 -43.55 84.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 123.758 0.823 . . . . 0.0 111.241 171.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.9 mtt-85 -65.43 -24.99 67.33 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.531 0.937 . . . . 0.0 113.531 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.1 pt -97.86 5.63 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 C-N-CA 124.392 1.077 . . . . 0.0 113.671 170.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 60.0 t30 68.06 21.64 8.69 Favored 'General case' 0 CA--C 1.551 1.012 0 C-N-CA 126.529 1.932 . . . . 0.0 114.433 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -91.47 -5.05 54.88 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 125.147 1.379 . . . . 0.0 113.195 176.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 69' ' ' LEU . 90.2 t -137.24 137.95 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.758 0 C-N-CA 127.176 2.19 . . . . 0.0 107.88 169.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -83.82 126.13 32.64 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 122.927 0.491 . . . . 0.0 109.898 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 35.1 p -55.3 -34.32 64.04 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -176.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -63.52 -15.35 57.65 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 114.32 1.23 . . . . 0.0 114.32 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -91.26 -15.81 28.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.56 1.144 . . . . 0.0 113.126 175.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -77.42 123.25 86.87 Favored Pre-proline 0 N--CA 1.476 0.869 0 C-N-CA 124.055 0.942 . . . . 0.0 111.142 -169.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -82.59 150.11 14.69 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.504 2.803 . . . . 0.0 111.593 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -93.52 134.28 35.95 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.216 1.006 . . . . 0.0 111.181 175.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.3 p -63.03 -19.4 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.781 0 C-N-CA 125.227 1.411 . . . . 0.0 114.123 178.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.77 151.88 18.1 Favored Glycine 0 CA--C 1.53 1.03 0 C-N-CA 126.218 1.866 . . . . 0.0 111.609 174.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 49.8 mt -129.65 124.72 59.89 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.9 0 C-N-CA 125.069 1.348 . . . . 0.0 109.201 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 46.3 t -146.26 130.64 8.72 Favored Pre-proline 0 N--CA 1.48 1.064 0 C-N-CA 126.001 1.721 . . . . 0.0 108.432 -177.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.6 156.76 53.43 Favored 'Trans proline' 0 CA--C 1.544 1.009 0 C-N-CA 123.174 2.583 . . . . 0.0 111.772 -178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_exo -56.24 124.08 15.4 Favored 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 123.654 2.903 . . . . 0.0 112.521 -179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -82.75 161.62 16.38 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 123.671 2.914 . . . . 0.0 111.83 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.6 m -74.49 -3.49 31.08 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 62.16 -124.73 34.44 Favored Glycine 0 CA--C 1.538 1.526 0 CA-C-O 118.284 -1.287 . . . . 0.0 111.137 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -77.55 -11.68 17.05 Favored 'Trans proline' 0 CA--C 1.54 0.812 0 C-N-CA 123.295 2.663 . . . . 0.0 113.274 176.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 25.3 m -82.71 6.43 18.02 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -174.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 68.3 p -77.29 -10.7 59.59 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.884 1.274 . . . . 0.0 114.266 175.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.183 0 C-N-CA 125.341 1.448 . . . . 0.0 113.101 178.621 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 111.67 -0.572 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 45.9 p -89.08 -9.97 49.15 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -176.326 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 11.1 t -163.61 151.24 12.8 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.685 1.594 . . . . 0.0 111.043 -178.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -78.63 172.32 55.23 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.671 1.129 . . . . 0.0 113.898 179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 88.5 p -159.63 174.51 14.48 Favored 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 125.492 1.517 . . . . 0.0 111.611 -176.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.0 t -159.88 145.05 15.24 Favored 'General case' 0 N--CA 1.473 0.677 0 O-C-N 120.876 -1.14 . . . . 0.0 112.258 -172.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -71.08 -35.3 64.46 Favored Glycine 0 C--N 1.341 0.836 0 C-N-CA 124.119 0.866 . . . . 0.0 114.051 -172.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp -77.11 -33.08 19.89 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.111 0 CA-C-N 119.19 1.495 . . . . 0.0 112.3 176.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.4 tmtt? -67.1 -42.45 84.54 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.011 0.925 . . . . 0.0 110.343 173.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -67.76 -31.11 70.78 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.903 0.881 . . . . 0.0 112.977 171.556 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -67.74 -41.84 82.77 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 119.241 0.928 . . . . 0.0 111.978 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 26.8 tp -63.26 -43.86 96.78 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 118.661 0.664 . . . . 0.0 111.081 173.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.7 t80 -61.59 -42.56 99.04 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 112.676 0.621 . . . . 0.0 112.676 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.0 -38.8 79.49 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 124.547 1.139 . . . . 0.0 112.782 176.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.4 t90 -61.83 -46.94 87.29 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.901 0.881 . . . . 0.0 111.407 174.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 37.8 m -57.55 -44.67 85.41 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.916 0.887 . . . . 0.0 111.937 171.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.18 -26.52 72.52 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.336 0.969 . . . . 0.0 114.001 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -77.92 -7.86 57.33 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.49 1.116 . . . . 0.0 112.785 172.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.5 mtt180 -119.44 8.91 11.44 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 127.261 2.224 . . . . 0.0 112.797 179.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.9 mttp 63.62 28.44 15.09 Favored 'General case' 0 CA--C 1.553 1.077 0 C-N-CA 126.426 1.89 . . . . 0.0 113.58 -178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 65.5 mtm -112.36 172.51 6.87 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.865 2.066 . . . . 0.0 111.504 178.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 43.7 m -140.73 129.22 12.7 Favored Pre-proline 0 N--CA 1.476 0.834 0 C-N-CA 126.207 1.803 . . . . 0.0 108.609 174.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -76.57 145.88 26.69 Favored 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 123.056 2.504 . . . . 0.0 110.753 177.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.15 115.49 26.13 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.57 1.148 . . . . 0.0 110.681 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.6 m-85 -99.1 156.85 16.73 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 125.448 1.499 . . . . 0.0 112.221 -178.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.98 149.06 32.4 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.338 1.455 . . . . 0.0 110.097 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 66.4 mt -131.93 146.26 33.58 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.652 1.581 . . . . 0.0 110.756 -169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 39.3 ttm105 -145.11 134.2 22.69 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.56 1.544 . . . . 0.0 111.164 -171.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.43 138.64 31.31 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.599 1.16 . . . . 0.0 111.618 -177.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -148.61 155.33 9.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 125.346 1.458 . . . . 0.0 112.2 -174.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.93 -157.46 28.44 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.525 1.059 . . . . 0.0 113.599 177.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -67.42 141.77 56.9 Favored 'General case' 0 CA--C 1.546 0.822 0 C-N-CA 124.827 1.251 . . . . 0.0 112.674 -176.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -63.92 -25.37 68.12 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -175.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 43.9 t30 -95.69 -50.18 5.04 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.768 1.227 . . . . 0.0 111.22 174.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 83.0 mtp180 -85.66 62.77 7.67 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.218 1.407 . . . . 0.0 110.113 173.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 6.8 tp-100 -69.12 143.35 54.18 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.816 1.646 . . . . 0.0 111.541 -172.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -133.27 159.71 39.44 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 125.649 1.579 . . . . 0.0 110.943 175.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -132.94 130.69 39.91 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.338 1.055 . . . . 0.0 111.639 -172.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 40.8 mtp -95.97 155.31 16.81 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.398 1.479 . . . . 0.0 108.822 167.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.5 t -142.27 149.77 40.0 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.251 1.021 . . . . 0.0 110.285 175.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.57 151.05 49.91 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 125.754 1.622 . . . . 0.0 109.861 174.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -140.78 142.23 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.687 1.195 . . . . 0.0 111.503 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 46.5 mtt180 -139.78 158.0 44.81 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 126.539 1.936 . . . . 0.0 110.066 -173.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 50.3 t -140.77 135.5 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 C-N-CA 125.443 1.497 . . . . 0.0 108.748 -179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -59.95 129.22 40.75 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.128 0.971 . . . . 0.0 111.598 -178.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.84 2.44 66.88 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 124.434 1.016 . . . . 0.0 114.482 -176.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.6 m-85 -126.95 127.28 44.61 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.451 1.5 . . . . 0.0 110.039 177.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 17.4 p30 -79.51 -11.52 59.89 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 114.368 1.248 . . . . 0.0 114.368 -174.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -78.3 155.8 29.98 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.506 1.122 . . . . 0.0 113.048 -179.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -133.18 107.73 8.36 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.848 1.259 . . . . 0.0 109.021 170.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -84.0 144.12 21.7 Favored Glycine 0 N--CA 1.467 0.707 0 N-CA-C 109.995 -1.242 . . . . 0.0 109.995 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 27.9 ptm -149.11 152.84 36.85 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 114.315 1.228 . . . . 0.0 114.315 -169.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.01 -178.11 28.12 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 126.157 1.837 . . . . 0.0 112.663 -178.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -154.9 162.58 41.05 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 124.032 0.933 . . . . 0.0 112.877 176.244 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.5 t -168.59 -178.01 3.32 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.959 1.703 . . . . 0.0 111.154 171.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 21.4 m -74.63 -14.81 60.81 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.329 1.452 . . . . 0.0 112.139 171.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.2 p-10 -138.97 146.83 41.43 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.628 1.571 . . . . 0.0 112.422 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -67.92 -28.22 67.31 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 -169.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -68.24 -42.86 79.1 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 119.398 0.999 . . . . 0.0 112.014 175.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -73.81 -33.03 64.01 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 121.578 -0.701 . . . . 0.0 112.031 177.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.82 -46.01 89.93 Favored 'General case' 0 CA--C 1.541 0.63 0 O-C-N 121.825 -0.547 . . . . 0.0 111.674 171.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 38.3 mt-30 -63.29 -38.05 89.65 Favored 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 123.69 0.796 . . . . 0.0 112.271 173.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 59.5 m -64.14 -38.39 90.9 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 118.729 0.695 . . . . 0.0 112.069 176.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -73.76 -37.19 65.1 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.377 0.671 . . . . 0.0 111.335 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.69 -44.46 96.19 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 123.648 0.779 . . . . 0.0 112.381 170.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.81 -49.36 77.79 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.005 0.922 . . . . 0.0 111.204 175.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -57.8 -40.26 79.51 Favored 'General case' 0 N--CA 1.465 0.284 0 C-N-CA 122.916 0.486 . . . . 0.0 112.005 177.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -70.27 -32.37 70.15 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.113 0.782 . . . . 0.0 113.113 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 37.2 t80 -77.35 -38.31 50.48 Favored 'General case' 0 N--CA 1.469 0.482 0 O-C-N 121.72 -0.613 . . . . 0.0 112.196 172.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 64.8 t -61.75 -41.29 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 O-C-N 121.207 -0.933 . . . . 0.0 110.358 171.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -59.87 -33.87 72.38 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 123.391 0.676 . . . . 0.0 112.132 171.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 35.1 t80 -67.31 -44.43 79.21 Favored 'General case' 0 N--CA 1.475 0.802 0 O-C-N 120.054 -1.654 . . . . 0.0 112.03 169.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.8 mt -60.94 -32.45 71.97 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 176.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 81.4 t -69.28 -44.7 80.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.988 0 C-N-CA 124.002 0.921 . . . . 0.0 111.367 169.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtm180 -62.73 -22.66 66.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 177.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.29 8.12 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.201 0 C-N-CA 124.799 1.239 . . . . 0.0 114.086 172.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 64.0 t30 68.46 20.73 8.43 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 126.041 1.736 . . . . 0.0 114.321 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 80.4 mm-40 -93.19 -6.04 48.7 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 125.35 1.46 . . . . 0.0 113.298 175.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.7 t -138.53 139.27 41.63 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 126.887 2.075 . . . . 0.0 107.796 169.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -88.95 133.14 34.41 Favored 'General case' 0 N--CA 1.47 0.536 0 O-C-N 121.865 -0.522 . . . . 0.0 110.696 169.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 33.7 p -57.12 -35.39 69.41 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -63.09 -15.21 55.91 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 114.555 1.317 . . . . 0.0 114.555 178.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 36.7 mm-40 -89.07 -17.5 29.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.359 1.063 . . . . 0.0 113.025 174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 46.0 t -78.23 123.78 85.88 Favored Pre-proline 0 N--CA 1.475 0.775 0 C-N-CA 124.055 0.942 . . . . 0.0 110.462 -169.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -78.62 159.87 28.39 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.354 2.702 . . . . 0.0 112.581 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.69 170.54 20.63 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.503 1.921 . . . . 0.0 110.469 174.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -59.45 -21.02 19.6 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.228 1.411 . . . . 0.0 114.723 -177.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -172.62 133.98 2.84 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.522 1.534 . . . . 0.0 111.653 172.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 45.5 mt -130.9 109.2 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.923 1.289 . . . . 0.0 108.976 -178.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.1 m -151.98 149.07 22.63 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 126.84 2.056 . . . . 0.0 110.176 -178.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -72.46 131.21 17.19 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 123.032 2.488 . . . . 0.0 110.287 176.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.96 140.1 22.56 Favored 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 122.978 2.452 . . . . 0.0 110.893 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -77.58 -20.98 11.8 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 123.198 2.599 . . . . 0.0 113.054 179.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.4 t -170.47 162.32 8.18 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 126.613 1.965 . . . . 0.0 110.509 -178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 179.64 157.92 20.83 Favored Glycine 0 CA--C 1.539 1.554 0 C-N-CA 124.788 1.185 . . . . 0.0 113.635 175.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -75.82 143.01 26.08 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.798 2.999 . . . . 0.0 111.355 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 85.8 p -148.01 3.63 0.71 Allowed 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -176.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 12.0 m -170.2 159.11 7.19 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 127.374 2.27 . . . . 0.0 110.631 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.324 -1.264 . . . . 0.0 112.848 179.314 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.565 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 29.0 m -124.39 7.21 8.36 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.068 1.136 . . . . 0.0 114.068 -170.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 19.5 m 68.48 -10.61 0.45 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 127.284 2.234 . . . . 0.0 116.029 171.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -85.42 150.45 24.59 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 125.279 1.419 . . . . 0.0 112.585 176.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 72.3 p -134.07 5.32 3.56 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 124.621 1.168 . . . . 0.0 113.935 -174.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 64.7 m -75.82 104.68 6.47 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 120.77 -1.206 . . . . 0.0 111.49 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -75.1 -14.55 81.73 Favored Glycine 0 N--CA 1.473 1.102 0 C-N-CA 123.869 0.747 . . . . 0.0 114.928 -170.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -65.27 -31.54 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.803 1.302 . . . . 0.0 113.293 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.53 -35.97 78.2 Favored 'General case' 0 CA--C 1.541 0.597 0 O-C-N 121.549 -0.719 . . . . 0.0 111.509 176.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -76.91 -29.55 55.76 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.911 0.885 . . . . 0.0 112.553 171.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 87.9 t80 -65.49 -45.35 83.94 Favored 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.852 0.861 . . . . 0.0 111.511 178.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 33.6 tp -62.94 -43.07 99.81 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.155 0.434 . . . . 0.0 111.371 174.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -62.55 -42.71 99.71 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.248 0.619 . . . . 0.0 112.628 178.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.34 -41.11 81.23 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.345 1.058 . . . . 0.0 112.449 176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 83.6 t90 -60.83 -45.28 95.08 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.059 0.943 . . . . 0.0 111.66 174.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 84.0 m -59.04 -44.1 91.72 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.882 0.873 . . . . 0.0 111.877 171.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.55 73.66 Favored Glycine 0 CA--C 1.532 1.107 0 C-N-CA 124.611 1.101 . . . . 0.0 114.163 -178.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 72.8 mmtt -78.5 -8.08 58.16 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 118.467 1.134 . . . . 0.0 112.846 172.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.8 mtp180 -119.72 8.17 11.15 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.071 2.149 . . . . 0.0 112.912 -177.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm 66.75 28.54 8.93 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.742 2.017 . . . . 0.0 113.617 -178.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 52.9 mtm -116.71 172.15 7.42 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 126.598 1.959 . . . . 0.0 111.627 -179.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 45.3 m -142.55 130.47 11.4 Favored Pre-proline 0 N--CA 1.475 0.813 0 C-N-CA 126.185 1.794 . . . . 0.0 108.771 174.386 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.9 136.59 18.8 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 122.906 2.404 . . . . 0.0 110.339 176.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -113.14 114.59 27.01 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.499 1.12 . . . . 0.0 111.437 -175.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -98.04 152.27 19.47 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.746 1.218 . . . . 0.0 112.867 -174.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -140.54 148.34 40.87 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 126.307 1.843 . . . . 0.0 108.971 171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 59.3 mt -137.23 147.04 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 125.017 1.327 . . . . 0.0 111.653 -168.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -139.5 137.38 35.46 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.707 1.603 . . . . 0.0 110.975 176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.88 139.69 31.03 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.328 1.051 . . . . 0.0 111.338 176.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 24.6 m -146.84 176.78 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 126.33 1.852 . . . . 0.0 110.774 -176.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.91 -149.74 19.27 Favored Glycine 0 N--CA 1.472 1.034 0 C-N-CA 124.339 0.971 . . . . 0.0 113.058 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 74.1 m-80 -116.84 161.18 19.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.24 1.416 . . . . 0.0 112.364 -174.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -62.73 -21.31 65.7 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -96.86 -11.57 24.64 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 125.217 1.407 . . . . 0.0 113.648 176.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 43.4 ttm180 -159.3 98.57 1.43 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.943 1.697 . . . . 0.0 110.261 179.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 47.0 tt0 -93.08 150.55 20.45 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.712 1.205 . . . . 0.0 111.062 -177.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -138.08 167.03 22.65 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 127.216 2.207 . . . . 0.0 110.719 -179.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -133.19 138.09 46.43 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 125.126 1.37 . . . . 0.0 111.203 -179.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.6 mtm -103.38 153.85 20.03 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.094 1.757 . . . . 0.0 109.386 169.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.7 t -144.19 146.28 32.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.385 1.074 . . . . 0.0 111.886 -179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -129.38 136.8 50.43 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.546 1.938 . . . . 0.0 108.827 177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -127.16 135.78 62.55 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 124.215 1.006 . . . . 0.0 111.657 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -124.94 153.37 42.81 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 126.457 1.903 . . . . 0.0 109.752 -177.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -142.11 135.61 28.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 C-N-CA 125.645 1.578 . . . . 0.0 108.546 176.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.08 139.3 57.01 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.108 0.963 . . . . 0.0 112.06 -178.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.69 -4.07 86.28 Favored Glycine 0 CA--C 1.535 1.326 0 C-N-CA 124.768 1.175 . . . . 0.0 114.916 -178.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.5 m-85 -117.72 133.01 56.39 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 118.895 1.347 . . . . 0.0 111.136 177.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -81.55 -16.03 52.97 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -83.42 157.55 22.44 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 124.69 1.196 . . . . 0.0 112.393 176.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.43 129.14 32.78 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.689 1.195 . . . . 0.0 109.856 169.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.23 144.5 28.44 Favored Glycine 0 C--N 1.338 0.682 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 177.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 74.4 mtm -134.7 135.46 42.02 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 124.802 1.241 . . . . 0.0 111.486 -171.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.24 173.41 28.26 Favored Glycine 0 N--CA 1.467 0.701 0 C-N-CA 124.984 1.278 . . . . 0.0 113.259 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -154.6 160.32 41.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.433 1.093 . . . . 0.0 111.873 173.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.7 t -169.04 -173.6 1.83 Allowed 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 125.418 1.487 . . . . 0.0 111.815 177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 58.2 p -74.09 -12.49 60.62 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.525 1.53 . . . . 0.0 113.436 173.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -149.67 151.74 34.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.476 1.511 . . . . 0.0 111.822 -170.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -63.56 -29.63 70.86 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 114.271 1.212 . . . . 0.0 114.271 -174.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 50.4 mtmt -74.16 -46.63 41.03 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.082 0.953 . . . . 0.0 112.066 -176.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -74.65 -28.45 60.86 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 121.492 -0.755 . . . . 0.0 112.05 176.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.53 -44.89 89.42 Favored 'General case' 0 CA--C 1.541 0.613 0 O-C-N 121.657 -0.652 . . . . 0.0 111.756 171.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 50.0 mt-30 -61.1 -40.62 94.41 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.393 0.677 . . . . 0.0 111.872 170.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.0 m -64.22 -37.38 87.27 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 118.576 0.625 . . . . 0.0 112.057 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -72.83 -36.26 67.46 Favored 'General case' 0 CA--C 1.542 0.662 0 O-C-N 121.552 -0.717 . . . . 0.0 111.598 176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.72 94.56 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.488 0.715 . . . . 0.0 111.888 171.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.84 -47.95 82.78 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.467 1.107 . . . . 0.0 111.461 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.1 tpt180 -56.9 -41.29 77.84 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.302 0.501 . . . . 0.0 111.794 175.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -69.14 -28.14 66.17 Favored 'General case' 0 CA--C 1.544 0.741 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 42.9 t80 -80.87 -37.71 29.36 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 118.703 0.683 . . . . 0.0 112.672 170.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.3 t -61.58 -40.54 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 118.961 0.8 . . . . 0.0 110.534 173.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -55.14 -47.51 74.97 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.604 0.761 . . . . 0.0 111.531 170.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -59.18 -44.07 92.17 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 121.112 -0.993 . . . . 0.0 112.59 173.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 99.1 mt -62.38 -35.9 80.61 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 113.001 0.741 . . . . 0.0 113.001 177.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.1 t -66.51 -42.73 90.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.687 0.795 . . . . 0.0 111.071 172.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 28.0 mmt85 -66.36 -13.4 60.56 Favored 'General case' 0 N--CA 1.474 0.744 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.8 pt -114.04 9.92 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 C-N-CA 125.21 1.404 . . . . 0.0 113.252 170.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.6 m120 67.23 17.52 10.28 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 126.507 1.923 . . . . 0.0 114.592 175.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -83.9 -11.09 57.44 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 125.242 1.417 . . . . 0.0 113.139 175.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.3 t -134.35 138.07 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 126.546 1.938 . . . . 0.0 107.923 169.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -83.72 126.13 32.59 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 122.826 0.451 . . . . 0.0 109.929 169.654 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.17 -33.04 62.63 Favored 'General case' 0 N--CA 1.474 0.769 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.38 61.65 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.943 1.297 . . . . 0.0 113.579 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.2 mm-40 -91.66 -16.51 26.91 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.627 1.171 . . . . 0.0 113.304 177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.2 t -77.5 126.07 85.2 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 124.213 1.005 . . . . 0.0 110.871 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.26 150.98 37.85 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.299 2.666 . . . . 0.0 111.962 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -147.79 156.88 43.2 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.509 1.524 . . . . 0.0 111.688 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -66.8 -14.98 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 -174.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 179.85 177.0 47.73 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 125.084 1.326 . . . . 0.0 113.477 -179.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 39.6 mm -115.23 141.14 33.26 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 126.191 1.797 . . . . 0.0 109.846 -178.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 10.8 m -140.4 150.58 61.49 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 126.093 1.757 . . . . 0.0 110.948 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -72.99 164.16 36.34 Favored 'Trans proline' 0 CA--C 1.544 0.999 0 C-N-CA 123.433 2.755 . . . . 0.0 111.81 178.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.28 145.88 85.08 Favored 'Trans proline' 0 CA--C 1.542 0.921 0 C-N-CA 123.797 2.998 . . . . 0.0 112.481 175.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_exo -57.7 -23.62 58.71 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.679 2.919 . . . . 0.0 114.905 176.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 19.9 m -78.02 -7.23 56.61 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 124.423 1.089 . . . . 0.0 113.84 177.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -87.64 175.59 45.65 Favored Glycine 0 CA--C 1.542 1.74 0 C-N-CA 125.15 1.357 . . . . 0.0 113.825 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -66.26 -33.7 38.39 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.7 2.933 . . . . 0.0 114.006 179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 66.8 m 66.85 -9.78 0.34 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 127.307 2.243 . . . . 0.0 115.507 177.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.9 p -165.01 166.07 19.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 126.464 1.905 . . . . 0.0 111.695 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.181 0 CA-C-O 118.251 -1.305 . . . . 0.0 112.887 179.627 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.572 0 N-CA-C 112.177 -0.369 . . . . 0.0 112.177 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 8.7 t -163.69 175.43 10.58 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 125.636 1.574 . . . . 0.0 110.949 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 9.4 t -161.84 154.61 20.25 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.492 1.517 . . . . 0.0 111.572 -178.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -89.45 165.75 32.71 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 124.938 1.256 . . . . 0.0 113.625 -179.003 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 11.1 t -162.38 156.49 21.37 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.287 1.435 . . . . 0.0 111.234 177.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t -169.2 140.57 2.41 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.972 1.709 . . . . 0.0 110.367 -177.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -69.32 -38.5 81.27 Favored Glycine 0 CA--C 1.528 0.845 0 CA-C-O 119.183 -0.787 . . . . 0.0 113.817 -169.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.6 tp -77.13 -34.5 21.63 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 CA-C-N 118.843 1.321 . . . . 0.0 112.247 178.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.74 -43.28 84.61 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.167 0.987 . . . . 0.0 110.313 174.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.8 t30 -66.94 -31.82 72.67 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.207 1.003 . . . . 0.0 112.821 172.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.6 t80 -68.49 -42.91 77.95 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 118.994 0.815 . . . . 0.0 111.734 179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -62.71 -42.88 99.87 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 118.626 0.648 . . . . 0.0 111.234 172.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.8 t80 -63.01 -42.28 99.79 Favored 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 112.694 0.627 . . . . 0.0 112.694 178.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.05 -40.22 78.68 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.484 1.114 . . . . 0.0 112.434 176.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.7 t90 -60.42 -45.64 92.9 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.952 0.901 . . . . 0.0 111.456 174.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 88.7 m -58.05 -45.43 87.05 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 123.648 0.779 . . . . 0.0 111.758 172.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.81 -26.82 73.12 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.491 1.043 . . . . 0.0 114.145 -178.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 32.1 mmtp -78.92 -7.5 58.04 Favored 'General case' 0 N--CA 1.475 0.822 0 CA-C-N 118.545 1.173 . . . . 0.0 112.876 172.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 25.7 mtp180 -119.55 9.21 11.44 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 127.166 2.187 . . . . 0.0 112.709 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.98 31.45 11.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.451 1.9 . . . . 0.0 113.549 -179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 60.3 mtm -119.79 172.83 7.42 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 126.804 2.041 . . . . 0.0 111.56 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 32.0 m -142.94 131.04 11.26 Favored Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 126.26 1.824 . . . . 0.0 108.755 174.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.82 147.37 24.37 Favored 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.954 2.436 . . . . 0.0 110.734 177.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.93 117.35 27.1 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.648 1.179 . . . . 0.0 110.761 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -100.3 156.52 17.19 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.328 1.451 . . . . 0.0 112.343 -177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.22 149.65 33.33 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.102 1.361 . . . . 0.0 110.318 171.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 69.4 mt -134.26 147.89 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 125.566 1.547 . . . . 0.0 111.867 -168.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 47.9 ttt-85 -135.44 138.3 43.07 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.773 1.629 . . . . 0.0 110.792 170.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -77.93 145.67 35.98 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 123.754 0.822 . . . . 0.0 111.622 171.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.8 m -148.28 172.27 2.22 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.875 2.07 . . . . 0.0 110.456 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.46 176.64 50.48 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.092 0.853 . . . . 0.0 113.894 177.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -83.37 163.07 20.83 Favored 'General case' 0 CA--C 1.547 0.838 0 C-N-CA 124.356 1.062 . . . . 0.0 112.988 -175.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 48.7 mttp -58.17 -36.43 73.02 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.322 1.449 . . . . 0.0 114.148 -174.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.4 p-10 -70.68 -28.09 64.5 Favored 'General case' 0 CA--C 1.544 0.715 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 -178.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.5 ttm180 -150.37 90.39 1.65 Allowed 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 125.978 1.711 . . . . 0.0 110.238 177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 48.4 tt0 -78.94 148.12 32.77 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.191 0.996 . . . . 0.0 110.703 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -132.57 166.17 22.71 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.754 2.021 . . . . 0.0 110.905 -179.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.5 m-85 -135.46 131.78 36.58 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.906 1.282 . . . . 0.0 111.343 -173.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 38.3 mtm -99.17 152.14 20.21 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 125.612 1.565 . . . . 0.0 108.937 169.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.1 t -146.06 147.71 31.89 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 111.515 -177.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -128.88 156.19 44.08 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.331 1.452 . . . . 0.0 110.757 170.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -139.48 143.1 31.57 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 124.892 1.277 . . . . 0.0 111.254 176.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.9 mtt180 -138.08 157.68 45.84 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.246 1.818 . . . . 0.0 110.688 -176.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 55.6 t -140.62 135.92 35.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 125.851 1.661 . . . . 0.0 108.319 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -60.15 129.38 41.43 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.101 0.96 . . . . 0.0 111.731 -177.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.95 0.62 65.97 Favored Glycine 0 CA--C 1.536 1.365 0 C-N-CA 124.653 1.12 . . . . 0.0 114.715 -178.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -119.29 131.06 55.7 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 125.228 1.411 . . . . 0.0 110.631 177.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -77.85 -24.76 48.51 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 113.517 0.932 . . . . 0.0 113.517 -174.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 52.4 t80 -75.11 155.93 36.55 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.287 1.035 . . . . 0.0 113.144 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.44 114.22 15.27 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 125.261 1.424 . . . . 0.0 108.669 169.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.49 143.89 25.11 Favored Glycine 0 N--CA 1.467 0.75 0 N-CA-C 110.538 -1.025 . . . . 0.0 110.538 -178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 83.5 mtp -137.98 146.64 43.38 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 113.654 0.983 . . . . 0.0 113.654 -169.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -154.28 177.67 31.54 Favored Glycine 0 CA--C 1.528 0.857 0 C-N-CA 125.789 1.662 . . . . 0.0 112.895 177.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -155.67 159.2 39.37 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.492 1.117 . . . . 0.0 111.981 176.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 t -169.2 -179.44 3.55 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 125.134 1.374 . . . . 0.0 112.083 178.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.2 m -78.64 -13.13 59.98 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 125.395 1.478 . . . . 0.0 112.101 172.009 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -134.21 142.89 47.54 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.238 1.415 . . . . 0.0 111.628 -178.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.2 mttp -63.98 -30.81 71.86 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -175.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 14.1 mptt -69.85 -42.25 73.79 Favored 'General case' 0 N--CA 1.475 0.814 0 O-C-N 121.359 -0.838 . . . . 0.0 111.543 177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -76.72 -29.46 56.23 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.456 0.702 . . . . 0.0 112.03 178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.28 -44.94 90.11 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.636 -0.665 . . . . 0.0 111.817 170.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -62.81 -39.13 93.36 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 123.509 0.724 . . . . 0.0 111.775 171.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 51.9 m -63.19 -36.42 83.57 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 118.558 0.617 . . . . 0.0 112.27 176.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -75.38 -34.11 61.09 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 123.308 0.643 . . . . 0.0 111.749 177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.68 -44.08 91.48 Favored 'General case' 0 CA--C 1.538 0.515 0 O-C-N 121.523 -0.735 . . . . 0.0 111.924 169.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.98 -47.81 83.18 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 124.29 1.036 . . . . 0.0 111.686 175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 24.7 tpt180 -52.48 -44.4 65.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.337 1.055 . . . . 0.0 111.647 175.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -71.63 -35.98 70.61 Favored 'General case' 0 CA--C 1.542 0.67 0 N-CA-C 113.033 0.753 . . . . 0.0 113.033 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 41.3 t80 -73.41 -37.33 65.95 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.406 0.548 . . . . 0.0 112.428 174.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 54.3 t -62.05 -43.15 97.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.357 -0.84 . . . . 0.0 110.169 171.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.6 m-80 -61.73 -33.68 74.47 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 172.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -63.9 -45.8 87.7 Favored 'General case' 0 N--CA 1.476 0.855 0 O-C-N 120.062 -1.649 . . . . 0.0 111.882 168.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.414 ' HB3' HG23 ' A' ' 75' ' ' VAL . 91.7 mt -61.89 -33.84 74.94 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 123.531 0.732 . . . . 0.0 112.735 176.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.01 -43.89 85.2 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 123.842 0.857 . . . . 0.0 111.291 170.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 85.7 mtm180 -63.78 -21.1 66.25 Favored 'General case' 0 N--CA 1.475 0.779 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 177.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -106.03 6.95 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.24 0 C-N-CA 124.794 1.238 . . . . 0.0 113.959 171.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 44.0 m-80 70.53 16.03 7.05 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.829 2.052 . . . . 0.0 114.82 174.135 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -87.25 -6.72 58.46 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.356 1.462 . . . . 0.0 113.364 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 69' ' ' LEU . 74.5 t -135.05 137.13 50.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 127.058 2.143 . . . . 0.0 107.473 168.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 6.3 mtpm? -86.47 128.37 34.95 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.994 -0.441 . . . . 0.0 110.165 169.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 85.9 p -53.52 -33.13 53.39 Favored 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -175.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -61.12 -20.71 62.98 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.702 1.601 . . . . 0.0 113.339 -178.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 47.9 mm-40 -88.37 -17.84 29.68 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.602 1.161 . . . . 0.0 113.091 178.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.5 t -76.38 127.13 85.37 Favored Pre-proline 0 N--CA 1.474 0.769 0 C-N-CA 124.329 1.052 . . . . 0.0 110.258 -169.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.79 144.08 38.4 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 123.128 2.552 . . . . 0.0 111.46 -179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.89 163.89 39.29 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.513 1.525 . . . . 0.0 111.406 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -63.63 -15.88 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 C-N-CA 125.469 1.507 . . . . 0.0 114.711 179.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -178.82 175.37 47.3 Favored Glycine 0 CA--C 1.53 0.976 0 C-N-CA 125.988 1.756 . . . . 0.0 112.323 178.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 66.8 mt -85.84 111.8 21.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 176.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 13.4 m -146.45 151.97 44.74 Favored Pre-proline 0 N--CA 1.473 0.699 0 C-N-CA 126.106 1.763 . . . . 0.0 111.098 -173.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -69.95 158.53 56.39 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 123.31 2.673 . . . . 0.0 111.318 173.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -69.3 148.11 67.34 Favored 'Trans proline' 0 CA--C 1.544 1.003 0 C-N-CA 123.37 2.713 . . . . 0.0 111.641 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.92 163.52 33.17 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 C-N-CA 123.899 3.066 . . . . 0.0 112.404 -177.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 17.7 t -159.4 151.85 21.3 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 125.449 1.5 . . . . 0.0 110.659 177.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.38 -152.15 37.39 Favored Glycine 0 CA--C 1.542 1.729 0 CA-C-O 118.976 -0.902 . . . . 0.0 112.314 -172.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -56.78 148.06 68.39 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 124.331 3.354 . . . . 0.0 113.214 177.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.0 m -73.83 -5.24 39.72 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 114.623 1.342 . . . . 0.0 114.623 -174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 66.9 m -146.23 145.83 30.56 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 126.03 1.732 . . . . 0.0 111.238 -175.199 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.211 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.88 178.893 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.586 0 N-CA-C 111.921 -0.472 . . . . 0.0 111.921 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 76.7 p -164.56 165.15 21.43 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.297 1.439 . . . . 0.0 111.748 -176.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 17.3 m -164.72 157.49 16.68 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.563 1.945 . . . . 0.0 110.665 -179.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -176.29 162.08 30.69 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 123.994 0.807 . . . . 0.0 114.041 177.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.2 t -168.16 -161.52 0.37 Allowed 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 126.807 2.043 . . . . 0.0 109.757 -177.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 57.2 p -152.59 169.28 23.05 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.029 1.332 . . . . 0.0 112.484 -179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -66.68 -33.37 84.17 Favored Glycine 0 CA--C 1.528 0.875 0 O-C-N 121.614 -0.679 . . . . 0.0 112.898 -179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.3 tp -79.03 -34.45 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 CA-C-N 118.56 1.18 . . . . 0.0 112.268 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 mmmt -60.82 -46.18 91.55 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.463 0.705 . . . . 0.0 111.162 169.657 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.1 t30 -64.46 -36.49 84.34 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 123.335 0.654 . . . . 0.0 112.346 174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.1 t80 -68.21 -45.31 73.7 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.741 0.7 . . . . 0.0 111.87 -179.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.7 tp -63.92 -43.22 96.58 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 118.66 0.664 . . . . 0.0 111.246 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 59.0 t80 -63.66 -43.02 97.95 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 178.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.75 -40.0 88.13 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 123.901 0.88 . . . . 0.0 112.568 175.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.6 t90 -61.55 -45.52 93.82 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 123.769 0.827 . . . . 0.0 111.531 174.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.9 m -59.36 -45.93 90.06 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 123.706 0.802 . . . . 0.0 111.751 172.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.56 -27.11 73.56 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.419 1.009 . . . . 0.0 113.963 -177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -77.14 -8.84 58.2 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 118.389 1.094 . . . . 0.0 112.715 173.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 26.9 mtp180 -119.63 8.83 11.31 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 127.248 2.219 . . . . 0.0 112.656 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.4 mttp 64.95 32.58 10.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 126.536 1.935 . . . . 0.0 113.547 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.1 mtm -120.46 171.73 8.33 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.741 2.016 . . . . 0.0 111.735 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 39.3 m -142.71 130.53 11.27 Favored Pre-proline 0 N--CA 1.476 0.852 0 C-N-CA 126.192 1.797 . . . . 0.0 109.011 176.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -77.53 145.22 23.27 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.151 2.567 . . . . 0.0 110.903 177.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -126.34 129.52 49.0 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.912 1.285 . . . . 0.0 111.046 -176.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -114.72 160.1 19.78 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 124.997 1.319 . . . . 0.0 113.484 -169.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -141.6 144.21 34.09 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 126.162 1.785 . . . . 0.0 109.075 169.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 52.3 mt -130.03 144.05 39.18 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 C-N-CA 125.596 1.558 . . . . 0.0 109.649 -175.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 32.7 ttm105 -143.9 129.9 19.53 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 124.811 1.244 . . . . 0.0 111.458 -172.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.72 137.19 34.5 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.024 0.93 . . . . 0.0 111.721 -176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.3 m -146.35 176.45 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 C-N-CA 126.537 1.935 . . . . 0.0 110.616 -177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.4 -146.28 18.89 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.011 0.815 . . . . 0.0 112.666 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -116.1 164.39 14.53 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.018 1.327 . . . . 0.0 112.32 -174.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.8 tptt -61.84 -38.95 90.12 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.107 0.963 . . . . 0.0 113.104 178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -80.17 -25.02 39.96 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.946 1.298 . . . . 0.0 114.349 178.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 60.7 ttp180 -142.93 87.06 1.96 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.504 1.921 . . . . 0.0 109.955 -179.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -91.0 149.64 21.76 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.733 1.213 . . . . 0.0 110.853 -176.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -136.77 164.3 28.59 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 126.729 2.012 . . . . 0.0 110.754 -178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -133.89 125.3 28.02 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 124.93 1.292 . . . . 0.0 111.126 -175.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 55.1 mtp -89.47 155.35 19.36 Favored 'General case' 0 C--O 1.235 0.311 0 C-N-CA 125.055 1.342 . . . . 0.0 108.951 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.6 t -143.43 147.82 35.19 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.956 0.903 . . . . 0.0 111.536 176.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 67.6 mt-10 -129.12 145.12 51.37 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 126.302 1.841 . . . . 0.0 108.884 175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.5 p -134.53 142.78 39.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 C-N-CA 124.655 1.182 . . . . 0.0 111.439 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 82.3 mtt85 -137.88 157.15 47.0 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.656 1.982 . . . . 0.0 110.67 -176.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.64 135.36 34.63 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 126.079 1.752 . . . . 0.0 108.282 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -59.82 129.6 42.67 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.146 0.978 . . . . 0.0 111.766 -177.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.09 0.9 65.42 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.588 1.089 . . . . 0.0 114.762 -178.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -122.23 132.09 54.25 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.177 1.391 . . . . 0.0 110.57 178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -83.65 -14.87 50.86 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 60.4 t80 -81.74 155.84 25.29 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 124.657 1.183 . . . . 0.0 112.675 177.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.26 120.14 25.2 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.847 1.259 . . . . 0.0 109.284 169.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -77.72 140.87 24.76 Favored Glycine 0 N--CA 1.466 0.696 0 N-CA-C 110.39 -1.084 . . . . 0.0 110.39 177.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.0 mtt -135.17 142.53 46.13 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.22 0.822 . . . . 0.0 113.22 -169.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -146.42 172.07 27.09 Favored Glycine 0 N--CA 1.468 0.775 0 C-N-CA 125.782 1.658 . . . . 0.0 113.35 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -158.32 149.69 21.06 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.776 1.23 . . . . 0.0 111.392 176.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 t -167.57 179.84 4.7 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.796 1.238 . . . . 0.0 112.703 -179.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 28.5 p -78.51 -8.84 58.99 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.88 1.672 . . . . 0.0 112.999 170.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -137.87 142.75 40.7 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.661 1.584 . . . . 0.0 111.373 -178.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -60.39 -42.34 95.69 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.442 1.097 . . . . 0.0 113.231 -176.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -66.96 -37.53 84.45 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -75.76 -29.71 58.9 Favored 'General case' 0 CA--C 1.539 0.525 0 O-C-N 121.475 -0.766 . . . . 0.0 111.834 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.1 -44.44 79.99 Favored 'General case' 0 CA--C 1.54 0.566 0 O-C-N 121.688 -0.632 . . . . 0.0 111.413 170.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 85.7 mt-30 -60.56 -39.07 86.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 124.248 1.019 . . . . 0.0 112.031 171.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.0 m -67.25 -34.58 77.73 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 118.805 0.73 . . . . 0.0 112.413 177.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -71.72 -38.52 70.48 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.531 -0.731 . . . . 0.0 111.72 172.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.74 -45.59 92.02 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 118.587 0.631 . . . . 0.0 111.644 173.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.05 -48.23 82.57 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.346 1.058 . . . . 0.0 111.544 174.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -58.35 -39.48 79.64 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 118.761 -0.638 . . . . 0.0 112.202 177.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -73.35 -29.52 62.7 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 119.197 0.908 . . . . 0.0 113.2 178.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 40.5 t80 -74.38 -39.71 62.53 Favored 'General case' 0 CA--C 1.535 0.389 0 O-C-N 121.443 -0.786 . . . . 0.0 111.863 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.6 t -62.45 -40.93 89.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 O-C-N 121.49 -0.756 . . . . 0.0 110.761 172.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -56.44 -50.62 71.14 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 118.838 -0.601 . . . . 0.0 110.739 170.348 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.35 -41.41 63.02 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 120.086 1.312 . . . . 0.0 113.731 172.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 86.8 mt -64.36 -22.52 66.98 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 113.409 0.892 . . . . 0.0 113.409 174.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 58.9 t -80.7 -38.12 17.09 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-N 119.507 1.049 . . . . 0.0 110.726 168.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 51.2 mtt180 -59.74 -29.54 68.22 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.974 0.91 . . . . 0.0 112.35 175.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 15.8 pt -104.63 4.93 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.242 0 C-N-CA 125.047 1.339 . . . . 0.0 114.339 175.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 69.73 16.29 7.92 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 126.699 2.0 . . . . 0.0 115.162 173.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -83.91 -8.98 59.05 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.35 1.46 . . . . 0.0 113.392 174.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.6 t -135.96 141.64 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 126.792 2.037 . . . . 0.0 108.259 168.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -89.82 129.82 36.15 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 123.484 0.713 . . . . 0.0 110.218 169.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 25.6 p -55.26 -32.61 62.49 Favored 'General case' 0 N--CA 1.474 0.758 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 -177.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.16 -19.38 53.59 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 124.837 1.255 . . . . 0.0 113.613 179.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 49.8 mm-40 -90.51 -16.77 28.26 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.645 1.178 . . . . 0.0 113.41 176.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.8 t -79.8 126.25 80.57 Favored Pre-proline 0 N--CA 1.475 0.792 0 C-N-CA 124.399 1.079 . . . . 0.0 110.851 -169.106 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -77.24 155.57 32.98 Favored 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 123.448 2.765 . . . . 0.0 112.537 -178.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.65 165.67 34.51 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 126.121 1.768 . . . . 0.0 111.218 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -18.58 19.83 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 125.314 1.446 . . . . 0.0 114.51 179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -163.38 156.47 28.27 Favored Glycine 0 CA--C 1.529 0.946 0 C-N-CA 125.965 1.745 . . . . 0.0 111.879 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 3.1 mp -83.26 96.55 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.663 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -179.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 p -165.93 139.75 3.61 Favored Pre-proline 0 N--CA 1.478 0.929 0 C-N-CA 126.402 1.881 . . . . 0.0 110.018 -178.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -59.84 150.87 75.03 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 123.296 2.664 . . . . 0.0 112.873 174.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -71.21 151.37 60.69 Favored 'Trans proline' 0 CA--C 1.544 1.01 0 C-N-CA 123.351 2.701 . . . . 0.0 111.39 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -73.24 144.86 37.86 Favored 'Trans proline' 0 CA--C 1.536 0.606 0 C-N-CA 123.664 2.909 . . . . 0.0 111.672 -178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 20.9 m -80.48 -3.86 51.59 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.2 1.185 . . . . 0.0 114.2 -177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -78.34 157.43 44.48 Favored Glycine 0 CA--C 1.541 1.712 0 C-N-CA 124.663 1.125 . . . . 0.0 113.589 -177.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 91.7 Cg_endo -75.36 161.64 37.41 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 124.077 3.185 . . . . 0.0 111.543 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.0 m -64.79 -12.31 46.39 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 179.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 20.1 m -80.6 -7.98 59.45 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.386 1.474 . . . . 0.0 113.946 177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.206 0 CA-C-O 118.247 -1.307 . . . . 0.0 113.465 -179.562 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.675 0 N-CA-C 112.051 -0.42 . . . . 0.0 112.051 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 10.2 m -77.01 -12.69 59.97 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.45 1.278 . . . . 0.0 114.45 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 70.4 m -144.79 153.67 41.89 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.81 1.644 . . . . 0.0 111.066 -175.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -78.59 -7.51 88.05 Favored Glycine 0 CA--C 1.535 1.287 0 C-N-CA 124.204 0.907 . . . . 0.0 115.013 -177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 9.0 t -165.91 176.42 7.86 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 126.597 1.959 . . . . 0.0 110.656 178.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 31.7 t -158.79 127.81 5.47 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.699 1.599 . . . . 0.0 110.133 176.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -106.86 -80.72 1.33 Allowed Glycine 0 C--N 1.341 0.847 0 C-N-CA 124.803 1.192 . . . . 0.0 112.784 -170.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.0 tp -75.49 -36.55 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -169.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -66.66 -40.65 88.73 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 123.931 0.892 . . . . 0.0 110.587 175.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -64.94 -36.4 84.26 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.439 1.496 . . . . 0.0 112.258 171.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.7 t80 -70.33 -41.41 73.26 Favored 'General case' 0 N--CA 1.466 0.338 0 C-N-CA 123.926 0.891 . . . . 0.0 112.106 -178.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.2 tp -62.64 -43.48 98.71 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.917 0.781 . . . . 0.0 111.143 173.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 61.3 t80 -62.59 -43.75 98.03 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 123.12 0.568 . . . . 0.0 112.52 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.69 -39.85 88.29 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.167 0.987 . . . . 0.0 112.779 175.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 86.6 t90 -61.85 -45.8 92.23 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.139 0.976 . . . . 0.0 111.525 175.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 97.3 m -58.41 -45.33 88.63 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.542 0.737 . . . . 0.0 111.708 172.674 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.05 -26.12 73.32 Favored Glycine 0 CA--C 1.531 1.07 0 C-N-CA 124.355 0.979 . . . . 0.0 114.159 -178.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -78.18 -8.68 58.6 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.498 1.149 . . . . 0.0 112.819 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 23.2 mtp180 -119.72 9.53 11.43 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 127.203 2.201 . . . . 0.0 112.669 -178.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.02 29.66 12.1 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 126.408 1.883 . . . . 0.0 113.648 -179.209 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 59.3 mtm -116.77 172.42 7.25 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.708 2.003 . . . . 0.0 111.547 179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 36.3 m -141.96 130.72 12.07 Favored Pre-proline 0 N--CA 1.476 0.856 0 C-N-CA 126.116 1.766 . . . . 0.0 108.752 175.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -77.39 146.23 24.53 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 122.988 2.459 . . . . 0.0 110.578 177.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -118.56 114.8 23.35 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.597 1.159 . . . . 0.0 110.806 -179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.0 m-85 -99.13 156.95 16.69 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.444 1.498 . . . . 0.0 112.287 -178.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -146.47 151.74 37.88 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.598 1.559 . . . . 0.0 109.805 169.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 64.2 mt -131.42 139.87 49.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.793 0 C-N-CA 125.087 1.355 . . . . 0.0 111.299 -169.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.0 mpt_? -122.52 154.01 38.43 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 128.264 2.626 . . . . 0.0 109.662 176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -116.52 141.38 48.25 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.466 1.107 . . . . 0.0 111.55 179.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 19.1 m -149.56 176.6 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 C-N-CA 126.132 1.773 . . . . 0.0 111.102 -172.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.78 -142.33 15.99 Favored Glycine 0 N--CA 1.471 0.968 0 C-N-CA 124.355 0.978 . . . . 0.0 112.427 179.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -128.47 165.45 20.66 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.516 1.526 . . . . 0.0 111.863 -174.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.1 mttm -59.23 -34.57 72.36 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.135 0.974 . . . . 0.0 113.467 178.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -97.47 2.64 50.52 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.15 1.78 . . . . 0.0 113.726 178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 54.3 ttp180 -153.62 72.84 0.93 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 126.288 1.835 . . . . 0.0 109.695 -176.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 71.4 tp60 -75.97 138.55 41.02 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 124.068 0.947 . . . . 0.0 110.848 -174.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -142.8 162.36 35.67 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 125.482 1.513 . . . . 0.0 111.061 178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -135.75 149.72 49.26 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 124.836 1.255 . . . . 0.0 111.842 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 86.2 mtp -118.66 155.05 31.69 Favored 'General case' 0 N--CA 1.463 0.217 0 C-N-CA 126.688 1.995 . . . . 0.0 109.081 171.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.7 t -148.31 154.78 40.47 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.574 0.75 . . . . 0.0 111.271 -176.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -144.12 144.85 31.78 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 126.243 1.817 . . . . 0.0 109.475 -178.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.1 p -140.24 142.21 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 124.2 1.0 . . . . 0.0 111.821 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 81.1 mtt85 -136.31 160.14 39.62 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.657 1.983 . . . . 0.0 110.482 -177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.1 t -139.59 136.11 39.92 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.746 1.618 . . . . 0.0 108.435 178.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.45 129.57 42.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.022 0.929 . . . . 0.0 111.674 -177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.24 1.38 66.88 Favored Glycine 0 CA--C 1.535 1.322 0 C-N-CA 124.612 1.101 . . . . 0.0 114.601 -177.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -124.08 131.47 53.55 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.334 1.454 . . . . 0.0 110.437 177.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.2 p30 -81.87 -12.14 58.6 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 -174.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 53.2 t80 -83.77 157.06 22.23 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.461 1.104 . . . . 0.0 113.228 -178.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -130.35 112.87 13.7 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.906 1.282 . . . . 0.0 109.348 169.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -80.44 142.38 23.81 Favored Glycine 0 N--CA 1.468 0.778 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 176.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 54.8 mtt -136.43 148.91 47.99 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 113.417 0.895 . . . . 0.0 113.417 -169.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -144.5 170.09 26.26 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.116 1.817 . . . . 0.0 113.594 -175.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -155.93 150.69 26.15 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.573 1.149 . . . . 0.0 112.001 174.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.8 t -168.87 -174.62 2.14 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 124.897 1.279 . . . . 0.0 112.381 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.2 p -77.04 -13.19 59.99 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 125.659 1.584 . . . . 0.0 113.407 173.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -148.26 152.33 36.96 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.162 1.385 . . . . 0.0 112.286 -170.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -67.08 -29.02 68.68 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -173.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 13.8 mptt -69.78 -51.45 33.78 Favored 'General case' 0 N--CA 1.474 0.744 0 O-C-N 121.339 -0.851 . . . . 0.0 111.369 177.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -71.61 -28.89 64.11 Favored 'General case' 0 CA--C 1.537 0.47 0 O-C-N 121.664 -0.648 . . . . 0.0 112.675 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.05 -43.2 99.34 Favored 'General case' 0 CA--C 1.544 0.735 0 O-C-N 121.503 -0.748 . . . . 0.0 111.804 169.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -64.23 -40.33 95.81 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 123.31 0.644 . . . . 0.0 111.899 172.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 68.3 m -61.39 -35.92 78.84 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.277 0.944 . . . . 0.0 112.735 174.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -72.77 -37.34 67.66 Favored 'General case' 0 CA--C 1.544 0.716 0 O-C-N 121.232 -0.918 . . . . 0.0 111.905 174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.21 -44.78 90.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 118.741 0.701 . . . . 0.0 111.625 173.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -59.68 -47.86 83.98 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.46 1.104 . . . . 0.0 111.537 173.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -54.58 -43.85 72.47 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 123.305 0.642 . . . . 0.0 111.682 176.192 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -73.11 -29.29 62.8 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-N 119.119 0.872 . . . . 0.0 113.348 -178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -77.39 -38.09 50.64 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.462 -0.774 . . . . 0.0 112.154 171.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 69.8 t -63.98 -40.58 89.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.875 0 O-C-N 121.271 -0.893 . . . . 0.0 110.43 172.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -56.52 -49.12 75.68 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 118.601 -0.714 . . . . 0.0 110.411 169.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.2 t80 -52.87 -41.84 64.69 Favored 'General case' 0 N--CA 1.476 0.859 0 CA-C-N 120.384 1.447 . . . . 0.0 113.767 171.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.4 mt -64.1 -22.63 67.01 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 113.482 0.919 . . . . 0.0 113.482 174.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 48.9 t -80.95 -38.62 17.05 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.131 0 CA-C-N 119.511 1.05 . . . . 0.0 110.799 168.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -59.8 -29.69 68.39 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.302 1.041 . . . . 0.0 112.431 175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 18.4 pt -105.5 5.77 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 124.993 1.317 . . . . 0.0 114.344 175.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 68.69 17.11 8.94 Favored 'General case' 0 CA--C 1.551 1.017 0 C-N-CA 126.481 1.912 . . . . 0.0 115.041 173.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -80.69 -13.57 58.9 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.374 1.469 . . . . 0.0 113.376 173.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 86.6 t -137.87 139.69 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.274 1.83 . . . . 0.0 108.888 171.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -85.09 133.64 34.22 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.046 0.538 . . . . 0.0 110.695 168.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 27.1 p -54.89 -33.95 62.53 Favored 'General case' 0 N--CA 1.475 0.778 0 O-C-N 121.333 -0.854 . . . . 0.0 113.084 176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -56.96 -21.81 33.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.193 1.397 . . . . 0.0 113.923 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -90.61 -16.55 28.49 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.353 1.061 . . . . 0.0 113.514 177.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -79.4 124.06 84.22 Favored Pre-proline 0 N--CA 1.474 0.746 0 C-N-CA 124.281 1.033 . . . . 0.0 111.098 -168.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -79.05 126.58 7.16 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.281 2.654 . . . . 0.0 109.79 174.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.95 130.06 11.9 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.996 0.919 . . . . 0.0 112.023 -175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -9.78 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.886 0 C-N-CA 125.172 1.389 . . . . 0.0 113.2 173.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 163.15 -158.47 30.83 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.899 1.714 . . . . 0.0 112.491 -176.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 42.1 mm -104.8 132.43 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 125.261 1.424 . . . . 0.0 109.532 177.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 4.3 m -142.02 133.16 13.07 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.735 1.614 . . . . 0.0 110.256 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -88.35 153.03 6.64 Favored 'Trans proline' 0 CA--C 1.543 0.949 0 C-N-CA 123.126 2.551 . . . . 0.0 112.486 -174.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -77.48 169.51 20.95 Favored 'Trans proline' 0 CA--C 1.547 1.155 0 C-N-CA 123.833 3.022 . . . . 0.0 110.819 169.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_exo -52.48 128.53 28.23 Favored 'Trans proline' 0 C--N 1.351 0.677 0 C-N-CA 124.112 3.208 . . . . 0.0 112.043 171.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 8.2 t -168.54 179.87 4.15 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.323 1.449 . . . . 0.0 111.21 -171.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 91.74 -159.8 26.03 Favored Glycine 0 CA--C 1.541 1.703 0 C-N-CA 125.303 1.43 . . . . 0.0 113.464 -179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.64 154.24 37.94 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 124.553 3.502 . . . . 0.0 113.787 -178.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 15.5 m -75.71 19.66 0.2 Allowed 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 125.883 1.673 . . . . 0.0 114.739 -174.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 29.6 m 70.28 6.2 5.68 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 127.206 2.202 . . . . 0.0 114.829 176.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.22 0 C-N-CA 125.613 1.577 . . . . 0.0 112.876 178.078 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 111.753 -0.539 . . . . 0.0 111.753 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 17.9 m -162.1 150.15 14.67 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 126.51 1.924 . . . . 0.0 110.495 178.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 65.1 p -124.8 7.38 8.11 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.849 1.26 . . . . 0.0 114.233 -170.33 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -86.05 -150.31 15.02 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 125.293 1.425 . . . . 0.0 113.44 179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.8 m -72.52 3.22 5.13 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 -173.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -58.53 -10.97 2.5 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 126.726 2.01 . . . . 0.0 115.515 -176.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -63.98 -22.74 67.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 124.411 1.005 . . . . 0.0 113.889 177.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.2 tp -72.2 -31.59 39.96 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 CA-C-N 119.341 1.57 . . . . 0.0 112.664 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.34 -43.75 76.79 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.336 1.054 . . . . 0.0 109.991 174.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -65.76 -32.42 73.96 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.536 0.734 . . . . 0.0 112.68 171.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -69.47 -43.01 74.09 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.532 -0.73 . . . . 0.0 112.006 178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 40.5 tp -61.8 -43.69 98.36 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 118.717 0.69 . . . . 0.0 110.992 172.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -62.13 -43.16 99.44 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.214 0.606 . . . . 0.0 112.63 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.82 -39.91 83.88 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.235 1.014 . . . . 0.0 112.678 176.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.2 t90 -61.87 -45.21 94.75 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.951 0.9 . . . . 0.0 111.596 174.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 94.2 m -58.62 -45.05 90.06 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.688 0.795 . . . . 0.0 111.591 172.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.01 -26.05 73.29 Favored Glycine 0 CA--C 1.533 1.164 0 C-N-CA 124.503 1.049 . . . . 0.0 114.134 -178.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -77.41 -9.22 58.74 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 118.425 1.113 . . . . 0.0 112.744 172.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 22.3 mtp180 -119.64 9.18 11.38 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 127.327 2.251 . . . . 0.0 112.688 -178.278 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt 64.95 29.58 12.28 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.456 1.902 . . . . 0.0 113.672 -179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.2 mtm -116.14 172.21 7.32 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.799 2.04 . . . . 0.0 111.443 179.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 31.5 m -143.04 130.54 10.96 Favored Pre-proline 0 N--CA 1.476 0.838 0 C-N-CA 126.062 1.745 . . . . 0.0 109.03 175.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -76.8 144.19 24.32 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 122.965 2.443 . . . . 0.0 110.68 176.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -119.85 119.72 34.38 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 124.861 1.264 . . . . 0.0 110.708 -177.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -103.83 157.68 16.92 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.147 1.379 . . . . 0.0 112.783 -174.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -146.23 146.07 30.64 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.865 1.666 . . . . 0.0 109.557 172.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 61.4 mt -134.88 146.78 30.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 125.112 1.365 . . . . 0.0 110.983 -169.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -134.98 140.53 45.76 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.772 2.029 . . . . 0.0 110.255 177.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.4 138.08 31.86 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 124.404 1.081 . . . . 0.0 110.996 172.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.2 m -146.49 -179.88 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 126.412 1.885 . . . . 0.0 110.63 -175.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.74 -146.95 18.4 Favored Glycine 0 CA--C 1.532 1.096 0 C-N-CA 124.084 0.85 . . . . 0.0 112.899 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -116.43 163.21 16.39 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.066 1.346 . . . . 0.0 112.702 -172.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -62.22 -37.67 86.26 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 124.177 0.991 . . . . 0.0 113.336 179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 23.0 p-10 -80.94 -24.64 38.0 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.089 1.356 . . . . 0.0 114.294 177.679 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 62.5 ttm-85 -145.75 89.74 1.93 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.38 1.872 . . . . 0.0 110.201 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -83.83 152.08 24.8 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.662 1.185 . . . . 0.0 110.812 -179.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -139.09 167.18 22.64 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.889 2.076 . . . . 0.0 110.784 -178.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -135.0 145.4 48.05 Favored 'General case' 0 N--CA 1.464 0.239 0 C-N-CA 124.878 1.271 . . . . 0.0 111.497 -178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 50.1 mtp -116.97 154.84 30.17 Favored 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 126.229 1.812 . . . . 0.0 109.583 171.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 46.6 t -145.12 146.53 31.84 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.335 1.054 . . . . 0.0 111.722 -176.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 61.7 mt-10 -125.7 146.96 49.52 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 126.402 1.881 . . . . 0.0 109.187 173.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.9 p -137.0 142.43 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 C-N-CA 124.278 1.031 . . . . 0.0 111.669 173.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 80.7 mtt85 -136.97 159.29 42.31 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 126.409 1.883 . . . . 0.0 110.701 -178.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -139.25 135.69 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 C-N-CA 125.953 1.701 . . . . 0.0 108.209 177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -59.66 130.02 44.8 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.082 0.953 . . . . 0.0 111.784 -177.461 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.1 0.29 65.94 Favored Glycine 0 CA--C 1.533 1.21 0 C-N-CA 124.612 1.101 . . . . 0.0 114.822 -178.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -120.72 135.35 55.16 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 125.235 1.414 . . . . 0.0 110.845 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -83.2 -11.69 57.61 Favored 'General case' 0 CA--C 1.546 0.824 0 N-CA-C 114.28 1.215 . . . . 0.0 114.28 -176.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 50.2 t80 -82.98 159.66 22.18 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.762 1.225 . . . . 0.0 113.02 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -135.02 119.28 17.73 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.861 1.264 . . . . 0.0 109.504 169.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -78.47 139.29 22.21 Favored Glycine 0 C--N 1.338 0.642 0 N-CA-C 110.408 -1.077 . . . . 0.0 110.408 178.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 84.3 mtp -129.36 140.43 51.37 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.954 0.902 . . . . 0.0 112.577 -170.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.14 165.89 28.97 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 125.132 1.348 . . . . 0.0 113.686 179.074 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.69 153.68 25.14 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.61 1.164 . . . . 0.0 112.581 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.6 t -169.59 -169.97 0.99 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.536 1.534 . . . . 0.0 111.541 178.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.7 p -73.47 -12.03 60.66 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.71 1.604 . . . . 0.0 113.613 174.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.4 p30 -150.64 157.36 42.89 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.291 1.436 . . . . 0.0 112.443 -170.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.62 -30.8 71.57 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 -175.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -70.9 -49.25 47.95 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 121.39 -0.818 . . . . 0.0 111.888 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.7 m-20 -68.37 -30.71 69.71 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.101 0.56 . . . . 0.0 112.311 176.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.04 -41.66 86.17 Favored 'General case' 0 CA--C 1.544 0.743 0 O-C-N 121.19 -0.943 . . . . 0.0 111.612 174.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -65.71 -40.09 91.88 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 123.792 0.837 . . . . 0.0 112.727 174.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 99.3 p -69.65 -31.64 69.84 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 119.705 1.139 . . . . 0.0 112.371 178.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -69.04 -41.16 78.03 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.203 -0.936 . . . . 0.0 111.792 170.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.67 -45.3 93.42 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.549 0.613 . . . . 0.0 111.714 175.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.32 -48.91 79.73 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.237 1.015 . . . . 0.0 111.768 174.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -56.65 -40.4 75.4 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 118.669 -0.681 . . . . 0.0 112.008 177.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -71.92 -30.48 65.4 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 119.408 1.004 . . . . 0.0 113.216 178.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 25.0 t80 -75.53 -39.07 58.84 Favored 'General case' 0 CA--C 1.538 0.505 0 O-C-N 121.373 -0.829 . . . . 0.0 112.005 171.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 75.8 t -61.83 -42.37 94.3 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 O-C-N 121.496 -0.752 . . . . 0.0 110.407 172.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -57.51 -48.31 79.59 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 118.45 -0.786 . . . . 0.0 110.865 171.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 20.4 t80 -52.95 -42.67 65.68 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 120.517 1.508 . . . . 0.0 113.39 171.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.7 mt -65.83 -21.23 66.46 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.171 -0.956 . . . . 0.0 113.537 174.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 90.3 t -81.5 -38.21 16.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 124.604 1.162 . . . . 0.0 110.873 168.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 49.6 mtt180 -59.1 -30.67 68.28 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.326 1.05 . . . . 0.0 112.143 174.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 19.4 pt -106.84 5.55 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.284 0 C-N-CA 124.967 1.307 . . . . 0.0 114.387 176.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 67.17 16.98 10.32 Favored 'General case' 0 CA--C 1.553 1.095 0 C-N-CA 126.504 1.922 . . . . 0.0 115.045 173.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -79.41 -12.78 59.89 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 125.61 1.564 . . . . 0.0 113.264 172.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.6 t -132.56 134.59 58.66 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.744 0 C-N-CA 126.53 1.932 . . . . 0.0 107.691 168.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -79.54 131.93 36.16 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 122.185 -0.322 . . . . 0.0 110.148 168.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.1 p -55.16 -34.54 63.89 Favored 'General case' 0 N--CA 1.472 0.632 0 O-C-N 121.439 -0.788 . . . . 0.0 112.883 177.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -56.25 -22.4 29.55 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.313 1.445 . . . . 0.0 113.909 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -91.05 -16.73 27.4 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.418 1.087 . . . . 0.0 113.312 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 62.6 t -76.91 127.65 83.34 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 124.236 1.014 . . . . 0.0 110.63 -169.454 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.09 113.61 3.82 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.739 2.293 . . . . 0.0 109.769 174.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -161.44 166.44 27.25 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.789 1.635 . . . . 0.0 111.235 -174.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -68.17 -14.45 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.039 0 C-N-CA 124.777 1.231 . . . . 0.0 113.671 178.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.63 162.98 36.34 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.585 1.564 . . . . 0.0 112.622 176.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 38.1 mm -110.51 136.28 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.38 1.472 . . . . 0.0 109.648 -179.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.7 t -140.96 136.22 15.97 Favored Pre-proline 0 N--CA 1.478 0.96 0 C-N-CA 125.826 1.65 . . . . 0.0 108.846 -176.4 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -54.4 155.51 16.23 Favored 'Trans proline' 0 CA--C 1.544 0.986 0 C-N-CA 124.197 3.265 . . . . 0.0 113.886 177.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -63.43 141.44 80.98 Favored 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 123.246 2.631 . . . . 0.0 111.194 178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -73.71 144.32 35.11 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.446 2.764 . . . . 0.0 112.402 -170.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 10.4 t -166.7 165.61 16.38 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 126.181 1.793 . . . . 0.0 110.599 -179.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 82.32 -163.76 43.24 Favored Glycine 0 CA--C 1.542 1.725 0 C-N-CA 124.418 1.009 . . . . 0.0 113.674 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -74.04 158.38 45.83 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.941 3.094 . . . . 0.0 112.031 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 18.7 m -66.48 138.85 57.83 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.57 1.148 . . . . 0.0 113.184 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 17.5 m -69.55 146.03 52.14 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.265 1.026 . . . . 0.0 112.946 178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.2 0 CA-C-O 118.415 -1.214 . . . . 0.0 112.826 178.503 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.608 0 N-CA-C 111.849 -0.5 . . . . 0.0 111.849 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 19.8 m -83.23 -6.03 59.33 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 -174.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 85.1 p -162.92 170.64 17.84 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.938 1.695 . . . . 0.0 111.555 -175.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 94.32 -152.54 20.68 Favored Glycine 0 CA--C 1.53 1.031 0 C-N-CA 124.689 1.137 . . . . 0.0 112.724 -176.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.8 m 71.92 -4.73 1.87 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.934 2.093 . . . . 0.0 115.026 177.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.3 m -164.98 117.96 1.23 Allowed 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 127.088 2.155 . . . . 0.0 109.74 175.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -85.88 -7.96 80.19 Favored Glycine 0 N--CA 1.474 1.227 0 C-N-CA 123.919 0.771 . . . . 0.0 114.774 -175.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.0 tp -64.88 -32.35 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 CA-C-N 118.681 1.24 . . . . 0.0 113.891 -173.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.93 -33.37 73.62 Favored 'General case' 0 CA--C 1.542 0.654 0 O-C-N 121.593 -0.692 . . . . 0.0 111.743 176.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.7 t30 -79.54 -28.67 41.25 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 123.981 0.912 . . . . 0.0 112.484 171.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 85.0 t80 -65.68 -44.56 85.84 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.987 0.915 . . . . 0.0 111.709 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 25.8 tp -63.6 -42.81 98.21 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 118.317 0.508 . . . . 0.0 111.276 174.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 54.2 t80 -62.38 -42.76 99.67 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.672 0.619 . . . . 0.0 112.672 177.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.59 -39.14 77.46 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 124.539 1.136 . . . . 0.0 112.707 176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 81.6 t90 -60.84 -47.59 85.65 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 124.035 0.934 . . . . 0.0 111.316 174.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 22.7 m -57.73 -45.46 85.79 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.013 0.925 . . . . 0.0 112.021 171.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.27 -26.1 72.52 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 124.28 0.943 . . . . 0.0 113.986 -178.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -79.9 -7.25 58.64 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.506 1.122 . . . . 0.0 112.79 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 32.9 mtp180 -119.58 9.14 11.41 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 127.304 2.242 . . . . 0.0 112.64 -178.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.74 31.45 11.86 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.452 1.901 . . . . 0.0 113.515 -178.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.6 mtm -119.35 172.32 7.7 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 126.71 2.004 . . . . 0.0 111.643 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 42.2 m -141.97 129.36 11.49 Favored Pre-proline 0 N--CA 1.476 0.842 0 C-N-CA 126.227 1.811 . . . . 0.0 108.668 174.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -76.91 141.65 21.54 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.905 2.404 . . . . 0.0 110.588 177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.13 117.23 30.65 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.602 1.161 . . . . 0.0 110.697 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 93.0 m-85 -99.66 157.43 16.48 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.996 1.318 . . . . 0.0 112.672 -177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -146.6 149.67 33.98 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 125.506 1.523 . . . . 0.0 109.907 170.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 62.4 mt -132.64 145.84 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 C-N-CA 125.632 1.573 . . . . 0.0 110.799 -169.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 38.7 ttm105 -145.25 133.5 21.67 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.21 1.404 . . . . 0.0 111.45 -171.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.53 137.38 32.39 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 124.784 1.234 . . . . 0.0 111.323 -177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -149.32 165.48 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 125.657 1.583 . . . . 0.0 111.397 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.49 -132.99 11.32 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 123.978 0.799 . . . . 0.0 112.208 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -116.61 156.32 27.23 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 125.314 1.445 . . . . 0.0 112.3 -172.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -56.51 -44.2 80.52 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.549 1.14 . . . . 0.0 113.181 177.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -84.14 -28.24 27.57 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.038 1.335 . . . . 0.0 113.252 177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -120.39 81.48 1.76 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.491 1.516 . . . . 0.0 110.264 175.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -71.49 148.99 46.24 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.253 1.421 . . . . 0.0 111.409 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -144.15 153.89 42.59 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.2 2.2 . . . . 0.0 109.957 171.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -127.48 124.17 37.7 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.244 1.018 . . . . 0.0 111.883 -176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 43.4 mtp -89.49 155.16 19.48 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.756 1.222 . . . . 0.0 109.085 167.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.3 t -142.23 149.97 40.33 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 124.268 1.027 . . . . 0.0 110.149 174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -135.74 153.02 51.69 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 125.528 1.531 . . . . 0.0 110.123 174.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -139.66 141.81 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 C-N-CA 125.022 1.329 . . . . 0.0 111.228 -176.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 64.4 mtt180 -137.97 153.74 49.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 126.072 1.749 . . . . 0.0 110.486 -173.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.3 t -141.66 134.85 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 125.798 1.639 . . . . 0.0 108.557 -179.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -61.59 129.68 42.27 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.015 0.926 . . . . 0.0 111.649 -177.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.89 1.89 65.11 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.566 1.079 . . . . 0.0 114.742 -178.49 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.6 m-85 -120.22 130.88 54.73 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.182 1.393 . . . . 0.0 110.529 178.064 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -76.6 -25.75 54.25 Favored 'General case' 0 CA--C 1.545 0.776 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 -174.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.1 t80 -79.21 155.45 28.6 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.338 1.055 . . . . 0.0 113.083 -179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.78 109.85 11.27 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.396 1.478 . . . . 0.0 108.603 170.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.82 149.24 26.66 Favored Glycine 0 N--CA 1.469 0.835 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 -177.226 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 28.1 ptm -151.19 151.94 32.6 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 114.727 1.38 . . . . 0.0 114.727 -169.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -149.0 179.67 25.63 Favored Glycine 0 CA--C 1.528 0.902 0 C-N-CA 126.52 2.009 . . . . 0.0 112.818 -179.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.5 t30 -151.86 155.22 37.72 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.964 1.306 . . . . 0.0 111.455 179.114 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.3 t -168.04 -176.09 2.88 Favored 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 125.403 1.481 . . . . 0.0 112.149 176.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 97.1 m -79.93 -22.97 42.09 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.377 1.471 . . . . 0.0 111.471 169.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -119.6 142.96 47.93 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 125.069 1.348 . . . . 0.0 111.391 -177.461 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.5 mttp -61.59 -30.66 70.82 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -74.32 -42.57 59.25 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.294 1.037 . . . . 0.0 112.541 178.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -68.49 -34.05 75.22 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 123.795 0.838 . . . . 0.0 111.693 173.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.8 -44.74 80.47 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.417 0.687 . . . . 0.0 111.625 175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -60.13 -41.14 92.02 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.623 0.769 . . . . 0.0 111.995 171.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 67.9 m -63.98 -37.69 88.34 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 118.661 0.664 . . . . 0.0 111.927 177.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -72.55 -37.07 68.37 Favored 'General case' 0 CA--C 1.542 0.666 0 O-C-N 121.429 -0.794 . . . . 0.0 111.955 175.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -63.07 -43.41 98.63 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.781 0.833 . . . . 0.0 112.376 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.24 -49.04 78.72 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.878 0.871 . . . . 0.0 111.123 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.8 tpt85 -57.32 -38.05 73.45 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.686 0.625 . . . . 0.0 112.686 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -72.2 -38.48 69.01 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.623 1.169 . . . . 0.0 112.885 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -72.16 -37.72 69.3 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 118.831 0.741 . . . . 0.0 112.169 174.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 70.7 t -62.49 -36.91 77.25 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 O-C-N 121.531 -0.73 . . . . 0.0 110.84 172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -58.25 -49.86 75.62 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-O 119.146 -0.454 . . . . 0.0 110.402 171.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 15.4 t80 -54.76 -42.94 72.27 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 121.224 -0.923 . . . . 0.0 113.086 172.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.403 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.9 mt -63.02 -27.65 69.56 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 175.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 93.2 t -73.68 -40.41 54.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.058 0 CA-C-N 119.294 0.952 . . . . 0.0 111.049 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 17.9 mmt180 -61.96 -30.94 71.26 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 178.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 24.8 pt -96.91 4.91 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 C-N-CA 124.457 1.103 . . . . 0.0 113.836 174.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.8 m-80 70.73 18.1 6.36 Favored 'General case' 0 CA--C 1.55 0.979 0 C-N-CA 126.888 2.075 . . . . 0.0 114.625 173.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -89.74 -6.47 55.99 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 125.481 1.512 . . . . 0.0 113.363 178.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 69' ' ' LEU . 94.7 t -136.68 139.26 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 127.011 2.125 . . . . 0.0 107.893 168.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -86.21 127.61 34.77 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.073 0.549 . . . . 0.0 110.068 169.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 30.1 p -54.72 -33.9 61.68 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.359 0.874 . . . . 0.0 113.359 -178.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -60.83 -19.13 59.27 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 125.044 1.337 . . . . 0.0 113.689 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -91.33 -16.43 27.5 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.543 1.137 . . . . 0.0 113.341 177.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.5 t -76.79 123.76 87.55 Favored Pre-proline 0 N--CA 1.476 0.839 0 C-N-CA 124.197 0.999 . . . . 0.0 111.119 -169.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -80.37 150.66 19.8 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.492 2.795 . . . . 0.0 111.614 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -153.59 167.22 30.28 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 125.406 1.482 . . . . 0.0 111.555 178.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 1.6 p -63.65 -13.94 13.93 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.76 0 C-N-CA 126.054 1.741 . . . . 0.0 115.444 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 101.9 136.28 9.18 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.378 1.466 . . . . 0.0 112.346 -177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 47.9 mt -133.62 135.98 54.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.898 0 C-N-CA 125.736 1.615 . . . . 0.0 109.361 -177.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 63.1 t -134.56 110.73 11.39 Favored Pre-proline 0 N--CA 1.477 0.882 0 C-N-CA 125.302 1.441 . . . . 0.0 108.307 174.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -61.21 144.56 98.94 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 123.445 2.763 . . . . 0.0 112.88 179.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -70.65 131.53 20.16 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.22 2.613 . . . . 0.0 110.612 177.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -72.74 -19.44 24.03 Favored 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.171 2.581 . . . . 0.0 113.016 -177.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.5 p -89.6 -1.41 58.02 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.696 1.598 . . . . 0.0 113.37 173.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 85.52 164.99 39.78 Favored Glycine 0 CA--C 1.541 1.696 0 C-N-CA 125.642 1.592 . . . . 0.0 113.483 -176.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -69.93 133.3 24.93 Favored 'Trans proline' 0 C--N 1.349 0.591 0 C-N-CA 123.601 2.868 . . . . 0.0 110.79 -177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 71.4 p -168.31 165.3 12.94 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.388 1.475 . . . . 0.0 111.844 -174.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 80.2 p -162.08 163.45 28.64 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.176 1.39 . . . . 0.0 111.945 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.152 0 C-N-CA 124.928 1.251 . . . . 0.0 112.928 -178.962 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.605 0 N-CA-C 111.722 -0.551 . . . . 0.0 111.722 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 42.6 p -92.71 -15.31 26.86 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 61.5 p -110.28 -3.19 16.37 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.884 1.673 . . . . 0.0 113.71 -178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 166.6 -176.97 41.62 Favored Glycine 0 CA--C 1.528 0.87 0 C-N-CA 126.221 1.867 . . . . 0.0 112.248 -173.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.5 p -72.89 -73.91 0.19 Allowed 'General case' 0 N--CA 1.473 0.682 0 O-C-N 121.895 -0.768 . . . . 0.0 112.374 -175.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.3 p -90.7 -4.38 56.78 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.801 1.64 . . . . 0.0 113.705 179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 88.45 8.32 71.07 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.71 1.148 . . . . 0.0 113.523 -169.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 10.3 tp -59.7 -29.11 42.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 C-N-CA 125.108 1.363 . . . . 0.0 113.951 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -57.92 -51.51 69.34 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.377 1.071 . . . . 0.0 110.559 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -69.62 -26.94 64.67 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 123.56 0.744 . . . . 0.0 112.744 176.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 83.3 t80 -65.47 -46.9 78.02 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 118.915 0.78 . . . . 0.0 111.518 175.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.8 tp -63.11 -41.86 99.44 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 118.138 0.426 . . . . 0.0 111.219 175.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -62.91 -42.35 99.76 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 177.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -70.57 -37.56 73.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.328 1.051 . . . . 0.0 112.625 176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 85.5 t90 -61.07 -46.52 90.33 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 123.893 0.877 . . . . 0.0 111.224 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.3 m -58.31 -45.91 87.12 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.657 0.783 . . . . 0.0 111.718 172.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.65 -27.38 73.2 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 124.345 0.974 . . . . 0.0 114.092 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -79.56 -6.38 56.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 118.358 1.079 . . . . 0.0 112.915 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 31.8 mtp180 -119.53 9.29 11.48 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.301 2.24 . . . . 0.0 112.577 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 64.82 30.97 12.0 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 126.501 1.92 . . . . 0.0 113.59 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -118.93 172.53 7.47 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.718 2.007 . . . . 0.0 111.562 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 33.9 m -141.69 130.81 12.37 Favored Pre-proline 0 N--CA 1.477 0.891 0 C-N-CA 126.158 1.783 . . . . 0.0 108.557 174.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -77.16 146.68 25.55 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.967 2.445 . . . . 0.0 110.806 178.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -116.79 116.89 28.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.738 1.215 . . . . 0.0 110.576 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -99.89 157.62 16.39 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.217 1.407 . . . . 0.0 112.372 -178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.39 150.36 34.52 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 125.318 1.447 . . . . 0.0 110.053 172.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 57.1 mt -138.53 145.86 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 C-N-CA 125.228 1.411 . . . . 0.0 111.288 -169.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 59.5 ttt85 -139.16 135.1 33.67 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 125.742 1.617 . . . . 0.0 111.046 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.52 137.77 33.72 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 124.259 1.023 . . . . 0.0 111.378 176.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.4 m -144.28 176.15 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 C-N-CA 126.086 1.754 . . . . 0.0 110.843 -177.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 90.32 -150.04 20.6 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.297 0.951 . . . . 0.0 112.537 -177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 57.9 t30 -116.89 168.16 10.48 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 125.092 1.357 . . . . 0.0 112.231 -179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 76.0 mmtt -54.46 -45.07 73.07 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.859 1.264 . . . . 0.0 113.589 -178.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 32.8 p-10 -79.59 -29.03 41.06 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 96.0 mtt-85 -130.33 78.53 1.85 Allowed 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 126.966 2.107 . . . . 0.0 109.897 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -94.24 145.35 24.78 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.505 1.122 . . . . 0.0 110.721 -176.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -137.59 168.66 19.22 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 126.868 2.067 . . . . 0.0 111.2 -178.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -134.8 124.08 24.57 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.2 1.4 . . . . 0.0 111.233 -174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 51.8 mtp -89.11 154.74 19.93 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.166 1.387 . . . . 0.0 109.395 168.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.9 t -143.84 145.05 32.05 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 124.224 1.01 . . . . 0.0 111.766 -178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -121.86 151.8 40.26 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.321 1.848 . . . . 0.0 109.563 170.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.4 p -140.74 141.2 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.184 0.994 . . . . 0.0 111.242 169.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 73.5 mtt180 -140.45 158.05 44.59 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.28 1.832 . . . . 0.0 110.404 -174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 47.5 t -140.86 135.44 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 125.551 1.54 . . . . 0.0 108.66 -179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -60.08 129.97 44.37 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.133 0.973 . . . . 0.0 111.606 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.82 1.27 65.72 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 124.622 1.105 . . . . 0.0 114.604 -177.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -123.86 128.36 49.37 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.278 1.431 . . . . 0.0 110.351 177.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -76.63 -22.76 53.67 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.564 0.95 . . . . 0.0 113.564 -176.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -72.04 155.98 39.72 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.583 1.153 . . . . 0.0 113.269 179.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -132.34 117.74 18.52 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.342 1.457 . . . . 0.0 109.232 170.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.39 141.66 21.48 Favored Glycine 0 N--CA 1.467 0.726 0 N-CA-C 110.418 -1.073 . . . . 0.0 110.418 179.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 41.2 mtt -136.06 144.04 44.99 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 -168.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -148.79 173.0 28.86 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 125.83 1.681 . . . . 0.0 113.501 179.59 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -158.78 148.94 19.57 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 124.84 1.256 . . . . 0.0 111.337 175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.4 t -168.15 178.86 4.82 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.725 1.21 . . . . 0.0 112.868 179.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 m -78.79 -8.66 58.98 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 125.756 1.623 . . . . 0.0 112.442 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 10.9 p30 -142.14 153.69 44.29 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.051 1.34 . . . . 0.0 112.229 175.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -67.1 -30.25 70.22 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -172.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -73.15 -41.99 63.32 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 119.169 0.895 . . . . 0.0 112.495 -179.299 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 26.9 t70 -74.09 -29.48 61.88 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.602 -0.687 . . . . 0.0 111.858 175.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.61 -44.66 85.88 Favored 'General case' 0 CA--C 1.543 0.678 0 O-C-N 121.548 -0.72 . . . . 0.0 111.692 170.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -63.38 -38.04 89.6 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 123.833 0.853 . . . . 0.0 112.252 171.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 69.2 m -63.2 -38.74 92.35 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-N 118.731 0.696 . . . . 0.0 111.565 176.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -69.26 -41.32 77.08 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.39 -0.819 . . . . 0.0 111.791 174.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.71 -43.65 98.26 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 118.715 0.689 . . . . 0.0 112.055 176.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.76 -48.95 76.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.28 1.032 . . . . 0.0 111.492 174.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 46.3 tpt85 -58.33 -37.07 74.4 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-O 118.971 -0.538 . . . . 0.0 112.431 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -72.88 -36.67 67.39 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.955 1.302 . . . . 0.0 112.835 177.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -70.21 -39.78 74.96 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 118.929 0.786 . . . . 0.0 111.821 172.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 74.2 t -63.83 -36.26 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.905 0 O-C-N 121.637 -0.664 . . . . 0.0 110.961 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.93 -40.52 89.2 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.204 0.601 . . . . 0.0 111.347 172.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 29.5 t80 -64.62 -44.39 90.69 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.097 -1.002 . . . . 0.0 112.14 171.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.4 ' HB3' HG23 ' A' ' 75' ' ' VAL . 95.4 mt -60.78 -34.91 75.2 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 177.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 72.5 t -67.49 -43.56 87.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.65 0.78 . . . . 0.0 111.221 171.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 90.8 mtt-85 -65.16 -24.66 67.45 Favored 'General case' 0 N--CA 1.475 0.794 0 N-CA-C 113.56 0.948 . . . . 0.0 113.56 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 20.9 pt -98.34 5.54 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 C-N-CA 124.411 1.084 . . . . 0.0 113.623 171.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.4 m-80 71.35 17.31 5.88 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.898 2.079 . . . . 0.0 114.586 174.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -90.1 -5.09 56.9 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.203 1.401 . . . . 0.0 113.396 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.4 HG23 ' HB3' ' A' ' 69' ' ' LEU . 96.3 t -137.54 139.33 43.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 C-N-CA 127.148 2.179 . . . . 0.0 107.826 169.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -87.13 129.18 35.04 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 122.82 0.448 . . . . 0.0 110.779 169.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.1 p -59.14 -30.15 67.94 Favored 'General case' 0 N--CA 1.473 0.701 0 O-C-N 121.25 -0.906 . . . . 0.0 113.357 -175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -58.54 -23.29 57.91 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.369 1.068 . . . . 0.0 113.417 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.6 mm-40 -90.13 -16.31 29.84 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.55 1.14 . . . . 0.0 113.482 -178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -78.06 124.42 86.01 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 124.102 0.961 . . . . 0.0 111.545 -168.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.62 143.07 16.63 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.447 2.765 . . . . 0.0 111.379 177.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -152.09 153.45 33.97 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.237 1.415 . . . . 0.0 111.225 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -65.34 -16.68 20.65 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.788 0 C-N-CA 125.005 1.322 . . . . 0.0 114.171 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -169.54 158.92 31.51 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.219 1.866 . . . . 0.0 111.945 175.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.6 mt -129.13 130.43 68.05 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.151 1.381 . . . . 0.0 109.272 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.93 134.0 11.91 Favored Pre-proline 0 N--CA 1.479 1.014 0 C-N-CA 125.883 1.673 . . . . 0.0 108.727 -179.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -57.51 151.61 52.87 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 123.607 2.871 . . . . 0.0 113.655 178.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -57.31 145.33 88.05 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.764 2.976 . . . . 0.0 113.077 175.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -57.1 149.7 61.33 Favored 'Trans proline' 0 C--N 1.351 0.667 0 C-N-CA 124.024 3.149 . . . . 0.0 113.521 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.2 m -84.92 2.29 43.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 179.206 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -80.73 -179.29 52.83 Favored Glycine 0 CA--C 1.542 1.764 0 C-N-CA 125.138 1.351 . . . . 0.0 113.79 178.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -77.86 -6.23 15.84 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 124.245 3.297 . . . . 0.0 113.964 -176.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 75.5 p -163.11 -39.33 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 125.012 1.325 . . . . 0.0 112.5 -177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 8.0 t -160.79 -176.21 5.4 Favored 'General case' 0 CA--C 1.548 0.867 0 C-N-CA 126.322 1.849 . . . . 0.0 110.741 175.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.146 0 C-N-CA 125.399 1.476 . . . . 0.0 112.843 -179.515 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.639 0 N-CA-C 112.066 -0.413 . . . . 0.0 112.066 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 8.6 t -163.17 172.79 14.31 Favored 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.554 1.542 . . . . 0.0 111.144 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 54.6 p -165.03 156.89 15.32 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.574 1.55 . . . . 0.0 112.373 -173.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -84.29 172.23 48.87 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.408 1.004 . . . . 0.0 112.912 174.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 23.2 m -73.1 -11.89 60.7 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 -175.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 99.6 p -163.22 166.67 23.0 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 126.208 1.803 . . . . 0.0 110.987 173.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -83.86 1.52 88.66 Favored Glycine 0 N--CA 1.472 1.083 0 C-N-CA 124.217 0.913 . . . . 0.0 115.217 -173.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp -64.29 -31.05 51.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.026 0 CA-C-N 119.221 1.51 . . . . 0.0 113.99 -172.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -68.01 -40.61 82.97 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 123.827 0.851 . . . . 0.0 111.199 176.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -74.97 -28.13 60.44 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.988 0.915 . . . . 0.0 112.606 173.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -64.91 -43.88 91.39 Favored 'General case' 0 N--CA 1.466 0.341 0 C-N-CA 123.885 0.874 . . . . 0.0 111.286 176.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 28.4 tp -63.14 -42.09 99.41 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 118.485 0.584 . . . . 0.0 111.714 173.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 51.1 t80 -62.86 -42.5 99.78 Favored 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 178.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.52 -38.31 77.5 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.486 1.114 . . . . 0.0 112.54 175.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 80.6 t90 -61.64 -43.32 99.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.552 1.141 . . . . 0.0 111.801 174.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 99.2 m -61.95 -43.23 99.27 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.353 1.061 . . . . 0.0 111.868 171.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.56 -25.23 72.72 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.487 1.042 . . . . 0.0 114.032 -178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 63.4 mtpt -78.22 -7.08 56.69 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 118.358 1.079 . . . . 0.0 112.744 172.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 45.1 mtt85 -119.65 7.47 11.08 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.471 2.308 . . . . 0.0 112.619 -179.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 63.87 28.47 14.62 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 126.416 1.886 . . . . 0.0 113.371 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 57.9 mtm -112.17 171.94 7.21 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.758 2.023 . . . . 0.0 111.583 179.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 49.5 m -140.86 129.87 12.82 Favored Pre-proline 0 N--CA 1.476 0.836 0 C-N-CA 126.324 1.85 . . . . 0.0 108.664 174.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -76.6 140.58 21.37 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.971 2.447 . . . . 0.0 110.588 177.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -114.91 118.05 32.38 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 124.582 1.153 . . . . 0.0 110.853 -177.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -101.13 159.37 15.29 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.991 1.316 . . . . 0.0 112.954 -175.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -147.09 149.23 32.64 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 125.405 1.482 . . . . 0.0 110.152 170.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 71.3 mt -134.74 147.07 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 125.549 1.539 . . . . 0.0 111.54 -169.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 80.4 ttt180 -134.96 138.96 44.53 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 126.56 1.944 . . . . 0.0 110.285 176.038 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -89.66 137.32 32.43 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.433 1.093 . . . . 0.0 111.423 175.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.6 m -146.21 -174.84 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 C-N-CA 126.911 2.085 . . . . 0.0 110.138 -176.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.8 -147.1 18.46 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.097 0.856 . . . . 0.0 112.983 176.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.6 m120 -116.82 162.13 18.21 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 125.084 1.353 . . . . 0.0 112.436 -172.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -62.1 -35.92 80.16 Favored 'General case' 0 N--CA 1.476 0.837 0 O-C-N 121.236 -0.915 . . . . 0.0 112.944 175.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -75.92 -24.16 55.54 Favored 'General case' 0 CA--C 1.549 0.915 0 C-N-CA 125.038 1.335 . . . . 0.0 113.722 176.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 42.2 ttm105 -154.42 97.27 2.0 Allowed 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.702 1.601 . . . . 0.0 110.277 179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.0 tt0 -78.2 148.51 33.99 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.235 1.014 . . . . 0.0 110.499 178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -135.56 165.35 25.74 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.476 1.911 . . . . 0.0 111.003 -179.237 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -135.69 134.06 38.74 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 124.377 1.071 . . . . 0.0 112.071 -173.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 54.2 mtp -102.45 153.47 20.01 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 125.581 1.553 . . . . 0.0 108.938 168.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 42.4 t -148.19 149.25 31.62 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 123.978 0.911 . . . . 0.0 111.322 -176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -133.8 159.64 40.02 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.092 1.357 . . . . 0.0 111.073 170.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -140.95 143.03 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 C-N-CA 125.419 1.487 . . . . 0.0 111.0 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 57.9 mtt180 -137.42 155.54 49.22 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.05 1.74 . . . . 0.0 110.878 -175.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 48.3 t -141.47 134.32 29.68 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.965 1.706 . . . . 0.0 108.461 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -61.75 128.7 37.47 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.115 0.966 . . . . 0.0 111.977 -175.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.17 1.21 67.17 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 124.765 1.174 . . . . 0.0 115.0 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -111.15 140.74 45.44 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.001 1.32 . . . . 0.0 111.273 178.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -85.3 0.83 50.78 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 115.022 1.49 . . . . 0.0 115.022 -170.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -120.1 155.79 32.29 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.696 1.599 . . . . 0.0 112.898 -175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -125.96 110.3 13.44 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.358 1.463 . . . . 0.0 108.894 170.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -79.06 146.94 29.88 Favored Glycine 0 N--CA 1.468 0.801 0 N-CA-C 110.787 -0.925 . . . . 0.0 110.787 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 24.6 ptp -150.48 148.44 28.73 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 114.377 1.251 . . . . 0.0 114.377 -169.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.35 -179.25 27.79 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 126.36 1.934 . . . . 0.0 112.772 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.3 p30 -154.24 160.9 42.05 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 124.412 1.085 . . . . 0.0 112.102 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.2 t -168.32 -179.65 4.07 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.37 1.468 . . . . 0.0 111.844 176.329 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.6 m -80.38 -6.56 58.22 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 125.23 1.412 . . . . 0.0 112.277 175.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -142.4 152.05 42.43 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 125.203 1.401 . . . . 0.0 112.224 175.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -65.48 -27.1 68.25 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 -174.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 53.9 tptt -71.62 -52.51 17.67 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.773 0.829 . . . . 0.0 111.538 -179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -69.66 -27.28 64.91 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.762 0.825 . . . . 0.0 112.252 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -64.22 -43.17 95.82 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 121.833 -0.542 . . . . 0.0 111.754 170.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -65.48 -40.01 92.6 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.386 0.675 . . . . 0.0 111.93 172.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 56.0 m -60.81 -37.12 80.9 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 119.407 1.003 . . . . 0.0 112.442 173.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -74.33 -37.28 63.6 Favored 'General case' 0 CA--C 1.542 0.665 0 O-C-N 121.278 -0.889 . . . . 0.0 111.657 178.089 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.27 -43.2 99.37 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.632 0.773 . . . . 0.0 112.361 169.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.13 -48.06 81.82 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.199 0.999 . . . . 0.0 111.546 175.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -56.59 -42.08 78.07 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 123.109 0.564 . . . . 0.0 111.819 176.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -69.05 -30.92 69.36 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 113.108 0.781 . . . . 0.0 113.108 179.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 46.4 t80 -77.17 -37.41 53.78 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.628 -0.67 . . . . 0.0 112.422 171.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 68.2 t -62.72 -39.88 86.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 121.268 -0.895 . . . . 0.0 110.836 173.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 99.0 m-20 -56.18 -46.15 79.47 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 123.122 0.569 . . . . 0.0 111.47 171.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 18.4 t80 -58.5 -43.56 89.09 Favored 'General case' 0 N--CA 1.474 0.727 0 O-C-N 120.951 -1.093 . . . . 0.0 113.062 170.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.9 mt -63.54 -35.01 79.09 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 118.955 0.798 . . . . 0.0 113.059 177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.4 t -66.62 -41.99 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 123.575 0.75 . . . . 0.0 111.091 171.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -66.89 -16.02 64.04 Favored 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 34.3 pt -108.31 7.39 9.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 125.152 1.381 . . . . 0.0 113.398 170.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 59.4 t30 68.12 21.09 8.79 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.676 1.99 . . . . 0.0 114.381 177.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 54.0 mm-40 -86.0 -8.66 57.8 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.806 1.242 . . . . 0.0 113.348 173.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 57.8 t -140.09 139.98 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 C-N-CA 126.167 1.787 . . . . 0.0 108.282 171.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -87.74 130.12 34.94 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 169.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 51.9 p -54.27 -33.78 59.36 Favored 'General case' 0 N--CA 1.477 0.922 0 O-C-N 121.26 -0.9 . . . . 0.0 113.131 -177.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -58.38 -21.28 49.62 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 125.45 1.5 . . . . 0.0 113.955 177.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 55.1 mm-40 -90.19 -16.84 28.67 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.498 1.119 . . . . 0.0 113.308 177.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.9 t -75.79 122.75 87.66 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.979 0.912 . . . . 0.0 110.913 -169.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -79.64 141.44 15.52 Favored 'Trans proline' 0 C--N 1.352 0.732 0 C-N-CA 123.316 2.677 . . . . 0.0 111.099 178.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.78 161.27 41.56 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.498 1.519 . . . . 0.0 111.141 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -67.4 -17.05 22.02 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 N-CA-C 114.765 1.395 . . . . 0.0 114.765 -177.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -95.3 -162.19 34.14 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 125.285 1.421 . . . . 0.0 113.863 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 50.6 mt -125.04 145.35 32.5 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.932 0 C-N-CA 126.194 1.797 . . . . 0.0 108.226 176.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 21.9 t 81.4 132.3 0.04 OUTLIER Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 129.026 2.931 . . . . 0.0 110.578 -175.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_exo -56.7 156.91 21.01 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 123.977 3.118 . . . . 0.0 114.279 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 77.3 Cg_exo -53.57 131.06 41.83 Favored 'Trans proline' 0 CA--C 1.545 1.057 0 C-N-CA 124.001 3.134 . . . . 0.0 113.099 178.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -79.64 160.86 25.0 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 123.888 3.059 . . . . 0.0 112.205 -177.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 59.7 m -91.73 0.32 57.5 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 113.815 1.043 . . . . 0.0 113.815 177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . -86.38 -176.43 49.69 Favored Glycine 0 CA--C 1.542 1.744 0 C-N-CA 125.185 1.374 . . . . 0.0 114.084 -179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -57.37 150.75 57.13 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.588 3.526 . . . . 0.0 113.304 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 49.5 p -81.24 -4.08 54.38 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.719 1.208 . . . . 0.0 114.195 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 16.7 m -166.21 152.43 9.03 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 127.38 2.272 . . . . 0.0 110.769 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.132 0 CA-C-O 118.413 -1.215 . . . . 0.0 112.823 -179.882 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.578 0 N-CA-C 111.858 -0.497 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 8.9 m -164.15 156.64 17.18 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.551 1.94 . . . . 0.0 110.653 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 8.0 t -162.9 179.06 7.87 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.263 1.425 . . . . 0.0 111.343 -177.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . 93.92 -178.14 37.43 Favored Glycine 0 CA--C 1.532 1.137 0 C-N-CA 125.677 1.608 . . . . 0.0 113.272 -175.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 86.0 p -163.08 167.24 22.59 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.825 1.25 . . . . 0.0 112.509 -173.221 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.4 m -150.96 47.54 0.85 Allowed 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.385 1.474 . . . . 0.0 110.259 -177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -65.2 -29.38 75.18 Favored Glycine 0 N--CA 1.473 1.108 0 O-C-N 121.026 -1.047 . . . . 0.0 114.68 -168.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 9.4 tp -79.23 -30.03 13.93 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 CA-C-N 118.214 1.007 . . . . 0.0 112.584 174.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.4 tmtt? -66.36 -44.14 84.04 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 123.989 0.915 . . . . 0.0 110.081 170.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -65.74 -31.33 72.26 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 123.962 0.905 . . . . 0.0 112.784 172.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -66.75 -44.62 80.96 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 118.973 0.806 . . . . 0.0 111.678 177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 31.3 tp -62.86 -42.69 99.85 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 118.453 0.57 . . . . 0.0 111.245 174.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 52.0 t80 -63.04 -43.05 99.73 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 112.751 0.649 . . . . 0.0 112.751 177.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -68.08 -40.78 82.6 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.261 1.024 . . . . 0.0 112.419 176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 82.6 t90 -59.89 -45.96 90.85 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.263 1.025 . . . . 0.0 111.514 174.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 85.8 m -58.01 -44.81 87.48 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 123.599 0.76 . . . . 0.0 111.778 172.085 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.84 -26.88 73.14 Favored Glycine 0 CA--C 1.533 1.188 0 C-N-CA 124.443 1.02 . . . . 0.0 114.145 -178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm -79.03 -7.25 57.94 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 118.481 1.141 . . . . 0.0 112.9 172.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 30.6 mtp180 -119.63 8.73 11.29 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.041 2.136 . . . . 0.0 112.755 -178.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 61.5 mttp 64.42 31.15 12.83 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 126.406 1.883 . . . . 0.0 113.499 -178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.4 mtm -117.98 171.77 7.86 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.716 2.007 . . . . 0.0 111.536 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 57.5 m -140.44 130.71 13.65 Favored Pre-proline 0 N--CA 1.476 0.863 0 C-N-CA 126.24 1.816 . . . . 0.0 108.682 172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -77.18 150.46 29.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.196 2.597 . . . . 0.0 110.953 177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -120.34 115.66 24.0 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.588 1.155 . . . . 0.0 111.05 -178.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -100.5 158.24 16.06 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.44 1.496 . . . . 0.0 112.703 -177.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.7 tt0 -147.22 145.15 29.36 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 125.955 1.702 . . . . 0.0 109.581 173.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 68.1 mt -135.72 147.13 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 125.266 1.426 . . . . 0.0 110.849 -169.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -137.53 137.19 38.35 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 126.194 1.798 . . . . 0.0 110.777 176.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.67 137.22 32.52 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 124.444 1.098 . . . . 0.0 110.916 175.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 29.6 m -147.02 171.74 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 125.501 1.52 . . . . 0.0 111.533 -173.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.71 179.91 51.31 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 124.438 1.018 . . . . 0.0 114.34 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -65.59 139.65 58.46 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 124.427 1.091 . . . . 0.0 112.144 -178.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.4 ttmm -53.27 -38.03 62.69 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 125.271 1.428 . . . . 0.0 114.356 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 56.5 t30 -74.39 -16.63 60.88 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.659 1.183 . . . . 0.0 114.105 -178.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -149.46 67.38 1.01 Allowed 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 125.536 1.534 . . . . 0.0 110.13 175.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -68.96 151.68 46.22 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.248 1.419 . . . . 0.0 111.727 -172.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -136.23 166.14 24.1 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 126.598 1.959 . . . . 0.0 111.141 -171.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -135.09 137.68 43.09 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.791 1.236 . . . . 0.0 111.535 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 47.9 mtp -106.86 155.05 20.15 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.173 1.789 . . . . 0.0 109.379 169.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.5 t -147.19 148.87 31.96 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.918 0.887 . . . . 0.0 112.047 -176.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -129.33 151.58 49.83 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.396 1.879 . . . . 0.0 109.719 171.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -141.91 142.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 124.68 1.192 . . . . 0.0 111.62 175.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -137.73 162.25 34.38 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.242 1.817 . . . . 0.0 110.431 -177.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 52.0 t -139.33 136.47 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.936 0 C-N-CA 125.637 1.575 . . . . 0.0 108.521 175.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -60.68 129.29 40.81 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.208 1.003 . . . . 0.0 111.776 -177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.24 -0.17 66.01 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 124.63 1.109 . . . . 0.0 114.806 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -114.05 140.55 48.37 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.135 1.374 . . . . 0.0 110.963 178.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 p-10 -83.65 -0.49 50.86 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.771 1.397 . . . . 0.0 114.771 -172.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -112.83 160.37 18.07 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.703 1.601 . . . . 0.0 113.214 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.92 116.58 14.88 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.202 1.401 . . . . 0.0 109.412 170.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -83.99 149.78 25.69 Favored Glycine 0 N--CA 1.467 0.73 0 N-CA-C 110.474 -1.051 . . . . 0.0 110.474 177.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 25.2 ptp -146.64 150.49 35.55 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 114.009 1.114 . . . . 0.0 114.009 -169.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -155.19 175.0 33.31 Favored Glycine 0 CA--C 1.526 0.744 0 C-N-CA 125.571 1.558 . . . . 0.0 113.491 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -158.96 154.11 25.32 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.345 1.058 . . . . 0.0 112.403 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.0 t -168.13 -173.72 2.12 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.106 1.362 . . . . 0.0 112.025 -179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 55.8 p -75.79 -10.34 59.35 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 125.5 1.52 . . . . 0.0 113.482 174.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -150.93 151.62 32.41 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.271 1.428 . . . . 0.0 111.925 -170.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -66.26 -30.27 70.67 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 27.1 mtpp -68.25 -48.14 65.86 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.796 0.839 . . . . 0.0 112.045 179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -75.47 -29.33 59.57 Favored 'General case' 0 CA--C 1.538 0.507 0 O-C-N 121.778 -0.576 . . . . 0.0 112.327 178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.65 -45.75 88.75 Favored 'General case' 0 CA--C 1.543 0.699 0 O-C-N 121.42 -0.8 . . . . 0.0 111.837 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -64.36 -38.17 90.1 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.407 0.683 . . . . 0.0 112.044 172.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 71.7 m -64.69 -35.75 82.04 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 118.787 0.721 . . . . 0.0 112.278 176.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -71.48 -39.99 70.55 Favored 'General case' 0 CA--C 1.541 0.625 0 O-C-N 121.226 -0.921 . . . . 0.0 111.709 173.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.7 -42.93 99.6 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 118.652 0.66 . . . . 0.0 111.856 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.11 -49.44 75.88 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.184 0.994 . . . . 0.0 111.559 174.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 47.2 tpt85 -56.35 -37.89 70.65 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 123.105 0.562 . . . . 0.0 112.354 177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -73.9 -35.63 64.68 Favored 'General case' 0 CA--C 1.542 0.673 0 C-N-CA 124.965 1.306 . . . . 0.0 112.737 178.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 50.5 t80 -72.55 -37.31 68.29 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.357 -0.839 . . . . 0.0 112.009 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 67.0 t -62.52 -37.1 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 O-C-N 121.465 -0.772 . . . . 0.0 110.87 172.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -59.69 -40.88 89.32 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.232 0.613 . . . . 0.0 111.423 173.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -62.95 -45.7 91.2 Favored 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.052 -1.03 . . . . 0.0 112.488 169.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 95.1 mt -60.7 -34.51 74.47 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 69.6 t -68.91 -42.98 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 123.69 0.796 . . . . 0.0 111.237 172.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -64.68 -26.03 68.2 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.4 pt -97.55 5.33 9.23 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.222 0 C-N-CA 124.304 1.042 . . . . 0.0 113.67 171.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 71.02 17.37 6.21 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 126.957 2.103 . . . . 0.0 114.574 173.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -89.66 -5.33 57.2 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.248 1.419 . . . . 0.0 113.431 178.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.9 t -138.41 140.18 40.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.827 0 C-N-CA 127.277 2.231 . . . . 0.0 107.844 169.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 36.0 mtmt -86.86 130.61 34.4 Favored 'General case' 0 N--CA 1.472 0.646 0 O-C-N 121.88 -0.513 . . . . 0.0 110.293 168.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 31.2 p -53.57 -34.68 59.18 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.746 0.818 . . . . 0.0 112.905 176.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -51.04 -27.56 8.26 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 126.367 1.867 . . . . 0.0 114.022 175.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 57.8 mm-40 -93.4 -15.47 25.63 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.611 1.164 . . . . 0.0 113.549 -177.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.7 t -76.57 123.61 87.71 Favored Pre-proline 0 N--CA 1.476 0.837 0 C-N-CA 124.139 0.976 . . . . 0.0 111.12 -169.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -79.27 143.48 17.58 Favored 'Trans proline' 0 C--N 1.35 0.642 0 C-N-CA 123.452 2.768 . . . . 0.0 111.305 177.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -154.51 162.33 41.2 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.327 1.451 . . . . 0.0 111.513 178.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -70.46 -13.22 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.005 0 C-N-CA 124.872 1.269 . . . . 0.0 113.816 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -167.77 177.65 42.0 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 125.824 1.678 . . . . 0.0 112.562 177.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 57.1 mt -124.56 124.48 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 C-N-CA 125.301 1.44 . . . . 0.0 108.76 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 33.6 t -146.34 136.43 11.99 Favored Pre-proline 0 N--CA 1.479 0.991 0 C-N-CA 125.854 1.662 . . . . 0.0 108.772 -176.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_exo -57.17 159.42 15.39 Favored 'Trans proline' 0 CA--C 1.543 0.969 0 C-N-CA 123.8 3.0 . . . . 0.0 113.904 176.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -55.12 140.92 80.75 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.921 3.081 . . . . 0.0 112.98 177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.45 148.55 43.05 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.548 2.832 . . . . 0.0 112.031 -176.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 13.3 t -164.62 158.0 17.48 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.759 1.624 . . . . 0.0 110.779 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 78.91 -148.86 32.22 Favored Glycine 0 CA--C 1.542 1.726 0 CA-C-O 118.8 -1.0 . . . . 0.0 112.657 -176.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -55.89 149.76 49.72 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 124.514 3.476 . . . . 0.0 113.413 178.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.2 t -162.21 -179.76 7.3 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 125.16 1.384 . . . . 0.0 111.529 -177.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 46.5 m -66.41 139.17 57.98 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.168 1.387 . . . . 0.0 113.156 -177.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.184 0 C-N-CA 124.982 1.277 . . . . 0.0 112.802 178.697 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.632 0 N-CA-C 112.074 -0.41 . . . . 0.0 112.074 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' SER . . . . . . . . . . . . . 90.0 p -164.65 173.21 12.18 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.32 1.448 . . . . 0.0 111.686 -177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' SER . . . . . . . . . . . . . 15.0 m -78.47 9.93 3.56 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 124.665 1.186 . . . . 0.0 114.048 178.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' GLY . . . . . . . . . . . . . . . -77.11 38.34 1.56 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 126.237 1.875 . . . . 0.0 114.157 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.4 m -71.3 -18.06 62.43 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 124.955 1.302 . . . . 0.0 114.202 -172.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 39.9 t -156.71 146.65 20.98 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.804 1.642 . . . . 0.0 110.642 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -95.2 2.34 65.6 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 124.916 1.246 . . . . 0.0 114.358 178.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 11.1 tp -61.16 -32.39 52.69 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.049 0 CA-C-N 119.384 1.592 . . . . 0.0 114.388 -171.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.27 -37.13 82.96 Favored 'General case' 0 CA--C 1.542 0.656 0 O-C-N 121.531 -0.731 . . . . 0.0 111.627 177.131 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASN . . . . . . . . . . . . . 53.3 t30 -78.75 -27.5 44.74 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.221 1.009 . . . . 0.0 112.49 172.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -64.6 -43.93 92.24 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.849 0.86 . . . . 0.0 111.515 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 24.9 tp -62.28 -43.53 98.61 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 118.464 0.575 . . . . 0.0 111.345 174.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -63.36 -42.56 98.9 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.374 0.67 . . . . 0.0 112.806 178.023 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -69.24 -39.31 78.58 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.533 1.133 . . . . 0.0 112.451 177.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TRP . . . . . . . . . . . . . 84.8 t90 -61.05 -45.68 93.8 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 123.94 0.896 . . . . 0.0 111.342 173.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . . . . . . . . . 96.8 m -58.06 -46.37 85.53 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 123.483 0.713 . . . . 0.0 111.669 172.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -66.78 -26.93 73.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 124.396 0.998 . . . . 0.0 114.157 -178.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 61.7 mtpt -77.69 -8.27 57.68 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.476 1.11 . . . . 0.0 112.747 173.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 29.5 mtp180 -119.55 8.19 11.25 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 127.332 2.253 . . . . 0.0 112.769 -178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 mtmm 66.41 28.33 9.68 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 126.674 1.989 . . . . 0.0 113.705 -178.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' MET . . . . . . . . . . . . . 61.1 mtm -116.05 173.45 6.57 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 126.666 1.986 . . . . 0.0 111.618 179.675 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 28.0 m -142.79 132.0 11.82 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 126.109 1.764 . . . . 0.0 108.696 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.35 154.58 32.05 Favored 'Trans proline' 0 C--N 1.352 0.714 0 C-N-CA 123.04 2.494 . . . . 0.0 110.908 176.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -125.75 115.8 20.61 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.656 1.183 . . . . 0.0 110.564 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -101.23 158.37 16.08 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.63 1.572 . . . . 0.0 112.292 -178.62 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -146.65 148.5 32.12 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 125.716 1.607 . . . . 0.0 109.927 171.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 63.7 mt -136.19 145.31 31.04 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 C-N-CA 125.23 1.412 . . . . 0.0 111.449 -169.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -133.67 139.04 46.21 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 126.485 1.914 . . . . 0.0 110.278 176.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -91.86 136.49 33.11 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.486 1.114 . . . . 0.0 110.767 172.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -145.39 176.31 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.063 0 C-N-CA 125.691 1.597 . . . . 0.0 111.138 -173.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.93 -170.04 37.44 Favored Glycine 0 CA--C 1.531 1.066 0 C-N-CA 124.213 0.911 . . . . 0.0 114.126 174.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -74.05 148.17 42.18 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.546 1.138 . . . . 0.0 112.565 -174.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -65.44 -21.13 66.62 Favored 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 55.7 t30 -87.62 -19.11 28.22 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.716 1.206 . . . . 0.0 113.572 175.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 19.2 tpp180 -157.96 93.12 1.23 Allowed 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 125.796 1.638 . . . . 0.0 110.166 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 18.9 pt20 -83.85 166.02 18.28 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.539 1.136 . . . . 0.0 112.895 -176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -139.58 167.96 20.91 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 127.601 2.36 . . . . 0.0 110.715 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -130.94 137.66 49.38 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.954 1.301 . . . . 0.0 111.127 -178.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' MET . . . . . . . . . . . . . 58.3 mtp -108.55 153.88 22.74 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 125.881 1.672 . . . . 0.0 109.389 169.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 49.4 t -145.18 147.44 32.47 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.096 0.958 . . . . 0.0 111.84 -176.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -129.29 147.02 51.09 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.78 2.032 . . . . 0.0 108.774 177.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.52 143.16 24.67 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 123.792 0.837 . . . . 0.0 112.294 177.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 49.5 mtm105 -138.69 165.26 27.4 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.676 1.99 . . . . 0.0 110.707 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 57.6 t -138.57 137.14 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 125.806 1.642 . . . . 0.0 108.209 175.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -58.28 129.03 40.1 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.021 0.928 . . . . 0.0 111.579 -178.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.15 0.74 65.42 Favored Glycine 0 CA--C 1.535 1.327 0 C-N-CA 124.662 1.125 . . . . 0.0 114.618 -177.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -124.0 129.59 51.18 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.295 1.438 . . . . 0.0 110.381 177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -83.66 -11.99 56.53 Favored 'General case' 0 CA--C 1.545 0.767 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -176.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 49.8 t80 -74.25 157.32 36.05 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.5 1.12 . . . . 0.0 112.69 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -134.99 119.39 17.9 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 124.72 1.208 . . . . 0.0 109.915 170.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -82.87 143.74 22.46 Favored Glycine 0 C--N 1.338 0.66 0 N-CA-C 110.28 -1.128 . . . . 0.0 110.28 176.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' MET . . . . . . . . . . . . . 72.7 mtm -138.81 141.65 38.72 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.281 1.033 . . . . 0.0 112.12 -170.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -152.72 173.25 31.75 Favored Glycine 0 CA--C 1.526 0.768 0 C-N-CA 125.035 1.302 . . . . 0.0 113.399 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -155.29 159.49 40.05 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.621 1.168 . . . . 0.0 112.01 174.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 t -170.06 -175.86 2.13 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.414 1.485 . . . . 0.0 112.069 177.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.5 p -80.93 -7.66 59.55 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.675 1.59 . . . . 0.0 113.36 172.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -142.61 150.56 40.46 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 125.356 1.463 . . . . 0.0 111.8 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.82 -32.57 74.12 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.029 1.332 . . . . 0.0 113.795 -174.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 60.3 tttm -71.35 -45.2 63.5 Favored 'General case' 0 N--CA 1.473 0.715 0 O-C-N 121.311 -0.868 . . . . 0.0 112.285 179.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -73.02 -26.48 61.33 Favored 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 122.732 0.413 . . . . 0.0 111.407 178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.75 -46.3 72.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 122.894 0.478 . . . . 0.0 111.432 171.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 49.5 mt-30 -61.65 -40.4 94.8 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.436 0.694 . . . . 0.0 111.954 171.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 66.0 m -63.99 -37.23 86.65 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 118.886 0.767 . . . . 0.0 111.789 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -71.23 -38.12 71.97 Favored 'General case' 0 CA--C 1.543 0.684 0 O-C-N 121.562 -0.711 . . . . 0.0 111.64 175.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -65.21 -42.49 93.47 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.614 -0.679 . . . . 0.0 112.191 173.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.35 -47.75 82.84 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 124.609 1.164 . . . . 0.0 111.431 175.645 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -57.83 -40.99 81.37 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 118.375 0.534 . . . . 0.0 111.638 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -67.86 -31.08 70.65 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.757 0.823 . . . . 0.0 113.087 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -77.7 -40.08 42.57 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.567 -0.708 . . . . 0.0 112.414 172.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 81.9 t -64.11 -37.89 81.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 O-C-N 121.34 -0.85 . . . . 0.0 110.818 175.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -56.59 -42.86 79.4 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.284 0.634 . . . . 0.0 111.688 170.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TYR . . . . . . . . . . . . . 51.2 t80 -62.36 -43.32 99.1 Favored 'General case' 0 N--CA 1.472 0.663 0 O-C-N 120.859 -1.15 . . . . 0.0 112.722 170.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.408 ' HB3' HG23 ' A' ' 75' ' ' VAL . 96.0 mt -61.49 -34.02 74.77 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 119.16 0.891 . . . . 0.0 113.038 176.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 76.7 t -68.49 -43.25 83.96 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.029 0 C-N-CA 124.026 0.93 . . . . 0.0 111.137 170.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 40.3 mtp180 -62.49 -25.97 68.29 Favored 'General case' 0 N--CA 1.475 0.817 0 C-N-CA 124.175 0.99 . . . . 0.0 113.326 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ILE . . . . . . . . . . . . . 21.5 pt -101.1 6.01 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 124.619 1.168 . . . . 0.0 113.865 172.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 70.89 16.96 6.47 Favored 'General case' 0 CA--C 1.55 0.967 0 C-N-CA 126.834 2.054 . . . . 0.0 114.669 174.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -88.57 -5.48 58.16 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 125.155 1.382 . . . . 0.0 113.448 177.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.408 HG23 ' HB3' ' A' ' 69' ' ' LEU . 90.6 t -136.84 138.7 45.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 126.906 2.082 . . . . 0.0 108.155 169.338 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 96.1 mttt -84.82 125.69 32.81 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 122.901 0.48 . . . . 0.0 109.931 169.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' SER . . . . . . . . . . . . . 34.3 p -55.31 -32.79 62.75 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 113.395 0.887 . . . . 0.0 113.395 -177.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -60.95 -19.74 61.26 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.097 1.359 . . . . 0.0 113.475 -179.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 48.3 mm-40 -92.0 -15.8 27.41 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.633 1.173 . . . . 0.0 113.342 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.4 t -79.8 124.06 83.56 Favored Pre-proline 0 N--CA 1.477 0.902 0 C-N-CA 124.132 0.973 . . . . 0.0 111.52 -168.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -80.99 167.63 17.96 Favored 'Trans proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.803 3.002 . . . . 0.0 112.706 178.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -151.69 166.52 31.02 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 125.654 1.582 . . . . 0.0 111.487 176.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -64.37 -14.69 16.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 125.561 1.545 . . . . 0.0 114.782 179.48 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 153.87 170.26 19.69 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.977 1.751 . . . . 0.0 112.782 -178.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ILE . . . . . . . . . . . . . 53.5 mt -124.82 115.91 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 C-N-CA 125.097 1.359 . . . . 0.0 108.716 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.7 m -151.01 150.87 28.58 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 126.56 1.944 . . . . 0.0 110.317 -175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -71.47 151.83 59.64 Favored 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.164 2.576 . . . . 0.0 111.057 175.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -72.98 149.14 46.42 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 123.314 2.676 . . . . 0.0 111.436 179.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -73.16 141.12 32.03 Favored 'Trans proline' 0 C--N 1.349 0.594 0 C-N-CA 123.482 2.788 . . . . 0.0 111.215 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 44.5 p -87.97 -5.31 58.6 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -179.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 80.16 -173.95 54.98 Favored Glycine 0 CA--C 1.542 1.726 0 C-N-CA 125.072 1.32 . . . . 0.0 113.839 -179.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -73.41 146.19 39.35 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 123.75 2.967 . . . . 0.0 111.299 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 81.9 p -144.84 9.14 1.3 Allowed 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -172.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' SER . . . . . . . . . . . . . 88.5 p -162.89 165.72 24.85 Favored 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 125.641 1.576 . . . . 0.0 112.011 -175.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.225 0 C-N-CA 124.998 1.285 . . . . 0.0 112.955 -179.088 . . . . . . . . 0 0 . 1 stop_ save_